Clustering O 0 3.3247292208216095e-07
of O 0 3.9573636034795356e-11
missense O 0 4.1281657559011364e-07
mutations O 0 5.2697917141131256e-08
in O 0 6.952563524897926e-10
the O 0 9.484290686145869e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 5.368215170165058e-06
in O 0 8.541610196921567e-10
a O 0 2.069752563782501e-10
sporadic B-Disease 0 0.00787348672747612
T I-Disease 1 0.9998194575309753
- I-Disease 0 0.00149678869638592
cell I-Disease 1 0.9691241979598999
leukaemia I-Disease 1 0.9999908208847046
. O 0 5.745385500688371e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.5485928654670715
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.761009650076307e-11
is O 0 1.2120854450334284e-12
a O 0 8.27266467134935e-12
recessive B-Disease 0 0.00032892372109927237
multi I-Disease 0 0.042810529470443726
- I-Disease 1 0.9999905824661255
system I-Disease 0 0.04586777836084366
disorder I-Disease 1 0.9999192953109741
caused O 0 1.4935390424408723e-10
by O 0 2.3530759589093786e-13
mutations O 0 3.3187097514542074e-10
in O 0 4.720180409728547e-12
the O 0 4.028597659459787e-13
ATM O 0 3.920419544556353e-09
gene O 0 2.971446977362291e-10
at O 0 6.359338056149966e-11
11q22 O 0 8.433764797644017e-09
- O 0 1.9837550269130588e-08
q23 O 0 9.41878326443657e-08
( O 0 1.3029735623781846e-10
ref O 0 1.8031872173196462e-07
. O 0 1.4480666015240229e-12
3 O 0 8.623170753840892e-12
) O 0 4.084072489918267e-12
. O 0 3.93625548822385e-11

The O 0 2.8788058048512255e-10
risk O 0 4.902380279503404e-09
of O 0 9.353523814856213e-13
cancer B-Disease 0 2.3990850195332314e-08
, O 0 9.874735577841687e-12
especially O 0 9.790628030525994e-11
lymphoid B-Disease 0 3.640655279468774e-07
neoplasias I-Disease 0 1.089263037101773e-06
, O 0 8.719610970764347e-12
is O 0 8.077788112882678e-13
substantially O 0 3.625366673531971e-09
elevated O 0 1.8913116905938665e-10
in O 0 1.95280880355142e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.4353698492050171
and O 0 1.9441004361908654e-10
has O 0 2.9215785606745426e-12
long O 0 8.732355658881696e-13
been O 0 7.748754437576777e-13
associated O 0 2.109563565499961e-11
with O 0 1.8229340259523497e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 3.660553193896021e-09

By O 0 1.094018625691362e-10
analysing O 0 9.153372104719892e-08
tumour B-Disease 1 0.9999997615814209
DNA O 0 6.13872064292309e-09
from O 0 4.250279815598557e-12
patients O 0 1.753024114758972e-11
with O 0 1.523650725986786e-13
sporadic B-Disease 0 7.3530577537894715e-06
T I-Disease 1 0.8102472424507141
- I-Disease 0 9.299435987486504e-06
cell I-Disease 0 0.25029706954956055
prolymphocytic I-Disease 1 0.6058104038238525
leukaemia I-Disease 1 0.9999901056289673
( O 0 1.0752680967840433e-09
T B-Disease 0 3.145538585158647e-06
- I-Disease 0 5.889225107580387e-08
PLL I-Disease 0 3.69418756918094e-07
) O 0 3.799505415152948e-12
, O 0 3.1414451660653764e-13
a O 0 6.866168332682332e-13
rare O 0 1.7979406852219881e-10
clonal B-Disease 0 1.4043954443820894e-08
malignancy I-Disease 0 2.2382975828350027e-07
with O 0 3.9076757780108495e-13
similarities O 0 5.130124797192437e-11
to O 0 7.042588625987001e-13
a O 0 8.175103649588067e-11
mature B-Disease 0 5.1735653983087104e-08
T I-Disease 0 2.4639200546516804e-06
- I-Disease 0 9.242352660976394e-08
cell I-Disease 0 0.0004931196453981102
leukaemia I-Disease 1 0.9999544620513916
seen O 0 7.813284241819929e-09
in O 0 2.0848243964532998e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999817609786987
T I-Disease 1 1.0
, O 0 5.736113840859591e-12
we O 0 1.2559628359033737e-13
demonstrate O 0 1.5375439636755583e-13
a O 0 4.863533620974581e-13
high O 0 1.422824618541041e-11
frequency O 0 2.285206052166089e-11
of O 0 1.5115744756138277e-13
ATM O 0 5.606508679534272e-08
mutations O 0 5.32871247127531e-10
in O 0 2.2850850378564047e-10
T B-Disease 0 3.061982715735212e-05
- I-Disease 0 2.4585702362855955e-07
PLL I-Disease 0 8.239167073043063e-06
. O 0 1.9952062224604106e-09

In O 0 1.6430057314664737e-10
marked O 0 1.5928376673191025e-11
contrast O 0 1.0520065721331129e-11
to O 0 1.3886472267216066e-13
the O 0 6.046014925688292e-13
ATM O 0 7.42198494663171e-07
mutation O 0 4.945768794506478e-10
pattern O 0 2.58846277745306e-09
in O 0 8.281628716133582e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.0413897175154396e-11
the O 0 3.463103352805037e-14
most O 0 3.434207332029225e-14
frequent O 0 9.39321320378439e-13
nucleotide O 0 9.939740003295228e-12
changes O 0 3.5189446842553984e-12
in O 0 3.354535616298393e-12
this O 0 7.699757498258464e-12
leukaemia B-Disease 0 7.324713351408718e-06
were O 0 2.670037524410418e-10
missense O 0 7.912445880720043e-07
mutations O 0 1.333454946461643e-07
. O 0 2.1195316612931947e-09

These O 0 1.6803258437447788e-11
clustered O 0 3.761917721778474e-10
in O 0 2.2348327615578922e-12
the O 0 4.7884852821204055e-14
region O 0 1.2172240212299235e-12
corresponding O 0 3.630431458928607e-13
to O 0 3.495503040663872e-13
the O 0 3.180579714531784e-13
kinase O 0 2.666415310770276e-09
domain O 0 1.2835407216249539e-11
, O 0 4.412640500391085e-13
which O 0 1.2244933257458956e-13
is O 0 6.417314731910553e-14
highly O 0 2.3454632333552716e-13
conserved O 0 4.2842015742297623e-13
in O 0 1.7534378896760794e-12
ATM O 0 5.5723372582860975e-09
- O 0 1.792850937154533e-11
related O 0 3.735351871564374e-12
proteins O 0 8.7733916269081e-13
in O 0 1.2350591035992231e-11
mouse O 0 8.810014939797384e-09
, O 0 1.095337622686321e-11
yeast O 0 5.917992318416054e-09
and O 0 1.6980946163092092e-11
Drosophila O 0 3.932610070922493e-10
. O 0 3.508979912192345e-11

The O 0 1.8028434647932023e-11
resulting O 0 3.221384964335883e-11
amino O 0 3.002794124462582e-10
- O 0 9.197079764433624e-10
acid O 0 1.7728426365826166e-11
substitutions O 0 1.2156746963254417e-11
are O 0 1.2800482516398676e-13
predicted O 0 1.8941842885866755e-11
to O 0 1.8154953180995331e-13
interfere O 0 3.6065778141747273e-10
with O 0 3.889838104398358e-12
ATP O 0 3.4130520631947547e-09
binding O 0 1.4475820542259044e-10
or O 0 1.3667084131085971e-10
substrate O 0 6.089404092080031e-09
recognition O 0 4.669805098167501e-10
. O 0 9.10013120414277e-10

Two O 0 9.345971219154592e-11
of O 0 9.672180591169255e-13
seventeen O 0 1.2855291275926106e-09
mutated O 0 1.3229995943220274e-07
T B-Disease 0 1.5138092521738145e-06
- I-Disease 0 1.641823210718485e-08
PLL I-Disease 0 7.129388279736304e-08
samples O 0 5.250183066074499e-10
had O 0 9.072950724053896e-11
a O 0 9.928404669581892e-13
previously O 0 3.7012837239558394e-11
reported O 0 5.421190053311875e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 1.641182097955607e-05
. O 0 2.0642074716192838e-08

In O 0 1.674155813979894e-10
contrast O 0 2.4363643047475847e-11
, O 0 9.007866067639592e-13
no O 0 1.3765254127523496e-12
mutations O 0 3.4616493699290984e-11
were O 0 3.338286938547874e-11
detected O 0 9.344479634521008e-10
in O 0 1.1887754235856418e-12
the O 0 3.567817631502761e-14
p53 O 0 5.802179483399561e-12
gene O 0 4.10986938925717e-11
, O 0 2.6353653417507394e-13
suggesting O 0 3.274811671838407e-11
that O 0 9.775037767070782e-13
this O 0 7.057441436808531e-11
tumour B-Disease 1 1.0
suppressor O 0 1.1076764394601923e-07
is O 0 7.947978213074247e-12
not O 0 1.2961336648062427e-12
frequently O 0 1.1056226247030398e-11
altered O 0 2.3089417044985794e-09
in O 0 9.436935677342717e-10
this O 0 1.3843870494412158e-09
leukaemia B-Disease 0 0.014056692831218243
. O 0 6.356551396358157e-10

Occasional O 0 1.617064981473959e-06
missense O 0 2.0691779354820028e-05
mutations O 0 6.72185791472657e-08
in O 0 4.731901676047201e-11
ATM O 0 4.7566461880421684e-09
were O 0 8.711465576682897e-12
also O 0 3.6883834203006727e-13
found O 0 5.8403525071693e-12
in O 0 8.494587672158715e-11
tumour B-Disease 1 1.0
DNA O 0 1.5482413129319639e-09
from O 0 1.2320304281984717e-12
patients O 0 7.72616432637152e-12
with O 0 1.3580300349969737e-13
B B-Disease 0 1.5053383606300486e-07
- I-Disease 0 5.6535505166266375e-09
cell I-Disease 0 0.00015707248530816287
non I-Disease 1 0.9997695088386536
- I-Disease 1 0.999997615814209
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9998151659965515
( O 0 5.951869552767164e-10
B B-Disease 0 1.3419564481864654e-07
- I-Disease 0 3.1172422421121837e-09
NHL I-Disease 0 1.1066696170569656e-10
) O 0 2.2245610030707103e-13
and O 0 3.655215236389453e-13
a O 0 1.6444689360239906e-11
B B-Disease 0 5.608850415228517e-07
- I-Disease 0 2.3884729749568123e-09
NHL I-Disease 0 9.68981117566159e-10
cell O 0 8.400328255220302e-08
line O 0 7.9534068220255e-08
. O 0 7.247346056615811e-10

The O 0 2.0723615965639874e-12
evidence O 0 2.57730555647262e-12
of O 0 3.931685113248021e-15
a O 0 1.5786479653882857e-13
significant O 0 1.6646018331095691e-12
proportion O 0 1.3322828951167764e-11
of O 0 1.4636940747977945e-13
loss O 0 2.122593212305901e-10
- O 0 5.275838099727537e-11
of O 0 5.236054103317789e-13
- O 0 3.6858993635036086e-10
function O 0 3.5051054940449244e-12
mutations O 0 2.865109711980285e-11
and O 0 2.4991827184128734e-12
a O 0 3.174369404487787e-12
complete O 0 1.2432580138999061e-11
absence O 0 1.0188756956186484e-11
of O 0 3.130251125917972e-15
the O 0 5.6002179618912934e-14
normal O 0 1.608898431149086e-11
copy O 0 3.608077725480996e-10
of O 0 1.5432967404027664e-13
ATM O 0 4.840407186179618e-09
in O 0 5.200157145168749e-12
the O 0 1.4226494331540107e-13
majority O 0 1.2275385785978643e-12
of O 0 5.077767633449026e-12
mutated O 0 0.16332349181175232
tumours B-Disease 1 1.0
establishes O 0 2.3923680814164072e-08
somatic O 0 3.343919274811924e-08
inactivation O 0 1.0447993581408355e-08
of O 0 1.0929970172207995e-13
this O 0 7.103102421567378e-14
gene O 0 3.6578413908916474e-11
in O 0 3.732873385398072e-12
the O 0 1.2533932225444744e-12
pathogenesis O 0 5.271424963204652e-10
of O 0 2.894371482937974e-13
sporadic B-Disease 0 1.2916565310661099e-06
T I-Disease 0 0.003885439829900861
- I-Disease 0 1.2054649687343044e-06
PLL I-Disease 0 5.872836368325807e-07
and O 0 1.7929843373898358e-11
suggests O 0 1.2360772128072739e-11
that O 0 9.286058114945858e-14
ATM O 0 1.969397978029974e-09
acts O 0 1.413511495351738e-11
as O 0 2.3404870055920846e-11
a O 0 2.0133263944899227e-09
tumour B-Disease 1 1.0
suppressor O 0 2.8616300369321834e-06
. O 0 8.122124639520223e-10

As O 0 8.413351959557502e-11
constitutional O 0 5.251900043329316e-12
DNA O 0 1.5348185222752164e-10
was O 0 7.313269781428211e-12
not O 0 1.7585135821465703e-14
available O 0 9.985981768052821e-14
, O 0 1.8118275299126504e-14
a O 0 2.578333380132136e-12
putative O 0 3.7342484660030095e-08
hereditary O 0 0.00019720004638656974
predisposition O 0 4.938110009788943e-07
to O 0 9.970168024509007e-10
T B-Disease 0 0.0010146672138944268
- I-Disease 0 1.1005643045791658e-06
PLL I-Disease 0 1.1826758736788179e-06
will O 0 1.971993228433444e-11
require O 0 9.371260711876772e-12
further O 0 6.0543731486562e-12
investigation O 0 7.55103618521602e-11
. O 0 2.825308997173037e-12
. O 0 1.42618824736096e-11

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 7.689909580221865e-06
kinase O 0 3.7544174347203807e-07
is O 0 3.285840349809277e-12
involved O 0 3.3336004854993273e-13
in O 0 1.2212232364684078e-13
the O 0 3.02701487736156e-14
modulation O 0 9.910510780086756e-12
of O 0 2.637813063680397e-14
the O 0 1.2875515540897164e-12
Ca2 O 0 8.081996405451264e-09
+ O 0 8.943821683260467e-09
homeostasis O 0 2.613756500124964e-08
in O 0 3.099636519676707e-11
skeletal O 0 3.010329976405046e-07
muscle O 0 2.771788487621052e-08
cells O 0 1.122303050493656e-08
. O 0 3.530349901303964e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9991559982299805
DM B-Disease 1 1.0
) O 0 2.618404382204176e-10
, O 0 4.2412403341955673e-13
the O 0 1.7485934710815068e-14
most O 0 6.48291533303369e-13
prevalent O 0 2.8955946618225425e-07
muscular B-Disease 0 0.002808245597407222
disorder I-Disease 0 0.019062520936131477
in O 0 3.641336884796509e-11
adults O 0 1.0154568741427283e-08
, O 0 2.502216316091488e-12
is O 0 9.314338579938242e-13
caused O 0 8.792560429737861e-12
by O 0 3.1729211814358893e-13
( O 0 1.031412889124228e-11
CTG O 0 9.822416657812028e-09
) O 0 1.8858237454261184e-12
n O 0 2.060665110770188e-10
- O 0 2.2850514813654854e-09
repeat O 0 5.657171953110662e-10
expansion O 0 1.1025207656556457e-11
in O 0 1.0537089863843496e-12
a O 0 2.1112479169430043e-13
gene O 0 2.781529173656594e-11
encoding O 0 1.2003641136626442e-11
a O 0 2.5435213830971026e-12
protein O 0 1.5537229280937481e-09
kinase O 0 5.933580951023032e-07
( O 0 1.955824391330907e-09
DM B-Disease 1 1.0
protein O 0 1.8300216453326357e-08
kinase O 0 5.737449271236983e-08
; O 0 1.572834050500571e-11
DMPK O 0 3.990673125287003e-09
) O 0 2.0327194246404223e-13
and O 0 6.89987821110398e-14
involves O 0 2.628372779839294e-13
changes O 0 8.616671829178579e-13
in O 0 1.604461181969885e-11
cytoarchitecture O 0 3.952986560307181e-08
and O 0 2.37209019787743e-11
ion O 0 1.1358307627773456e-09
homeostasis O 0 7.217665398684403e-08
. O 0 1.9298067310824507e-10

To O 0 1.3836068575578953e-11
obtain O 0 3.812014245929696e-11
clues O 0 6.334547886233111e-10
to O 0 3.836745916634132e-13
the O 0 1.0292796752712705e-13
normal O 0 7.540698100660936e-12
biological O 0 2.6772774969208157e-11
role O 0 3.794580968885519e-12
of O 0 1.7001246872989928e-13
DMPK O 0 8.090371039770616e-09
in O 0 1.2933856242958175e-11
cellular O 0 6.175855382650752e-09
ion O 0 6.778035910315339e-10
homeostasis O 0 5.323645968502433e-09
, O 0 1.2526762396478097e-12
we O 0 4.878305333473609e-13
have O 0 6.977896721809679e-14
compared O 0 1.383756607561959e-12
the O 0 1.1413053390817857e-13
resting O 0 1.6670810565333483e-11
[ O 0 6.26163747588504e-12
Ca2 O 0 1.3054909930865222e-10
+ O 0 1.1476773975616084e-09
] O 0 1.4828640537700721e-09
i O 0 7.919798150624047e-09
, O 0 3.888016753168799e-14
the O 0 8.729248809793803e-15
amplitude O 0 3.8383342728168235e-13
and O 0 4.082130683827345e-13
shape O 0 2.7266265634207087e-11
of O 0 8.222803406059132e-14
depolarization O 0 1.1081038864269033e-10
- O 0 2.655482944646792e-09
induced O 0 1.649327785457899e-08
Ca2 O 0 1.349363110136892e-08
+ O 0 4.88622120542459e-09
transients O 0 7.997369522172448e-08
, O 0 1.1000457272522524e-12
and O 0 3.717763469583864e-14
the O 0 5.1918740506351306e-15
content O 0 1.0160805573658505e-12
of O 0 1.5410077185661064e-14
ATP O 0 5.357492227631155e-10
- O 0 2.47144370940644e-11
driven O 0 5.96687005360863e-11
ion O 0 5.7551192977900456e-11
pumps O 0 9.858147631547354e-10
in O 0 3.017133765048641e-11
cultured O 0 4.982415475751623e-07
skeletal O 0 7.945043307699962e-07
muscle O 0 2.1616406442603875e-09
cells O 0 6.517524714366729e-11
of O 0 1.1971276563365468e-13
wild O 0 3.695484890320344e-11
- O 0 5.820166126824233e-09
type O 0 1.0444431097766937e-07
and O 0 2.873857263274715e-10
DMPK O 0 1.4824271943325584e-07
[ O 0 5.649914425198688e-10
- O 0 1.0008240458603268e-08
/ O 0 5.707585728487174e-07
- O 0 1.8168515225625015e-07
] O 0 1.2216387013097574e-08
knockout O 0 1.564655008223781e-06
mice O 0 5.549225079448661e-06
. O 0 1.4286837268784325e-09

In O 0 6.994581025487889e-10
vitro O 0 1.9333755574280076e-07
- O 0 1.2796466819509078e-07
differentiated O 0 3.673725501585068e-08
DMPK O 0 4.2879077000179677e-07
[ O 0 1.1327887516898727e-09
- O 0 5.381151968464337e-09
/ O 0 4.592599722741397e-08
- O 0 6.688335663085354e-09
] O 0 1.0127769456413915e-10
myotubes O 0 2.2253623943591094e-10
exhibit O 0 1.2905658529696606e-12
a O 0 4.4956169863163975e-12
higher O 0 1.3747347704651247e-10
resting O 0 5.3017430723389936e-11
[ O 0 1.5889355803322402e-11
Ca2 O 0 3.987490615475764e-10
+ O 0 2.8592823664297384e-09
] O 0 1.4390213465276247e-09
i O 0 4.6039264067765373e-10
than O 0 2.541536588390042e-13
do O 0 8.961664418362381e-13
wild O 0 2.101458330266981e-12
- O 0 1.152891948574819e-10
type O 0 2.834845913568529e-09
myotubes O 0 1.2430583673506135e-08
because O 0 3.0122618809025337e-12
of O 0 7.881859261668709e-15
an O 0 6.366075337238888e-14
altered O 0 1.4610743170884177e-10
open O 0 7.442736010832007e-11
probability O 0 1.4026338684275386e-12
of O 0 1.522613551083532e-13
voltage O 0 6.843899336139714e-10
- O 0 1.0046870002611286e-09
dependent O 0 4.893738747568932e-09
l O 0 1.4288098704184904e-08
- O 0 5.462721386351177e-10
type O 0 8.585389288384704e-09
Ca2 O 0 4.8843484812266524e-09
+ O 0 1.8689823022555174e-09
and O 0 6.307490640899971e-11
Na O 0 5.006733694301602e-09
+ O 0 6.803188568049734e-10
channels O 0 7.323609718667967e-09
. O 0 1.122683612742037e-09

The O 0 1.3179479729785726e-10
mutant O 0 1.1011753286993553e-08
myotubes O 0 1.841506502842094e-08
exhibit O 0 6.161518517622255e-11
smaller O 0 1.5631210215083513e-10
and O 0 1.1019557488722853e-10
slower O 0 3.2554236639725787e-08
Ca2 O 0 1.8490938780146848e-09
+ O 0 2.652738029240709e-10
responses O 0 1.1054391776954553e-11
upon O 0 1.1152583305647223e-13
triggering O 0 1.4582394319839764e-11
by O 0 1.8986242157452426e-13
acetylcholine O 0 6.4635314878103145e-09
or O 0 6.401056351634793e-10
high O 0 1.076080557993464e-09
external O 0 1.2767280566094996e-08
K O 0 6.271651642464349e-09
+ O 0 3.1788276455557707e-09
. O 0 1.7285350928375465e-10

In O 0 1.5215620430275578e-10
addition O 0 1.990820269054394e-12
, O 0 1.0814120866148302e-12
we O 0 1.5574374472374086e-13
observed O 0 3.167314365426152e-14
that O 0 7.541377427860898e-15
these O 0 2.912056582199743e-14
Ca2 O 0 2.4462418202197966e-10
+ O 0 3.818951821443761e-10
transients O 0 2.89055424040896e-09
partially O 0 2.3254659309301928e-10
result O 0 1.3957832285804717e-12
from O 0 9.62825807038388e-14
an O 0 6.127028070557032e-15
influx O 0 5.807180908021237e-13
of O 0 4.511253770176325e-14
extracellular O 0 1.3148641030136243e-11
Ca2 O 0 5.476750997157609e-11
+ O 0 2.3068089105571232e-11
through O 0 6.867359870869894e-13
the O 0 1.229844676618741e-12
l O 0 1.0426070007341082e-09
- O 0 1.1696321688958733e-10
type O 0 2.8736559798403505e-09
Ca2 O 0 5.090692756226645e-09
+ O 0 4.329802738567423e-09
channel O 0 8.265314477284846e-08
. O 0 2.0217036933445343e-09

Neither O 0 4.553894594749863e-09
the O 0 9.862815859157381e-13
content O 0 1.1180581634129272e-11
nor O 0 6.488921205916043e-11
the O 0 1.693968316313077e-13
activity O 0 3.974072460000144e-11
of O 0 9.218610575421893e-14
Na O 0 2.229157081146127e-09
+ O 0 9.326939220954955e-10
/ O 0 1.1723173543032317e-09
K O 0 3.67241181908895e-10
+ O 0 7.124053014173626e-10
ATPase O 0 2.64463722032815e-08
and O 0 9.960089003557826e-11
sarcoplasmic O 0 3.3198404025824857e-07
reticulum O 0 4.914591613669472e-07
Ca2 O 0 1.492701073857461e-07
+ O 0 4.143974408066242e-08
- O 0 4.9895643172703785e-09
ATPase O 0 4.243581486207404e-08
are O 0 1.8745604027370355e-11
affected O 0 3.451831875889155e-11
by O 0 1.9442763371513294e-12
DMPK O 0 6.928251536919561e-07
absence O 0 9.342839835113637e-10
. O 0 4.6971197764644756e-11

In O 0 4.2470590932985886e-10
conclusion O 0 6.139908720337317e-11
, O 0 2.9052010363378455e-13
our O 0 2.6599270610541334e-14
data O 0 3.2888169726637273e-13
suggest O 0 4.807348638093123e-13
that O 0 2.1360165155734356e-13
DMPK O 0 1.1402528699022696e-08
is O 0 1.3873076949375007e-13
involved O 0 5.399092089207469e-13
in O 0 1.1767288532471554e-12
modulating O 0 1.1197575505716983e-10
the O 0 2.723941948737374e-13
initial O 0 1.2961410373810156e-12
events O 0 6.838614012094971e-14
of O 0 3.761314515599891e-14
excitation O 0 1.7796134565983834e-09
- O 0 5.225970198807772e-07
contraction O 0 4.1556017293942205e-08
coupling O 0 4.4573447710583025e-10
in O 0 3.38651363895881e-11
skeletal O 0 2.0602669792424422e-07
muscle O 0 9.90812498713467e-09
. O 0 1.5661702837399538e-11
. O 0 5.883759451874582e-11

Constitutional O 0 6.41174224824681e-08
RB1 O 0 4.356595309218392e-05
- O 0 2.504786209556187e-07
gene O 0 3.6681523596371335e-08
mutations O 0 1.6303333794098762e-08
in O 0 1.3043535695977937e-10
patients O 0 8.488048597321551e-10
with O 0 9.181327573215547e-13
isolated O 0 4.1296534192269974e-08
unilateral B-Disease 0 7.379387625405798e-06
retinoblastoma I-Disease 0 0.0006763715064153075
. O 0 1.505765645504198e-08

In O 0 5.339028663620127e-10
most O 0 2.3327503123615756e-11
patients O 0 4.039157897040013e-11
with O 0 1.238775927539862e-13
isolated O 0 3.380044910628044e-09
unilateral B-Disease 0 3.523922771364596e-07
retinoblastoma I-Disease 0 7.019668555585667e-05
, O 0 2.5925231406098703e-10
tumor B-Disease 0 5.6397220227211164e-09
development O 0 6.076898532991759e-12
is O 0 5.624305817082675e-13
initiated O 0 3.098960974987075e-12
by O 0 3.022683286394573e-13
somatic O 0 1.195022081290631e-09
inactivation O 0 1.9817536500710276e-09
of O 0 2.1516476615820665e-14
both O 0 1.7700770048919429e-13
alleles O 0 3.204452675431568e-11
of O 0 4.4464350821074583e-13
the O 0 3.6153777888126015e-11
RB1 O 0 2.543527273246582e-07
gene O 0 2.198066795244813e-08
. O 0 1.763623580508522e-09

However O 0 6.478301783907625e-10
, O 0 9.116517219950881e-13
some O 0 1.8161143636587045e-14
of O 0 1.54171537224189e-15
these O 0 3.597487840392363e-14
patients O 0 1.9814859388705974e-12
can O 0 3.253608862364976e-13
transmit O 0 2.1497785773760825e-09
retinoblastoma B-Disease 0 1.7246135257664719e-06
predisposition O 0 2.6439067823957885e-06
to O 0 1.0379398035498255e-10
their O 0 2.9726131278717816e-11
offspring O 0 1.6697399018994474e-09
. O 0 1.7448155420485278e-10

To O 0 2.5087213556540533e-11
determine O 0 7.973197622967998e-12
the O 0 2.6716381385828714e-13
frequency O 0 5.5247511426825824e-11
and O 0 2.4183207519845595e-12
nature O 0 6.366199884963453e-13
of O 0 6.140051710340835e-14
constitutional O 0 7.507493932079612e-11
RB1 O 0 2.5434641770516464e-07
- O 0 4.753578641825129e-10
gene O 0 2.1830037777448297e-09
mutations O 0 2.4041502122429392e-09
in O 0 3.2041352210354646e-11
patients O 0 3.1013291934556264e-10
with O 0 1.3716603536589184e-13
isolated O 0 1.0406679962216003e-09
unilateral B-Disease 0 5.674154834878209e-08
retinoblastoma I-Disease 0 1.1823183285741834e-06
, O 0 2.5033345188441025e-11
we O 0 3.059690630198564e-13
analyzed O 0 1.0160359966565613e-12
DNA O 0 2.0985834597864184e-11
from O 0 4.698888847465277e-13
peripheral O 0 9.081200680327584e-09
blood O 0 8.003098739273184e-10
and O 0 1.4221246576184843e-11
from O 0 1.51863591146828e-11
tumor B-Disease 0 6.83597320971785e-08
tissue O 0 3.3177136060658086e-07
. O 0 3.305336282455329e-10

The O 0 2.937476997755262e-11
analysis O 0 5.2589595872509776e-11
of O 0 2.2729550446659585e-12
tumors B-Disease 1 1.0
from O 0 1.420511711730521e-11
54 O 0 6.662469881346667e-11
( O 0 2.5457053999533574e-12
71 O 0 1.2896542167517566e-10
% O 0 1.2435444384298333e-12
) O 0 1.268714002128704e-13
of O 0 4.3463317119614084e-14
76 O 0 1.5906920225461363e-10
informative O 0 9.1076888253383e-09
patients O 0 1.2739188548493985e-07
showed O 0 3.214926280747932e-08
loss O 0 7.22367776706534e-10
of O 0 3.2744521070299237e-13
constitutional O 0 2.8628441284261896e-10
heterozygosity O 0 2.103397036989918e-06
( O 0 1.0570365027717799e-08
LOH O 1 0.999995231628418
) O 0 7.448572314494584e-11
at O 0 3.5504732487368074e-10
intragenic O 0 9.364220687757552e-08
loci O 0 1.5417532139849754e-08
. O 0 1.3387391195607279e-09

Three O 0 1.9922125060745088e-10
of O 0 2.1218866507605183e-12
13 O 0 2.9172313870118316e-11
uninformative O 0 3.4577320207063167e-07
patients O 0 1.2205700272716058e-07
had O 0 5.755912413363262e-10
constitutional O 0 9.427900821146196e-11
deletions O 0 6.69161721589262e-08
. O 0 9.952839663540658e-10

For O 0 4.2695225827005245e-11
39 O 0 1.5497945982101413e-10
randomly O 0 3.2578970771135474e-11
selected O 0 1.5524158347712813e-10
tumors B-Disease 1 1.0
, O 0 4.871234665637658e-11
SSCP O 0 9.44324725082879e-08
, O 0 5.587505718523955e-12
hetero O 0 1.7195407053804956e-07
- O 0 6.199172841725442e-10
duplex O 0 2.4299080081391367e-08
analysis O 0 1.0069535483214764e-11
, O 0 8.866076818027369e-14
sequencing O 0 1.0090757439698561e-12
, O 0 1.5950493692778317e-13
and O 0 6.692389697970924e-14
Southern O 0 2.6647284639275126e-12
blot O 0 4.328434144440507e-08
analysis O 0 1.155127729579597e-11
were O 0 1.5463619967848174e-12
used O 0 4.620642518778084e-13
to O 0 3.877339801224705e-13
identify O 0 3.7721709089666433e-10
mutations O 0 2.4939958986891497e-09
. O 0 2.8522434414313125e-10

Mutations O 0 8.442105325912053e-08
were O 0 2.0072556117245455e-10
detected O 0 1.1531741117565275e-09
in O 0 5.799612526335984e-12
21 O 0 4.6254597374506545e-12
( O 0 6.159549866685543e-13
91 O 0 9.268160891529043e-12
% O 0 1.1276736922721797e-12
) O 0 2.7591224118807267e-13
of O 0 1.0705290820478552e-12
23 O 0 7.235087906565241e-08
tumors B-Disease 1 1.0
with O 0 1.7727067813666508e-08
LOH O 1 0.9999991655349731
. O 0 1.9093848724338613e-09

In O 0 4.642292661394265e-10
6 O 0 4.1672318373819905e-11
( O 0 2.6849624953917406e-12
38 O 0 7.361776119263475e-12
% O 0 2.333112815357946e-13
) O 0 1.2976715513778048e-13
of O 0 6.5620584324428e-14
16 O 0 2.9738751461394486e-09
tumors B-Disease 1 1.0
without O 0 2.3510844382457208e-09
LOH O 1 0.9977231621742249
, O 0 5.857473252095236e-13
one O 0 4.236324561545518e-13
mutation O 0 3.7120015394798145e-11
was O 0 6.331911384105382e-11
detected O 0 5.224489729727111e-10
, O 0 8.142757843866699e-13
and O 0 6.886707458637897e-13
in O 0 2.475953036346068e-12
9 O 0 7.622691540476456e-12
( O 0 8.441504873585304e-13
56 O 0 1.1415568143546828e-11
% O 0 3.537057528379267e-13
) O 0 1.053005203649135e-13
of O 0 4.136183854187153e-14
the O 0 1.0610774758834651e-10
tumors B-Disease 1 1.0
without O 0 9.00159857764038e-09
LOH O 1 0.999966025352478
, O 0 1.2922062508566312e-12
both O 0 4.144240560530893e-13
mutations O 0 4.4042977598302e-10
were O 0 2.792832631826059e-10
found O 0 5.941865333092267e-10
. O 0 6.541960029249339e-11

Thus O 0 9.189798227948742e-11
, O 0 1.5585228420322839e-12
a O 0 2.242089706169098e-13
total O 0 1.6884805592544058e-14
of O 0 1.3919985295180771e-14
45 O 0 1.2412008270137886e-12
mutations O 0 1.2163750909288673e-11
were O 0 9.491116226278962e-12
identified O 0 4.5168593865163587e-10
in O 0 1.1020503259961956e-10
tumors B-Disease 1 1.0
of O 0 3.5038087882466318e-12
36 O 0 5.964359006682685e-10
patients O 0 4.058143154850313e-09
. O 0 1.2439203833647383e-10

Thirty O 0 8.174912835556825e-08
- O 0 2.6248773821180293e-08
nine O 0 4.308856049739518e-11
of O 0 3.597691551816178e-15
the O 0 3.7462434277759846e-14
mutations O 0 4.2743298483971515e-11
- O 0 8.75641052722198e-12
including O 0 2.1509390676997114e-13
34 O 0 4.210356455841557e-12
small O 0 2.1649715440524853e-12
mutations O 0 6.702622346033138e-10
, O 0 1.1492485565631205e-12
2 O 0 4.3450967379243116e-14
large O 0 3.54716473208172e-13
structural O 0 6.900897915329551e-07
alterations O 0 6.1709638430329505e-06
, O 0 6.2313162442484415e-12
and O 0 5.1008611397229675e-12
hypermethylation O 0 4.6322583102664794e-08
in O 0 1.9219678626392067e-10
3 O 0 1.0611892475864693e-09
tumors O 1 1.0
- O 0 1.2180927377869466e-08
were O 0 7.526060330498296e-11
not O 0 1.981039898096837e-12
detected O 0 1.405112137753406e-10
in O 0 6.761717379587251e-13
the O 0 7.657511235346914e-14
corresponding O 0 2.1544179201055114e-12
peripheral O 0 4.368549966216051e-09
blood O 0 9.756685459549885e-10
DNA O 0 1.9430459019531554e-08
. O 0 3.374529267130555e-10

In O 0 3.393052228073401e-10
6 O 0 5.3629285040601715e-11
( O 0 3.3614274558280144e-12
17 O 0 1.1472992694772088e-12
% O 0 5.573215906785542e-14
) O 0 3.96362545513956e-15
of O 0 9.68135682942971e-16
the O 0 6.163166900658226e-14
36 O 0 8.97122914150783e-12
patients O 0 1.1167538248313402e-11
, O 0 3.407014186290573e-14
a O 0 1.044787303547401e-12
mutation O 0 9.28849983039548e-11
was O 0 1.7097140370125885e-10
detected O 0 2.2863842763509723e-10
in O 0 1.0358107600805244e-12
constitutional O 0 5.118176932619733e-13
DNA O 0 4.996626029596385e-11
, O 0 1.7238898568187888e-13
and O 0 3.5630791936705486e-13
1 O 0 1.6107238156107262e-13
of O 0 5.35788742609929e-15
these O 0 5.912868935795124e-13
mutations O 0 1.9808521142805624e-11
is O 0 9.93499106225447e-14
known O 0 1.287745517858374e-12
to O 0 6.155802863977433e-13
be O 0 5.136604249583732e-12
associated O 0 3.099447434817826e-11
with O 0 3.1929810358211075e-12
reduced O 0 2.0068315897958655e-09
expressivity O 0 2.4588797487012926e-07
. O 0 5.866080399208329e-10

The O 0 1.6982459275644013e-12
presence O 0 1.360488327897813e-12
of O 0 1.0831366897411532e-14
a O 0 1.1249668731283524e-12
constitutional O 0 3.3643524164489458e-12
mutation O 0 4.479689882930238e-11
was O 0 2.369175133853929e-10
not O 0 2.2712853733203309e-13
associated O 0 2.1741278482395598e-13
with O 0 2.4763897597574087e-14
an O 0 2.576891337032622e-13
early O 0 9.625161112580827e-09
age O 0 1.2066474208705102e-10
at O 0 9.3241378160136e-12
treatment O 0 9.599538525195683e-11
. O 0 2.433860751827055e-11

In O 0 1.114486503084322e-09
1 O 0 1.8420069636260195e-10
patient O 0 4.4254275799460174e-09
, O 0 1.6533971457580177e-12
somatic O 0 3.280053340048994e-09
mosaicism O 0 2.794186855226144e-07
was O 0 2.80632073135223e-10
demonstrated O 0 5.178350153192679e-13
by O 0 3.253009916897643e-15
molecular O 0 3.777759626389515e-13
analysis O 0 3.4462366228955876e-13
of O 0 1.7054113926173037e-14
DNA O 0 9.501971431902234e-11
and O 0 3.9183483931462537e-13
RNA O 0 2.5099097800129755e-10
from O 0 4.406797409622909e-12
peripheral O 0 2.0795054922473355e-07
blood O 0 3.150952565533771e-08
. O 0 1.110052716413179e-09

In O 0 1.340520028314529e-09
2 O 0 1.0360608204695865e-10
patients O 0 8.765940057164912e-11
without O 0 1.5599921528164362e-12
a O 0 6.924195591895277e-12
detectable O 0 9.545525614385042e-08
mutation O 0 2.9109310517583253e-09
in O 0 5.2148601409340856e-11
peripheral O 0 1.0682977062970167e-06
blood O 0 3.637593692928931e-08
, O 0 3.226002451284238e-11
mosaicism O 0 7.050280004250453e-08
was O 0 9.590447325180662e-10
suggested O 0 3.986173197079168e-11
because O 0 3.516368186212704e-12
1 O 0 1.3279281103548146e-13
of O 0 7.786525703455238e-15
the O 0 1.2208279092512653e-12
patients O 0 8.960242547928488e-10
showed O 0 2.8139455210407505e-08
multifocal O 1 0.9993849992752075
tumors B-Disease 1 1.0
and O 0 2.6559083821098284e-09
the O 0 3.9942745291843273e-13
other O 0 3.5191643978256526e-13
later O 0 3.0799883476984036e-11
developed O 0 2.1098019165055604e-10
bilateral B-Disease 0 2.4482094573841096e-08
retinoblastoma I-Disease 0 2.8752970138157252e-06
. O 0 3.860081143614025e-09

In O 0 4.4686068734201e-10
conclusion O 0 1.5283704857260716e-11
, O 0 1.497364515365418e-13
our O 0 3.384565102682903e-14
results O 0 2.3293064525808926e-13
emphasize O 0 5.629135395660012e-13
that O 0 3.45572637346081e-14
the O 0 4.5186168581802175e-14
manifestation O 0 3.486377853079148e-11
and O 0 2.3113130333263232e-12
transmissibility O 0 2.2149071465804582e-10
of O 0 1.5040791149448923e-14
retinoblastoma B-Disease 0 1.4519178914706998e-10
depend O 0 5.67464087872227e-12
on O 0 1.7781178005688014e-12
the O 0 1.9368643313006674e-14
nature O 0 7.006985188471107e-14
of O 0 1.7033363524789438e-15
the O 0 2.3882300623874128e-14
first O 0 1.0671388902747103e-12
mutation O 0 8.800776947481825e-13
, O 0 2.7732239857932058e-14
its O 0 7.332253463513284e-15
time O 0 3.151136578234681e-13
in O 0 3.4271224096452113e-13
development O 0 1.7905527050204179e-13
, O 0 1.9308236650153465e-13
and O 0 1.831116909576519e-13
the O 0 6.694402925879958e-15
number O 0 1.2884327936155127e-13
and O 0 2.942363692103045e-13
types O 0 6.861795745320698e-13
of O 0 2.2293542947565866e-15
cells O 0 1.851141418970914e-12
that O 0 5.288637908683336e-13
are O 0 6.911340531996768e-13
affected O 0 1.4617035012931545e-11
. O 0 6.538161396833775e-13
. O 0 2.6467425473519768e-11

Hereditary B-Disease 1 0.999998927116394
deficiency I-Disease 1 0.9999947547912598
of I-Disease 0 1.5084474468129994e-12
the I-Disease 0 1.5540821667742177e-12
fifth I-Disease 0 3.478148671853809e-11
component I-Disease 0 2.4184373254021452e-11
of I-Disease 0 7.508684836008903e-14
complement I-Disease 0 1.036525310027514e-10
in O 0 2.020813294478785e-09
man O 0 7.726111448391748e-07
. O 0 2.07937972396266e-10

I O 0 0.0028057070448994637
. O 0 1.968500473736867e-09

Clinical O 0 7.506529868805956e-07
, O 0 5.552558413057795e-10
immunochemical O 0 2.1633684355037985e-07
, O 0 5.147384948833711e-11
and O 0 9.170480347320265e-12
family O 0 1.6080026199460917e-11
studies O 0 4.765931746475438e-11
. O 0 3.909737464335983e-11

The O 0 4.1666652766947365e-12
first O 0 4.657522739877351e-13
recognized O 0 2.869558703069014e-13
human O 0 1.7374313793228069e-12
kindred O 0 3.478025973890908e-06
with O 0 2.608570470741256e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9989909529685974
of I-Disease 0 3.1705494891835773e-13
the I-Disease 0 7.967478131247485e-13
fifth I-Disease 0 3.7668486385644684e-11
component I-Disease 0 1.2651727755719211e-11
of I-Disease 0 3.6195950615025216e-14
complement I-Disease 0 5.007180226002106e-10
( O 0 2.2477882055671472e-10
C5 O 0 2.5526976088485753e-08
) O 0 3.2439688955887558e-12
is O 0 2.0759615814575083e-12
described O 0 3.9649358796189915e-10
. O 0 1.290658274699652e-10

The O 0 7.153187070452205e-11
proband O 0 4.329738700903363e-08
, O 0 2.3885787011485027e-12
a O 0 2.8194089857908056e-12
20 O 0 1.3206499262230498e-11
- O 0 2.2601910620867471e-10
year O 0 2.7259261514700484e-10
- O 0 2.868130843936001e-09
old O 0 8.381362448517393e-08
black O 0 2.715319635804292e-10
female O 0 3.6716135687342444e-10
with O 0 2.7175420247438353e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 0.9999997615814209
erythematosus I-Disease 1 1.0
since O 0 8.242515114886828e-09
age O 0 3.5938483300412827e-09
11 O 0 3.645136276153593e-12
, O 0 2.1916480132458394e-13
lacked O 0 3.0123742389420727e-10
serum O 0 5.818709403193623e-10
hemolytic O 0 6.775986349794039e-08
complement O 0 1.1614844502849664e-10
activity O 0 1.2597374698941621e-08
, O 0 6.953789540714572e-12
even O 0 1.3173592425252956e-11
during O 0 1.6952669823488975e-10
remission O 0 9.67295576970173e-09
. O 0 5.850389617201301e-11

C5 O 0 2.3997521566343494e-05
was O 0 1.5019335108945597e-08
undetectable O 0 2.2883062555933975e-08
in O 0 1.3562296251323769e-11
her O 0 5.7149385050692114e-12
serum O 0 9.575997980681983e-12
by O 0 1.0361264119905164e-13
both O 0 4.747122400033943e-12
immunodiffusion O 0 3.459291519902763e-08
and O 0 4.42476437434447e-11
hemolytic O 0 7.424597470162553e-07
assays O 0 3.0247272775341116e-07
. O 0 1.4307943718705474e-09

Other O 0 6.54841155259267e-12
complement O 0 1.1443995924509398e-11
components O 0 2.7273860253584914e-11
were O 0 6.715296287790329e-12
normal O 0 6.170892269397044e-11
during O 0 9.519327166807035e-12
remission O 0 7.532393458964393e-11
of O 0 2.4894936982646117e-14
lupus O 0 1.1346793726829674e-08
, O 0 1.6601145100530318e-13
but O 0 1.0601563897594257e-11
C1 O 0 2.4845867585554515e-08
, O 0 9.520775010388172e-13
C4 O 0 1.6593524776453705e-08
, O 0 1.1288342656456951e-11
C2 O 0 9.30592314318801e-09
, O 0 1.4392169097113272e-12
and O 0 9.02210858105823e-12
C3 O 0 4.030149511891068e-07
levels O 0 2.8297462151272157e-09
fell O 0 2.3151771529228427e-05
during O 0 2.729942938373142e-10
exacerbations O 0 6.873784741401323e-07
. O 0 4.0783548760359167e-10

A O 0 3.407694038060072e-08
younger O 0 5.2804041139609126e-09
half O 0 6.194891127853097e-11
- O 0 8.676386276107451e-10
sister O 0 1.0286620444333039e-08
, O 0 2.6320313116501293e-12
who O 0 5.206876596552945e-12
had O 0 6.110980471651928e-11
no O 0 3.683100699425346e-11
underlying O 0 8.600631318245178e-09
disease O 0 5.225230026439931e-09
, O 0 1.6878607886350316e-12
was O 0 9.129233480287269e-10
also O 0 2.1787367916747957e-12
found O 0 1.1864178910137024e-11
to O 0 1.6619083496524634e-12
lack O 0 8.924101457807865e-10
immunochemically O 0 9.12474774850125e-07
detectable O 0 1.2840901035815477e-05
C5 O 0 3.1925362691254122e-06
. O 0 2.7292517135180105e-09

By O 0 3.2222408075099906e-10
hemolytic O 0 2.7050928110838868e-05
assay O 0 2.2751875405901956e-07
, O 0 1.4281271998317635e-10
she O 0 2.3594207143595725e-10
exhibited O 0 4.0779248033917526e-11
1 O 0 5.673761157079515e-13
- O 0 3.091759834261687e-11
2 O 0 3.4839546612236427e-13
% O 0 7.271270987662531e-14
of O 0 1.6660762201621744e-15
the O 0 9.24523451501999e-14
normal O 0 1.1849032865995923e-10
serum O 0 2.6745330949928814e-10
C5 O 0 1.699700380441982e-09
level O 0 5.540598362052673e-12
and O 0 1.8799508662032532e-13
normal O 0 2.5156103328899393e-12
concentrations O 0 5.17268606420318e-12
of O 0 5.441805097766142e-15
other O 0 4.6607195099829246e-14
complement O 0 1.0011814294275112e-11
components O 0 1.5781695950067842e-09
. O 0 1.1440880881563587e-10

C5 O 0 7.179658041422954e-06
levels O 0 4.4109557673088773e-10
of O 0 1.136998329010928e-14
other O 0 3.84016277978072e-14
family O 0 9.425872083725084e-14
members O 0 4.303098472707191e-15
were O 0 2.9935486056155425e-13
either O 0 6.639514242220979e-13
normal O 0 1.2373414792765658e-11
or O 0 2.0691070384826205e-12
approximately O 0 1.4953838135215586e-13
half O 0 5.657795065783233e-11
- O 0 1.9732482314793742e-09
normal O 0 1.8385258870878829e-09
, O 0 3.051690193947576e-12
consistent O 0 4.699162586829786e-11
with O 0 9.943015378058306e-13
autosomal O 0 2.091889257371804e-07
codominant O 0 6.291026721783055e-08
inheritance O 0 1.432476470775157e-09
of O 0 3.149604600564959e-13
the O 0 3.7855877287051864e-12
gene O 0 1.6831839388942171e-07
determining O 0 2.3436634819518076e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 6.457875123544454e-09

Normal O 0 1.0295698302797973e-05
hemolytic O 0 0.0025162752717733383
titers O 0 0.00010117083002114668
were O 0 1.4296623884746396e-09
restored O 0 5.112700818266092e-10
to O 0 1.5185684740931515e-12
both O 0 4.168423939354682e-11
homozygous O 1 0.9999289512634277
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 2.7994914830742346e-08
C5D B-Disease 1 1.0
) O 0 4.23977042710022e-12
sera O 0 3.843240725664998e-10
by O 0 3.76074090488801e-14
addition O 0 1.6794110047936572e-13
of O 0 4.2614695138550734e-14
highly O 0 1.761396410671079e-11
purified O 0 1.3315983871109438e-09
human O 0 2.4149446331556135e-10
C5 O 0 1.796116180230456e-07
. O 0 6.903249083478613e-10

In O 0 3.977904117213882e-10
specific O 0 1.2885773004178702e-10
C5 O 0 2.53426755136843e-08
titrations O 0 9.979570947393768e-09
, O 0 1.5951141232525834e-12
however O 0 8.078558438526229e-13
, O 0 2.1026840750330844e-13
it O 0 4.732267095547416e-13
was O 0 1.0878932199531732e-09
noted O 0 1.054020586088722e-12
that O 0 1.114713315685141e-14
when O 0 4.6597240768633114e-14
limited O 0 3.124467034382704e-14
amounts O 0 9.379387593206126e-14
of O 0 1.0144437915561577e-13
C5 O 0 3.1728167315669964e-10
were O 0 1.7108670166340878e-12
assayed O 0 3.756617239503157e-11
in O 0 7.718805927542025e-14
the O 0 1.1077740829680549e-14
presence O 0 1.1513811822363995e-12
of O 0 8.29735450269195e-14
low O 0 6.096850246883889e-10
dilutions O 0 1.9442209620024187e-08
of O 0 3.2065772563247275e-13
either O 0 6.151481546368132e-10
C5D B-Disease 1 1.0
serum O 0 3.1145026557766187e-09
, O 0 9.50934101427714e-13
curving O 0 7.99259963768506e-11
rather O 0 4.810863946796973e-12
than O 0 6.492269829377895e-13
linear O 0 2.9877329776883954e-11
dose O 0 1.8437452453667902e-08
- O 0 1.560378271037166e-09
response O 0 7.907047412658574e-12
plots O 0 5.366080149671326e-11
were O 0 4.8898433913091566e-11
consistently O 0 2.1017870603656785e-12
obtained O 0 5.058055753751067e-13
, O 0 1.9503060665472353e-14
suggesting O 0 3.879908980902735e-12
some O 0 1.993851725433718e-13
inhibitory O 0 4.0112144161774665e-10
effect O 0 1.1710586667046385e-10
. O 0 8.504979359669207e-11

Further O 0 1.1584356390814676e-10
studies O 0 3.2806132810314637e-11
suggested O 0 6.275354541562805e-11
that O 0 1.7168819534466029e-12
low O 0 5.35189559336402e-10
dilutions O 0 3.8519198142239475e-07
of O 0 6.864783914928285e-12
C5D B-Disease 1 1.0
serum O 0 6.939818164575229e-10
contain O 0 1.0292629595842762e-11
a O 0 2.632658847867564e-12
factor O 0 6.160445851360885e-12
( O 0 2.7184607646543735e-13
or O 0 5.203500824668694e-12
factors O 0 1.5634951016155196e-12
) O 0 6.879365783626912e-14
interfering O 0 1.6476148570476745e-11
at O 0 1.0202972147710376e-11
some O 0 1.7187911250521326e-13
step O 0 1.4368908623704768e-12
in O 0 1.7071630567522256e-13
the O 0 3.3186791531004955e-13
hemolytic O 0 3.880893828522858e-08
assay O 0 2.958418843235222e-09
of O 0 2.8704358768366633e-12
C5 O 0 3.4691236550088433e-08
, O 0 5.920395467276518e-13
rather O 0 6.195214697149454e-13
than O 0 3.2439670524450626e-13
a O 0 1.795543314725423e-12
true O 0 2.2802437715796486e-10
C5 O 0 4.086067306730001e-08
inhibitor O 0 1.678771610613694e-08
or O 0 5.136462366550631e-10
inactivator O 0 3.8117877920740284e-07
. O 0 8.779497684408e-10

Of O 0 8.176050982078298e-12
clinical O 0 1.6520315115897688e-09
interest O 0 1.6438636910032223e-11
are O 0 6.143464101153462e-13
( O 0 9.370898154670293e-13
a O 0 1.3052632976198741e-12
) O 0 1.6531817147863448e-13
the O 0 3.298346838709332e-13
documentation O 0 5.829517979449861e-10
of O 0 2.2625740257048443e-12
membranous O 0 0.0017185498727485538
glomerulonephritis B-Disease 1 1.0
, O 0 4.406553699709548e-08
vasculitis B-Disease 1 1.0
, O 0 2.393891307406193e-09
and O 0 3.1166143799055135e-07
arthritis B-Disease 1 1.0
in O 0 8.340538329432157e-12
an O 0 1.5901981066570453e-13
individual O 0 5.393060672521932e-13
lacking O 0 4.20399359768453e-08
C5 O 0 5.287451543267707e-08
( O 0 3.0628511879515763e-12
and O 0 1.9089002839360603e-13
its O 0 2.7538423473007223e-14
biologic O 0 6.5046618091813e-10
functions O 0 1.6050348712864232e-13
) O 0 6.074227085943809e-14
, O 0 8.871590663700815e-14
and O 0 9.078585322744304e-13
( O 0 1.3689168071664981e-12
b O 0 2.906391516344087e-10
) O 0 2.5234891961960736e-14
a O 0 4.248899680443091e-13
remarkable O 0 6.742111036128762e-11
propensity O 0 1.2661402593039384e-08
to O 0 5.34787492068034e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 6.032490063034857e-10
the O 0 2.5735919471914226e-12
proband O 0 2.0047975723969103e-08
, O 0 3.958431347463043e-13
even O 0 1.0893138604681218e-12
during O 0 1.3011915763611048e-12
periods O 0 4.294806697779929e-12
of O 0 1.3504455495213282e-14
low O 0 2.6579138889815113e-10
- O 0 2.7099942082053907e-11
dose O 0 7.099975052327068e-10
or O 0 5.272981010162603e-11
alternate O 0 4.967682931678041e-10
- O 0 4.665427155714497e-09
day O 0 4.539860154473274e-10
corticosteroid O 0 4.5085150190971035e-07
therapy O 0 2.375019221290131e-07
. O 0 2.275186705702481e-10

Other O 0 8.742575240139328e-12
observations O 0 1.5491231561415297e-11
indicate O 0 2.5711988094201388e-11
that O 0 4.1017674825248596e-13
the O 0 3.906738647863062e-12
C5D B-Disease 1 1.0
state O 0 6.586827437649045e-13
is O 0 3.1719527178453166e-13
compatible O 0 5.0178281668644686e-11
with O 0 2.0594792960858949e-13
normal O 0 3.1936769201434956e-11
coagulation O 0 3.557141387000584e-11
function O 0 2.206572815091623e-12
and O 0 5.939181980420261e-13
the O 0 3.579909873857763e-14
capacity O 0 1.5095402412877018e-13
to O 0 8.6475545149102e-14
mount O 0 1.7962278331395964e-09
a O 0 4.182333146474093e-09
neutrophilic O 0 0.0001671768695814535
leukocytosis O 0 5.1883645937778056e-05
during O 0 2.3884423328013327e-08
pyogenic B-Disease 0 0.00036898039979860187
infection I-Disease 0 0.0018606474623084068
. O 0 3.2483554734952236e-10
. O 0 1.6553867998592153e-10

Susceptibility O 0 1.5483577954000793e-05
to O 0 2.744216942573985e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 7.047940897564331e-08
twins O 0 1.2675029914532843e-08
: O 0 1.3645939304744725e-13
the O 0 3.684722916597136e-15
role O 0 2.332489941209853e-13
of O 0 1.2802990242142317e-14
genes O 0 4.0553688879230165e-11
, O 0 1.0912462773682297e-11
HLA O 0 1.6160825566657877e-08
, O 0 2.8916472081391698e-12
and O 0 7.650628394695325e-12
the O 0 6.777059382429007e-12
environment O 0 3.365679512867814e-09
. O 0 9.285044955120725e-11

OBJECTIVE O 0 4.144707688169547e-09
To O 0 1.9372212167745317e-12
determine O 0 5.569096074055369e-13
the O 0 1.3752905505236019e-14
relative O 0 1.0073411289140966e-12
effects O 0 1.1452184686677747e-11
of O 0 3.322559919251636e-14
genetic O 0 2.9430302639354977e-10
and O 0 3.722294174279828e-12
environmental O 0 5.451971339665018e-13
factors O 0 5.815516254323305e-13
in O 0 5.2049701354528466e-12
susceptibility O 0 3.5558304745109126e-08
to O 0 4.5745025545329554e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.6229790844590752e-06
AS B-Disease 1 0.9999995231628418
) O 0 5.339372000090492e-11
. O 0 6.363098242756493e-11

METHODS O 0 1.2048323583258025e-07
Twins O 0 1.2007511429601436e-07
with O 0 6.891651745805083e-12
AS B-Disease 1 1.0
were O 0 7.519384420673347e-12
identified O 0 4.028246486376119e-12
from O 0 5.408086156091958e-14
the O 0 4.646641483586379e-14
Royal O 0 2.7358906806718153e-10
National O 0 5.905914320959715e-13
Hospital O 0 1.5800829089585022e-08
for O 0 6.514305761484707e-11
Rheumatic B-Disease 1 0.9999250173568726
Diseases I-Disease 0 0.00014105380978435278
database O 0 2.755358607942071e-08
. O 0 1.0653914417346755e-09

Clinical O 0 1.085507960851828e-06
and O 0 8.887576091742844e-11
radiographic O 0 1.8007692403898545e-07
examinations O 0 4.912567064252471e-08
were O 0 3.776990872839114e-12
performed O 0 9.382093626303378e-13
to O 0 2.77117738478605e-14
establish O 0 1.4275980571298863e-11
diagnoses O 0 2.5486666345386766e-05
, O 0 1.4346351363825338e-11
and O 0 1.8185731809339245e-09
disease O 0 3.0899952889740234e-06
severity O 0 1.767173607447603e-08
was O 0 5.6378662155465165e-11
assessed O 0 1.8397718244689276e-12
using O 0 4.748913393602672e-13
a O 0 2.8078062878217347e-12
combination O 0 3.532828751762196e-10
of O 0 1.1547967443403806e-12
validated O 0 1.9941788220734225e-09
scoring O 0 4.51228693298944e-10
systems O 0 2.564678780458962e-08
. O 0 4.4041295610419695e-10

HLA O 0 0.0003381002461537719
typing O 0 3.6478948004514677e-06
for O 0 6.708758548690241e-11
HLA O 0 3.514897457534971e-07
- O 0 3.4139504556662814e-09
B27 O 0 9.477509443911458e-09
, O 0 8.483201120734751e-12
HLA O 0 9.997269678763132e-09
- O 0 1.668312987757048e-10
B60 O 0 1.3741613402729058e-09
, O 0 5.482159322854618e-13
and O 0 3.234990834238838e-12
HLA O 0 1.7897451698445366e-07
- O 0 1.5223735161384866e-08
DR1 O 0 0.0008670352981425822
was O 0 6.9031041993739e-10
performed O 0 6.476611781602859e-13
by O 0 8.41384846858714e-15
polymerase O 0 1.371408021866305e-11
chain O 0 9.945921690401871e-12
reaction O 0 4.746522727812341e-13
with O 0 1.2397302965021922e-14
sequence O 0 1.5075607591712864e-13
- O 0 2.2563684861504063e-12
specific O 0 5.323574155287336e-13
primers O 0 5.198449226639923e-09
, O 0 1.5825438832647865e-12
and O 0 4.3504414480588505e-12
zygosity O 0 1.6812483849548698e-08
was O 0 1.3133782950092154e-10
assessed O 0 3.367242942808879e-11
using O 0 1.5893173929693027e-11
microsatellite O 0 4.525435315372306e-08
markers O 0 1.3850538493898057e-07
. O 0 4.027753242041854e-09

Genetic O 0 2.8392531703502755e-07
and O 0 3.555283151213118e-11
environmental O 0 2.560396773071405e-12
variance O 0 1.2049328548813243e-12
components O 0 1.137423627506351e-10
were O 0 1.6329833318895481e-10
assessed O 0 6.29385016326367e-11
with O 0 5.476774090663883e-14
the O 0 2.4734405604416587e-13
program O 0 1.3456087806507089e-11
Mx O 0 1.9630476411069964e-10
, O 0 1.937584817525602e-14
using O 0 1.954955159344171e-13
data O 0 4.0680800741932366e-12
from O 0 1.5912388052173598e-13
this O 0 4.2511997475893834e-14
and O 0 3.7320458680899227e-13
previous O 0 9.383435868592915e-13
studies O 0 2.333919515984384e-12
of O 0 8.286094385504331e-14
twins O 0 1.3532156506457227e-09
with O 0 2.3247506350521085e-11
AS B-Disease 1 1.0
. O 0 2.970982071470729e-10

RESULTS O 0 5.298142582432774e-07
Six O 0 1.1280792966417152e-10
of O 0 9.795343789559263e-13
8 O 0 1.36555933227811e-10
monozygotic O 0 1.069019162969198e-06
( O 0 6.213783709796417e-09
MZ O 1 0.9993892908096313
) O 0 6.776895017379658e-11
twin O 0 2.2882058914319714e-08
pairs O 0 3.4068001197873343e-10
were O 0 2.795104148134442e-09
disease O 0 3.4842489782249686e-08
concordant O 0 6.713629652210784e-09
, O 0 4.0372687831746745e-12
compared O 0 3.513487070727628e-11
with O 0 5.054979872187726e-13
4 O 0 7.342368900375984e-12
of O 0 4.021664999718372e-13
15 O 0 7.88620488356706e-11
B27 O 0 1.9979376375545144e-08
- O 0 5.470304653698577e-09
positive O 0 4.999230474034277e-10
dizygotic O 0 2.370111360505689e-07
( O 0 1.1010649336729017e-10
DZ O 0 2.135432850991492e-06
) O 0 1.7140385248290424e-12
twin O 0 2.0632213992843873e-10
pairs O 0 2.4325428824023554e-11
( O 0 2.1500306743305053e-11
27 O 0 7.012664754446618e-11
% O 0 1.5697612480713996e-12
) O 0 2.663736202099254e-13
and O 0 5.881243408945025e-12
4 O 0 1.074057075917123e-12
of O 0 2.391850823305064e-13
32 O 0 2.1212827050476335e-09
DZ O 0 0.0582733117043972
twin O 0 1.4045348883939823e-08
pairs O 0 2.3941276738881356e-10
overall O 0 4.533718289678745e-09
( O 0 6.012292746992998e-11
12 O 0 1.688827723500541e-11
. O 0 5.942966930204407e-13
5 O 0 1.4107339428581778e-12
% O 0 3.3921752125992688e-12
) O 0 3.890943556933424e-12
. O 0 7.00018376598166e-11

Nonsignificant O 0 3.4857894206652418e-06
increases O 0 4.525758934281754e-10
in O 0 1.5296731980043998e-12
similarity O 0 7.717931328754535e-12
with O 0 1.5834601628495447e-14
regard O 0 1.6889621212018424e-12
to O 0 1.7792813663403129e-12
age O 0 1.6922141465869345e-10
at O 0 8.3547606333223e-11
disease O 0 5.712974537885884e-09
onset O 0 7.006504820772363e-10
and O 0 1.2391122199487126e-12
all O 0 1.7728128535489385e-14
of O 0 4.552491230400222e-15
the O 0 2.611593450177474e-12
disease O 0 4.313336177119709e-08
severity O 0 1.4037601081540174e-09
scores O 0 5.666391314496089e-11
assessed O 0 1.395618776794949e-11
were O 0 1.8384391231585084e-12
noted O 0 1.3272862843527466e-11
in O 0 5.846239464757375e-11
disease O 0 1.670596475378261e-06
- O 0 3.0304347546916688e-06
concordant O 0 0.0013976761838421226
MZ O 1 0.9999122619628906
twins O 0 2.9510431431845063e-06
compared O 0 9.883248885955709e-09
with O 0 8.373648996418126e-11
concordant O 0 2.8224223569850437e-05
DZ O 1 0.9974738955497742
twins O 0 3.618540631578071e-06
. O 0 3.848362961633711e-09

HLA O 0 0.0029153255745768547
- O 0 7.004138751653954e-06
B27 O 0 2.061263302266525e-07
and O 0 2.069238357049752e-11
B60 O 0 3.7271644104386326e-10
were O 0 6.37319786788576e-13
associated O 0 8.881225155256064e-14
with O 0 4.63233933227199e-15
the O 0 3.5826989161838463e-13
disease O 0 8.948458085633604e-10
in O 0 3.3279609536890353e-12
probands O 0 2.3048805086745006e-09
, O 0 1.3480194608131435e-13
and O 0 8.05407579821879e-14
the O 0 6.296277789506061e-14
rate O 0 2.63661120714076e-10
of O 0 1.7366974015570885e-14
disease O 0 1.6061091345775935e-10
concordance O 0 4.05391720192938e-10
was O 0 1.3766134066006686e-10
significantly O 0 1.0504090652840858e-10
increased O 0 1.0773568669131262e-11
among O 0 1.0020067241212072e-11
DZ O 0 0.005462799221277237
twin O 0 6.656265316706822e-09
pairs O 0 1.8969320905726228e-11
in O 0 5.720031653194679e-12
which O 0 6.437263374257929e-13
the O 0 1.119540658095497e-12
co O 0 1.7914631200710573e-07
- O 0 1.292187334911432e-07
twin O 0 5.213013878346828e-07
was O 0 6.276919606307274e-08
positive O 0 1.4587319199788062e-11
for O 0 7.681531056851973e-14
both O 0 2.4389993063395066e-12
B27 O 0 1.2309289587619787e-08
and O 0 5.683160053671088e-10
DR1 O 0 0.00034069395042024553
. O 0 7.671677737519644e-10

Additive O 0 1.0404898276306085e-08
genetic O 0 4.879115333977779e-09
effects O 0 3.6153799398697117e-10
were O 0 2.540544380771892e-12
estimated O 0 4.612064582239922e-14
to O 0 7.756466198223077e-15
contribute O 0 1.6974289541223792e-13
97 O 0 8.018247524277378e-12
% O 0 1.2312945259738972e-13
of O 0 4.7407087275437056e-15
the O 0 5.334497966513578e-14
population O 0 6.947127741780898e-14
variance O 0 1.1756279109931267e-11
. O 0 1.2063666732231582e-10

CONCLUSION O 0 2.8588789113825896e-09
Susceptibility O 0 3.702191220256168e-09
to O 0 4.738042597152159e-11
AS B-Disease 1 1.0
is O 0 2.3706947863133543e-13
largely O 0 4.5167751375023435e-13
genetically O 0 9.570817749438021e-11
determined O 0 8.559518094308771e-10
, O 0 5.760794185433182e-12
and O 0 5.506019902165593e-13
the O 0 7.115116736891233e-14
environmental O 0 8.37109027929106e-12
trigger O 0 7.388567535571156e-10
for O 0 5.816936559169261e-13
the O 0 1.5736981162639552e-11
disease O 0 1.2474315269628278e-07
is O 0 1.989985953798623e-11
probably O 0 2.7929938362092344e-09
ubiquitous O 0 1.9492746972105124e-08
. O 0 5.5616522498525e-10

HLA O 0 3.7156078178668395e-05
- O 0 4.9519844225187626e-08
B27 O 0 1.524153803167394e-09
accounts O 0 1.8587019944005245e-12
for O 0 6.011455083585393e-15
a O 0 7.665284964923635e-14
minority O 0 7.551532099289715e-13
of O 0 4.640474660213894e-15
the O 0 1.8933190789899995e-13
overall O 0 6.715774464316482e-11
genetic O 0 7.496250842287111e-10
susceptibility O 0 1.5129389963064455e-09
to O 0 7.728309103782749e-10
AS B-Disease 1 1.0
. O 0 5.607261877038638e-10

Cell O 0 8.825676559354179e-06
cycle O 0 2.990195184793265e-07
- O 0 2.2961671675147954e-08
dependent O 0 6.62215038360614e-09
colocalization O 0 3.8731588603013734e-08
of O 0 1.761026003840871e-12
BARD1 O 0 5.3392376742067427e-08
and O 0 8.3331119782315e-12
BRCA1 O 0 1.720917075509476e-09
proteins O 0 9.693276563360609e-12
in O 0 1.340126902678318e-12
discrete O 0 1.8181560423879972e-10
nuclear O 0 1.0721374010813634e-08
domains O 0 3.3178650937770726e-08
. O 0 4.216741678053637e-10

Germ O 0 0.0001430457050446421
- O 0 6.174085137899965e-05
line O 0 7.68823404939667e-09
mutations O 0 3.851562679901832e-10
of O 0 5.093088494348419e-14
the O 0 2.9123692390012335e-13
BRCA1 O 0 1.662285775694272e-08
gene O 0 1.2655841929998246e-09
predispose O 0 1.203889432588312e-09
women O 0 5.640939538392731e-12
to O 0 1.1277462389500462e-13
early O 0 7.22755686410892e-08
- O 0 0.000439391122199595
onset O 1 0.5540480613708496
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
by O 0 9.327939896192072e-13
compromising O 0 2.3080788391638407e-09
the O 0 3.368042064862131e-13
genes O 0 1.1391104726143908e-10
presumptive O 0 4.3944381467042604e-10
function O 0 7.906583027184055e-11
as O 0 5.694018520574495e-11
a O 0 3.9345460223216833e-10
tumor B-Disease 0 3.302685399830807e-06
suppressor O 0 1.0566066521278117e-05
. O 0 1.2627492829153653e-08

Although O 0 9.767238406954704e-11
the O 0 3.9874543554183073e-13
biochemical O 0 8.326506845124371e-11
properties O 0 3.990623456684439e-11
of O 0 7.625664151782868e-14
BRCA1 O 0 9.315139770649239e-09
polypeptides O 0 1.9259420447337305e-10
are O 0 1.393664778850598e-13
not O 0 1.4065445585586395e-13
understood O 0 5.695579424758179e-12
, O 0 1.5051753449852288e-14
their O 0 5.687603047631025e-15
expression O 0 4.866967289254842e-13
pattern O 0 3.576714965869421e-11
and O 0 6.182300765072979e-13
subcellular O 0 1.1906446939491389e-09
localization O 0 3.2174934938566935e-10
suggest O 0 4.977532275241003e-12
a O 0 7.896462888949685e-13
role O 0 3.583931111952876e-12
in O 0 3.133101070251776e-11
cell O 0 1.5753961633890867e-05
- O 0 3.2261916203424335e-05
cycle O 0 8.910333804124093e-08
regulation O 0 1.4473826581706817e-07
. O 0 3.912066504074829e-10

When O 0 1.3220499139876551e-09
resting O 0 5.312019712988558e-10
cells O 0 1.0930154004107351e-10
are O 0 4.456751536829201e-13
induced O 0 2.8613580255187898e-11
to O 0 1.778015126623067e-13
proliferate O 0 1.106750469048734e-09
, O 0 1.3745832271906677e-13
the O 0 5.6739098283024175e-14
steady O 0 4.536510334052224e-10
- O 0 8.716796273504357e-13
state O 0 4.603021319681856e-14
levels O 0 1.0294274113697988e-12
of O 0 3.449744965600479e-15
BRCA1 O 0 2.9157640191179723e-10
increase O 0 1.818695151076244e-12
in O 0 3.5138406941082057e-12
late O 0 5.5819404654045e-10
G1 O 0 7.27621074503304e-10
and O 0 3.43007821581795e-13
reach O 0 1.3119974941536161e-12
a O 0 1.2124184035205987e-12
maximum O 0 3.5123330025671473e-12
during O 0 2.4831286332682723e-11
S O 0 6.839257160606849e-09
phase O 0 2.230517021084566e-10
. O 0 8.824957431485814e-11

Moreover O 0 6.644253147669588e-09
, O 0 2.704360693717156e-11
in O 0 9.789931885995085e-12
S O 0 6.050238532395724e-09
phase O 0 4.5120178426838464e-11
cells O 0 2.6737781433361363e-10
, O 0 7.958581710321155e-12
BRCA1 O 0 2.6699739308355674e-08
polypeptides O 0 3.8027883064728485e-09
are O 0 1.5529865587948777e-11
hyperphosphorylated O 0 3.223061284529649e-08
and O 0 3.641941262455539e-11
accumulate O 0 1.045502573404633e-09
into O 0 6.313180013484132e-12
discrete O 0 2.4647519580867083e-09
subnuclear O 0 9.16937551664887e-07
foci O 0 3.4499092294026923e-07
termed O 0 1.0069804545764782e-07
" O 0 2.658077535855341e-09
BRCA1 O 0 6.407768751159892e-07
nuclear O 0 8.506127358032245e-08
dots O 0 4.243697276251623e-06
. O 0 8.203868695488836e-09

" O 0 2.251051078872024e-08
BRCA1 O 0 1.1890656423929613e-06
associates O 0 1.0359728186415396e-08
in O 0 6.975788436475172e-12
vivo O 0 3.939593984370049e-09
with O 0 2.974941256880803e-13
a O 0 1.4431648584500856e-11
structurally O 0 1.1559282029338647e-06
related O 0 2.2776094898979693e-10
protein O 0 1.5289638444215825e-09
termed O 0 4.809809439620949e-08
BARD1 O 0 1.1732970051525626e-05
. O 0 1.7992349832240961e-09

Here O 0 1.4114277524512886e-09
we O 0 1.2428875203335243e-12
show O 0 2.3617045818991045e-13
that O 0 9.509511843881942e-15
the O 0 2.991577729353871e-14
steady O 0 2.8229038551152996e-10
- O 0 1.1119688069632927e-12
state O 0 4.011496877406352e-14
levels O 0 2.6740048977152986e-12
of O 0 1.1515776295056585e-14
BARD1 O 0 6.681663555774264e-10
, O 0 6.5624678034662074e-15
unlike O 0 5.4634400980082057e-14
those O 0 2.301325329032069e-14
of O 0 5.478881423933357e-15
BRCA1 O 0 5.601631603013857e-09
, O 0 3.3948289058366443e-12
remain O 0 3.481560179041665e-11
relatively O 0 6.0104551544148954e-12
constant O 0 1.2036173273333173e-11
during O 0 2.7356440029935314e-11
cell O 0 1.44919752642636e-07
cycle O 0 5.531768376698665e-09
progression O 0 7.725954098702914e-09
. O 0 1.7341687807981288e-10

However O 0 2.383657937699013e-09
, O 0 4.194784103406235e-11
immunostaining O 0 1.5973855127526804e-08
revealed O 0 1.4911203383149996e-09
that O 0 3.542568799072554e-12
BARD1 O 0 3.5711373413960246e-08
resides O 0 6.984565703582746e-11
within O 0 2.3140656058018294e-12
BRCA1 O 0 9.902895214963792e-08
nuclear O 0 7.845795124694632e-09
dots O 0 1.4602232312199703e-08
during O 0 1.3634199325096574e-10
S O 0 9.668081890623625e-10
phase O 0 3.0629739196375017e-12
of O 0 8.452839936248097e-15
the O 0 3.1864392851729817e-13
cell O 0 1.4147408577969145e-08
cycle O 0 1.2077734645732363e-10
, O 0 3.8012865424819076e-13
but O 0 2.125511789144441e-12
not O 0 3.461586215152551e-13
during O 0 2.888051939525099e-13
the O 0 2.475031085028695e-13
G1 O 0 9.54758050397686e-09
phase O 0 1.3898152073643644e-10
. O 0 3.665439826661121e-11

Nevertheless O 0 8.878101454001808e-08
, O 0 4.4316314506964716e-11
BARD1 O 0 9.060958205964198e-09
polypeptides O 0 3.215315513838135e-10
are O 0 2.1165659285990457e-13
found O 0 2.9492855098227355e-13
exclusively O 0 6.948664598360396e-14
in O 0 1.0121366635432172e-12
the O 0 9.192467072911478e-14
nuclear O 0 4.059880903684032e-11
fractions O 0 2.57802477282576e-11
of O 0 6.2891213775412985e-15
both O 0 1.3975352450810996e-13
G1 O 0 2.383376163095363e-09
- O 0 3.247573390763314e-11
and O 0 1.8744639521117712e-11
S O 0 1.312828601385263e-08
- O 0 1.7699108845192768e-10
phase O 0 7.195292278661114e-11
cells O 0 4.798872410560762e-10
. O 0 1.059150475657411e-10

Therefore O 0 1.9873898082778396e-09
, O 0 1.4158563210742159e-11
progression O 0 1.0700911684535797e-10
to O 0 2.1981546357435766e-12
S O 0 1.5206612857809887e-08
phase O 0 5.862631907715965e-11
is O 0 1.2890970842865945e-12
accompanied O 0 1.3339044495699892e-12
by O 0 4.126027251523216e-14
the O 0 1.0432952245176264e-13
aggregation O 0 2.5215240052195442e-12
of O 0 1.1352561516450154e-14
nuclear O 0 3.9800293616387705e-10
BARD1 O 0 3.5891510208330146e-08
polypeptides O 0 2.3463402332168926e-09
into O 0 1.0565798930217696e-10
BRCA1 O 0 3.16617075668546e-07
nuclear O 0 6.35528465409152e-08
dots O 0 1.2671665672314703e-06
. O 0 2.5640318757069736e-09

This O 0 2.48915693612517e-10
cell O 0 6.926758544523182e-08
cycle O 0 6.1673097739856075e-09
- O 0 2.2606363447863487e-09
dependent O 0 1.9231385373075227e-09
colocalization O 0 8.730125067302197e-09
of O 0 6.423354686688199e-13
BARD1 O 0 7.764678144894788e-08
and O 0 7.241521184780941e-12
BRCA1 O 0 1.3893422412536438e-08
indicates O 0 4.7495517935258746e-11
a O 0 7.924209248846847e-13
role O 0 2.27603526303799e-12
for O 0 1.9432335786068872e-13
BARD1 O 0 1.539364191671666e-08
in O 0 6.039463373852527e-11
BRCA1 O 0 5.511717972694896e-05
- O 0 3.234016787700966e-07
mediated O 0 4.525954864220694e-06
tumor B-Disease 0 1.4572855434380472e-05
suppression O 0 4.644369866468878e-08
. O 0 1.313130937319329e-09

Ethnic O 0 1.1420921097737846e-08
differences O 0 4.8656797702051335e-08
in O 0 4.1601974642979656e-10
the O 0 7.817017866340592e-11
HFE O 0 2.5085562811000273e-05
codon O 0 5.901008535147412e-07
282 O 0 1.4665067737951176e-07
( O 0 3.5464953196395754e-09
Cys O 0 0.021085932850837708
/ O 0 2.9990335406182567e-06
Tyr O 0 3.1596900953445584e-06
) O 0 1.3219667582831107e-09
polymorphism O 0 5.081566882836341e-07
. O 0 2.0288655200317862e-09

Recent O 0 2.508583896165817e-10
studies O 0 2.511014486616947e-11
have O 0 5.207747752998537e-13
shown O 0 2.177707493500325e-11
that O 0 9.639454567889061e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 2.4452373281746986e-07
HH B-Disease 0 0.04886395111680031
) O 0 2.877342678356265e-12
is O 0 9.30526489195671e-13
likely O 0 7.512894473205023e-11
to O 0 4.3362896281519403e-13
be O 0 7.184906749418962e-12
caused O 0 1.6044817384430754e-12
by O 0 4.455712125758966e-14
homozygosity O 0 5.638309819033793e-10
for O 0 2.4685001560735033e-14
a O 0 3.622036698347486e-12
Cys282Tyr O 0 1.1073401751104939e-08
mutation O 0 1.6869290686560845e-10
in O 0 2.1861807503187336e-11
the O 0 4.001765065153595e-12
HFE O 0 9.173384540872576e-08
gene O 0 1.6169726668735507e-09
located O 0 1.6355494736330911e-09
4 O 0 2.0688104562793797e-09
. O 0 7.862434592276202e-10

5 O 0 7.455647477172533e-08
Mb O 0 3.6966932839277433e-06
telomeric O 0 7.708117664151359e-07
to O 0 2.8182933764497875e-10
HLA O 0 1.0137673598364927e-06
- O 0 1.438188057534262e-08
A O 0 1.8759072073493144e-09
. O 0 2.4567531342611915e-10

Population O 0 2.046887138951181e-11
studies O 0 4.841353359874567e-11
of O 0 2.526012507345944e-14
this O 0 6.519367971901183e-14
polymorphism O 0 1.1479439621098209e-10
are O 0 5.580512926219548e-14
facilitated O 0 9.986215413620991e-13
by O 0 2.025596961756186e-14
the O 0 1.641160894249455e-14
fact O 0 1.7342256916543647e-13
that O 0 2.5057860381918692e-14
the O 0 1.8841293813760124e-13
Cys282Tyr O 0 6.215822523358838e-09
mutation O 0 1.2799257487206006e-10
creates O 0 6.367396887529964e-11
a O 0 6.265379881575939e-11
Rsal O 0 2.0524767663232524e-08
restriction O 0 1.6590574469788066e-09
site O 0 1.6760385301850533e-09
. O 0 2.7683991210558645e-10

We O 0 4.5984588359360146e-10
have O 0 3.197399593354855e-12
studied O 0 2.7082423109670017e-11
the O 0 9.722026786049276e-13
codon O 0 1.2780192903960597e-08
282 O 0 2.1599551036644016e-09
( O 0 2.1237310521282637e-10
Cys O 0 0.001604770659469068
/ O 0 1.9870198286753293e-07
Tyr O 0 9.835299863425462e-08
) O 0 2.520366380875938e-11
polymorphism O 0 7.027883164312243e-09
in O 0 6.555434146904293e-12
different O 0 7.615754814976894e-13
ethnic O 0 8.467633712261335e-12
groups O 0 1.5190501634343434e-11
. O 0 9.798904049285184e-11

In O 0 7.651744793335524e-10
agreement O 0 4.303796555249484e-11
with O 0 2.556116397104541e-13
previous O 0 7.408202523651042e-12
observations O 0 1.8512304536533186e-11
the O 0 1.0111371375604028e-12
Tyr O 0 1.1441547265178542e-08
allele O 0 3.0291824604233852e-09
appeared O 0 1.7121077888759828e-08
to O 0 5.740149024505148e-13
be O 0 1.2737725370998154e-12
rare O 0 2.206359400735991e-11
or O 0 3.9691427922150524e-10
absent O 0 2.6980609413307377e-10
in O 0 4.9176851826815415e-12
Asiatic O 0 2.304466062419408e-10
( O 0 9.432567574241268e-13
Indian O 0 1.4008345265020816e-12
, O 0 3.637633271859342e-13
Chinese O 0 1.8155680951703612e-13
) O 0 2.3611594992568874e-13
populations O 0 1.97252353340005e-11
. O 0 6.631307308824219e-11

The O 0 1.0355234031367289e-10
highest O 0 1.2925305270528042e-10
allele O 0 6.671351915343848e-09
frequency O 0 1.1533302091137898e-09
( O 0 3.205846699216863e-11
7 O 0 3.3126351054596492e-12
. O 0 4.5704769585956304e-14
5 O 0 1.0509746285053412e-13
% O 0 1.1049468902780274e-13
) O 0 5.2849949893837844e-14
was O 0 7.797004708542943e-11
found O 0 5.559178811731513e-11
in O 0 6.629751608810963e-11
Swedes O 0 8.484091296168117e-08
. O 0 6.64418312035231e-11

Saamis O 0 9.456392717765993e-07
( O 0 3.1341662598549647e-10
2 O 0 5.609289074892665e-12
% O 0 7.317479413203321e-13
) O 0 9.437745452766516e-14
and O 0 4.662873819699653e-13
Mordvinians O 0 4.897761085587149e-10
( O 0 2.3189956899205555e-13
1 O 0 6.587025575596067e-14
. O 0 1.701207398693491e-14
8 O 0 1.90893674023411e-13
% O 0 2.5821645237050946e-14
) O 0 2.2639660938604707e-14
had O 0 4.452490459661007e-11
significantly O 0 4.85407880557176e-10
lower O 0 1.6501663924195498e-10
frequencies O 0 9.192270555846704e-11
of O 0 2.52775366827232e-13
the O 0 7.896181104805056e-12
Tyr O 0 7.241051491746475e-08
allele O 0 5.655710566543348e-08
. O 0 2.3129309578706625e-09

Comparisons O 0 2.5899149491692697e-09
with O 0 7.589180152367536e-12
allele O 0 2.298712109549683e-09
frequencies O 0 1.9636768600062027e-10
based O 0 1.488101482316484e-11
on O 0 1.69176242459379e-10
prevalence O 0 1.2051375897215166e-08
estimates O 0 8.469511203479385e-11
of O 0 2.5225726455607722e-12
HH B-Disease 1 0.9997184872627258
showed O 0 3.883810961724521e-08
some O 0 2.4675986080857637e-12
disagreements O 0 1.4327708464101363e-10
with O 0 1.81795123930812e-14
the O 0 1.071455952932586e-13
RFLP O 0 1.1264500443530778e-09
data O 0 6.69372370032395e-12
, O 0 1.5165184375203616e-13
particularly O 0 7.283257330570336e-12
in O 0 3.09468631276566e-11
Finns O 0 5.240183398314002e-08
. O 0 2.5614396714779275e-10

The O 0 7.074180130572927e-11
newly O 0 1.7402755625450794e-10
described O 0 8.782977123367175e-11
HFE O 0 4.032251865737635e-08
marker O 0 7.367399051938506e-11
provides O 0 1.0886138995455652e-12
a O 0 1.620026378670869e-12
new O 0 4.7416202908490135e-12
approach O 0 5.765282001801708e-11
to O 0 2.466524705833917e-13
the O 0 6.894458555494268e-14
screening O 0 4.002835909955316e-11
of O 0 2.663817246211647e-13
HH B-Disease 0 2.0017384940729244e-06
as O 0 1.1844908734404136e-12
well O 0 6.098213297181521e-13
as O 0 1.3921292775238153e-13
studies O 0 2.113278492086798e-13
of O 0 1.6040111515015364e-15
the O 0 6.140168939700735e-14
relationship O 0 4.639917963733531e-11
between O 0 2.371066667658517e-12
the O 0 1.387769586747023e-11
HFE O 0 9.933993396771257e-07
Tyr O 0 9.875357420696673e-08
allele O 0 3.835277340158427e-08
and O 0 2.0175346115980375e-10
different O 0 5.11971687267021e-10
disorders O 0 2.352339288336225e-05
including O 0 2.5213967025372597e-10
cancer B-Disease 0 4.984498445992358e-05

Autosomal B-Disease 1 0.9999972581863403
dominant I-Disease 1 0.9999799728393555
neurohypophyseal I-Disease 1 0.9999991655349731
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9987922310829163
associated O 0 1.5516004481241907e-08
with O 0 8.051503908035329e-12
a O 0 2.0297702407745533e-10
missense O 0 4.243389412295073e-06
mutation O 0 8.526773598305226e-08
encoding O 0 2.7529054591468594e-08
Gly23 O 0 6.7676029402719e-07
- O 0 4.714737542599323e-07
- O 0 1.8454607015883084e-06
> O 0 2.075328353612349e-08
Val O 0 3.2014645512390416e-07
in O 0 9.095272313075498e-10
neurophysin O 0 4.765321136801504e-06
II O 0 1.760106869141964e-07
. O 0 2.6339019854049184e-10

Autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 0.9999915361404419
neurohypophyseal I-Disease 1 0.9999992847442627
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999150037765503
( O 0 1.7029071486263092e-08
ADNDI B-Disease 0 9.367290090267488e-07
) O 0 4.675967946177195e-12
is O 0 2.1902364904374805e-12
an O 0 2.7152301240729315e-11
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.1163997726271191e-08
by O 0 5.564352797970962e-12
progressive O 0 3.760479572179065e-08
degeneration O 0 0.00010169314191443846
of O 0 1.820096265543747e-13
the O 0 8.3050699564019e-13
magnocellular O 0 2.679012123252278e-09
neurons O 0 1.4450084184769452e-10
of O 0 7.267874046730863e-14
the O 0 9.649234671916043e-14
hypothalamus O 0 3.7199680835708904e-11
leading O 0 1.505343939778303e-11
to O 0 6.417403500963426e-13
decreased O 0 2.338249593947239e-09
ability O 0 8.461627232225766e-12
to O 0 3.092523253537399e-13
produce O 0 1.6762733562325494e-11
the O 0 2.335884784210318e-11
hormone O 0 2.0885506657464248e-09
arginine O 0 6.172287569938817e-09
vasopressin O 0 1.9178381105433573e-09
( O 0 7.703521848201333e-11
AVP O 0 6.417455722385057e-08
) O 0 2.917665414825521e-11
. O 0 6.499747268184919e-11

Affected O 0 8.546944485487984e-09
individuals O 0 4.137308551310781e-12
are O 0 3.3473503374507885e-13
not O 0 3.7038384512189104e-12
symptomatic O 0 2.204372018255185e-09
at O 0 9.35380037314637e-11
birth O 0 3.16580484049922e-10
, O 0 1.2799291791362744e-12
but O 0 2.8657329981252033e-11
usually O 0 1.2596569620715314e-10
develop O 0 2.17475957242641e-08
diabetes B-Disease 0 0.12302331626415253
insipidus I-Disease 0 8.230316780100111e-06
at O 0 5.976862893497525e-10
1 O 0 1.6985132744729015e-10
- O 0 2.2365957192960195e-06
6 O 0 5.047445572614606e-09
yr O 0 1.2774340802934603e-06
of O 0 4.993669540376278e-12
age O 0 7.701586590691534e-10
. O 0 6.548651898530267e-11

The O 0 1.9194684036660803e-11
genetic O 0 1.6933289215259606e-09
locus O 0 6.359535120736837e-10
of O 0 2.485140999236579e-12
the O 0 1.2199120880129755e-10
disease O 0 6.883611263219791e-07
is O 0 4.846755809195802e-12
the O 0 8.060677125776294e-12
AVP O 0 8.378216989513021e-06
- O 0 1.3274604526714029e-08
neurophysin O 0 2.3595410425514274e-07
II O 0 9.178227955430884e-09
( O 0 6.643938871286892e-12
NPII O 0 1.7254658812859702e-09
) O 0 2.3755788460498584e-13
gene O 0 3.783452717787128e-11
, O 0 1.1820850288196683e-12
and O 0 9.587689800069632e-13
mutations O 0 5.323894450293132e-11
that O 0 1.735433357349242e-13
cause O 0 5.0893451779276955e-12
ADNDI B-Disease 0 6.683655406902744e-09
have O 0 1.5046371266980163e-12
been O 0 3.404997204331517e-12
found O 0 2.758629045682137e-12
in O 0 1.7782016093967346e-13
both O 0 4.1537032060418033e-14
the O 0 5.37043384752061e-14
signal O 0 4.157958352624114e-11
peptide O 0 9.508470399932634e-13
of O 0 1.8649322605407588e-14
the O 0 5.582665948446197e-13
prepro O 0 9.343969509245653e-08
- O 0 2.4475790283418064e-08
AVP O 0 1.5490093119296944e-06
- O 0 5.641130673694761e-09
NPII O 0 3.867961240189288e-08
precursor O 0 7.827271053528762e-10
and O 0 2.6428026433933383e-11
within O 0 1.4964696148922485e-11
NPII O 0 1.0090106883353656e-07
itself O 0 4.866640423983881e-10
. O 0 2.821073930014961e-10

An O 0 3.1563990310345957e-10
affected O 0 3.2107454472907193e-09
girl O 0 2.6073710614582524e-05
who O 0 7.733771956175417e-12
presented O 0 4.100625546586689e-13
at O 0 6.119597450310321e-12
9 O 0 2.710881866208048e-12
months O 0 1.8331273998750675e-12
of O 0 6.693023956241828e-15
age O 0 1.666963442281677e-11
and O 0 6.166461655535138e-13
her O 0 1.2548237188908518e-12
similarly O 0 1.3086441652543357e-11
affected O 0 3.645332646851074e-11
younger O 0 7.330380052961161e-11
brother O 0 3.802465287083834e-11
and O 0 1.3678884414058956e-12
father O 0 4.538989410024508e-12
were O 0 5.51234567974096e-13
all O 0 3.381214494453449e-15
found O 0 3.0637317227459604e-13
to O 0 2.642692820489529e-14
have O 0 1.6059574460200454e-12
a O 0 2.5803012070751974e-12
novel O 0 1.8360965525765494e-10
missense O 0 3.728270598912786e-07
mutation O 0 6.322842249772975e-09
( O 0 5.29311421082479e-11
G1758 O 0 3.933294578928326e-09
- O 0 3.37971606256815e-09
- O 0 1.0512760439951307e-08
> O 0 1.0734975131043711e-09
T O 0 1.5297747513187687e-09
) O 0 1.6200316912615143e-13
encoding O 0 7.947022380438984e-12
the O 0 2.2267898516867973e-13
amino O 0 7.19291466666494e-12
acid O 0 3.071023036566034e-12
substitution O 0 5.29490860878834e-12
Gly23 O 0 6.2419953650305615e-09
- O 0 1.037618169164034e-08
- O 0 8.132207796052171e-08
> O 0 4.322887825480848e-09
Val O 0 7.546266544977698e-08
within O 0 5.772271549631114e-10
NPII O 0 8.52532684803009e-06
. O 0 1.7136292385089291e-09

The O 0 1.635352131490464e-10
mutation O 0 2.7151292325555687e-09
was O 0 1.5718338852721558e-09
confirmed O 0 3.888081870351279e-11
by O 0 3.2290896302342165e-13
restriction O 0 1.2838579088736424e-09
endonuclease O 0 2.926755655607849e-07
analysis O 0 9.529146360875984e-10
. O 0 2.7316043871294937e-10

A O 0 4.1621618152021256e-08
T1 O 0 8.642073953524232e-05
- O 0 7.633031984255467e-09
weighted O 0 4.92396901030645e-10
magnetic O 0 1.0324271298989274e-10
resonance O 0 2.159106449184378e-09
imaging O 0 9.214617762154376e-07
of O 0 1.9114698972949595e-12
the O 0 6.817288053517778e-12
fathers O 0 1.4404191173156278e-09
pituitary O 0 7.512625521677307e-10
gland O 0 7.72873653964723e-10
demonstrates O 0 1.5154999477573483e-10
an O 0 2.0539841528999236e-12
attenuated O 0 4.96117351644898e-08
posterior O 0 4.860152102992288e-07
pituitary O 0 5.9368690017436165e-06
bright O 0 7.833421841496602e-05
spot O 0 4.4435823838284705e-06
. O 0 4.0288599123528e-09

This O 0 8.961160979925609e-11
mutation O 0 1.979305608301729e-09
may O 0 2.0933514643939333e-10
be O 0 1.664343000169679e-14
valuable O 0 8.569007455645414e-14
for O 0 6.912148309202082e-16
developing O 0 2.4968942928874083e-13
models O 0 1.0997951854774257e-10
of O 0 2.415544706532019e-13
dominantly B-Disease 0 5.086997703074303e-07
inherited I-Disease 1 0.8214647769927979
neurodegeneration I-Disease 1 1.0
, O 0 1.1783690342936914e-11
as O 0 1.7147405457357268e-13
the O 0 9.671063896812913e-15
early O 0 5.43580978840108e-11
age O 0 4.0458023216338734e-12
of O 0 9.224357355155834e-15
onset O 0 2.21739682171318e-10
of O 0 1.3448838126050439e-13
symptoms O 0 1.110313174734756e-09
suggests O 0 1.7035794433115092e-12
that O 0 2.1199184850042782e-14
this O 0 7.93296092878315e-14
mutation O 0 6.005805575082235e-11
may O 0 1.0338972039614092e-10
be O 0 7.243782938932963e-13
particularly O 0 5.299566775002207e-12
deleterious O 0 3.268940673706311e-10
to O 0 2.1480701332260432e-12
the O 0 5.414377713536256e-12
magnocellular O 0 1.7523714035405646e-08
neuron O 0 7.0831522869241326e-09
. O 0 5.0292495862303e-11
. O 0 1.8500417864331098e-10

Frequent O 0 1.5041703136375872e-06
inactivation O 0 3.6092972095502773e-06
of O 0 7.178061617318932e-11
PTEN O 0 0.0005176303675398231
/ O 0 3.221358565497212e-05
MMAC1 O 0 1.8998311134055257e-05
in O 0 1.2696951934287881e-08
primary O 1 0.5740374326705933
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.7504675042800955e-08

Sporadic B-Disease 1 0.9999940395355225
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 9.030639569473919e-10
the O 0 2.0983491636969442e-13
most O 0 2.6607402804461333e-13
common O 0 2.760651776623213e-11
male B-Disease 0 6.07518924056194e-10
cancer I-Disease 0 1.2567993312728731e-09
in O 0 8.047481084294539e-12
the O 0 1.7282555323915733e-13
Western O 0 4.469099049164704e-11
world O 0 6.885243764020998e-11
, O 0 1.1633057798304813e-12
yet O 0 2.9007508201006615e-12
many O 0 1.161761167817318e-14
of O 0 8.218530400125941e-16
the O 0 5.895453074425969e-15
major O 0 2.8879142458491935e-13
genetic O 0 4.306660063291279e-12
events O 0 9.91352589211833e-14
involved O 0 2.9409679986464043e-12
in O 0 5.625532158159974e-12
the O 0 1.1014041241541594e-12
progression O 0 6.69589800272874e-11
of O 0 1.1146452989394765e-14
this O 0 2.80845821858805e-13
often O 0 1.6221583798436967e-10
fatal O 0 4.168169027707336e-07
cancer B-Disease 0 7.347030077653471e-06
remain O 0 2.2356898554676263e-08
to O 0 5.445022037420255e-12
be O 0 6.729648088787954e-11
elucidated O 0 1.9908089399223172e-08
. O 0 8.531543527201535e-11

Numerous O 0 1.800103399673958e-09
cytogenetic O 0 2.6958905436913483e-06
and O 0 4.156406330224627e-10
allelotype O 0 3.043738416863562e-08
studies O 0 9.245972043547823e-11
have O 0 4.8591222191751715e-12
reported O 0 3.93950205790361e-10
frequent O 0 2.1574340924868096e-10
loss O 0 1.0985272691499404e-09
of O 0 7.999393790598941e-13
heterozygosity O 0 1.261768716176448e-07
on O 0 1.519170345076759e-09
chromosomal O 0 0.0005947361350990832
arm O 0 0.015216599218547344
10q O 0 7.427522064062941e-07
in O 0 4.729677094417184e-09
sporadic B-Disease 1 0.999997615814209
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.4726058978075116e-09

Deletion O 0 1.9467188394628465e-07
mapping O 0 2.086408601442713e-09
studies O 0 2.2019756851232586e-10
have O 0 2.3736370941690454e-12
unambiguously O 0 1.4099928169475362e-10
identified O 0 5.691835891497021e-11
a O 0 1.2594875229560154e-12
region O 0 9.601456782415418e-12
of O 0 1.5835302632962595e-13
chromosome O 0 4.412868293002248e-09
10q23 O 0 9.833583947127522e-10
to O 0 2.657332090916925e-13
be O 0 3.250631372148788e-13
the O 0 3.821195679212623e-14
minimal O 0 1.3727453201939355e-11
area O 0 1.1073785118054236e-11
of O 0 2.8769148521790022e-12
loss O 0 1.7202747670808094e-08
. O 0 2.62142751950023e-10

A O 0 5.1295849345933675e-08
new O 0 2.6803819164200604e-09
tumor B-Disease 0 1.3905940932090743e-07
suppressor O 0 2.2870219140713743e-07
gene O 0 4.331506531229934e-08
, O 0 1.545871070041116e-10
PTEN O 0 2.5990944777731784e-05
/ O 0 6.3314168983197305e-06
MMAC1 O 0 7.194380486907903e-06
, O 0 1.8956950592619037e-11
was O 0 1.6501537636326447e-10
isolated O 0 1.9292693831385321e-10
recently O 0 1.6331087593357552e-09
at O 0 3.8356939152661695e-12
this O 0 6.299926976849422e-15
region O 0 4.4234857747224576e-13
of O 0 5.354580101253441e-14
chromosome O 0 3.588320973690884e-09
10q23 O 0 1.1655462150983453e-09
and O 0 1.207629374104513e-12
found O 0 2.861875016482718e-12
to O 0 4.3461826341626916e-14
be O 0 1.8633475296590818e-13
inactivated O 0 3.6036174044795644e-12
by O 0 3.3456764648217424e-14
mutation O 0 4.461144301193265e-11
in O 0 1.919901321256745e-10
three O 0 3.376566937163261e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 0 2.058102154478547e-06
lines O 0 1.898236803299369e-07
. O 0 1.9866734923823515e-09

We O 0 4.786716356619536e-09
screened O 0 1.2029839524529962e-07
80 O 0 3.4727891673469458e-09
prostate B-Disease 0 0.00024160454631783068
tumors I-Disease 1 1.0
by O 0 6.732555051652822e-13
microsatellite O 0 1.177767994242629e-09
analysis O 0 1.1943145257486965e-11
and O 0 5.344257480131842e-13
found O 0 4.460070333889288e-12
chromosome O 0 2.9145201807523335e-09
10q23 O 0 1.2033890550711135e-09
to O 0 7.118038255170267e-13
be O 0 4.3766171242687335e-12
deleted O 0 1.3132712695096416e-09
in O 0 3.553140420775591e-11
23 O 0 9.678704365745361e-11
cases O 0 3.8857392997693196e-11
. O 0 2.3011793859328833e-11

We O 0 4.214755766618339e-10
then O 0 2.188874949349273e-12
proceeded O 0 1.2219770334498392e-11
with O 0 2.15274249401804e-15
sequence O 0 1.2595180703522252e-13
analysis O 0 2.513474996711229e-13
of O 0 5.762444761268047e-15
the O 0 2.4938910528696234e-13
entire O 0 8.201200829560662e-11
PTEN O 0 2.9770897526759654e-05
/ O 0 6.388743827301369e-07
MMAC1 O 0 5.341061637409439e-07
coding O 0 4.576073564521721e-08
region O 0 3.739790144230426e-10
and O 0 1.681486547222555e-11
tested O 0 4.655777499640301e-11
for O 0 3.83197535931256e-14
homozygous O 0 1.4715059726277957e-10
deletion O 0 9.216848811943734e-11
with O 0 1.1544018236990528e-13
new O 0 6.9014121674426665e-12
intragenic O 0 6.040483224722948e-09
markers O 0 6.786470274633416e-10
in O 0 1.0267435339439412e-11
these O 0 9.2961825303578e-13
23 O 0 7.625278880540876e-12
cases O 0 1.989772496074904e-12
with O 0 7.76618461380274e-13
10q23 O 0 5.2432927333256885e-08
loss O 0 5.142150261150391e-09
of O 0 5.253041925057378e-12
heterozygosity O 0 5.382539711717982e-07
. O 0 1.103923286116526e-09

The O 0 1.5004194067747e-11
identification O 0 4.63570744291264e-11
of O 0 1.4652497693900396e-13
the O 0 8.644624187488514e-13
second O 0 2.792614195445964e-10
mutational O 0 2.8627599846231533e-08
event O 0 1.3858096094276906e-11
in O 0 5.199396468924533e-11
10 O 0 2.607318224170929e-12
( O 0 1.4692413952133165e-12
43 O 0 2.6599411909189463e-11
% O 0 2.1938877797778034e-11
) O 0 4.082028048912889e-10
tumors B-Disease 1 1.0
establishes O 0 3.023585293249198e-07
PTEN O 0 0.00033428939059376717
/ O 0 2.363095700275153e-05
MMAC1 O 0 5.051068455941277e-06
as O 0 2.8522963504973298e-11
a O 0 4.131969506132593e-12
main O 0 2.953330635602214e-11
inactivation O 0 8.088067993128334e-10
target O 0 6.358513021664791e-11
of O 0 5.720584596302647e-13
10q O 0 3.245163426868203e-08
loss O 0 9.323334104749392e-09
in O 0 3.9111882621511995e-09
sporadic B-Disease 1 0.9999996423721313
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3771642987391317e-10
. O 0 7.600279433583879e-11

Risk O 0 9.264260256713897e-07
reversals O 0 1.172168140328722e-08
in O 0 9.338038155226602e-12
predictive O 0 3.539838866473133e-09
testing O 0 1.0612216660987883e-09
for O 0 4.216240898080592e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.0791823818200328e-09

The O 0 2.2822788797727256e-11
first O 0 1.1653538377343065e-11
predictive O 0 3.79949671724944e-09
testing O 0 6.160722487713599e-10
for O 0 1.8161586817777575e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.501620075649583e-11
HD B-Disease 0 1.7241713123894442e-07
) O 0 2.047631812371331e-12
was O 0 1.8171981280845628e-11
based O 0 3.5950067792459017e-13
on O 0 1.6236519507356606e-12
analysis O 0 8.369281287966268e-13
of O 0 8.083497995861437e-15
linked O 0 1.3797152309535932e-10
polymorphic O 0 1.328913229459161e-10
DNA O 0 4.638670350609608e-11
markers O 0 7.589107293981545e-12
to O 0 9.647228897896945e-14
estimate O 0 7.623068842832481e-12
the O 0 5.206195514300717e-14
likelihood O 0 3.475204152225686e-11
of O 0 9.04196151545883e-14
inheriting O 0 3.589297747907949e-10
the O 0 1.156710144334383e-12
mutation O 0 7.99973767784401e-11
for O 0 6.2894429248006034e-12
HD B-Disease 0 1.2837896292694495e-06
. O 0 5.127583913022704e-10

Limits O 0 1.933424670363948e-10
to O 0 1.417790581118017e-12
accuracy O 0 2.3640821938952783e-11
included O 0 3.639713449252527e-14
recombination O 0 9.042845682330491e-13
between O 0 7.062951704614809e-14
the O 0 3.255159135946359e-14
DNA O 0 8.795075778778028e-12
markers O 0 7.972406589062953e-12
and O 0 2.072447438270994e-13
the O 0 4.6252522076023136e-14
mutation O 0 1.293106854233228e-11
, O 0 1.1825766060846732e-12
pedigree O 0 6.769005356233038e-10
structure O 0 4.880299723369896e-12
, O 0 1.6442446362785468e-13
and O 0 1.1786937799494052e-13
whether O 0 1.5932737171698436e-13
DNA O 0 9.071268042282199e-12
samples O 0 6.901224383626392e-13
were O 0 2.877028313936353e-13
available O 0 3.06499427617582e-13
from O 0 3.277764073616324e-13
family O 0 4.123710487663468e-12
members O 0 4.307093147849078e-13
. O 0 1.3917908492366848e-11

With O 0 9.764085373564768e-12
direct O 0 3.018261682252721e-11
tests O 0 3.0633157122039734e-10
for O 0 9.503057452823864e-15
the O 0 5.675663525316413e-14
HD B-Disease 0 1.5730395830360067e-07
mutation O 0 1.558416763691728e-11
, O 0 2.776299969000501e-13
we O 0 1.7669366132993386e-13
have O 0 1.576982901901891e-14
assessed O 0 2.683256178012683e-13
the O 0 1.9692376764348426e-15
accuracy O 0 5.427863714047021e-11
of O 0 1.4824418277138707e-14
results O 0 1.6673854137672084e-12
obtained O 0 5.593388707932079e-13
by O 0 8.989719911403973e-14
linkage O 0 2.8808821994630307e-10
approaches O 0 2.9766869524827655e-11
when O 0 9.672882069974853e-13
requested O 0 1.0095569128940052e-12
to O 0 2.484841217335887e-13
do O 0 1.5455078189452465e-11
so O 0 9.088525288261651e-14
by O 0 3.681042134924843e-15
the O 0 1.0492401083172717e-13
test O 0 1.1975718160195381e-11
individuals O 0 2.618645046897211e-13
. O 0 1.1913613325031935e-11

For O 0 3.010067889386292e-12
six O 0 4.1146572911029966e-13
such O 0 5.5311293807353175e-15
individuals O 0 4.2902588084795315e-14
, O 0 3.713676230681501e-13
there O 0 1.856306991801504e-12
was O 0 1.6664674848398953e-11
significant O 0 3.7803617116034804e-13
disparity O 0 8.452787948753926e-12
between O 0 3.390918459651032e-13
the O 0 2.8728241573822144e-12
tests O 0 9.681035972874952e-10
. O 0 2.3821510736210527e-11

Three O 0 4.8676587066642796e-11
went O 0 7.068515217589777e-11
from O 0 2.0808604405536668e-13
a O 0 8.595120058393912e-13
decreased O 0 2.765450313191309e-09
risk O 0 1.6760262882414834e-12
to O 0 1.8032454767943646e-15
an O 0 2.3159430848226047e-15
increased O 0 7.897400615408667e-12
risk O 0 4.9872949520191057e-11
, O 0 1.124846133663919e-13
while O 0 3.224879402147912e-13
in O 0 3.213679593706137e-13
another O 0 1.4220696018321655e-12
three O 0 2.98532059532855e-13
the O 0 5.231123151837325e-13
risk O 0 2.179122216006135e-09
was O 0 2.106963936654438e-09
decreased O 0 1.4996722086380032e-08
. O 0 7.38749200701605e-11

Knowledge O 0 4.768898609341932e-10
of O 0 9.603937382775957e-14
the O 0 3.908665044730607e-14
potential O 0 1.7268386156774063e-13
reasons O 0 4.163048757718085e-13
for O 0 3.6887450525471734e-15
these O 0 4.422806251010852e-15
changes O 0 1.2346551461327876e-13
in O 0 4.21860376492722e-12
results O 0 3.6353479254680465e-11
and O 0 1.2712677048207222e-12
impact O 0 1.4288150740685013e-12
of O 0 9.035423268138974e-15
these O 0 1.5647802064505667e-13
risk O 0 6.575583393758633e-12
reversals O 0 8.826838565623163e-12
on O 0 1.6866626910243265e-13
both O 0 7.100095793417804e-14
patients O 0 4.906227334122715e-12
and O 0 5.491177377712174e-14
the O 0 5.703009814611928e-14
counseling O 0 1.203973205854414e-11
team O 0 1.987100330743015e-14
can O 0 7.906009018027876e-15
assist O 0 1.4289989615332184e-14
in O 0 4.884851204089991e-13
the O 0 2.987814192562631e-14
development O 0 1.2494017864565776e-13
of O 0 2.0528923443715718e-15
strategies O 0 5.338653781203351e-13
for O 0 2.3887665307045563e-15
the O 0 2.864553958078185e-14
prevention O 0 7.874147514574936e-12
and O 0 3.5950683077191903e-13
, O 0 1.7306922767742344e-14
where O 0 8.803252384329517e-15
necessary O 0 2.4585598314141865e-12
, O 0 3.550853729973602e-13
management O 0 9.3793028899114e-13
of O 0 7.707352898600668e-16
a O 0 6.627915230539294e-12
risk O 0 5.746368936243584e-10
reversal O 0 1.1004224614863389e-10
in O 0 8.436515917288612e-13
any O 0 9.219476310856622e-13
predictive O 0 1.618564948735468e-09
testing O 0 3.0410657325674606e-10
program O 0 5.28541654887249e-11
. O 0 3.874998412423114e-12
. O 0 1.9162895228963528e-11

A O 0 4.072705284130507e-09
novel O 0 1.5162205935226325e-09
common O 0 3.375000723337962e-09
missense O 0 3.6516819363896502e-06
mutation O 0 7.127090384528856e-08
G301C O 0 2.1708599362568748e-08
in O 0 1.1325759774472033e-11
the O 0 8.372266638648207e-13
N O 0 3.06993852561277e-09
- O 0 1.434666607735835e-09
acetylgalactosamine O 0 2.152493379981024e-06
- O 0 8.831803732789467e-09
6 O 0 3.942538795431716e-10
- O 0 2.342633198537669e-09
sulfate O 0 2.6367885652689438e-09
sulfatase O 0 2.135728749408372e-08
gene O 0 3.4579901164732973e-09
in O 0 4.433746980669895e-10
mucopolysaccharidosis B-Disease 0 9.742186648509232e-07
IVA I-Disease 0 1.691618854238186e-05
. O 0 1.8072245921985086e-09

Mucopolysaccharidosis B-Disease 0 0.002988919848576188
IVA I-Disease 1 0.9977580904960632
( O 0 3.0848321330267936e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 3.842991758151726e-10
is O 0 1.482848392686531e-11
an O 0 1.3562141860934407e-11
autosomal B-Disease 1 0.999988317489624
recessive I-Disease 1 0.9999995231628418
lysosomal I-Disease 1 0.9999971389770508
storage I-Disease 1 0.9999948740005493
disorder I-Disease 1 0.9999998807907104
caused O 0 3.6268881231649175e-09
by O 0 1.5793264048977185e-12
a O 0 7.36489411679031e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.0740205386449162e-10
N O 0 8.836153853053474e-08
- O 0 2.999031067929536e-08
acetylgalactosamine O 0 5.482633787323721e-05
- O 0 1.189181872973677e-07
6 O 0 4.358321703534784e-09
- O 0 2.8446510924595714e-08
sulfate O 0 5.482643317122893e-08
sulfatase O 0 7.545646667495021e-07
( O 0 1.3442087720694218e-10
GALNS O 0 1.068461159547951e-07
) O 0 3.9293769626969066e-11
. O 0 6.661377005556801e-11

In O 0 3.3559985346265364e-10
previous O 0 2.266462538480507e-11
studies O 0 1.9906390771873284e-11
, O 0 3.9070572406714466e-13
we O 0 1.3082560750866945e-13
have O 0 1.0692729626802632e-14
found O 0 1.2996382941186935e-13
two O 0 4.892426727957054e-15
common O 0 6.251621941476271e-13
mutations O 0 1.4936179029700902e-11
in O 0 4.475878435244995e-12
Caucasians O 0 1.248985026514049e-09
and O 0 1.1094504655251303e-11
Japanese O 0 2.862658443625321e-10
, O 0 2.050751062021572e-12
respectively O 0 1.0353792129214057e-10
. O 0 5.4591775544565735e-11

To O 0 5.7053244073568266e-11
characterize O 0 3.4752212219046896e-09
the O 0 9.847332151091681e-12
mutational O 0 4.619614557554996e-08
spectrum O 0 2.362685602719239e-10
in O 0 1.7821276138835218e-12
various O 0 7.904670705971215e-14
ethnic O 0 1.891189705923238e-13
groups O 0 2.3539154024414255e-13
, O 0 1.3925974089168403e-12
mutations O 0 3.4653419023200627e-11
in O 0 2.9859656414110702e-12
the O 0 4.3988003886087645e-13
GALNS O 0 7.718424233082999e-10
gene O 0 4.639944678475061e-11
in O 0 4.967147353152068e-12
Colombian O 0 1.2453983622151554e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 9.601676254078484e-08
were O 0 7.218312319395848e-12
investigated O 0 4.1354804997117967e-11
, O 0 6.835653462537727e-14
and O 0 9.458686140101716e-14
genetic O 0 3.0426192815236064e-11
backgrounds O 0 2.695816833653275e-11
were O 0 3.8025482827601376e-13
extensively O 0 1.953618039909899e-12
analyzed O 0 3.7721887245767416e-12
to O 0 8.300077205397605e-14
identify O 0 7.344049847424206e-12
racial O 0 1.3755333677645254e-12
origin O 0 2.243382779890113e-12
, O 0 3.0804430729315657e-13
based O 0 6.698139222091615e-13
on O 0 3.929779245070986e-12
mitochondrial O 0 2.7993710127738325e-10
DNA O 0 2.351963512836619e-09
( O 0 1.5079361370684552e-11
mtDNA O 0 8.631987569174271e-09
) O 0 3.1712542314377146e-11
lineages O 0 1.5248350138108435e-08
. O 0 9.002916190326005e-10

Three O 0 1.680765943090634e-10
novel O 0 2.578006419451384e-10
missense O 0 5.170734311832348e-07
mutations O 0 1.859748266497263e-08
never O 0 1.9201586987094288e-09
identified O 0 1.3160689205093945e-10
previously O 0 3.5009627575438573e-12
in O 0 2.8309711345986255e-13
other O 0 2.012929584029998e-14
populations O 0 1.8206517836318742e-13
and O 0 1.881300453962509e-12
found O 0 1.1701745128434027e-10
in O 0 1.8901215315114683e-10
16 O 0 3.111305310610213e-11
out O 0 1.5926182898515218e-12
of O 0 8.466461581292661e-14
19 O 0 1.1320430703953832e-10
Colombian O 0 1.8371071774936354e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 0.9999994039535522
unrelated O 0 2.0193038352545045e-08
alleles O 0 1.61108049123726e-09
account O 0 1.6703825822528273e-10
for O 0 6.4388138917848e-12
84 O 0 6.084976966747035e-10
. O 0 2.3192643638925148e-10

2 O 0 6.780027095310004e-10
% O 0 1.3050149502702446e-11
of O 0 1.4861733466597048e-14
the O 0 1.062373862384218e-13
alleles O 0 2.733468833227004e-11
in O 0 4.886859319985781e-11
this O 0 1.0768473786282318e-11
study O 0 3.4959334038742185e-11
. O 0 7.604367829872061e-11

The O 0 2.2691194756507826e-10
G301C O 0 5.289690463428087e-08
and O 0 1.5085431168126995e-11
S162F O 0 1.0289931129392471e-09
mutations O 0 2.0306298309513693e-10
account O 0 2.0993120436463286e-11
for O 0 1.016532235990908e-12
68 O 0 9.670221290392078e-10
. O 0 1.4624712552091523e-10

4 O 0 1.1003564281963918e-08
% O 0 3.9089115277946007e-10
and O 0 3.428924158499491e-11
10 O 0 2.6201115929658236e-11
. O 0 2.30793995026346e-11

5 O 0 8.327877276670392e-10
% O 0 1.0572868969216387e-11
of O 0 3.555487542296169e-14
mutations O 0 1.0201305078449963e-10
, O 0 3.0482578267099214e-12
respectively O 0 2.0092042612995797e-11
, O 0 4.4707651209591193e-13
whereas O 0 4.690573016802313e-12
the O 0 3.8736586637985737e-13
remaining O 0 6.927462770089932e-11
F69V O 0 1.07412937211393e-07
is O 0 8.582375803957432e-13
limited O 0 2.5529016834530127e-12
to O 0 2.2356600078154987e-12
a O 0 9.62753834987673e-11
single O 0 2.1790058646331545e-09
allele O 0 2.4958015387710475e-07
. O 0 3.469465603700428e-09

The O 0 1.5300950784169487e-10
skewed O 0 3.527762260091549e-08
prevalence O 0 5.27558441376641e-08
of O 0 6.52523011752254e-13
G301C O 0 5.742348263559904e-10
in O 0 7.343933404110881e-13
only O 0 2.811856650297706e-13
Colombian O 0 6.771726235310638e-11
patients O 0 2.5891136457012465e-10
and O 0 1.066278142169974e-12
haplotype O 0 5.865565255724903e-10
analysis O 0 3.862653252806325e-12
by O 0 8.848675373158976e-14
restriction O 0 2.029691692495561e-11
fragment O 0 6.70793906532019e-11
length O 0 7.845753560720148e-12
polymorphisms O 0 1.4860777053371521e-09
in O 0 1.2529110561543266e-11
the O 0 1.021488449381991e-12
GALNS O 0 1.1607104610789065e-08
gene O 0 2.4128771203280053e-10
suggest O 0 5.480836964832925e-11
that O 0 1.259367393355304e-12
G301C O 0 6.402521846027298e-10
originated O 0 3.228084466400105e-10
from O 0 4.1241038362116456e-12
a O 0 6.24185512304587e-12
common O 0 6.717119221955059e-11
ancestor O 0 1.8549082270169492e-09
. O 0 1.2256383685738115e-09

Investigation O 0 1.216290623773375e-09
of O 0 8.729570343500581e-14
the O 0 7.70439145965883e-14
genetic O 0 9.961684949155725e-11
background O 0 3.302196363574872e-11
by O 0 5.1453260326451283e-14
means O 0 2.9894244631817335e-12
of O 0 1.6349091134723603e-14
mtDNA O 0 1.3127447739957887e-10
lineages O 0 2.142114263747885e-11
indicate O 0 3.444065171942512e-11
that O 0 5.99637960813082e-13
all O 0 8.138934269380158e-14
our O 0 5.280403393183308e-13
patients O 0 1.3557376792386333e-12
are O 0 5.5593050846927845e-15
probably O 0 6.348366710789977e-12
of O 0 4.021054712479875e-15
native O 0 3.667998196843492e-12
American O 0 2.2131757537735552e-10
descent O 0 8.827897204355395e-07

Low O 0 4.2967741364918766e-07
frequency O 0 7.643697230719226e-09
of O 0 9.30811070581905e-12
BRCA1 O 0 2.7017074444302125e-06
germline O 0 9.601254902236178e-08
mutations O 0 3.3536771137931964e-09
in O 0 1.8954204525356566e-11
45 O 0 2.2009846722959026e-10
German O 1 0.9999823570251465
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.3680977179196816e-08
. O 0 8.704896248268312e-10

In O 0 2.7724839091192166e-10
this O 0 4.221056555502034e-13
study O 0 6.138919125646403e-13
we O 0 3.654629767216311e-13
investigated O 0 3.1668782179972155e-11
45 O 0 1.0715899521895889e-11
German O 1 0.971447765827179
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.684344191899001e-10
for O 0 6.785450023041872e-13
germline O 0 3.858051300653642e-08
mutations O 0 5.355482723956584e-09
in O 0 2.05153827953497e-11
the O 0 9.853400213810648e-12
BRCA1 O 0 3.9444876165362075e-07
gene O 0 1.3754907968177577e-07
. O 0 2.7815638681261134e-09

We O 0 4.2987288728646433e-10
identified O 0 2.6695998189829595e-10
four O 0 1.408488885419612e-12
germline O 0 5.469814379210902e-09
mutations O 0 2.8181978972696697e-09
in O 0 1.8093414266839858e-10
three O 0 3.7109204598095857e-10
breast B-Disease 0 0.00023275184503290802
cancer I-Disease 0 3.649224026958109e-06
families O 0 4.36462324615583e-11
and O 0 2.5674438703521263e-12
in O 0 3.6881900311591664e-11
one O 0 4.125861323700519e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 5.88951110103153e-10
. O 0 6.480649079442652e-14
among O 0 2.7927628336006996e-14
these O 0 1.2998781060867201e-14
were O 0 6.164936183078451e-12
one O 0 5.239673278589763e-12
frameshift O 0 1.4767097411549912e-07
mutation O 0 4.349624549426778e-10
, O 0 1.1583996782638106e-11
one O 0 4.402363543154486e-11
nonsense O 0 1.4373618796525989e-05
mutation O 0 3.7079292969366406e-09
, O 0 4.106795632730087e-12
one O 0 5.33575245618978e-13
novel O 0 2.2605995200764006e-11
splice O 0 2.4984163360386447e-07
site O 0 2.071700588857084e-09
mutation O 0 1.2682018102339043e-08
, O 0 2.479065008831327e-10
and O 0 7.056513012804189e-11
one O 0 8.566994336156597e-11
missense O 0 1.2899348803330213e-05
mutation O 0 1.5047054091610335e-07
. O 0 2.9374012111560432e-09

The O 0 7.824520892318887e-11
missense O 0 1.2380685632251698e-07
mutation O 0 2.2641961638925068e-09
was O 0 6.587179690598077e-09
also O 0 2.808309791310637e-12
found O 0 1.5751277018805077e-11
in O 0 4.228030772712721e-11
2 O 0 3.687528754570124e-11
. O 0 1.3819197175468645e-10

8 O 0 1.9370245407657194e-09
% O 0 4.4257579372153355e-12
of O 0 4.125812359264498e-15
the O 0 4.288791662711592e-15
general O 0 1.782996391860598e-14
population O 0 7.35438304629325e-15
, O 0 8.574745595643293e-14
suggesting O 0 2.7241731440086348e-11
that O 0 3.6497050498983385e-13
it O 0 1.9296576055788384e-12
is O 0 2.696514886380008e-12
not O 0 9.073124196401494e-11
disease O 0 1.7743125857450082e-09
associated O 0 2.0592663685370383e-10
. O 0 3.348549493242814e-10

The O 0 4.9370008081695005e-11
average O 0 3.6013829696202038e-09
age O 0 1.197874022196288e-10
of O 0 9.84631321788998e-13
disease O 0 5.274799619314763e-08
onset O 0 2.70065703134037e-09
in O 0 9.818351643861578e-13
those O 0 1.3736448502103815e-13
families O 0 3.787449141205018e-13
harbouring O 0 1.132607341247649e-09
causative O 0 2.113586283769564e-08
mutations O 0 7.944034763340824e-09
was O 0 4.690839272569747e-09
between O 0 4.972117162438394e-11
32 O 0 1.4446949192503666e-09
. O 0 1.9279304541708342e-10

3 O 0 5.8060876995114086e-08
and O 0 4.489914273708706e-10
37 O 0 1.367441937460967e-09
. O 0 5.8083166748490456e-11

4 O 0 7.437180649105812e-09
years O 0 2.315197165925209e-11
, O 0 1.5949824197936807e-13
whereas O 0 5.703774041618259e-13
the O 0 3.0899216426618845e-14
family O 0 3.1581421505721963e-12
harbouring O 0 4.189164848344973e-10
the O 0 4.759695242106954e-13
missense O 0 8.817025332064077e-09
mutation O 0 2.544654487124376e-10
had O 0 6.875677110995682e-11
an O 0 9.05974310871395e-14
average O 0 1.225855111863794e-10
age O 0 2.3155505290972656e-11
of O 0 1.7259429291576617e-13
onset O 0 5.191038265905945e-09
of O 0 7.914164115718769e-13
51 O 0 3.178542540283047e-09
. O 0 2.3712590224711505e-10

2 O 0 8.794943084922124e-08
years O 0 1.867254129095386e-09
. O 0 3.170022300214015e-10

These O 0 7.722701818313471e-12
findings O 0 1.1918749841244303e-11
show O 0 9.23891518844755e-12
that O 0 5.96528252141959e-13
BRCA1 O 0 4.608947961060039e-07
is O 0 7.007152670601702e-12
implicated O 0 1.0861096050307495e-10
in O 0 7.032105475181238e-13
a O 0 1.2070462088609873e-13
small O 0 5.345684290190833e-13
fraction O 0 5.168566616364778e-11
of O 0 8.54429915708721e-10
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.698248288834364e-11
suggesting O 0 3.029393055853369e-11
the O 0 7.678323173674131e-14
involvement O 0 9.938943765219754e-12
of O 0 3.165387873690917e-14
another O 0 2.7833850675673677e-12
susceptibility O 0 1.1397153221182066e-09
gene O 0 3.959770467076851e-08
( O 0 1.2088550160882505e-09
s O 0 1.0005463764173328e-06
) O 0 9.38393807103921e-09

Paternal O 0 0.00021852627105545253
transmission O 0 0.0007078507333062589
of O 0 1.2587407560715747e-08
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.7274845137981174e-07

We O 0 4.432667122244993e-09
report O 0 1.4682539906107905e-10
a O 0 1.2378507507210257e-12
rare O 0 1.2912271252218943e-10
case O 0 1.1494694085456558e-09
of O 0 1.6249911138910278e-11
paternally O 0 0.00499220285564661
transmitted O 1 0.9999802112579346
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0005837167263962328
DM B-Disease 1 1.0
) O 0 6.158070942063887e-09
. O 0 5.460409346902395e-10

The O 0 8.720280747498421e-11
proband O 0 4.9761947451543165e-08
is O 0 7.191666099443106e-12
a O 0 9.715970215873337e-12
23 O 0 6.071074198921167e-11
year O 0 1.7404305427404232e-11
old O 0 9.046885679708794e-06
, O 0 3.901628797819967e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 8.886653191098048e-09
who O 0 4.386156438052069e-10
suffers O 0 2.9493405236280523e-05
severe O 0 0.00019833032274618745
muscular B-Disease 0 0.3633789122104645
weakness I-Disease 1 0.9813427329063416
. O 0 1.1064850369280066e-08

He O 0 1.8062872308988176e-09
presented O 0 1.3322480618693788e-10
with O 0 1.2165962681720544e-10
respiratory O 1 0.9978418350219727
and O 0 1.5013427168142357e-09
feeding O 0 2.1320807341851378e-09
difficulties O 0 8.00266075628997e-09
at O 0 1.1198642707599404e-10
birth O 0 4.944052389710407e-10
. O 0 6.416712300394423e-11

His O 0 1.5518283547066858e-08
two O 0 8.408575502549809e-10
sibs O 0 0.0036472862120717764
suffer O 0 2.9284045012900606e-05
from O 0 5.15553322255613e-10
childhood O 0 4.97968767376733e-06
onset O 1 0.5282029509544373
DM B-Disease 1 1.0
. O 0 1.5541269604568697e-08

Their O 0 8.997074613104061e-11
late O 0 7.430984272360774e-09
father O 0 1.3928379283267844e-10
had O 0 5.48966427871278e-12
the O 0 9.934379335059963e-15
adult O 0 2.5135336520487606e-12
type O 0 8.107111648669729e-10
of O 0 1.0760595192671474e-10
DM B-Disease 1 1.0
, O 0 3.3420523293248294e-11
with O 0 1.6841625750246836e-12
onset O 0 6.491478021786179e-09
around O 0 1.0406396577788968e-10
30 O 0 3.957869101900435e-11
years O 0 7.038765403866165e-12
. O 0 1.4521692008606646e-11

Only O 0 2.6878191339285706e-10
six O 0 2.603620877922319e-12
other O 0 2.5211557898329774e-14
cases O 0 1.1482400317022745e-13
of O 0 8.00188806545938e-15
paternal O 0 3.778540502707983e-08
transmission O 0 4.535664174909471e-06
of O 0 6.876794689247845e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.345758698396594e-09
been O 0 2.513579344665118e-10
reported O 0 2.0871449013526444e-09
recently O 0 1.4817812532541552e-09
. O 0 6.986071443559894e-11

We O 0 1.896253015720717e-10
review O 0 4.0674902682114045e-12
the O 0 2.276684293563494e-14
sex O 0 8.809145253529937e-12
related O 0 5.361044073948218e-12
effects O 0 5.4189156634132374e-11
on O 0 4.957772525848725e-10
transmission O 0 6.95672088113497e-06
of O 0 3.6178098294925576e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.6938111357944763e-08

Decreased O 0 5.940261758041743e-07
fertility O 0 5.740981912083498e-09
of O 0 6.234305470953147e-14
males O 0 3.2232886065103328e-12
with O 0 3.4245346901100315e-13
adult O 0 4.513571738584687e-09
onset O 0 0.00013596072676591575
DM B-Disease 1 1.0
and O 0 3.4287755967810085e-10
contraction O 0 3.85153509085967e-09
of O 0 5.588605224887732e-15
the O 0 3.839122962134671e-14
repeat O 0 6.9130842543507764e-12
upon O 0 4.006732825297815e-14
male O 0 1.8847555894457857e-12
transmission O 0 4.728752805993608e-11
contribute O 0 8.023215880732792e-13
to O 0 5.536644276729619e-13
the O 0 2.1373094266641246e-12
almost O 0 9.063645667328757e-11
absent O 0 3.083303404260995e-11
occurrence O 0 6.998991664008969e-12
of O 0 2.672426726256765e-14
paternal O 0 1.4534764503082442e-08
transmission O 0 7.392978886855417e-07
of O 0 1.2198080323599925e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.258585851677708e-08

Also O 0 1.6478325648439096e-10
the O 0 3.0731309424297804e-13
fathers O 0 1.6618259502873545e-12
of O 0 1.207606826087457e-15
the O 0 8.642278516088342e-14
reported O 0 4.153826438368924e-08
congenitally O 0 5.135427727509523e-06
affected O 0 6.246173023249924e-10
children O 0 6.898309701242056e-11
showed O 0 5.335313302268219e-10
, O 0 4.040656427072714e-13
on O 0 1.4524379095270934e-11
average O 0 1.4828038796821374e-10
, O 0 2.3089603146120297e-12
shorter O 0 1.6766914967547564e-08
CTG O 0 1.1309634828648996e-07
repeat O 0 3.280778981817889e-09
lengths O 0 1.2130824345035762e-08
and O 0 8.660290366779844e-12
hence O 0 3.041609672460588e-11
less O 0 4.9210746588812526e-11
severe O 0 2.277168675846042e-08
clinical O 0 1.1667834698414481e-08
symptoms O 0 4.638403083845333e-08
than O 0 4.618386836158228e-13
the O 0 1.8989139687758394e-13
mothers O 0 2.472834784161826e-11
of O 0 2.5719747173496253e-14
children O 0 6.988096906690444e-11
with O 0 1.0271872241673918e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 4.4162131729308385e-08

We O 0 3.540626958287163e-10
conclude O 0 4.095199734877042e-10
that O 0 6.759898630442907e-13
paternal O 0 1.4358144895254554e-08
transmission O 0 4.45659281922417e-07
of O 0 1.1481942063795714e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.570877732921417e-09
rare O 0 1.2007821403869912e-09
and O 0 8.716252546114855e-12
preferentially O 0 1.3035279800011068e-10
occurs O 0 1.6952685999785388e-12
with O 0 1.1868671735519587e-13
onset O 0 4.05282163384868e-09
of O 0 3.680472159678372e-12
DM B-Disease 1 1.0
past O 0 5.1387036986705326e-11
30 O 0 5.2069164951928926e-12
years O 0 6.679385235013047e-13
in O 0 3.11083895188774e-13
the O 0 1.8702017202682636e-13
father O 0 3.1114059245718195e-11
. O 0 4.4325903624659047e-13
. O 0 4.872895489893558e-12

The O 0 8.604548185076055e-10
RB1 O 0 4.788481646755827e-07
gene O 0 4.448861723460595e-09
mutation O 0 1.6438121974715614e-09
in O 0 6.507339112005184e-11
a O 0 7.63072827147937e-10
child O 0 4.062853349751094e-06
with O 0 3.80811604472342e-09
ectopic B-Disease 1 0.9999998807907104
intracranial I-Disease 1 0.9999986886978149
retinoblastoma I-Disease 1 0.9985600113868713
. O 0 3.4758400602186157e-07

The O 0 1.1266649835306453e-09
RB1 O 0 3.908424162091251e-07
gene O 0 9.624206320779649e-09
mutation O 0 2.823072220436984e-09
was O 0 2.698354317764995e-10
investigated O 0 1.5680542975182732e-10
in O 0 6.764777540219091e-12
a O 0 3.868304288001667e-10
child O 0 1.6543521041967324e-06
with O 0 3.9606201651665174e-10
ectopic B-Disease 1 0.999994158744812
intracranial I-Disease 0 0.015623264014720917
retinoblastoma I-Disease 0 8.50963246534775e-08
using O 0 4.2441657827074764e-11
DNA O 0 2.9091701270189674e-10
obtained O 0 8.879032058206615e-12
from O 0 5.617444443634101e-13
both O 0 1.4692209308973109e-13
the O 0 3.1680105587461593e-13
pineal B-Disease 0 3.337649090440209e-08
and I-Disease 0 3.085031252680892e-08
retinal I-Disease 1 0.9998846054077148
tumours I-Disease 1 1.0
of O 0 1.1066437696771736e-11
the O 0 1.5855417673238392e-11
patient O 0 2.5002748316182988e-08
. O 0 7.382816580303597e-11

A O 0 6.828845044992704e-08
nonsense O 0 2.5818626454565674e-06
mutation O 0 7.863023121501556e-09
in O 0 8.339189755401932e-11
exon O 0 1.2573202923249482e-08
17 O 0 1.944044786261756e-10
( O 0 1.6870570912486116e-11
codon O 0 1.6148800074944347e-09
556 O 0 2.5473498310724096e-10
) O 0 3.0216167025073903e-13
of O 0 1.000214112380736e-14
the O 0 3.506574371148208e-13
RB1 O 0 1.6979506689551727e-09
gene O 0 2.5973031017589854e-11
was O 0 3.995977854165389e-11
found O 0 1.157162473480744e-12
to O 0 3.344884997235828e-14
be O 0 1.2248039496683127e-13
present O 0 8.579326349822045e-14
homozygously O 0 1.2502124890900745e-09
in O 0 2.8835729377202357e-12
both O 0 1.3157640125008307e-12
the O 0 3.28335969523863e-12
retinal B-Disease 0 9.379357948091638e-07
and I-Disease 0 1.0129763694521898e-09
the I-Disease 0 1.977930874641487e-10
pineal I-Disease 0 0.00012740357487928122
tumours I-Disease 1 1.0
. O 0 1.3699434475711314e-08

The O 0 7.72078755095773e-12
same O 0 5.648648215839103e-12
mutation O 0 4.9212061509207317e-11
was O 0 2.8736693580277972e-11
present O 0 1.4583046413236406e-13
heterozygously O 0 3.6837768946362814e-10
in O 0 1.6778454168565882e-13
the O 0 1.533872990644794e-14
DNA O 0 3.1362440856136375e-12
from O 0 1.757856284579501e-14
the O 0 1.1279693813096708e-14
constitutional O 0 1.2493565210158764e-13
cells O 0 1.2414612523756197e-12
of O 0 6.010675389757445e-15
the O 0 1.626347575492057e-13
patient O 0 4.5751175070662953e-10
, O 0 1.6549705128456743e-13
proving O 0 5.54340254255159e-11
it O 0 1.4097542035650112e-13
to O 0 1.3354286209840693e-13
be O 0 7.223046488182006e-13
of O 0 4.463129085058304e-14
germline O 0 2.1857411436343455e-09
origin O 0 3.4638106272133484e-10
. O 0 2.0017576485287236e-10

The O 0 1.2704272529806548e-11
initial O 0 3.0210726281731937e-11
mutation O 0 2.72320152538974e-11
was O 0 3.3904955232255674e-11
shown O 0 6.486415137646473e-13
to O 0 1.9043691320067002e-13
have O 0 1.1597261345697163e-11
occurred O 0 2.932831755231291e-10
in O 0 2.3079871347420067e-12
the O 0 1.1798819300051777e-12
paternally O 0 8.434794196432449e-09
derived O 0 2.7819775372250888e-09
RB1 O 0 2.733885594352614e-06
allele O 0 8.767103736317949e-07
. O 0 1.588095699389669e-08

The O 0 2.3114465202977996e-11
mutation O 0 3.1897948171710766e-10
is O 0 2.68908268048762e-12
in O 0 1.3101345095606343e-12
an O 0 5.0200217382523685e-14
area O 0 2.6269355614394474e-12
of O 0 5.583430446503071e-14
the O 0 1.0631887080794766e-13
gene O 0 1.7196750967674035e-11
that O 0 8.398492947099545e-14
encodes O 0 7.979523075282713e-13
the O 0 3.212482905558256e-14
protein O 0 5.858440121908615e-11
- O 0 7.734704543516102e-11
binding O 0 1.5475697112687925e-11
region O 0 5.365384178612764e-11
known O 0 9.781836451949744e-11
as O 0 1.1291981238947812e-11
the O 0 3.530721721933805e-13
pocket O 0 1.3545471801990061e-06
region O 0 1.574750663202451e-09
and O 0 4.902950490048852e-09
has O 0 1.1589123757871356e-11
been O 0 2.004751399609095e-12
detected O 0 6.237906718942199e-11
in O 0 4.13269272319175e-13
other O 0 2.426218643038821e-14
cases O 0 1.6768216589552187e-13
of O 0 8.559953181659034e-15
retinoblastoma B-Disease 0 5.12684117381923e-10
. O 0 2.0312718521098283e-11
. O 0 1.046653250180718e-10

Low O 0 4.5527113456955703e-07
levels O 0 9.315947319121776e-11
of O 0 2.4709590927193825e-14
beta O 0 2.0642675069293404e-11
hexosaminidase O 0 2.698457290950529e-10
A O 0 7.582147583395926e-12
in O 0 4.09727373557045e-12
healthy O 0 5.583694617783408e-11
individuals O 0 1.4217644531307194e-14
with O 0 8.818634163838476e-14
apparent O 0 9.230615383160057e-09
deficiency O 0 4.935454126098193e-05
of O 0 1.726558620466362e-13
this O 0 2.320186794427248e-12
enzyme O 0 3.641458690140098e-09
. O 0 4.811242376723257e-11

Appreciable O 0 2.9639581953233574e-06
beta O 0 5.90323807614368e-08
hexosaminidase O 0 1.9053700839322119e-07
A O 0 3.6573549744289835e-10
( O 0 3.481686119966021e-11
hex O 0 1.6643917355452231e-09
A O 0 1.385000968079364e-11
) O 0 4.946902804926767e-13
activity O 0 1.5755249882509759e-10
has O 0 4.610439634233909e-13
been O 0 1.2702472537359788e-12
detected O 0 8.154971697926783e-10
in O 0 1.1839997038354255e-10
cultured O 0 0.159077987074852
skin O 1 0.9899638295173645
fibroblasts O 0 1.136226501330384e-06
and O 0 1.4880697563057765e-08
melanoma B-Disease 0 0.000207522462005727
tissue O 0 8.720343203094671e-08
from O 0 4.941256171592245e-12
healthy O 0 5.7112911622247964e-11
individuals O 0 1.2135275863887646e-14
previously O 0 4.779773040038127e-13
reported O 0 2.7739596730746996e-10
as O 0 1.578785192857257e-11
having O 0 9.823203583891882e-09
deficiency B-Disease 0 3.952292900066823e-06
of I-Disease 0 5.514919711223712e-14
hex I-Disease 0 1.3996455106024541e-09
A I-Disease 0 2.026025007484389e-11
activity O 0 3.6103287026634234e-10
indistinguishable O 0 2.7904989083338272e-11
from O 0 1.11212722245322e-13
that O 0 2.7394253383186858e-14
of O 0 1.3442162998206306e-14
patients O 0 4.555175334153283e-11
with O 0 4.781184892443946e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.5025331974029541
( O 0 5.03101726945232e-10
TSD B-Disease 0 3.0021099064470036e-06
) O 0 7.837770016339007e-11
. O 0 2.4349858240846345e-10

Identification O 0 8.544352780859299e-09
and O 0 2.3682207236919162e-11
quantitation O 0 4.223263516678344e-09
of O 0 5.351672880890557e-13
hex O 0 6.0385945133134555e-09
A O 0 1.3069685611544202e-10
, O 0 4.156558452463044e-13
amounting O 0 9.145467369520155e-12
to O 0 3.4104505244186845e-12
3 O 0 7.363577803065624e-11
. O 0 1.6887898024453563e-10

5 O 0 1.519356729318133e-08
% O 0 2.3608086596738076e-09
- O 0 2.975241955027741e-07
6 O 0 7.630874265807108e-10
. O 0 9.077624762987568e-11

9 O 0 1.9074410939623476e-09
% O 0 2.2288646622792285e-12
of O 0 2.0911951742464113e-15
total O 0 4.197090266479242e-14
beta O 0 4.021301000523003e-11
hexosaminidase O 0 9.229343400640744e-10
activity O 0 4.714588719423318e-10
, O 0 3.693846715047827e-13
has O 0 2.0673614458798645e-14
been O 0 3.237703819782521e-14
obtained O 0 1.62876277135654e-13
by O 0 2.6465177163474685e-13
cellulose O 0 3.810144733051857e-08
acetate O 0 7.375669519582573e-10
gel O 0 5.375448530742233e-09
electrophoresis O 0 9.8075103593942e-10
, O 0 7.762708011116448e-12
DEAE O 0 2.7661798185363295e-08
- O 0 5.823472815080777e-10
cellulose O 0 2.2118319620290094e-08
ion O 0 1.661225601523597e-10
- O 0 3.123376834945901e-10
exchange O 0 3.807844872749655e-10
chromatography O 0 6.36882976912112e-11
, O 0 6.232215806790953e-13
radial O 0 5.64467972363758e-10
immunodiffusion O 0 6.310555988875421e-08
, O 0 3.429584741199143e-11
and O 0 7.244439770293098e-11
radioimmunoassay O 0 2.6874687364397687e-07
. O 0 2.939686827296839e-10

Previous O 0 9.522610255885411e-09
family O 0 4.845714107748478e-11
studies O 0 6.7776283717291275e-12
suggested O 0 5.997171509397603e-12
that O 0 3.996528449975653e-14
these O 0 8.193710534826378e-15
individuals O 0 3.689640959295484e-14
may O 0 1.525667613078152e-11
be O 0 1.5922711012108376e-13
compound O 0 1.5456462498786294e-11
heterozygotes O 0 1.363752860639167e-10
for O 0 4.300327319716954e-14
the O 0 3.9577197720247134e-14
common O 0 6.935368251914653e-11
mutant O 0 2.1586751941526927e-08
TSD B-Disease 0 2.4403891529800603e-07
gene O 0 1.0601419297984194e-08
and O 0 2.2995265414049726e-10
a O 0 1.2946672900415734e-10
rare O 0 7.1399455237042275e-09
( O 0 2.845445823407289e-10
allelic O 0 1.2505112501060012e-08
) O 0 3.043849547412769e-11
mutant O 0 3.4966923578849674e-08
gene O 0 4.347850222075067e-07
. O 0 7.213465380573325e-09

Thus O 0 3.6297931327311517e-10
, O 0 2.5875755531312716e-12
the O 0 2.0462135404044485e-13
postulated O 0 1.196500010181012e-09
rate O 0 3.023472028296226e-10
mutant O 0 1.3704987145146674e-10
gene O 0 2.0318542681696528e-10
appears O 0 8.512606591848382e-11
to O 0 6.118716644465394e-14
code O 0 1.4415162856787345e-12
for O 0 1.0268672746155134e-14
the O 0 1.2256843726543478e-14
expression O 0 2.25067750894703e-12
of O 0 7.429052219318916e-14
low O 0 1.9958257269081514e-10
amounts O 0 5.512096421661505e-12
of O 0 1.654734725978213e-12
hex O 0 8.179046062650741e-08
A O 0 2.1080532874862e-09
. O 0 4.825305710554062e-10

Heterozygotes O 0 1.5705961686762748e-07
for O 0 3.338781941891744e-12
the O 0 2.1882436184242349e-13
rare O 0 1.6541865099917175e-11
mutant O 0 5.613710030161201e-08
may O 0 1.1335069771689632e-08
be O 0 9.107305838293445e-13
indistinguishable O 0 3.906472367809499e-11
from O 0 1.108692564838476e-12
heterozygotes O 0 2.5707883044567836e-10
for O 0 1.222780150788097e-13
the O 0 4.1475777348178033e-13
common O 0 4.863234814855844e-10
TSD B-Disease 0 7.481829698008369e-07
mutant O 0 8.192004230522798e-08
. O 0 4.253148944144414e-09

However O 0 2.5051699603650945e-10
, O 0 6.499691193248558e-13
direct O 0 7.549764632908129e-12
visualization O 0 8.523724503994856e-10
and O 0 2.1915998529853375e-11
quantitation O 0 2.5252639090922457e-08
of O 0 8.131257711423145e-13
hex O 0 5.311424633447359e-09
A O 0 6.629988658773955e-12
by O 0 4.2261536609654315e-14
the O 0 4.9961892804352426e-14
methods O 0 2.6239824549301183e-11
described O 0 6.835676469307828e-11
may O 0 3.5842336043589995e-11
prevent O 0 5.3614430603476926e-12
false O 0 8.177212795779099e-10
- O 0 1.2299988805253292e-09
positive O 0 1.3996394321313943e-10
prenatal O 0 4.2005390810118115e-07
diagnosis O 0 8.691532826787807e-08
of O 0 2.0443216076134613e-13
TSD B-Disease 0 4.246625806558768e-08
in O 0 1.4367518459679207e-11
fetuses O 0 7.676713154047832e-10
having O 0 2.58960496275773e-12
the O 0 1.323508224673406e-13
incomplete O 0 8.293384867741338e-10
hex B-Disease 0 9.086991781259712e-08
A I-Disease 0 3.250422864198299e-08
deficiency I-Disease 0 0.00035802615457214415
of O 0 6.314751239272498e-14
the O 0 5.189008402649298e-13
type O 0 5.292022251524031e-07
described O 0 2.3131998538872267e-09
in O 0 9.538433237699095e-11
the O 0 1.3300282750150494e-11
four O 0 1.1134874272622497e-10
healthy O 0 3.5279015264677582e-09
individuals O 0 6.577067362956157e-11

The O 0 8.042640442518234e-10
tumor B-Disease 0 2.83844059367766e-07
suppressor O 0 3.5793888741864066e-07
gene O 0 1.7322638257155631e-07
Smad4 O 0 2.9779573651467217e-06
/ O 0 1.0731644124462036e-06
Dpc4 O 0 2.4511951579597735e-08
is O 0 1.0467461316124305e-12
required O 0 2.3340297793453257e-13
for O 0 1.4820828551508243e-14
gastrulation O 0 3.2343076133978244e-11
and O 0 2.161921900181718e-12
later O 0 1.0331062394453028e-11
for O 0 9.082425973415062e-14
anterior O 0 4.425313240852269e-11
development O 0 2.728362891515901e-12
of O 0 4.596458847219709e-14
the O 0 4.3979381768310954e-12
mouse O 0 5.930096236284044e-08
embryo O 0 1.413341177425309e-08
. O 0 1.6047749795689015e-09

Mutations O 0 2.544005042182107e-07
in O 0 2.7331470420222104e-10
the O 0 2.400317097861482e-11
SMAD4 O 0 4.7170404286589473e-05
/ O 0 3.638250291260192e-06
DPC4 O 0 3.5078428481938317e-06
tumor B-Disease 0 4.1948143802983395e-07
suppressor O 0 4.9641457167126646e-08
gene O 0 2.779479535419682e-09
, O 0 4.003780380151811e-12
a O 0 6.328648109038548e-12
key O 0 4.4231320828203025e-09
signal O 0 2.6886421977678765e-08
transducer O 0 3.569305206951867e-08
in O 0 2.7934437749066454e-11
most O 0 9.332820107010864e-12
TGFbeta O 0 1.253544468227119e-07
- O 0 1.639312796619663e-09
related O 0 2.0111567966552002e-10
pathways O 0 1.6373957745230427e-11
, O 0 5.274119425154218e-14
are O 0 1.780110465906008e-15
involved O 0 3.7792495912250534e-14
in O 0 1.326409278636434e-13
50 O 0 5.166018979783915e-13
% O 0 3.0495430399651857e-12
of O 0 1.3314141456000073e-11
pancreatic B-Disease 0 1.985679591598455e-05
cancers I-Disease 0 1.4776410353078973e-06
. O 0 4.4696038536962135e-10

Homozygous O 0 1.8595676010590978e-05
Smad4 O 0 1.0270504390064161e-05
mutant O 0 2.9775344501103973e-06
mice O 0 0.01764243096113205
die O 0 0.00027996476273983717
before O 0 7.910463950544511e-10
day O 0 3.446064544831984e-10
7 O 0 1.0799908883862841e-10
. O 0 5.5335881710139034e-11

5 O 0 1.3497337469914328e-08
of O 0 2.8135655263938908e-11
embryogenesis O 0 4.899158412285942e-08
. O 0 1.1724538007129581e-09

Mutant O 0 3.083743038700959e-08
embryos O 0 7.163297954804193e-09
have O 0 1.431678109398149e-10
reduced O 0 1.7687490361240066e-11
size O 0 2.280068495119636e-11
, O 0 8.365870496351846e-12
fail O 0 3.6117441482019785e-08
to O 0 4.441775506430767e-12
gastrulate O 0 1.400100586579356e-07
or O 0 4.520709848132576e-11
express O 0 1.7538501900782322e-11
a O 0 1.1386146366032524e-11
mesodermal O 0 2.6889535043039814e-09
marker O 0 2.207283467114962e-09
, O 0 1.7717405667583286e-11
and O 0 7.613493169245089e-12
show O 0 1.6164145577590716e-09
abnormal O 0 1.278358610079522e-07
visceral O 0 1.0358918167696629e-08
endoderm O 0 3.191624102782953e-07
development O 0 2.4210473625885243e-09
. O 0 6.996676016335357e-10

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 3.14148717889956e-13
the O 0 8.031682957598818e-13
Smad4 O 0 1.3357650630041462e-07
- O 0 1.0372644254630359e-07
deficient O 0 2.1434625807614793e-07
embryos O 0 2.1624932400321484e-10
results O 0 3.3169675339728144e-11
from O 0 7.553419153170926e-13
reduced O 0 7.862201341357622e-12
cell O 0 3.2040023412172047e-10
proliferation O 0 1.569861740602363e-10
rather O 0 2.4133074011389866e-12
than O 0 4.529163231525163e-13
increased O 0 6.793962094298056e-12
apoptosis O 0 2.266282023155597e-10
. O 0 5.432742103406163e-11

Aggregation O 0 1.5494622473966047e-08
of O 0 3.616176151924333e-12
mutant O 0 1.9739793799544714e-08
Smad4 O 0 1.7958848275156925e-07
ES O 0 2.4067022152962636e-08
cells O 0 7.372660260074326e-10
with O 0 6.713721592555011e-12
wild O 0 9.221830521433105e-10
- O 0 1.9905628789729235e-07
type O 0 6.189868031469814e-07
tetraploid O 0 3.2414757242804626e-06
morulae O 0 7.514666503993794e-05
rescues O 0 8.023394912015647e-06
the O 0 2.615519190118931e-10
gastrulation B-Disease 0 1.5769779793117777e-06
defect I-Disease 0 1.5590545672239386e-06
. O 0 1.5256661489715384e-09

These O 0 1.818914636964042e-11
results O 0 8.130656738158937e-12
indicate O 0 2.8226748195747664e-12
that O 0 6.209526707927349e-14
Smad4 O 0 4.0087438923919194e-10
is O 0 3.2964774031134236e-14
initially O 0 5.022878814264775e-13
required O 0 4.3123599309524696e-14
for O 0 1.4054731931704696e-15
the O 0 3.66574006121622e-15
differentiation O 0 1.2338646814338827e-12
of O 0 4.001987577320707e-15
the O 0 7.510919647736938e-14
visceral O 0 9.4883658222078e-12
endoderm O 0 5.733800656493315e-10
and O 0 1.3012785293753382e-12
that O 0 7.93977242893179e-14
the O 0 3.5941152940095755e-13
gastrulation B-Disease 0 1.8356280939713088e-09
defect I-Disease 0 3.777572921137562e-09
in O 0 3.5039957047011683e-12
the O 0 7.498856136739507e-13
epiblast O 0 2.5780384049767235e-08
is O 0 6.65027798454898e-12
secondary O 0 3.2476801803404953e-10
and O 0 1.278041821678455e-11
non O 0 1.4568516171209467e-08
- O 0 6.022493437285448e-08
cell O 0 7.557626304333098e-06
autonomous O 0 3.995122810351859e-08
. O 0 8.325641509543402e-09

Rescued O 0 2.509233354430762e-06
embryos O 0 1.0638795799877698e-07
show O 0 7.789494560483945e-08
severe O 0 3.742464105016552e-05
anterior O 0 3.722369910974521e-06
truncations O 0 4.894002927358088e-07
, O 0 1.7703295773774386e-10
indicating O 0 5.946085845920379e-09
a O 0 3.2995960130843827e-11
second O 0 2.7022930768061393e-11
important O 0 1.787721229731809e-12
role O 0 1.0590812081490153e-11
for O 0 5.173088520049607e-13
Smad4 O 0 6.900791049702093e-09
in O 0 1.2279238736923048e-10
anterior O 0 1.5769853689562296e-07
patterning O 0 6.295960588431626e-07
during O 0 9.944280954243823e-10
embryogenesis O 0 1.535114932949e-07
. O 0 9.396077249590462e-10

Prevalence O 0 2.2893464119988494e-05
of O 0 2.9957106240097175e-11
p16 O 0 1.5384080143121537e-07
and O 0 2.0974999515033232e-10
CDK4 O 0 2.657694437857572e-07
germline O 0 7.268976531804583e-08
mutations O 0 6.886958558993683e-09
in O 0 6.192221041478874e-11
48 O 0 6.7883378918054404e-09
melanoma B-Disease 1 0.9998953342437744
- O 0 0.1885247528553009
prone O 0 0.0033604411873966455
families O 0 2.3400252846528247e-09
in O 0 5.929366442281037e-10
France O 0 2.9447091947076842e-06
. O 0 1.430090490472935e-09

The O 0 2.948637722877123e-10
French O 0 5.012043970964442e-07
Familial B-Disease 0 0.10251154005527496
Melanoma I-Disease 1 0.985136091709137
Study O 0 3.4929308334596954e-09
Group O 0 2.8751636627077914e-09
. O 0 3.823908134581444e-10

Germline O 0 1.8423115761834197e-05
mutations O 0 2.3661027626076248e-07
in O 0 3.511370014197546e-11
the O 0 4.173113406485268e-13
p16 O 0 1.4137906401145983e-09
and O 0 4.625124068458053e-12
CDK4 O 0 2.723427705575432e-09
genes O 0 2.014791805615701e-11
have O 0 1.798274853678783e-12
been O 0 2.2650438382537663e-12
reported O 0 1.396410209686394e-10
in O 0 3.0725568573794493e-13
a O 0 2.8093743694238005e-13
subset O 0 1.2875546115398429e-11
of O 0 6.039169273171219e-13
melanoma B-Disease 0 8.787494607531698e-07
pedigrees O 0 8.531523576493782e-08
, O 0 3.63814837631149e-12
but O 0 2.796075870836745e-12
their O 0 2.585911628057158e-13
prevalence O 0 1.1764051954799015e-09
is O 0 5.75019795234083e-13
not O 0 1.4926917124222228e-12
well O 0 2.71560681927574e-12
known O 0 7.993926354199488e-11
. O 0 1.482634154337248e-10

We O 0 1.9674520346235624e-10
searched O 0 4.353450933081149e-10
for O 0 4.291518854691867e-14
such O 0 2.3978255904270884e-13
germline O 0 1.3523416164673563e-08
mutations O 0 1.1589201820427775e-09
in O 0 1.0290804666746034e-11
48 O 0 6.437199107089953e-10
French O 0 0.0011229354422539473
melanoma B-Disease 1 1.0
- O 1 0.8436537384986877
prone O 0 3.6073546652914956e-05
families O 0 7.768351933945539e-12
selected O 0 1.271849243760989e-13
according O 0 1.7639766058431816e-13
to O 0 4.680496035235418e-14
two O 0 2.274758343929345e-13
major O 0 5.753425947468971e-12
criteria O 0 1.252206324742211e-11
families O 0 2.3641414618070372e-14
with O 0 1.3782737158605368e-14
at O 0 9.800006639526515e-11
least O 0 9.341689748143533e-12
three O 0 5.373612796052973e-13
affected O 0 4.632319701436405e-12
members O 0 5.163671411029941e-14
( O 0 6.372043192572063e-13
n O 0 8.306853122030944e-11
= O 0 1.9687133867574147e-10
20 O 0 4.146646567781964e-12
) O 0 1.413410268815904e-13
or O 0 1.1019363373165891e-11
families O 0 4.79076251325844e-13
with O 0 1.0149038659717884e-14
two O 0 2.2232927575794453e-13
affected O 0 1.7819984854047788e-12
members O 0 6.905430596776526e-15
, O 0 2.5452950429835988e-14
one O 0 2.1441260090104483e-14
of O 0 7.787116932452421e-16
them O 0 6.14205545148086e-14
affected O 0 7.454619603899926e-13
before O 0 2.0688770249917277e-13
the O 0 4.1503689455482315e-14
age O 0 7.768776941197153e-13
of O 0 5.890840980028169e-16
50 O 0 7.977448454425662e-14
( O 0 2.1689837155069308e-13
n O 0 8.274073093339496e-11
= O 0 3.305153373212022e-10
28 O 0 4.959238575352742e-10
) O 0 1.988277598119481e-12
, O 0 4.5571025251989195e-12
and O 0 3.2112914757909117e-12
one O 0 2.919655077600336e-13
additional O 0 4.2854928590171926e-13
minor O 0 1.9048079780148441e-10
criterion O 0 3.6688482807356593e-10
. O 0 2.361906226155952e-10

Sixteen O 0 6.385719952817226e-09
different O 0 9.723556682050827e-11
p16 O 0 4.01904536317943e-08
germline O 0 2.5279723203652793e-08
mutations O 0 6.000381302939672e-10
were O 0 9.336488179800817e-12
found O 0 2.2610036672782163e-12
in O 0 6.281838656023442e-13
21 O 0 1.5466834627289594e-12
families O 0 9.901865975379606e-14
, O 0 3.466923471397154e-14
while O 0 4.394573897489873e-13
one O 0 1.8300565056417195e-12
germline O 0 8.096144199498667e-09
mutation O 0 2.791405440127903e-10
, O 0 6.8874203215663066e-12
Arg24His O 0 1.984003850097338e-09
, O 0 2.4279942206079097e-12
was O 0 2.0026207081524916e-10
detected O 0 5.870695041210183e-09
in O 0 4.8503187577431106e-11
the O 0 8.42327162881018e-12
CDK4 O 0 1.4584925622784795e-07
gene O 0 2.563906065233823e-08
. O 0 8.075998203516122e-10

The O 0 3.87869007745234e-11
frequency O 0 7.989373052019744e-10
of O 0 4.548069820059508e-13
p16 O 0 4.277514786821257e-09
gene O 0 1.788255987733578e-09
mutation O 0 1.5939934094877373e-10
in O 0 1.148446572216133e-12
our O 0 1.8774138331196372e-13
sample O 0 4.444391632062866e-13
( O 0 6.091807830746476e-13
44 O 0 1.5908148279578094e-12
% O 0 9.666463593113739e-13
) O 0 1.7577229277122852e-13
is O 0 2.873359644835205e-13
among O 0 1.6861867262706054e-13
the O 0 6.215893143084184e-13
highest O 0 6.279692321697894e-10
rates O 0 1.4113557433859114e-08
yet O 0 1.2025342527310912e-11
reported O 0 1.8905831067339562e-10
and O 0 4.796522337299769e-13
the O 0 2.241743303574989e-13
CDK4 O 0 7.950961666836065e-09
mutation O 0 1.2984428636453327e-11
is O 0 3.2277720535441035e-13
the O 0 9.250473922018526e-14
second O 0 2.606573637486953e-11
mutation O 0 3.6581082607511917e-10
detected O 0 2.9182709582187272e-08
in O 0 1.6302414973523582e-10
this O 0 2.7791467044346874e-12
gene O 0 1.6613215247929247e-09
worldwide O 0 2.1231599811599722e-10
. O 0 9.288078639535513e-10

In O 0 1.7278106723139786e-09
summary O 0 9.455209948328047e-09
, O 0 1.135798703352786e-12
our O 0 2.1954049092987732e-13
results O 0 1.1272693932820599e-12
show O 0 2.861558429448352e-12
frequent O 0 1.0198380334669466e-11
involvement O 0 2.5192226776882265e-11
of O 0 1.8778891541283184e-14
the O 0 2.622714057650549e-13
p16 O 0 6.637486116289892e-10
gene O 0 7.797960610567145e-10
in O 0 8.415486363322344e-11
familial B-Disease 0 6.088389000069583e-06
melanoma I-Disease 0 0.00018891863874159753
and O 0 4.0953695296108705e-11
confirm O 0 6.130457252950805e-10
the O 0 2.3643774113048244e-13
role O 0 6.17898007065909e-12
of O 0 2.26532676758694e-14
the O 0 5.589890529622554e-13
CDK4 O 0 9.51692680217775e-09
gene O 0 4.172610312824787e-10
as O 0 2.3953870137427558e-11
a O 0 3.180342100783662e-10
melanoma B-Disease 0 0.009948753751814365
- O 0 3.288688219527103e-07
predisposing O 0 5.962260161140875e-07
gene O 0 4.2730889049380494e-08
. O 0 2.661099673950673e-10
. O 0 2.2214395600794745e-10

Progression O 0 1.8523181211094197e-07
of O 0 7.371639756947879e-12
somatic O 0 3.81971325680297e-08
CTG O 0 6.056105803509126e-07
repeat O 0 3.315301366768608e-09
length O 0 5.465532887383162e-11
heterogeneity O 0 1.8255714995252248e-10
in O 0 3.86968799018228e-12
the O 0 9.571373641575898e-13
blood O 0 7.130360191176521e-10
cells O 0 5.099380473438941e-09
of O 0 1.3321921343845133e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0003269272274337709
. O 0 1.247299485918063e-09

The O 0 7.703403887004967e-11
genetic O 0 3.263360692784545e-09
basis O 0 4.872955927659461e-10
of O 0 1.0911552911219147e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.1267820557113737e-05
DM B-Disease 1 1.0
) O 0 2.2137064750737956e-11
is O 0 1.432271320859005e-13
the O 0 8.415164757787173e-15
expansion O 0 1.5216968310416412e-12
of O 0 3.358860363239166e-14
an O 0 2.0204979182814053e-12
unstable O 0 8.309699524033931e-07
CTG O 0 5.555169835247398e-08
repeat O 0 3.7978861722187673e-10
in O 0 2.2171663376785444e-12
the O 0 1.5037728278311652e-13
34 O 0 3.704629485123956e-12
UTR O 0 2.418886202448789e-10
of O 0 8.203753973888561e-14
the O 0 2.7304884048229283e-11
DM B-Disease 1 1.0
protein O 0 3.299574169446373e-09
kinase O 0 3.214754684677246e-08
gene O 0 4.565461342309618e-09
on O 0 6.338632951852219e-10
chromosome O 0 9.321306606580038e-07
19 O 0 7.4305308572775175e-09
. O 0 7.555966963224137e-10

One O 0 6.743550856613822e-11
of O 0 5.5688594469312236e-14
the O 0 6.221571516437305e-14
principal O 0 2.071974102707541e-12
features O 0 2.5205415554209465e-13
of O 0 4.071631134463724e-14
the O 0 3.872972165197552e-09
DM B-Disease 1 1.0
mutation O 0 2.318516906241186e-10
is O 0 8.167068909180342e-13
an O 0 2.0154930784228864e-13
extraordinarily O 0 8.996654976556329e-09
high O 0 5.063633401469758e-10
level O 0 2.0856863111595736e-11
of O 0 5.266770906117019e-14
somatic O 0 7.458911821522918e-10
mosaicism O 0 2.5901041311726658e-08
, O 0 3.1720817379038424e-12
due O 0 2.9510317800518493e-12
to O 0 1.3783138313409188e-13
an O 0 3.6456626020982263e-13
extremely O 0 3.7308954148329576e-08
high O 0 1.1333162186488721e-09
degree O 0 1.1250936182705118e-08
of O 0 5.494186377554e-13
somatic O 0 1.4625535449397375e-08
instability O 0 4.5846939578098045e-09
both O 0 1.858567336490702e-12
within O 0 1.3200171207830569e-12
and O 0 6.473836657722165e-12
between O 0 1.7613451929604507e-12
different O 0 1.489541129329197e-11
tissues O 0 1.7077528280395882e-09
. O 0 2.5016078097905847e-10

This O 0 3.147033467154614e-10
instability O 0 2.1322597021367073e-09
appears O 0 4.556791402543503e-11
to O 0 7.612222077723121e-14
be O 0 1.0591609647713288e-13
biased O 0 1.1191205948057892e-11
towards O 0 7.144013435293403e-14
further O 0 8.422346072520584e-14
expansion O 0 3.9259340136460485e-13
and O 0 1.6332050187077563e-13
continuous O 0 1.561312927902958e-13
throughout O 0 4.766772371787853e-13
the O 0 5.666145246681527e-14
life O 0 8.806028280704259e-14
of O 0 1.8814905952832338e-16
an O 0 1.167046441649948e-15
individual O 0 6.191330682626961e-16
, O 0 2.8306460433534693e-14
features O 0 5.980639703091761e-13
that O 0 2.550799198600129e-12
could O 0 2.0302590719722957e-09
be O 0 7.493809175626587e-13
associated O 0 8.984101440220882e-13
with O 0 7.683641185330173e-14
the O 0 8.82563878749909e-13
progressive O 0 6.143935620678276e-12
nature O 0 9.610398414572341e-12
of O 0 6.344308216797712e-13
the O 0 7.394766743384906e-11
disease O 0 9.390602428993589e-08
. O 0 1.261888510351028e-10

Although O 0 1.3291312495056218e-10
increasing O 0 7.482415728676806e-12
measured O 0 5.643912767694381e-11
allele O 0 2.2048417258613284e-10
size O 0 3.260352404721445e-11
between O 0 3.202240902999698e-11
patients O 0 1.5746425274798526e-09
clearly O 0 6.917173431264523e-12
correlates O 0 3.1453498659794743e-12
with O 0 8.335101509546802e-15
an O 0 3.640185416010737e-14
increased O 0 3.2885194567455756e-11
severity O 0 7.940061386157993e-10
of O 0 4.676269137540712e-13
symptoms O 0 3.0751072799262147e-09
and O 0 2.4952755790438874e-13
an O 0 1.5453756980685074e-14
earlier O 0 8.640083093425233e-11
age O 0 2.695816833653275e-11
of O 0 1.7902615628557876e-14
onset O 0 1.0997049104677359e-10
, O 0 5.0648690834908736e-14
this O 0 1.438068482112649e-14
correlation O 0 5.244042613344879e-12
is O 0 2.718128998789593e-13
not O 0 7.024826141795171e-13
precise O 0 2.175359059553017e-10
and O 0 9.698343690633937e-12
measured O 0 4.032661010677785e-11
allele O 0 8.162421433199896e-11
length O 0 1.2839521112972818e-11
cannot O 0 4.417925400512779e-11
be O 0 1.232363549315968e-13
used O 0 8.423893093495449e-13
as O 0 8.764293002276602e-13
an O 0 3.56653149667565e-14
accurate O 0 8.065252909972287e-10
predictor O 0 7.173223792733552e-09
of O 0 1.570689650391699e-12
age O 0 1.6775607569741169e-09
of O 0 6.5076837148236866e-12
onset O 0 5.004683245601882e-08
. O 0 4.2704123570658226e-10

In O 0 1.3078713112513185e-10
order O 0 6.716420497022979e-13
to O 0 1.169596917146437e-13
further O 0 3.600860115724608e-13
characterize O 0 5.80374324987698e-11
the O 0 9.296980503156749e-13
dynamics O 0 1.9121839667235463e-09
of O 0 7.508525051713733e-11
DM B-Disease 1 1.0
CTG O 0 3.008917474289774e-06
repeat O 0 2.1804456906693304e-08
somatic O 0 2.2423861878451135e-08
instability O 0 5.071368214260019e-09
, O 0 6.502543187063281e-13
we O 0 1.2689801737620493e-13
have O 0 3.336677586790113e-14
studied O 0 8.36540732518376e-12
repeat O 0 1.2981432769010315e-11
length O 0 2.0050265701204717e-12
changes O 0 1.7495359544775213e-12
over O 0 3.3072229308449275e-13
time O 0 5.420928896743282e-12
in O 0 2.3617115207930084e-11
111 O 0 5.818437998073023e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.56099602577342e-07
with O 0 1.6146272144822171e-13
varying O 0 9.451662542903083e-12
clinical O 0 4.569120193309573e-09
severity O 0 1.560893991836565e-08
and O 0 2.121543565825057e-11
CTG O 0 1.1089785800777463e-07
repeat O 0 6.151000819798469e-10
size O 0 1.2529158266438856e-11
over O 0 3.3853044065917937e-12
time O 0 6.012599272631203e-12
intervals O 0 5.545739562018426e-11
of O 0 3.695923572071859e-14
1 O 0 5.982616745753289e-12
- O 0 5.264243707614469e-09
7 O 0 3.6107625223102957e-10
years O 0 4.219217336620673e-11
. O 0 2.4293202866010333e-11

We O 0 4.3947796790622107e-11
have O 0 2.320995771878248e-13
found O 0 6.092548747406099e-14
a O 0 1.0955908692745174e-14
direct O 0 9.676019751062026e-13
progression O 0 2.8511121241692194e-10
of O 0 9.793390700989484e-15
the O 0 7.125696517215618e-14
size O 0 1.2903278272247132e-11
heterogeneity O 0 5.6859440766832137e-11
over O 0 3.679995110722478e-12
time O 0 3.694961437511468e-12
related O 0 2.4376366810491268e-12
to O 0 1.1366866378269974e-13
initial O 0 8.029145057153464e-12
CTG O 0 9.599310679675455e-09
repeat O 0 8.596620637568719e-11
size O 0 1.5946006667877377e-11
and O 0 5.090296673754269e-12
the O 0 2.7074184365781517e-13
time O 0 5.450351975300194e-12
interval O 0 6.1425409030035905e-12
and O 0 4.2847737619262916e-13
always O 0 2.326040185116063e-12
biased O 0 3.9103338622670236e-11
towards O 0 3.71276956661476e-13
further O 0 5.394678627423932e-12
expansion O 0 9.338006756731687e-11
. O 0 7.575096799827818e-11

Attempts O 0 1.6692972559795294e-09
to O 0 5.894180542947991e-12
mathematically O 0 2.8322502676481065e-10
model O 0 2.7053357817830026e-11
the O 0 1.9760727071587575e-13
dynamics O 0 5.364814148478558e-10
have O 0 3.037957038709571e-11
proved O 0 4.860492008873507e-09
only O 0 8.176093265963025e-13
partially O 0 1.547616895747339e-11
successful O 0 2.600474089536897e-12
suggesting O 0 4.855140942061631e-11
that O 0 2.5452174547656303e-14
individual O 0 3.441228049315837e-15
specific O 0 8.048209586839286e-14
genetic O 0 3.4350070010624734e-10
and O 0 2.7657706680450644e-10
/ O 0 2.4700382184050795e-08
or O 0 9.029343245314791e-11
environmental O 0 1.3762216193036192e-11
factors O 0 1.494062512596983e-11
also O 0 1.4532747401319046e-11
play O 0 1.7112276873287868e-10
a O 0 1.028629178362328e-11
role O 0 5.0221271585826344e-11
in O 0 2.1737153743650595e-11
somatic O 0 3.663912950813142e-09
mosaicism O 0 1.2293737938762206e-07
. O 0 9.488044377947702e-11
. O 0 1.7888007741717615e-10

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 4.368125416931434e-09
Palestinian O 0 2.383714559073269e-07
Arabs O 0 1.7078163239148125e-07
. O 0 1.2695008377860972e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.00031866965582594275
AGU B-Disease 1 1.0
) O 0 9.12275324727041e-11
is O 0 1.3016484591565902e-12
a O 0 3.30450705861296e-12
rare O 0 2.181036151682747e-08
disorder B-Disease 0 0.0014658942818641663
of I-Disease 0 3.435250402281792e-13
glycoprotein I-Disease 0 1.4975232431879704e-07
metabolism I-Disease 0 2.4635980935272528e-06
caused O 0 2.434654561289662e-11
by O 0 4.523232374591124e-13
the O 0 7.825252251736359e-11
deficiency B-Disease 0 4.408425957080908e-05
of I-Disease 0 7.05833300336002e-14
the I-Disease 0 1.8254373707060623e-12
lysosomal I-Disease 0 9.657070165758341e-08
enzyme I-Disease 0 2.3249580038964268e-08
aspartylglucosaminidase I-Disease 0 1.982344244311207e-08
( O 0 7.099050514103311e-11
AGA O 0 4.498413375131349e-08
) O 0 8.578848742502032e-11
. O 0 2.380975971938426e-10

AGU B-Disease 1 1.0
is O 0 4.4426800016594825e-09
inherited O 0 3.435692690345604e-07
as O 0 8.976659693349376e-11
an O 0 9.059804122191206e-12
autosomal O 0 0.0025173367466777563
recessive O 0 0.024309705942869186
trait O 0 1.2512851981227868e-06
and O 0 6.707892019619521e-10
occurs O 0 4.632151866940104e-12
with O 0 4.8424450078054723e-14
a O 0 2.302171647761142e-11
high O 0 8.166555431898814e-09
frequency O 0 2.6384892048980646e-09
in O 0 3.887865673846136e-08
Finland O 0 9.956379898312662e-08
because O 0 4.135937772820064e-11
of O 0 2.0031592283900092e-14
a O 0 7.001968883174614e-12
founder O 0 2.7205240837879785e-10
effect O 0 1.6230166099973076e-09
. O 0 2.902115214808987e-10

While O 0 4.170384482193867e-09
very O 0 8.426622177815091e-10
few O 0 1.2296317609961083e-11
patients O 0 3.269319537313464e-11
with O 0 1.0363522106454637e-12
AGU B-Disease 1 1.0
have O 0 4.403184414303318e-12
been O 0 1.0655157312022823e-12
reported O 0 1.0580212053690197e-11
from O 0 1.3943615142716914e-13
non O 0 2.0888245300110242e-10
- O 0 5.340390976660281e-11
Finnish O 0 6.529145973876993e-11
origin O 0 5.6624991154330395e-12
, O 0 1.6041733913452205e-11
we O 0 9.731558892056569e-10
diagnosed O 0 3.4720633834695036e-07
the O 0 1.4046766137407185e-12
disorder O 0 6.580037137382533e-08
in O 0 8.904857645535003e-13
8 O 0 1.2439049356521847e-12
patients O 0 3.292879857674791e-12
originating O 0 1.7593582840591537e-11
from O 0 3.5231353424924894e-12
3 O 0 3.379994634872263e-12
unrelated O 0 1.5872128611427172e-10
families O 0 2.9575567255663016e-12
, O 0 1.4027669271391568e-13
all O 0 2.2693139210762554e-14
Palestinian O 0 4.567261846499804e-10
Arabs O 0 3.215965549419053e-10
from O 0 4.0189448990979315e-12
the O 0 3.5317050933042493e-13
region O 0 1.460187699919846e-11
of O 0 6.828424002451594e-13
Jerusalem O 0 3.2354807899537263e-06
. O 0 9.709569814830843e-10

The O 0 1.8644061294814662e-10
clinical O 0 3.763809530710205e-08
diagnosis O 0 6.72382811899297e-05
of O 0 2.3352032113566068e-11
AGU B-Disease 1 1.0
is O 0 2.9854545918750475e-11
often O 0 1.1471204194868356e-11
difficult O 0 8.426023073715427e-11
, O 0 5.464680493056165e-14
in O 0 2.41301173920655e-13
particular O 0 6.34425942769995e-13
early O 0 8.026074804767802e-10
in O 0 6.181113780534542e-12
the O 0 2.778975508911652e-13
course O 0 2.1229210056539216e-10
of O 0 4.123012068340875e-15
the O 0 7.363668594155548e-13
disease O 0 2.8760960280038717e-09
, O 0 1.9654499653232876e-13
and O 0 7.938136638904053e-14
most O 0 8.417187472465216e-15
of O 0 3.0073933909021495e-16
the O 0 6.390650812357346e-14
patients O 0 2.699243432935372e-11
are O 0 1.2574904225542971e-12
diagnosed O 0 1.47692311713854e-08
after O 0 1.6993346833860112e-12
the O 0 2.1712518664517705e-13
age O 0 1.4549894622462034e-10
of O 0 9.506397811954656e-14
5 O 0 2.1847385012208065e-11
years O 0 4.712806533913039e-11
. O 0 3.909588278117049e-11

However O 0 1.2482396227753156e-09
, O 0 5.165627040698562e-12
since O 0 7.424976432302e-13
these O 0 9.910935326552447e-14
patients O 0 1.7627869650094219e-12
excrete O 0 5.5690881593795094e-12
early O 0 8.312454999499785e-13
large O 0 4.8142276298270004e-14
amounts O 0 1.8077078462602758e-12
of O 0 4.669192549960899e-13
aspartylglucosamine O 0 2.7058302265459133e-08
in O 0 3.067564952052848e-11
urine O 0 3.229856659903163e-11
, O 0 3.139474628616884e-13
biochemical O 0 9.035562575920864e-11
screening O 0 2.0850829396401593e-10
is O 0 3.9924712841310495e-12
easy O 0 5.754671739133244e-10
by O 0 3.1420400135873106e-12
urine O 0 1.843592223327306e-10
chromatography O 0 2.6180096979189216e-10
. O 0 4.4315189538790545e-12
. O 0 3.126784942075744e-11

Detection O 0 1.395125881487047e-08
of O 0 2.2226539185543626e-12
heterozygous O 0 1.2813576866221865e-09
carriers O 0 5.40491096323592e-10
of O 0 1.4985253706314983e-12
the O 0 6.312720568502073e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 7.900908371993864e-09
ATM O 0 6.509284844469221e-08
) O 0 2.069288750766729e-12
gene O 0 1.6904012911655997e-10
by O 0 5.232562647061734e-12
G2 O 0 2.8750233127539104e-07
phase O 0 7.641127175439522e-10
chromosomal O 0 4.94570713271969e-07
radiosensitivity O 0 9.735892803064417e-08
of O 0 1.8796051520775237e-11
peripheral O 0 7.001647645665798e-06
blood O 0 2.3234159129970067e-07
lymphocytes O 0 8.780625648796558e-07
. O 0 2.099582507852915e-09

In O 0 1.014821737044258e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.080291910213418e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 2.2050845524534957e-11
patients O 0 9.738799766623174e-10
, O 0 2.8913644482125855e-13
mutations O 0 3.1416761553382244e-11
in O 0 2.4785989233278016e-12
a O 0 9.144939579902589e-13
single O 0 8.512906633957595e-13
gene O 0 5.0354307529199005e-11
, O 0 2.0271449449604795e-12
ATM O 0 9.449621529711294e-09
, O 0 4.4047781372867634e-13
result O 0 3.7086948095899075e-12
in O 0 3.682708860086592e-10
an O 0 1.61508148721623e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 9.89050397137703e-10
embraces O 0 2.0819276858041746e-10
a O 0 8.174600753252381e-12
variety O 0 9.013370778909735e-12
of O 0 1.3122821243289479e-13
clinical O 0 1.0355945267992439e-10
features O 0 4.267910330701952e-11
and O 0 8.099888815227274e-11
manifests O 0 1.262221327458235e-09
extreme O 0 4.899685657200337e-10
radiosensitivity O 0 1.11259998902824e-06
and O 0 3.670140927281018e-11
a O 0 1.5707804848497098e-11
strong O 0 1.046709718899308e-09
pre O 0 9.98060045276361e-07
- O 0 4.3530735638341866e-07
disposition O 0 5.210245390685486e-08
to O 0 7.250702122041375e-11
malignancy B-Disease 0 1.4841008351140772e-06
. O 0 5.396896818332664e-10

Heterozygotes O 0 1.5942890740916482e-07
for O 0 1.4758479160992266e-11
the O 0 5.266211728846559e-13
ATM O 0 2.985617086892489e-09
gene O 0 2.5085408750236127e-10
have O 0 2.7368168495356393e-12
no O 0 1.927487249669957e-12
clinical O 0 7.965703617551778e-12
expression O 0 1.3763704802619015e-12
of O 0 9.800408097906943e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 9.372993758915982e-08
may O 0 5.231053368248695e-09
be O 0 1.8104830135090566e-11
cancer B-Disease 0 5.609241404691545e-10
prone O 0 1.0699360841748273e-10
with O 0 6.526645678983992e-14
a O 0 1.7949005129413997e-11
moderate O 0 4.554591370720118e-08
increase O 0 8.711303900454936e-11
in O 0 3.0498192860051176e-10
in O 0 2.089637490820806e-10
vitro O 0 1.0530444427558905e-07
radiosensitivity O 0 2.8714282507280586e-07
. O 0 3.4726616027214163e-10

We O 0 1.2888730083204791e-09
performed O 0 1.0925380738990853e-10
a O 0 1.624042914039059e-11
blind O 0 6.157002019335778e-09
chromosomal O 0 5.185973961374657e-08
analysis O 0 2.352168737562721e-10
on O 0 2.725962511274105e-10
G2 O 0 2.072099050565157e-06
- O 0 3.0327145239539277e-09
phase O 0 1.991946468882233e-10
lymphocytes O 0 8.982522503586665e-10
from O 0 6.384710902335167e-12
7 O 0 1.238129997832571e-11
unrelated O 0 4.22155643775568e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.747000715113245e-05
, O 0 1.1009021385482987e-12
13 O 0 2.0031918832041917e-12
obligate O 0 5.682371906345907e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999864101409912
T I-Disease 1 1.0
heterozygotes O 0 1.7671440843969322e-07
( O 0 8.570552254005825e-12
parents O 0 2.0905764099021784e-12
of O 0 9.530024864282073e-16
the O 0 2.5285336162101518e-14
patients O 0 7.213743491440994e-12
) O 0 3.2097883243464506e-14
, O 0 3.7685265606886287e-13
and O 0 2.7713508571336476e-11
14 O 0 1.2742445987257156e-11
normal O 0 1.2101923629881384e-10
controls O 0 3.290976158254466e-09
following O 0 1.8445963072960536e-12
X O 0 2.0615928408851403e-10
- O 0 2.1054472401638158e-11
irradiation O 0 1.5263232344686628e-10
with O 0 1.616390506685439e-12
1 O 0 1.272704684696091e-11
Gy O 0 2.25984742030505e-09
in O 0 4.003213505045927e-13
order O 0 6.752743167155045e-14
to O 0 1.0093388256270097e-13
evaluate O 0 2.2430191384814613e-12
this O 0 2.9766936664047186e-14
cytogenetic O 0 1.9585000288202536e-10
method O 0 6.48874487127471e-12
as O 0 2.3280995187224818e-12
a O 0 2.011185488981493e-12
tool O 0 4.5594369946222457e-10
for O 0 1.2017006855748191e-13
detection O 0 9.162617192748357e-11
of O 0 1.1661982143862382e-12
ATM O 0 3.1733259220345644e-07
carriers O 0 2.5803998937590222e-08
. O 0 7.098769905233837e-10

Both O 0 7.789788369905182e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 5.80840287511819e-06
and O 0 6.923153023086215e-12
heterozygotes O 0 1.3314358504601387e-09
showed O 0 9.784243554245009e-11
significantly O 0 4.6915412527104294e-11
increased O 0 3.2771780081319868e-12
levels O 0 7.27256471190485e-13
of O 0 1.4733370705638342e-14
radiation O 0 2.43336302219177e-08
- O 0 4.701052773725678e-07
induced O 0 7.752543496053477e-08
chromatid O 0 1.6657858168400708e-06
damage O 0 5.031547622991184e-09
relative O 0 4.629628277963427e-11
to O 0 4.994314965929558e-13
that O 0 3.3936164967572624e-13
of O 0 1.136949014752739e-13
normal O 0 2.20564633224285e-09
controls O 0 1.7377899439452449e-06
. O 0 8.236225035318512e-10

These O 0 3.806761156299743e-11
results O 0 2.9673791202000643e-11
show O 0 8.897257063045227e-12
that O 0 2.391422021345846e-13
the O 0 2.995885874448878e-12
G2 O 0 5.957213033980224e-07
- O 0 1.2722932707376344e-09
phase O 0 2.235171908671063e-10
chromosomal O 0 5.285384574449381e-08
radiosensitivity O 0 6.032240040809711e-09
assay O 0 4.3823764062089765e-10
can O 0 3.1445562841993235e-13
be O 0 7.044690860118132e-15
used O 0 3.9671441994090437e-14
for O 0 1.8492785411040836e-15
the O 0 1.3326519283983571e-14
detection O 0 2.256434102065885e-11
of O 0 1.104476059221593e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.2739130145055242e-05
. O 0 5.18978060526365e-09

In O 0 2.566599155429117e-10
combination O 0 5.082404497258608e-10
with O 0 4.279970746302181e-13
molecular O 0 2.1625746332576412e-11
genetic O 0 1.8568860338241677e-10
analyses O 0 1.5808589159949094e-10
, O 0 4.668506792086802e-13
this O 0 5.6157488191989693e-14
test O 0 5.207216949298932e-11
may O 0 2.116309905098035e-11
be O 0 1.753917750781358e-14
of O 0 2.4893011888515244e-16
value O 0 1.148748251470627e-13
in O 0 6.853224991621928e-14
studies O 0 3.474955241090927e-13
of O 0 2.464924491189964e-14
familial B-Disease 0 2.1213233392103348e-09
and I-Disease 0 4.938347647476249e-11
sporadic I-Disease 0 6.520816668853513e-07
cancers I-Disease 0 3.5650674590215203e-07
aimed O 0 2.3308299734736693e-10
at O 0 8.242742599584574e-11
determination O 0 4.811992818098965e-12
of O 0 2.2741483616227093e-15
the O 0 5.494285988628597e-15
potential O 0 1.4458193756811122e-13
involvement O 0 2.4658955433132235e-12
of O 0 5.77154426681381e-14
ATM O 0 1.4104064405273675e-07
mutations O 0 7.865058604394903e-10
in O 0 1.6810951936063745e-11
tumor B-Disease 0 4.654807739257194e-08
risk O 0 1.4834892203552386e-09
or O 0 2.7465606178278534e-11
development O 0 2.2255480444655085e-11
. O 0 1.1427397222929514e-11
. O 0 1.1115945663942028e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.5453883728255846e-09
identification O 0 2.696497192200553e-10
and O 0 8.01188434172706e-13
detection O 0 1.3252777347760869e-11
of O 0 1.450508855008973e-14
founder O 0 1.007054023505205e-10
- O 0 4.36040892282108e-09
effect O 0 2.115931596602394e-10
mutations O 0 2.0554716262388695e-10
in O 0 4.445309571832201e-12
the O 0 2.1985896176551778e-13
ATM O 0 1.4175088880463704e-09
gene O 0 1.101102681255739e-10
in O 0 5.537302387448317e-12
ethnic O 0 9.200754741423012e-12
populations O 0 4.1763045799392273e-10
. O 0 4.1036754550027865e-10

To O 0 1.619483540327149e-11
facilitate O 0 1.5112588264143412e-11
the O 0 5.665704992836862e-13
evaluation O 0 5.5644482077621404e-12
of O 0 9.456913638956291e-15
ATM O 0 4.4208126048772556e-09
heterozygotes O 0 4.736978587160934e-10
for O 0 1.1348604347927171e-13
susceptibility O 0 3.2944896810604973e-11
to O 0 1.1050570181136976e-12
other O 0 9.336167255957761e-12
diseases O 0 3.150589407141524e-07
, O 0 2.257847907119817e-13
such O 0 1.1221360212559928e-12
as O 0 1.8020417158481905e-08
breast B-Disease 0 2.3635166144231334e-06
cancer I-Disease 0 1.3945850696472917e-07
, O 0 8.066367886139236e-12
we O 0 1.6300502614363666e-12
have O 0 6.064665100408845e-14
attempted O 0 8.812804002181207e-13
to O 0 3.3005418060075287e-14
define O 0 2.753575904616834e-13
the O 0 1.442978223888114e-14
most O 0 1.22708145185689e-13
common O 0 4.328483318299936e-12
mutations O 0 1.8202751805862505e-11
and O 0 6.597162594858264e-13
their O 0 1.635580505667672e-13
frequencies O 0 4.616844129223807e-10
in O 0 1.2595721443631192e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0001586247090017423
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.532005409314422e-11
homozygotes O 0 3.712169771574736e-08
from O 0 1.0112764792236106e-11
10 O 0 1.5342607826568377e-12
ethnic O 0 1.9345625362071628e-12
populations O 0 1.0568499547725096e-10
. O 0 1.6598984686755358e-10

Both O 0 7.037587873570672e-11
genomic O 0 3.918401159097584e-09
mutations O 0 7.022228576403222e-09
and O 0 3.1265223049414814e-11
their O 0 9.125111690572174e-13
effects O 0 2.2539648966701797e-11
on O 0 7.138981246435083e-12
cDNA O 0 1.916798525458674e-10
were O 0 2.4986465674281533e-10
characterized O 0 8.893549785504717e-10
. O 0 2.067815085826652e-10

Protein O 0 6.028342625086225e-08
- O 0 2.0649125076488417e-08
truncation O 0 8.316103361494243e-09
testing O 0 6.644541028499873e-10
of O 0 2.4580791097234336e-14
the O 0 1.2328401069927521e-14
entire O 0 1.2568645126401212e-12
ATM O 0 2.900277795703232e-10
cDNA O 0 6.439946492742266e-11
detected O 0 1.643357450120675e-09
92 O 0 2.1976623298947118e-10
( O 0 2.7171041024759424e-12
66 O 0 4.036616527147707e-11
% O 0 1.834914815576627e-12
) O 0 1.0792690526006954e-12
truncating O 0 4.297279865284054e-09
mutations O 0 1.0599518596166035e-08
in O 0 4.941777195788255e-11
140 O 0 5.599457703064914e-11
mutant O 0 2.1951676032472278e-08
alleles O 0 7.492698728128744e-08
screened O 0 8.334985750479973e-07
. O 0 6.162371057882865e-09

The O 0 2.5226027863811673e-11
haplotyping O 0 1.071877697711443e-08
of O 0 2.401917640476592e-13
patients O 0 4.4058326431617445e-11
with O 0 1.9726033618507575e-14
identical O 0 1.685526856975983e-10
mutations O 0 2.0739225892185686e-09
indicates O 0 1.7371258875797935e-09
that O 0 2.056316705453809e-12
almost O 0 1.5788936130745057e-11
all O 0 2.4275518728977992e-14
of O 0 2.193225189652418e-16
these O 0 4.3999515550884776e-16
represent O 0 4.299045843571053e-15
common O 0 3.958841501144894e-12
ancestry O 0 4.711837586768297e-10
and O 0 1.918587094751345e-10
that O 0 7.903880674953179e-12
very O 0 3.96548044401257e-10
few O 0 6.831766402592976e-11
spontaneously O 0 1.8080303920697816e-10
recurring O 0 7.947277502751149e-09
ATM O 0 8.056571800807433e-07
mutations O 0 1.3444332758183464e-08
exist O 0 4.7631649735535575e-09
. O 0 8.506638171645875e-10

Assays O 0 1.0534542838058769e-07
requiring O 0 2.438304003149483e-10
minimal O 0 1.034427821178241e-10
amounts O 0 3.2356697616392482e-12
of O 0 1.565134605035698e-14
genomic O 0 8.500709684777785e-12
DNA O 0 1.7866357004958644e-10
were O 0 7.440201883410213e-13
designed O 0 6.44636741990029e-13
to O 0 4.433010965146193e-14
allow O 0 1.8903349480355047e-13
rapid O 0 1.3004678063588404e-11
screening O 0 2.763011694439932e-11
for O 0 1.0410113526412856e-13
common O 0 2.7850435499465753e-11
ethnic O 0 9.606260925609789e-11
mutations O 0 1.269700646844285e-07
. O 0 2.3580184471683197e-09

These O 0 9.28860599547221e-11
rapid O 0 3.2195746069163533e-10
assays O 0 1.1990730186539622e-08
detected O 0 1.1826505330603254e-09
mutations O 0 1.3763325201754384e-10
in O 0 3.5586325553005338e-12
76 O 0 3.1269042910508915e-11
% O 0 2.0553900920670942e-13
of O 0 8.645572119000446e-15
Costa O 0 1.6354261694884187e-11
Rican O 0 2.674501071997515e-11
patients O 0 2.9421098890480835e-10
( O 0 3.1890476045494387e-13
3 O 0 9.447957281978614e-14
) O 0 1.731319589374971e-14
, O 0 1.3939033372098626e-14
50 O 0 4.251767598477223e-14
% O 0 1.2810959975143033e-13
of O 0 3.5613652733237564e-14
Norwegian O 0 2.036063960986212e-05
patients O 0 2.457194669958085e-09
( O 0 5.124662630015542e-13
1 O 0 4.132401072807351e-13
) O 0 1.4196975572141474e-13
, O 0 3.1095696221943026e-13
25 O 0 4.188934897737806e-13
% O 0 3.94254778563613e-13
of O 0 4.007161085155947e-14
Polish O 0 1.2309172348068387e-08
patients O 0 2.5588433594236903e-09
( O 0 1.0042869313942049e-12
4 O 0 8.105491104692941e-13
) O 0 1.10239976056168e-13
, O 0 1.902865885694549e-13
and O 0 2.3712388389635075e-12
14 O 0 1.199367970390608e-12
% O 0 1.165112656961037e-13
of O 0 6.8924040770807025e-15
Italian O 0 4.675422271560592e-09
patients O 0 3.9115516381471593e-10
( O 0 2.7914755468087804e-13
1 O 0 6.916219983874039e-13
) O 0 2.3657261588073963e-13
, O 0 4.4388426853440854e-13
as O 0 4.418569731021865e-13
well O 0 8.108444471410792e-13
as O 0 3.652016839980621e-13
in O 0 1.3888228674735492e-12
patients O 0 8.05445293794449e-12
of O 0 5.015647998925926e-14
Amish O 0 3.247246058890596e-05
/ O 0 2.221924432888045e-06
Mennonite O 0 1.2040069350405247e-06
and O 0 1.4111208868072822e-09
Irish O 0 4.387262997340713e-09
English O 0 7.51855022684822e-09
backgrounds O 0 6.221515747029116e-09
. O 0 1.7837721577596e-10

Additional O 0 1.6971013483413344e-10
mutations O 0 9.400683564919632e-10
were O 0 2.634659504452408e-11
observed O 0 1.113027638804942e-12
in O 0 5.599355072487266e-13
Japanese O 0 1.988642930883522e-11
, O 0 1.555824527099247e-14
Utah O 0 5.020857861415262e-13
Mormon O 0 1.0601888290884265e-11
, O 0 9.975745273241299e-13
and O 0 2.0841093878887912e-13
African O 0 1.6026802281132735e-12
American O 0 4.782103532607884e-11
patients O 0 5.399058422561609e-10
. O 0 2.0171258760526278e-11

These O 0 2.954671576849144e-11
assays O 0 1.140872396554471e-09
should O 0 1.1562314690752307e-12
facilitate O 0 8.923747157885131e-13
screening O 0 9.92360013607474e-12
for O 0 1.2390223395886135e-12
A B-Disease 1 1.0
- I-Disease 1 0.9999939203262329
T I-Disease 1 1.0
heterozygotes O 0 3.387384595043841e-08
in O 0 6.65650867759382e-12
the O 0 5.97696466430285e-14
populations O 0 1.5285357615052453e-12
studied O 0 8.578783516899335e-11
. O 0 2.7124231680164534e-12
. O 0 1.3391232567272482e-11

The O 0 2.1848531872592503e-09
von B-Disease 1 0.9772854447364807
Hippel I-Disease 1 0.9992877840995789
- I-Disease 1 0.9998431205749512
Lindau I-Disease 1 0.9994246959686279
tumor I-Disease 0 0.0035716339480131865
suppressor O 0 5.696204539162864e-07
gene O 0 8.77166872470525e-09
is O 0 3.383438928333815e-12
required O 0 4.078792154287719e-13
for O 0 1.359994744858789e-13
cell O 0 1.10712043976946e-08
cycle O 0 7.085769748726989e-10
exit O 0 3.0840927034425647e-10
upon O 0 1.0334176223092406e-11
serum O 0 1.8908254961758075e-09
withdrawal O 0 6.464222046531631e-09
. O 0 2.827090783696917e-10

The O 0 1.2486914280351868e-10
inactivation O 0 4.560221977811807e-09
of O 0 3.3396592782897194e-13
the O 0 3.642849476931387e-12
von B-Disease 1 0.9521312713623047
Hippel I-Disease 1 0.9989398121833801
- I-Disease 1 0.999075174331665
Lindau I-Disease 1 0.9999407529830933
( I-Disease 0 1.2843879915180878e-07
VHL I-Disease 0 0.0006383631261996925
) I-Disease 0 2.2478234829037547e-09
tumor I-Disease 0 7.718122105870862e-06
suppressor O 0 7.021995770628564e-06
gene O 0 3.387020228728943e-07
predisposes O 0 8.764847052589175e-07
affected O 0 1.4271830384160467e-09
individuals O 0 2.0301165262748277e-12
to O 0 4.286253155790648e-13
the O 0 3.188647913418552e-12
human O 0 1.6897524801606778e-07
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 8.527557826543131e-11
is O 0 4.471040725151365e-12
associated O 0 1.1991289905477487e-10
with O 0 1.201892751989675e-10
sporadic B-Disease 1 0.9999983310699463
renal I-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
( O 0 2.2270423016834684e-07
RCC B-Disease 0 0.000311558396788314
) O 0 7.141412461386665e-10
and O 0 1.6767290889063702e-09
brain B-Disease 0 7.260362326633185e-05
hemangioblastomas I-Disease 0 1.2429370144673157e-05
. O 0 2.954652078557274e-09

VHL O 0 0.026597466319799423
- O 0 4.5544606109615415e-05
negative O 0 7.049506507428305e-07
786 O 0 4.003440153610427e-06
- O 0 1.1510363719935413e-06
0 O 0 2.9857977201785957e-10
RCC B-Disease 0 3.544339932659568e-08
cells O 0 2.0615535667456442e-10
are O 0 1.6582608767037876e-12
tumorigenic O 0 2.9809281709702873e-09
in O 0 2.356541350945207e-11
nude O 0 4.873779744229978e-07
mice O 0 1.2088813150512578e-07
which O 0 1.0873977499686882e-12
is O 0 5.599640963047624e-14
suppressed O 0 7.568041787871238e-13
by O 0 5.886040081986427e-14
the O 0 2.1715749586991712e-13
reintroduction O 0 4.999705163766244e-11
of O 0 2.6384799293316386e-12
VHL B-Disease 0 4.649905065434723e-07
. O 0 5.980762551871521e-10

Remarkably O 0 9.921799937728792e-05
, O 0 1.5894206090161234e-11
this O 0 5.914557987254584e-14
occurs O 0 5.5291278418809556e-14
without O 0 5.002434962575117e-14
affecting O 0 2.863926543833495e-13
the O 0 1.3368226339273426e-13
growth O 0 1.8003273538624853e-08
rate O 0 8.10318478983163e-10
and O 0 6.996585385707355e-13
cell O 0 1.01973460786553e-08
cycle O 0 4.0881346918819617e-11
profile O 0 1.1980218900253803e-11
of O 0 1.2895631082616467e-14
these O 0 6.907172858845734e-14
cells O 0 1.1858884534088343e-11
in O 0 1.4360449461514602e-11
culture O 0 6.796016527310655e-10
. O 0 8.257913103326686e-11

The O 0 3.10653891499868e-10
786 O 0 5.440185191218916e-08
- O 0 5.658351120985117e-09
0 O 0 1.917953296182162e-11
cell O 0 2.2624351281308464e-09
line O 0 1.0098319958018465e-09
, O 0 2.7352810771583136e-13
like O 0 3.9476646777891755e-13
many O 0 8.490541033917207e-14
cancer B-Disease 0 5.923101592530955e-11
cells O 0 4.2295146551740714e-11
, O 0 1.826924679246278e-12
fails O 0 9.887084900794818e-11
to O 0 3.288271347920424e-13
exit O 0 3.880142318557489e-10
the O 0 3.801194602137681e-12
cell O 0 1.0239663339461913e-07
cycle O 0 1.8293219716802867e-10
upon O 0 3.3670551156245176e-12
serum O 0 1.3202230420006345e-09
withdrawal O 0 5.771702227264086e-09
. O 0 3.0602440026505917e-10

Here O 0 4.047382873295646e-09
, O 0 8.668846890325099e-13
it O 0 2.68016538866947e-14
is O 0 2.770784954421587e-15
shown O 0 1.819751692540804e-14
that O 0 1.2317918190172302e-14
reintroduction O 0 2.0905044188779254e-12
of O 0 1.3723034888351096e-14
the O 0 2.0381039792048e-13
wild O 0 7.601888563080195e-11
- O 0 5.140551984084141e-09
type O 0 1.3176570234918472e-07
VHL B-Disease 0 3.6177220863464754e-07
gene O 0 2.1846917164225488e-08
restores O 0 2.4416345922873006e-07
the O 0 6.9110546278838836e-12
ability O 0 3.363188061378253e-10
of O 0 8.594846188925143e-12
VHL O 0 0.00021454112720675766
- O 0 9.463850801694207e-06
negative O 0 1.2475450148485834e-06
RCC B-Disease 0 0.0005655591958202422
cancer I-Disease 0 1.5028983568754484e-07
cells O 0 4.3594336474050976e-10
to O 0 2.6084124010034015e-12
exit O 0 1.915424346909944e-10
the O 0 9.354969056352136e-13
cell O 0 9.877599183027996e-08
cycle O 0 8.062192580204908e-10
and O 0 1.0578981267383991e-11
enter O 0 5.950759884854051e-09
G0 O 0 1.5373918358818628e-05
/ O 0 8.721890054630421e-08
quiescence O 0 1.1874729466399003e-07
in O 0 1.0136992356635233e-09
low O 0 4.398006225869722e-08
serum O 0 1.813253902582801e-08
. O 0 4.0547989965666886e-10

Both O 0 9.305496817546555e-09
VHL O 0 0.00022463365166913718
- O 0 1.434166051694774e-06
positive O 0 6.842453714739349e-09
and O 0 2.6947077902406136e-10
VHL O 0 6.828962796134874e-06
- O 0 3.40881207705479e-08
negative O 0 6.963861043374209e-09
RCC B-Disease 0 2.071785445423302e-07
cells O 0 2.4286881394885995e-09
exit O 0 1.126548965224572e-09
the O 0 1.3784118161122572e-12
cell O 0 1.0553523388523445e-08
cycle O 0 6.804456997855368e-11
by O 0 3.1241762649125704e-13
contact O 0 3.760169509092748e-09
inhibition O 0 3.4307263696575774e-09
. O 0 1.1873467486989142e-10

The O 0 7.401741441981358e-10
cyclin O 0 1.1705470797096496e-06
- O 0 1.7056702716899963e-08
dependent O 0 1.3645375496196266e-08
kinase O 0 2.9635211262757366e-07
inhibitor O 0 1.1271431077375382e-07
, O 0 7.213522747878676e-12
p27 O 0 5.2271240669199415e-09
, O 0 1.3579270086855333e-12
accumulates O 0 3.0704080770938003e-12
upon O 0 2.229840322261721e-14
serum O 0 1.760435720810083e-11
withdrawal O 0 2.8367143703467157e-11
, O 0 1.324301047512036e-13
only O 0 2.27879560788782e-14
in O 0 5.34042347019939e-14
the O 0 5.642652703186134e-15
presence O 0 8.572444512057464e-13
of O 0 5.294276776419797e-14
VHL B-Disease 0 1.5963552701947492e-09
, O 0 1.9230575248538329e-13
as O 0 2.4751348973867104e-13
a O 0 1.6506926576488612e-13
result O 0 5.743489451398576e-13
of O 0 6.595797279391243e-15
the O 0 1.5192049549785092e-13
stabilization O 0 5.3588362046441684e-12
of O 0 3.010941876615994e-15
the O 0 7.434282139548443e-14
protein O 0 5.31790687874345e-11
. O 0 1.9353052146953154e-11

We O 0 5.164959779313527e-11
propose O 0 1.74882955339406e-11
that O 0 7.613266977566854e-14
the O 0 2.688419961909688e-13
loss O 0 5.2247962900597855e-11
of O 0 5.2955195431600086e-14
wild O 0 1.9614383728328022e-10
- O 0 7.369980608018523e-07
type O 0 2.127124935213942e-05
VHL B-Disease 0 5.718733291359968e-07
gene O 0 4.0407033274902915e-09
results O 0 4.679256426776135e-10
in O 0 1.4325234791792707e-12
a O 0 9.8052880918853e-13
specific O 0 6.50976928612268e-12
cellular O 0 1.8816423619227862e-07
defect O 0 4.294109068325724e-09
in O 0 3.2118121096741392e-12
serum O 0 9.297952408005017e-10
- O 0 2.688338218703734e-09
dependent O 0 2.6963697941084774e-09
growth O 0 1.0037695119535783e-09
control O 0 1.8391177469823106e-10
, O 0 1.5823053587868396e-12
which O 0 2.632001170829734e-12
may O 0 2.2326707149744607e-10
initiate O 0 9.455850685791134e-11
tumor B-Disease 0 6.8470886738225545e-09
formation O 0 1.7064887003481743e-10
. O 0 2.6359020521837806e-10

This O 0 1.488448531095088e-10
is O 0 2.898573221721268e-11
corrected O 0 1.3884461358415479e-09
by O 0 1.545010864037466e-13
the O 0 1.8591122293975387e-13
reintroduction O 0 1.4409425042050117e-11
of O 0 6.007973524062293e-14
wild O 0 6.69794150698344e-11
- O 0 1.2253005365892022e-07
type O 0 1.516359861852834e-05
VHL B-Disease 0 3.89986371374107e-06
, O 0 7.51804035692416e-11
implicating O 0 1.0635038627526683e-08
VHL B-Disease 0 9.144088863877187e-08
as O 0 1.0419142111584012e-11
the O 0 3.4961497672597597e-13
first O 0 6.287320056946877e-12
tumor B-Disease 0 1.31565303096437e-09
suppressor O 0 2.194781467679263e-09
involved O 0 4.791023133776662e-11
in O 0 8.642386285784287e-12
the O 0 6.347890420775604e-13
regulation O 0 9.394315186872504e-11
of O 0 4.514498922803846e-14
cell O 0 1.8406426605110937e-08
cycle O 0 2.467549498064159e-10
exit O 0 2.469070226052139e-10
, O 0 1.409104386992932e-12
which O 0 4.5017237008428135e-13
is O 0 4.0241434858846736e-13
consistent O 0 3.199371670370432e-11
with O 0 3.7302646594458005e-14
its O 0 3.9003040163895775e-13
gatekeeper O 0 8.803208162433407e-10
function O 0 4.547741957322549e-12
in O 0 1.1888597745146612e-11
the O 0 2.4538855322719932e-11
kidney O 0 1.955720918545012e-08
. O 0 1.4127594927249021e-11
. O 0 2.0152501889469931e-10

Piebaldism B-Disease 1 1.0
with O 0 0.00037104691728018224
deafness B-Disease 1 1.0
: O 0 2.6446015516379262e-12
molecular O 0 5.415369108002777e-12
evidence O 0 2.5787562189794055e-12
for O 0 1.3497304673665972e-13
an O 0 2.9237918509894545e-12
expanded O 0 4.835634399569244e-07
syndrome O 1 0.9998065829277039
. O 0 5.108548584153993e-10

In O 0 1.2264352033941606e-10
a O 0 1.3802067128088069e-11
South O 0 1.4638434561731195e-11
African O 0 1.013774134084322e-10
girl O 0 3.2349853995583544e-07
of O 0 4.21327821806608e-13
Xhosa O 0 3.4937795589939924e-07
stock O 0 8.589156053062652e-09
with O 0 2.5525365241613196e-12
severe O 0 1.757822190029401e-07
piebaldism B-Disease 0 1.861876171460608e-06
and O 0 4.242460271974835e-10
profound O 0 9.976907904274412e-07
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 2.086615547014503e-09
identified O 0 1.0548461409909393e-10
a O 0 1.338198432274118e-12
novel O 0 1.6306542921507017e-11
missense O 0 7.076049080012581e-09
substitution O 0 1.4931686442842818e-10
at O 0 2.480619702704967e-11
a O 0 1.7834674709282794e-12
highly O 0 5.40676141011498e-12
conserved O 0 2.3337826463021294e-11
residue O 0 2.3188631015358396e-09
in O 0 1.8335051359119614e-12
the O 0 2.378358198319025e-13
intracellular O 0 1.3867146320123425e-10
kinase O 0 1.7562119536407295e-09
domain O 0 4.319562069143856e-11
of O 0 2.7429138604526115e-13
the O 0 9.200071260373477e-12
KIT O 0 2.999500111400266e-06
proto O 0 2.0240204321453348e-05
- O 0 8.354676594990451e-08
oncogene O 0 2.9728792583227914e-07
, O 0 1.7691277609532818e-10
R796G O 0 5.313981077392782e-08
. O 0 2.4102186912955403e-10

Though O 0 9.10076014548622e-09
auditory B-Disease 0 5.805921432511241e-07
anomalies I-Disease 0 8.721755193619174e-07
have O 0 1.748585998218033e-11
been O 0 4.9313044966914354e-12
observed O 0 1.76705536054228e-12
in O 0 1.1132893218412931e-11
mice O 0 6.034289867784537e-08
with O 0 1.4543360005864203e-12
dominant O 0 9.251364474494039e-08
white O 0 1.3564491752049435e-08
spotting O 0 1.6375770428567193e-05
( O 0 1.869969956658224e-09
W O 0 1.7736791050992906e-05
) O 0 9.565520250887083e-12
due O 0 5.608115014044124e-11
to O 0 1.884789026240785e-11
KIT O 0 4.318778883316554e-05
mutations O 0 1.647223598411074e-06
, O 0 2.5102986001002137e-06
deafness B-Disease 1 1.0
is O 0 3.6891049243203966e-11
not O 0 7.673865015656034e-12
typical O 0 1.4999737563137217e-10
in O 0 2.0605067999057702e-11
human O 0 9.684539975518547e-11
piebaldism B-Disease 0 4.5391979597297905e-07
. O 0 3.729475617220146e-10

Thus O 0 3.114322688624327e-10
, O 0 2.7305391021165137e-12
the O 0 2.722124012744659e-13
occurrence O 0 6.288249920771705e-10
of O 0 3.2809341354855803e-10
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 1.3361989736893065e-08
this O 0 1.850252763502258e-11
patient O 0 2.605353488505102e-09
extends O 0 6.047206572296071e-12
considerably O 0 1.9440114795710173e-10
the O 0 6.616389158558764e-14
phenotypic O 0 1.6011778708469038e-11
range O 0 1.0193615916642695e-11
of O 0 1.4415926135116774e-13
piebaldism B-Disease 0 6.196787971646245e-09
due O 0 3.503048545683285e-11
to O 0 5.350624457389763e-12
KIT O 0 3.491154032531085e-08
gene O 0 1.0172223063875663e-09
mutation O 0 6.09196512679766e-11
in O 0 2.6892830410490953e-12
humans O 0 3.8814430836087155e-11
and O 0 1.3256981623577246e-10
tightens O 0 1.4849187834897748e-07
the O 0 1.7996808741611164e-13
clinical O 0 1.6414950995691235e-11
similarity O 0 1.0053146683175473e-11
between O 0 4.940897951194456e-12
piebaldism B-Disease 0 2.22059938437269e-07
and O 0 2.9873725021500874e-12
the O 0 1.779934875976042e-14
various O 0 3.438238192418619e-14
forms O 0 4.941569722860528e-11
of O 0 5.058053975659504e-10
Waardenburg B-Disease 1 0.9999872446060181
syndrome I-Disease 1 0.9999603033065796
. O 0 1.1025717838730742e-10
. O 0 2.497745898999426e-10

Cycloheximide O 0 3.3807501154115016e-07
facilitates O 0 2.4538600040813208e-09
the O 0 2.2015954597581766e-12
identification O 0 2.6271774686281724e-11
of O 0 1.419353729600198e-13
aberrant O 0 3.917751012494364e-09
transcripts O 0 5.288396831559794e-09
resulting O 0 1.1435726497699417e-11
from O 0 1.3555902277431753e-12
a O 0 1.6439977634438718e-12
novel O 0 8.876581414352103e-11
splice O 0 4.5995690811651e-07
- O 0 4.383323481960133e-09
site O 0 3.9765007953107556e-10
mutation O 0 3.638493950575139e-09
in O 0 2.784773800446061e-10
COL17A1 O 0 2.2294061636785045e-06
in O 0 5.7385020346689686e-11
a O 0 1.4080364652002686e-10
patient O 0 1.7209737634971134e-08
with O 0 7.763256183734857e-12
generalized O 0 3.1069961892171705e-07
atrophic B-Disease 1 0.9899333119392395
benign I-Disease 1 0.9990062117576599
epidermolysis I-Disease 1 0.8533499836921692
bullosa I-Disease 1 0.561476469039917
. O 0 1.110548737415229e-06

Patients O 0 8.026493014767766e-05
with O 0 5.584581685980083e-10
generalized O 0 6.679180387436645e-06
atrophic B-Disease 1 0.9997835755348206
benign I-Disease 1 0.9997511506080627
epidermolysis I-Disease 1 0.9356247782707214
bullosa I-Disease 0 0.04545041173696518
often O 0 1.8206256413577648e-07
show O 0 3.4758707023740953e-09
decreased O 0 3.295153039317711e-09
expression O 0 5.227664655327313e-12
of O 0 5.108440458297635e-14
type O 0 3.956961691642391e-08
XVII O 0 2.152857092596605e-08
collagen O 0 4.235662487417358e-09
, O 0 2.1135656159271266e-12
a O 0 2.9894645786621155e-12
transmembrane O 0 5.046115192364198e-10
hemidesmosomal O 0 2.1335209154926815e-09
protein O 0 1.8525596334750816e-10
encoded O 0 1.7561707643665159e-10
by O 0 1.3315842352368268e-11
COL17A1 O 0 2.8030024168401724e-07
. O 0 2.069488053146884e-10

This O 0 9.632240144386017e-11
report O 0 1.3673628895816137e-10
documents O 0 2.686075147029232e-11
a O 0 3.937454529090445e-12
novel O 0 1.1091166179921785e-10
splice O 0 8.223492500292195e-07
- O 0 5.515112366794028e-09
site O 0 2.072711446921005e-10
mutation O 0 1.5287189292223502e-09
in O 0 1.7871469581987043e-10
COL17A1 O 0 1.1375873327779118e-06
in O 0 6.426793125458019e-11
a O 0 1.1766761176534857e-10
patient O 0 9.279194301825555e-09
with O 0 5.114880741174943e-12
generalized O 0 1.3616144656225515e-07
atrophic B-Disease 1 0.6764910817146301
benign I-Disease 1 0.8835113644599915
epidermolysis I-Disease 0 0.029868530109524727
bullosa I-Disease 0 0.0061770156025886536
, O 0 2.5946120807418538e-09
and O 0 4.833120882674624e-12
applies O 0 2.9200966731451894e-12
a O 0 3.479140261476721e-13
new O 0 1.0618112292193338e-12
methodology O 0 3.3733883741948745e-11
to O 0 3.0353239995235815e-13
define O 0 2.0527635147260526e-11
and O 0 8.919787651551214e-12
characterize O 0 2.869978976693943e-10
the O 0 1.6437187982248913e-12
resulting O 0 3.576626148027451e-11
mRNA O 0 8.960994724027671e-10
splice O 0 1.8395674317162047e-07
variants O 0 2.8471262680795917e-08
. O 0 1.5995372804056274e-09

Mutational O 0 7.2709567575657275e-06
analysis O 0 2.789746211817601e-09
of O 0 5.563259922181096e-12
COL17A1 O 0 1.0900875224706397e-07
identified O 0 1.40432243611599e-09
a O 0 4.675542591980886e-11
maternally O 0 2.534495934014558e-06
inherited O 0 1.3655941302204155e-06
G O 0 3.119438574117339e-08
- O 0 7.203246332743163e-10
to O 0 2.4050558419808077e-11
- O 0 3.779989299346198e-08
T O 0 5.162485550158635e-08
transversion O 0 2.8541278229710088e-09
at O 0 1.2273425331610355e-11
the O 0 1.8757709957777785e-13
- O 0 3.464006859132951e-11
1 O 0 5.614391330316382e-13
position O 0 2.5926110217011633e-11
of O 0 2.1279973497299182e-13
exon O 0 2.328609527424419e-09
32 O 0 1.6221127774329602e-09
. O 0 2.0111567966552002e-10

This O 0 3.064478670822268e-10
acceptor O 0 6.501440275030745e-09
splice O 0 2.2073861316584953e-07
- O 0 1.0831543661993237e-08
site O 0 1.5657708463123754e-10
mutation O 0 7.490790765452005e-10
led O 0 7.391237795417727e-12
to O 0 3.1340181101333076e-13
the O 0 7.059220693888743e-14
formation O 0 9.367069701273975e-14
of O 0 2.0706326871221606e-14
aberrant O 0 1.4175324802856437e-10
transcripts O 0 1.0197452604554513e-10
present O 0 7.151774832070412e-13
at O 0 5.5427891443304844e-11
extremely O 0 8.012389862699365e-09
low O 0 2.5276156279119277e-08
levels O 0 1.5463369473778243e-10
. O 0 2.547639876837593e-11

Based O 0 9.403696710208465e-10
on O 0 2.0448200077627376e-10
our O 0 6.906096246088456e-13
recent O 0 9.468727885098005e-13
finding O 0 5.944058179691014e-12
that O 0 1.2758806598039962e-12
cycloheximide O 0 5.5801681497769096e-08
stabilized O 0 1.282798280044517e-06
mutant O 0 1.682136918645938e-08
COL17A1 O 0 1.6329762786426727e-07
transcripts O 0 5.062640973108046e-09
in O 0 9.156148929323482e-12
keratinocytes O 0 1.9343551205253107e-09
homozygous O 0 4.621099336521439e-10
for O 0 3.342590689913577e-13
a O 0 8.63258423078328e-12
frameshift O 0 8.106599125312641e-07
mutation O 0 6.867632573737126e-10
, O 0 1.4898017715314626e-12
the O 0 1.288536063872442e-13
effects O 0 7.624003511841337e-11
of O 0 7.597151667525573e-14
the O 0 1.8920060830540653e-12
splice O 0 6.755660706403432e-07
- O 0 2.9268705237228687e-09
site O 0 2.5388319224717293e-10
mutation O 0 5.798401758738692e-10
on O 0 6.91671581121156e-11
splicing O 0 1.609041344607931e-09
of O 0 6.367827272424353e-13
COL17A1 O 0 1.0637107195066164e-08
transcripts O 0 6.265730156940208e-10
were O 0 4.523087633601097e-12
determined O 0 3.5854077953118013e-12
using O 0 3.538908532538243e-12
reverse O 0 6.54775622610515e-10
transcriptase O 0 3.683539917531675e-09
polymerase O 0 1.6174961370296614e-10
chain O 0 1.2677120464488212e-10
reaction O 0 6.693748853814352e-12
of O 0 7.815988050459584e-15
total O 0 9.943408536871104e-14
RNA O 0 1.0360785840379805e-10
from O 0 3.5610904416255584e-12
keratinocytes O 0 1.7451193823347921e-09
incubated O 0 5.011498438456385e-10
for O 0 1.3554893969411341e-12
2 O 0 1.8264239079468503e-11
. O 0 3.572794143869018e-11

5 O 0 2.0471624395668186e-09
h O 0 3.1459905791564324e-09
in O 0 4.8983165613913915e-12
the O 0 2.2588474059975772e-13
presence O 0 1.2465610141343397e-11
or O 0 6.596694301919115e-10
absence O 0 1.3908733886847102e-10
of O 0 1.511038202114262e-13
10 O 0 4.001642767148539e-12
microg O 0 6.588650069971891e-09
cycloheximide O 0 3.278497828773652e-08
per O 0 3.482041766034172e-09
ml O 0 5.518681973626371e-07
. O 0 2.1204200895130754e-10

Using O 0 8.451180033564043e-11
this O 0 2.362931465077489e-12
approach O 0 2.649355179684676e-10
, O 0 1.731027430770804e-12
an O 0 4.721168660008768e-13
abnormally O 0 4.702502831577249e-09
spliced O 0 9.275181156453982e-08
transcript O 0 9.999180861086643e-08
was O 0 3.082187283176552e-10
identified O 0 2.392396176997824e-11
that O 0 1.1890167398841828e-14
contains O 0 5.3219139368294e-15
an O 0 9.227770897933269e-15
extra O 0 3.0104354339227646e-12
264 O 0 4.046111102412597e-12
bases O 0 4.267539555243005e-13
upstream O 0 9.137585653407054e-12
from O 0 8.350912192658932e-13
exon O 0 2.1857066156982796e-10
32 O 0 5.265663946540933e-11
, O 0 4.3134400673668083e-13
resulting O 0 2.4099680584477312e-12
in O 0 2.9946937291081e-11
a O 0 5.535386038424406e-10
premature O 0 5.800796998300939e-08
termination O 0 4.059768965447574e-09
codon O 0 1.3498033801795373e-08
27 O 0 4.317529667119402e-10
bp O 0 1.0296121288888571e-08
downstream O 0 6.736046720412503e-10
from O 0 2.2510906333428338e-11
the O 0 1.191072674516791e-11
cryptic O 0 4.351662141743873e-08
splice O 0 7.92926812209771e-07
site O 0 1.3597259318487431e-08
. O 0 1.5282757281909198e-09

Three O 0 3.8784753186860144e-11
other O 0 1.2226804855033913e-12
splice O 0 2.1654670945281396e-08
variants O 0 1.2331348164806855e-09
, O 0 6.817675222113573e-13
including O 0 1.6061487873746984e-14
one O 0 4.1287984045134535e-14
derived O 0 4.3061653418399737e-13
from O 0 4.909650702482338e-13
the O 0 3.6186304603821884e-13
skipping O 0 1.7339901736690422e-10
of O 0 4.7504324963715955e-14
exon O 0 1.6652926260185552e-10
32 O 0 9.002259354629061e-11
, O 0 1.7931510226318337e-12
were O 0 8.804530021722101e-11
also O 0 7.606772850499155e-12
identified O 0 1.104936475648799e-09
. O 0 6.2223164121189e-11

These O 0 3.9944766244692786e-11
results O 0 2.7576888689262447e-11
indicate O 0 3.615086528740985e-12
the O 0 3.3601549683957496e-14
usefulness O 0 8.957533499664994e-12
of O 0 3.094138511486495e-14
cycloheximide O 0 2.7273561187257656e-10
treatment O 0 1.3498656185884084e-11
in O 0 1.4127554107037227e-13
evaluating O 0 8.402887760605715e-13
the O 0 2.720534301309252e-14
abnormal O 0 9.021871444359064e-11
processing O 0 1.0175492393127428e-11
of O 0 5.607526246863498e-15
mRNA O 0 3.7724910001424306e-12
due O 0 7.054513765682169e-13
to O 0 9.049074423811421e-13
splice O 0 1.7736611823693238e-07
- O 0 9.558069891113519e-10
site O 0 7.823819370145202e-11
mutations O 0 2.026893097806237e-09
, O 0 2.7990214312989536e-12
because O 0 1.2063385013139083e-11
( O 0 4.316133388193588e-12
i O 0 2.8524407280627884e-09
) O 0 8.41863606821161e-14
aberrant O 0 4.641599604671143e-11
splicing O 0 3.1236030428871686e-10
often O 0 1.037925474733914e-11
generates O 0 6.819034226168696e-11
a O 0 1.308569919089564e-10
premature O 0 3.411374649431309e-08
termination O 0 6.629439219807409e-10
codon O 0 4.073029691298302e-10
, O 0 7.297297531863589e-13
( O 0 5.840115175313743e-13
ii O 0 2.5841490405853484e-11
) O 0 5.791242051883527e-13
transcripts O 0 3.838420692403588e-10
with O 0 2.509787299861954e-12
premature O 0 2.3527979564619272e-09
termination O 0 7.37344421630759e-11
codons O 0 7.269964491518621e-11
can O 0 6.873610838495359e-13
occur O 0 9.212023505122957e-13
at O 0 6.843134999628964e-12
low O 0 1.482821754272834e-09
or O 0 2.5069527009868864e-10
undetectable O 0 9.316848803564426e-08
levels O 0 7.402119195365486e-11
due O 0 2.391893107189791e-12
to O 0 5.456902833246569e-13
nonsense O 0 1.2055353160178583e-08
- O 0 3.807335002825596e-11
mediated O 0 7.623600084549764e-10
mRNA O 0 1.6133851199473526e-11
decay O 0 9.459237212960936e-12
, O 0 2.7780044703409196e-14
and O 0 4.30212404600467e-14
( O 0 3.213420740437456e-14
iii O 0 6.845550602069261e-12
) O 0 3.584856885082907e-14
the O 0 1.0359584961790527e-13
levels O 0 2.1044266589748117e-12
of O 0 1.1632506752550648e-15
these O 0 9.761873452055099e-15
transcripts O 0 6.585385882440509e-12
can O 0 4.795495326791882e-14
be O 0 6.843572204155018e-14
increased O 0 5.927989219292606e-13
by O 0 6.894527266806949e-13
cycloheximide O 0 8.095406656138948e-08
. O 0 1.9806754847362384e-10

A O 0 6.997813883913295e-09
deletion O 0 5.8240338773885014e-08
mutation O 0 3.249274405092706e-09
in O 0 1.0200623679068599e-10
COL17A1 O 0 3.0749541224395216e-07
in O 0 4.2451781673280564e-11
five O 0 8.640112063307281e-12
Austrian O 0 4.2475253536622404e-08
families O 0 7.957792411139586e-12
with O 0 1.9938831401916657e-12
generalized O 0 2.630973199302389e-07
atrophic B-Disease 1 0.9797235727310181
benign I-Disease 1 0.9934604167938232
epidermolysis I-Disease 0 0.052288271486759186
bullosa I-Disease 0 0.00535155925899744
represents O 0 5.4521933634532616e-08
propagation O 0 5.576526351802613e-09
of O 0 2.475735762230702e-12
an O 0 4.5630864538293014e-12
ancestral O 0 7.642282362496644e-09
allele O 0 2.421352519377251e-06
. O 0 7.043852612298451e-09

Patients O 0 6.330853648250923e-05
with O 0 1.5377494833046512e-09
generalized O 0 1.2769254681188613e-05
atrophic B-Disease 1 0.9999127388000488
benign I-Disease 1 0.9999419450759888
epidermolysis I-Disease 1 0.9983826875686646
bullosa I-Disease 1 0.9919251799583435
, O 0 2.636669194089336e-08
a O 0 2.6547777864927014e-10
usually O 0 5.5147070937566767e-11
nonlethal O 0 2.9534366063899142e-08
form O 0 2.646861396726763e-09
of O 0 5.953141313241872e-10
junctional B-Disease 0 0.007791595067828894
epidermolysis I-Disease 1 0.8434058427810669
bullosa I-Disease 1 0.5028032064437866
, O 0 7.958806058638856e-09
have O 0 1.4982382001704764e-10
generalized O 0 6.725959345033061e-09
blistering B-Disease 0 3.0476501251541777e-06
, O 0 3.2393858706569745e-09
nail B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9998767375946045
, O 0 4.2555425849855055e-09
patchy B-Disease 1 0.9998408555984497
alopecia I-Disease 1 0.9999890327453613
, O 0 4.76312855823835e-09
and O 0 1.3657533770583541e-08
dental B-Disease 1 0.999984860420227
abnormalities I-Disease 1 0.9999896287918091
. O 0 3.3938891697005147e-09

Skin B-Disease 1 1.0
fragility I-Disease 0 0.00914311595261097
in O 0 1.8249578931373023e-11
most O 0 1.7059262531239627e-13
cases O 0 5.842242922077245e-13
is O 0 3.8163953740939435e-14
due O 0 7.840064318240247e-13
to O 0 5.749737166417523e-13
mutations O 0 8.542975354908222e-11
in O 0 2.155408447210294e-12
the O 0 2.2221355072855886e-13
gene O 0 6.691190379548573e-10
encoding O 0 1.7278898312156343e-09
type O 0 2.2548030642610684e-07
XVII O 0 3.7225294136078446e-07
collagen O 0 4.4558024114849104e-07
( O 0 5.986560691617626e-10
COL17A1 O 0 5.591583658315358e-07
) O 0 2.84486517676541e-10
. O 0 3.3245636799072997e-10

Recently O 0 1.6120563373078767e-07
, O 0 5.996316637668642e-11
we O 0 3.1199619710681192e-12
reported O 0 1.3209403015856935e-10
five O 0 1.0325894870058527e-12
Austrian O 0 1.1572620195465788e-08
families O 0 2.7201947291888295e-12
with O 0 1.2059375850345666e-12
generalized O 0 2.3057330622577865e-07
atrophic B-Disease 1 0.9359212517738342
benign I-Disease 1 0.8780529499053955
epidermolysis I-Disease 0 0.06631264090538025
bullosa I-Disease 0 0.044151078909635544
who O 0 2.2515391151500808e-07
share O 0 1.997319420965482e-09
the O 0 3.671630707802187e-12
same O 0 1.606740435144971e-10
COL17A1 O 0 1.7611189377930714e-06
mutation O 0 3.429910577779083e-08
. O 0 1.0485859958109245e-09

Affected O 0 9.69149738239139e-09
individuals O 0 4.674987393732399e-12
in O 0 4.6716085860820655e-12
three O 0 2.2295990195157073e-13
families O 0 5.912674185979891e-14
are O 0 7.024055443457123e-15
homozygous O 0 6.328913955411242e-12
for O 0 4.9389522148706594e-14
4003delTC O 0 1.8565779469348342e-10
, O 0 8.157848176279167e-14
whereas O 0 1.893038460362706e-12
those O 0 2.0491778846692954e-13
in O 0 7.801370769007498e-13
two O 0 3.39262634912324e-13
others O 0 2.0994551583330967e-12
are O 0 8.365973658188558e-14
compound O 0 1.4021725447399547e-10
heterozygotes O 0 1.3445434987602312e-08
. O 0 3.234790213468841e-10

To O 0 2.2807818134129576e-11
determine O 0 1.0788908828829324e-11
if O 0 1.3990028753518846e-12
the O 0 7.016574279060384e-14
occurrence O 0 2.0181379137285127e-11
of O 0 9.370249801771147e-14
4003delTC O 0 7.858566020146895e-10
in O 0 5.134152651631307e-13
these O 0 1.3479442612280863e-14
unrelated O 0 6.950037333836034e-12
families O 0 9.548849070391968e-14
signifies O 0 1.4871443920067007e-12
propagation O 0 2.6680391836814144e-12
of O 0 2.142339616524689e-14
an O 0 1.5801993231718409e-13
ancestral O 0 2.1989829401825034e-10
allele O 0 3.804066750490165e-08
or O 0 1.549923211996429e-08
a O 0 1.548605332857278e-08
mutational O 0 0.0006713651237078011
hot O 0 8.693892596056685e-05
spot O 0 6.542783012264408e-06
, O 0 1.0451531307076323e-10
haplotypes O 0 5.56536949858355e-09
were O 0 1.652147169073359e-10
determined O 0 7.602831558761736e-11
for O 0 2.1146613919578033e-13
polymorphisms O 0 2.7238628019787825e-10
both O 0 4.163876708707104e-12
within O 0 2.4959635053223295e-11
and O 0 5.62912272350502e-10
flanking O 0 4.81345296066138e-07
COL17A1 O 0 7.928178092697635e-05
. O 0 1.441229802168209e-09

Five O 0 2.661898035327681e-09
intragenic O 0 1.0446144216302855e-07
polymorphisms O 0 1.852095010690391e-08
were O 0 2.998345668969726e-11
chosen O 0 4.029519773407486e-13
based O 0 4.787284717949758e-12
on O 0 1.1401712907144201e-10
their O 0 1.1782992984099572e-11
informativeness O 0 3.411322424540231e-08
. O 0 1.1816488065807818e-10

One O 0 6.018454484779667e-11
of O 0 3.814328613702643e-14
these O 0 3.0976401456904445e-14
, O 0 3.58182958932942e-14
not O 0 6.520673080266312e-14
previously O 0 6.385685383247797e-12
reported O 0 2.453260927737233e-09
, O 0 7.941943001681107e-13
was O 0 5.678411560405827e-11
2988 O 0 3.624159999882082e-11
A O 0 4.558571835983072e-12
or O 0 3.4937133047696634e-11
C O 0 1.5701088429409538e-08
that O 0 3.997239280024989e-13
introduces O 0 7.617894162703642e-12
a O 0 2.137966019499782e-12
new O 0 3.639050866199867e-12
restriction O 0 1.1181434250717714e-11
site O 0 1.0034889585952556e-11
for O 0 1.6795335738492567e-12
Eco0109 O 0 4.930035402139765e-08
I O 0 1.7425628584533115e-06
. O 0 7.40010067112884e-11

All O 0 1.5771599304326145e-11
the O 0 1.896620230659729e-12
4003delTC O 0 9.159161762362089e-10
alleles O 0 1.9226827074891872e-10
showed O 0 9.931866440382464e-10
the O 0 3.1630416601896583e-13
same O 0 2.585084490219769e-12
haplotype O 0 8.080943691979314e-10
for O 0 2.2002004710329481e-13
these O 0 1.596629051843143e-13
five O 0 8.255794051864607e-13
polymorphic O 0 2.2571120528169786e-09
markers O 0 1.064307486586813e-08
. O 0 5.948340153771881e-10

Fourteen O 0 1.053976372844545e-08
microsatellite O 0 5.927065771516027e-08
polymorphisms O 0 3.0952634233472054e-08
were O 0 2.5973823786218375e-11
selected O 0 2.4441719806943263e-13
based O 0 5.515027453814603e-13
on O 0 1.6599957519680686e-11
their O 0 1.877733645655466e-12
high O 0 2.498136697504094e-10
heterozygosity O 0 1.594103626878507e-09
and O 0 2.0236412372198753e-12
their O 0 2.2848363080544588e-14
location O 0 9.549710197967465e-13
within O 0 4.000208150833906e-12
10q23 O 0 1.0443136488902383e-07
- O 0 1.621730127965293e-08
q25 O 0 4.739134240594467e-08
near O 0 4.3620911327479917e-08
COL17A1 O 0 8.631573109596502e-06
. O 0 8.667652706684237e-10

Three O 0 4.5779804946910474e-10
families O 0 6.221295700825635e-11
shared O 0 1.945260445779251e-11
microsatellite O 0 2.063137038987861e-08
polymorphisms O 0 1.386660954949548e-07
covering O 0 7.498657694782196e-09
at O 0 1.170809005301976e-09
most O 0 1.3842219037663028e-11
19 O 0 1.8955071887094554e-11
cM O 0 9.948848689322887e-11
, O 0 1.8458554183840153e-13
whereas O 0 3.689419429686591e-12
the O 0 1.256470784621183e-13
others O 0 2.8889679277305236e-12
shared O 0 3.1498268620103187e-13
smaller O 0 6.180819311224495e-12
regions O 0 5.171761630062832e-11
consistent O 0 9.428593017446474e-09
with O 0 1.4999549996161377e-12
cross O 0 5.091806976054158e-10
- O 0 7.59310037068417e-09
over O 0 4.495873725390842e-12
events O 0 4.30402187414497e-13
during O 0 1.2452581283836639e-12
passage O 0 7.279308991518796e-13
of O 0 6.788938579057116e-15
this O 0 6.051630957416496e-14
mutation O 0 6.444659259377539e-13
through O 0 4.474433519009724e-13
several O 0 3.94449794008378e-12
generations O 0 8.307961957276788e-11
. O 0 3.551114957645041e-11

These O 0 6.48538237002505e-11
results O 0 6.701213195459133e-11
indicate O 0 3.025103084697278e-11
that O 0 7.149633532779753e-13
4003delTC O 0 1.5856743473818824e-08
occurs O 0 1.957180945089121e-11
on O 0 8.95611623058512e-12
a O 0 8.92938761126727e-12
single O 0 1.746436155414255e-11
ancestral O 0 1.4706088569127473e-09
allele O 0 3.6831480088039825e-08
. O 0 2.5304444650764424e-10
. O 0 6.528912410708188e-10

The O 0 6.125396301293051e-10
haptoglobin O 0 3.178106680934434e-06
- O 0 1.0924208737606023e-07
gene O 0 2.736874549214008e-08
deletion O 0 2.2434814894722876e-08
responsible O 0 1.8747259300511132e-10
for O 0 7.791500084008973e-12
anhaptoglobinemia B-Disease 0 1.6610727016086457e-07
. O 0 3.570963247323533e-10

We O 0 3.074167587158172e-10
have O 0 1.228808287762062e-12
found O 0 7.416087600790877e-13
an O 0 5.2606770122812924e-14
allelic O 0 2.643610608199509e-10
deletion O 0 5.335282216023529e-10
of O 0 1.3144289801557407e-13
the O 0 5.958152807933326e-13
haptoglobin O 0 3.933527281674287e-09
( O 0 3.5440151247706497e-12
Hp O 0 8.299868431427271e-11
) O 0 8.105950806414075e-14
gene O 0 1.7966987272965973e-11
from O 0 3.162192729888602e-12
an O 0 2.2182226216450884e-13
individual O 0 1.9183060088329151e-13
with O 0 6.404909155127703e-12
anhaptoglobinemia B-Disease 0 2.84337102129939e-06
. O 0 1.1246896747252322e-09

The O 0 9.488261565326894e-11
Hp O 0 1.7859449474855182e-09
gene O 0 3.9026243348061485e-10
cluster O 0 5.389692858681627e-11
consists O 0 1.0320125830298732e-12
of O 0 9.315168943277094e-14
coding O 0 6.35798569348367e-09
regions O 0 5.534612004809425e-11
of O 0 4.682078834881975e-13
the O 0 1.176381041190222e-12
alpha O 0 1.3273065806174156e-11
chain O 0 5.55031090532232e-11
and O 0 5.921333302155718e-13
beta O 0 4.831286846279648e-12
chain O 0 1.1495165930242024e-11
of O 0 2.0190704034910023e-14
the O 0 2.0125504182014892e-13
haptoglobin O 0 6.111683381604394e-10
gene O 0 9.42565261952133e-11
( O 0 1.6542929135929252e-12
Hp O 0 1.4510873058704021e-10
) O 0 1.537919504203053e-13
and O 0 6.186854956298504e-13
of O 0 6.642838524666432e-15
the O 0 4.7108489526805075e-14
alpha O 0 1.6502056882430893e-12
chain O 0 2.4075710175486265e-11
and O 0 2.2578995422482817e-13
beta O 0 1.4535845400606706e-12
chain O 0 7.705913164512967e-12
of O 0 1.4136414918698454e-14
the O 0 6.010292090408154e-13
haptoglobin O 0 1.729229381908226e-08
- O 0 2.567847878776064e-10
related O 0 2.242088875670234e-10
gene O 0 3.045745877727768e-09
( O 0 1.4889816810081946e-11
Hpr O 0 2.187101877382247e-08
) O 0 4.864602644316651e-12
, O 0 1.7427350795101715e-12
in O 0 9.251135447974068e-12
tandem O 0 5.817380355210844e-09
from O 0 1.631485051223347e-11
the O 0 1.7318771416974243e-11
5 O 0 2.517325237150203e-11
side O 0 2.5571746942176787e-09
. O 0 2.6117155660365654e-10

Southern O 0 7.89383207688843e-08
blot O 0 8.760586752032395e-06
and O 0 5.768746591527929e-11
PCR O 0 2.3351565126006335e-09
analyses O 0 1.0008186987486845e-11
have O 0 1.9897981645613377e-13
indicated O 0 9.314752962008566e-12
that O 0 5.095515159039008e-15
the O 0 3.654514333566259e-15
individual O 0 2.604540550721064e-15
with O 0 7.855433019560501e-14
anhaptoglobinemia B-Disease 0 3.3993455161862585e-08
was O 0 1.2754269862469414e-10
homozygous O 0 1.3940596940709149e-11
for O 0 1.2579424366044017e-14
the O 0 1.5993440634896362e-14
gene O 0 5.2248760873396805e-11
deletion O 0 9.811191442610223e-11
and O 0 6.40798557879213e-13
that O 0 2.7823633018874902e-14
the O 0 2.1314532102733978e-14
gene O 0 1.0131073063801566e-10
deletion O 0 1.3947200339092802e-10
was O 0 5.340105441176135e-11
included O 0 1.2499308771167505e-13
at O 0 6.058797560881679e-12
least O 0 7.039111047518753e-13
from O 0 1.915461739958671e-13
the O 0 1.2565905889612428e-13
promoter O 0 2.6386134943656714e-10
region O 0 1.530496909762924e-11
of O 0 5.779919728596261e-13
Hp O 0 1.064061283528872e-09
to O 0 6.727408343940033e-13
Hpr O 0 2.6298623279075173e-09
alpha O 0 2.1146556727913435e-11
but O 0 6.5591490572280975e-12
not O 0 1.4802874637870334e-12
to O 0 6.759679621604064e-13
Hpr O 0 1.6777537581447177e-08
beta O 0 1.2465098953029496e-09
( O 0 4.343098103376519e-11
Hpdel O 0 2.210225069632088e-08
) O 0 4.6818784960045434e-11
. O 0 1.3408237020673397e-10

In O 0 5.313324086264615e-11
addition O 0 1.3144721856123143e-12
, O 0 8.859032214411644e-13
we O 0 3.8938370214812446e-13
found O 0 4.521524214068373e-13
seven O 0 1.2803406135319419e-14
individuals O 0 1.0229218798504976e-15
with O 0 1.0314487911239172e-14
hypohaptoglobinemia B-Disease 0 2.690169420560551e-09
in O 0 8.177423148347795e-12
three O 0 7.028029417113779e-13
families O 0 3.054757510313755e-13
, O 0 5.504285043164345e-14
and O 0 2.292538175355935e-13
the O 0 1.3675956797142702e-13
genotypes O 0 6.426695287053974e-11
of O 0 3.9219356793218293e-14
six O 0 3.3771206317534386e-12
of O 0 4.66502125150885e-15
the O 0 7.56864460427914e-14
seven O 0 1.3408011137992781e-13
individuals O 0 3.85509554712434e-15
were O 0 5.674649118658781e-13
found O 0 6.665410953211881e-13
to O 0 1.0218308675331161e-13
be O 0 2.7545556113839353e-11
Hp2 O 0 3.756841806534794e-07
/ O 0 2.6427167654219375e-07
Hpdel O 0 4.838046834265697e-07
. O 0 8.899946890572608e-10

The O 0 1.1581573200469819e-10
phenotypes O 0 1.3811437327149179e-08
and O 0 5.2315072412989494e-11
genotypes O 0 2.421569167410098e-09
in O 0 1.632929555461793e-11
one O 0 5.975919086832759e-13
of O 0 1.2745142762284295e-15
these O 0 1.3700961209745649e-14
three O 0 7.049748832659367e-14
families O 0 9.547136708585799e-14
showed O 0 1.5012846521500478e-10
the O 0 2.490592096709293e-13
father O 0 4.550694543414835e-11
to O 0 1.8877481771772259e-13
be O 0 2.3938466226641752e-12
hypohaptoglobinemic B-Disease 0 1.194286114447607e-09
( O 0 1.141109992955358e-12
Hp2 O 0 9.805004586027621e-10
) O 0 4.88720880171406e-13
and O 0 2.347952778383733e-12
Hp2 O 0 5.940545477756132e-08
/ O 0 1.5507010786564024e-08
Hpdel O 0 1.0048926135652891e-08
, O 0 9.11797764027722e-13
the O 0 9.461175739340286e-14
mother O 0 3.8387112932802836e-11
to O 0 3.193045193484664e-14
be O 0 3.525015836950557e-13
Hp2 O 0 6.354611836734136e-10
- O 0 3.4140641702595786e-11
1 O 0 8.247750898048023e-13
and O 0 2.383999898533662e-12
Hp1 O 0 1.2687414674417141e-08
/ O 0 1.9408707974122308e-09
Hp2 O 0 1.1987065784424544e-09
, O 0 2.944693371521173e-13
one O 0 3.639165249529064e-14
of O 0 1.1951415715983076e-15
the O 0 4.588435412330137e-14
two O 0 2.944951682688768e-13
children O 0 4.861020440338759e-13
to O 0 2.0249865898143947e-14
be O 0 4.5078866854619815e-12
hypohaptoglobinemic B-Disease 0 1.913825764532362e-09
( O 0 1.2852597675375166e-12
Hp2 O 0 4.895426286566362e-10
) O 0 3.771086090967324e-13
and O 0 4.21054944382826e-12
Hp2 O 0 2.8024830456274685e-08
/ O 0 1.7041744015955373e-08
Hpdel O 0 1.852935938018163e-08
, O 0 3.171186403749804e-12
and O 0 2.3127496012048665e-13
the O 0 1.0873676193126885e-14
other O 0 2.79077298380101e-13
child O 0 1.2915465572027607e-11
to O 0 1.3285151041872618e-14
be O 0 3.61767798877366e-13
Hp1 O 0 4.3657327752910646e-10
and O 0 3.4567450898220775e-12
Hp1 O 0 3.0169196918450325e-08
/ O 0 1.7639608884678637e-08
Hpdel O 0 6.210667091721689e-09
, O 0 8.167240213123594e-13
showing O 0 3.6662790858787986e-11
an O 0 1.0496945245528147e-13
anomalous O 0 3.499864842382294e-10
inheritance O 0 1.1216776396594241e-09
of O 0 1.7833585086099446e-12
Hp O 0 6.262244500732095e-09
phenotypes O 0 8.469741574756995e-10
in O 0 1.5477917558737175e-10
the O 0 4.073152232164645e-11
child O 0 7.563872195248678e-09
with O 0 9.125168502766012e-12
Hp1 O 0 1.9080722779563075e-07
. O 0 5.301300509685802e-10

The O 0 1.8252650779704283e-10
Hp2 O 0 2.2859076409531554e-07
/ O 0 6.078347780658078e-08
Hpdel O 0 6.0520504163719124e-09
individuals O 0 5.044358594025189e-12
had O 0 1.792651138643464e-09
an O 0 8.155083054163514e-13
extremely O 0 2.2063499471869363e-08
low O 0 1.177330677393229e-08
level O 0 6.58455755198073e-12
of O 0 1.910101308892631e-14
Hp O 0 1.671160015925821e-10
( O 0 5.042864997112373e-13
mean O 0 1.87978521637433e-10
+ O 0 1.0571186148666811e-09
/ O 0 8.587813127292065e-09
- O 0 5.637108113631939e-09
SD O 0 5.67598306133732e-07
= O 0 6.210095770953217e-10
0 O 0 1.2035759541784152e-11
. O 0 2.9423761604280285e-12
049 O 0 7.549189007249879e-08
+ O 0 5.587236895365777e-09
/ O 0 1.7399520046978978e-08
- O 0 2.1422021934114355e-09
0 O 0 1.2437394864006635e-11
. O 0 4.165942330686123e-12
043 O 0 2.4081028726641307e-08
mg O 0 4.981493020750349e-06
/ O 0 3.45956188141372e-08
ml O 0 9.670742429079837e-09
; O 0 7.522594201204991e-13
n O 0 6.999902740778552e-11
= O 0 1.3230709583478273e-10
6 O 0 3.0914160120687484e-12
) O 0 1.3328559447540328e-13
, O 0 8.812194002933912e-14
compared O 0 3.35383196908845e-12
with O 0 4.482717230183328e-14
the O 0 6.397971345425968e-13
level O 0 6.63125665489872e-11
( O 0 9.370518141808837e-14
1 O 0 2.6558409741165787e-14
. O 0 2.9654169473713327e-14
64 O 0 2.3894718668981962e-12
+ O 0 1.264657129018687e-10
/ O 0 8.761097403109375e-10
- O 0 2.50649390132196e-10
1 O 0 4.277410023401096e-12
. O 0 3.190893079277335e-12
07 O 0 1.160900375829499e-09
mg O 0 1.2540610327960167e-07
/ O 0 2.378643948475201e-09
ml O 0 8.338207901914529e-10
) O 0 3.351187599989758e-14
obtained O 0 4.688352028651976e-13
from O 0 7.498670196066926e-13
52 O 0 1.2523716785839412e-10
healthy O 0 1.4421998317803997e-10
volunteers O 0 5.503856918831485e-13
having O 0 1.5341913503497118e-11
phenotype O 0 4.675118958630264e-09
Hp2 O 0 1.4901763156771608e-09
, O 0 1.5421286480871849e-13
whereas O 0 4.3192359411303727e-13
the O 0 1.3431629296474252e-14
serum O 0 2.6609357078877238e-11
Hp O 0 2.621382555467733e-10
level O 0 8.873089762939657e-12
of O 0 1.5381319993585307e-15
an O 0 1.1330581858501852e-14
individual O 0 8.114609516014087e-15
with O 0 5.97032514572382e-13
Hp1 O 0 4.557130523608066e-06
/ O 0 3.822103735728888e-06
Hpdel O 0 1.1768130434575141e-06
was O 0 3.1937915423441154e-08
0 O 0 1.1168055369381591e-10
. O 0 5.653835732921664e-11

50 O 0 1.1164104307681555e-08
mg O 0 0.00010282033326802775
/ O 0 9.776194929145277e-07
ml O 0 9.148764235078488e-08
, O 0 4.114155305497136e-13
which O 0 6.275034203188923e-14
was O 0 9.548548583759864e-12
approximately O 0 1.0986041042810799e-14
half O 0 2.77233666795898e-13
the O 0 7.851748087426766e-14
level O 0 3.6224376363108712e-12
of O 0 1.0950559679683263e-14
Hp O 0 9.433008540948862e-11
in O 0 2.245805971745618e-12
control O 0 6.054113876885481e-10
sera O 0 1.0018744944773061e-08
from O 0 6.002845247786437e-13
the O 0 1.9561385931204933e-12
Hp1 O 0 5.9323927104060203e-08
phenotype O 0 1.1432211621809074e-08
( O 0 1.978902501933999e-12
1 O 0 2.909026914754004e-13
. O 0 1.1692646091805703e-13
26 O 0 7.53029236189029e-12
+ O 0 1.1365930419060533e-10
/ O 0 5.604439134998529e-10
- O 0 1.037793323499514e-10
0 O 0 1.7628978788916672e-12
. O 0 4.251201983756364e-13
33 O 0 9.397738143235301e-11
mg O 0 5.035514732298907e-06
/ O 0 1.3971230394815848e-08
ml O 0 5.244530143500015e-09
; O 0 6.414001816647252e-13
n O 0 1.2176758212856242e-10
= O 0 1.1350158313216951e-10
9 O 0 2.7616050071732623e-11
) O 0 1.5338210844657862e-13
, O 0 1.4889742813283674e-13
showing O 0 2.2209047101373613e-11
a O 0 6.195478158277368e-12
gene O 0 8.56576143348775e-09
- O 0 1.374114866337095e-08
dosage O 0 2.0877598672086606e-07
effect O 0 2.613495864167703e-09
. O 0 3.9229908210813846e-10

The O 0 2.8876361371499293e-11
other O 0 8.080766090989844e-12
allele O 0 7.680627689410358e-09
( O 0 2.1974096153787315e-11
Hp2 O 0 1.4420823424288187e-09
) O 0 8.342708712446092e-14
of O 0 1.6062030610107937e-15
individuals O 0 2.274956685164274e-14
with O 0 1.544147703582896e-13
Hp2 O 0 7.151450631681655e-08
/ O 0 1.516759340347562e-08
Hpdel O 0 1.1539337485544365e-08
was O 0 2.0561853608658254e-10
found O 0 2.410234555341728e-12
to O 0 1.2844547372600507e-14
have O 0 1.432288532568493e-12
, O 0 4.9707820189625815e-14
in O 0 1.8809910226624815e-13
all O 0 7.422352527519313e-14
exons O 0 1.706836061377004e-11
, O 0 4.2634716286918395e-13
no O 0 7.01022790164374e-12
mutation O 0 7.420987435668991e-12
, O 0 6.153899004962549e-14
by O 0 5.793669445022451e-14
DNA O 0 8.720213440227553e-11
sequencing O 0 2.3418905703564974e-10
. O 0 6.823432097124993e-11

On O 0 9.517407001391476e-11
the O 0 4.8839821482861076e-14
basis O 0 1.464280357122566e-13
of O 0 7.308986950759866e-16
the O 0 7.71197409860265e-15
present O 0 5.115831328982197e-14
study O 0 1.633809461418917e-13
, O 0 1.9188796195447957e-14
the O 0 8.458032248214765e-15
mechanism O 0 2.0708048990847328e-12
of O 0 2.084374780251825e-14
anhaptoglobinemia B-Disease 0 2.817193145432384e-09
and O 0 2.38710310199175e-12
the O 0 2.1869042221654006e-13
mechanism O 0 6.321723092922449e-12
of O 0 6.239301610089232e-14
anomalous O 0 3.4794706005314424e-10
inheritance O 0 8.530848250032363e-10
of O 0 1.702663292475759e-12
Hp O 0 2.4823449962241284e-09
phenotypes O 0 6.196229085375649e-10
were O 0 5.972384253816188e-10
well O 0 1.4299943174034269e-10
explained O 0 1.1551751777361119e-09
. O 0 4.4729109305308157e-11

However O 0 2.0983375037531005e-09
, O 0 4.307572527839643e-12
the O 0 2.791859083327297e-13
mechanism O 0 2.7299466506813808e-11
of O 0 4.90358621763054e-13
hypohaptoglobinemia B-Disease 0 1.0910542869169149e-06
remains O 0 2.4396648257152265e-08
unknown O 0 3.8900907384231687e-08

ATM O 0 1.9152463210048154e-05
mutations O 0 2.695962848520139e-07
and O 0 1.7201613744521893e-10
phenotypes O 0 8.006924190340214e-08
in O 0 4.011004932635842e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.835303687083069e-06
in O 0 4.1650384530189655e-11
the O 0 3.039217098474434e-13
British O 0 3.118354463538253e-09
Isles O 0 5.9905387317371606e-09
: O 0 9.574308170281001e-14
expression O 0 2.2711423941588343e-13
of O 0 6.670135855457596e-15
mutant O 0 7.187213324488795e-11
ATM O 0 1.9528907380106375e-09
and O 0 5.425891398506966e-13
the O 0 1.2437098605763003e-13
risk O 0 1.0548964479717426e-10
of O 0 1.022412406473383e-12
leukemia B-Disease 1 0.984840452671051
, O 0 7.103915891093493e-07
lymphoma B-Disease 1 1.0
, O 0 1.7078351177701734e-08
and O 0 1.871698600552918e-07
breast B-Disease 0 0.0064612519927322865
cancer I-Disease 0 2.625158231239766e-05
. O 0 3.1718625503884823e-09

We O 0 1.6268286717746605e-09
report O 0 5.985975604083649e-11
the O 0 2.4065893321125603e-14
spectrum O 0 1.9841901559292108e-12
of O 0 5.458940320179212e-14
59 O 0 7.914006255882455e-11
ATM O 0 2.6194060254169926e-08
mutations O 0 6.20257845085348e-10
observed O 0 9.51363154921836e-11
in O 0 1.4588981578356197e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.166126043652184e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.6940898257009636e-11
patients O 0 1.105094682429808e-09
in O 0 1.2009520981848265e-12
the O 0 9.35109737039419e-13
British O 0 2.0971221204035828e-08
Isles O 0 2.1896023838507972e-07
. O 0 2.5580124130009096e-10

Of O 0 2.276704866299717e-11
51 O 0 1.3406096233126163e-09
ATM O 0 2.8351285763505985e-08
mutations O 0 3.9367079041063846e-10
identified O 0 1.0521275517483275e-10
in O 0 6.86426989467831e-13
families O 0 1.4196189525566422e-13
native O 0 8.962344484175072e-14
to O 0 1.7836936693827778e-14
the O 0 1.2235197121950037e-13
British O 0 1.263612290358651e-07
Isles O 0 1.332186343461217e-07
, O 0 1.862541804814599e-12
11 O 0 2.1223752193644946e-13
were O 0 1.2356285699482994e-12
founder O 0 5.942470907710495e-12
mutations O 0 6.73759797953366e-11
, O 0 1.2624047857415222e-12
and O 0 3.323989521131221e-12
2 O 0 3.8268064932178714e-13
of O 0 8.941678743734551e-15
these O 0 1.6180183278272087e-13
11 O 0 2.578091006736477e-13
conferred O 0 2.2043937855653617e-12
a O 0 3.5942336346767023e-12
milder O 0 2.8456096856643853e-07
clinical O 0 2.1971446884094803e-08
phenotype O 0 4.091017302698674e-09
with O 0 4.958474494713705e-13
respect O 0 7.853339831741246e-13
to O 0 1.4659242786665971e-12
both O 0 1.0088996305057663e-10
cerebellar B-Disease 0 2.0922789190080948e-05
degeneration I-Disease 1 0.9559107422828674
and O 0 7.258856293823612e-10
cellular O 0 5.69560221208576e-08
features O 0 6.213688674705509e-09
. O 0 1.7157877341134053e-09

We O 0 1.1768226393371606e-09
report O 0 8.936139328508119e-11
, O 0 5.4087570061861837e-14
in O 0 2.5007358922350675e-13
two O 0 8.05168865608552e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.5531917418876162e-10
, O 0 4.607547524938804e-13
an O 0 1.2847225182559957e-13
ATM O 0 1.0188328758431453e-07
mutation O 0 5.985099083005707e-10
( O 0 5.4002683401443985e-12
7271T O 0 5.8079123732568405e-09
- O 0 4.303842171538008e-09
- O 0 2.26837748584785e-08
> O 0 7.878512287007311e-10
G O 0 2.4231297524046624e-10
) O 0 5.4949700524368e-14
that O 0 1.0764190916650457e-13
may O 0 2.6420669471671765e-11
be O 0 9.252903212511251e-15
associated O 0 2.5997079312954467e-14
with O 0 2.0642946783910356e-15
an O 0 1.5680570381103147e-14
increased O 0 1.2556844453115446e-10
risk O 0 3.181314323086326e-09
of O 0 3.968185155467374e-12
breast B-Disease 0 4.748381797980983e-06
cancer I-Disease 0 8.861504596779923e-08
in O 0 4.7251733775732774e-11
both O 0 1.496038709580816e-11
homozygotes O 0 3.751968336018763e-08
and O 0 9.294995328978928e-13
heterozygotes O 0 2.0962251934264486e-09
( O 0 3.128465368706923e-12
relative O 0 1.431891133440999e-10
risk O 0 1.0071625311525167e-08
12 O 0 2.0541214128949603e-12
. O 0 1.5057245272669106e-13
7 O 0 2.530374130713109e-12
; O 0 5.513526267486579e-12
P O 0 3.1790161756362068e-06
= O 0 4.835588041096628e-10
. O 0 2.5866528970824865e-12
0025 O 0 1.6019102488940007e-08
) O 0 5.051297921609965e-13
, O 0 8.51259438373192e-14
although O 0 1.500080170756951e-13
there O 0 4.2692818681341893e-13
is O 0 2.225400175552214e-14
a O 0 9.5590950519725e-13
less O 0 1.6019002790912396e-09
severe O 0 0.006298826076090336
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 5.562129672398441e-07
in O 0 1.2042855428162635e-11
terms O 0 1.9535471330878185e-12
of O 0 3.845327986693077e-15
the O 0 5.904300757076514e-14
degree O 0 3.17468745736349e-10
of O 0 5.215762717558636e-12
cerebellar B-Disease 0 3.5877251320926007e-06
degeneration I-Disease 0 0.0035563171841204166
. O 0 5.530555124977354e-09

This O 0 2.3365454016044396e-10
mutation O 0 1.8746446617257106e-09
( O 0 3.2871837196690734e-11
7271T O 0 2.472021032318139e-09
- O 0 2.2513075847996333e-09
- O 0 1.0422337659576897e-08
> O 0 3.374200918671022e-10
G O 0 1.1893752649427825e-10
) O 0 5.844413494826561e-14
also O 0 2.5327135543982623e-14
allows O 0 1.4207424231765624e-14
expression O 0 3.1838816522480884e-13
of O 0 8.496352865781497e-15
full O 0 1.7552714923901869e-12
- O 0 4.041652863079337e-12
length O 0 3.6497606152596784e-13
ATM O 0 5.681567438742263e-10
protein O 0 4.86838043836646e-12
at O 0 4.8599475138688675e-12
a O 0 4.0700415585535887e-13
level O 0 1.5212877615619624e-12
comparable O 0 5.075047153357826e-12
with O 0 3.080142139066065e-14
that O 0 9.816627762407326e-13
in O 0 3.105109919188109e-11
unaffected O 0 4.468609038354998e-09
individuals O 0 7.15480712870642e-12
. O 0 9.080637630720645e-11

In O 0 4.980374446184044e-11
addition O 0 5.241599797430052e-13
, O 0 1.9859459942424967e-13
we O 0 5.533611356677362e-14
have O 0 3.274513161164762e-14
studied O 0 2.2929044773967178e-10
18 O 0 5.721583623552462e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999985694885254
T I-Disease 1 1.0
patients O 0 3.7495863125514006e-07
, O 0 1.410620210050284e-13
in O 0 1.5812968068209393e-13
15 O 0 1.7720159649521616e-13
families O 0 3.4981288428003604e-14
, O 0 7.408435437382746e-14
who O 0 4.686843795009832e-12
developed O 0 1.560525646482347e-07
leukemia B-Disease 1 0.9999988079071045
, O 0 4.164519395999378e-06
lymphoma B-Disease 1 1.0
, O 0 1.1242173164616176e-10
preleukemic O 0 7.390786436189956e-07
T O 0 1.298536062677158e-06
- O 0 5.27570254149623e-09
cell O 0 8.250163574530234e-08
proliferation O 0 4.2599307903401495e-07
, O 0 2.9042634963616365e-10
or O 0 0.0006364883156493306
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.942895705431269e-10
mostly O 0 2.267526270915976e-11
in O 0 3.006003224115261e-10
childhood O 0 3.242168844508342e-08
. O 0 2.421757516746226e-10

A O 0 3.5011817889341046e-09
wide O 0 1.335119931278328e-10
variety O 0 5.751168638545856e-11
of O 0 1.1270287003997681e-12
ATM O 0 4.851353310186823e-07
mutation O 0 2.0234773578930998e-10
types O 0 8.424142633467468e-11
, O 0 3.551700491870313e-13
including O 0 3.689044783625889e-13
missense O 0 1.3966001688459073e-06
mutations O 0 3.967920747527387e-08
and O 0 2.109234592539977e-10
in O 0 7.357123799067722e-10
- O 0 4.4400565002433723e-07
frame O 0 8.386543726146556e-08
deletions O 0 2.779162855404138e-08
, O 0 7.632787631106641e-12
were O 0 2.0040984496927372e-11
seen O 0 1.0886751916627802e-10
in O 0 7.860637596564246e-13
these O 0 8.317847279004642e-13
patients O 0 3.233746256880998e-11
. O 0 1.1714042930099922e-11

We O 0 2.0767876307559163e-10
also O 0 6.267250173691563e-13
show O 0 5.213303747031439e-13
that O 0 4.172991840316678e-14
25 O 0 1.2939740153938145e-13
% O 0 2.4015682902078263e-14
of O 0 5.1508810441198115e-15
all O 0 9.016482872825637e-12
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 8.984346067109072e-08
carried O 0 5.0055352224243066e-11
in O 0 3.813461699198051e-11
- O 0 3.4204032939300077e-09
frame O 0 2.8924458383983165e-09
deletions O 0 1.638132118841895e-08
or O 0 1.768096447030132e-09
missense O 0 1.1306980951530932e-07
mutations O 0 1.6907374389418806e-09
, O 0 6.711439130141494e-13
many O 0 5.446893648196772e-15
of O 0 8.608215319048571e-16
which O 0 8.771747163262983e-14
were O 0 6.323378626271747e-11
also O 0 3.482273876805747e-13
associated O 0 5.153686722172979e-13
with O 0 3.9188396044930254e-14
expression O 0 2.7486656613978644e-12
of O 0 2.7911973473075842e-14
mutant O 0 8.785243643671947e-10
ATM O 0 5.882018072611572e-08
protein O 0 5.164314753614008e-09
. O 0 4.888017768323039e-10

The O 0 5.631656807558727e-10
DMPK O 0 4.2234026409460057e-07
gene O 0 5.294474902939328e-08
of O 0 3.870988946053089e-11
severely O 0 0.02987881563603878
affected O 0 2.147689201592584e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.002641795901581645
is O 0 4.3826001855373775e-11
hypermethylated O 0 2.3519199032762117e-08
proximal O 0 2.6240563499868585e-08
to O 0 6.4558575499362725e-12
the O 0 1.5990284183559078e-12
largely O 0 1.1996711957174e-10
expanded O 0 2.5917730184232823e-09
CTG O 0 2.2272258775046794e-06
repeat O 0 9.372975995347588e-08
. O 0 7.667889101448111e-10

Using O 0 2.7873792163291e-09
methylation O 0 3.3377162367287383e-07
- O 0 2.407389558811701e-07
sensitive O 0 2.6491811411233357e-08
restriction O 0 2.9676971990966194e-10
enzymes O 0 1.0004412576147814e-10
, O 0 2.2115298416343354e-14
we O 0 1.9966668902558944e-14
characterized O 0 9.314813867065605e-14
the O 0 4.1160837623488086e-14
methylation O 0 4.993827018573427e-10
pattern O 0 1.590186204936117e-09
on O 0 7.271878238457319e-11
the O 0 7.846661688459822e-13
5 O 0 1.6068919198725107e-12
side O 0 4.307687453269926e-12
of O 0 3.730805405279328e-14
the O 0 1.1494369909006985e-12
CTG O 0 1.8071187213308804e-08
repeat O 0 1.6101088518016837e-10
in O 0 1.9313366010631494e-12
the O 0 1.848028837164034e-13
DMPK O 0 5.978470496437183e-10
gene O 0 1.7232935564659435e-11
of O 0 3.345772010138193e-14
normal O 0 7.092414763126831e-12
individuals O 0 2.6149801047410312e-14
and O 0 9.338366804010137e-14
of O 0 2.026420108374328e-14
patients O 0 5.452371887315621e-11
affected O 0 9.608693181395456e-12
with O 0 3.3784107456025225e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.3678422110252608e-11
showing O 0 6.786415179815819e-11
expansions O 0 1.8537966994802701e-10
of O 0 2.3464742518811144e-13
the O 0 3.3984247707619097e-12
repetitive O 0 2.968566370498138e-08
sequence O 0 4.930434949201867e-10
. O 0 3.314268859355707e-10

The O 0 4.2520334475604216e-11
gene O 0 6.414463959991679e-10
segment O 0 1.3321064251670123e-09
analyzed O 0 1.8904064424951628e-10
corresponds O 0 9.396586807264296e-12
to O 0 5.577579413953981e-13
the O 0 7.616088749246019e-13
genomic O 0 9.899789876754994e-10
SacI O 0 1.2889936442661565e-06
- O 0 1.6747993214494272e-08
HindIII O 0 1.7245389116737897e-08
fragment O 0 4.602392245089959e-09
carrying O 0 7.706935090112665e-10
exons O 0 8.723582745062686e-09
11 O 0 2.3803006232725465e-09
- O 0 1.7336313717919438e-08
15 O 0 1.755812439885318e-10
. O 0 7.152109460228928e-11

There O 0 3.1882316231524044e-10
is O 0 8.711946962447481e-12
constitutive O 0 6.23520957088175e-10
methylation O 0 1.904939761487867e-09
in O 0 7.189859818623745e-11
intron O 0 8.661892536565574e-08
12 O 0 6.740644847846866e-11
at O 0 4.453686117816824e-12
restriction O 0 4.922424013537041e-12
sites O 0 6.818338211742048e-13
of O 0 7.134590363161789e-14
SacII O 0 8.462511580376031e-09
and O 0 3.9248750083320516e-11
HhaI O 0 6.7210095267000725e-09
, O 0 3.7245152708503815e-13
localized O 0 4.645753920451412e-11
1 O 0 2.667713706189234e-12
, O 0 7.460892797669927e-13
159 O 0 3.845382068323744e-10
- O 0 1.8375784227586678e-10
1 O 0 3.2561184651336283e-12
, O 0 1.2406588343477631e-12
232 O 0 2.614086551389061e-11
bp O 0 3.3576375013666393e-10
upstream O 0 9.277800749885046e-12
of O 0 1.6289360065349125e-14
the O 0 4.316534380367082e-13
CTG O 0 2.1797054827743523e-08
repeat O 0 1.1793881149468888e-10
, O 0 5.41432031858375e-14
whereas O 0 4.922609628948971e-13
most O 0 7.686337460607873e-14
, O 0 2.232819506543804e-14
if O 0 9.149802362171458e-14
not O 0 9.93437103413708e-13
all O 0 4.628781963300112e-14
, O 0 3.598860372580094e-14
of O 0 2.9003355732096984e-16
the O 0 1.6210872298390647e-15
other O 0 4.2135149976561554e-15
sites O 0 1.2914220745303268e-13
of O 0 6.659965954376387e-15
SacII O 0 3.2651148451634526e-10
, O 0 5.501275433458797e-13
HhaI O 0 9.736756956257864e-10
, O 0 7.078991256029288e-13
and O 0 1.9126332462260365e-12
HpaII O 0 8.029459319658372e-10
in O 0 2.1592721100721635e-12
this O 0 3.125277475506637e-14
region O 0 1.1571338505433904e-12
are O 0 4.825887953141539e-13
unmethylated O 0 4.089650007532697e-10
, O 0 1.3761152048603897e-13
in O 0 1.8135952537922523e-13
normal O 0 5.653477685996222e-12
individuals O 0 3.263601343925053e-14
and O 0 2.156517423402421e-13
most O 0 2.8222573678570416e-14
of O 0 2.8974949423419627e-15
the O 0 8.743354889921562e-13
patients O 0 1.305687780117637e-10
. O 0 1.2509172517272127e-11

In O 0 3.083810429238554e-10
a O 0 4.304943988092669e-12
number O 0 1.787849924529683e-13
of O 0 3.239946085400493e-14
young O 0 4.2350464801721444e-10
and O 0 5.087406884651813e-11
severely O 0 4.115577212360222e-06
affected O 0 2.2066454566371796e-11
patients O 0 5.295678826011674e-11
, O 0 6.659765376974477e-14
however O 0 1.0520863694130078e-12
, O 0 2.6041956134939537e-13
complete O 0 8.891280181728967e-13
methylation O 0 6.192433371632333e-11
of O 0 1.2150654594077995e-14
these O 0 1.791983411430966e-14
restriction O 0 6.506166048622641e-13
sites O 0 5.165959348664428e-13
was O 0 1.0690773266652798e-10
found O 0 1.661861794011177e-11
in O 0 2.8063126909089187e-12
the O 0 1.0221198887272465e-12
mutated O 0 7.317274253182404e-08
allele O 0 1.3237038842817128e-07
. O 0 3.7460101687258884e-09

In O 0 1.7008734698453765e-10
most O 0 7.716881604211134e-13
of O 0 2.78511209320792e-15
these O 0 2.4889144971352792e-14
patients O 0 2.3642205814605743e-12
, O 0 7.367186796323946e-15
the O 0 7.153367389536522e-14
onset O 0 4.736924741344239e-10
of O 0 3.4074366863246636e-14
the O 0 1.611921013333628e-11
disease O 0 1.1844652362924535e-05
was O 0 1.1503252608235925e-06
congenital O 1 0.9997150301933289
. O 0 3.034907880561377e-09

Preliminary O 0 4.1815535922751224e-08
in O 0 1.748983735616605e-10
vivo O 0 1.6521133261448995e-07
footprinting O 0 1.221641383608585e-07
data O 0 6.08656458567225e-11
gave O 0 1.6364050956299558e-12
evidence O 0 3.559906818113856e-13
for O 0 1.4927840999998457e-14
protein O 0 6.0880822952413816e-12
- O 0 1.4972233522425604e-11
DNA O 0 7.750255298644149e-11
contact O 0 1.762264223437171e-10
in O 0 9.81732663912771e-12
normal O 0 7.205633312246107e-11
genes O 0 6.350901055052205e-11
at O 0 1.3359624170816708e-11
an O 0 5.786546236749221e-14
Sp1 O 0 8.579127686036969e-11
consensus O 0 7.235594502025267e-13
binding O 0 2.8943067560682767e-12
site O 0 5.046023061200389e-12
upstream O 0 1.0030986458131608e-11
of O 0 3.774458772875383e-14
the O 0 1.4858940900613904e-12
CTG O 0 1.6350979237245156e-08
repeat O 0 2.1478674394614927e-10
and O 0 1.9657874232494738e-13
for O 0 1.7212598872802e-15
a O 0 2.1301890983029155e-14
significant O 0 1.4238818999735836e-13
reduction O 0 2.470573929897607e-13
of O 0 1.3338312523708193e-15
this O 0 4.5981839992233816e-15
interaction O 0 4.503636572288257e-14
in O 0 1.2537083730109616e-13
cells O 0 6.090533025832068e-12
with O 0 2.2192764661567443e-13
a O 0 5.555797488732139e-11
hypermethylated O 0 1.271251477419355e-07
DMPK O 0 3.415867055878152e-08
gene O 0 2.571544754914612e-09
. O 0 3.671667483939878e-11
. O 0 8.51720360905972e-11

The O 0 2.679645838554734e-09
hemochromatosis B-Disease 1 1.0
gene O 0 7.307451532767573e-09
product O 0 4.39841912891481e-11
complexes O 0 8.934446932284956e-12
with O 0 1.8024110646380244e-14
the O 0 3.208545557606239e-14
transferrin O 0 1.188846937560939e-10
receptor O 0 3.1489290341912834e-11
and O 0 1.3266762688424194e-11
lowers O 0 2.587509095874907e-10
its O 0 4.7841488122436424e-14
affinity O 0 5.987251059519361e-12
for O 0 7.870655218062197e-14
ligand O 0 8.09437586402062e-11
binding O 0 1.3599559256505245e-09
. O 0 7.463950013608667e-10

We O 0 3.3861538573098926e-10
recently O 0 2.0280907508940516e-10
reported O 0 8.714860083580689e-11
the O 0 8.652603508902193e-14
positional O 0 1.0082667339927909e-10
cloning O 0 5.818362458498427e-11
of O 0 4.8305265766112465e-14
a O 0 4.719757570881278e-12
candidate O 0 2.1032689478950317e-10
gene O 0 1.1700783488777233e-06
for O 0 2.479692398082989e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 1.93683536053868e-06
HFE O 0 0.0004693208320531994
. O 0 1.048162623362714e-08

The O 0 8.271307250229398e-12
gene O 0 3.1379468468095695e-10
product O 0 5.880730624685526e-11
, O 0 7.578788941906001e-13
a O 0 5.816683940063072e-12
member O 0 1.2099978137503076e-11
of O 0 3.125551575368368e-14
the O 0 1.8288517401876536e-13
major O 0 7.454651479443797e-12
histocompatibility O 0 2.1453452903053005e-10
complex O 0 1.2367901147669613e-10
class O 0 1.2199126153689122e-09
I O 0 4.3327872845111415e-08
- O 0 4.680217671748643e-11
like O 0 7.99043123334009e-12
family O 0 4.089052881017796e-12
, O 0 5.991232087266402e-14
was O 0 2.436121400092861e-12
found O 0 4.4431285365319206e-13
to O 0 3.9346730219694606e-14
have O 0 4.7829036738111785e-12
a O 0 4.939936914388765e-12
mutation O 0 1.0862587912496835e-10
, O 0 1.0553910176347436e-11
Cys O 0 5.217900707066292e-06
- O 0 4.71135486179719e-09
282 O 0 4.126142272298239e-08
- O 0 2.293882239712275e-08
- O 0 3.155451366865236e-08
> O 0 9.429739211697097e-10
Tyr O 0 4.596978797621887e-09
( O 0 2.7466692115174496e-12
C282Y O 0 9.690730162770222e-11
) O 0 7.02585504965686e-14
, O 0 2.0495366539444344e-14
in O 0 6.659435372938227e-14
85 O 0 9.04446764878053e-13
% O 0 4.2007044544212224e-13
of O 0 2.5985588463992015e-13
patient O 0 2.7848126027407716e-09
chromosomes O 0 3.660636904712078e-09
. O 0 5.627340260438984e-10

This O 0 3.583051216837774e-11
mutation O 0 1.067417265687709e-09
eliminates O 0 1.7504598881501465e-09
the O 0 1.3962465081687747e-12
ability O 0 4.725001986893851e-11
of O 0 3.921107145574143e-13
HFE O 0 2.0826134061735502e-07
to O 0 6.282644977179119e-12
associate O 0 1.2812005623086264e-10
with O 0 1.0855347653757064e-12
beta2 O 0 1.3639850294566713e-05
- O 0 3.117601181656937e-07
microglobulin O 0 1.0602560678307782e-06
( O 0 3.7052673429460725e-11
beta2m O 0 8.761234404630613e-09
) O 0 4.020092906568268e-13
and O 0 7.393814293460421e-13
prevents O 0 8.16539110631842e-12
cell O 0 3.732938225198268e-08
- O 0 6.945342967412671e-09
surface O 0 5.031257077625639e-10
expression O 0 1.6528823865158415e-09
. O 0 3.0612948287433994e-10

A O 0 1.3161406187123248e-08
second O 0 1.9720093613617706e-10
mutation O 0 7.548803943047133e-11
that O 0 7.714041536620309e-13
has O 0 2.3300365543238444e-12
no O 0 3.3595173084405294e-12
effect O 0 3.7848457007383374e-11
on O 0 2.0212785611928297e-10
beta2m O 0 2.1007572570397315e-08
association O 0 1.888627925925035e-12
, O 0 1.0719117244208445e-13
H63D O 0 1.108241831637713e-09
, O 0 1.5872558530114628e-13
was O 0 1.923958388438951e-11
found O 0 5.900445496781481e-12
in O 0 1.5960088068853184e-12
eight O 0 1.2718256352586832e-12
out O 0 4.098193681113804e-13
of O 0 2.9873808505068156e-14
nine O 0 1.1959837287189856e-10
patients O 0 3.877188500811535e-11
heterozygous O 0 6.270042124389974e-11
for O 0 1.34150205050379e-13
the O 0 1.3496306936616742e-12
C282Y O 0 1.413912809056228e-08
mutant O 0 6.211167402625506e-08
. O 0 1.844015162788537e-09

In O 0 4.2648770626207977e-10
this O 0 5.870167633231782e-13
report O 0 1.4081807768462351e-11
, O 0 5.116124402381947e-14
we O 0 6.831599901665347e-14
demonstrate O 0 3.667618238192144e-13
in O 0 7.683351567824848e-13
cultured O 0 1.4795368485920335e-08
293 O 0 1.8061899198507092e-10
cells O 0 1.0454023063877216e-10
overexpressing O 0 1.4616276189372002e-08
wild O 0 2.921213826390101e-10
- O 0 4.245668261404489e-09
type O 0 1.1096298990764808e-08
or O 0 1.1551150314037528e-10
mutant O 0 1.713835184879997e-09
HFE O 0 2.3357813461188925e-08
proteins O 0 8.829296668788622e-12
that O 0 6.710104206216622e-14
both O 0 5.4635444524673074e-14
the O 0 7.718658204996023e-14
wild O 0 1.253193798733676e-10
- O 0 4.5115516655869214e-08
type O 0 8.69027076078055e-07
and O 0 7.523021094968385e-10
H63D O 0 4.1598451616664534e-07
HFE O 0 1.1326775251063737e-07
proteins O 0 1.321827369782369e-10
form O 0 1.2138774707626254e-10
stable O 0 3.5431688694131935e-09
complexes O 0 3.252625252470054e-11
with O 0 7.477043750857629e-14
the O 0 3.1613587073674176e-13
transferrin O 0 1.2608810662229075e-09
receptor O 0 9.51612344479713e-10
( O 0 7.065899948477394e-11
TfR O 0 4.695268387422402e-07
) O 0 4.9738244772834506e-11
. O 0 3.668393366851319e-10

The O 0 3.406163406882712e-10
C282Y O 0 6.90009613890652e-08
mutation O 0 4.0398711043110325e-09
nearly O 0 6.849210781867399e-11
completely O 0 4.493366512203778e-10
prevents O 0 1.907686508761941e-11
the O 0 2.932200651988709e-13
association O 0 3.900497275426823e-13
of O 0 2.0981147981507684e-15
the O 0 1.2882705698654545e-13
mutant O 0 1.4458555464003098e-09
HFE O 0 7.87978180483151e-08
protein O 0 4.912084072827838e-10
with O 0 2.7875770268470657e-12
the O 0 3.095967232580321e-11
TfR O 0 8.7922917373362e-06
. O 0 9.848938331558088e-10

Studies O 0 2.8945335017738216e-08
on O 0 1.0667125516228282e-10
cell O 0 5.681342507557474e-09
- O 0 9.962107805350229e-10
associated O 0 1.9767042169771543e-11
transferrin O 0 8.626436787118053e-10
at O 0 7.522716477526004e-11
37 O 0 1.0680068808499588e-11
degrees O 0 9.840639414449015e-10
C O 0 9.865661354524491e-08
suggest O 0 1.4142424210883409e-11
that O 0 4.1518679228143285e-13
the O 0 6.893646352541805e-13
overexpressed O 0 1.1193955984367676e-08
wild O 0 3.1309518866429187e-10
- O 0 5.659311685946022e-09
type O 0 1.1744352157450066e-08
HFE O 0 5.576678674401592e-08
protein O 0 2.1474333422588643e-10
decreases O 0 3.7855316104007386e-11
the O 0 2.5717392421902886e-14
affinity O 0 6.351987946046078e-12
of O 0 1.2120893752663037e-13
the O 0 2.673082024826079e-12
TfR O 0 3.7516318940333804e-08
for O 0 1.025032706283846e-12
transferrin O 0 6.0173466209789694e-09
. O 0 3.6416789028770324e-10

The O 0 8.856980426852346e-11
overexpressed O 0 2.0942407275015285e-07
H63D O 0 2.660117814912155e-08
protein O 0 6.625162918272309e-11
does O 0 1.5722333374448838e-12
not O 0 2.1957221739594968e-14
have O 0 1.0520691305984653e-14
this O 0 4.087120741266869e-15
effect O 0 4.239323464754613e-13
, O 0 1.3814740604451477e-14
providing O 0 2.714894417133254e-14
the O 0 1.8139809841261024e-15
first O 0 7.249484792039382e-15
direct O 0 2.7719863012506778e-14
evidence O 0 1.5086602756994583e-12
for O 0 7.433584862026263e-15
a O 0 4.0124172972881567e-13
functional O 0 1.1379068694250538e-11
consequence O 0 1.197925873080985e-11
of O 0 5.0876125957510093e-14
the O 0 5.121919815359588e-12
H63D O 0 1.0652790933818324e-06
mutation O 0 7.185329220504855e-09
. O 0 5.907320743681055e-10

Addition O 0 2.4827273570338093e-10
of O 0 1.468947142743704e-12
soluble O 0 5.499579103229735e-08
wild O 0 3.598292996898067e-09
- O 0 3.6611422729038168e-06
type O 0 0.0001702594745438546
HFE O 0 0.23937298357486725
/ O 0 2.7137848519487306e-06
beta2m O 0 6.641771932436313e-08
heterodimers O 0 5.379674039573956e-09
to O 0 1.583295669051188e-12
cultured O 0 2.1626593849077835e-09
cells O 0 2.2455598491788464e-10
also O 0 1.2290262123987317e-12
decreased O 0 1.1534039348615188e-11
the O 0 5.471613034212968e-15
apparent O 0 2.468898132809705e-12
affinity O 0 1.1311101361100029e-11
of O 0 3.6506428847775385e-14
the O 0 5.676900464469947e-13
TfR O 0 1.6865181473590951e-09
for O 0 7.245032786868614e-15
its O 0 5.905987199674497e-15
ligand O 0 2.3916695447018244e-12
under O 0 2.340347533824616e-12
steady O 0 4.096138983555875e-09
- O 0 1.66640069798607e-11
state O 0 6.009649700620956e-13
conditions O 0 7.386457667735158e-09
, O 0 2.6453758820532518e-14
both O 0 3.1590005676422617e-14
in O 0 1.9849887792494636e-12
293 O 0 6.6136705487163105e-12
cells O 0 9.735261208287938e-12
and O 0 8.825593034167412e-12
in O 0 7.004320300846301e-12
HeLa O 0 2.1017472207063292e-08
cells O 0 6.000910879322419e-09
. O 0 7.499253995568722e-10

Furthermore O 0 8.683770369444233e-10
, O 0 2.4597418286226302e-12
at O 0 4.7440809960996866e-12
4 O 0 1.3433001455967486e-12
degrees O 0 1.254571770914481e-07
C O 0 0.002366540487855673
, O 0 7.533179809116053e-12
the O 0 2.295943600169603e-12
added O 0 2.3875951882246227e-08
soluble O 0 3.924232883090184e-10
complex O 0 7.551607776601355e-12
of O 0 7.159609276968792e-13
HFE O 0 5.129250894242432e-06
/ O 0 9.927328648018374e-08
beta2m O 0 2.9553467228993213e-08
inhibited O 0 1.5622515503466161e-09
binding O 0 3.074547214043655e-11
of O 0 1.3694958795468226e-13
transferrin O 0 4.68881600212967e-10
to O 0 7.069306945384213e-12
HeLa O 0 4.950010890070189e-08
cell O 0 2.845720814548258e-07
TfR O 0 1.4268429140429362e-06
in O 0 1.3560823471092665e-11
a O 0 3.309403445728165e-11
concentration O 0 1.0654773063834e-08
- O 0 1.8153120118213906e-09
dependent O 0 2.6563087285325082e-09
manner O 0 4.154634680730851e-08
. O 0 6.596014845428044e-10

Scatchard O 0 1.196577954942768e-06
plots O 0 4.750516868767818e-09
of O 0 4.3898741521226914e-13
these O 0 6.489122119420626e-14
data O 0 9.518813688658145e-13
indicate O 0 8.588286874201823e-13
that O 0 4.838050262061938e-14
the O 0 2.285186471474854e-13
added O 0 1.9401255602069511e-10
heterodimer O 0 1.2665658452593043e-11
substantially O 0 2.9267516188369314e-10
reduced O 0 1.8830668361419223e-12
the O 0 6.21549862901867e-14
affinity O 0 2.6857575191607808e-11
of O 0 1.1573656529678678e-12
TfR O 0 1.932150972550062e-08
for O 0 2.8702827874899084e-12
transferrin O 0 1.3030048151563278e-08
. O 0 5.382699286293757e-10

These O 0 1.8368556675696368e-11
results O 0 6.320795015862801e-12
establish O 0 2.1406589608558013e-12
a O 0 1.919701810709773e-12
molecular O 0 2.7234769994777253e-11
link O 0 9.410191514902522e-10
between O 0 1.878971561675158e-10
HFE O 0 1.7952168036572402e-06
and O 0 8.871871119697783e-12
a O 0 2.018240826198725e-12
key O 0 2.9018202771236012e-11
protein O 0 6.879936724490943e-12
involved O 0 2.417121841222225e-12
in O 0 2.0192805760821386e-12
iron O 0 1.5182289869741794e-09
transport O 0 4.629822220048041e-11
, O 0 1.2437715245748604e-13
the O 0 1.7683659983384892e-13
TfR O 0 7.046703842661373e-08
, O 0 8.92824171799117e-13
and O 0 6.469759081771664e-13
raise O 0 3.995448178036043e-13
the O 0 1.0618831084352378e-14
possibility O 0 8.484571552280773e-13
that O 0 3.096879306815903e-13
alterations O 0 1.908167929220994e-10
in O 0 3.006600502418466e-13
this O 0 1.5204921740077926e-13
regulatory O 0 1.5096902616917873e-09
mechanism O 0 1.4200735032332545e-10
may O 0 7.979808480662598e-10
play O 0 1.5727140076360335e-11
a O 0 4.603691017811273e-13
role O 0 3.846155598868917e-12
in O 0 8.592448584240908e-13
the O 0 6.903804784796908e-13
pathogenesis O 0 3.826718941724039e-09
of O 0 3.501727519061859e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 3.897040024014586e-09
. O 0 2.1147533724175105e-10

Genomic O 0 4.710881285063806e-08
organization O 0 8.615732571826129e-10
of O 0 1.7694162107728673e-12
the O 0 6.358437214248891e-12
UBE3A O 0 3.831672984233592e-06
/ O 0 4.1711821552326e-08
E6 O 0 2.4340037541037418e-08
- O 0 6.001806696076528e-08
AP O 0 4.736419043638307e-07
gene O 0 3.696560169075269e-09
and O 0 2.1887134465936597e-11
related O 0 3.321952157797625e-10
pseudogenes O 0 1.0693251617510668e-08
. O 0 3.6576269790700167e-10

The O 0 3.017653071868409e-10
UBE3A O 0 5.685848805114802e-07
gene O 0 4.589794766474142e-09
encodes O 0 1.537547089647262e-09
the O 0 4.947952637890385e-12
E6 O 0 5.126980617831123e-09
- O 0 4.545953835588534e-09
AP O 0 6.78924720887153e-08
ubiquitin O 0 1.055734277777276e-09
- O 0 1.5778135742383625e-10
protein O 0 1.7645640157382125e-11
ligase O 0 5.835722877156613e-11
and O 0 9.352738852483333e-13
has O 0 1.6156253581072616e-13
recently O 0 1.2879378119556861e-11
been O 0 2.6784802674428843e-13
shown O 0 1.2148390475009985e-13
to O 0 7.912348890231485e-14
be O 0 2.3381255698923242e-12
mutated O 0 3.051170267553971e-07
in O 0 3.284522608737461e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 5.347280875867e-06
who O 0 3.626427977354574e-11
lack O 0 1.4976724027615518e-10
15q11 O 0 1.261765163462769e-07
- O 0 6.053795686966623e-08
q13 O 0 8.713875843113783e-08
deletions O 0 2.452177625400509e-07
or O 0 7.021130343787263e-09
chromosome O 0 1.1462906513770577e-05
15 O 0 8.517374361360908e-09
paternal O 0 2.9932048164482694e-06
uniparental B-Disease 0 0.0010837451554834843
disomy I-Disease 0 0.00011723549687303603
. O 0 1.536835370075096e-08

Previous O 0 5.8398703650652806e-09
UBE3A O 0 9.829017244555871e-08
cDNA O 0 6.658331663800254e-10
analysis O 0 5.2177352716231695e-11
has O 0 8.198455477871625e-13
shown O 0 4.0205835080513175e-13
a O 0 3.751674752111578e-12
coding O 0 1.1089607010461577e-09
region O 0 1.6795825147353227e-11
of O 0 2.4734218579541833e-13
approximately O 0 4.848448031946617e-12
2 O 0 3.556381578118106e-11
. O 0 1.175920055773716e-10

6 O 0 8.013509500415239e-08
kb O 0 8.521571004393991e-08
and O 0 2.026345757855097e-11
a O 0 5.382912171558729e-11
3 O 0 8.228374093199875e-10
- O 0 7.4149274951196276e-06
untranslated O 0 3.068428486585617e-05
region O 0 1.0581196363546042e-08
( O 0 1.6981084594025475e-10
UTR O 0 4.943808917801107e-09
) O 0 6.351063880534469e-13
of O 0 5.878074584150447e-14
< O 0 4.823152988109314e-10
50 O 0 2.0433208076930942e-12
bp O 0 8.241316518109443e-10
, O 0 1.2783574383518764e-13
whereas O 0 6.861481326690677e-13
Northern O 0 6.153807389878974e-13
analysis O 0 1.28573367230711e-11
has O 0 2.4296573867405025e-12
indicated O 0 1.1839629103505e-11
mRNA O 0 3.9042879172723755e-12
sizes O 0 1.518401376854328e-11
of O 0 1.9563689589770922e-13
5 O 0 2.9466476481054826e-10
- O 0 4.6306683998409426e-07
8 O 0 2.217072303523082e-09
kb O 0 3.567481883237633e-07
. O 0 5.77002612356381e-10

We O 0 2.0891910423870286e-10
have O 0 3.748582661725758e-13
analyzed O 0 9.932381523150569e-13
additional O 0 1.7685910719332336e-14
cDNA O 0 1.2818403456738015e-11
clones O 0 1.0782742754233965e-10
and O 0 2.1664324522698009e-13
provide O 0 4.935863593931791e-14
evidence O 0 8.642315921063293e-13
for O 0 2.9827919648117707e-14
an O 0 1.451395156403662e-13
additional O 0 1.1228280458186468e-11
0 O 0 1.2948055128081393e-10
. O 0 3.3963543089043924e-10

5 O 0 9.705463988041174e-09
kb O 0 2.5112289137041444e-08
of O 0 1.2811016353656002e-12
5 O 0 2.0579460011105333e-11
- O 0 4.6788031227151805e-09
UTR O 0 4.4209667038330736e-08
and O 0 3.516765698097224e-11
> O 0 1.4043298468546794e-10
2 O 0 3.1845272946418035e-12
kb O 0 1.3503510531975849e-09
of O 0 7.239266694783475e-13
3 O 0 5.454559026674133e-10
- O 0 1.185473550435745e-07
UTR O 0 7.918893061287235e-07
. O 0 1.1613299211177264e-09

We O 0 8.30469859547378e-11
have O 0 1.3491565178415377e-13
established O 0 2.5200597291992304e-14
the O 0 3.1512056622418592e-15
genomic O 0 1.244310752525346e-12
organization O 0 4.540121533933017e-13
of O 0 2.3697803295434985e-14
UBE3A O 0 3.6193006369700242e-09
and O 0 1.5188813748401309e-12
the O 0 6.784826064691607e-14
sequence O 0 1.8733443615803758e-12
of O 0 1.546874472046697e-13
intron O 0 9.232696385197414e-08
- O 0 1.9805490580893093e-08
exon O 0 5.537883396300458e-08
borders O 0 2.6982180045820314e-08
. O 0 4.020292987405583e-09

We O 0 1.2755833056488086e-09
have O 0 7.072327966317626e-12
also O 0 2.8967353147245356e-13
mapped O 0 9.021713064105708e-12
two O 0 3.413474743748507e-13
highly O 0 1.6758121583124175e-12
homologous O 0 1.0554896366643529e-11
processed O 0 8.179502214433754e-11
pseudogenes O 0 1.774555363764918e-10
, O 0 1.4426220634744524e-12
UBE3AP1 O 0 2.161413936718759e-09
and O 0 1.7658525466521247e-12
UBE3AP2 O 0 3.5722460545173362e-09
, O 0 4.4045828453704444e-14
to O 0 9.607339914125077e-15
chromosomes O 0 6.782050615550261e-12
2 O 0 7.112840589955371e-13
and O 0 2.4421274464475617e-12
21 O 0 7.994577222447674e-12
, O 0 1.6819947940959618e-13
respectively O 0 3.727572937817225e-12
, O 0 7.534009223778004e-13
and O 0 1.3006457889874756e-12
determined O 0 1.500058931236392e-11
their O 0 1.2492445771415672e-13
genomic O 0 8.115120381235741e-11
organization O 0 5.939256031428641e-11
. O 0 1.4198758835348713e-10

These O 0 3.2627473639523785e-11
results O 0 3.355305616681292e-11
will O 0 5.408148158903697e-14
form O 0 1.5381915034230753e-14
the O 0 7.118303105432214e-15
basis O 0 2.1338094865260698e-13
for O 0 3.775918718863271e-15
studies O 0 3.6684229872546714e-13
of O 0 1.1764201741123852e-14
mutation O 0 4.185297594605508e-11
and O 0 2.0753055524069808e-11
imprinting O 0 4.904157524521224e-09
of O 0 4.242075874599793e-12
UBE3A O 0 1.8720409116212977e-06
. O 0 1.03377539861782e-09

Mutation O 0 9.673067324911244e-07
spectrum O 0 2.5482075116656233e-08
and O 0 2.048666347675976e-09
genotype O 0 0.0031313016079366207
- O 0 0.00014381347864400595
phenotype O 0 1.3435023902275134e-06
analyses O 0 7.521389733256001e-09
in O 0 4.989409996269956e-10
Cowden B-Disease 0 0.020414838567376137
disease I-Disease 0 3.616137837525457e-05
and O 0 2.3508692770235484e-09
Bannayan B-Disease 1 0.999972939491272
- I-Disease 1 0.9999998807907104
Zonana I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
, O 0 2.1936417959889098e-10
two O 0 9.402005562986204e-11
hamartoma B-Disease 0 0.0005774322780780494
syndromes I-Disease 0 0.004559475928544998
with O 0 5.902173749738893e-10
germline O 0 0.00031131846481002867
PTEN O 0 0.000920208462048322
mutation O 0 8.266233635367826e-06
. O 0 3.4432691364827406e-08

The O 0 3.707273421582613e-08
tumour B-Disease 1 1.0
suppressor O 0 1.24880270959693e-05
gene O 0 4.815826741833007e-07
PTEN O 0 3.987825948570389e-06
, O 0 4.8331789959110694e-11
which O 0 1.7233450994372235e-12
maps O 0 3.021938532743462e-10
to O 0 1.3610139404374166e-10
10q23 O 0 6.563228680533939e-07
. O 0 1.5131006447788309e-09

3 O 0 1.60505353452578e-09
and O 0 2.3191030259356316e-12
encodes O 0 1.8507645069276712e-11
a O 0 1.1685718582024607e-12
403 O 0 1.4538458111001962e-11
amino O 0 6.784629108524953e-11
acid O 0 1.28627886120114e-10
dual O 0 1.8815070335076456e-10
specificity O 0 4.7079504739144795e-09
phosphatase O 0 1.9405408238526434e-05
( O 0 7.362945669830978e-11
protein O 0 5.8131992553001055e-09
tyrosine O 0 1.1803417265809912e-07
phosphatase O 0 7.426063461934973e-07
; O 0 9.617311287624108e-12
PTPase O 0 2.0473849282609535e-09
) O 0 9.70711033256022e-13
, O 0 3.725552581278907e-13
was O 0 1.7681351174858584e-11
shown O 0 6.401705879809094e-13
recently O 0 3.322940811401054e-10
to O 0 6.819131305631221e-13
play O 0 1.9546933516245701e-10
a O 0 5.173870446656403e-12
broad O 0 8.69843572171014e-11
role O 0 9.866570060967916e-11
in O 0 4.433119149549469e-11
human O 0 9.773555575964821e-11
malignancy B-Disease 0 1.4927095435268711e-06
. O 0 5.594613661230596e-10

Somatic O 0 4.988820728613064e-05
PTEN O 0 0.00011179498687852174
deletions O 0 1.0562604302322143e-06
and O 0 3.490498168279288e-10
mutations O 0 8.420195096725536e-10
were O 0 7.716194003193344e-12
observed O 0 4.17603755395457e-12
in O 0 8.980937521441135e-12
sporadic B-Disease 0 0.00028094826848246157
breast I-Disease 1 0.6533787250518799
, I-Disease 0 2.895891881848911e-08
brain I-Disease 0 0.4717436730861664
, I-Disease 0 2.577978053253105e-09
prostate I-Disease 0 0.0001731088268570602
and I-Disease 0 4.628414096430333e-09
kidney I-Disease 0 6.187306667015946e-07
cancer I-Disease 0 2.8275895402885e-08
cell O 0 1.1572485618671635e-06
lines O 0 1.3195285646361299e-06
and O 0 1.0057957133824402e-08
in O 0 1.3067741333472327e-10
several O 0 2.6281596690602704e-11
primary O 0 1.086875869305004e-07
tumours B-Disease 1 1.0
such O 0 3.499844858367851e-10
as O 0 1.0991319498998564e-07
endometrial B-Disease 1 0.9999517202377319
carcinomas I-Disease 1 1.0
, O 0 0.460835725069046
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.6260222792625427
thyroid B-Disease 1 0.9999995231628418
tumours I-Disease 1 1.0
. O 0 7.65716468009714e-09

In O 0 5.5956354133579467e-11
addition O 0 1.9377865197872657e-12
, O 0 1.98034861079166e-12
PTEN O 0 8.564148146206207e-08
was O 0 4.0165121228952216e-10
identified O 0 4.733544459178951e-11
as O 0 3.170863907813598e-13
the O 0 5.5387331955028193e-14
susceptibility O 0 1.8058617101690544e-11
gene O 0 2.735879855997325e-10
for O 0 9.920647636718627e-12
two O 0 5.129403568560065e-10
hamartoma B-Disease 1 0.9993240833282471
syndromes I-Disease 1 0.9999996423721313
Cowden B-Disease 1 0.9999924898147583
disease I-Disease 1 0.9999904632568359
( O 0 6.219961434794641e-09
CD B-Disease 0 9.819235202712662e-08
; O 0 1.779446173744148e-10
MIM O 0 0.00034501959453336895
158350 O 0 1.6348797871046372e-08
) O 0 6.8263970864901324e-12
and O 0 1.7091196513607798e-11
Bannayan B-Disease 0 1.1706325494742487e-05
- I-Disease 0 2.801462642310071e-06
Zonana I-Disease 0 7.5180241765338e-06
( I-Disease 0 8.300406889594214e-11
BZS I-Disease 0 4.351047877548808e-08
) I-Disease 0 3.752662243450278e-12
or I-Disease 0 2.7280521591732665e-11
Ruvalcaba I-Disease 0 5.650491061715002e-07
- I-Disease 0 6.163772923173383e-07
Riley I-Disease 0 0.011343277990818024
- I-Disease 1 0.9999607801437378
Smith I-Disease 1 0.7307478785514832
syndrome I-Disease 1 0.999948263168335
( O 0 7.98455468409287e-11
MIM O 0 2.6300089302822016e-05
153480 O 0 5.553697590698903e-08
) O 0 6.862077572833414e-11
. O 0 7.30004737214962e-11

Constitutive O 0 2.15025167449312e-07
DNA O 0 1.7089332615682906e-08
from O 0 4.702946712620282e-11
37 O 0 1.2085084322155382e-10
CD B-Disease 0 1.1035464764219682e-09
families O 0 1.6620257687477435e-12
and O 0 4.65414816061549e-13
seven O 0 5.466299071374414e-13
BZS B-Disease 0 1.8434603177297504e-08
families O 0 3.983632868020948e-12
was O 0 1.520160212986621e-11
screened O 0 4.267717013117789e-10
for O 0 5.731924917345976e-12
germline O 0 4.334643222136947e-07
PTEN O 0 5.429628799902275e-06
mutations O 0 3.2775665204098914e-07
. O 0 2.6320652324329785e-09

PTEN O 0 5.504615910467692e-05
mutations O 0 1.3375325735864863e-08
were O 0 3.87714409189055e-11
identified O 0 2.1671497929531824e-11
in O 0 5.058837463517429e-13
30 O 0 1.370415689564905e-13
of O 0 5.636736178049563e-15
37 O 0 5.147058560611706e-12
( O 0 7.685110143748619e-13
81 O 0 4.0130027773033206e-11
% O 0 3.144954132186517e-12
) O 0 6.771642166274183e-13
CD B-Disease 0 6.536325924955122e-10
families O 0 3.9190062328144093e-13
, O 0 3.1856841383598455e-14
including O 0 1.3716969454822397e-13
missense O 0 1.2545096694793756e-07
and O 0 5.153212856434664e-10
nonsense O 0 3.345407321830862e-06
point O 0 2.9160698855612566e-10
mutations O 0 5.580449990993941e-10
, O 0 1.577826953293171e-12
deletions O 0 5.167208882994601e-10
, O 0 4.037260976919033e-12
insertions O 0 4.860557289987355e-09
, O 0 6.933817235654782e-12
a O 0 2.619661779168503e-11
deletion O 0 3.8114100675556983e-07
/ O 0 1.7095419480028795e-07
insertion O 0 1.3183440117359169e-08
and O 0 5.020223681206915e-10
splice O 0 6.064114586479263e-06
site O 0 1.7369844229619957e-08
mutations O 0 1.0330830946259084e-06
. O 0 4.029174771602584e-09

These O 0 3.205027562791507e-11
mutations O 0 1.5016884957752552e-10
were O 0 6.791215159673847e-12
scattered O 0 3.3442823163531976e-12
over O 0 3.889012592864227e-13
the O 0 1.5405263328015228e-13
entire O 0 1.9611521608065008e-12
length O 0 4.923269257550711e-12
of O 0 9.267779821570468e-14
PTEN O 0 2.6853722800979085e-08
, O 0 7.737101974727989e-13
with O 0 1.1607822518401763e-14
the O 0 3.882429046222352e-14
exception O 0 2.097822133020899e-12
of O 0 7.804249020843586e-15
the O 0 3.694931730371942e-13
first O 0 8.436330800609682e-11
, O 0 1.674424071618219e-10
fourth O 0 1.9527507788552612e-07
and O 0 1.3283361077753852e-09
last O 0 1.2054916176396091e-08
exons O 0 3.235725642980469e-08
. O 0 1.0365712732607335e-09

A O 0 1.3089835704249708e-07
hot O 0 9.295229119743453e-08
spot O 0 6.974082644717328e-09
for O 0 1.1404795510761012e-11
PTEN O 0 1.4043332612345694e-06
mutation O 0 1.6439970496051615e-09
in O 0 8.657684985591274e-11
CD B-Disease 0 2.578484759041544e-09
was O 0 1.019861972650915e-10
identified O 0 1.868991073017412e-11
in O 0 1.1464440508035523e-12
exon O 0 1.7536938567985771e-10
5 O 0 2.0727133117487417e-12
that O 0 1.0822471526806057e-13
contains O 0 1.400246157088128e-13
the O 0 9.087455722818494e-13
PTPase O 0 9.214801366397296e-09
core O 0 2.3275781302345422e-10
motif O 0 1.074078673224399e-10
, O 0 5.149559706603413e-13
with O 0 8.102952309780795e-14
13 O 0 5.935240905523276e-13
of O 0 5.1146585271634286e-15
30 O 0 7.896658587441818e-13
( O 0 4.635296053240312e-13
43 O 0 1.3381989960592477e-11
% O 0 1.7164333105876284e-12
) O 0 7.55212298947372e-13
CD B-Disease 0 1.685887762725713e-09
mutations O 0 3.629633815727118e-10
identified O 0 1.186333142833007e-09
in O 0 6.516849993670748e-12
this O 0 4.002986310480683e-12
exon O 0 1.4111726898136112e-08
. O 0 8.157087227900206e-10

Seven O 0 1.3300011092454156e-10
of O 0 5.718422426120168e-14
30 O 0 8.798931093283169e-13
( O 0 5.573155326989154e-13
23 O 0 1.07116843606897e-12
% O 0 7.519936144053871e-14
) O 0 1.504997298659716e-14
were O 0 5.477173619164444e-13
within O 0 2.4586513651825986e-14
the O 0 1.0514196934971465e-13
core O 0 2.7432672453087115e-11
motif O 0 1.5737551886663148e-11
, O 0 1.3479193076374602e-13
the O 0 5.3193797836578044e-14
majority O 0 1.389874868841512e-12
( O 0 5.109644478362707e-12
five O 0 6.1173332024933025e-12
of O 0 3.7988204568779535e-14
seven O 0 2.3445069670391394e-12
) O 0 1.9551072186988622e-14
of O 0 1.3924517556723292e-15
which O 0 9.015033728201893e-13
were O 0 3.2689595474977295e-10
missense O 0 3.714882623739868e-08
mutations O 0 2.874778470829398e-10
, O 0 5.891647846673065e-13
possibly O 0 8.183695908436928e-12
pointing O 0 3.326860176233737e-10
to O 0 4.4274696756052556e-13
the O 0 1.8003915686851807e-13
functional O 0 2.7692993297828705e-12
significance O 0 2.4179102730420565e-12
of O 0 1.797073910037375e-13
this O 0 1.0995533476776398e-11
region O 0 1.3688771227649e-09
. O 0 1.2448871933301575e-09

Germline O 0 8.505562436766922e-05
PTEN O 0 3.48461871908512e-05
mutations O 0 4.803657560614738e-08
were O 0 7.985438005286838e-11
identified O 0 8.52524856265191e-11
in O 0 1.2085903024899869e-12
four O 0 1.9477087585990926e-13
of O 0 7.142211457401414e-15
seven O 0 6.255215095896105e-12
( O 0 3.3624019367406444e-12
57 O 0 1.731448595609919e-10
% O 0 5.0555410552322044e-12
) O 0 3.967125673104421e-12
BZS B-Disease 0 1.0198302646813318e-07
families O 0 3.6746241466323326e-11
studied O 0 3.0918041460381573e-09
. O 0 3.3883892913699754e-10

Interestingly O 0 3.985218199886731e-07
, O 0 3.6896465049895966e-11
none O 0 2.4406665924403548e-11
of O 0 1.108057246082322e-14
these O 0 1.2246987820575816e-13
mutations O 0 1.0197452604554513e-10
was O 0 4.881309800808253e-10
observed O 0 2.204805782390906e-12
in O 0 3.913376133563018e-12
the O 0 2.3355449518813742e-12
PTPase O 0 2.9697446279897122e-08
core O 0 4.056038616084834e-09
motif O 0 1.4623554811521444e-08
. O 0 1.1576875014185362e-09

It O 0 1.1408651801048109e-10
is O 0 1.2357040304195044e-12
also O 0 1.6717728004884969e-13
worthy O 0 7.419624810378611e-13
of O 0 3.858584052317607e-14
note O 0 8.525317674035193e-10
that O 0 1.655456777520034e-13
a O 0 2.9100385295910414e-12
single O 0 6.200683716484079e-11
nonsense O 0 1.523524417734734e-07
point O 0 7.815407349065495e-11
mutation O 0 5.4746936151151004e-11
, O 0 6.558270094526863e-13
R233X O 0 1.6527555712908537e-10
, O 0 5.898405678814167e-13
was O 0 1.1004597406938377e-11
observed O 0 8.94612400652306e-13
in O 0 1.908601721762812e-13
the O 0 8.422025555253343e-14
germline O 0 1.3088494177360133e-10
DNA O 0 6.472838931514957e-11
from O 0 2.3141791217692886e-13
two O 0 1.3775647831650029e-13
unrelated O 0 6.164715959933176e-11
CD B-Disease 0 3.5593168412617615e-09
families O 0 7.033558197672152e-12
and O 0 2.1009491889267817e-12
one O 0 2.4220195293800373e-11
BZS B-Disease 0 1.2593478686540038e-06
family O 0 1.2647927150055693e-09
. O 0 4.1353007129707464e-10

Genotype O 0 0.01952841877937317
- O 0 0.023561416193842888
phenotype O 0 2.647676353717543e-07
studies O 0 9.605807260726351e-10
were O 0 2.073738576691131e-11
not O 0 6.955549959782037e-13
performed O 0 2.110041308345245e-12
on O 0 2.5603236978449795e-12
this O 0 3.312164453296573e-14
small O 0 1.6725358077673835e-12
group O 0 5.473208258138795e-12
of O 0 5.056801873938588e-13
BZS B-Disease 0 1.9677474938362138e-07
families O 0 1.6721006523834347e-10
. O 0 1.2225907786156398e-10

However O 0 1.1305354430390935e-09
, O 0 8.701771248009749e-11
genotype O 0 2.566842567830463e-06
- O 0 1.6109956959553529e-06
phenotype O 0 1.5372729933460505e-07
analysis O 0 5.688485238408703e-10
inthe O 0 3.3416938549635233e-08
group O 0 1.7528044293779743e-10
of O 0 2.8019362004194637e-13
CD B-Disease 0 1.3170144974594677e-08
families O 0 4.877731031582844e-12
revealed O 0 9.09176414709556e-11
two O 0 3.8471054006295954e-14
possible O 0 3.5123781053775227e-13
associations O 0 4.163715813104707e-13
worthy O 0 3.4347806716905627e-12
of O 0 5.170886098861474e-14
follow O 0 2.370675877827466e-10
- O 0 4.037861955907829e-08
up O 0 8.02309052527761e-10
in O 0 1.574806257620409e-11
independent O 0 2.6183031437421178e-11
analyses O 0 1.0474187073228336e-09
. O 0 6.098219151873252e-11

The O 0 7.431838131011226e-12
first O 0 1.53595990093347e-11
was O 0 1.5719471557762432e-10
an O 0 3.7650255363484014e-14
association O 0 7.641956999929894e-14
noted O 0 1.7223066505964169e-12
in O 0 4.4385209483494004e-13
the O 0 5.4606377742055096e-14
group O 0 1.831170414953731e-12
of O 0 3.74319377035269e-14
CD B-Disease 0 1.2304102625648738e-08
families O 0 8.651952418392561e-12
with O 0 4.035330750107313e-11
breast B-Disease 0 0.0006675733020529151
disease I-Disease 0 8.322552457684651e-05
. O 0 2.581905134135809e-09

A O 0 4.281007992545938e-09
correlation O 0 1.7057930623565198e-09
was O 0 1.749257405592175e-10
observed O 0 2.8975809924190743e-13
between O 0 5.617848783281802e-14
the O 0 7.953292430022685e-14
presence O 0 5.670802716295498e-11
/ O 0 4.015168286741755e-08
absence O 0 2.138799033712946e-11
of O 0 3.090340076937828e-14
a O 0 1.727993616251755e-11
PTEN O 0 3.8164367310855596e-07
mutation O 0 3.0370023162973325e-10
and O 0 4.201050965435549e-12
the O 0 1.5924593458130354e-13
type O 0 1.870385233360139e-07
of O 0 1.1981521677584261e-11
breast O 0 1.4906659998814575e-05
involvement O 0 2.6428724098082057e-08
( O 0 1.981578651166771e-10
unaffected O 0 3.1966978895070497e-06
versus O 0 1.5658193888157257e-06
benign O 0 0.011663543060421944
versus O 0 6.53384768156684e-06
malignant O 0 0.0958242192864418
) O 0 3.290411054734932e-09
. O 0 8.699585496430018e-10

Specifically O 0 8.686867891682937e-10
and O 0 1.4371355668008068e-11
more O 0 2.7107188835164692e-14
directly O 0 4.8408380168979415e-14
, O 0 3.4473145909055813e-13
an O 0 1.0822492533223149e-13
association O 0 5.243452807363047e-12
was O 0 7.870191165437745e-10
also O 0 1.6659159403527302e-13
observed O 0 1.3913746897524244e-14
between O 0 1.8264105573523488e-14
the O 0 1.1088902182826519e-14
presence O 0 1.4452245823692866e-12
of O 0 3.841855490422513e-14
a O 0 5.024053048585664e-11
PTEN O 0 6.617414328502491e-05
mutation O 0 1.8117867739420035e-06
and O 0 6.65133654820238e-07
malignant B-Disease 1 0.9999996423721313
breast I-Disease 1 0.9999692440032959
disease I-Disease 1 0.7344527840614319
. O 0 1.614773026403782e-08

Secondly O 0 1.0506231774343178e-05
, O 0 5.495911364894468e-11
there O 0 2.5087967727571714e-12
appeared O 0 1.5555792209909214e-09
to O 0 5.510264553670874e-13
be O 0 2.303356507263321e-12
an O 0 6.204720304171449e-14
interdependent O 0 1.8236399890181332e-10
association O 0 2.1186420402340839e-13
between O 0 1.7714819953822125e-13
mutations O 0 2.2645137501275947e-11
upstream O 0 2.2046513920015443e-11
and O 0 3.036198408575691e-13
within O 0 6.196015515979106e-14
the O 0 3.6304870242899467e-13
PTPase O 0 2.6792523755148068e-09
core O 0 2.5923352353629525e-10
motif O 0 1.9398851969221198e-10
, O 0 5.778762342777133e-13
the O 0 3.725472147030236e-14
core O 0 1.3348595666318186e-11
motif O 0 2.920358616390062e-12
containing O 0 1.4643138318646415e-13
the O 0 4.9491460869842754e-14
majority O 0 6.577650208360042e-13
of O 0 3.3481672837877563e-13
missense O 0 2.390617055425537e-07
mutations O 0 5.19839948864842e-09
, O 0 3.0277641505094266e-11
and O 0 1.0077869528474226e-12
the O 0 5.484812772146505e-14
involvement O 0 2.2514127714923227e-11
of O 0 2.384334049643222e-14
all O 0 8.96839772042933e-14
major O 0 2.85875446578987e-12
organ O 0 9.036101311643563e-10
systems O 0 1.2909747937328575e-08
( O 0 4.3994426157656363e-11
central O 0 8.19242274019416e-09
nervous O 1 0.9999661445617676
system O 0 4.211776261087152e-09
, O 0 9.255799598983927e-11
thyroid O 0 2.9474542770913104e-06
, O 0 6.624657766796105e-11
breast O 0 0.00037305764271877706
, O 0 2.101975042023696e-06
skin O 1 1.0
and O 0 6.900716834934428e-05
gastrointestinal O 1 0.7647989392280579
tract O 0 0.004692580550909042
) O 0 1.4279890603319245e-09
. O 0 7.15332681977543e-10

However O 0 2.82014828156818e-10
, O 0 2.6409457303325223e-13
these O 0 2.4838199327707235e-15
observations O 0 4.3650600170010156e-13
would O 0 3.091221723039439e-12
need O 0 5.000300846123851e-13
to O 0 2.195818396902305e-14
be O 0 4.629861489850728e-13
confirmed O 0 1.0651074206641242e-12
by O 0 8.197024127716036e-15
studying O 0 8.730207312276916e-13
a O 0 2.3459136515953036e-14
larger O 0 7.78467392002595e-14
number O 0 6.392920589605444e-13
of O 0 1.7032470540304795e-13
CD B-Disease 0 1.2375420510579715e-07
families O 0 1.1805466326730851e-11
. O 0 2.2919020847833593e-11

Molecular O 0 8.35337232274469e-06
defects O 0 0.00165743927937001
leading O 0 2.6152883678132177e-11
to O 0 2.031734833542534e-13
human O 0 1.551159266137414e-12
complement B-Disease 0 5.6382617685812875e-08
component I-Disease 1 0.999988317489624
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.815296177265502e-11
an O 0 1.9552646990644157e-13
African O 0 5.972196261833096e-12
- O 0 3.5503244788515076e-10
American O 0 1.3649344154931242e-10
family O 0 4.1883740919956836e-10
. O 0 7.50603329491284e-11

Complement B-Disease 0 2.4204637156799436e-06
component I-Disease 1 0.9996722936630249
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.0225263958350013e-10
C6D B-Disease 0 4.477142567793635e-08
) O 0 1.7214864950210185e-11
was O 0 6.295768173458782e-08
diagnosed O 0 6.463475074269809e-06
in O 0 1.6408337362439074e-12
a O 0 1.0096998757924691e-11
16 O 0 1.661484491655152e-11
- O 0 5.7448757556644026e-11
year O 0 1.0151822091297724e-11
- O 0 2.7799644530812628e-11
old O 0 5.992981111369033e-10
African O 0 1.8025159273168945e-12
- O 0 4.449270812889594e-12
American O 0 3.918373004535569e-12
male O 0 1.7740071911465094e-10
with O 0 8.69617988730198e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.2577490987885085e-09

The O 0 1.9357382363693887e-10
patients O 0 3.030033113304853e-08
father O 0 4.696575905960287e-10
and O 0 1.8103232671609626e-12
two O 0 6.988569879046169e-13
brothers O 0 1.947997874118812e-10
also O 0 2.4713857262742556e-12
had O 0 1.0413644946360989e-10
C6D B-Disease 0 3.515718205449048e-08
, O 0 3.340117895808681e-13
but O 0 2.1071375980868945e-12
gave O 0 5.6461172542876525e-12
no O 0 1.107853912774015e-11
history O 0 6.48523075519325e-12
of O 0 4.96891026588453e-12
meningitis B-Disease 1 1.0
or O 0 4.878945580877314e-10
other O 0 4.165419745238985e-11
neisserial B-Disease 0 1.1216779967071488e-05
infection I-Disease 0 0.00026514206547290087
. O 0 1.8455914574388999e-09

By O 0 4.872969649322156e-12
using O 0 8.05983543794575e-11
exon O 0 5.867023311623143e-09
- O 0 7.563421555722982e-10
specific O 0 2.235533112793231e-11
polymerase O 0 7.91141430145359e-10
chain O 0 3.7765046645432676e-10
reaction O 0 1.8569664902989835e-11
( O 0 1.2117963967342438e-12
PCR O 0 4.900246874939285e-10
) O 0 4.676768412641141e-13
/ O 0 6.274349095836129e-11
single O 0 2.257032234720402e-11
- O 0 3.6096834410415113e-09
strand O 0 2.5906622624916054e-08
conformation O 0 8.037671639371524e-10
polymorphism O 0 5.671844105492596e-10
as O 0 9.533130578345816e-13
a O 0 3.8812686788472495e-13
screening O 0 3.043165025529149e-11
step O 0 1.227669767060735e-12
and O 0 3.761659088602834e-14
nucleotide O 0 3.369481614296649e-13
sequencing O 0 4.857034913152702e-13
of O 0 8.164849581214582e-15
target O 0 2.989791053620294e-11
exons O 0 1.0641763859009501e-10
, O 0 4.3286732705205555e-12
we O 0 1.0207990052205074e-12
determined O 0 2.8440919324496106e-12
that O 0 5.884042439483622e-14
the O 0 5.998061205700345e-13
proband O 0 1.666838578273655e-08
was O 0 1.4357115496466122e-10
a O 0 1.6917251020182045e-12
compound O 0 9.944049056409554e-11
heterozygote O 0 2.8410165331393955e-09
for O 0 6.018772286120466e-12
two O 0 9.248388166405164e-11
C6 O 0 7.929949106255663e-07
gene O 0 9.959646263268951e-08
mutations O 0 2.952801025912777e-07
. O 0 5.762253341146106e-09

The O 0 2.2129130125558838e-11
first O 0 6.250361773291191e-12
, O 0 1.6871387913033192e-13
1195delC O 0 2.2010254729920575e-11
located O 0 1.3784328496344034e-12
in O 0 5.4766126529604e-12
exon O 0 4.810510878527907e-10
7 O 0 3.2219688722578965e-11
, O 0 4.2704303092853946e-13
is O 0 6.448295131362969e-14
a O 0 1.5739487621221904e-13
novel O 0 4.833499052392387e-12
mutation O 0 1.0500259516044164e-11
, O 0 5.943861939097794e-13
while O 0 5.069046853274639e-13
the O 0 3.8693589890330393e-14
second O 0 1.2212827103785795e-11
, O 0 1.2625974484675728e-12
1936delG O 0 1.4355527877540908e-10
in O 0 2.176099578310442e-12
exon O 0 3.5593014646728705e-10
12 O 0 3.183399030493028e-11
, O 0 1.2502797191657478e-12
has O 0 6.277011787951536e-13
been O 0 1.4779853773141949e-12
described O 0 3.4009598522816153e-12
before O 0 8.758410121288696e-13
to O 0 2.106537600604641e-13
cause O 0 2.7599462645855333e-11
C6D B-Disease 0 4.825605159908264e-08
in O 0 1.8308490574298064e-12
an O 0 6.375942254634864e-14
unrelated O 0 2.8118703546131663e-11
African O 0 8.78848643165453e-12
- O 0 2.4806448561953687e-10
American O 0 6.346178443861206e-11
individual O 0 2.3452417091673894e-11
. O 0 2.150716549298437e-10

Both O 0 1.165141649828172e-09
mutations O 0 5.079347786818289e-08
result O 0 1.119484616118882e-09
in O 0 6.634827687257427e-10
premature O 0 3.6620772192463846e-08
termination O 0 4.0729308814491105e-09
codons O 0 1.3520218722362642e-08
and O 0 2.2867419069427797e-10
C6 O 0 8.25664699277695e-07
null O 0 4.1404004491596424e-07
alleles O 0 6.737620310559578e-07
. O 0 1.3526718412038008e-08

Allele O 0 7.545237394879223e-07
- O 0 1.2549794092819866e-08
specific O 0 2.5195205297090517e-11
PCR O 0 1.0023216923116252e-08
indicated O 0 7.016946051985329e-11
that O 0 8.65389099898202e-14
the O 0 1.0845430185434796e-13
probands O 0 7.47113215737727e-09
two O 0 3.0538037376626193e-12
brothers O 0 2.2929218246314775e-10
also O 0 1.03070644467268e-12
inherited O 0 1.918345621243489e-10
the O 0 3.3201861941202504e-13
1195delC O 0 1.5461224522894668e-09
mutation O 0 4.2068504929604345e-11
from O 0 1.3860123986020323e-12
their O 0 6.306665259470101e-13
heterozygous O 0 1.0472848144260638e-09
mother O 0 1.3947580868034493e-09
and O 0 4.570601709608102e-13
the O 0 2.5810085947826356e-13
1936delG O 0 2.047662261972505e-09
mutation O 0 8.929205291829945e-11
from O 0 2.663493774493486e-12
their O 0 2.043324710820915e-12
homozygous O 0 3.266324766215689e-09
father O 0 1.6676933167758534e-09
. O 0 9.233595658908467e-12
. O 0 3.911907950349125e-11

PAX6 O 0 0.0010363884503021836
mutations O 0 1.1052658919652458e-05
reviewed O 0 2.651031536515802e-07
. O 0 1.778378333483488e-09

Mutations O 0 1.3015786635151017e-06
in O 0 7.037644911278562e-10
PAX6 O 0 1.4086482735820027e-07
are O 0 1.1635630610060121e-12
responsible O 0 7.473283602198177e-13
for O 0 4.380487468526491e-14
human O 0 6.9420216103344146e-12
aniridia B-Disease 1 1.0
and O 0 1.9019506802830932e-10
have O 0 4.282831467944392e-12
also O 0 2.2270955966994382e-13
been O 0 4.1057673753897017e-13
found O 0 1.8084975791227142e-12
in O 0 2.105165217494709e-12
patients O 0 2.5704926034930686e-11
with O 0 1.603273286701623e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.898750184858855e-10
with O 0 2.447073432776392e-09
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.5219198123972433e-09
with O 0 1.1421259077382118e-10
autosomal B-Disease 1 0.9919811487197876
dominant I-Disease 1 0.7409743666648865
keratitis I-Disease 1 0.9999998807907104
, O 0 4.5140215121364236e-08
and O 0 1.9241097604094648e-10
with O 0 4.185281635149529e-11
isolated B-Disease 1 0.9929584264755249
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 2.7406253266804015e-08

No O 0 2.3664697978986737e-10
locus O 0 9.299844921928369e-11
other O 0 3.3796189046093883e-13
than O 0 5.888918367703833e-13
chromosome O 0 1.3201280957275685e-08
11p13 O 0 4.33635660712639e-09
has O 0 3.3882113694566618e-12
been O 0 2.90102750849508e-12
implicated O 0 1.7208964808723692e-10
in O 0 9.616857310490445e-11
aniridia B-Disease 1 1.0
, O 0 4.0458717105729125e-12
and O 0 1.3446484594184516e-12
PAX6 O 0 8.098908210740774e-09
is O 0 6.890307551951635e-13
clearly O 0 3.566596453938309e-12
the O 0 2.1762924239956093e-14
major O 0 2.488774594397447e-12
, O 0 8.890822106311091e-13
if O 0 1.5661813209180697e-12
not O 0 2.396779606381183e-12
only O 0 2.0866164698873924e-12
, O 0 4.0736140047119285e-13
gene O 0 6.299654131680654e-10
responsible O 0 6.923793760549302e-10
. O 0 6.996235812906093e-10

Twenty O 0 3.055907527027557e-08
- O 0 5.867473618081931e-08
eight O 0 1.0335501898772748e-10
percent O 0 1.7438274435566115e-10
of O 0 3.664120195407891e-14
identified O 0 6.670864971525248e-10
PAX6 O 0 5.730504426537664e-08
mutations O 0 8.24946277955263e-10
are O 0 1.0634697115985414e-11
C O 0 7.997984994290164e-07
- O 0 6.761139559330331e-08
T O 0 1.2857704234647827e-07
changes O 0 2.0349402718444765e-11
at O 0 1.210997534889513e-11
CpG O 0 1.136266303269906e-09
dinucleotides O 0 2.256948405943149e-09
, O 0 2.9850983338831905e-13
20 O 0 4.672005038158962e-14
% O 0 1.3504327593238247e-14
are O 0 1.507013914700539e-14
splicing O 0 2.8045227251638494e-10
errors O 0 7.058929440972861e-09
, O 0 2.602487452971203e-13
and O 0 6.746191197901444e-14
more O 0 4.111860456073799e-15
than O 0 9.426729619880884e-15
30 O 0 6.576204560288304e-14
% O 0 3.388240548047629e-14
are O 0 1.2805196085343556e-13
deletion O 0 9.014612667446187e-11
or O 0 2.2400916191434028e-11
insertion O 0 6.305592714639374e-10
events O 0 1.073812427865306e-10
. O 0 4.707741418918943e-10

There O 0 3.3144587074929177e-10
is O 0 1.6334457658001567e-12
a O 0 7.982327472622064e-12
noticeably O 0 4.2362589169897547e-07
elevated O 0 7.791949724333946e-11
level O 0 1.6953534062724707e-11
of O 0 9.279661830347962e-15
mutation O 0 2.203515364965214e-12
in O 0 6.729191856513772e-13
the O 0 7.134263747257327e-14
paired O 0 8.515737594250172e-12
domain O 0 1.6810496137470432e-12
compared O 0 7.644939369055859e-12
with O 0 4.223704041681972e-14
the O 0 4.711309467553271e-13
rest O 0 9.237435469322541e-12
of O 0 1.527016089530181e-14
the O 0 4.950007959948766e-13
gene O 0 2.00921768112039e-09
. O 0 9.910836734627892e-11

Increased O 0 4.403922115869818e-09
mutation O 0 1.0345329037875217e-09
in O 0 7.873336531349917e-12
the O 0 1.8642895658217001e-13
homeodomain O 0 6.602195457006133e-10
is O 0 2.0712750091467225e-12
accounted O 0 5.22062219843189e-11
for O 0 9.92490950670966e-15
by O 0 5.981081922052864e-14
the O 0 3.4880655221808388e-12
hypermutable O 0 1.0205502576354775e-07
CpG O 0 5.131219182885616e-08
dinucleotide O 0 3.847271301538058e-08
in O 0 1.2734774346156996e-10
codon O 0 2.607631799378396e-08
240 O 0 3.2373023706178117e-10
. O 0 5.102274852619715e-11

Very O 0 8.082612801274536e-09
nearly O 0 2.3264895218644277e-11
all O 0 8.964378718501198e-14
mutations O 0 1.4816271473594433e-11
appear O 0 1.6838615571335147e-11
to O 0 6.895487327830685e-13
cause O 0 1.1595807647424294e-10
loss O 0 1.6986397011198306e-10
of O 0 7.433953321358319e-15
function O 0 3.342903211189796e-13
of O 0 5.158372627021802e-15
the O 0 1.5149398391572227e-13
mutant O 0 3.955426264301565e-10
allele O 0 1.0392675608983382e-09
, O 0 6.307992756610092e-12
and O 0 6.552231088426119e-13
more O 0 7.668790664885732e-15
than O 0 3.198634594497006e-14
80 O 0 9.43594567716019e-14
% O 0 1.23272323338669e-13
of O 0 6.386811381414031e-14
exonic O 0 5.427786220479902e-09
substitutions O 0 1.9905602166581104e-10
result O 0 5.7260050867480317e-11
in O 0 8.117566341336868e-11
nonsense O 0 5.318949547472585e-07
codons O 0 1.9577399257286743e-08
. O 0 1.4789061641984347e-10

In O 0 8.049131916543217e-10
a O 0 2.0257158797609698e-11
gene O 0 1.095467744294254e-10
with O 0 2.9834931725668257e-13
such O 0 3.1614329210061243e-12
extraordinarily O 0 3.3549017075529264e-07
high O 0 1.3355937189540867e-10
sequence O 0 2.931048958230986e-13
conservation O 0 1.941621098925858e-14
throughout O 0 3.3017143706570717e-13
evolution O 0 1.1862996479247712e-12
, O 0 3.5428509626879434e-13
there O 0 3.7360341057814106e-13
are O 0 3.5612924284902925e-13
presumed O 0 1.2226940571125056e-09
undiscovered O 0 1.5973887101949913e-08
missense O 0 1.6331539143266127e-07
mutations O 0 3.845603835372913e-09
, O 0 1.9395910658831506e-12
these O 0 5.5594035099212555e-14
are O 0 8.667734227845586e-14
hypothesized O 0 9.73687710320581e-12
to O 0 2.4152774506965013e-13
exist O 0 6.281003495089976e-12
in O 0 3.139633344972914e-11
as O 0 5.034300198936137e-10
- O 0 1.329086396495427e-09
yet O 0 5.322354224013282e-10
unidentified O 0 1.0906033054425279e-07
phenotypes O 0 3.1088998042605454e-09
. O 0 1.6284164988666916e-11
. O 0 1.2545377237049848e-10

Genetic O 0 1.9294664070912404e-06
heterogeneity O 0 3.0390631877708074e-07
and O 0 5.208272146894899e-10
penetrance O 0 1.1964097268446494e-07
analysis O 0 2.227238012075805e-11
of O 0 1.282607104292205e-13
the O 0 1.9280976554930662e-12
BRCA1 O 0 5.609226718661375e-06
and O 0 4.2361048002703683e-10
BRCA2 O 0 1.5352832633652724e-05
genes O 0 3.1686116130913433e-07
in O 0 8.537497819816053e-08
breast B-Disease 0 0.05146806314587593
cancer I-Disease 0 6.784293509554118e-05
families O 0 5.93269566806498e-09
. O 0 6.013350928313344e-10

The O 0 3.8494883369821764e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.2802824130631052e-05
Consortium O 0 3.0582492627218016e-07
. O 0 3.6405418679663626e-09

The O 0 2.137549902705982e-12
contribution O 0 6.80105006600068e-13
of O 0 1.3982525803434703e-13
BRCA1 O 0 1.197233814309584e-07
and O 0 6.796959522992196e-11
BRCA2 O 0 0.01659136451780796
to O 0 3.991055109509034e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.5402871440528543e-06
assessed O 0 1.7517749750783906e-10
by O 0 1.0369468819845448e-13
linkage O 0 4.495126049164355e-09
and O 0 7.345758550048043e-12
mutation O 0 1.649479511312002e-11
analysis O 0 3.0934098598639492e-12
in O 0 1.6365423556249925e-12
237 O 0 3.6916247836416005e-11
families O 0 9.820880003327814e-13
, O 0 5.3103266955175504e-14
each O 0 7.795948097960494e-15
with O 0 5.195346106448562e-13
at O 0 7.814696112440345e-10
least O 0 5.778082005913898e-12
four O 0 8.031100741032193e-13
cases O 0 5.107786069102893e-11
of O 0 5.3314522935332676e-12
breast B-Disease 0 7.415949949063361e-05
cancer I-Disease 0 2.348542835761691e-07
, O 0 1.0164741227544627e-12
collected O 0 7.338752544029659e-13
by O 0 3.576508013358737e-12
the O 0 5.429528471267986e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.614443357946584e-06
Consortium O 0 2.3942493498907425e-07
. O 0 3.215133270728643e-09

Families O 0 4.4375203511748396e-10
were O 0 2.5441376436119434e-12
included O 0 3.8451396065656077e-14
without O 0 7.814918417253791e-14
regard O 0 1.9380292726536852e-13
to O 0 1.1335121955099135e-14
the O 0 7.330592431903718e-14
occurrence O 0 4.581037771345109e-10
of O 0 1.5064239786144462e-11
ovarian B-Disease 0 7.016929970404817e-08
or I-Disease 0 1.8364046394658828e-10
other I-Disease 0 1.5044292200894205e-10
cancers I-Disease 0 3.2071961868496146e-06
. O 0 7.427296000450667e-10

Overall O 0 2.0180389128654497e-06
, O 0 1.6694310378539967e-09
disease O 0 9.565319203375111e-08
was O 0 2.111303493146366e-10
linked O 0 6.983090772294531e-10
to O 0 1.4761513409192184e-12
BRCA1 O 0 4.971381972751487e-09
in O 0 1.2254495378519192e-12
an O 0 3.7412356842885224e-15
estimated O 0 7.16855502909397e-14
52 O 0 1.6314997313207624e-12
% O 0 1.296172506349072e-13
of O 0 5.1701535847686886e-15
families O 0 2.224684195542559e-13
, O 0 6.385922335632593e-14
to O 0 8.949668805526001e-14
BRCA2 O 0 7.045330541188832e-09
in O 0 5.997308552552205e-12
32 O 0 6.237368694456125e-12
% O 0 2.8873358239901725e-13
of O 0 9.25233908856838e-15
families O 0 7.569298378189149e-13
, O 0 1.5488524633851253e-13
and O 0 2.1063248259282907e-13
to O 0 3.0440192331842794e-14
neither O 0 1.0272331596450357e-11
gene O 0 5.0921055566588436e-11
in O 0 5.672855414584621e-12
16 O 0 2.057399389743253e-12
% O 0 1.8026560604476882e-13
( O 0 2.8810097753642627e-13
95 O 0 1.1607247801803666e-10
% O 0 4.5161788198022634e-10
confidence O 0 1.0290613090546685e-06
interval O 0 4.681675047635281e-10
[ O 0 1.2157264084322605e-10
CI O 0 1.462036891552998e-07
] O 0 3.549978921935093e-10
6 O 0 4.870544505902741e-12
% O 0 1.4341234796932945e-11
- O 0 3.2193427923488116e-09
28 O 0 1.376143504705496e-10
% O 0 2.6200103284829135e-12
) O 0 2.0066630648796213e-13
, O 0 1.189523197824005e-13
suggesting O 0 3.5135946235831383e-11
other O 0 1.7854312863233024e-12
predisposition O 0 1.138193006511301e-08
genes O 0 1.1585959747151264e-08
. O 0 7.549253999705741e-10

The O 0 1.0382976596556848e-11
majority O 0 7.840816537707518e-12
( O 0 1.2152435308054876e-11
81 O 0 3.5408818238602535e-11
% O 0 3.562698638708006e-13
) O 0 5.3569602638352254e-14
of O 0 3.194232733676715e-14
the O 0 2.4961470668216634e-09
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.630306133149073e-11
were O 0 1.4718442393688025e-12
due O 0 6.306990520121847e-13
to O 0 1.9466614193004717e-13
BRCA1 O 0 1.4683533500203794e-08
, O 0 1.692799139795323e-13
with O 0 6.926642419358142e-15
most O 0 1.6399788428309026e-13
others O 0 3.1194324467270773e-12
( O 0 8.789353251291432e-13
14 O 0 4.19914450433545e-12
% O 0 2.326590309298382e-12
) O 0 1.315114141718643e-12
due O 0 5.860339991059504e-11
to O 0 9.697016106757772e-11
BRCA2 O 0 1.1827360140159726e-05
. O 0 1.454191211891498e-09

Conversely O 0 1.1038542524488548e-08
, O 0 2.962016699623038e-12
the O 0 1.3171964570229868e-14
majority O 0 2.8531314138526e-13
of O 0 8.767627872633896e-15
families O 0 2.323095058334723e-13
with O 0 6.44654888823891e-14
male B-Disease 0 1.6129960700439483e-09
and I-Disease 0 3.566942075039492e-09
female I-Disease 0 6.231898197484043e-08
breast I-Disease 0 3.370597596585867e-06
cancer I-Disease 0 6.677528290310875e-07
were O 0 1.8747126073748177e-09
due O 0 5.294194596605628e-11
to O 0 5.11570993899646e-12
BRCA2 O 0 4.5365450773715565e-07
( O 0 4.3797337284656734e-11
76 O 0 1.086854051202124e-09
% O 0 4.9638633481396965e-11
) O 0 2.1582973255829252e-11
. O 0 2.2546454980787445e-10

The O 0 4.955338223089356e-12
largest O 0 2.6888263750940444e-12
proportion O 0 1.5991022742078975e-11
( O 0 1.0297577894557985e-11
67 O 0 1.0177633735786173e-10
% O 0 9.659165828290739e-13
) O 0 6.128597114388526e-14
of O 0 7.904742703771731e-15
families O 0 2.383753188329313e-13
due O 0 1.1501558169410564e-13
to O 0 6.011409343806241e-15
other O 0 1.3668906941922705e-14
genes O 0 7.607556078148558e-12
was O 0 2.3013825567463897e-10
found O 0 1.9370888573733147e-11
in O 0 2.6282988372511307e-12
families O 0 8.263776761410074e-14
with O 0 1.189924250983871e-14
four O 0 1.1365376955535522e-12
or O 0 3.0578036630535266e-11
five O 0 1.734709489768782e-12
cases O 0 1.4642483406324125e-11
of O 0 1.2030933974754854e-12
female O 0 2.6546166509433533e-07
breast B-Disease 0 7.886495586717501e-05
cancer I-Disease 0 5.657550900650676e-06
only O 0 2.504855878271428e-09
. O 0 1.0553437013172129e-09

These O 0 1.5723811142009936e-11
estimates O 0 2.6246331497059572e-11
were O 0 2.6015259824846426e-12
not O 0 8.807947318549558e-13
substantially O 0 1.460464110758508e-10
affected O 0 2.6372008960287574e-13
either O 0 6.732719308281954e-14
by O 0 8.274723137594031e-14
changing O 0 6.526133106143917e-11
the O 0 9.310165485776345e-13
assumed O 0 1.6173419548071166e-10
penetrance O 0 1.0731372457328803e-09
model O 0 2.686859068568026e-11
for O 0 3.987256759572372e-13
BRCA1 O 0 4.019341748318084e-09
or O 0 8.065091129660917e-12
by O 0 8.660661163922834e-14
including O 0 4.901005816460025e-13
or O 0 1.6241862021981746e-10
excluding O 0 6.431486099245376e-08
BRCA1 O 0 4.176152287982404e-06
mutation O 0 3.127707870476115e-08
data O 0 1.552162842699545e-08
. O 0 3.432413520076949e-10

Among O 0 3.670918430342951e-11
those O 0 5.433824505803042e-13
families O 0 7.178355674632153e-13
with O 0 1.783871309132476e-13
disease O 0 7.997381423763272e-09
due O 0 8.904828263656128e-12
to O 0 9.314872007407105e-13
BRCA1 O 0 8.847347743312639e-09
that O 0 6.674062344447229e-13
were O 0 2.1919499635508766e-12
tested O 0 1.7228456074963594e-12
by O 0 2.923296412948276e-15
one O 0 4.1525309124428034e-14
of O 0 8.55061496105291e-16
the O 0 1.2625384373762035e-14
standard O 0 1.8798022166643946e-11
screening O 0 8.701530706915761e-13
methods O 0 2.7631631791674716e-12
, O 0 8.658546969686487e-14
mutations O 0 6.2452374001431554e-12
were O 0 5.2392339598694715e-12
detected O 0 2.8865362877716905e-10
in O 0 2.1758712453329165e-12
the O 0 4.026462052230534e-13
coding O 0 4.3239575808762254e-10
sequence O 0 4.721765513304721e-12
or O 0 1.109835660872971e-11
splice O 0 3.740483922598514e-09
sites O 0 1.1134443193838717e-11
in O 0 5.4080507433384994e-12
an O 0 1.43647639898499e-13
estimated O 0 2.192786317106732e-12
63 O 0 1.0791179061442335e-10
% O 0 1.9712703691610045e-12
( O 0 6.391274770707611e-13
95 O 0 8.179112248596354e-11
% O 0 4.486607266263043e-11
CI O 0 1.60085107836494e-06
51 O 0 1.2843672791973404e-09
% O 0 9.976497405972395e-11
- O 0 1.722129638892511e-08
77 O 0 8.999379019769549e-10
% O 0 5.5722891578735556e-11
) O 0 1.0178170806174336e-11
. O 0 7.67875971141585e-11

The O 0 4.434613700560197e-12
estimated O 0 1.918021947863724e-12
sensitivity O 0 2.193583370502239e-10
was O 0 6.016227099836513e-11
identical O 0 2.2939913857378258e-12
for O 0 6.12784630438408e-15
direct O 0 5.567694200646345e-13
sequencing O 0 5.861313517874223e-11
and O 0 8.910808722839558e-12
other O 0 1.9920584279353726e-12
techniques O 0 2.9285176506022026e-09
. O 0 1.6560690319078475e-10

The O 0 5.549561921114332e-10
penetrance O 0 2.720200882322388e-07
of O 0 1.6992697396758794e-12
BRCA2 O 0 1.6602871255599894e-07
was O 0 1.3243334207047042e-10
estimated O 0 8.490589823014968e-14
by O 0 2.2085074586719426e-14
maximizing O 0 7.081830781519027e-12
the O 0 2.062798282881362e-12
LOD O 0 3.9879137148091104e-07
score O 0 2.4011964291914545e-11
in O 0 6.495134291517601e-12
BRCA2 O 0 8.025246643228456e-06
- O 0 7.148955205593666e-08
mutation O 0 1.925281711834259e-09
families O 0 5.270828912218306e-11
, O 0 1.2477639364447124e-12
over O 0 4.424810398726692e-13
all O 0 9.97774345784519e-13
possible O 0 6.339077179839947e-11
penetrance O 0 4.4012029576379064e-08
functions O 0 7.193768497559816e-11
. O 0 1.5847111123346025e-10

The O 0 3.162325653074949e-12
estimated O 0 5.44924999221208e-12
cumulative O 0 4.648669990614529e-11
risk O 0 2.0709343129254876e-09
of O 0 1.656237863870147e-12
breast B-Disease 0 0.0002582264132797718
cancer I-Disease 0 2.5177189399983035e-06
reached O 0 2.8522502137917627e-09
28 O 0 8.87774489338744e-12
% O 0 4.3401957375288625e-13
( O 0 1.9116220379648136e-13
95 O 0 1.1974758858113166e-11
% O 0 9.115026441963714e-12
CI O 0 1.7731437651491433e-07
9 O 0 1.582203638939017e-11
% O 0 7.1432308852703574e-12
- O 0 3.4980962571040664e-10
44 O 0 1.5885749313215847e-11
% O 0 4.529163231525163e-13
) O 0 8.533641797218473e-15
by O 0 3.8725780530457846e-14
age O 0 1.592114808046663e-11
50 O 0 1.7479140151325373e-13
years O 0 1.8228234405833627e-13
and O 0 1.2930958116341013e-13
84 O 0 4.567873856942128e-13
% O 0 8.669487247233224e-14
( O 0 1.1811985580183898e-13
95 O 0 1.1888462436715486e-11
% O 0 7.965141567145562e-12
CI O 0 1.7458367551625997e-07
43 O 0 7.867996532073818e-11
% O 0 8.11815111662062e-12
- O 0 2.4444693491609826e-10
95 O 0 1.2374247460034127e-10
% O 0 1.6789633919267466e-12
) O 0 3.983628477002149e-14
by O 0 1.3255266025427592e-13
age O 0 2.1880341982694063e-10
70 O 0 5.9130634416648675e-12
years O 0 4.676378641960133e-12
. O 0 1.0269118888572848e-11

The O 0 1.8365317044910512e-09
corresponding O 0 0.00016279351257253438
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 5.292885134622338e-07
were O 0 2.0330211125685338e-10
0 O 0 9.926614391586597e-11
. O 0 5.515496392938246e-11

4 O 0 1.1605769678624256e-09
% O 0 1.4387921409841908e-11
( O 0 1.1182238945570133e-12
95 O 0 1.9384528704424753e-11
% O 0 1.4936293521450317e-11
CI O 0 1.0403473993392254e-07
0 O 0 7.597318607555081e-12
% O 0 7.585446160085496e-12
- O 0 1.6381430933964936e-10
1 O 0 1.7273796325614765e-12
% O 0 3.606751128228808e-13
) O 0 5.209729505163251e-15
by O 0 1.621168545002001e-14
age O 0 1.363299664131068e-11
50 O 0 7.754161760386777e-14
years O 0 5.835180158075132e-14
and O 0 1.4863183925815926e-13
27 O 0 4.69365811408412e-13
% O 0 5.085546174172888e-14
( O 0 8.568173975225316e-14
95 O 0 1.184699387202226e-11
% O 0 5.785735172209039e-12
CI O 0 2.4330011783035843e-08
0 O 0 1.9114078809306934e-12
% O 0 7.52563983352772e-12
- O 0 7.294483350683834e-10
47 O 0 2.4032961731812463e-10
% O 0 2.4189021011894463e-12
) O 0 5.876897547166943e-14
by O 0 2.78626270276347e-13
age O 0 4.667623509924113e-10
70 O 0 1.3727950200215222e-11
years O 0 1.0349819092037027e-11
. O 0 1.4652709601215008e-11

The O 0 4.691130123246623e-11
lifetime O 0 4.01065597399608e-10
risk O 0 9.24115006739612e-09
of O 0 2.29402629704778e-12
breast B-Disease 0 1.989373777178116e-05
cancer I-Disease 0 1.8494338860364223e-07
appears O 0 5.216165832599984e-10
similar O 0 4.707719023638868e-12
to O 0 8.975828977644817e-13
the O 0 7.129247821431595e-13
risk O 0 6.505278954405114e-11
in O 0 4.602909308044911e-13
BRCA1 O 0 6.382135930849131e-10
carriers O 0 7.885363195736517e-11
, O 0 3.4079648283079356e-13
but O 0 7.260977301186411e-13
there O 0 3.1717109407608524e-13
was O 0 2.044392866801248e-12
some O 0 1.3159502809751626e-15
suggestion O 0 9.512388706583996e-13
of O 0 7.495831619254087e-15
a O 0 5.98942423435389e-11
lower O 0 8.536900963918015e-07
risk O 0 7.257693335205317e-10
in O 0 4.6918792635797235e-12
BRCA2 O 0 3.493272515697754e-08
carriers O 0 2.4043060875555966e-09
< O 0 2.3700348350530476e-09
50 O 0 6.6829315518990295e-12
years O 0 4.254018578370156e-12
of O 0 3.382508032348519e-13
age O 0 1.2273244920368853e-10
. O 0 3.3516085740092905e-11

Eye B-Disease 1 0.9994946718215942
movement I-Disease 0 1.5779646673763636e-06
abnormalities I-Disease 1 0.9848743081092834
correlate O 0 2.927642306360667e-08
with O 0 2.6490759238995132e-11
genotype O 0 2.097005199175328e-05
in O 0 6.4694760659733674e-09
autosomal O 0 0.17362608015537262
dominant O 0 0.00050413265125826
cerebellar B-Disease 0 0.00838881079107523
ataxia I-Disease 1 0.9999939203262329
type I-Disease 1 0.9999998807907104
I I-Disease 1 0.9999947547912598
. O 0 6.03822547518007e-09

We O 0 3.941104775861959e-09
compared O 0 2.043588853695155e-09
horizontal O 0 1.01680029729323e-07
eye O 1 0.524911642074585
movements O 0 1.5561964801236172e-06
( O 0 2.360874828966075e-10
visually O 0 8.123100525558868e-10
guided O 0 5.749153375589344e-10
saccades O 0 1.5097924688234343e-07
, O 0 8.62086877578827e-12
antisaccades O 0 4.682937149169675e-09
, O 0 1.0334426456953816e-12
and O 0 8.024975540858736e-13
smooth O 0 2.946117655389102e-11
pursuit O 0 3.99898968106438e-11
) O 0 1.8246706500347348e-13
in O 0 8.801834586701085e-13
control O 0 1.528998039290741e-10
subjects O 0 2.5403434911197564e-10
( O 0 2.165491744254844e-12
n O 0 1.4614170984472707e-10
= O 0 3.148246108253261e-10
14 O 0 3.467861067751876e-11
) O 0 6.577487035933083e-13
and O 0 1.6004510217104695e-11
patients O 0 5.920187257091314e-11
with O 0 8.389491189155895e-15
three O 0 4.038859090921276e-14
forms O 0 4.240385386572454e-12
of O 0 3.2709332204589048e-12
autosomal O 0 1.5763187548145652e-05
dominant O 0 1.7097944464694592e-06
cerebellar B-Disease 0 1.6599195078015327e-05
ataxias I-Disease 0 0.07181057333946228
type I-Disease 1 0.9999750852584839
I I-Disease 1 0.9969344139099121
spinocerebellar B-Disease 0 0.06709866225719452
ataxias I-Disease 0 1.504582633060636e-05
1 I-Disease 0 2.475941396351544e-10
and I-Disease 0 2.1550065551489972e-11
2 I-Disease 0 7.086587393290156e-12
( O 0 5.677542203735841e-12
SCA1 B-Disease 0 2.7476543706939083e-08
, O 0 1.3087058563579501e-12
n O 0 1.465640525610823e-10
= O 0 3.8051514716919144e-10
11 O 0 1.4439991737058566e-11
; O 0 2.006269933171878e-12
SCA2 B-Disease 0 8.198788492563835e-08
, O 0 4.2751917457561905e-12
n O 0 3.6574385187115865e-10
= O 0 3.024244743521365e-10
10 O 0 4.7136491758414945e-12
) O 0 3.1055169286836604e-12
and O 0 1.4352879995627177e-09
SCA3 B-Disease 1 1.0
/ O 0 9.247039542970015e-07
Machado B-Disease 0 2.206303584273428e-08
- I-Disease 0 1.8589467742913257e-08
Joseph I-Disease 0 6.948182118549084e-08
disease I-Disease 0 0.0018822181737050414
( O 0 2.781318231281915e-10
MJD B-Disease 1 1.0
) O 0 3.6187290143596673e-12
( O 0 1.249435776194685e-12
n O 0 3.628630174112857e-10
= O 0 1.435079943767903e-09
16 O 0 1.1424701462647846e-10
) O 0 1.6148752474132166e-11
. O 0 1.1583428660699724e-10

In O 0 5.160120331026974e-09
SCA1 B-Disease 0 3.12464663920764e-07
, O 0 7.033035178544145e-12
saccade O 0 3.739107246047979e-09
amplitude O 0 1.0447125803336732e-10
was O 0 1.2686433847886036e-10
significantly O 0 1.9210331936303504e-10
increased O 0 9.708152684528848e-12
, O 0 6.450266753013634e-13
resulting O 0 4.63800482394805e-12
in O 0 1.3871642723373157e-10
hypermetria B-Disease 0 1.3077549283480039e-06
. O 0 2.4341870186184167e-10

The O 0 9.026415725976733e-11
smooth O 0 3.1083662310749105e-09
pursuit O 0 1.3795711240049968e-09
gain O 0 8.536765250255485e-08
was O 0 2.2084636341901387e-08
decreased O 0 3.3672865384914985e-08
. O 0 7.384449995928577e-11

In O 0 3.2396576532534027e-09
SCA2 B-Disease 0 4.7337414343928685e-07
, O 0 1.584118079767105e-11
saccade O 0 3.3335517457544483e-08
velocity O 0 2.8765676507447324e-09
was O 0 3.838905637820744e-09
markedly O 0 2.66321023900673e-07
decreased O 0 1.4341612342150256e-08
. O 0 7.426995130010994e-11

The O 0 6.675418551260748e-11
percentage O 0 3.524940339616478e-10
of O 0 1.0105389696693154e-13
errors O 0 3.928471714598203e-10
in O 0 5.1571017421758736e-12
antisaccades O 0 3.674461623859315e-08
was O 0 1.0271553052554339e-10
greatly O 0 4.797220346658415e-12
increased O 0 2.4472147398812982e-12
and O 0 5.720410581853963e-13
was O 0 6.537516621801798e-12
significantly O 0 4.393687670634083e-12
correlated O 0 1.0290014283362292e-12
with O 0 1.4368078937992274e-13
age O 0 1.7470100366345775e-10
at O 0 1.1210866956989918e-10
disease O 0 7.74661224056672e-09
onset O 0 1.128825122265198e-08
. O 0 1.5538852149443727e-10

In O 0 1.7515735389883602e-11
addition O 0 3.774194769646383e-13
, O 0 1.0935996981034299e-13
a O 0 1.8403606817738588e-13
correlation O 0 5.377083847624142e-11
between O 0 4.447361749704282e-12
smooth O 0 4.3947565031565716e-10
pursuit O 0 2.577908164713705e-10
gain O 0 1.0019260976434907e-08
and O 0 9.005070127077186e-12
the O 0 1.1468568607807261e-13
number O 0 1.9244115578419957e-13
of O 0 1.0277573198958292e-13
trinucleotide O 0 6.7832641725829035e-09
repeats O 0 2.0650294807467162e-09
was O 0 1.7384086392624454e-09
found O 0 3.951331761786747e-10
. O 0 4.178246984509748e-11

In O 0 6.52299334547024e-08
SCA3 B-Disease 1 1.0
, O 0 1.5748468085163836e-09
gaze B-Disease 0 9.127001590059081e-07
- I-Disease 0 4.6492267813391663e-08
evoked I-Disease 0 4.3815093775378955e-09
nystagmus I-Disease 0 8.309320520538677e-08
was O 0 2.603330329087328e-10
often O 0 7.07160946553792e-13
present O 0 4.8918975017716096e-14
as O 0 9.276451135020736e-13
was O 0 1.3563461118137887e-11
saccade O 0 1.4985162000158425e-09
hypometria O 0 1.3434796386491143e-08
and O 0 3.4859105619428066e-12
smooth O 0 6.39129374424563e-11
pursuit O 0 1.5741252745726797e-10
gain O 0 1.5562804378532746e-08
was O 0 1.2321997644448857e-08
markedly O 0 2.483689627297281e-07
decreased O 0 8.350482971763995e-09
. O 0 5.1287550595358056e-11

Three O 0 6.197443946920345e-11
major O 0 2.3624864217697272e-11
criteria O 0 1.7235957452954587e-11
, O 0 2.485537817231709e-13
saccade O 0 1.8160427606161988e-09
amplitude O 0 5.4892278222862245e-11
, O 0 2.192853103960557e-12
saccade O 0 2.330306836384466e-09
velocity O 0 1.5691492549763097e-10
, O 0 3.6176799403375703e-12
and O 0 4.192163922858011e-13
presence O 0 4.443648140423084e-12
of O 0 1.7107299734794856e-12
gaze B-Disease 0 1.768534457369242e-05
- I-Disease 0 3.866596998136629e-08
evoked I-Disease 0 3.288591621242176e-09
nystagmus I-Disease 0 6.18785866990379e-09
, O 0 1.305294983428365e-13
permitted O 0 4.904250291461187e-13
the O 0 1.3862257966946318e-13
correct O 0 1.4901757605656485e-10
assignment O 0 6.727257639838058e-12
of O 0 1.0480549355823088e-15
90 O 0 8.932206374285406e-14
% O 0 3.5167805082989e-14
of O 0 5.757059008152049e-16
the O 0 4.983312346757904e-14
SCA1 B-Disease 0 1.4820525917613736e-09
, O 0 3.127340847766148e-14
90 O 0 6.243575399527898e-14
% O 0 2.5279935480029825e-14
of O 0 1.4859315822807347e-15
the O 0 1.1018175439950553e-13
SCA2 B-Disease 0 3.847247409538568e-09
, O 0 1.1185517979515544e-13
and O 0 9.721538759546386e-14
93 O 0 1.0000319799682855e-12
% O 0 5.923544668011774e-14
of O 0 3.2096335714269873e-15
the O 0 4.829221332720846e-13
patients O 0 7.48360401425785e-11
with O 0 1.1226797486454942e-12
SCA3 B-Disease 1 1.0
to O 0 8.420037670570091e-13
their O 0 6.800139065125249e-14
genetically O 0 6.619327308499123e-11
confirmed O 0 5.666869751230763e-10
patient O 0 6.754885983895065e-09
group O 0 4.82193365097805e-12
and O 0 6.487074766248213e-12
, O 0 2.575613875822891e-13
therefore O 0 4.2360034750721365e-12
, O 0 4.277190147200516e-12
may O 0 4.923612073604033e-10
help O 0 8.388931910241482e-11
orient O 0 1.0905781891779043e-05
diagnoses O 0 6.154190032248152e-06
of O 0 6.414075000293895e-13
SCA1 B-Disease 0 1.6670841773702705e-07
, O 0 6.824105516778367e-12
SCA2 B-Disease 0 7.450771022377012e-08
, O 0 3.884433139728083e-12
and O 0 5.977817546520825e-11
SCA3 B-Disease 1 1.0
at O 0 8.404049678389924e-11
early O 0 8.455387778827372e-11
clinical O 0 3.224747552321716e-11
stages O 0 6.368462181216561e-12
of O 0 5.6485777833554726e-14
the O 0 4.498927706070299e-12
diseases O 0 4.601455430019996e-07
. O 0 1.2796198128883773e-11
. O 0 7.390748429925154e-11

Genetic O 0 2.3161109652392042e-07
basis O 0 2.1151820295273183e-09
and O 0 4.495001593163295e-11
molecular O 0 1.5347431103762688e-09
mechanism O 0 5.035332506508894e-08
for O 0 8.23786692194517e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 7.133869530662196e-07

Ventricular B-Disease 1 0.9999867677688599
fibrillation I-Disease 1 0.9999899864196777
causes O 0 3.658153957530885e-08
more O 0 3.832586158158957e-12
than O 0 2.9176287037399606e-13
300 O 0 2.6624001939722086e-13
, O 0 1.820325438777956e-13
000 O 0 2.13915690716604e-12
sudden O 0 4.920699264721051e-11
deaths O 0 4.060415198514633e-11
each O 0 1.5835664485437662e-13
year O 0 2.0909123391033013e-11
in O 0 6.894701823356719e-12
the O 0 1.868309326691353e-12
USA O 0 7.124817624770685e-09
alone O 0 1.181626907431621e-09
. O 0 8.982191379569571e-11

In O 0 9.760143387937958e-11
approximately O 0 4.742687579467608e-12
5 O 0 7.505857914369418e-12
- O 0 1.931549364897478e-09
12 O 0 1.3146985236578423e-11
% O 0 1.7540523612573355e-13
of O 0 1.0582552239705003e-15
these O 0 2.190551715442867e-14
cases O 0 5.407336362527049e-13
, O 0 1.8127711246158917e-14
there O 0 4.796053352097533e-14
are O 0 1.924010436919494e-14
no O 0 6.882168012561918e-12
demonstrable O 0 4.993856350665737e-07
cardiac O 0 9.86771269140263e-08
or O 0 1.896455492644833e-10
non O 0 6.375660177582176e-06
- O 0 0.04022299125790596
cardiac O 0 0.007854141294956207
causes O 0 2.270071908228033e-10
to O 0 8.109156250137028e-13
account O 0 3.4916401367435235e-12
for O 0 4.67992479621579e-14
the O 0 8.901898180179932e-14
episode O 0 1.0737755129497373e-10
, O 0 4.404618759567408e-13
which O 0 1.4034814163708248e-13
is O 0 1.6624147804872313e-13
therefore O 0 6.269130180258653e-12
classified O 0 4.7525407609327885e-08
as O 0 1.1316091104163206e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.0195682079938706e-05
IVF B-Disease 1 1.0
) O 0 4.348871929238385e-09
. O 0 6.673563368586599e-10

A O 0 3.842641760343213e-09
distinct O 0 2.2539531352450126e-10
group O 0 8.145018687288896e-11
of O 0 3.6543112286180346e-12
IVF B-Disease 1 1.0
patients O 0 4.982743462278449e-07
has O 0 7.167520158120333e-13
been O 0 6.819456566282966e-13
found O 0 7.724834227146316e-13
to O 0 3.213058887962389e-14
present O 0 7.141234489600051e-14
with O 0 1.0062153069307148e-13
a O 0 3.500510645237931e-11
characteristic O 0 2.7612128139509196e-09
electrocardiographic O 0 3.36635412168107e-06
pattern O 0 4.997977498533146e-07
. O 0 2.6227240379483874e-09

Because O 0 3.481893662282687e-10
of O 0 3.992360709061983e-14
the O 0 1.6462617266578203e-14
small O 0 2.2394740684279768e-13
size O 0 1.6527601769816824e-12
of O 0 6.769129866552627e-15
most O 0 2.930702284586334e-13
pedigrees O 0 2.0559226543426234e-10
and O 0 4.836878984902475e-14
the O 0 4.287501885642808e-14
high O 0 1.3342314753028717e-10
incidence O 0 2.5939637104954727e-09
of O 0 1.2719444638167876e-12
sudden B-Disease 0 8.153933528376456e-09
death I-Disease 0 1.8923111688717853e-10
, O 0 2.1544002476100998e-13
however O 0 2.725043498144619e-13
, O 0 1.2587872672659931e-14
molecular O 0 4.077384317766747e-13
genetic O 0 1.7706730179312125e-11
studies O 0 3.52024867589229e-11
of O 0 9.8853585907277e-13
IVF B-Disease 1 1.0
have O 0 4.473552916994805e-10
not O 0 1.3821351181608765e-11
yet O 0 6.945402586389093e-11
been O 0 2.9866106115994384e-11
done O 0 4.3487868861546985e-10
. O 0 2.1241472122901506e-11

Because O 0 2.3683422512021934e-07
IVF B-Disease 1 1.0
causes O 0 1.2045148650940973e-05
cardiac O 1 0.8600915670394897
rhythm O 0 0.0004688553453888744
disturbance O 0 6.060034252186597e-08
, O 0 4.006499992881274e-12
we O 0 7.622424826742025e-13
investigated O 0 4.4849965755155985e-12
whether O 0 1.7674598763728344e-12
malfunction O 0 3.525831360207121e-08
of O 0 3.670380785327637e-14
ion O 0 1.2181815452205758e-11
channels O 0 2.2299224688993036e-09
could O 0 6.03442842361801e-08
cause O 0 7.433234028297875e-10
the O 0 2.142016078399145e-11
disorder O 0 2.4748800786511538e-09
by O 0 9.731756348582525e-15
studying O 0 3.1504774917340272e-12
mutations O 0 2.287395099720424e-11
in O 0 2.3085903848307776e-12
the O 0 2.850369679868736e-12
cardiac O 0 2.1760209634180683e-08
sodium O 0 1.8553965031031794e-09
channel O 0 2.942618060330915e-08
gene O 0 3.3907207352967816e-07
SCN5A O 0 7.416865173581755e-06
. O 0 1.7699995913389444e-09

We O 0 9.331383582500408e-11
have O 0 6.785553564349345e-13
now O 0 4.9005851460171e-13
identified O 0 8.591829504800419e-12
a O 0 4.227657720429212e-12
missense O 0 1.601947730023312e-07
mutation O 0 2.8269842022865532e-09
, O 0 4.0970391142203244e-12
a O 0 9.002821058090582e-12
splice O 0 3.801024604399572e-06
- O 0 1.949557137947977e-08
donor O 0 4.5565182738016574e-09
mutation O 0 6.625070625432272e-08
, O 0 6.020887954871768e-11
and O 0 5.740053831554404e-12
a O 0 4.6468259795595657e-11
frameshift O 0 4.915659701509867e-06
mutation O 0 4.3803125016061983e-10
in O 0 8.214189745059386e-12
the O 0 8.281153540679043e-13
coding O 0 1.9134862583314316e-09
region O 0 4.446575052607926e-11
of O 0 1.9083261446756206e-12
SCN5A O 0 2.2494937468309217e-07
in O 0 4.5335759452092006e-11
three O 0 8.047638944130853e-11
IVF B-Disease 1 1.0
families O 0 2.117425262904149e-10
. O 0 6.332442903378421e-11

We O 0 6.616676651027831e-11
show O 0 1.6754349643766098e-12
that O 0 9.619001863742874e-15
sodium O 0 2.0840219740886345e-13
channels O 0 1.017098991834553e-11
with O 0 8.507254010406071e-14
the O 0 7.282363731139774e-13
missense O 0 5.5847891644589254e-08
mutation O 0 4.658187169326311e-10
recover O 0 4.2630330376880465e-09
from O 0 7.306280146862631e-13
inactivation O 0 7.978709359868219e-11
more O 0 1.1365516885378409e-14
rapidly O 0 4.515896120591001e-13
than O 0 1.9331035050148583e-14
normal O 0 2.1146383255565837e-12
and O 0 3.2318562431278564e-13
that O 0 4.493400687340457e-14
the O 0 7.903951473355042e-13
frameshift O 0 9.20209515697934e-07
mutation O 0 2.668016640949844e-10
causes O 0 7.270834542077997e-12
the O 0 2.808602959578077e-13
sodium O 0 2.1929170285206467e-11
channel O 0 2.0044091386672847e-10
to O 0 1.1006397616225572e-12
be O 0 8.279799589006043e-12
non O 0 1.5060837021962925e-09
- O 0 1.386908476952442e-09
functional O 0 7.707170457393886e-10
. O 0 3.105218027155132e-10

Our O 0 3.858437458426067e-10
results O 0 1.1808827526937904e-10
indicate O 0 2.1935571414832822e-11
that O 0 7.125590807503801e-13
mutations O 0 9.621778929158609e-10
in O 0 2.7608413818991373e-11
cardiac O 0 4.319442581390831e-09
ion O 0 8.826742114997899e-11
- O 0 4.619733207089638e-10
channel O 0 4.2949749312626295e-10
genes O 0 1.51548537608015e-10
contribute O 0 4.191694300686999e-12
to O 0 3.711027795824662e-13
the O 0 4.106879766818672e-13
risk O 0 1.983892043699864e-11
of O 0 3.760826963435451e-14
developing O 0 5.227580035516155e-10
IVF B-Disease 1 1.0
. O 0 8.54796233795696e-11
. O 0 4.226208619173555e-11

Molecular O 0 1.7092526505280148e-08
heterogeneity O 0 2.035871382588539e-08
in O 0 1.1609180283755904e-09
mucopolysaccharidosis B-Disease 0 5.368982783693355e-06
IVA I-Disease 0 1.620707735128235e-05
in O 0 4.271072107098206e-10
Australia O 0 7.803387103155757e-11
and O 0 8.82456109053964e-13
Northern O 0 2.9978824978016405e-11
Ireland O 0 6.188309242816104e-08
: O 0 2.776273677097818e-13
nine O 0 2.320508694052259e-13
novel O 0 6.725894255606157e-13
mutations O 0 1.1695935886457676e-11
including O 0 4.983410060478699e-13
T312S O 0 1.2157640449927953e-09
, O 0 4.769919268593492e-13
a O 0 4.49587144856628e-13
common O 0 1.9599264919345494e-11
allele O 0 1.378742564561719e-09
that O 0 1.5534013311779837e-11
confers O 0 4.1826044849813115e-09
a O 0 1.0885164769547373e-08
mild O 1 0.9801384210586548
phenotype O 0 0.00022338569397106767
. O 0 3.778192425585303e-09

Mucopolysaccharidosis B-Disease 0 0.00318503356538713
IVA I-Disease 1 0.9991494417190552
( O 0 2.6634957976057194e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.3022084799363398e-10
is O 0 9.745516893477912e-12
an O 0 1.8922922256914276e-11
autosomal B-Disease 1 0.9999728202819824
recessive I-Disease 1 0.9999996423721313
lysosomal I-Disease 1 0.9999985694885254
storage I-Disease 1 0.9999911785125732
disorder I-Disease 1 1.0
caused O 0 8.37084712657088e-09
by O 0 3.1916537555215507e-12
a O 0 7.120363676449415e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.9340738172400904e-10
N O 0 5.7284935905954626e-08
- O 0 7.903108389939462e-09
acetylgalactosamine O 0 4.1031733417185023e-05
- O 0 4.66829561673876e-08
6 O 0 2.446840063896616e-09
- O 0 1.5298338595925998e-08
sulfate O 0 1.689896755863174e-08
sulfatase O 0 3.8627570120297605e-07
( O 0 7.731577877923002e-11
GALNS O 0 5.042357997808722e-08
) O 0 2.676103262599927e-11
. O 0 6.856962220247453e-11

Previous O 0 1.6275517600305989e-09
studies O 0 6.974248956126416e-11
of O 0 1.0039723636863854e-13
patients O 0 1.2373320250336217e-11
from O 0 3.3903994656235906e-14
a O 0 8.83781763050262e-13
British O 0 2.1975553821107496e-08
- O 0 2.6291750998552743e-09
Irish O 0 5.661206226026394e-11
population O 0 4.907251498599899e-14
showed O 0 3.704772946755419e-11
that O 0 3.8752604369831495e-14
the O 0 1.9121471983921112e-13
I113F O 0 1.2930514436959584e-09
mutation O 0 3.1316071263942646e-11
is O 0 5.260108212716552e-13
the O 0 3.937450612410097e-14
most O 0 1.8443104302882235e-13
common O 0 9.330239705840349e-12
single O 0 5.7108880124889794e-11
mutation O 0 5.135945890799576e-09
among O 0 1.8009490787562754e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.029207902029156685
and O 0 6.690344805937443e-11
produces O 0 1.4069652387593834e-10
a O 0 8.102133963738822e-10
severe O 0 0.00016032934945542365
clinical O 0 7.398261345770152e-07
phenotype O 0 5.051063453720417e-06
. O 0 2.3226167655820973e-09

We O 0 1.5185909196802072e-09
studied O 0 1.0499829894428103e-09
mutations O 0 1.8240609023223442e-10
in O 0 1.8629253955432246e-12
the O 0 2.531990188261307e-13
GALNS O 0 3.40373640383973e-09
gene O 0 1.260707371830705e-10
from O 0 6.6884657534682646e-12
23 O 0 2.3682207236919162e-11
additional O 0 1.51669996006909e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.0846887562365737e-05
( O 0 9.70618984491578e-12
15 O 0 1.7452765578226948e-12
from O 0 9.130474154517287e-13
Australia O 0 9.884666002379916e-12
, O 0 2.622378768128708e-13
8 O 0 1.0583572321483381e-13
from O 0 1.0147456740985591e-13
Northern O 0 4.6350884935764114e-11
Ireland O 0 1.8595425643752606e-08
) O 0 3.3175778747437934e-13
, O 0 2.039498974706292e-14
with O 0 2.3591358359019432e-15
various O 0 3.660978584087843e-13
clinical O 0 2.721475267364326e-09
phenotypes O 0 1.935980087353073e-08
( O 0 5.547911019476715e-10
severe O 0 0.0013745203614234924
, O 0 2.2400404448008615e-11
16 O 0 6.4649023981400155e-12
cases O 0 5.582871838438752e-12
; O 0 5.068959574999754e-13
intermediate O 0 1.63137073294628e-10
, O 0 1.6631450990706176e-12
4 O 0 6.000833076974521e-12
cases O 0 3.295270722958321e-10
; O 0 3.7504763183981993e-10
mild O 1 0.9731065034866333
, O 0 3.1905675323962157e-10
3 O 0 3.390734568120557e-11
cases O 0 2.1692599105893606e-10
) O 0 8.382562005637695e-12
. O 0 1.450080194809189e-10

We O 0 2.896640427518804e-10
found O 0 3.904935836490653e-12
two O 0 4.0658960437844546e-14
common O 0 1.4155343563970746e-12
mutations O 0 7.143435148959654e-12
that O 0 1.5321661853747587e-13
together O 0 1.2146536489295034e-13
accounted O 0 3.8014064118740976e-11
for O 0 3.8442888466733854e-14
32 O 0 2.038707744289603e-12
% O 0 2.2959382333688494e-13
of O 0 1.5110520595732792e-14
the O 0 1.6965817856498533e-12
44 O 0 1.8487322783755644e-11
unrelated O 0 3.651625390954649e-10
alleles O 0 1.8917879762714307e-10
in O 0 4.367079614597813e-11
these O 0 2.8480722988333262e-11
patients O 0 1.7711342392701113e-09
. O 0 7.351396574817315e-11

One O 0 1.1169887237372222e-10
is O 0 1.323311902765023e-12
the O 0 4.753145034681883e-13
T312S O 0 2.4059392256248202e-09
mutation O 0 1.4838706652309241e-10
, O 0 1.0292487348517732e-12
a O 0 8.369297008897769e-13
novel O 0 3.003926968281334e-11
mutation O 0 1.8916652966272096e-10
found O 0 2.8519209563371284e-11
exclusively O 0 2.7658167423005864e-11
in O 0 1.8213074104433957e-10
milder O 0 2.7044350645155646e-05
patients O 0 5.596689334197436e-07
. O 0 6.72332634010786e-10

The O 0 1.4828201166938726e-11
other O 0 4.888150431300864e-13
is O 0 1.5090652252108816e-13
the O 0 2.404492586754927e-14
previously O 0 5.892010837560413e-12
described O 0 2.4080119842562198e-11
I113F O 0 6.240361560827523e-10
that O 0 5.809762393393925e-13
produces O 0 3.527588637863843e-11
a O 0 8.939962659049172e-10
severe O 0 6.466937338700518e-05
phenotype O 0 8.169835382432211e-06
. O 0 2.5979891571381586e-09

The O 0 4.0254699573694097e-10
I113F O 0 3.347843957612895e-08
and O 0 2.1952731299457184e-11
T312S O 0 1.6394879898129489e-09
mutations O 0 3.727328168334765e-10
accounted O 0 1.3463000159141814e-10
for O 0 4.4970869747269077e-14
8 O 0 1.1112393557416445e-12
( O 0 8.557692857298627e-13
18 O 0 1.4187211518426612e-12
% O 0 1.0737575108568653e-13
) O 0 2.7197767150412278e-14
and O 0 1.136329528736435e-12
6 O 0 1.3372238429412708e-12
( O 0 1.2185876223022585e-12
14 O 0 1.1744103953215124e-12
% O 0 1.3310370600844168e-13
) O 0 3.540822352660587e-14
of O 0 2.7901221236843396e-14
44 O 0 1.3769358049586788e-11
unrelated O 0 2.0143893497692744e-10
alleles O 0 1.1609223582453865e-09
, O 0 1.0437067876623018e-10
respectively O 0 9.397976841185596e-10
. O 0 6.802773344638524e-10

The O 0 1.698098744951082e-10
relatively O 0 9.397743694350424e-10
high O 0 2.655157482767123e-10
residual O 0 8.636681592122386e-09
GALNS O 0 8.832588491713977e-07
activity O 0 8.638939341665264e-09
seen O 0 1.3850122437819579e-10
when O 0 1.0439945349188795e-12
the O 0 6.19478630176605e-14
T312S O 0 8.69694316563141e-11
mutant O 0 6.591484302820305e-11
cDNA O 0 1.6945138348045674e-10
is O 0 7.210139169738783e-12
overexpressed O 0 1.5922501095388952e-09
in O 0 1.5464002691215062e-12
mutant O 0 1.0547274165162435e-10
cells O 0 5.0255959116451976e-11
provides O 0 1.0850691005426238e-12
an O 0 5.308514383823605e-14
explanation O 0 2.1477548472342844e-12
for O 0 1.301518707261598e-13
the O 0 1.131042633682744e-12
mild O 0 3.8030644645914435e-05
phenotype O 0 2.457616403717111e-07
in O 0 2.2185560333287668e-10
patients O 0 1.3663156162024848e-09
with O 0 2.1313850749431207e-13
this O 0 5.2363963859436424e-12
mutation O 0 3.909510049027176e-09
. O 0 3.306527829316508e-10

The O 0 2.7208586945992597e-12
distribution O 0 1.4608889185169227e-12
and O 0 1.9525255978009026e-13
relative O 0 7.633832259899831e-13
frequencies O 0 8.49690023202454e-12
of O 0 1.6299678620712577e-14
the O 0 3.456789433690932e-13
I113F O 0 8.186935573917253e-10
and O 0 4.571815582360417e-12
T312S O 0 2.2377995290145947e-10
mutations O 0 1.6093772148284557e-11
in O 0 9.454542183873205e-13
Australia O 0 3.6707117380407883e-13
corresponded O 0 2.366755066669085e-13
to O 0 1.3202675443798467e-14
those O 0 1.3953983503617665e-14
observed O 0 7.884884693949712e-14
in O 0 3.513168759811808e-13
Northern O 0 4.9263527285292597e-11
Ireland O 0 1.9755953317712738e-08
and O 0 1.6565790622938281e-12
are O 0 9.485926211465646e-15
unique O 0 4.1295443864301e-15
to O 0 2.205081210400299e-14
these O 0 6.283486067343216e-15
two O 0 1.0715514813083773e-14
populations O 0 4.698250184623047e-14
, O 0 1.7021454029792805e-14
suggesting O 0 2.6465090969401972e-12
that O 0 2.6082106174265748e-14
both O 0 1.8189579887879087e-13
mutations O 0 9.618943662415003e-12
were O 0 1.9421833932775634e-11
probably O 0 4.306079104399174e-11
introduced O 0 2.847869726499419e-12
to O 0 1.952313229700367e-13
Australia O 0 7.739522998179149e-13
by O 0 4.251831972981214e-14
Irish O 0 8.69971386596724e-11
migrants O 0 3.0675708501126664e-11
during O 0 1.0017310331927876e-12
the O 0 7.028401569509485e-14
19th O 0 2.0168267056419609e-10
century O 0 2.0290280566825913e-09
. O 0 3.9470382517947655e-10

Haplotype O 0 5.3385624596558046e-06
analysis O 0 1.8454154870894968e-09
using O 0 3.8089997822510213e-10
6 O 0 1.2605005927923685e-10
RFLPs O 0 6.939315233545074e-10
provides O 0 6.963741107195165e-13
additional O 0 2.868683209814732e-13
data O 0 9.232609468612374e-12
that O 0 1.555558253821948e-13
the O 0 5.542053903469235e-13
I113F O 0 2.7248203693375217e-09
mutation O 0 5.0465551876266446e-11
originated O 0 2.6700630595399844e-10
from O 0 4.6377216303405966e-12
a O 0 6.265663335391913e-12
common O 0 3.128305947619481e-11
ancestor O 0 6.34307162350467e-10
. O 0 8.039711119067761e-10

The O 0 3.8766340831886126e-11
other O 0 1.6388164696817809e-12
9 O 0 9.255918947959074e-12
novel O 0 1.0458605335939009e-11
mutations O 0 1.9594155464819352e-10
identified O 0 3.8971864624315344e-10
in O 0 2.463685939285698e-12
these O 0 1.373629264804152e-13
23 O 0 2.7050555805735454e-12
patients O 0 4.299388536160853e-12
were O 0 8.013041456495645e-14
each O 0 5.772496713011351e-16
limited O 0 5.479535011496117e-13
to O 0 7.182614962866762e-13
a O 0 2.9415825331113865e-10
single O 0 3.5475102855286877e-09
family O 0 1.046456254982786e-09
. O 0 3.7396474805717617e-10

These O 0 8.684357052923808e-12
data O 0 8.509988720650785e-12
provide O 0 4.0865849929277304e-14
further O 0 3.592854095832432e-13
evidence O 0 1.2215033672047237e-12
for O 0 7.23519009461493e-14
extensive O 0 8.593944132717635e-12
allelic O 0 2.5568527295405374e-09
heterogeneity O 0 5.777187173094944e-09
in O 0 2.377393393260263e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 0.9999998807907104
in O 0 6.784654782432398e-11
British O 0 4.3197907473313535e-08
- O 0 3.428595718446559e-08
Irish O 0 9.85465153924281e-10
patients O 0 7.039158145261126e-11
and O 0 3.7634531043851185e-14
provide O 0 8.271531686855366e-15
evidence O 0 1.5228981541538095e-13
for O 0 5.741621726809221e-15
their O 0 8.017994905171189e-14
transmission O 0 7.779802496665766e-11
to O 0 4.098357937742936e-13
Australia O 0 4.858434076056295e-13
by O 0 3.597329953450995e-14
British O 0 3.698290029774398e-08
- O 0 9.238237397291016e-10
Irish O 0 1.6349591125397467e-10
migrants O 0 1.1737599781014296e-10
. O 0 7.035808567701363e-13
. O 0 5.6574146409249515e-12

Identification O 0 7.267323631765521e-09
of O 0 3.69823312598716e-12
constitutional O 0 3.202352549802612e-10
WT1 O 0 1.0922328783635749e-06
mutations O 0 5.73928815583713e-08
, O 0 2.7645826600197765e-11
in O 0 1.4316747440346056e-11
patients O 0 3.843108886680824e-10
with O 0 3.563305249823512e-12
isolated O 0 4.10077118431218e-05
diffuse B-Disease 1 0.9989221096038818
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 8.048038624419718e-11
and O 0 4.2095832570622493e-13
analysis O 0 1.45824693466301e-12
of O 0 2.598791949866286e-13
genotype O 0 0.0002523173170629889
/ O 0 1.1652426110231318e-05
phenotype O 0 4.816878629299026e-08
correlations O 0 9.714089532764092e-10
by O 0 4.472104110642139e-13
use O 0 1.582505480823837e-11
of O 0 2.417351258401923e-13
a O 0 2.7332499111243358e-11
computerized O 0 3.3248142017328064e-08
mutation O 0 8.562069275797057e-09
database O 0 7.673730095802966e-09
. O 0 2.246438035591325e-10

Constitutional O 0 5.60345858602318e-09
mutations O 0 9.235705533683358e-09
of O 0 4.1501416019051884e-13
the O 0 7.980314000767541e-13
WT1 O 0 8.637950799084138e-09
gene O 0 2.4619034588724276e-10
, O 0 6.995504436141387e-13
encoding O 0 2.6820922219283894e-11
a O 0 2.665436274473798e-11
zinc O 0 3.089622259722091e-05
- O 0 1.1352852880008868e-06
finger O 0 8.46949296828825e-06
transcription O 0 7.533234480661122e-09
factor O 0 3.433223497162352e-11
involved O 0 2.5774838860459504e-11
in O 0 6.535952334907336e-10
renal O 0 7.268432455020957e-06
and O 0 1.4026320035998019e-11
gonadal O 0 5.719778428669997e-09
development O 0 7.54046824980037e-12
, O 0 3.4161451336993387e-13
are O 0 2.2782870493062886e-14
found O 0 1.692038111185401e-12
in O 0 4.896296584323834e-13
most O 0 2.407614580791917e-13
patients O 0 3.076029448517703e-12
with O 0 7.1484062159205e-13
Denys B-Disease 1 0.9999926090240479
- I-Disease 1 0.9999997615814209
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 7.303219007326334e-08
DDS B-Disease 1 1.0
) O 0 2.240725244240238e-10
, O 0 1.825737651339754e-11
or O 0 1.1922132614472503e-08
diffuse B-Disease 1 0.9993358254432678
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.9036481546663708e-07
DMS B-Disease 0 0.0027753845788538456
) O 0 3.20645658462293e-12
associated O 0 7.416855324349214e-12
with O 0 2.21356318691468e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 3.741335603990592e-06
/ O 0 8.763828373048455e-05
or O 0 1.8943720192510227e-07
Wilms B-Disease 0 0.009488624520599842
tumor I-Disease 0 0.00044568488374352455
( O 0 2.4346119786855525e-08
WT B-Disease 1 0.9998708963394165
) O 0 3.7087974358307463e-10
. O 0 3.273233351031024e-10

Most O 0 1.6064776175994666e-09
mutations O 0 5.168836310076586e-07
in O 0 6.750869374627655e-08
DDS B-Disease 1 1.0
patients O 0 2.6363046345068142e-05
lie O 0 2.3614212807387958e-09
in O 0 1.9407539811333585e-11
exon O 0 1.1523677123648213e-08
8 O 0 2.0172884196423269e-10
or O 0 2.910574559145118e-10
exon O 0 8.253778993605465e-09
9 O 0 4.1537276396219625e-10
, O 0 4.391073442355786e-12
encoding O 0 2.963377321307803e-09
zinc O 0 3.637129793787608e-06
finger O 0 0.0014790776185691357
2 O 0 1.9192275546586757e-10
or O 0 5.559396054621857e-09
zinc O 0 5.242635961622e-05
finger O 0 0.0029472429305315018
3 O 0 1.6460106888604997e-10
, O 0 2.503371425086054e-12
respectively O 0 8.858175477854946e-12
, O 0 4.4733070329525115e-13
with O 0 1.468957469769397e-13
a O 0 1.2747856104056154e-09
hot O 0 3.5966868381365202e-06
spot O 0 1.26496058783232e-06
( O 0 9.568846409679921e-11
R394W O 0 2.289042733139013e-09
) O 0 1.5371870443203761e-12
in O 0 1.906787922001385e-11
exon O 0 2.7012408310156388e-08
9 O 0 2.931395792771241e-09
. O 0 2.608534221959502e-10

We O 0 2.598027626365962e-10
analyzed O 0 6.5017560779701e-11
a O 0 1.401577530250886e-12
series O 0 2.090767663165405e-12
of O 0 1.238414617165881e-13
24 O 0 2.868906223696399e-10
patients O 0 2.3647236946366945e-10
, O 0 3.896905855730465e-13
10 O 0 1.6649407004985795e-13
with O 0 1.8883818933470436e-13
isolated B-Disease 0 2.223581986982026e-06
DMS I-Disease 1 0.9985137581825256
( O 0 1.6525088589181003e-11
IDMS B-Disease 0 5.2881876655419546e-08
) O 0 1.788096363683489e-12
, O 0 1.125061307137576e-12
10 O 0 1.3669391139836673e-12
with O 0 3.010637919520498e-11
DDS B-Disease 1 1.0
, O 0 3.3494054751948e-10
and O 0 2.080941842452777e-11
4 O 0 3.681068904554108e-12
with O 0 5.308580831864251e-12
urogenital B-Disease 0 0.0012628271942958236
abnormalities I-Disease 1 0.9999998807907104
and O 0 4.155514332637722e-08
/ O 0 0.00040780456038191915
or O 0 2.2141626686789095e-05
WT B-Disease 1 0.9999995231628418
. O 0 5.402285285782682e-09

We O 0 5.353103293970207e-09
report O 0 7.569829763021119e-10
WT1 O 0 4.065846894718561e-07
heterozygous O 0 4.2777863029641594e-08
mutations O 0 1.0114419524143159e-08
in O 0 8.210811197617573e-11
16 O 0 2.4795741848659958e-11
patients O 0 4.789088570156252e-10
, O 0 6.739300415468941e-13
4 O 0 8.956094329701236e-13
of O 0 3.515935508230719e-14
whom O 0 8.392340294927081e-11
presented O 0 2.629182635494054e-11
with O 0 4.1889314933429844e-11
IDMS B-Disease 0 9.722560207592323e-06
. O 0 5.290128890500512e-10

One O 0 1.1581534620219713e-09
male O 0 1.4637276946061206e-09
and O 0 1.0501221420211593e-11
two O 0 8.6447611222229e-12
female O 0 8.934149531292235e-10
IDMS B-Disease 0 1.058746966009494e-05
patients O 0 3.812318638551915e-08
with O 0 4.79027373323504e-11
WT1 O 0 6.915592530276626e-05
mutations O 0 1.301813517784467e-05
underwent O 0 4.713730959338136e-06
normal O 0 4.6596667857556895e-07
puberty O 0 6.710739398840815e-06
. O 0 1.7321796219604835e-09

Two O 0 1.1516617659523831e-09
mutations O 0 1.7851828459924945e-08
associated O 0 1.0527618360400837e-10
with O 0 1.784083189342034e-12
IDMS B-Disease 0 1.9818722307718417e-07
are O 0 4.2481705544820947e-13
different O 0 6.481860675370404e-14
from O 0 8.73785364809837e-13
those O 0 6.766374570019162e-13
described O 0 9.81663847432479e-11
in O 0 1.0157744867456131e-08
DDS B-Disease 1 1.0
patients O 0 2.590801386759267e-07
. O 0 1.8469216434002789e-10

No O 0 1.8959292802378513e-08
WT1 O 0 2.5672979973023757e-06
mutations O 0 3.2043356412714274e-08
were O 0 2.7094526622306603e-10
detected O 0 3.379929003344273e-09
in O 0 7.100197600001801e-12
the O 0 3.6905295985011077e-13
six O 0 1.8583298962149275e-12
other O 0 1.2021529605110715e-12
IDMS B-Disease 0 5.871100370313798e-07
patients O 0 7.419296288446731e-10
, O 0 2.3014009860149176e-13
suggesting O 0 2.4067364767788035e-10
genetic O 0 3.6804357339548233e-09
heterogeneity O 0 3.520453706329363e-09
of O 0 2.613058640993371e-12
this O 0 1.723192422087294e-10
disease O 0 4.556042654257908e-07
. O 0 3.563342954038262e-10

We O 0 1.8730756945473104e-09
analyzed O 0 1.4061698472289663e-08
genotype O 0 7.830585673218593e-06
/ O 0 2.5730334982654313e-06
phenotype O 0 6.235869420834206e-08
correlations O 0 2.2108954667032776e-08
, O 0 8.043951789382664e-12
on O 0 1.2947351524239537e-12
the O 0 3.034402359914333e-14
basis O 0 5.682685225161244e-13
of O 0 1.7206427178990068e-15
the O 0 1.8845606227901185e-13
constitution O 0 1.7678905756858543e-13
of O 0 4.9186436682239956e-15
a O 0 6.330084893757526e-12
WT1 O 0 1.4580580298684254e-08
mutation O 0 5.426352076010055e-11
database O 0 1.3152252724413227e-11
of O 0 3.627806198893205e-14
84 O 0 3.493193928560956e-11
germ O 0 4.7840862862358335e-06
- O 0 7.932823677947454e-07
line O 0 1.144211481118873e-08
mutations O 0 1.88085147456718e-09
, O 0 6.603897658753743e-13
to O 0 3.1082931096614724e-14
compare O 0 9.589500417697683e-13
the O 0 3.0809336913552744e-15
distribution O 0 1.1710791570414963e-13
and O 0 9.38558367309661e-13
type O 0 1.8399326506823854e-09
of O 0 5.2155186365445555e-14
mutations O 0 3.677772322796535e-11
, O 0 3.1285352997470484e-13
according O 0 1.9930189226399775e-13
to O 0 2.4304023420532173e-13
the O 0 1.8182894426232998e-12
different O 0 3.087300415316463e-10
symptoms O 0 1.1140284783550669e-07
. O 0 1.0707854047886656e-10

This O 0 2.2264905197300067e-11
demonstrated O 0 6.437441552042955e-11
( O 0 4.559832546269238e-12
1 O 0 8.310631371445665e-13
) O 0 4.512209223340828e-14
the O 0 2.1308394501998174e-14
association O 0 9.086346041894955e-13
between O 0 3.314611768650416e-13
mutations O 0 1.339778149533899e-10
in O 0 2.851154035088399e-11
exons O 0 9.766405462130479e-10
8 O 0 2.818324393305538e-11
and O 0 1.1222242753128331e-11
9 O 0 3.600122283620166e-11
and O 0 8.951646368604571e-11
DMS B-Disease 0 0.00014806448598392308
; O 0 3.237612543512125e-13
( O 0 5.952371299848547e-13
2 O 0 6.045450056356427e-13
) O 0 8.234135351640678e-14
among O 0 2.385504174837877e-13
patients O 0 6.849599012981322e-12
with O 0 8.429401518158033e-14
DMS B-Disease 0 7.211927731987089e-05
, O 0 2.0144784007147115e-13
a O 0 3.744473806542581e-13
higher O 0 2.624863520983567e-11
frequency O 0 2.4078787574932647e-11
of O 0 2.031479097355099e-13
exon O 0 6.428414467407606e-10
8 O 0 2.0950239806860615e-11
mutations O 0 3.917024204991293e-10
among O 0 2.981753949651833e-12
46 O 0 4.281068902156626e-11
, O 0 3.567616905023052e-12
XY O 0 8.189103937183972e-07
patients O 0 7.143009739252193e-09
with O 0 2.7442080725859075e-12
female O 0 3.255751002129159e-09
phenotype O 0 3.1190698024374797e-08
than O 0 5.299809202607975e-12
among O 0 9.774496750186712e-13
46 O 0 3.439109066971646e-11
, O 0 3.924797986609718e-12
XY O 0 2.5977510631491896e-07
patients O 0 1.0985189424772557e-09
with O 0 4.3350658349497473e-13
sexual O 0 9.822556656935433e-11
ambiguity O 0 7.382087718887931e-10
or O 0 1.4731187381045174e-09
male O 0 3.1213891471537636e-09
phenotype O 0 1.8541909341251994e-08
; O 0 8.884927515939722e-12
and O 0 3.779298748951554e-11
( O 0 1.0139824743737869e-11
3 O 0 8.858069442882477e-13
) O 0 7.601152373542044e-14
statistically O 0 1.209132707152838e-11
significant O 0 1.0193397775165591e-12
evidence O 0 6.237121930041667e-11
that O 0 4.721539999252844e-12
mutations O 0 1.6257670210073627e-10
in O 0 1.867430168833728e-11
exons O 0 4.532816899605052e-10
8 O 0 1.0459761529135747e-11
and O 0 3.783768437459756e-12
9 O 0 6.010787787641414e-12
preferentially O 0 3.827021685665066e-11
affect O 0 3.55771141713479e-11
amino O 0 5.703765151160445e-12
acids O 0 1.5429120654719686e-12
with O 0 7.686187874589388e-15
different O 0 7.701776499544066e-14
functions O 0 5.417391253474679e-13
. O 0 2.3333631034294644e-12
. O 0 7.234662868782493e-11

The O 0 3.276443838462484e-10
185delAG O 0 1.363793842301675e-07
BRCA1 O 0 1.8104604748714337e-07
mutation O 0 2.0647487886105154e-10
originated O 0 1.2680675953724574e-10
before O 0 1.0277421275128873e-12
the O 0 9.823135956998214e-15
dispersion O 0 4.085856653013309e-12
of O 0 1.2012114096983319e-15
Jews O 0 1.6640581599301763e-13
in O 0 1.72920176983761e-13
the O 0 1.5353131160617157e-14
diaspora O 0 2.2998621236614003e-12
and O 0 9.281481833101068e-12
is O 0 3.3828888583616046e-13
not O 0 1.3029400692046722e-12
limited O 0 1.7190707407924166e-12
to O 0 9.59653190246712e-12
Ashkenazim O 0 2.2893676998592127e-07
. O 0 2.0493844121727278e-10

The O 0 2.432571921673343e-10
185delAG O 0 6.391059059751569e-08
mutation O 0 2.2123411991259445e-09
in O 0 5.349320639225219e-11
BRCA1 O 0 2.0507908971012512e-07
is O 0 7.0132762444719e-12
detected O 0 3.3476825755940354e-09
in O 0 1.4410854454194322e-11
Ashkenazi O 0 1.0572335229497298e-09
Jews O 0 1.2334410836450926e-12
both O 0 2.6056961493006736e-13
in O 0 2.6400569230755622e-11
familial B-Disease 0 0.4920032322406769
breast I-Disease 1 0.9999992847442627
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.1319780663109356e-10
in O 0 6.758987033256281e-12
the O 0 6.819960991343715e-14
general O 0 2.4438548515588743e-13
population O 0 1.8070900407573393e-13
. O 0 3.1353964563551884e-11

All O 0 1.2149312111908728e-10
tested O 0 3.773496626280348e-09
Ashkenazi O 0 1.4057194519523364e-08
mutation O 0 4.4091535977841545e-11
carriers O 0 1.0330575284100973e-10
share O 0 1.752897965667799e-10
the O 0 1.401764663545857e-12
same O 0 1.7393819023991952e-11
allelic O 0 2.4622524019690673e-09
pattern O 0 6.545289465975657e-08
at O 0 1.4633284584064654e-09
the O 0 2.308802801720411e-11
BRCA1 O 0 5.16165926001122e-07
locus O 0 2.425828071750402e-08
. O 0 2.3113695402088297e-09

Our O 0 1.1795905918710048e-10
previous O 0 9.561397680546424e-12
study O 0 3.3778082869813375e-13
showed O 0 3.907409552167396e-12
that O 0 7.124877775168802e-15
this O 0 4.08587551813111e-14
Ashkenazi O 0 8.477697654996064e-09
mutation O 0 1.4434373835081615e-11
also O 0 1.6052194296012345e-12
occurs O 0 1.275201325827771e-13
in O 0 2.960682100958817e-13
Iraqi O 0 2.0117159674204466e-11
Jews O 0 6.083009963797625e-12
with O 0 1.8848697559345484e-13
a O 0 1.1297841134849662e-11
similar O 0 2.6845248246587516e-10
allelic O 0 8.729512757099656e-08
pattern O 0 1.348878868157044e-06
. O 0 1.504370494842533e-08

We O 0 1.0783858250817957e-09
extended O 0 4.770879177828924e-11
our O 0 6.066877685992345e-13
analysis O 0 3.2808226079449054e-13
to O 0 3.761042109804054e-14
other O 0 6.386278767096798e-13
non O 0 3.1203712946847872e-09
- O 0 3.2229185986665243e-09
Ashkenazi O 0 5.6904845280314476e-09
subsets O 0 8.281304114676757e-11
354 O 0 1.1347041362075316e-10
of O 0 2.3963248174511433e-14
Moroccan O 0 1.455145032247529e-10
origin O 0 3.402335487998065e-12
, O 0 2.320836394158893e-13
200 O 0 2.318146488568956e-13
Yemenites O 0 2.675395460727259e-10
and O 0 2.431603095959245e-13
150 O 0 2.404897570147668e-13
Iranian O 0 1.3044251442884125e-11
Jews O 0 4.985459614581522e-11
. O 0 4.387559759955195e-11

Heteroduplex O 0 4.495797440995375e-07
analysis O 0 5.473693720503547e-10
complemented O 0 1.0639734926431998e-10
by O 0 3.920977854465074e-14
direct O 0 9.48441629053387e-13
DNA O 0 6.245133576943118e-11
sequencing O 0 2.1343895401093604e-11
of O 0 1.56654501653683e-13
abnormally O 0 2.334015203331319e-10
migrating O 0 1.6586919338035244e-11
bands O 0 3.559537387065603e-11
were O 0 2.6427474791868022e-11
employed O 0 3.519887992187165e-10
. O 0 4.729988622997894e-11

Four O 0 1.75754029385633e-11
of O 0 3.565878603679906e-14
Moroccan O 0 1.6034952532439917e-10
origin O 0 3.5462396907881555e-12
( O 0 3.1350047341102694e-13
1 O 0 5.964198861348191e-14
. O 0 7.712886353086843e-15
1 O 0 4.1175050836343013e-14
% O 0 1.1012880467590677e-13
) O 0 3.517518443402548e-14
and O 0 2.856104296209555e-13
none O 0 7.797685240562569e-12
of O 0 1.997976445543997e-15
the O 0 4.625772624645107e-14
Yemenites O 0 2.461161829891978e-10
or O 0 3.2147910635632604e-12
Iranians O 0 5.221378884812111e-11
was O 0 9.728992611535148e-11
a O 0 8.462139409332048e-13
carrier O 0 8.327968176180534e-11
of O 0 1.2585094912812705e-13
the O 0 1.53539160552274e-11
185delAG O 0 6.782542527616897e-08
mutation O 0 1.4638373180275721e-08
. O 0 4.671123488009243e-10

BRCA1 O 0 0.00016134936595335603
allelic O 0 5.970265988253232e-07
patterns O 0 8.415322838573047e-08
were O 0 1.0628883190255678e-10
determined O 0 3.0376787890640244e-11
for O 0 3.703904994127247e-14
four O 0 4.481024519541535e-14
of O 0 3.7651437715599263e-16
these O 0 4.8491340269899395e-15
individuals O 0 8.602574185498976e-15
and O 0 6.608295182765345e-13
for O 0 1.87506904263373e-14
12 O 0 1.1524087890554813e-13
additional O 0 7.952296048226171e-13
non O 0 1.1687458112419336e-08
- O 0 2.0091984254122508e-07
Ashkenazi O 0 5.0234184811870364e-08
185delAG O 0 1.8539956236907074e-09
mutation O 0 2.1199227095980433e-10
carriers O 0 6.3530638527709016e-09
who O 0 2.676402210965989e-09
had O 0 0.00013629926252178848
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2695765327919162e-08

Six O 0 3.484307065093617e-09
non O 0 2.451866407682246e-07
- O 0 2.014077290368732e-05
Ashkenazi O 0 4.788170926417479e-08
individuals O 0 5.566438287954792e-14
shared O 0 5.590591601852338e-14
the O 0 2.6376873639910245e-14
common O 0 2.643333329999109e-10
Ashkenazi O 0 1.0696576282498427e-06
haplotype O 0 2.3487729094995302e-08
, O 0 2.0275016041071403e-11
four O 0 4.806809898033615e-12
had O 0 1.840524954666023e-10
a O 0 1.0345629518002109e-12
closely O 0 3.359108824430024e-11
related O 0 1.0486680412924443e-09
pattern O 0 6.339001856758841e-08
, O 0 1.3603340676127118e-10
and O 0 1.2389284043123894e-11
the O 0 3.0889036445845564e-13
rest O 0 3.462421668820603e-11
( O 0 2.524786803237422e-12
n O 0 1.1310573588829698e-09
= O 0 1.6789756251966992e-09
6 O 0 6.906182570265429e-11
) O 0 9.383435868592915e-13
displayed O 0 1.777705899153048e-10
a O 0 1.0920797599567322e-10
distinct O 0 3.7179856970936953e-09
BRCA1 O 0 8.400426850130316e-06
allelic O 0 4.037100609366462e-07
pattern O 0 1.525095854049141e-06
. O 0 9.189754734961753e-09

We O 0 8.929737504992374e-10
conclude O 0 3.453829167110456e-10
that O 0 2.1083948389261087e-13
the O 0 5.259095025786364e-13
185delAG O 0 4.725640323499647e-08
BRCA1 O 0 3.4444760785845574e-06
mutation O 0 3.571026585547088e-09
occurs O 0 7.274704276472033e-12
in O 0 2.6628777850291885e-13
some O 0 2.2348954826535705e-13
non O 0 6.189401768885716e-10
- O 0 1.2679262084702714e-08
Ashkenazi O 0 1.3151669975286495e-08
populations O 0 5.219166245018503e-12
at O 0 5.498847210905211e-11
rates O 0 1.476997690819104e-10
comparable O 0 3.975927660021528e-12
with O 0 4.975657540606977e-14
that O 0 2.5951314122814317e-13
of O 0 7.159104038756414e-13
Ashkenazim O 0 6.588225005543791e-07
. O 0 2.3407295546284956e-10

The O 0 1.5022922142393647e-11
majority O 0 5.710046151186088e-12
of O 0 6.527716328629321e-14
Jewish O 0 1.5823189980501695e-10
185delAG O 0 5.7717901569276364e-09
mutation O 0 5.7430022543103476e-11
carriers O 0 1.9285556485115762e-10
have O 0 2.3135360814607875e-12
a O 0 2.648175298838873e-12
common O 0 1.3238485307986991e-10
allelic O 0 2.511879149125207e-09
pattern O 0 7.229139509234983e-09
, O 0 2.242296192472848e-12
supporting O 0 1.968301281511653e-13
the O 0 1.076386294549328e-13
founder O 0 6.073364467590325e-12
effect O 0 8.632996227608825e-12
notion O 0 8.482763970418805e-12
, O 0 8.267801590924884e-13
but O 0 1.0379565046000905e-12
dating O 0 1.533085637606124e-11
the O 0 3.266402143068444e-15
mutations O 0 5.06273733873186e-13
origin O 0 1.4749207172433387e-13
to O 0 2.474242870049298e-13
an O 0 1.4502992990578223e-13
earlier O 0 1.2028560092414153e-10
date O 0 8.596096057189584e-11
than O 0 1.0853091429036121e-12
currently O 0 7.606391645015309e-13
estimated O 0 4.045246776440692e-12
. O 0 7.74294101058004e-11

However O 0 1.1965616275588786e-09
, O 0 1.4858827059385793e-12
the O 0 3.439936662884453e-14
different O 0 2.767470768608865e-13
allelic O 0 2.25886795379715e-10
pattern O 0 4.544350229451766e-09
at O 0 2.0071101725083196e-10
the O 0 1.6361429355446488e-12
BRCA1 O 0 1.7707231236840926e-08
locus O 0 9.918741522563224e-11
even O 0 4.872423992052788e-11
in O 0 2.178192522184208e-12
some O 0 8.98053400849759e-14
Jewish O 0 2.67697517798704e-12
mutation O 0 6.172619273353552e-12
carriers O 0 3.7703205141292884e-11
, O 0 5.366832195666249e-13
might O 0 6.339839070390596e-11
suggest O 0 7.095030118975387e-11
that O 0 2.405545597786163e-12
the O 0 7.553592083417437e-13
mutation O 0 3.403427539794279e-11
arose O 0 2.9535221490739616e-11
independently O 0 2.1875500022527916e-10
. O 0 2.3955788741591988e-11
. O 0 9.608807499672523e-11

Crystal O 0 3.790841560658009e-07
structure O 0 5.033416461408535e-10
of O 0 7.134920367198039e-13
the O 0 4.259078853485754e-11
hemochromatosis B-Disease 1 1.0
protein O 0 5.3650626163914694e-09
HFE O 0 7.29291826928602e-08
and O 0 2.9910100004387763e-12
characterization O 0 1.1258351889642526e-10
of O 0 2.4628096193272594e-14
its O 0 1.4332578093106951e-13
interaction O 0 4.591451784746736e-12
with O 0 3.8836604288397525e-13
transferrin O 0 1.7433426924284845e-09
receptor O 0 1.6064164443108098e-09
. O 0 2.158150325115571e-10

HFE O 0 0.00031821883749216795
is O 0 2.2518904796431372e-10
an O 0 1.2825343001163225e-12
MHC O 0 2.221661077328463e-09
- O 0 2.668052168086632e-10
related O 0 1.849113223650889e-11
protein O 0 7.47112094412472e-12
that O 0 1.415293256938968e-13
is O 0 4.485753335079466e-14
mutated O 0 1.271254490564644e-10
in O 0 1.6645327477471383e-11
the O 0 5.413471407256232e-11
iron B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999988079071045
overload I-Disease 1 0.9997122883796692
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.486331342448466e-07

HFE O 0 4.217636524117552e-05
binds O 0 1.4111781077019714e-08
to O 0 2.988234659717648e-11
transferrin O 0 3.8808325442118985e-09
receptor O 0 7.661032919159538e-10
( O 0 4.101138179057884e-11
TfR O 0 5.67200117984612e-08
) O 0 1.7742489335365041e-12
and O 0 1.0789892200199769e-12
reduces O 0 2.4418852356822285e-12
its O 0 1.699284295090045e-14
affinity O 0 3.4508951685802147e-12
for O 0 1.5779825363049227e-13
iron O 0 1.5294604693849578e-08
- O 0 5.355694221442775e-10
loaded O 0 2.6773658290402125e-10
transferrin O 0 8.503167614470897e-10
, O 0 5.779426850288649e-12
implicating O 0 3.974743645329681e-09
HFE O 0 1.3491838899426511e-06
in O 0 4.862502067659591e-10
iron O 0 1.10964892883203e-05
metabolism O 0 8.203025458897173e-07
. O 0 1.431134794005473e-10

The O 0 9.45253653128475e-10
2 O 0 1.0930659710695068e-09
. O 0 1.865313320470463e-10

6 O 0 4.366112094089658e-08
A O 0 3.366409928595715e-10
crystal O 0 1.7330924251268698e-08
structure O 0 1.869640969820452e-10
of O 0 6.202640397828807e-13
HFE O 0 5.587062901213358e-07
reveals O 0 4.2943198996781007e-10
the O 0 5.552038727851469e-14
locations O 0 2.004706470271067e-11
of O 0 4.517632448686193e-11
hemochromatosis B-Disease 1 1.0
mutations O 0 1.1843220448781722e-07
and O 0 6.434090760176758e-11
a O 0 5.946669545675576e-11
patch O 0 9.880271818474284e-07
of O 0 2.8213979004661216e-13
histidines O 0 1.9909911941340397e-08
that O 0 6.222167963157443e-13
could O 0 9.379844123635905e-12
be O 0 1.726160311693245e-13
involved O 0 1.7454828814961187e-12
in O 0 8.637973669678445e-11
pH O 0 2.3765307499701294e-09
- O 0 9.164749514845028e-11
dependent O 0 2.7668842217387635e-10
interactions O 0 4.3835471363884437e-10
. O 0 1.4916713697576967e-10

We O 0 3.610005072651745e-10
also O 0 6.886760042443263e-13
demonstrate O 0 6.468574590898224e-13
that O 0 7.873617664973243e-13
soluble O 0 4.951323262503138e-08
TfR O 0 9.878989430944785e-07
and O 0 6.739471394151542e-12
HFE O 0 2.0513066800731394e-08
bind O 0 5.1193535521854017e-11
tightly O 0 4.722137264545623e-11
at O 0 2.8843539969652943e-12
the O 0 1.7802743667813016e-14
basic O 0 3.568270245252192e-12
pH O 0 1.128801370951782e-12
of O 0 2.410625062941401e-16
the O 0 9.802473435282892e-15
cell O 0 1.0794719285112109e-10
surface O 0 4.0806459773723436e-12
, O 0 5.001054366633728e-13
but O 0 1.2904501685978564e-12
not O 0 4.2663594011782546e-13
at O 0 1.2910213263023218e-12
the O 0 6.732709550462401e-13
acidic O 0 5.600976904496235e-10
pH O 0 4.252414739780441e-11
of O 0 7.140199076525328e-14
intracellular O 0 3.3620914385856793e-10
vesicles O 0 1.1067615268700592e-08
. O 0 5.133201086415795e-10

TfR O 1 0.6770241260528564
HFE O 0 0.0005200117011554539
stoichiometry O 0 2.639802403336944e-07
( O 0 7.642909416460952e-09
2 O 0 6.477767627854902e-11
1 O 0 4.078685306163621e-12
) O 0 3.2862712659627313e-13
differs O 0 2.3239304577926667e-11
from O 0 3.8534249575949975e-12
TfR O 0 2.8408122076939435e-08
transferrin O 0 2.4022239752952146e-10
stoichiometry O 0 5.025250701673478e-11
( O 0 3.442296794831101e-12
2 O 0 1.3661675957177266e-12
2 O 0 3.690825314643653e-13
) O 0 1.631069411478503e-13
, O 0 7.285097275867153e-14
implying O 0 2.5258187902332807e-11
a O 0 5.429711584861718e-13
different O 0 3.6944172764410976e-13
mode O 0 4.968192177101649e-11
of O 0 1.1021552899124435e-14
binding O 0 3.2414142984299454e-12
for O 0 3.9777542696316226e-13
HFE O 0 1.6444714034946628e-08
and O 0 2.9990133640356298e-12
transferrin O 0 4.6382656049281934e-10
to O 0 2.838110822744877e-11
TfR O 0 1.896819298963237e-06
, O 0 6.136791162042465e-12
consistent O 0 7.054817147134074e-11
with O 0 7.522934640687151e-14
our O 0 2.7228509703013104e-13
demonstration O 0 1.8609298130245477e-12
that O 0 1.529730796244813e-13
HFE O 0 7.797815726462431e-09
, O 0 3.244090651492726e-13
transferrin O 0 1.4550784188660515e-10
, O 0 3.1569317472668335e-12
and O 0 1.2745849514717023e-11
TfR O 0 2.1651415238466143e-07
form O 0 1.919336564681906e-11
a O 0 1.2509250579828546e-10
ternary O 0 4.105400019938088e-09
complex O 0 4.017402854827878e-09
. O 0 4.5165146622672125e-10

Identification O 0 3.8909351296467776e-09
of O 0 2.1155287536957917e-13
three O 0 1.1502962211223933e-13
novel O 0 1.0165129371922377e-12
mutations O 0 1.0285668844423057e-10
and O 0 1.188376914235123e-11
a O 0 3.0213952867397253e-11
high O 0 4.5379727753314114e-10
frequency O 0 1.528525639393763e-10
of O 0 1.3118691788265024e-13
the O 0 1.5191942755871102e-12
Arg778Leu O 0 6.850379818956753e-09
mutation O 0 1.3705275803133077e-10
in O 0 7.794443909747706e-12
Korean O 0 8.217018732104009e-10
patients O 0 9.109769605331053e-10
with O 0 7.811275931635109e-12
Wilson B-Disease 0 5.2421228247112595e-08
disease I-Disease 0 9.051605047716293e-07
. O 0 8.821983144002843e-10

Four O 0 1.6621962695140269e-09
mutations O 0 1.176958406290396e-07
- O 0 1.4357422628563654e-07
- O 0 7.823621928082503e-08
R778L O 0 1.745060274060961e-08
, O 0 3.2673043957875958e-12
A874V O 0 3.4878427923601407e-10
, O 0 3.0503326101972983e-13
L1083F O 0 3.6485463955626685e-11
, O 0 2.482016938439198e-14
and O 0 5.168972820840216e-14
2304delC O 0 1.2475796784539028e-10
- O 0 9.461113316400205e-12
- O 0 5.555942858559426e-12
in O 0 5.979669884248473e-13
the O 0 1.235361774898705e-13
copper O 0 6.701177945878101e-10
- O 0 6.953418309890713e-12
transporting O 0 1.1216401071822979e-11
enzyme O 0 4.1449562532269724e-11
, O 0 1.3874321071367934e-13
P O 0 1.557031481524973e-08
- O 0 1.5548369536322326e-10
type O 0 6.144694975063203e-09
ATPase O 0 8.096888848285744e-08
( O 0 3.9505385074356525e-11
ATP7B O 0 2.5726990315888543e-08
) O 0 3.5415266097342524e-13
, O 0 4.582461797172921e-14
were O 0 5.321686017203953e-13
identified O 0 5.6693074713953795e-12
in O 0 2.4907249114754226e-13
Korean O 0 3.545294613438443e-11
Patients O 0 1.0923416685071352e-11
with O 0 3.742195897778189e-13
Wilson B-Disease 0 7.00227342775861e-09
disease I-Disease 0 1.1152084056220701e-07
. O 0 2.28112681521786e-10

Arg778Leu O 0 3.0691960546391783e-06
, O 0 2.161213916163085e-11
the O 0 3.441991226001313e-14
most O 0 1.7219698702965885e-14
frequently O 0 1.3217076088103963e-12
reported O 0 1.5560412680581948e-10
mutation O 0 2.674183574233324e-12
of O 0 5.005467509932877e-15
this O 0 2.6338364133996275e-14
enzyme O 0 5.134782356253087e-12
, O 0 3.685526073237723e-14
was O 0 1.511477921989357e-11
found O 0 4.29245658115085e-12
in O 0 2.202553027116916e-12
six O 0 9.967433779387025e-13
of O 0 3.0947269876266e-15
eight O 0 5.59565089576497e-13
unrelated O 0 6.645741595923127e-11
patients O 0 1.1223704604601537e-10
studied O 0 6.120172424406434e-11
, O 0 7.627544971501588e-13
an O 0 1.8994356055460765e-13
allele O 0 4.105728645953377e-09
frequency O 0 8.228817627298213e-09
of O 0 9.007788959181084e-11
37 O 0 2.532238241315099e-08
. O 0 5.070427966380464e-10

5 O 0 1.6591017448774892e-09
% O 0 2.0240861070552896e-11
, O 0 2.9861234470372755e-13
which O 0 9.19541271468885e-14
is O 0 1.575164965909176e-13
considerably O 0 5.383366530331557e-10
higher O 0 2.0008444553965e-11
than O 0 1.7744916050877607e-13
those O 0 5.429946721207876e-14
in O 0 1.828879658393595e-13
other O 0 2.470150006848165e-13
Asian O 0 1.3755839349538501e-11
populations O 0 2.996533576826721e-11
. O 0 7.636577481484608e-11

The O 0 2.3873684279474006e-11
novel O 0 3.8062528823212816e-11
single O 0 6.43025953664389e-12
nucleotide O 0 3.1139901768284517e-10
deletion O 0 6.381649653164345e-10
, O 0 2.4083367678590095e-12
2304delC O 0 1.8593360184837593e-09
, O 0 4.662751088013728e-12
was O 0 2.862402259662389e-10
found O 0 3.3539296340201474e-11
in O 0 9.65902271360397e-12
one O 0 2.0846126908002915e-11
patient O 0 2.152211520112246e-09
. O 0 2.906994610307745e-11

Since O 0 5.549826709305705e-10
a O 0 1.6885668210897542e-11
mutation O 0 7.985712091596042e-11
at O 0 7.02674637226286e-12
cDNA O 0 9.872843653724317e-10
nucleotide O 0 8.148102637051124e-09
2302 O 0 5.935357876296621e-07
( O 0 2.190375485155993e-11
2302insC O 0 2.825710498921552e-10
) O 0 6.03829323781585e-13
had O 0 2.8615053035419002e-11
been O 0 1.794882493501293e-12
previously O 0 5.068614365028035e-12
described O 0 1.1814927508568829e-11
, O 0 6.794486983674811e-14
this O 0 6.731328903699036e-15
region O 0 6.659210400987436e-13
of O 0 2.092528827621863e-14
the O 0 2.0248639733249502e-13
ATP7B O 0 1.774465729909025e-08
gene O 0 8.633317394313167e-10
may O 0 5.338335884452761e-10
be O 0 3.671182715464516e-12
susceptible O 0 6.375910466260848e-09
to O 0 6.7580971201131046e-12
gene O 0 3.840958981982112e-07
rearrangements O 0 2.8771291908924468e-06
causing O 0 1.2096701595964987e-07
Wilson B-Disease 0 1.1158386996612535e-06
disease I-Disease 0 8.835260814521462e-05
. O 0 2.5720059415590413e-09

Disruption O 0 2.6852475798477826e-07
of O 0 2.723111883554119e-12
splicing O 0 9.529563804733243e-10
regulated O 0 8.552447638976446e-11
by O 0 4.701632421062751e-13
a O 0 1.8578806895708233e-11
CUG O 0 3.6260121305531356e-07
- O 0 6.198522251033012e-10
binding O 0 8.381226823672705e-10
protein O 0 1.1703898294967985e-08
in O 0 7.501317789149198e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.0808182793198284e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.992993175983429
DM B-Disease 1 1.0
) O 0 3.3718092762313745e-09
is O 0 4.985732313111946e-12
caused O 0 2.8104801472195184e-12
by O 0 6.385569292300178e-14
a O 0 9.796152604379937e-12
CTG O 0 5.550528481279571e-09
expansion O 0 2.182955725904545e-11
in O 0 3.128592176993017e-11
the O 0 3.604043495933351e-12
3 O 0 2.052254546858201e-11
untranslated O 0 1.5091467631123123e-08
region O 0 1.3005205246052753e-10
of O 0 6.204192975339806e-12
the O 0 4.396267794248843e-09
DM B-Disease 1 1.0
gene O 0 5.031156291579464e-08
. O 0 5.69426006347129e-10

One O 0 1.072416461189718e-10
model O 0 5.893219245933778e-10
of O 0 4.174741455309494e-11
DM B-Disease 1 1.0
pathogenesis O 0 1.6104667821537078e-08
suggests O 0 3.0675358086984517e-11
that O 0 4.890824141620849e-14
RNAs O 0 2.2136739663558558e-10
from O 0 7.584096653641403e-13
the O 0 2.5311827964559844e-14
expanded O 0 1.5655631088393185e-12
allele O 0 9.108513249200811e-11
create O 0 9.13493347805272e-13
a O 0 8.326867841079721e-12
gain O 0 1.4181125607137801e-08
- O 0 6.264284091450634e-10
of O 0 3.8440804359107794e-12
- O 0 2.5773538858686607e-09
function O 0 2.0679786008614975e-12
mutation O 0 1.4447945877876789e-12
by O 0 3.8091522259553826e-14
the O 0 1.1965774237340104e-13
inappropriate O 0 1.604595796511621e-11
binding O 0 5.676640798049637e-13
of O 0 9.544000484395295e-15
proteins O 0 1.7397585108658298e-13
to O 0 9.75198329207505e-13
the O 0 1.439272399178515e-11
CUG O 0 5.351395770958334e-07
repeats O 0 1.5630153171741767e-08
. O 0 3.41137784687362e-10

Data O 0 4.6482488968990765e-09
presented O 0 1.1225118057289762e-10
here O 0 4.305931305959021e-11
indicate O 0 3.4790375441628996e-11
that O 0 2.3774054556599533e-13
the O 0 1.0396460710555833e-13
conserved O 0 1.5376451847903816e-11
heterogeneous O 0 3.560983799499873e-11
nuclear O 0 1.0076866008290608e-09
ribonucleoprotein O 0 1.3619606775705506e-08
, O 0 3.5669366765800348e-12
CUG O 0 4.017019605839778e-09
- O 0 7.150417757895156e-11
binding O 0 6.422528481264678e-11
protein O 0 2.7984423112137335e-10
( O 0 6.255441910990589e-12
CUG O 0 5.140927328284306e-08
- O 0 1.3352836614188845e-09
BP O 0 4.546008014472136e-08
) O 0 4.626516184047524e-13
, O 0 3.104733809454474e-13
may O 0 1.658970183449071e-11
mediate O 0 1.8077442320851844e-10
the O 0 7.724863500604973e-13
trans O 0 3.225292255493173e-09
- O 0 2.1254056292718815e-09
dominant O 0 4.739367120976112e-09
effect O 0 4.016006693863261e-10
of O 0 4.5067752698149666e-13
the O 0 2.401666972934313e-12
RNA O 0 1.6022791982095441e-09
. O 0 3.209927809666446e-11

CUG O 0 0.0003790322516579181
- O 0 4.0794748201733455e-05
BP O 0 3.5504676816344727e-06
was O 0 1.6675365255292007e-10
found O 0 1.7967903640642158e-12
to O 0 1.5036603418557698e-14
bind O 0 2.8062001507234147e-12
to O 0 9.126882328245114e-14
the O 0 3.141205557385257e-13
human O 0 4.10158400299121e-11
cardiac O 0 1.9663118564494653e-06
troponin O 0 8.557482260584948e-07
T O 0 5.342772624317149e-08
( O 0 5.9722981768373096e-12
cTNT O 0 1.8166065873792547e-10
) O 0 4.81775752105007e-13
pre O 0 1.308321007087443e-09
- O 0 4.891319016486761e-10
messenger O 0 3.506539780762097e-10
RNA O 0 3.6896907751327035e-10
and O 0 1.4553988439761079e-12
regulate O 0 7.983180089210506e-12
its O 0 1.079405011553125e-12
alternative O 0 2.0927087840405534e-10
splicing O 0 7.887029340736262e-08
. O 0 1.9797361527906787e-09

Splicing O 0 9.797123112775807e-08
of O 0 2.196349525862562e-11
cTNT O 0 1.9852160804134655e-08
was O 0 9.255998745238969e-10
disrupted O 0 1.5361122507329128e-07
in O 0 1.539974903153052e-08
DM B-Disease 1 1.0
striated O 0 9.816620831770706e-07
muscle O 0 7.026759476502775e-07
and O 0 3.740644252681058e-11
in O 0 3.1310919568899864e-12
normal O 0 5.552280163412249e-11
cells O 0 2.44191906279001e-11
expressing O 0 2.352390851556585e-12
transcripts O 0 1.9696111408507022e-10
that O 0 3.015669040439678e-13
contain O 0 9.649563093017122e-11
CUG O 0 5.439790129457833e-07
repeats O 0 5.323618523789264e-08
. O 0 6.607574487560441e-10

Altered O 0 1.0065676292470016e-07
expression O 0 4.341021708764714e-10
of O 0 5.511536322819199e-13
genes O 0 2.130705611946837e-10
regulated O 0 1.0364012981156634e-09
posttranscriptionally O 0 4.1605328071625536e-09
by O 0 3.2430345301565078e-12
CUG O 0 2.8996037144679576e-06
- O 0 1.843432251291688e-08
BP O 0 5.0058865497248917e-08
therefore O 0 1.2587532578767213e-11
may O 0 2.3823965369929034e-11
contribute O 0 1.4993229097495786e-12
to O 0 1.7119981821078767e-10
DM B-Disease 1 1.0
pathogenesis O 0 4.5729589004395166e-08
. O 0 2.86744968047703e-11
. O 0 6.942025426726062e-11

Identification O 0 1.2937594329187618e-09
of O 0 4.230696468068146e-13
a O 0 6.918229010499655e-12
novel O 0 5.844013051259367e-10
nonsense O 0 4.237570010445779e-06
mutation O 0 1.6886683162908867e-09
and O 0 7.720905512154097e-12
a O 0 4.566281814472051e-12
missense O 0 6.931342166893728e-09
substitution O 0 8.743263751886943e-11
in O 0 5.0606155550803056e-12
the O 0 1.3196470825815876e-12
vasopressin O 0 1.2316023756397954e-09
- O 0 6.593527945852884e-09
neurophysin O 0 9.269734846384381e-08
II O 0 1.1389265086592104e-09
gene O 0 3.0278579643550074e-10
in O 0 8.892641831237391e-12
two O 0 7.450880732708109e-13
Spanish O 0 4.0274053536570875e-10
kindreds O 0 8.59509228234856e-08
with O 0 1.9777914028740184e-10
familial B-Disease 1 0.9080010056495667
neurohypophyseal I-Disease 1 0.9983446598052979
diabetes I-Disease 1 0.9999978542327881
insipidus I-Disease 1 0.981543779373169
. O 0 8.389023520294359e-08

Familial B-Disease 1 0.999998927116394
neurohypophyseal I-Disease 1 0.999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999978542327881
( O 0 2.006388058362063e-05
FNDI B-Disease 1 1.0
) O 0 1.8113648081463651e-10
is O 0 5.3111933254190724e-12
an O 0 1.8630427062182875e-12
autosomal B-Disease 1 0.9998524188995361
dominant I-Disease 1 0.999996542930603
disease I-Disease 1 0.9999997615814209
caused O 0 1.5298098787752679e-06
by O 0 1.8205791318948172e-09
deficiency O 1 0.9954989552497864
in O 0 1.811059809064819e-11
the O 0 3.63814837631149e-12
antidiuretic O 0 1.0022532137554663e-07
hormone O 0 4.625122507206925e-09
arginine O 0 6.494202953177819e-09
vasopressin O 0 4.156051502945957e-09
( O 0 4.432806205434403e-11
AVP O 0 6.787561179777413e-09
) O 0 1.7207887675549371e-13
encoded O 0 3.2145028826258137e-12
by O 0 3.397399007086521e-13
the O 0 4.842062081150678e-12
AVP O 0 2.1142247987882e-06
- O 0 8.674140516973239e-09
neurophysin O 0 2.480979048868903e-07
II O 0 9.039397674825977e-09
( O 0 3.259021871815371e-11
AVP O 0 1.7880716995932744e-07
- O 0 2.4912814033939412e-09
NPII O 0 4.930364383426422e-08
) O 0 3.001806051991518e-12
gene O 0 7.820585845585981e-10
on O 0 4.137502285228578e-10
chromosome O 0 6.823694320701179e-07
20p13 O 0 2.928832998350117e-07
. O 0 6.786806672209877e-10

In O 0 3.795554148755542e-10
this O 0 4.571377456262515e-13
study O 0 2.8992945739526876e-13
, O 0 4.242799552444873e-14
we O 0 3.0193455022439405e-14
analyzed O 0 4.4526730393068537e-13
two O 0 1.688612526987588e-14
families O 0 6.249461262071779e-14
with O 0 4.179021359648413e-14
FNDI B-Disease 1 0.9999819993972778
using O 0 9.957742096167177e-13
direct O 0 1.4992007635328264e-11
automated O 0 6.282115272426836e-09
fluorescent O 0 1.7366919013994675e-09
, O 0 7.253288941688751e-11
solid O 0 6.330396207232525e-09
phase O 0 2.3140624832995726e-11
, O 0 4.1267691846223753e-13
single O 0 4.9160441342732675e-12
- O 0 1.892387080371094e-10
stranded O 0 1.1728872040261962e-10
DNA O 0 1.509346120309729e-11
sequencing O 0 5.479203462471771e-12
of O 0 1.7360689708728616e-13
PCR O 0 1.593882537065383e-08
- O 0 1.7466944557398278e-09
amplified O 0 2.9171467019750708e-08
AVP O 0 1.0022243941421038e-06
- O 0 4.230713113173579e-09
NPII O 0 1.3710575785808032e-07
DNA O 0 1.4332642628289705e-08
. O 0 2.0074815421100567e-10

In O 0 1.9921821137192097e-10
one O 0 6.501972896720554e-13
of O 0 3.641225233656786e-15
the O 0 4.632553631607646e-14
families O 0 3.4683998837055363e-13
, O 0 1.2191373161918404e-14
affected O 0 7.894379594475254e-14
individuals O 0 2.7308579388703874e-15
presented O 0 2.0361961899570402e-13
a O 0 1.0810449757592266e-12
novel O 0 1.4396135672445354e-10
nonsense O 0 2.357496242666457e-07
mutation O 0 3.046360386171898e-10
in O 0 8.68893065136822e-12
exon O 0 1.6732012997344725e-10
3 O 0 2.262664665006464e-12
of O 0 1.677377481975207e-14
the O 0 1.479372180313021e-13
gene O 0 3.959779726336876e-11
, O 0 1.1835915277383369e-13
consisting O 0 2.3634067454285888e-14
in O 0 3.2571746948900637e-12
a O 0 1.9118327754252817e-10
G O 0 1.0964684804548597e-07
to O 0 3.278292567965302e-11
T O 0 2.468084403517423e-07
transition O 0 2.2681058420293e-11
at O 0 1.3448287622397359e-11
nucleotide O 0 1.6565490645881198e-10
2101 O 0 2.1095334368226304e-09
, O 0 2.2998080219729933e-13
which O 0 4.485847525143201e-14
produces O 0 7.621712505914702e-13
a O 0 7.031895031539559e-12
stop O 0 1.5517090945493806e-09
signal O 0 8.166123421915472e-08
in O 0 9.58721102506388e-10
codon O 0 1.4176474216753832e-08
82 O 0 2.29770702464549e-10
( O 0 2.4244091109681953e-11
Glu O 0 3.043041729711149e-08
) O 0 5.4469432436698995e-12
of O 0 2.1793103346240406e-12
NPII O 0 1.2998121974305832e-06
. O 0 2.9689314895442465e-10

The O 0 5.00926244928479e-10
premature O 0 1.5823507837353645e-08
termination O 0 3.122244962572296e-10
eliminates O 0 1.2671270976927218e-10
part O 0 1.762531418557367e-12
of O 0 2.0630283641348904e-14
the O 0 5.267909589448672e-13
C O 0 2.0245678911123832e-08
- O 0 5.334251790278799e-11
terminal O 0 6.163610594134283e-11
domain O 0 6.0261587386811755e-12
of O 0 2.334923399104679e-14
NPII O 0 1.0969862795917606e-09
, O 0 1.226989565722772e-14
including O 0 2.8485828130445263e-15
a O 0 4.29414940021286e-13
cysteine O 0 4.983842852301912e-11
residue O 0 2.3961377326742195e-10
in O 0 2.9509849967281065e-13
position O 0 2.5277161006670434e-12
85 O 0 2.796410292996848e-13
, O 0 3.1819615979632523e-14
which O 0 4.437020141492137e-14
could O 0 3.255387279188504e-11
be O 0 4.20650927285271e-13
involved O 0 6.377137858580573e-13
in O 0 2.068625652718037e-12
the O 0 2.3733111829959963e-12
correct O 0 7.717265049222988e-09
folding O 0 5.628861959872111e-11
of O 0 1.5297717248768244e-13
the O 0 1.6526001053729367e-11
prohormone O 0 9.732641501614125e-07
. O 0 4.891860250211266e-10

In O 0 2.003060217692365e-10
the O 0 8.860113706078698e-13
second O 0 6.042824660795754e-12
family O 0 3.081690501741119e-12
, O 0 6.338886257258383e-14
a O 0 2.1512467100661542e-13
G279A O 0 4.539961462324271e-11
substitution O 0 2.450283465710301e-12
at O 0 4.061381439490752e-12
position O 0 9.381705481925628e-12
- O 0 1.527886497876274e-11
1 O 0 1.0385640372874427e-13
of O 0 4.55763441445595e-15
the O 0 6.052970624725873e-14
signal O 0 5.2266500155662143e-11
peptide O 0 9.771515194212377e-13
was O 0 3.234040856295306e-12
observed O 0 1.2219688965125347e-13
in O 0 1.3883479869220006e-13
all O 0 5.731055414308697e-14
affected O 0 1.2494023827677725e-12
individuals O 0 2.1811140404632418e-13
. O 0 1.9120068375788613e-11

This O 0 2.0932275357488095e-10
missense O 0 2.714396032388322e-07
mutation O 0 9.260382682896307e-09
, O 0 2.717748075198312e-11
which O 0 2.7023137200155034e-11
replaces O 0 1.1564878832359682e-07
Ala O 0 1.711171194074268e-06
with O 0 1.7501642496364767e-11
Thr O 0 0.00018247809202875942
, O 0 2.524759221134154e-11
is O 0 5.794556457924815e-13
frequent O 0 3.5656255725768915e-11
among O 0 1.386587650253901e-10
FNDI B-Disease 1 1.0
patients O 0 1.8168722704103857e-07
and O 0 1.3700399321969758e-12
is O 0 6.098955026992772e-14
thought O 0 3.2143801509398884e-12
to O 0 7.460290794413654e-14
reduce O 0 1.9055837637005357e-12
the O 0 3.6169401891952835e-13
efficiency O 0 6.267647859048431e-12
of O 0 2.120411796992759e-14
cleavage O 0 1.4173809348427824e-10
by O 0 1.0120382179859555e-12
signal O 0 1.2855958964053116e-08
peptidases O 0 1.976704027129017e-07
. O 0 1.9798548217542233e-11
. O 0 3.887251631695676e-11

Genetic O 0 4.2946848566316476e-07
heterogeneity O 0 3.927082303789575e-08
of O 0 2.3125491105391305e-11
Saethre B-Disease 0 0.2614205479621887
- I-Disease 1 0.9999992847442627
Chotzen I-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
, O 0 7.647126855359065e-12
due O 0 4.475058778402596e-12
to O 0 2.031061516888366e-12
TWIST O 0 4.0607901041767036e-07
and O 0 1.0280417628294458e-09
FGFR O 0 1.2497348507167771e-06
mutations O 0 6.848580369478441e-08
. O 0 4.877252490764761e-10

Thirty O 0 1.5435074374181568e-07
- O 0 1.5940443631734524e-07
two O 0 4.9457347939263485e-12
unrelated O 0 4.5169973317271683e-10
patients O 0 9.300057945971218e-11
with O 0 5.8752246570961154e-15
features O 0 1.851519155007808e-12
of O 0 7.950809607047693e-13
Saethre B-Disease 1 0.9772266149520874
- I-Disease 1 0.9999786615371704
Chotzen I-Disease 1 0.9999979734420776
syndrome I-Disease 1 1.0
, O 0 1.0942616170822594e-12
a O 0 6.015398248959691e-12
common O 0 6.342772085332626e-09
autosomal B-Disease 0 0.054185640066862106
dominant I-Disease 0 0.008004955016076565
condition I-Disease 1 0.936601459980011
of O 0 1.3441472934694332e-10
craniosynostosis B-Disease 0 0.05347117781639099
and O 0 1.4560736616431313e-08
limb B-Disease 1 0.5100527405738831
anomalies I-Disease 0 0.0001288874918827787
, O 0 9.701008225893037e-12
were O 0 6.7604953753186425e-12
screened O 0 1.7275034180919135e-10
for O 0 2.828920095138826e-13
mutations O 0 5.662793498006913e-11
in O 0 1.9778846963025565e-11
TWIST O 0 4.702541289702822e-08
, O 0 1.658868875598074e-11
FGFR2 O 0 8.863499090239202e-08
, O 0 8.511450225179296e-12
and O 0 4.3095960827743696e-11
FGFR3 O 0 1.0370492873335024e-06
. O 0 3.676595972113006e-10

Nine O 0 3.15746051526844e-09
novel O 0 6.201325009058678e-10
and O 0 2.8873552854191686e-11
three O 0 1.558056201417246e-12
recurrent O 0 1.381599545879908e-08
TWIST O 0 2.0410000445281185e-07
mutations O 0 2.122533482307176e-09
were O 0 1.6162134131025852e-10
found O 0 3.4863844450283565e-11
in O 0 8.540477353102816e-12
12 O 0 5.92210438674079e-12
families O 0 2.374719127937186e-12
. O 0 8.926323222246957e-12

Seven O 0 8.990881650294824e-11
families O 0 1.5111542659568267e-12
were O 0 2.095557343102794e-13
found O 0 8.211926147763671e-14
to O 0 4.548012543691615e-15
have O 0 9.048362374034641e-14
the O 0 1.0426566294380324e-13
FGFR3 O 0 4.745990977994552e-08
P250R O 0 4.664152952749134e-10
mutation O 0 2.5016398674804208e-11
, O 0 4.930728676917628e-13
and O 0 2.0315566178104316e-13
one O 0 1.8642033039863518e-14
individual O 0 4.937046729552516e-15
was O 0 9.999948785699431e-11
found O 0 3.464487594376231e-12
to O 0 1.1220562104235707e-13
have O 0 1.1151992957564305e-12
an O 0 2.4973038502580647e-13
FGFR2 O 0 1.745340654224492e-07
VV269 O 0 2.921004949030248e-08
- O 0 4.236527129108936e-09
270 O 0 6.65883959083402e-10
deletion O 0 1.1411040645725734e-07
. O 0 1.3352760008800146e-09

To O 0 7.195648937807775e-11
date O 0 5.170344152816142e-10
, O 0 5.314362231528813e-13
our O 0 4.2600168184692144e-13
detection O 0 6.740644847846866e-11
rate O 0 5.653566156893497e-11
for O 0 4.604215297324306e-14
TWIST O 0 1.2112714165013472e-09
or O 0 1.8733675721804843e-10
FGFR O 0 7.289470005389376e-08
mutations O 0 3.1041638703932506e-10
is O 0 1.1134820279354307e-12
68 O 0 9.153830471397839e-11
% O 0 1.5333479928478222e-12
in O 0 4.371219098492363e-12
our O 0 2.18508558469388e-10
Saethre B-Disease 0 0.03468236327171326
- I-Disease 1 0.999920129776001
Chotzen I-Disease 1 0.9999934434890747
syndrome I-Disease 1 1.0
patients O 0 1.1737996175043008e-07
, O 0 1.0314630551587489e-13
including O 0 6.048549790367563e-14
our O 0 2.3160395042770565e-12
five O 0 4.458638861760955e-13
patients O 0 8.877862854583807e-12
elsewhere O 0 2.103745302961535e-11
reported O 0 1.0290579499638852e-09
with O 0 1.9401830402693276e-12
TWIST O 0 1.1362535587977618e-06
mutations O 0 2.035402104638706e-07
. O 0 1.1235103958284753e-09

More O 0 4.4819377376104086e-11
than O 0 1.8853382396932794e-12
35 O 0 1.8542474413546506e-12
different O 0 9.101952454541526e-14
TWIST O 0 4.922093399528649e-09
mutations O 0 9.24445589522982e-11
are O 0 5.987316762171013e-13
now O 0 8.70684329756094e-13
known O 0 8.882974108885555e-13
in O 0 4.219666283056256e-12
the O 0 6.035725847071405e-13
literature O 0 1.205437555329425e-10
. O 0 7.113010874748582e-11

The O 0 1.2285697632841153e-11
most O 0 4.717837990934892e-13
common O 0 1.4234725594433617e-12
phenotypic O 0 1.8979273014307907e-11
features O 0 5.717522375686679e-12
, O 0 8.752147769540419e-13
present O 0 7.673476789963121e-14
in O 0 4.231917333924473e-12
more O 0 1.5539064718121665e-13
than O 0 1.0572757404812838e-13
a O 0 7.734726487768073e-13
third O 0 1.8032185120087085e-11
of O 0 1.8645019678035536e-14
our O 0 5.29897046380734e-12
patients O 0 2.6461001358807357e-12
with O 0 3.6503016999063845e-14
TWIST O 0 2.3295701367942456e-08
mutations O 0 9.63018775834712e-10
, O 0 4.161716977979513e-12
are O 0 5.113843918637395e-13
coronal B-Disease 0 1.5693602861688305e-08
synostosis I-Disease 0 1.3886503893445479e-06
, O 0 9.61715013181319e-11
brachycephaly B-Disease 0 1.62667629410862e-06
, O 0 4.1309411447087996e-10
low B-Disease 0 0.0018949727527797222
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 0 8.748593849361441e-09
facial B-Disease 1 0.9939193725585938
asymmetry I-Disease 0 9.750355093274266e-05
, O 0 4.17070245006812e-09
ptosis B-Disease 0 0.04706636816263199
, O 0 4.698842981376572e-10
hypertelorism B-Disease 0 3.47545174008701e-05
, O 0 2.372611829226656e-10
broad B-Disease 0 1.513667058361534e-08
great I-Disease 0 9.673196927906247e-07
toes I-Disease 1 0.9665259122848511
, O 0 4.914902165809032e-11
and O 0 3.37988040333137e-11
clinodactyly B-Disease 0 1.9431797682045726e-07
. O 0 2.538623755654612e-10

Significant O 0 2.1106815850657767e-08
intra O 0 0.0005656804423779249
- O 0 2.769929778878577e-05
and O 0 1.1909098707185706e-10
interfamilial O 0 2.0582318072115413e-08
phenotypic O 0 7.362883192030267e-09
variability O 0 2.7244357880817915e-09
is O 0 7.73727924178319e-13
present O 0 1.0649260065356131e-13
for O 0 4.423348690910274e-14
either O 0 4.331252023703769e-11
TWIST O 0 5.877509465790354e-07
mutations O 0 7.781297739484216e-08
or O 0 1.0090411173280245e-08
FGFR O 0 3.0793960377195617e-06
mutations O 0 2.3750847333303682e-07
. O 0 1.5931979069350177e-09

The O 0 2.1312979159304746e-11
overlap O 0 3.7568625987915993e-10
in O 0 7.152460481524292e-12
clinical O 0 4.1582279286522805e-11
features O 0 2.4150570866049437e-12
and O 0 2.0443421261395756e-12
the O 0 5.633138744419279e-14
presence O 0 5.872163866271762e-12
, O 0 6.349634359970047e-13
in O 0 1.4206807930593202e-13
the O 0 1.588951308040005e-14
same O 0 2.1343629717351237e-13
genes O 0 6.388194660755797e-12
, O 0 1.3543568935618644e-13
of O 0 2.0879427794871916e-15
mutations O 0 6.703890372515564e-13
for O 0 1.5743321969967534e-14
more O 0 1.2974679585386027e-14
than O 0 9.578144213092527e-14
one O 0 2.5698640264415484e-12
craniosynostotic B-Disease 0 6.891131647535076e-07
condition I-Disease 0 6.292353305070719e-07
- O 0 2.1214505846467446e-11
such O 0 2.8921860024087864e-13
as O 0 1.30600348244303e-11
Saethre B-Disease 0 1.084038991905345e-08
- I-Disease 0 8.86213880058051e-10
Chotzen I-Disease 0 4.504137507410633e-09
, I-Disease 0 1.1487883127409004e-12
Crouzon I-Disease 0 9.964273850471272e-10
, I-Disease 0 7.89531797145554e-13
and I-Disease 0 1.3512901735068805e-11
Pfeiffer I-Disease 0 0.0016328939236700535
syndromes I-Disease 0 7.727828688075533e-07
- O 0 5.880865239227262e-11
support O 0 1.4836164252424872e-13
the O 0 6.548791863609724e-14
hypothesis O 0 3.456032985835189e-12
that O 0 8.27825899192905e-14
TWIST O 0 1.1040938163731084e-09
and O 0 2.8798682188968527e-12
FGFRs O 0 8.967897952016912e-11
are O 0 1.636540837741951e-14
components O 0 8.210489579885127e-13
of O 0 9.92490421275374e-16
the O 0 1.412684683452627e-14
same O 0 2.070744563233834e-13
molecular O 0 1.17247216709776e-12
pathway O 0 1.1885259486657529e-12
involved O 0 4.293559865281571e-13
in O 0 3.3711851669601667e-13
the O 0 1.547567954861273e-13
modulation O 0 7.686423025843325e-11
of O 0 2.3413924878784576e-12
craniofacial O 0 1.6739695638534613e-06
and O 0 3.983667007378955e-10
limb O 0 1.306027456848824e-06
development O 0 1.9335122045105457e-11
in O 0 1.4934983805225954e-11
humans O 0 9.512034909731071e-11
. O 0 1.0219020941948376e-11
. O 0 7.834272813811438e-11

Mutation O 0 1.0231853764253174e-07
analysis O 0 1.788692638449163e-09
of O 0 3.4507719598453335e-11
UBE3A O 0 0.003217574441805482
in O 0 0.0002240528992842883
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0003829709021374583
. O 0 4.278510434829741e-09

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0003368334728293121
AS B-Disease 1 1.0
) O 0 1.4982289714415842e-11
is O 0 8.696054943843623e-13
caused O 0 7.043318185628866e-12
by O 0 5.427464575859242e-13
chromosome O 0 9.985245696952916e-07
15q11 O 0 1.7567998611411895e-07
- O 0 1.2856547826345377e-08
q13 O 0 5.552857729185234e-09
deletions O 0 2.246083319334957e-09
of O 0 4.866502708623932e-13
maternal O 0 2.291457440461997e-10
origin O 0 6.7834613794170995e-12
, O 0 4.364318964816122e-13
by O 0 7.669632073534216e-13
paternal O 0 1.2717582364984992e-07
uniparental B-Disease 0 4.8433601477881894e-05
disomy I-Disease 0 7.476875907741487e-06
( O 0 4.139177445239284e-09
UPD B-Disease 1 0.9999998807907104
) O 0 3.113756821826463e-11
15 O 0 3.5443599010615e-12
, O 0 4.2213442078909216e-14
by O 0 4.98727090441492e-13
imprinting O 0 0.03448198735713959
defects O 1 0.9880691170692444
, O 0 2.3928103422277136e-12
and O 0 1.928585736206065e-13
by O 0 1.2417329534400445e-13
mutations O 0 3.884718380309238e-10
in O 0 1.0594691790544175e-11
the O 0 2.5543044242237745e-12
UBE3A O 0 1.9310536458760907e-07
gene O 0 1.8915372379524342e-08
. O 0 5.126342128569661e-10

UBE3A O 0 1.7824013411882333e-05
encodes O 0 1.374843705548301e-08
a O 0 8.107679111413191e-11
ubiquitin O 0 1.1262781818288659e-09
- O 0 7.932386969500271e-10
protein O 0 1.2888280720435574e-10
ligase O 0 4.365482697554768e-10
and O 0 3.4211028107633545e-12
shows O 0 1.9893230118750438e-10
brain O 0 1.4438135167438304e-06
- O 0 3.764762279701017e-09
specific O 0 2.955428124451487e-10
imprinting O 0 6.518466761917807e-07
. O 0 1.1445251413277902e-09

Here O 0 5.149894732880966e-09
we O 0 1.980765204634416e-11
describe O 0 7.406143753829753e-11
UBE3A O 0 7.580599685752532e-07
coding O 0 3.8950506109358685e-07
- O 0 1.523968506944584e-08
region O 0 1.710768415819075e-09
mutations O 0 2.771815132973643e-08
detected O 0 2.4182367219793832e-09
by O 0 6.771978268947654e-13
SSCP O 0 3.6443212891867915e-09
analysis O 0 7.003905701935542e-12
in O 0 7.667969557922927e-12
13 O 0 1.7018849871042185e-11
AS B-Disease 1 0.9969667792320251
individuals O 0 2.0169274778970847e-13
or O 0 8.316456030776909e-12
families O 0 5.880502682020783e-12
. O 0 2.1974096153787315e-11

Two O 0 3.0263624939408373e-10
identical O 0 8.089764969021473e-10
de O 0 7.282601188762783e-09
novo O 0 2.8390354955831754e-08
5 O 0 2.648077035427576e-10
- O 0 4.971913103446468e-09
bp O 0 1.604968602464396e-08
duplications O 0 5.887582421593152e-09
in O 0 4.373122697298726e-11
exon O 0 1.9789132554848265e-09
16 O 0 4.976746792451081e-11
were O 0 2.9449602478859305e-11
found O 0 8.516325838980876e-11
. O 0 2.2461669677009688e-11

Among O 0 5.863862867494518e-11
the O 0 5.00119693921941e-13
other O 0 3.285788524945432e-13
11 O 0 5.003315470264447e-13
unique O 0 2.7653706690007607e-13
mutations O 0 5.540836678363803e-10
, O 0 2.087541077500088e-11
8 O 0 2.8449055177598437e-12
were O 0 3.642293931738205e-12
small O 0 2.0667562713322374e-12
deletions O 0 2.3020201300738563e-09
or O 0 1.0837216540826589e-10
insertions O 0 1.5300352984581878e-08
predicted O 0 7.526713474703683e-09
to O 0 2.8900924622238255e-12
cause O 0 6.216340775466733e-10
frameshifts O 0 1.5775465271872235e-06
, O 0 1.0298737557201676e-11
1 O 0 2.8417166623301293e-12
was O 0 3.8056016671284e-10
a O 0 3.256255291447796e-12
mutation O 0 1.4089330396815924e-11
to O 0 3.954733947004324e-13
a O 0 1.1302324527673324e-11
stop O 0 2.5383864454830984e-10
codon O 0 8.14242895330608e-10
, O 0 3.2340761470760204e-13
1 O 0 5.092566451002367e-13
was O 0 6.269085944810016e-11
a O 0 3.2458872829127516e-12
missense O 0 2.7752747655540588e-08
mutation O 0 2.071146587567796e-10
, O 0 6.510787568803078e-12
and O 0 4.51601950279823e-12
1 O 0 4.088764483239915e-12
was O 0 2.0885069229592546e-09
predicted O 0 2.716288027837521e-10
to O 0 1.5450255007667946e-13
cause O 0 1.0569461972309568e-11
insertion O 0 5.0706862320115675e-11
of O 0 3.113682272085083e-13
an O 0 1.2346846635369335e-11
isoleucine O 0 2.4534736553505354e-07
in O 0 2.623911071059082e-12
the O 0 6.309878292608262e-13
hect O 0 1.4443284346299379e-09
domain O 0 6.523640568717459e-12
of O 0 2.771489262317229e-14
the O 0 2.2712117830978734e-13
UBE3A O 0 2.1952166751049162e-09
protein O 0 5.308957787275581e-11
, O 0 2.8865427301009994e-13
which O 0 2.5955161346460746e-14
functions O 0 1.792045786937202e-13
in O 0 9.030194669280844e-13
E2 O 0 1.1019605228312912e-09
binding O 0 2.3092918202682888e-11
and O 0 8.465953632574852e-12
ubiquitin O 0 8.11153089141925e-11
transfer O 0 9.490071228857033e-11
. O 0 1.528012577578508e-10

Eight O 0 5.08391717612966e-10
of O 0 2.362951380516145e-14
the O 0 4.318344049318232e-14
cases O 0 4.734939111801506e-13
were O 0 6.341456439823423e-12
familial O 0 1.745632083327564e-09
, O 0 9.060633320012723e-12
and O 0 2.6132490268948594e-11
five O 0 6.228345530295831e-12
were O 0 8.31251109612019e-11
sporadic O 0 1.1636147689841891e-07
. O 0 2.4369745110774943e-10

In O 0 1.1958976031678503e-09
two O 0 1.8619069827585655e-11
familial O 0 6.963372101154164e-08
cases O 0 1.3219315642132301e-09
and O 0 1.7271434282761788e-11
one O 0 5.2652600161795515e-12
sporadic O 0 2.691136273824668e-07
case O 0 1.889390865983387e-09
, O 0 3.3823807470134692e-12
mosaicism O 0 9.433792413915398e-09
for O 0 1.4965687109708137e-12
UBE3A O 0 5.8240782863094864e-08
mutations O 0 1.8195931428266476e-09
was O 0 6.276599379129166e-11
detected O 0 2.1420457074761146e-10
in O 0 2.3152753585858887e-12
the O 0 1.144339614386758e-13
mother O 0 2.5060969965906565e-10
of O 0 3.832996881046949e-15
three O 0 3.955339094446897e-12
AS B-Disease 1 1.0
sons O 0 2.0600442185436663e-10
, O 0 3.200954109519767e-14
in O 0 7.477871132640507e-14
the O 0 1.3644378053616346e-13
maternal O 0 2.738970994453638e-10
grandfather O 0 1.994539394756245e-10
of O 0 1.4466518057803558e-14
two O 0 1.967968106184048e-12
AS B-Disease 1 1.0
first O 0 9.64885398142823e-13
cousins O 0 2.388367281724868e-10
, O 0 8.685243415304869e-14
and O 0 2.296113332019706e-13
in O 0 3.778057294095971e-12
the O 0 1.186575685797886e-12
mother O 0 1.3558386413592416e-08
of O 0 7.316972819738227e-14
an O 0 3.545294613438443e-11
AS B-Disease 1 1.0
daughter O 0 0.00013306387700140476
. O 0 4.428523936450546e-10

The O 0 2.5454251553758134e-11
frequencies O 0 1.3042840418808765e-10
with O 0 1.486806283559211e-13
which O 0 3.698069140408572e-13
we O 0 1.870195404790609e-12
detected O 0 6.734424823351404e-11
mutations O 0 1.198805898300348e-11
were O 0 5.963590732349644e-12
5 O 0 1.0197845714578213e-13
( O 0 7.087971702623985e-14
14 O 0 1.04481866409524e-13
% O 0 6.858809310436587e-14
) O 0 1.7386298225229545e-14
of O 0 1.9022262741754184e-14
35 O 0 5.754885717274005e-12
in O 0 1.9516218068699187e-12
sporadic O 0 2.6716506340562773e-07
cases O 0 1.5518562823668702e-10
and O 0 4.400371560187022e-12
8 O 0 4.8465691095817e-13
( O 0 5.218623181702832e-14
80 O 0 1.309696573198113e-13
% O 0 2.135299451361608e-13
) O 0 9.007948060428886e-14
of O 0 8.4813314140883e-14
10 O 0 1.1831699899336745e-12
in O 0 5.8524842957985435e-12
familial O 0 2.1256784776824134e-08
cases O 0 3.299522322031123e-10
. O 0 7.643160410131244e-12
. O 0 1.1282858675132346e-10

The O 0 2.0822552571075903e-08
hemochromatosis B-Disease 1 1.0
845 O 0 8.690387289789214e-07
G O 0 1.5933908059651003e-07
- O 0 8.8617371218902e-09
- O 0 9.235300524323975e-09
> O 0 9.752699342557847e-11
A O 0 4.010934813447609e-12
and O 0 3.542837139110244e-13
187 O 0 7.87605571039851e-12
C O 0 1.2846270713851027e-09
- O 0 4.1734141142946157e-10
- O 0 6.914348205100396e-09
> O 0 6.777725602979956e-10
G O 0 2.5939490555515476e-09
mutations O 0 9.33744193076791e-10
: O 0 1.2687339243436235e-12
prevalence O 0 1.5567597211330053e-10
in O 0 3.920398727874641e-12
non O 0 1.8602662521516322e-08
- O 0 2.622985739719752e-08
Caucasian O 0 4.249526597277509e-08
populations O 0 1.8713686156246467e-09
. O 0 5.387743029494629e-10

Hemochromatosis B-Disease 1 0.9918997287750244
, O 0 6.604071733917749e-10
the O 0 2.11946585282341e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 2.7294143507827773e-12
iron I-Disease 0 1.842821075115353e-05
metabolism I-Disease 0 8.023378654797853e-07
, O 0 5.731932398340966e-13
leads O 0 1.6950099093401838e-12
, O 0 9.839779815598582e-13
if O 0 5.320504106731683e-11
untreated O 0 9.126664934910877e-08
, O 0 8.612400072618986e-13
to O 0 3.221770289787984e-12
progressive O 0 1.1671307476035508e-08
iron B-Disease 1 0.9996558427810669
overload I-Disease 1 0.644220769405365
and O 0 1.0126856153647168e-07
premature B-Disease 0 5.081445806354168e-07
death I-Disease 0 4.698923472545857e-10
. O 0 6.580028188984954e-11

The O 0 3.76961217796179e-09
hemochromatosis B-Disease 1 1.0
gene O 0 3.765985212567102e-08
, O 0 3.778837312506944e-11
HFE O 0 2.2240031682940753e-07
, O 0 2.9649897988204277e-12
recently O 0 1.7877366254026583e-10
has O 0 3.4116782207486984e-13
been O 0 4.713358609659268e-13
identified O 0 1.8901097700863012e-11
, O 0 5.436931693704114e-14
and O 0 4.933171723225417e-14
characterization O 0 9.08340503508187e-12
of O 0 4.235722507467269e-15
this O 0 8.851984900290488e-14
gene O 0 2.4385538727189626e-11
has O 0 1.5394344870037213e-12
shown O 0 5.986483010700372e-13
that O 0 1.0716889208743988e-13
it O 0 3.528464819586505e-14
contains O 0 5.984593127729117e-15
two O 0 3.3085337312714624e-14
mutations O 0 3.4138020101742717e-12
that O 0 6.370059102596415e-14
result O 0 8.113085398810116e-13
in O 0 2.207019072705818e-12
amino O 0 7.374762259204637e-12
acid O 0 3.1172911474364184e-12
substitutions O 0 1.3950307055365929e-11
- O 0 1.2437158074252164e-11
cDNA O 0 1.7328329049437485e-10
nucleotides O 0 1.2406843330481365e-09
845 O 0 5.273951497741791e-09
G O 0 6.758107407023317e-09
- O 0 1.7823038600539576e-09
- O 0 7.679528124526769e-09
> O 0 2.0893903274199488e-10
A O 0 2.0194354868885434e-11
( O 0 2.2548453989384987e-12
C282Y O 0 3.926447361690677e-11
) O 0 1.8564395693984083e-14
and O 0 5.4130914431838734e-14
187 O 0 4.657089384269009e-12
C O 0 2.4050994529289937e-09
- O 0 1.4501418954537826e-09
- O 0 2.0780019482913303e-08
> O 0 1.8018827541155247e-09
G O 0 9.058745753520725e-09
( O 0 1.8342403984572542e-11
H63D O 0 8.134069418019862e-08
) O 0 2.3703218207660193e-11
. O 0 7.189050049705159e-11

Although O 0 1.1790574490078143e-06
hemochromatosis B-Disease 1 1.0
is O 0 1.5443768486278486e-10
common O 0 4.2394331101203164e-11
in O 0 2.0010390913705045e-11
Caucasians O 0 7.97053729684194e-08
, O 0 3.2714696836938506e-12
affecting O 0 6.485642578546447e-11
> O 0 1.0885298912244323e-10
= O 0 1.0700524494255959e-10
1 O 0 1.1646694025868598e-11
/ O 0 1.46484757657106e-09
300 O 0 3.0783993518364305e-13
individuals O 0 1.1196996292390377e-14
of O 0 1.040855367288884e-15
northern O 0 1.1035805515952068e-12
European O 0 1.7857319789538195e-11
origin O 0 1.4633401912086952e-12
, O 0 1.9148966266813172e-12
it O 0 3.8377558509578025e-13
has O 0 4.089448235339993e-13
not O 0 2.1414502658113899e-13
been O 0 5.111309053958124e-13
recognized O 0 7.572658862822768e-14
in O 0 8.254297852866577e-13
other O 0 3.102259389046319e-13
populations O 0 3.1484589241292937e-12
. O 0 3.586770810914963e-11

The O 0 1.3005670325416663e-11
present O 0 1.0799486305224093e-12
study O 0 6.247256265903486e-14
used O 0 2.0282888324625603e-13
PCR O 0 3.9381270466876117e-10
and O 0 2.0494008237410127e-13
restriction O 0 2.9995925882042584e-11
- O 0 1.97264773960093e-11
enzyme O 0 4.1692510555080275e-11
digestion O 0 3.1082622586886544e-11
to O 0 9.140958660575765e-14
analyze O 0 6.127492610530361e-12
the O 0 2.2944805235479426e-13
frequency O 0 1.6215667697494496e-11
of O 0 2.446628579529271e-14
the O 0 3.9266753368814855e-13
845 O 0 9.746265600130144e-11
G O 0 1.5392923047308216e-10
- O 0 4.289635313625695e-11
- O 0 3.7287287146803294e-10
> O 0 1.6308190908809195e-11
A O 0 1.483263598750506e-12
and O 0 4.934077777428436e-13
187 O 0 1.343715850393723e-11
C O 0 1.632180723909471e-09
- O 0 6.412115283183084e-10
- O 0 4.724087787622011e-09
> O 0 1.3078220728601764e-09
G O 0 2.069315385710979e-09
mutations O 0 1.3447787328146887e-09
in O 0 7.010912683735882e-11
HLA O 0 2.3766135726077664e-08
- O 0 7.231972659615948e-11
typed O 0 1.6688571358169924e-10
samples O 0 3.147366265179863e-12
from O 0 2.8037695862931367e-13
non O 0 1.3758337524816255e-10
- O 0 3.8879430230842615e-10
Caucasian O 0 2.3142754379534836e-10
populations O 0 2.2791282749956565e-12
, O 0 4.492851809990636e-14
comprising O 0 4.654057087633001e-14
Australian O 0 1.0182302050132375e-12
Aboriginal O 0 2.048960393713495e-12
, O 0 3.5252626962327047e-14
Chinese O 0 6.276159062942877e-14
, O 0 2.0194834845187193e-13
and O 0 5.710043440680657e-13
Pacific O 0 3.6538810171959923e-11
Islanders O 0 6.213365377760738e-10
. O 0 2.9177320282069985e-11

Results O 0 6.205635116884878e-09
showed O 0 4.3474351896222174e-10
that O 0 4.8877748230107335e-14
the O 0 1.1846010554861924e-13
845 O 0 1.9862479716525883e-10
G O 0 7.063734042134229e-10
- O 0 2.6925089935403435e-10
- O 0 1.8155543735076662e-09
> O 0 7.12733830288137e-11
A O 0 1.1708167421686788e-11
mutation O 0 8.117923000483529e-11
was O 0 2.2259609433472605e-10
present O 0 5.606480584690113e-14
in O 0 1.4232792190909532e-13
these O 0 8.723955700906411e-15
populations O 0 2.2044472909425739e-13
( O 0 1.439325953344825e-13
allele O 0 3.914916307801164e-11
frequency O 0 3.58896766472494e-11
0 O 0 3.643737059039892e-13
. O 0 2.7588842262159588e-14
32 O 0 5.615462522062797e-13
% O 0 6.838248771488115e-14
) O 0 2.4315137848052865e-14
, O 0 7.551153712731518e-14
and O 0 3.750713661095778e-13
, O 0 7.945044361995501e-14
furthermore O 0 5.078821477960682e-13
, O 0 1.4014189927882142e-13
it O 0 2.5534179805275503e-12
was O 0 1.0310054143758407e-08
always O 0 1.9483125182628847e-11
seen O 0 4.130724408357711e-12
in O 0 1.2485799612098336e-13
conjunction O 0 6.81137058648057e-13
with O 0 3.1513129779281446e-12
HLA O 0 6.823636766739583e-08
haplotypes O 0 2.4796760200729295e-09
common O 0 3.8675518343467274e-10
in O 0 8.857098388048712e-11
Caucasians O 0 2.2462133486556013e-08
, O 0 1.1759883431633478e-12
suggesting O 0 2.6855679138848565e-11
that O 0 2.1944672099448448e-13
845 O 0 2.2528744147987112e-10
G O 0 7.312049299379453e-10
- O 0 4.812493181738375e-10
- O 0 4.534272068923428e-09
> O 0 1.0504411923628609e-10
A O 0 4.56166146522996e-11
may O 0 2.83520124044756e-10
have O 0 6.606732305333707e-13
been O 0 5.767354909619327e-13
introduced O 0 3.91873707962509e-13
into O 0 2.4965073004744667e-14
these O 0 6.97646955599685e-15
populations O 0 3.827994304460465e-14
by O 0 4.103974376046954e-13
Caucasian O 0 6.374280658860698e-09
admixture O 0 1.5450596890786983e-07
. O 0 1.2411766059372553e-09

187 O 0 2.2841026847686408e-08
C O 0 1.1415829703764757e-07
- O 0 7.370512644655491e-09
- O 0 9.430121572506778e-09
> O 0 4.19129092543713e-10
G O 0 2.997449788377793e-10
was O 0 4.916681645150689e-12
present O 0 4.174289155978693e-14
at O 0 1.8369635240017557e-12
an O 0 3.4336896254918634e-14
allele O 0 2.647208563466563e-10
frequency O 0 6.665905050162735e-10
of O 0 1.1392185805814137e-11
2 O 0 2.3136266513734682e-10
. O 0 2.5690088945040657e-10

68 O 0 9.028302088154305e-07
% O 0 2.419988931467998e-10
in O 0 8.64918033027795e-12
the O 0 7.31768432741392e-14
two O 0 1.0485439149972645e-13
populations O 0 3.975486389737326e-13
analyzed O 0 2.0976590256460703e-11
( O 0 1.8534093530753193e-12
Australian O 0 2.8556386422184943e-11
Aboriginal O 0 3.904744236282731e-11
and O 0 2.2121818266107596e-12
Chinese O 0 1.4313544923968968e-12
) O 0 1.7481217211637312e-12
. O 0 1.8852851571549145e-11

In O 0 1.2775915048113262e-10
the O 0 7.29607238340868e-13
Australian O 0 4.583043146377808e-12
Aboriginal O 0 1.4701915899972828e-12
samples O 0 3.526938940554003e-13
, O 0 2.7602630264474994e-14
187 O 0 2.0424441218164224e-12
C O 0 2.415382338583072e-10
- O 0 1.768588053785436e-10
- O 0 2.034996615662976e-09
> O 0 2.2006403643803907e-10
G O 0 5.515372603071e-10
was O 0 3.0118553484559385e-11
found O 0 1.1622367564884106e-12
to O 0 2.65655011010002e-14
be O 0 3.967015450401061e-14
associated O 0 6.715433873046017e-13
with O 0 9.046399697051899e-13
HLA O 0 2.7975804783864078e-08
haplotypes O 0 4.968763733792514e-10
common O 0 2.3583175343122598e-11
in O 0 7.056267029015295e-12
Caucasians O 0 1.3086953742913465e-09
, O 0 3.36476126908819e-13
suggesting O 0 3.516765698097224e-11
that O 0 5.790898901895936e-13
it O 0 1.8345054208362965e-12
was O 0 5.150370754880562e-11
introduced O 0 7.047304905437313e-13
by O 0 4.2243162770962475e-14
recent O 0 1.7679293792816075e-11
admixture O 0 1.3232767770432474e-08
. O 0 6.585769707356803e-10

In O 0 1.9917792415391489e-10
the O 0 4.007186021805914e-13
Chinese O 0 3.082723692201389e-13
samples O 0 1.742765003490132e-12
analyzed O 0 2.6744132082534566e-12
, O 0 3.116913533372269e-14
187 O 0 1.6207157144121354e-12
C O 0 1.4917794777247195e-10
- O 0 1.080658548757718e-10
- O 0 9.8488261990326e-10
> O 0 7.859806555599036e-11
G O 0 3.7202113611911614e-10
was O 0 3.185646538228504e-11
present O 0 1.4027642166337256e-13
in O 0 1.3580934987711402e-11
association O 0 1.4120611147375173e-12
with O 0 4.909533405359802e-15
a O 0 1.678162274941497e-13
wide O 0 7.513947146778333e-13
variety O 0 2.7780707421987128e-12
of O 0 3.133970134187175e-13
HLA O 0 2.794416475992989e-09
haplotypes O 0 2.7592053641889436e-10
, O 0 8.207921104938509e-13
showing O 0 2.7143289352271616e-11
this O 0 9.885731014173949e-14
mutation O 0 3.4133204075692536e-12
to O 0 6.86612564222179e-14
be O 0 2.0968926736034815e-13
widespread O 0 4.655453540031163e-13
and O 0 5.366896597275295e-12
likely O 0 2.2126555795920488e-11
to O 0 6.923026605112903e-14
predate O 0 1.0396040972526777e-10
the O 0 4.402575377285452e-14
more O 0 8.739416254479465e-14
genetically O 0 2.323628962852542e-11
restricted O 0 3.656732555645803e-11
845 O 0 6.373790939484536e-10
G O 0 6.565617383103017e-09
- O 0 6.999669732721259e-09
- O 0 5.3420901480194516e-08
> O 0 2.3326147680080567e-09
A O 0 3.192497100013014e-10
mutation O 0 1.7511954553128817e-08
. O 0 8.504870141479159e-10

Genotype O 1 0.9982580542564392
- O 1 0.9992469549179077
phenotype O 0 0.0005807182169519365
correlations O 0 0.00010739481513155624
in O 0 1.0947784403469996e-06
attenuated B-Disease 1 0.9999117851257324
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999984502792358
coli I-Disease 1 1.0
. O 0 5.800166036351584e-07

Germ O 0 0.0003180986677762121
- O 0 0.0002624742337502539
line O 0 1.6740010266858008e-08
mutations O 0 2.6887843063150285e-09
of O 0 2.191409624293164e-13
the O 0 1.2527694810346435e-12
tumor B-Disease 0 1.0729990407298828e-07
suppressor O 0 5.720183935409295e-07
APC O 0 1.2430726670231707e-08
are O 0 1.2415400305054725e-11
implicated O 0 1.1096404683996752e-08
in O 0 6.597578483535926e-09
attenuated B-Disease 1 0.9998997449874878
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.00014804641250520945
AAPC B-Disease 1 1.0
) O 0 2.6386637319575357e-10
, O 0 2.5132988138582e-12
a O 0 9.064781911205522e-12
variant O 0 0.00036915173404850066
of O 0 8.664785156042853e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.96402833252796e-06
FAP B-Disease 0 1.0732190276030451e-05
) O 0 3.611232868294678e-09
. O 0 1.0429810348711044e-09

AAPC B-Disease 1 0.9999998807907104
is O 0 4.443483081484345e-10
recognized O 0 2.0397850075681845e-12
by O 0 8.353648312366471e-14
the O 0 1.5384122740904477e-13
occurrence O 0 8.329588407907096e-11
of O 0 3.023179037837942e-13
< O 0 3.625083344616087e-09
100 O 0 2.2652554745178355e-12
colonic B-Disease 0 7.704763049787289e-09
adenomas I-Disease 0 1.1842853382404428e-06
and O 0 1.5414185552953263e-11
a O 0 1.2544845370832114e-11
later O 0 2.958631950544799e-10
onset O 0 7.637359544787614e-07
of O 0 3.346567112316734e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.5630614857986558e-10
age O 0 2.1183625686926888e-10
> O 0 1.3848379387670917e-10
40 O 0 1.324681336845046e-11
years O 0 8.792275067726063e-12
) O 0 1.9321397780325267e-12
. O 0 2.7891368034604902e-11

The O 0 7.793521904220224e-12
aim O 0 2.2277436839690523e-11
of O 0 2.367846553324917e-14
this O 0 5.339303015016762e-14
study O 0 1.4360462417730563e-13
was O 0 1.3325293993227127e-11
to O 0 5.283455964399941e-13
assess O 0 7.115931732748493e-10
genotype O 0 2.0449876956263324e-06
- O 0 3.5845675938617205e-07
phenotype O 0 2.398536764758319e-07
correlations O 0 5.317712066243985e-07
in O 0 2.016459355047573e-08
AAPC B-Disease 1 0.9999996423721313
families O 0 6.928288609486799e-09
. O 0 3.7344299874675357e-10

By O 0 2.181840298709492e-11
protein O 0 4.103881234840401e-09
- O 0 3.787326452453499e-09
truncation O 0 5.392392310454852e-09
test O 0 5.849031259330673e-10
( O 0 1.983425576557174e-12
PTT O 0 3.6904224121059315e-10
) O 0 5.980032278824626e-14
assay O 0 8.114359011102135e-12
, O 0 1.6846750096289817e-14
the O 0 3.214019719786107e-15
entire O 0 4.460067840224291e-13
coding O 0 1.6932408253289566e-10
region O 0 4.878075374192825e-12
of O 0 5.716371928761455e-14
the O 0 7.592679198038799e-13
APC B-Disease 0 5.7467829106538915e-11
gene O 0 1.1751062622966657e-10
was O 0 7.685001246482415e-11
screened O 0 1.320413778316265e-10
in O 0 1.8218130996838777e-12
affected O 0 2.836269196934693e-12
individuals O 0 1.8289379342603662e-14
from O 0 2.267347767870298e-12
11 O 0 2.6940910613504343e-10
AAPC B-Disease 1 0.9999997615814209
kindreds O 0 4.6476529291794577e-07
, O 0 2.014273123296384e-11
and O 0 5.045886126466004e-13
their O 0 1.710819528578933e-14
phenotypic O 0 4.083123769649255e-11
differences O 0 1.5429252320231512e-10
were O 0 1.4926454516839271e-09
examined O 0 3.2216416201436004e-08
. O 0 8.950945540320276e-11

Five O 0 3.121405356409923e-10
novel O 0 2.780883301412018e-10
germ O 0 4.8380743464804254e-06
- O 0 7.106402790668653e-07
line O 0 1.0772065017761179e-08
APC B-Disease 0 2.58911470041312e-09
mutations O 0 2.8280344732678486e-10
were O 0 5.826780724582648e-11
identified O 0 5.854064455412811e-10
in O 0 1.628329589220545e-11
seven O 0 5.342692954712902e-11
kindreds O 0 3.0137368867144687e-07
. O 0 7.093735043817162e-10

Mutations O 0 1.0243413584021255e-07
were O 0 2.661414144622398e-10
located O 0 9.15051021066482e-12
in O 0 2.8333498741650587e-12
three O 0 5.264391082348413e-14
different O 0 3.156296160848268e-14
regions O 0 4.5205671346006115e-13
of O 0 6.009050949971201e-14
the O 0 9.338122722996056e-13
APC B-Disease 0 5.011668163801275e-11
gene O 0 4.7696870758562326e-11
( O 0 9.315422782110727e-13
1 O 0 4.917823418458533e-13
) O 0 9.408090490469964e-14
at O 0 1.2726609696644964e-11
the O 0 5.271889695623866e-13
5 O 0 6.821515574628734e-12
end O 0 4.2775921693660734e-11
spanning O 0 3.556436048435252e-11
exons O 0 1.9160309450150237e-10
4 O 0 3.082213954549995e-12
and O 0 2.173167028274303e-12
5 O 0 1.1256364763900795e-12
, O 0 9.397191141555239e-13
( O 0 3.0244017468379625e-13
2 O 0 1.896141663820794e-13
) O 0 3.989795215671339e-14
within O 0 4.513131947152249e-13
exon O 0 3.57068402623284e-10
9 O 0 1.3309907342939908e-10
, O 0 2.580192786857949e-12
and O 0 6.4314001173293445e-12
( O 0 1.972759846105565e-12
3 O 0 1.125460510377485e-12
) O 0 2.225745087368336e-13
at O 0 2.1923275694835098e-11
the O 0 8.870919407030775e-13
3 O 0 1.1366574348414815e-11
distal O 0 3.2719740250541918e-09
end O 0 9.362390862577286e-10
of O 0 2.2386285262587097e-13
the O 0 2.5838619438500743e-12
gene O 0 5.771041866609039e-09
. O 0 3.708139628688656e-10

Variability O 0 2.5529075742269924e-07
in O 0 9.000112460855192e-11
the O 0 8.877079843774838e-13
number O 0 2.501357411130445e-12
of O 0 5.186819862501579e-10
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.150015527251469e-09
most O 0 1.1288007610880599e-13
apparent O 0 3.600841630077567e-12
in O 0 6.645506627628306e-13
individuals O 0 3.5872031663468015e-14
with O 0 1.3043940114230296e-13
mutations O 0 1.5651080431666742e-10
in O 0 1.2973807791971659e-11
region O 0 7.633315507460381e-11
1 O 0 4.0407066581593654e-11
, O 0 7.863056560031279e-12
and O 0 1.1165882107810887e-10
upper O 1 0.5778213143348694
- O 0 0.01621318981051445
gastrointestinal O 0 1.7679611119092442e-05
manifestations O 0 6.061708024418522e-09
were O 0 5.710074080234051e-10
more O 0 3.140560077621868e-12
severe O 0 1.850442643558381e-08
in O 0 5.674478248396397e-12
them O 0 5.415617173459841e-12
. O 0 3.249828878226779e-11

In O 0 9.537796247238717e-11
individuals O 0 9.747072940435864e-13
with O 0 1.681125670529443e-13
mutations O 0 4.690297802922849e-11
in O 0 3.6087690995223465e-12
either O 0 1.2778980131022966e-11
region O 0 2.2194490689741997e-10
2 O 0 1.0774596492790778e-11
or O 0 1.265443722031634e-10
region O 0 1.7759503589953596e-10
3 O 0 5.524318849592369e-11
, O 0 1.0912270436216898e-12
the O 0 8.168950406525419e-14
average O 0 4.80618669862487e-12
number O 0 2.5051121387790337e-14
of O 0 1.673389312046355e-14
adenomas B-Disease 0 5.9296407783904215e-09
tended O 0 3.836493622788595e-11
to O 0 1.0943800526170763e-13
be O 0 1.9855037752813942e-12
lower O 0 5.40810486671095e-11
than O 0 6.49580893631943e-14
those O 0 1.0711917464156784e-14
in O 0 7.77400604827505e-14
individuals O 0 1.7178299120635884e-14
with O 0 4.12726324199985e-14
mutations O 0 4.183015392400513e-11
in O 0 4.302957296031806e-12
region O 0 2.954964398171889e-11
1 O 0 4.475895348798886e-12
, O 0 1.4030860891536823e-12
although O 0 2.415643726716432e-11
age O 0 8.209558727267918e-11
at O 0 4.225329808260625e-11
diagnosis O 0 2.206514260194581e-08
was O 0 7.196431645040136e-11
similar O 0 2.6200116728936074e-11
. O 0 2.2957970247095005e-10

In O 0 6.5787171266151745e-09
all O 0 3.767712530855505e-10
AAPC B-Disease 1 0.9999998807907104
kindreds O 0 1.2340246939857025e-06
, O 0 8.829179574953994e-12
a O 0 5.236206433723023e-12
predominance O 0 4.293109867603562e-09
of O 0 7.552083090833772e-12
right O 1 0.5721873641014099
- O 1 0.9999997615814209
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 4.1579335174901644e-07
rectal B-Disease 1 0.9993415474891663
polyp I-Disease 0 9.566243534209207e-06
sparing O 0 1.4671188708348382e-08
was O 0 7.506724131189912e-10
observed O 0 1.4632524358848542e-10
. O 0 4.113672943950597e-11

No O 0 5.889966203653785e-08
desmoid B-Disease 0 0.001443266635760665
tumors I-Disease 1 1.0
were O 0 4.371417450244053e-09
found O 0 1.0946948902912368e-10
in O 0 3.3678062508896156e-12
these O 0 1.9945640191559866e-12
kindreds O 0 7.898862008914875e-08
. O 0 1.8124465817059843e-10

Our O 0 1.1978945613222436e-10
data O 0 2.184996975018727e-11
suggest O 0 2.342929019197304e-12
that O 0 1.1230904037708503e-13
, O 0 9.426111150304117e-13
in O 0 3.0291172348206885e-10
AAPC B-Disease 1 1.0
families O 0 1.7394681181559513e-11
, O 0 2.5145379214160796e-14
the O 0 1.936571427307507e-15
location O 0 4.4291081761384243e-13
of O 0 2.848557232649519e-14
the O 0 9.783959233067296e-12
APC B-Disease 0 2.3104540503027238e-08
mutation O 0 2.8017066444618877e-09
may O 0 7.037402882659194e-10
partially O 0 8.73000394197021e-10
predict O 0 3.494908251688855e-10
specific O 0 2.123628703443181e-11
phenotypic O 0 1.1689374801449048e-08
expression O 0 1.249164327532526e-08
. O 0 1.7757649795058228e-09

This O 0 1.0685141139943344e-11
should O 0 3.2610285999323807e-12
help O 0 1.213107739261865e-12
in O 0 7.730744213188534e-13
the O 0 4.924015635878777e-14
design O 0 4.810242482111704e-11
of O 0 3.0987568739281046e-14
tailored O 0 1.2979860519735098e-09
clinical O 0 2.5065395092838116e-08
- O 0 2.794881837075991e-08
management O 0 4.70185501644238e-10
protocols O 0 4.452804791554854e-11
in O 0 1.7748640285340095e-13
this O 0 1.6734563970557774e-14
subset O 0 4.141524796719143e-12
of O 0 2.2193016738572546e-13
FAP B-Disease 0 3.9842844579141e-09
patients O 0 3.464228681693271e-09
. O 0 5.209697690605752e-12
. O 0 5.837214739345953e-11

Wilms B-Disease 0 0.16158466041088104
' I-Disease 0 7.31245279439463e-07
tumor I-Disease 0 3.17992714826687e-07
1 O 0 8.194352141277506e-11
and O 0 3.06148613404833e-11
Dax O 1 0.9999016523361206
- O 0 1.341249000752498e-09
1 O 0 9.679530614536969e-12
modulate O 0 2.36968689115713e-09
the O 0 1.073918298039045e-11
orphan O 0 1.2414140826422226e-08
nuclear O 0 6.370047822557012e-10
receptor O 0 7.056220052703566e-10
SF O 0 1.2169291494501522e-06
- O 0 8.654453265144468e-10
1 O 0 2.9178974774585198e-12
in O 0 2.224600495134843e-12
sex O 0 1.3642784124634488e-10
- O 0 1.2277077791889024e-11
specific O 0 4.956784115106583e-12
gene O 0 2.2717103753677748e-09
expression O 0 1.833095009118324e-09
. O 0 5.770818822803392e-10

Products O 0 5.0034046239488816e-08
of O 0 6.94671056788998e-12
steroidogenic O 0 2.0206529427468922e-07
factor O 0 2.1575369268944655e-10
1 O 0 1.2871937023206659e-11
( O 0 2.6688958335019386e-11
SF O 0 0.00011419096699682996
- O 0 8.752149227575501e-09
1 O 0 2.2878837713236067e-11
) O 0 4.5024218728317855e-12
and O 0 2.4626831129914706e-10
Wilms B-Disease 0 8.099450496956706e-06
tumor I-Disease 0 1.438067727121961e-07
1 O 0 3.316828409150041e-11
( O 0 6.88358571532266e-12
WT1 O 0 4.265733544173145e-09
) O 0 4.377658175194754e-13
genes O 0 1.1681110939631978e-11
are O 0 1.4960228151769672e-13
essential O 0 2.9311507648149826e-12
for O 0 3.659245351389853e-14
mammalian O 0 9.278690316083527e-11
gonadogenesis O 0 1.0196523625438658e-09
prior O 0 2.575272460558775e-11
to O 0 1.6734676795346348e-12
sexual O 0 5.1511864218589665e-11
differentiation O 0 1.8474087815079088e-09
. O 0 1.553337042325964e-10

In O 0 1.9540932760797602e-10
males O 0 9.396752820300946e-11
, O 0 5.441616341556044e-12
SF O 0 4.350384551798925e-05
- O 0 4.780311702035078e-09
1 O 0 5.026571173183392e-12
participates O 0 1.3879118123880096e-12
in O 0 5.61968386322137e-13
sexual O 0 7.932344559848092e-13
development O 0 1.8659747886922394e-14
by O 0 8.69737326592273e-15
regulating O 0 4.505608559857155e-12
expression O 0 1.0977548080617905e-12
of O 0 5.650083723232396e-15
the O 0 1.8301427539245407e-13
polypeptide O 0 1.0506441272539746e-09
hormone O 0 1.0647814574493708e-10
Mullerian O 0 7.9491417892541e-09
inhibiting O 0 1.8995809369926064e-09
substance O 0 2.6771386885116044e-08
( O 0 4.0083231178655865e-10
MIS O 0 2.447292899887543e-06
) O 0 1.4258273728362525e-10
. O 0 1.1695630575125904e-10

Here O 0 1.1154951629066545e-08
, O 0 2.346318885709797e-12
we O 0 2.628016890476176e-13
show O 0 9.088356694823829e-13
that O 0 5.947139482265218e-13
WT1 O 0 8.80912580214499e-07
- O 0 1.5866666203123714e-08
KTS O 0 6.226278514986916e-07
isoforms O 0 1.3851926272678838e-09
associate O 0 1.643175040477729e-10
and O 0 9.075918727501076e-13
synergize O 0 2.3040365171311805e-09
with O 0 7.705280857805974e-12
SF O 0 0.0027874386869370937
- O 0 1.2719057806975798e-08
1 O 0 6.958513192739657e-12
to O 0 2.4283600304209063e-12
promote O 0 1.2141204708271403e-10
MIS O 0 1.9128908661514288e-06
expression O 0 1.9488572977621743e-09
. O 0 2.570611778995868e-10

In O 0 7.064986928817518e-10
contrast O 0 2.8840008159392028e-09
, O 0 1.866249238480222e-10
WT1 O 0 4.231783350405749e-06
missense O 0 2.772392008409952e-06
mutations O 0 9.078105023263561e-08
, O 0 5.104063005578752e-12
associated O 0 9.881838403114074e-12
with O 0 2.3804239829283702e-12
male B-Disease 0 2.239573859696975e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.128230036646528e-08
Denys B-Disease 1 0.9999938011169434
- I-Disease 1 0.9999994039535522
Drash I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
, O 0 1.0708262054848205e-10
fail O 0 1.5934812580553626e-08
to O 0 1.5906813626703764e-12
synergize O 0 1.3435206724921045e-08
with O 0 1.0168474395833016e-10
SF O 1 0.9997616410255432
- O 0 4.888666467195435e-07
1 O 0 3.1362296093462305e-10
. O 0 2.806459786786064e-10

Additionally O 0 7.403128776672929e-09
, O 0 1.501627641675718e-11
the O 0 8.145554001269539e-13
X O 0 3.748370716039062e-07
- O 0 7.733432738632473e-08
linked O 0 1.3903252238378627e-06
, O 0 2.3806932120118418e-11
candidate O 0 1.3298717682630468e-10
dosage O 0 3.5881552662431204e-07
- O 0 2.5138060522067462e-09
sensitive O 0 7.331631746154699e-09
sex O 0 5.349997111991911e-10
- O 0 6.012017966794403e-11
reversal O 0 1.0179709852842223e-10
gene O 0 9.667985162442605e-11
, O 0 6.5021499469353206e-12
Dax O 1 0.8768800497055054
- O 0 1.4340476028884552e-10
1 O 0 1.0577079576773452e-12
, O 0 3.273802940979148e-13
antagonizes O 0 5.820174342474616e-10
synergy O 0 2.6448362944186954e-10
between O 0 3.059448874798143e-11
SF O 0 0.00025434017879888415
- O 0 1.8812891244834873e-09
1 O 0 3.3949455659904038e-12
and O 0 2.6059657903809708e-12
WT1 O 0 3.561992478751108e-09
, O 0 2.305232014391395e-13
most O 0 6.378849949336199e-14
likely O 0 1.8200694857500865e-12
through O 0 2.4249555475078753e-14
a O 0 2.614024177238078e-13
direct O 0 1.1502748623395953e-12
interaction O 0 7.028811126880141e-12
with O 0 1.4414318696975847e-11
SF O 1 0.9664512872695923
- O 0 6.81581937556075e-08
1 O 0 3.511546053935888e-10
. O 0 2.3458157638600596e-10

We O 0 1.2251079040126456e-09
propose O 0 1.24927090894289e-09
that O 0 3.2719814271192638e-12
WT1 O 0 1.247524323844118e-07
and O 0 2.972302681758521e-10
Dax O 1 0.999995231628418
- O 0 5.6868714182201074e-09
1 O 0 3.748734829500666e-12
functionally O 0 6.545742420316358e-11
oppose O 0 2.9003303664981717e-12
each O 0 6.742588936183361e-14
other O 0 6.963275984463169e-13
in O 0 9.004950431157344e-12
testis O 0 4.313891188711949e-10
development O 0 1.1157738144876306e-12
by O 0 1.668906332574771e-12
modulating O 0 2.745003868653839e-08
SF O 0 2.4476044927723706e-05
- O 0 4.6106158890779625e-09
1 O 0 1.2452545938845816e-10
- O 0 1.2214259603737787e-09
mediated O 0 3.1149678392239366e-08
transactivation O 0 2.922326700627309e-07
. O 0 3.21654057555687e-11
. O 0 3.0142863899351724e-11

A O 0 5.351254994678811e-09
mouse O 0 1.1359293239365797e-07
model O 0 3.912665302863161e-09
for O 0 3.341513732380008e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 0 0.004127075895667076
- O 0 6.325796130113304e-05
centre O 0 4.407520748372917e-08
mutations O 0 2.556389233632217e-07
. O 0 1.1819063505669192e-09

Imprinting O 0 3.1729462079965742e-06
in O 0 5.642850076092998e-10
the O 0 8.451401037334882e-12
15q11 O 0 3.0014174257075865e-08
- O 0 8.481288560346911e-09
q13 O 0 5.227762223114496e-09
region O 0 5.592658280928475e-11
involves O 0 1.3643532484342025e-11
an O 0 1.3393909462436349e-12
imprinting O 0 2.7061435314834625e-09
centre O 0 1.4264067704772287e-10
( O 0 5.5857584183027775e-12
IC O 0 1.7203919400188283e-09
) O 0 2.4138221803304827e-13
, O 0 1.015049589520034e-13
mapping O 0 4.722684049385251e-12
in O 0 1.1027620873751975e-12
part O 0 1.0329618020318843e-12
to O 0 6.322756446013045e-13
the O 0 4.916022558650035e-13
promoter O 0 1.1381512399211147e-09
and O 0 1.0957556043078576e-11
first O 0 6.607680982234632e-12
exon O 0 7.797350543015114e-10
of O 0 1.2559545417567541e-11
SNRPN O 0 4.50085235570441e-06
. O 0 8.714332588866114e-10

Deletion O 0 7.381235889170057e-08
of O 0 4.716652415859279e-12
this O 0 7.665702274339825e-12
IC O 0 1.6386702839099598e-07
abolishes O 0 1.7356852621830399e-09
local O 0 1.4697437711319594e-11
paternally O 0 2.1084554102657194e-09
derived O 0 3.063080691867448e-11
gene O 0 2.1322586751804096e-10
expression O 0 2.162533346838913e-11
and O 0 2.920124428720805e-12
results O 0 1.693467033270224e-10
in O 0 8.04167939350009e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5340918935180525e-07
PWS B-Disease 1 0.9999998807907104
) O 0 3.1156075497307256e-09
. O 0 3.895603561954175e-10

We O 0 4.21987972343274e-10
have O 0 6.382479180583323e-13
created O 0 4.5467685064019825e-13
two O 0 3.8203302825910723e-13
deletion O 0 4.6291273592125037e-10
mutations O 0 1.7476700642227172e-10
in O 0 5.3475331801555726e-12
mice O 0 5.361809218840108e-09
to O 0 3.3111063803964447e-12
understand O 0 1.2260505499739338e-08
PWS B-Disease 1 1.0
and O 0 1.8178118732503634e-11
the O 0 3.1492500664545564e-13
mechanism O 0 1.4836519166006035e-11
of O 0 1.292358554156811e-13
this O 0 1.1484624883040251e-11
IC O 0 1.5318769897021411e-07
. O 0 1.2813106131659424e-10

Mice O 0 0.00031339016277343035
harbouring O 0 9.553096788295079e-06
an O 0 1.574482627608731e-10
intragenic O 0 2.2754109352263185e-07
deletion O 0 1.1292169865839696e-08
in O 0 1.418180763795851e-11
Snrpn O 0 8.960520325729249e-09
are O 0 1.83058017529103e-12
phenotypically O 0 1.649733682995702e-08
normal O 0 5.120615598208644e-10
, O 0 8.914747737752415e-13
suggesting O 0 5.758984261694522e-11
that O 0 2.762903295906727e-13
mutations O 0 2.7746143924090028e-11
of O 0 9.800870510133508e-14
SNRPN O 0 5.2749578038913114e-09
are O 0 1.0917552669201247e-13
not O 0 3.3031945776730576e-13
sufficient O 0 2.3351305698110503e-12
to O 0 3.365302177552043e-12
induce O 0 1.320309905850081e-07
PWS B-Disease 1 1.0
. O 0 7.277893843138372e-09

Mice O 0 2.4605067665106617e-05
with O 0 1.644083306995281e-11
a O 0 8.456802966239074e-12
larger O 0 1.261288729709209e-11
deletion O 0 1.1776219999148907e-09
involving O 0 7.45696993736944e-12
both O 0 1.3269319670827784e-11
Snrpn O 0 4.358723160180489e-08
and O 0 7.010828983328166e-12
the O 0 4.682814032375138e-12
putative O 0 1.9205172918645985e-07
PWS O 1 1.0
- O 0 1.4157175201034988e-06
IC O 0 1.5829793653665547e-07
lack O 0 5.221697726986996e-11
expression O 0 1.037784875396186e-11
of O 0 5.5623203525784204e-14
the O 0 5.498264604025804e-13
imprinted O 0 1.2569000285012066e-09
genes O 0 9.270309520026387e-10
Zfp127 O 0 8.553548980216874e-09
( O 0 1.7524490539266857e-11
mouse O 0 1.5077658233053626e-08
homologue O 0 5.747503806219356e-08
of O 0 1.1971881819228258e-11
ZNF127 O 0 5.405709657679836e-07
) O 0 2.7097251525942667e-11
, O 0 7.5626779144633e-12
Ndn O 0 1.6588526108307633e-08
and O 0 6.748646086407462e-11
Ipw O 0 1.9195942968508461e-07
, O 0 2.0723072563511025e-11
and O 0 1.3252827654741672e-11
manifest O 0 2.5010069015785064e-10
several O 0 8.924513146719992e-13
phenotypes O 0 8.006793561499137e-10
common O 0 1.0169876052401605e-09
to O 0 1.889582890157726e-08
PWS B-Disease 1 1.0
infants O 1 0.6445122361183167
. O 0 1.770272928247607e-09

These O 0 5.066468078407382e-12
data O 0 3.752168280940493e-12
demonstrate O 0 2.415332745007298e-13
that O 0 1.6565521605274233e-14
both O 0 3.9231174596898385e-14
the O 0 1.1572237309034894e-13
position O 0 1.269724776709058e-11
of O 0 9.936652771490393e-15
the O 0 2.0754457993790026e-13
IC O 0 2.5720354734914963e-09
and O 0 2.73418576191356e-13
its O 0 1.9981830792314796e-14
role O 0 8.586648644719197e-13
in O 0 1.8878921050156233e-13
the O 0 1.3332011445613568e-14
coordinate O 0 4.3162381221234503e-13
expression O 0 1.6029982246104635e-12
of O 0 3.6854417087561764e-14
genes O 0 9.640285965339945e-12
is O 0 1.2915527208921113e-13
conserved O 0 6.781943713216054e-13
between O 0 1.2270213057413715e-12
mouse O 0 2.1820587559062687e-09
and O 0 3.365160797588751e-12
human O 0 4.111590083157035e-13
, O 0 2.5016135538936946e-13
and O 0 2.52023879196428e-13
indicate O 0 6.78432787379335e-12
that O 0 2.636329231363397e-14
the O 0 3.4712243658901326e-14
mouse O 0 9.63024326949835e-10
is O 0 2.9899932356414194e-13
a O 0 1.6964903060915498e-13
suitable O 0 6.534673843705541e-12
model O 0 3.4996092829198133e-11
system O 0 7.185838729606431e-12
in O 0 1.3143443581761782e-12
which O 0 2.643057214063438e-13
to O 0 1.1618992172470616e-13
investigate O 0 8.083275260077627e-13
the O 0 8.980615154253937e-15
molecular O 0 6.128097703762825e-13
mechanisms O 0 1.2162167974116844e-12
of O 0 2.90837097243965e-14
imprinting O 0 4.440229572910681e-10
in O 0 1.7935144688840943e-11
this O 0 3.0395358539131445e-13
region O 0 4.736802096394488e-12
of O 0 5.532904592386173e-14
the O 0 1.198784181730833e-13
genome O 0 2.312892065370331e-12
. O 0 2.511679015812507e-12
. O 0 2.8377427144232747e-11

Mutations O 0 8.836052955984997e-08
of O 0 1.683295538547347e-12
the O 0 1.1356882231514098e-12
ATM O 0 6.913859706969561e-09
gene O 0 9.788000410182462e-10
detected O 0 5.005921899225996e-09
in O 0 1.4006248938436272e-10
Japanese O 0 3.311703403596766e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999861717224121
: O 0 2.554436046367514e-12
possible O 0 1.9482521065178338e-12
preponderance O 0 1.8801986634287005e-09
of O 0 7.956008356464761e-14
the O 0 2.987525049395756e-13
two O 0 2.021978287927717e-12
founder O 0 2.241165308891624e-10
mutations O 0 3.1104716580188096e-09
4612del165 O 0 1.298120455572871e-08
and O 0 1.0289749607927945e-10
7883del5 O 0 2.9184599625864394e-08
. O 0 3.521983260590389e-10

The O 0 3.309334056789126e-11
ATM O 0 1.2261561721516046e-07
( O 0 7.298713855519168e-10
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 8.494587672158715e-11
mutated O 0 1.3316346247904676e-08
) O 0 5.750573628393596e-12
gene O 0 2.1970755770261974e-10
on O 0 3.180461796703504e-11
human O 0 2.5188717431290364e-11
chromosome O 0 4.644130910946842e-07
11q22 O 0 3.0672364914607897e-07
. O 0 9.566057945775697e-10

3 O 0 3.6704388417518885e-09
has O 0 1.291430851146913e-11
recently O 0 3.904178022540172e-11
been O 0 2.6673626415257834e-12
identified O 0 1.3928769596049939e-11
as O 0 1.4301584818753738e-13
the O 0 4.794688443206328e-15
gene O 0 6.301066439451386e-12
responsible O 0 3.869862871992702e-13
for O 0 9.838699340371064e-15
the O 0 4.89217065295644e-13
human O 0 1.7602260760085642e-09
recessive B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.6773172616958618
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5126360164430253e-09
. O 0 4.485463389602984e-10

In O 0 1.6926951507123533e-10
order O 0 1.2546896030821153e-12
to O 0 1.0359663566448032e-13
define O 0 2.0884561441336658e-12
the O 0 7.35309640324637e-14
types O 0 4.4106843177793564e-11
of O 0 1.3222825612224653e-12
disease O 0 6.986493303884345e-07
- O 0 1.5158512667312607e-08
causing O 0 1.6045637041273153e-09
ATM O 0 8.977767862461405e-08
mutations O 0 4.5191947406486577e-10
in O 0 2.536428749325137e-12
Japanese O 0 2.0397492583867916e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 7.835978976800106e-06
as O 0 2.5524051188580144e-12
well O 0 4.699202723994211e-13
as O 0 1.6800165317069904e-13
to O 0 9.298695168892535e-14
look O 0 2.233086979219756e-11
for O 0 7.228718085271549e-15
possible O 0 5.332252651576996e-13
mutational O 0 2.4611770399474153e-09
hotspots O 0 1.6302019734126816e-09
, O 0 7.354492882749586e-12
reverse O 0 2.7506368294183403e-09
- O 0 3.005040105641399e-10
transcribed O 0 2.30420668656528e-10
RNA O 0 3.033973072774643e-11
derived O 0 1.2227155052335625e-12
from O 0 3.694424323755219e-13
ten O 0 2.943729027898856e-12
patients O 0 3.1991258600538863e-12
belonging O 0 3.3467516952212506e-12
to O 0 2.461674527415303e-13
eight O 0 9.291538892453044e-13
unrelated O 0 6.387418372000297e-11
Japanese O 0 2.2129754029265314e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
families O 0 2.1011958839523004e-10
was O 0 7.238541710474777e-11
analyzed O 0 5.699034993922325e-12
for O 0 1.695299174479803e-14
mutations O 0 1.3084863054180218e-12
by O 0 3.816031488739803e-14
the O 0 1.7336501158260464e-13
restriction O 0 1.4483829413602933e-10
endonuclease O 0 2.7820640013942466e-08
fingerprinting O 0 6.255320261772113e-09
method O 0 1.3009230359628532e-09
. O 0 3.777707868746205e-10

As O 0 6.712832512079103e-10
has O 0 3.756156843892633e-12
been O 0 5.704970458715597e-13
reported O 0 2.796475941438392e-12
by O 0 8.692033570223238e-15
others O 0 5.872287031638557e-12
, O 0 6.19374682293318e-14
mutations O 0 2.314162750316484e-12
that O 0 2.505768216618659e-13
lead O 0 4.7584536137790234e-12
to O 0 1.7884237927395796e-12
exon O 0 3.32677285719285e-09
skipping O 0 3.526006153720118e-08
or O 0 6.1074216795020675e-09
premature O 0 1.5659208374430023e-09
protein O 0 4.056916261263588e-11
truncation O 0 5.429646732224569e-10
were O 0 8.527280964676365e-11
also O 0 3.178847159460152e-12
predominant O 0 1.3518148822555531e-09
in O 0 1.1420190487720916e-10
our O 0 1.2305732821626947e-10
mutants O 0 8.921739791389882e-09
. O 0 3.0609270673664923e-10

Six O 0 1.3422436773158353e-10
different O 0 1.3550861821531868e-12
mutations O 0 2.9318738409278566e-11
were O 0 9.699878920910177e-12
identified O 0 7.980458655021394e-11
on O 0 3.1879745371332646e-11
12 O 0 1.926913706720712e-12
of O 0 2.82164394659664e-14
the O 0 2.9293178126221786e-12
16 O 0 3.776164103630464e-11
alleles O 0 1.72823588773241e-09
examined O 0 1.1155658086181575e-07
. O 0 6.442038569254294e-10

Four O 0 1.8016721448077533e-10
were O 0 8.544436859436733e-12
deletions O 0 3.4134672866059645e-10
involving O 0 1.878605083993623e-11
a O 0 6.074606789807646e-11
loss O 0 3.8533554125308456e-10
of O 0 2.0497163943358418e-14
a O 0 1.252997098438735e-11
single O 0 1.1802364641155805e-10
exon O 0 3.5406420018091467e-09
exon O 0 1.6137262193183233e-08
7 O 0 8.855481348213345e-10
, O 0 2.5012630855414386e-11
exon O 0 4.894737504201885e-09
16 O 0 1.9974633058694735e-10
, O 0 6.410763846859124e-12
exon O 0 6.311131173220019e-09
33 O 0 2.8452247224919347e-09
or O 0 2.0548103218942515e-09
exon O 0 1.168998124967402e-07
35 O 0 3.188277375443249e-08
. O 0 2.0252544086218904e-09

The O 0 2.2418738740426214e-11
others O 0 7.610633477594941e-12
were O 0 1.2957084407141939e-12
minute O 0 3.660129057475592e-12
deletions O 0 8.274392837570588e-10
, O 0 1.078717518955552e-12
4649delA O 0 1.0180389864444805e-10
in O 0 1.3057189877929698e-12
exon O 0 9.498515307626576e-10
33 O 0 1.1369073737999003e-10
and O 0 3.360440181329749e-12
7883del5 O 0 1.8183511363289995e-09
in O 0 4.3226772855620155e-11
exon O 0 2.521326969429083e-08
55 O 0 4.169589118419026e-09
. O 0 9.886260698976912e-10

The O 0 3.4110980706714145e-10
mutations O 0 2.442216207043657e-08
4612del165 O 0 1.4730463959722329e-08
and O 0 3.737133866255071e-12
7883del5 O 0 8.14261089110424e-11
were O 0 3.367517202590431e-12
found O 0 1.5776314716414719e-12
in O 0 1.462711652104251e-13
more O 0 7.51544466714776e-15
than O 0 2.340928862700712e-15
two O 0 1.3999402680798861e-15
unrelated O 0 1.5812667202106528e-13
families O 0 1.1192213944370179e-14
; O 0 3.887495404389764e-15
44 O 0 2.5521850800271084e-13
% O 0 6.05880580081819e-13
( O 0 1.3851006929951892e-12
7 O 0 2.2662709382725854e-12
of O 0 6.505343816800083e-14
16 O 0 3.6312645598779447e-12
) O 0 1.1748057293149185e-14
of O 0 6.873023327972814e-16
the O 0 7.915968431421692e-15
mutant O 0 2.853286704129765e-11
alleles O 0 1.1860875996638764e-11
had O 0 5.9317675216163934e-09
one O 0 2.2284821557527756e-12
of O 0 2.9174606524032254e-14
the O 0 2.456703894135326e-12
two O 0 3.219069108495454e-11
mutations O 0 7.160347426093949e-09
. O 0 3.8869718554934707e-10

The O 0 1.0975257508372138e-10
4612del165 O 0 7.949915392657658e-09
mutations O 0 4.2749923045981575e-10
in O 0 2.893158802808049e-12
three O 0 8.420435166191578e-14
different O 0 3.202602774448303e-14
families O 0 1.142551222903243e-13
were O 0 1.0593029274932886e-12
all O 0 1.0132250466703303e-14
ascribed O 0 6.674978495282979e-13
to O 0 1.720824004125543e-14
the O 0 3.6198505266394135e-14
same O 0 7.631080554786063e-13
T O 0 2.59327603835402e-09
- O 0 5.971743238797345e-11
- O 0 1.4107782997374585e-10
> O 0 7.325568970872887e-12
A O 0 1.307904956213135e-12
substitution O 0 1.4200043051137978e-12
at O 0 1.7138065055641305e-12
the O 0 6.298103992540341e-14
splice O 0 4.464400404913249e-09
donor O 0 1.5517578541568433e-11
site O 0 1.4534695669254916e-10
in O 0 3.057734898614939e-10
intron O 0 3.465682311798446e-06
33 O 0 5.7999780977979754e-08
. O 0 1.0646072912123827e-09

Microsatellite O 0 4.327132046455517e-06
genotyping O 0 1.209427296089416e-06
around O 0 4.0045330940152724e-10
the O 0 1.7594144457316885e-12
ATM O 0 2.081948391463584e-09
locus O 0 2.675113255912187e-11
also O 0 2.3908212649220717e-12
indicated O 0 9.01151462479044e-12
that O 0 2.2810829356585856e-14
a O 0 9.444413567177845e-13
common O 0 4.119414531711385e-10
haplotype O 0 1.0100196590201449e-07
was O 0 1.0275771344936402e-09
shared O 0 7.808128601148601e-13
by O 0 8.811656645232174e-14
the O 0 3.1015611628472384e-13
mutant O 0 4.878703552257946e-10
alleles O 0 5.693435167763994e-10
in O 0 6.507537564370836e-11
both O 0 1.0776492198605325e-10
mutations O 0 4.0574022364125994e-08
. O 0 1.1501976038275075e-09

This O 0 2.046083094620066e-11
suggests O 0 3.096162215499021e-11
that O 0 6.405758492004573e-14
these O 0 7.199244726838888e-15
two O 0 5.092019877582163e-14
founder O 0 4.09739291107325e-11
mutations O 0 5.90002668943157e-09
may O 0 3.6174923057075148e-09
be O 0 1.7092981760905013e-12
predominant O 0 4.753152316183673e-10
among O 0 1.8022305653050963e-12
Japanese O 0 3.5243821749908477e-10
ATM O 0 4.278610177266273e-08
mutant O 0 2.949012056774336e-08
alleles O 0 6.62838246512365e-08
. O 0 4.149675270070929e-09

W474C O 0 9.213010230268992e-07
amino O 0 6.599869095680333e-09
acid O 0 6.377366412735341e-10
substitution O 0 3.032052386942041e-11
affects O 0 2.045376715220648e-11
early O 0 3.2913916817728373e-12
processing O 0 2.2132959527632057e-12
of O 0 5.298150321615062e-16
the O 0 4.051479712428776e-15
alpha O 0 3.50237688243743e-13
- O 0 1.584134434956877e-13
subunit O 0 1.068429958221706e-12
of O 0 9.516044161971167e-15
beta O 0 6.371089766865623e-11
- O 0 3.872164811014045e-10
hexosaminidase O 0 2.046308544834119e-08
A O 0 3.017094907242779e-10
and O 0 9.40601936616492e-12
is O 0 1.019280891786066e-13
associated O 0 4.489532877405278e-12
with O 0 3.6217602267935023e-12
subacute O 0 1.150957245954487e-06
G B-Disease 0 2.197577089191327e-07
( I-Disease 0 7.808122204355783e-11
M2 I-Disease 0 4.28482138659092e-07
) I-Disease 0 6.384035522444265e-10
gangliosidosis I-Disease 0 1.8309665392735042e-06
. O 0 1.9435340004037016e-09

Mutations O 0 2.8206525826135476e-07
in O 0 1.60532517834433e-10
the O 0 5.705321198118396e-12
HEXA O 0 8.682320640218677e-08
gene O 0 3.239093437912288e-10
, O 0 5.698825742903035e-13
encoding O 0 3.4095593102329014e-12
the O 0 6.861164062029954e-14
alpha O 0 4.7792468767238194e-12
- O 0 2.620940140266037e-12
subunit O 0 1.1409668349005031e-11
of O 0 3.314262384500333e-14
beta O 0 2.0055296312548876e-10
- O 0 1.6568342253719948e-09
hexosaminidase O 0 2.7655099543721917e-08
A O 0 1.34511152216632e-10
( O 0 4.925636287733681e-12
Hex O 0 1.6459228424636763e-10
A O 0 7.644151804597765e-12
) O 0 2.2558764209944238e-13
, O 0 4.4733731015223974e-14
that O 0 8.072192816521023e-14
abolish O 0 2.9197544382242313e-10
Hex O 0 1.0193801358582277e-09
A O 0 1.62698830102892e-11
enzyme O 0 3.56065443796183e-09
activity O 0 7.293416537379471e-09
cause O 0 1.835619332268834e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.5898858308792114
( O 0 2.343418792349894e-10
TSD B-Disease 0 2.7632643195829587e-07
) O 0 2.6880522547428898e-12
, O 0 1.0497210739535134e-12
the O 0 4.626932951362628e-12
fatal O 0 1.1743805771402549e-05
infantile B-Disease 0 1.7571732314536348e-05
form I-Disease 0 4.559419508609608e-10
of I-Disease 0 4.4879915755968725e-12
G I-Disease 0 3.4377958257891805e-08
( I-Disease 0 3.2104709515867746e-12
M2 I-Disease 0 2.0066069694735233e-08
) I-Disease 0 7.33425126187015e-12
gangliosidosis I-Disease 0 6.978489608400196e-08
, I-Disease 0 1.5049650761711497e-11
Type I-Disease 0 1.213620919315872e-07
1 I-Disease 0 4.686938059883516e-10
. O 0 4.4555173439597695e-10

Less O 0 1.3547033859140356e-06
severe O 0 0.0003251108282711357
, O 0 2.607758176065289e-10
subacute O 0 5.534465526579879e-05
( O 0 8.499879022849655e-09
juvenile O 0 0.0005295887822285295
- O 0 2.6977324523613788e-05
onset O 0 2.211752325820271e-05
) O 0 1.988602199576306e-10
and O 0 2.9453566252612973e-09
chronic O 0 0.006193195935338736
( O 0 6.207570568683707e-11
adult O 0 8.834862796902598e-07
- O 0 4.2951373870891985e-06
onset O 0 7.712397831483031e-08
) O 0 8.088179106503779e-13
variants O 0 1.468886817734827e-10
are O 0 3.8487073771020786e-13
characterized O 0 2.1053417256083895e-12
by O 0 6.402081691387132e-14
a O 0 8.12817608358829e-12
broad O 0 6.585831879846182e-10
spectrum O 0 6.375392574975436e-11
of O 0 1.5133745222706968e-13
clinical O 0 5.259200366869443e-11
manifestations O 0 9.447913805471497e-12
and O 0 3.3292734346289377e-13
are O 0 1.531107936291777e-14
associated O 0 4.0791342200731384e-13
with O 0 3.630009162182424e-13
residual O 0 4.6934911068774454e-08
levels O 0 5.536716085607907e-10
of O 0 4.100250141584466e-13
Hex O 0 4.260846342418745e-09
A O 0 1.798345222736586e-10
enzyme O 0 6.672777441707467e-09
activity O 0 6.5380749703081165e-09
. O 0 1.5479599546619482e-10

We O 0 6.619103598559661e-10
identified O 0 2.700743517713988e-10
a O 0 1.4540815600205814e-11
1422 O 0 1.037834351791389e-07
G O 0 7.846931993071848e-09
- O 0 1.4787433499918734e-09
- O 0 7.60689999879105e-09
> O 0 5.214464415814746e-10
C O 0 3.721618346830269e-09
( O 0 2.7457159809674003e-12
amino O 0 1.0101545468155226e-11
acid O 0 1.2854418918184507e-11
W474C O 0 7.091900851297073e-12
) O 0 1.1266104863523908e-14
substitution O 0 2.4470266850144806e-13
in O 0 1.7510473594110204e-13
the O 0 7.859704098493736e-14
first O 0 1.0697758867986296e-12
position O 0 5.277284685634154e-12
of O 0 2.528490078716663e-14
exon O 0 2.136871513069849e-10
13 O 0 1.453136135726174e-11
of O 0 4.348738708546962e-13
HEXA O 0 2.2515284570090444e-07
of O 0 2.1539440695460266e-13
a O 0 2.473509071176938e-11
non O 0 1.4835749517772001e-08
- O 0 3.6433760453036257e-09
Jewish O 0 1.7412027375485195e-09
proband O 0 7.677255780436099e-05
who O 0 2.776330831899543e-10
manifested O 0 5.302453476296876e-10
a O 0 3.459425107488201e-11
subacute O 0 4.746778756725689e-07
variant O 0 9.526389703751192e-07
of O 0 1.2876166799458133e-10
G B-Disease 0 2.0438626506802393e-06
( I-Disease 0 1.5422015053889737e-10
M2 I-Disease 0 9.681557457952294e-07
) I-Disease 0 6.029245991356902e-10
gangliosidosis I-Disease 0 1.2829817706005997e-06
. O 0 1.7136259078398552e-09

On O 0 4.97141772193288e-10
the O 0 1.3127683618982533e-12
second O 0 7.092634812799758e-11
maternally O 0 1.2642827869058237e-06
inherited O 0 7.291317842827993e-07
allele O 0 1.5330119396139708e-08
, O 0 1.019118643641459e-11
we O 0 1.0001655536759357e-12
identified O 0 4.9868169489653e-12
the O 0 4.905766006098322e-13
common O 0 2.5573761774921877e-08
infantile O 1 0.5802639126777649
disease O 0 0.02664017863571644
- O 0 1.4777692740608472e-06
causing O 0 9.200807937759237e-08
4 O 0 5.953027515381848e-10
- O 0 1.401256977118237e-08
bp O 0 1.8952677649508587e-08
insertion O 0 8.327082912096273e-10
, O 0 1.6928621698886204e-11
+ O 0 8.19987522326926e-10
TATC O 0 5.658969115529544e-08
1278 O 0 2.7847926631352493e-08
, O 0 9.200386980046105e-12
in O 0 3.0050732735542596e-11
exon O 0 3.825706329507739e-08
11 O 0 1.1395283605608597e-09
. O 0 1.9287210717422454e-10

Pulse O 0 2.436021895846352e-05
- O 0 1.243142378370976e-06
chase O 0 7.2967272224389035e-09
analysis O 0 1.2262847855215586e-11
using O 0 3.9953911706858136e-11
proband O 0 4.975349909841498e-08
fibroblasts O 0 2.124977172002218e-08
revealed O 0 3.2741842570516155e-09
that O 0 2.1275509294853973e-13
the O 0 7.284750331171957e-14
W474C O 0 5.924649659760917e-11
- O 0 7.914949620192735e-13
containing O 0 1.090947536301623e-13
alpha O 0 4.646974645361457e-12
- O 0 1.917765859310583e-12
subunit O 0 3.63389028069927e-12
precursor O 0 1.1960606116634409e-11
was O 0 2.8249113118161695e-11
normally O 0 7.454662429885739e-13
synthesized O 0 4.005399744516636e-12
, O 0 1.1020927958215951e-13
but O 0 7.499353243435591e-14
not O 0 2.100782655473088e-14
phosphorylated O 0 1.5202666599559156e-12
or O 0 3.111343376948489e-13
secreted O 0 2.3753670471554633e-12
, O 0 2.7794528289180886e-13
and O 0 6.055398153390068e-13
the O 0 3.1539267725255726e-13
mature O 0 6.873591973377557e-11
lysosomal O 0 1.9979584653384563e-10
alpha O 0 2.2673359717506614e-11
- O 0 3.525671421478194e-11
subunit O 0 4.557906829738556e-10
was O 0 6.227567905803255e-10
not O 0 1.722393061509564e-11
detected O 0 7.830395887253871e-09
. O 0 1.4060262676363067e-10

When O 0 3.2347038936286765e-10
the O 0 2.770160619988693e-12
W474C O 0 7.762405163092012e-10
- O 0 1.086879978379196e-11
containing O 0 1.5382691865087339e-12
alpha O 0 2.1833389263203884e-11
- O 0 2.7019837756103726e-11
subunit O 0 1.9181735366746722e-10
was O 0 7.872108520601273e-11
transiently O 0 6.538171670733561e-10
co O 0 2.336095206167954e-10
- O 0 1.0624094486100244e-11
expressed O 0 8.29055248931232e-14
with O 0 4.727597504553156e-15
the O 0 1.752687181315587e-14
beta O 0 2.672786254473425e-12
- O 0 8.029829513984954e-13
subunit O 0 1.2447262187978425e-12
to O 0 5.239208115200185e-14
produce O 0 1.7070208094271955e-12
Hex O 0 9.890787078248309e-10
A O 0 4.150890395293594e-11
( O 0 2.9048035678214124e-12
alphabeta O 0 5.473547726175809e-10
) O 0 1.7558499684593165e-13
in O 0 4.552489461795428e-12
COS O 0 6.282345452746085e-07
- O 0 2.1122541216112012e-10
7 O 0 2.8135532098572114e-12
cells O 0 8.651341795729017e-12
, O 0 1.333593473281866e-13
the O 0 2.4924108797349555e-14
mature O 0 1.2937033172163992e-12
alpha O 0 4.566724060538208e-13
- O 0 4.0365660033264694e-13
subunit O 0 3.627270359074508e-12
was O 0 3.5267860680476826e-12
present O 0 2.5766542355700264e-14
, O 0 3.114720395665238e-14
but O 0 1.0884098933542849e-13
its O 0 9.93559228624043e-15
level O 0 1.4825082350969354e-12
was O 0 4.529778895728809e-12
much O 0 6.050848841074319e-13
lower O 0 2.7497932316572493e-12
than O 0 7.805381503894065e-15
that O 0 4.062173079871388e-15
from O 0 3.410096030965863e-14
normal O 0 2.4423184828703537e-12
alpha O 0 1.347858239950095e-12
- O 0 2.2253047928660896e-12
subunit O 0 6.223488304563096e-12
transfections O 0 5.3832820146038074e-11
, O 0 2.0712608467558444e-14
although O 0 1.4638335303022304e-13
higher O 0 1.8274370731929945e-12
than O 0 2.3351194025286737e-14
in O 0 1.3277786259802832e-13
those O 0 7.082566277167787e-14
cells O 0 1.1608940805180046e-12
transfected O 0 2.8201257301629923e-11
with O 0 2.032470295309976e-14
an O 0 4.359674174946558e-14
alpha O 0 1.3367908342776236e-11
- O 0 8.565752968037188e-11
subunit O 0 3.4628461209607053e-10
associated O 0 3.923147917639369e-10
with O 0 2.822123368328988e-10
infantile O 0 0.00014886473945807666
TSD B-Disease 0 2.592294549685903e-05
. O 0 2.8431850207510934e-09

Furthermore O 0 3.2987984566190676e-10
, O 0 8.489638571133884e-13
the O 0 3.0562713953597234e-14
precursor O 0 2.498826319474734e-11
level O 0 1.4672117687464237e-11
of O 0 3.1954620749447124e-15
the O 0 4.794617461845348e-14
W474C O 0 1.582119157905737e-11
alpha O 0 1.7453396583891334e-12
- O 0 6.340110185985848e-13
subunit O 0 2.4189619491493675e-12
was O 0 5.296545320387924e-12
found O 0 7.03013439563166e-13
to O 0 6.320475149116864e-14
accumulate O 0 6.14795670969559e-12
in O 0 9.85500743511114e-14
comparison O 0 3.945097829145816e-13
to O 0 6.595146249867984e-14
the O 0 9.073439292657873e-14
normal O 0 3.223905170601782e-11
alpha O 0 2.3563704806828234e-11
- O 0 1.2232782495291694e-11
subunit O 0 1.0578422166007684e-10
precursor O 0 7.818572456130823e-10
levels O 0 4.1378100945621554e-10
. O 0 4.4211960481543855e-11

We O 0 1.6131621594084322e-09
conclude O 0 2.5763643995979635e-10
that O 0 6.516843813718365e-14
the O 0 2.2069252350077895e-13
1422 O 0 3.967434381024759e-09
G O 0 8.225360947911042e-10
- O 0 4.440161849306179e-10
- O 0 2.837594159643686e-09
> O 0 4.958538579735716e-10
C O 0 5.159529692377873e-09
mutation O 0 1.18481752187094e-10
is O 0 2.439984520853644e-13
the O 0 6.950864851144184e-14
cause O 0 8.36180256980068e-12
of O 0 3.919230662664114e-13
Hex B-Disease 0 2.946460426755948e-07
A I-Disease 0 1.7548117057231138e-06
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.872554096313486e-11
the O 0 1.6405155012222394e-11
proband O 0 1.9196694722722896e-07
. O 0 4.054566682398786e-10

The O 0 1.0206520351108139e-10
resulting O 0 6.123675871938516e-11
W474C O 0 1.377430947080427e-09
substitution O 0 3.563660824768e-11
clearly O 0 9.591376304296517e-11
interferes O 0 1.1461673971036035e-10
with O 0 2.1015361759829654e-14
alpha O 0 2.271576806864295e-12
- O 0 8.043226458129271e-13
subunit O 0 2.728789633490991e-12
processing O 0 3.122289536292011e-12
, O 0 1.3798281907253379e-14
but O 0 1.4611353915520466e-14
because O 0 3.925840162395493e-15
the O 0 1.1535291722403087e-15
base O 0 3.669519861040048e-14
substitution O 0 1.1589340598305853e-12
falls O 0 1.049458409063675e-09
at O 0 2.9724187521062984e-12
the O 0 5.666231305228968e-14
first O 0 2.645474334386777e-12
position O 0 1.8213690972102015e-11
of O 0 5.3523442730858684e-14
exon O 0 3.503865808607287e-10
13 O 0 1.846751571110694e-11
, O 0 9.013262141852052e-13
aberrant O 0 5.016548287883893e-10
splicing O 0 2.944469112975412e-09
may O 0 7.448008321198074e-10
also O 0 5.947627373242836e-13
contribute O 0 1.824802922699778e-13
to O 0 1.386374738968077e-12
Hex B-Disease 0 2.221609776142941e-07
A I-Disease 0 3.178229519562592e-07
deficiency I-Disease 0 0.00019164150580763817
in O 0 2.4603251727595143e-11
this O 0 3.5840267385844893e-12
proband O 0 1.0712727593897853e-08
. O 0 5.673612621381885e-12
. O 0 3.666125389378827e-11

Two O 0 5.810380510062885e-10
frequent O 0 1.1044229530909888e-08
missense O 0 0.0001817595330066979
mutations O 0 0.0002843408437911421
in O 0 0.00015997490845620632
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.401739500143776e-09

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.1095510760460456e-07
an O 0 5.131914235789736e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 9.9731441878248e-05
by O 0 2.1693923046850472e-10
early O 0 9.648748346080538e-06
childhood O 1 0.9997207522392273
deafness B-Disease 1 1.0
and O 0 3.345069126226008e-05
goiter B-Disease 1 1.0
. O 0 1.0767545077783325e-08

A O 0 5.633722377496042e-09
century O 0 2.805903287494971e-10
after O 0 5.90350728371658e-12
its O 0 1.484793360582038e-14
recognition O 0 1.1731856805474727e-12
as O 0 6.770538296674289e-11
a O 0 1.9555381314262377e-08
syndrome O 0 0.02663581259548664
by O 0 2.469774168165073e-12
Vaughan O 0 7.532993606673699e-08
Pendred O 0 1.915104874683493e-08
, O 0 3.1122589314730442e-12
the O 0 2.8497499499069434e-12
disease O 0 1.4380262314261927e-08
gene O 0 1.3685175659361448e-08
( O 0 1.328289839230834e-10
PDS O 0 3.466121256678889e-07
) O 0 4.131047500605112e-12
was O 0 1.188962539533378e-10
mapped O 0 4.67686445126958e-10
to O 0 1.8156321932027986e-11
chromosome O 0 4.076266122865491e-06
7q22 O 0 7.096953140717233e-06
- O 0 9.254370638700493e-07
q31 O 0 8.231377819356567e-07
. O 0 1.3834421386249574e-09

1 O 0 9.069737738620631e-10
and O 0 3.3812327937532416e-12
, O 0 3.4803350522708e-13
recently O 0 5.281073495178035e-11
, O 0 8.94809874525497e-14
found O 0 3.9652325476910444e-13
to O 0 3.8187982371587145e-14
encode O 0 2.0320353039116057e-11
a O 0 1.0939387416752933e-11
putative O 0 5.490604859659243e-09
sulfate O 0 1.2684655104067133e-08
transporter O 0 3.196818170181359e-07
. O 0 7.776053134733729e-10

We O 0 1.4632001166248187e-09
performed O 0 8.701970394264791e-11
mutation O 0 1.8980214969155362e-11
analysis O 0 1.6720159328256767e-12
of O 0 1.1600252584952151e-14
the O 0 1.9281406712142596e-13
PDS B-Disease 0 1.0363009117497768e-08
gene O 0 1.6523489521080847e-10
in O 0 1.587548148496154e-11
patients O 0 1.3547542254688238e-10
from O 0 7.084407387981939e-13
14 O 0 2.0482335445770605e-12
Pendred B-Disease 0 3.0497032676990443e-10
families O 0 1.7047259057937497e-13
originating O 0 6.511035634260143e-12
from O 0 9.917275334281328e-13
seven O 0 4.77699368776896e-13
countries O 0 1.6626938270213748e-13
and O 0 2.3075779568421106e-12
identified O 0 7.160586013021941e-11
all O 0 8.105089407788035e-13
mutations O 0 5.475322972792185e-10
. O 0 5.146727488636316e-11

The O 0 2.3553549735599866e-11
mutations O 0 2.177314162299382e-10
include O 0 7.980283643106711e-13
three O 0 2.858316881793055e-13
single O 0 1.893063830693542e-12
base O 0 8.332222065088324e-12
deletions O 0 7.95044563517422e-09
, O 0 1.4154621051643002e-11
one O 0 3.6238401602411985e-12
splice O 0 1.9429981534813123e-07
site O 0 1.294243157090591e-09
mutation O 0 6.051186574040912e-08
and O 0 2.944626320555699e-09
10 O 0 1.2850331909675106e-10
missense O 0 2.1824362193001434e-06
mutations O 0 6.204039664226002e-07
. O 0 3.6271097236806327e-09

One O 0 8.867345746566002e-10
missense O 0 6.729086408086005e-07
mutation O 0 1.0153076601682187e-08
( O 0 8.145826374539311e-11
L236P O 0 1.0601575173296851e-09
) O 0 1.1419026531636622e-12
was O 0 5.713949452479383e-11
found O 0 1.5070274889117385e-11
in O 0 4.829709223698464e-13
a O 0 5.876878302578381e-13
homozygous O 0 2.8341509694662648e-11
state O 0 1.9005301076392006e-13
in O 0 4.4069821576731005e-12
two O 0 1.6321471084379535e-12
consanguineous O 0 1.0065667188641214e-09
families O 0 4.745456631816136e-12
and O 0 1.7253249610243993e-12
in O 0 2.093700863722847e-12
a O 0 4.2217106546726946e-12
heterozygous O 0 5.942452085960781e-11
state O 0 3.442485283378788e-13
in O 0 8.392880140872805e-12
five O 0 1.277373280934857e-12
additional O 0 2.739417850547432e-12
non O 0 8.756394009878932e-08
- O 0 1.3505328979590558e-06
consanguineous O 0 2.1923826807324076e-06
families O 0 1.7689328890568845e-09
. O 0 4.368489736616965e-10

Another O 0 6.7422458727151025e-09
missense O 0 4.504802745941561e-06
mutation O 0 3.76372319976781e-08
( O 0 1.455677939299349e-10
T416P O 0 4.4429407375368157e-10
) O 0 1.439535231469169e-12
was O 0 2.0368274775139916e-11
found O 0 4.144503750608264e-12
in O 0 1.3916302734739289e-13
a O 0 2.1718151094803767e-13
homozygous O 0 1.7854016876039935e-11
state O 0 6.27008075451338e-14
in O 0 3.3901958931131793e-12
one O 0 3.3897047495290433e-12
family O 0 1.737143089965143e-12
and O 0 6.448593286960402e-13
in O 0 8.949707294703124e-13
a O 0 1.2208861309079277e-12
heterozygous O 0 1.704331953344962e-10
state O 0 1.2269440021264733e-12
in O 0 1.441333580265436e-10
four O 0 2.8623296441376844e-11
families O 0 8.627382662440564e-12
. O 0 4.2392873933483344e-11

Pendred B-Disease 0 0.00015209261619020253
patients O 0 2.8298340112087317e-05
in O 0 5.197492783381996e-11
three O 0 1.073074246647765e-12
non O 0 8.464606238156591e-10
- O 0 7.865122775285727e-09
consanguineous O 0 1.6684831294355718e-08
families O 0 1.7918518231685443e-12
were O 0 2.92543008047208e-13
shown O 0 1.2655576185540557e-13
to O 0 4.232074421266739e-14
be O 0 9.81063375069674e-14
compound O 0 7.819399641673108e-12
heterozygotes O 0 7.267136198363389e-11
for O 0 8.76771596406041e-14
L236P O 0 1.4921160973457859e-09
and O 0 6.921704182039079e-11
T416P O 0 4.855278490367709e-08
. O 0 3.3599820148388915e-10

In O 0 5.0980140248180206e-11
total O 0 5.753653304664541e-13
, O 0 3.127521028614688e-13
one O 0 1.6502866239352654e-13
or O 0 1.7363481529322766e-12
both O 0 2.1586575029656357e-13
of O 0 2.428087917698469e-15
these O 0 3.338268992291414e-14
mutations O 0 4.4430184900114134e-13
were O 0 2.0898029400723273e-12
found O 0 1.0535722684903992e-12
in O 0 4.22734926491114e-13
nine O 0 1.348125712626047e-12
of O 0 1.8024890763724665e-15
the O 0 3.107873929996535e-13
14 O 0 5.4825068096509e-12
families O 0 4.9252485770368e-13
analyzed O 0 1.1145816908308959e-10
. O 0 9.211418433574536e-11

The O 0 1.5846317313883418e-11
identification O 0 4.74866396205087e-11
of O 0 3.536482155838856e-14
two O 0 6.700784133291393e-13
frequent O 0 5.351538101550091e-10
PDS B-Disease 0 1.3247386050352361e-05
mutations O 0 2.63327537552982e-09
will O 0 5.9235130906235e-13
facilitate O 0 1.4069880243522404e-12
the O 0 3.5767791723220754e-13
molecular O 0 1.604364863183605e-09
diagnosis O 0 6.614083395106718e-05
of O 0 3.384244662285596e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.2137327587424807e-08

Insertional O 0 6.861563178972574e-06
mutation O 0 1.6169858341186227e-08
by O 0 1.173707745577568e-11
transposable O 0 4.8706940702913926e-08
element O 0 3.6840035466667587e-09
, O 0 1.8040208216163478e-10
L1 O 0 7.322599913095473e-07
, O 0 5.5938400612964845e-12
in O 0 1.1152191149721435e-11
the O 0 1.2379534897188904e-10
DMD B-Disease 1 1.0
gene O 0 2.7661798185363295e-08
results O 0 5.527114876890948e-10
in O 0 6.011811187756066e-11
X B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
linked I-Disease 1 0.9999998807907104
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
. O 0 3.451955521427408e-08

X B-Disease 1 0.9999973773956299
- I-Disease 1 1.0
linked I-Disease 1 0.9999998807907104
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 1.4649993218540658e-08
XLDCM B-Disease 0 4.507642188400496e-07
) O 0 2.0585180695448235e-12
is O 0 1.6888516952105748e-13
a O 0 1.6601754693201798e-12
clinical O 0 2.0741837136739605e-09
phenotype O 0 2.5207837595075944e-08
of O 0 5.97917982486651e-13
dystrophinopathy B-Disease 0 1.1702942970259755e-07
which O 0 5.686743177052422e-12
is O 0 6.32471072042895e-13
characterized O 0 2.2705025793517963e-12
by O 0 5.618858785368108e-13
preferential O 0 1.9504126314018322e-08
myocardial B-Disease 0 3.36045417270725e-07
involvement I-Disease 0 3.0113400661946343e-10
without O 0 2.1343640830423505e-12
any O 0 7.592317074513188e-13
overt O 0 9.118339971969647e-10
clinical O 0 4.512134221812403e-09
signs O 0 5.729321017611255e-09
of O 0 1.0038321562877428e-10
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 4.4551818234594975e-08

To O 0 1.569669949574859e-10
date O 0 1.2902897639222033e-09
, O 0 1.2997777767281837e-12
several O 0 6.123085437119424e-13
mutations O 0 6.063497481889613e-10
in O 0 4.894601737803761e-11
the O 0 1.324530346513697e-10
Duchenne B-Disease 0 3.7459096347447485e-05
muscular I-Disease 0 3.4622039493115153e-06
dystrophy I-Disease 0 1.3992871572554577e-05
gene O 0 7.14474310825608e-08
, O 0 2.4643478369057448e-09
DMD O 1 1.0
, O 0 6.827177712054322e-12
have O 0 5.035348765551617e-13
been O 0 1.2144597393709544e-12
identified O 0 1.9135318329865925e-11
in O 0 2.2780330139610117e-12
patients O 0 2.735789893237861e-11
with O 0 2.117349400193938e-13
XLDCM B-Disease 0 3.4873255572165363e-06
, O 0 1.5907389338057354e-12
but O 0 1.1749324386675641e-12
a O 0 1.1123018738706802e-12
pathogenic O 0 7.484249886502425e-10
correlation O 0 2.553750613754069e-11
of O 0 4.272309841514034e-14
these O 0 1.3561824189697869e-12
cardiospecific O 0 1.1325344217993916e-08
mutations O 0 1.0187970467256946e-09
in O 0 7.825405323735879e-10
DMD O 1 1.0
with O 0 7.661375873990739e-12
the O 0 1.0699662510160746e-11
XLDCM B-Disease 0 0.00011761599307646975
phenotype O 0 4.906685717287473e-06
has O 0 9.106798093405644e-10
remained O 0 4.150514154588336e-09
to O 0 3.968637484613735e-13
be O 0 1.7725383660849303e-11
elucidated O 0 1.6522182733069712e-08
. O 0 1.0672212419349236e-10

We O 0 1.8164237891582502e-09
report O 0 6.714608730140625e-11
here O 0 3.6575169976016397e-13
the O 0 7.414100563140572e-15
identification O 0 1.0657148991413679e-12
of O 0 2.8004961173541893e-15
a O 0 2.3735451538248187e-13
unique O 0 9.253548448329152e-13
de O 0 5.986503515131858e-10
novo O 0 3.4924179104223185e-09
L1 O 0 1.9518751059877104e-08
insertion O 0 1.8517047617461202e-10
in O 0 4.1795993749316196e-12
the O 0 9.895942572335503e-13
muscle O 0 2.0497450403667017e-09
exon O 0 2.116877340085921e-09
1 O 0 8.051615624227182e-11
in O 0 4.894905814012418e-09
DMD O 1 1.0
in O 0 3.114994095998469e-10
three O 0 8.84735080336485e-12
XLDCM B-Disease 0 1.1639021835208041e-07
patients O 0 3.0843749776465756e-10
from O 0 2.278110154945584e-13
two O 0 4.721402847678025e-13
unrelated O 0 4.825784216677675e-10
Japanese O 0 1.3935507192641694e-09
families O 0 2.5581479642933225e-11
. O 0 3.284125402180926e-11

The O 0 2.376351546096167e-11
insertion O 0 3.8990227713142644e-10
was O 0 8.058779199515698e-10
a O 0 9.854903351702582e-12
5 O 0 4.924743772505291e-12
- O 0 1.0035316327927646e-10
truncated O 0 8.214962043950891e-11
form O 0 9.577112540515298e-12
of O 0 9.856566653360446e-14
human O 0 1.4872323208028893e-12
L1 O 0 6.495602722367266e-09
inversely O 0 4.51209555829557e-11
integrated O 0 5.6321374647394506e-11
in O 0 7.929640451209696e-12
the O 0 1.87149059270586e-12
5 O 0 3.951058230589055e-11
- O 0 8.406303209085308e-09
untranslated O 0 4.436830991494389e-08
region O 0 2.8568658549943393e-10
in O 0 9.254334798480812e-11
the O 0 2.1214818096693122e-12
muscle O 0 2.685067446162037e-10
exon O 0 1.197275473208137e-10
1 O 0 9.820561247889104e-13
, O 0 7.43304885957724e-14
which O 0 2.4294925947865482e-14
affected O 0 4.216976702726971e-13
the O 0 1.0990693794790066e-14
transcription O 0 6.804674445443082e-12
or O 0 6.552343845452058e-13
the O 0 1.5267867807707003e-13
stability O 0 7.885539443641676e-12
of O 0 5.047940706523523e-15
the O 0 1.0375403471487091e-13
muscle O 0 3.7992751306115125e-11
form O 0 9.528659328586486e-13
of O 0 4.671426006436219e-14
dystrophin O 0 5.685947268574409e-10
transcripts O 0 2.751432692793543e-10
but O 0 1.0013337815167889e-12
not O 0 4.805072220106718e-14
that O 0 2.9374147581131107e-15
of O 0 2.0822397066533284e-15
the O 0 6.261956556584403e-13
brain O 0 5.553324022855577e-09
or O 0 2.3916708891125182e-11
Purkinje O 0 1.986991682301209e-09
cell O 0 2.0346872631193946e-08
form O 0 1.1381056097548026e-09
, O 0 6.474262237432526e-10
probably O 0 4.774673243446159e-07
due O 0 2.3175210014936276e-11
to O 0 2.1889533642713982e-13
its O 0 2.7768282803903623e-14
unique O 0 1.5730963081640736e-13
site O 0 9.908544471026737e-12
of O 0 3.315578876988273e-13
integration O 0 4.454123736508109e-10
. O 0 1.5974996325773816e-10

We O 0 1.5380829943012486e-10
speculate O 0 1.7440204835850182e-10
that O 0 1.3749442834547643e-14
this O 0 3.3003194598588744e-15
insertion O 0 1.3479044269626428e-12
of O 0 1.223348679302294e-14
an O 0 2.0324402425810073e-13
L1 O 0 9.61019264167362e-09
sequence O 0 1.1091627616366395e-11
in O 0 1.8156584014050736e-09
DMD O 1 1.0
is O 0 6.518851864562025e-12
responsible O 0 3.9237631698461894e-13
for O 0 7.540571899528059e-15
some O 0 1.1501902742413507e-14
of O 0 2.9768041195010406e-16
the O 0 3.427838152485641e-15
population O 0 2.3667254628675785e-15
of O 0 3.288857621774866e-15
Japanese O 0 1.0284197105026038e-10
patients O 0 7.139689013613282e-12
with O 0 2.2008888038872049e-13
XLDCM B-Disease 0 7.634171339532259e-08
. O 0 1.4279275678541481e-11
. O 0 1.1469984684264745e-10

Severe O 1 0.9923046231269836
early O 0 0.0005058693350292742
- O 1 0.9999445676803589
onset O 1 0.9994567036628723
obesity B-Disease 1 1.0
, O 0 7.57776703608215e-08
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 1.0
and O 0 4.759296512446554e-09
red O 0 2.272497113153804e-06
hair O 1 1.0
pigmentation O 1 0.9962719678878784
caused O 0 1.1096510377228697e-08
by O 0 2.4224584144194594e-11
POMC O 0 2.62045114141074e-06
mutations O 0 1.5959937371690103e-08
in O 0 3.8680884884012556e-11
humans O 0 1.1210552486318193e-09
. O 0 6.222224402385734e-10

Sequential O 0 6.138348140893868e-08
cleavage O 0 5.979958217494641e-08
of O 0 9.485574218454085e-13
the O 0 8.034007216006084e-14
precursor O 0 5.191944096871737e-11
protein O 0 1.6029876037659818e-10
pre O 0 2.2122790710454865e-08
- O 0 1.1529855292735647e-08
pro O 0 3.234868017898407e-08
- O 0 3.111049124981946e-07
opiomelanocortin O 0 6.35487197087059e-07
( O 0 5.2950529377815414e-11
POMC O 0 8.18644352307274e-08
) O 0 4.303104747527264e-12
generates O 0 5.291479060476334e-11
the O 0 4.510552955444558e-12
melanocortin O 0 5.8263115221279804e-08
peptides O 0 9.672347367484235e-09
adrenocorticotrophin O 0 8.453707067701544e-08
( O 0 8.677573243298653e-11
ACTH O 0 8.374041016168121e-09
) O 0 3.2954873638996185e-12
, O 0 2.8032417966755707e-12
melanocyte O 0 1.6451531337224878e-07
- O 0 6.530051877007281e-08
stimulating O 0 3.000713277856448e-08
hormones O 0 3.4526650427579852e-09
( O 0 5.962043359009073e-12
MSH O 0 1.3704529955305134e-08
) O 0 8.493537497671413e-14
alpha O 0 4.396787296225002e-13
, O 0 1.4669297745376238e-14
beta O 0 3.5889366023326985e-13
and O 0 3.1798138612221943e-14
gamma O 0 9.285762263278041e-13
as O 0 9.947581359982458e-14
well O 0 4.212183377159777e-14
as O 0 1.6946073179684856e-14
the O 0 1.079066188209828e-14
opioid O 0 6.642734973194564e-12
- O 0 1.3168008350383786e-12
receptor O 0 5.930219856842278e-12
ligand O 0 2.6136143249644306e-10
beta O 0 7.2473773649051054e-09
- O 0 6.029434729271088e-08
endorphin O 0 4.235311280353926e-06
. O 0 1.4389637259526467e-09

While O 0 8.893600300652338e-10
a O 0 1.0038124845235252e-11
few O 0 4.244576912171283e-12
cases O 0 1.3472156333224627e-12
of O 0 8.120497411437042e-14
isolated O 0 0.00010387659858679399
ACTH B-Disease 1 0.5356937646865845
deficiency I-Disease 0 0.00013595877680927515
have O 0 1.3645894310354567e-12
been O 0 5.6907690365592956e-12
reported O 0 5.086264187603717e-10
( O 0 1.3568817076869966e-11
OMIM O 0 2.7895060839000507e-07
201400 O 0 9.025662994766037e-10
) O 0 1.8513283354254506e-12
, O 0 4.4911408034371825e-13
an O 0 4.88361196100684e-13
inherited O 0 5.284327198751271e-05
POMC O 0 0.006015137303620577
defect O 0 4.9980975745711476e-05
has O 0 9.144861257137649e-11
not O 0 8.171061917361389e-12
been O 0 5.012863041331528e-11
described O 0 9.804287937065226e-11
so O 0 2.0419737081778244e-11
far O 0 4.4509621682786715e-11
. O 0 5.0014218461180704e-11

Recent O 0 2.3943833027395556e-10
studies O 0 7.868956874990118e-11
in O 0 3.7468240858019863e-13
animal O 0 1.8732728042369917e-12
models O 0 2.489250645887342e-11
elucidated O 0 1.8823038960835703e-10
a O 0 9.142219316651823e-13
central O 0 1.4662933410861112e-12
role O 0 4.155783790010803e-12
of O 0 3.030614089761033e-14
alpha O 0 7.242588473399536e-11
- O 0 7.131584767172683e-10
MSH O 0 3.1747336493026523e-07
in O 0 1.4637012088480894e-11
the O 0 3.913896659026028e-13
regulation O 0 3.5608817977594853e-11
of O 0 1.0293694946449973e-14
food O 0 6.962824414258328e-13
intake O 0 3.500914293706747e-13
by O 0 5.6152965036051355e-15
activation O 0 5.867906529601064e-13
of O 0 1.7953532473083227e-14
the O 0 1.4306148496748272e-12
brain O 0 1.9254885685882073e-08
melanocortin O 0 2.2854012016182423e-08
- O 0 6.997917245676888e-10
4 O 0 2.4606769746804424e-11
- O 0 1.7527106155323935e-10
receptor O 0 2.7863200635636076e-10
( O 0 2.1756357132529658e-11
MC4 O 0 5.805467253594543e-07
- O 0 3.953950056256872e-09
R O 0 1.4545914694963358e-08
; O 0 6.482213637387657e-12
refs O 0 3.147594895835937e-08
3 O 0 6.93067044726936e-12
- O 0 2.154596639991624e-10
5 O 0 9.418292968438324e-13
) O 0 5.845930022615325e-14
and O 0 5.875227875821315e-14
the O 0 2.231593172242769e-14
linkage O 0 6.683087416803346e-11
of O 0 4.3773886831922557e-14
human O 0 2.1675961373035513e-11
obesity B-Disease 1 0.9999998807907104
to O 0 6.456815334135446e-13
chromosome O 0 1.1154520640488386e-09
2 O 0 2.37637318677153e-12
in O 0 1.3456542737738664e-12
close O 0 1.4984404342333058e-11
proximity O 0 1.6319176912582556e-11
to O 0 2.965464896212411e-12
the O 0 5.068730157820056e-12
POMC O 0 2.1263677041361007e-08
locus O 0 6.958383869104523e-11
, O 0 2.1824217780186395e-12
led O 0 2.209494523106037e-13
to O 0 7.739621931627388e-14
the O 0 2.925932337128484e-13
proposal O 0 8.204580070891865e-11
of O 0 1.6051880148432868e-13
an O 0 1.8037299084894265e-12
association O 0 1.0041495412949075e-11
of O 0 3.5842845618611063e-13
POMC O 0 6.442290612085344e-08
with O 0 6.8471040469419986e-12
human O 0 7.727575912497286e-09
obesity B-Disease 1 1.0
. O 0 2.0151744717367137e-09

The O 0 2.139819224589168e-11
dual O 0 4.088503147148259e-10
role O 0 1.7263497922859194e-11
of O 0 1.927081812267556e-13
alpha O 0 4.4979886482110487e-10
- O 0 9.057312233551329e-09
MSH O 0 8.934888455769396e-07
in O 0 1.3282207798892554e-11
regulating O 0 1.2830152218423763e-10
food O 0 4.362575578564787e-11
intake O 0 1.4616066690287255e-10
and O 0 1.7086558947235209e-12
influencing O 0 1.3280068156262814e-09
hair O 1 0.9386886358261108
pigmentation O 0 4.8064310249174014e-05
predicts O 0 7.873017793258441e-09
that O 0 3.1626554131657103e-13
the O 0 2.7737808252527307e-13
phenotype O 0 9.513455578868957e-10
associated O 0 1.5177845091862707e-11
with O 0 8.338576682441479e-13
a O 0 3.5200625747577874e-10
defect O 0 2.7671725888467336e-07
in O 0 4.7913156081547115e-11
POMC O 0 4.5936594972317835e-08
function O 0 6.437364530320622e-12
would O 0 2.113670566697423e-12
include O 0 7.345842684136628e-12
obesity B-Disease 1 1.0
, O 0 2.8583468925091893e-11
alteration O 0 6.142166597555843e-08
in O 0 4.401394360087352e-09
pigmentation O 0 0.38217893242836
and O 0 3.1654158760829887e-07
ACTH B-Disease 0 0.00017888803267851472
deficiency I-Disease 0 5.4122298024594784e-05
. O 0 2.802287846215279e-10

The O 0 1.7058725959584464e-11
observation O 0 2.5047686147416925e-10
of O 0 1.9084853055545414e-13
these O 0 1.2454605922973538e-11
symptoms O 0 1.4166986694874595e-08
in O 0 3.0447541189693172e-12
two O 0 7.710496195516281e-13
probands O 0 4.180004786746849e-09
prompted O 0 1.0859309111654891e-11
us O 0 3.754910445075144e-12
to O 0 2.5331629900800755e-14
search O 0 3.141009371002146e-12
for O 0 6.357678191412988e-14
mutations O 0 3.2464211874305704e-11
within O 0 2.270749343766254e-12
their O 0 4.2820656742659224e-11
POMC O 0 4.097728094620834e-07
genes O 0 1.8304092463949928e-08
. O 0 8.135117024465899e-10

Patient O 0 9.05646666069515e-05
1 O 0 3.422933603225431e-10
was O 0 5.4985745123747876e-11
found O 0 9.410249272520654e-13
to O 0 2.0573501940696765e-14
be O 0 7.310973793592593e-14
a O 0 1.8803741116263373e-13
compound O 0 1.1777218957009783e-11
heterozygote O 0 1.8295243098265246e-10
for O 0 2.831635479479816e-13
two O 0 1.4745726341358623e-12
mutations O 0 3.905356871225507e-10
in O 0 2.647716941528433e-11
exon O 0 1.5536517627978697e-09
3 O 0 2.0064009481624012e-11
( O 0 1.660388319890682e-11
G7013T O 0 1.8213605068595484e-09
, O 0 1.8362067508853608e-12
C7133delta O 0 3.399076298205017e-10
) O 0 5.631097395016396e-14
which O 0 1.770690527796298e-14
interfere O 0 4.273047627539883e-12
with O 0 4.403221832830796e-14
appropriate O 0 2.160009584389888e-12
synthesis O 0 1.0541799204399904e-11
of O 0 1.660899879001726e-13
ACTH O 0 9.487072238911765e-10
and O 0 7.335426537025125e-12
alpha O 0 1.366568413985192e-09
- O 0 1.83608079851183e-08
MSH O 0 3.5970660974271595e-05
. O 0 8.381450533612167e-10

Patient O 0 0.003382718423381448
2 O 0 6.603744218125485e-10
was O 0 4.057999422601988e-11
homozygous O 0 8.809485085858881e-11
for O 0 1.1100758441802416e-13
a O 0 3.2408145177881265e-12
mutation O 0 2.581155289504977e-10
in O 0 4.3960370066375987e-11
exon O 0 9.639768094871215e-09
2 O 0 1.929416487689295e-10
( O 0 5.125928848048744e-11
C3804A O 0 1.12153273335025e-08
) O 0 1.032204096501621e-11
which O 0 4.016862537037369e-11
abolishes O 0 1.4140941573259624e-07
POMC O 0 4.8289057303918526e-06
translation O 0 2.434055375033495e-07
. O 0 4.406114584298848e-09

These O 0 4.717327656972303e-12
findings O 0 2.915249422072441e-12
represent O 0 5.378573156517366e-14
the O 0 2.6035981842155963e-14
first O 0 6.599399032889558e-14
examples O 0 7.946594229001069e-13
of O 0 3.483334904156796e-14
a O 0 1.7816105257750792e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.1026321349028034e-11
the O 0 2.896029553320356e-12
POMC O 0 3.5488113780957065e-08
gene O 0 6.887860837245796e-10
and O 0 3.507941116406843e-12
define O 0 6.168032751219243e-11
a O 0 1.0004126693718973e-10
new O 0 1.3941416021623354e-08
monogenic B-Disease 1 0.9619215130805969
endocrine I-Disease 1 0.9313880801200867
disorder I-Disease 0 0.0005058488459326327
resulting O 0 4.181228280275562e-11
in O 0 2.3105385660304734e-11
early O 0 2.6993024221155792e-05
- O 1 0.9989476799964905
onset O 1 0.9999357461929321
obesity B-Disease 1 1.0
, O 0 1.2530328774573718e-07
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 1.0
and O 0 1.905136048918621e-09
red O 0 8.923004202188167e-08
hair O 1 0.9999724626541138
pigmentation O 0 0.0005583008751273155
. O 0 1.920362757701355e-10
. O 0 1.491432394251646e-10

A O 0 2.1824677176596197e-08
European O 0 2.5826436544917897e-09
multicenter O 0 1.7855029454949545e-08
study O 0 8.6692064638072e-10
of O 0 2.2336514859944145e-09
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.5633774830270397e-10
classification O 0 6.696230375746737e-11
of O 0 2.6136938005073308e-14
105 O 0 1.0083264084803645e-10
mutations O 0 7.929679135543211e-10
and O 0 1.4224121880346274e-11
a O 0 3.5652767630539595e-12
general O 0 5.162275771783409e-13
system O 0 2.6730464629948214e-12
for O 0 2.6935474250339153e-13
genotype O 0 1.4361375200167004e-08
- O 0 1.2121149639554574e-09
based O 0 2.2343449312955954e-10
prediction O 0 6.659379181428449e-08
of O 0 3.329829467713097e-11
metabolic O 0 4.400987108965637e-06
phenotype O 0 1.903889256027469e-06
. O 0 2.607003724008905e-09

Phenylketonuria B-Disease 1 0.9992032647132874
( O 0 1.2264490578672849e-06
PKU B-Disease 0 0.0023071670439094305
) O 0 1.068957589112074e-09
and O 0 5.248600998264408e-10
mild B-Disease 1 0.9999967813491821
hyperphenylalaninemia I-Disease 1 1.0
( O 0 4.739070573123172e-05
MHP B-Disease 1 1.0
) O 0 7.497891890695385e-11
are O 0 4.840475936740418e-11
allelic B-Disease 0 3.953698978875764e-06
disorders I-Disease 1 0.9998505115509033
caused O 0 1.6233375754737267e-10
by O 0 5.977754099009691e-13
mutations O 0 1.6832563121127464e-09
in O 0 2.0550432883181813e-11
the O 0 4.376817484830209e-12
gene O 0 1.1851875569846015e-07
encoding O 0 6.552940590154321e-07
phenylalanine O 0 5.0174578063888475e-05
hydroxylase O 0 0.00028125292737968266
( O 0 1.4668613879109671e-08
PAH O 0 2.843601350832614e-06
) O 0 5.846867434655678e-10
. O 0 5.160590288433298e-10

Previous O 0 2.71774963644944e-10
studies O 0 3.9108112581676124e-11
have O 0 5.152900675597927e-13
suggested O 0 1.026331688906701e-12
that O 0 1.2973095633774662e-14
the O 0 5.809105773453213e-14
highly O 0 1.2274227467745646e-10
variable O 0 4.3610488553724736e-09
metabolic O 0 1.3918864283368748e-07
phenotypes O 0 3.240338841692392e-08
of O 0 3.98904270726419e-10
PAH B-Disease 0 0.0006414548843167722
deficiency I-Disease 0 0.0028170226141810417
correlate O 0 4.0012318436311034e-07
with O 0 7.497256149235909e-09
PAH O 0 0.00019102140504401177
genotypes O 0 2.437183866277337e-05
. O 0 1.8529641820919096e-08

We O 0 2.1359791713138065e-10
identified O 0 1.4261610122023871e-11
both O 0 4.869715199661007e-13
causative O 0 3.585796548577491e-09
mutations O 0 1.400227600534265e-09
in O 0 1.5351785120909511e-10
686 O 0 2.6098909700067452e-08
patients O 0 4.398509645398008e-08
from O 0 2.5469647224607428e-11
seven O 0 2.7106145453204e-11
European O 0 1.393837129048947e-10
centers O 0 2.1531096350280166e-10
. O 0 1.2183098974105633e-10

On O 0 2.970823587133964e-10
the O 0 2.5708431152134115e-13
basis O 0 4.642480518936287e-13
of O 0 1.843552174864171e-15
the O 0 1.6859865554445103e-14
phenotypic O 0 5.2289537283423115e-11
characteristics O 0 7.215545869132534e-12
of O 0 8.711706079829809e-14
297 O 0 1.7042474376172123e-10
functionally O 0 2.563112388997979e-09
hemizygous O 0 3.3597867599155506e-08
patients O 0 4.2608623296302994e-09
, O 0 1.294875258449693e-13
105 O 0 2.1769756136658103e-12
of O 0 4.874952014738724e-15
the O 0 8.396122610099949e-14
mutations O 0 6.16106905076963e-12
were O 0 7.748093833193082e-12
assigned O 0 4.385078996964331e-13
to O 0 5.917988131877785e-14
one O 0 5.030500755537348e-13
of O 0 1.6289421051721327e-14
four O 0 7.439350242603726e-13
arbitrary O 0 4.58374484202384e-11
phenotype O 0 3.7355306403696886e-08
categories O 0 7.137344493202136e-09
. O 0 3.2588617915330076e-10

We O 0 5.752584172902253e-11
proposed O 0 2.8339117077308407e-12
and O 0 9.075693755550285e-13
tested O 0 1.5479357379222236e-11
a O 0 3.1164095826499705e-13
simple O 0 1.4360908295873998e-12
model O 0 1.1769875872535973e-11
for O 0 4.090335993631351e-14
correlation O 0 2.2778993968852745e-11
between O 0 7.439467444858572e-12
genotype O 0 1.1068755689791487e-08
and O 0 1.4474460692526225e-11
phenotypic O 0 6.6478786919788035e-09
outcome O 0 1.5889614068953506e-09
. O 0 2.2393152609989642e-10

The O 0 4.8440782635106316e-11
observed O 0 1.9641488435695464e-10
phenotype O 0 8.573933563127412e-09
matched O 0 1.2703776919309462e-09
the O 0 2.757955539292589e-12
predicted O 0 2.0689443491761494e-09
phenotype O 0 2.2476263072945812e-09
in O 0 1.4276824514269926e-11
79 O 0 2.3739474275252803e-10
% O 0 3.0862064206299555e-13
of O 0 5.149132344600205e-15
the O 0 1.2981716396298637e-13
cases O 0 2.67828381000923e-11
, O 0 7.795257495057939e-13
and O 0 1.845472342651422e-12
in O 0 1.9154187784475862e-12
only O 0 9.046779167812269e-13
5 O 0 3.252428301724411e-14
of O 0 8.16553483086891e-15
184 O 0 9.586159123442517e-12
patients O 0 4.031455724806676e-10
was O 0 4.169974782142205e-11
the O 0 9.850383990471848e-14
observed O 0 8.36440292029117e-12
phenotype O 0 4.69533079083817e-10
more O 0 2.362893951682321e-13
than O 0 2.609600361323794e-13
one O 0 3.8771327186097604e-13
category O 0 7.622607406387871e-11
away O 0 2.2264948565386966e-11
from O 0 6.8648363903134335e-12
that O 0 2.9541754459350145e-11
expected O 0 1.556151874027023e-09
. O 0 1.1891983231482328e-10

Among O 0 4.736524714110679e-11
the O 0 1.808020828322418e-13
seven O 0 1.2367220420493596e-13
contributing O 0 3.963846530738793e-14
centers O 0 4.3672503764399795e-13
, O 0 7.636070459759656e-14
the O 0 1.7255404529824443e-14
proportion O 0 3.4439122560681046e-12
of O 0 2.4545793389919683e-14
patients O 0 4.436720522221771e-12
for O 0 2.5100802834762117e-15
whom O 0 3.9084658903440483e-13
the O 0 2.4531332843444158e-14
observed O 0 2.7223381968838334e-12
phenotype O 0 9.27267929107245e-10
did O 0 5.80150982809613e-10
not O 0 5.216220684556294e-12
match O 0 2.1949048481517686e-11
the O 0 3.179676032021017e-13
predicted O 0 5.23512566630302e-09
phenotype O 0 8.676058982359791e-09
was O 0 6.928073670309232e-10
4 O 0 3.759683103038425e-12
% O 0 9.786347079931978e-12
- O 0 4.92913976302134e-09
23 O 0 1.1226787555163042e-10
% O 0 2.6986154630370685e-11
( O 0 8.914757126943229e-11
P O 0 6.704978295601904e-05
< O 0 6.826719634034362e-09
. O 0 1.3670276933011594e-12
0001 O 0 2.3057598053100037e-09
) O 0 7.554971459631382e-14
, O 0 1.789158895365052e-14
suggesting O 0 3.763413625873513e-12
that O 0 8.049284302242762e-14
differences O 0 1.9776424421691363e-12
in O 0 1.3169810565445e-13
methods O 0 3.9853710609438764e-13
used O 0 1.3736186938329703e-13
for O 0 2.5363730755435798e-14
mutation O 0 2.0729950742093273e-11
detection O 0 2.393963360880491e-10
or O 0 8.702739084931466e-10
phenotype O 0 3.801144714543625e-07
classification O 0 1.2403395643900694e-08
may O 0 6.760296211716366e-10
account O 0 2.61178275187679e-12
for O 0 6.607157854686407e-14
a O 0 1.260061824846781e-12
considerable O 0 4.81597990653615e-11
proportion O 0 7.793707901271318e-10
of O 0 2.681253309655407e-11
genotype O 1 0.7733698487281799
- O 1 0.5186751484870911
phenotype O 0 4.137534779147245e-05
inconsistencies O 0 5.2865616453345865e-06
. O 0 1.3474901194854283e-09

Our O 0 1.2315828912257132e-10
data O 0 2.8639405083574765e-11
indicate O 0 2.578170966646698e-12
that O 0 2.50558529138337e-14
the O 0 1.0537973488614072e-12
PAH O 0 6.040623645731102e-08
- O 0 1.5843523160086193e-09
mutation O 0 1.6999921470528534e-09
genotype O 0 1.8079012065186362e-08
is O 0 3.999824831155824e-13
the O 0 1.2501925086534985e-14
main O 0 1.8024024113494352e-12
determinant O 0 1.995871384830039e-10
of O 0 5.045724688762521e-12
metabolic O 0 2.483393927832367e-06
phenotype O 0 2.280041577762404e-08
in O 0 1.6630951824025964e-11
most O 0 2.7947496747393608e-11
patients O 0 9.00728291952646e-09
with O 0 1.2331677901045168e-09
PAH B-Disease 0 0.04213697090744972
deficiency I-Disease 0 0.027056269347667694
. O 0 1.5702756872570944e-09

In O 0 1.0204690564785679e-10
the O 0 1.7736457918679505e-13
present O 0 8.832320183387032e-14
study O 0 4.0133434769940024e-13
, O 0 3.891258517664531e-14
the O 0 7.091487905794627e-14
classification O 0 1.7051861658790024e-11
of O 0 3.829966197161673e-14
105 O 0 1.355496603849815e-09
PAH O 0 3.773110179849937e-08
mutations O 0 8.264581241590463e-10
may O 0 3.544314147729821e-11
allow O 0 1.9841550277788222e-13
the O 0 2.3174699464133253e-13
prediction O 0 1.9537169104744123e-10
of O 0 3.838439914766005e-15
the O 0 2.0427819050032603e-13
biochemical O 0 1.4667606684781731e-08
phenotype O 0 1.662564841353742e-08
in O 0 5.308401287984488e-11
> O 0 3.9794825767991426e-10
10 O 0 1.3183539546504641e-12
, O 0 4.934152587378338e-13
000 O 0 1.6587922441885228e-12
genotypes O 0 1.7961993004078636e-10
, O 0 4.0448203055161447e-13
which O 0 9.380287345484017e-13
may O 0 4.7481026055340436e-11
be O 0 5.270016736370897e-14
useful O 0 4.750779305541519e-13
for O 0 7.790626189952896e-15
the O 0 1.3357700091431307e-13
management O 0 2.2176156744269093e-11
of O 0 2.1133993806290302e-13
hyperphenylalaninemia B-Disease 1 1.0
in O 0 8.532171413833112e-09
newborns O 0 9.736430683915387e-08
. O 0 4.359231725592494e-11

Somatic O 0 3.2060870580608025e-05
instability O 0 4.859679165747366e-07
of O 0 1.708440897432717e-12
the O 0 3.7814022746385234e-12
CTG O 0 1.3365512074869912e-07
repeat O 0 1.794922876996452e-09
in O 0 8.714988800062606e-12
mice O 0 1.2341277999539102e-09
transgenic O 0 2.8708604937754956e-10
for O 0 3.5490460939015256e-13
the O 0 1.4310522385152513e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.79550937953843e-09
is O 0 4.9779621397183504e-11
age O 0 7.122932018516215e-12
dependent O 0 4.511361770265232e-12
but O 0 1.0005986924438437e-12
not O 0 1.825422408716082e-13
correlated O 0 3.6466294393855403e-13
to O 0 1.436333250416904e-14
the O 0 2.5959369406142706e-14
relative O 0 2.8730557863343442e-11
intertissue O 0 2.35258257319515e-09
transcription O 0 3.646275281710132e-09
levels O 0 2.604109983206371e-10
and O 0 1.0535170652525849e-10
proliferative O 0 2.6302334390493343e-06
capacities O 0 2.5845571016702706e-08
. O 0 5.453612006434128e-10

A O 0 1.514123404433576e-08
( O 0 3.9073536073352955e-10
CTG O 0 2.2358435103342345e-08
) O 0 6.12898924320926e-12
nexpansion O 0 1.9952746121987275e-09
in O 0 1.0142125854428752e-11
the O 0 2.5631870757825137e-12
3 O 0 3.1827634972003693e-10
- O 0 6.444182787390673e-08
untranslated O 0 1.702193344499392e-06
region O 0 1.764821622174395e-09
( O 0 3.290589675741806e-11
UTR O 0 1.4210767007583058e-09
) O 0 2.216898675267212e-13
of O 0 3.029527515896295e-14
the O 0 7.94411689208907e-11
DM O 1 1.0
protein O 0 6.616368342093892e-09
kinase O 0 4.714278745154843e-08
gene O 0 1.1020577339593274e-08
( O 0 7.623377623611205e-11
DMPK O 0 2.877584748262052e-08
) O 0 1.5319856928180942e-12
is O 0 1.9117679986822844e-13
responsible O 0 5.4861367185243815e-12
for O 0 3.6404113230859014e-12
causing O 0 4.870549901170307e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.070893919561058e-05
DM B-Disease 1 1.0
) O 0 3.676254189954875e-09
. O 0 1.1395413501702478e-09

Major O 0 4.502370742898165e-08
instability O 0 1.4207760159479221e-06
, O 0 5.244955511574112e-11
with O 0 1.791478478150449e-13
very O 0 3.062401244049995e-12
large O 0 1.4919585816894516e-14
expansions O 0 1.47068607292411e-11
between O 0 2.347109865404734e-13
generations O 0 1.1119242462540035e-12
and O 0 2.4677306639103724e-12
high O 0 1.1912090237820028e-11
levels O 0 6.572646073232935e-13
of O 0 6.585162357221992e-15
somatic O 0 5.1303499642996186e-11
mosaicism O 0 1.6919794454395287e-09
, O 0 1.2236674347410048e-12
is O 0 1.3352350908962807e-13
observed O 0 5.211804945948195e-12
in O 0 1.2168979712789962e-10
patients O 0 1.9799437644962836e-09
. O 0 4.6065942727047116e-11

There O 0 4.516213236716027e-10
is O 0 1.0253573164142882e-12
a O 0 1.3307837904569242e-12
good O 0 5.472240022230679e-11
correlation O 0 2.9543333057713284e-11
between O 0 7.08504609148175e-12
repeat O 0 1.0271656858407141e-09
size O 0 4.4383816066861925e-11
( O 0 5.536457143434648e-12
at O 0 8.199757713100997e-12
least O 0 8.982096750403956e-13
in O 0 9.900756429981339e-13
leucocytes O 0 6.229016746850391e-10
) O 0 9.620548037684792e-14
, O 0 6.777660165957836e-14
clinical O 0 3.101138443262208e-11
severity O 0 2.842587276674635e-10
and O 0 1.2864573989412875e-11
age O 0 3.8034662225294724e-11
of O 0 2.5775402320328544e-13
onset O 0 3.316534602504362e-09
. O 0 1.1840854685640778e-10

The O 0 4.428390987243347e-09
trinucleotide O 0 1.789705129340291e-05
repeat O 0 4.635930963559076e-07
instability O 0 3.3604070637238692e-09
mechanisms O 0 2.3651430813842467e-10
involved O 0 1.1507982761171931e-10
in O 0 4.238832929104319e-08
DM B-Disease 1 1.0
and O 0 4.3576171317172285e-12
other O 0 2.0151625322855499e-13
human O 0 7.618901343153794e-11
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.1266616979643818e-11
unknown O 0 4.892252714050471e-10
. O 0 1.6182152839938624e-10

We O 0 2.7248721057304692e-09
studied O 0 4.1707663989143384e-09
somatic O 0 3.046171670462172e-08
instability O 0 7.855044392712784e-10
by O 0 3.434975557031067e-13
measuring O 0 1.821206796481789e-10
the O 0 3.1851710938918254e-12
CTG O 0 1.0336817268807863e-07
repeat O 0 5.775850908662505e-10
length O 0 1.3539603466172778e-11
at O 0 7.952299409252905e-12
several O 0 7.55517271465965e-14
ages O 0 6.82660525330725e-12
in O 0 4.817038423959169e-14
various O 0 4.2910275755824595e-14
tissues O 0 1.933792362351916e-11
of O 0 2.2535916343225e-14
transgenic O 0 4.362361305521034e-10
mice O 0 2.7704869509648233e-09
carrying O 0 3.401701142990987e-11
a O 0 3.442731863478876e-11
( O 0 2.693812360676784e-11
CTG O 0 3.037926532556412e-08
) O 0 5.245003216469701e-12
55expansion O 0 1.6955007398067323e-09
surrounded O 0 6.446408077481758e-12
by O 0 3.017544710198078e-13
45 O 0 2.769891087328613e-12
kb O 0 4.0135866852253343e-10
of O 0 9.088728745575581e-15
the O 0 5.713180579666743e-13
human O 0 1.16209653011623e-09
DM B-Disease 1 1.0
region O 0 2.4676766186004784e-10
, O 0 1.4134192947989899e-12
using O 0 8.94838109860574e-12
small O 0 9.808184264770148e-10
- O 0 3.990522756680548e-08
pool O 0 1.4129099668025447e-08
PCR O 0 2.7789090495389246e-07
. O 0 2.9920058097765434e-10

These O 0 5.1886474283779904e-11
mice O 0 6.0350937580722075e-09
have O 0 5.539401402854249e-13
been O 0 9.988477465928611e-14
shown O 0 3.8497040977117716e-14
to O 0 3.175316793898632e-14
reproduce O 0 7.923990630320787e-11
the O 0 3.5652004352210165e-13
intergenerational O 0 2.256533987443632e-10
and O 0 3.391948831185654e-12
somatic O 0 4.660062336014903e-10
instability O 0 2.824460387795824e-10
of O 0 2.4305076790705378e-14
the O 0 3.1161599450997557e-13
55 O 0 3.319720887073885e-11
CTG O 0 1.5742109837901808e-08
repeat O 0 2.0621671037446276e-10
suggesting O 0 7.928072087715066e-11
that O 0 9.0358933714247e-14
surrounding O 0 1.0215502624583497e-13
sequences O 0 3.8474397279220085e-12
and O 0 4.486568451825268e-13
the O 0 4.3060068450348835e-14
chromatin O 0 1.735114135703597e-11
environment O 0 2.9077859911574855e-12
are O 0 3.5004117659998e-14
involved O 0 3.310664242750505e-12
in O 0 3.8374966399024046e-11
instability O 0 1.1923513287825926e-09
mechanisms O 0 1.168165675302646e-09
. O 0 2.659962805573457e-10

As O 0 9.168683867688543e-11
observed O 0 7.265414398577308e-12
in O 0 4.3509371995022195e-13
some O 0 1.1503745886106732e-14
of O 0 7.803025269993041e-16
the O 0 4.589494542327384e-14
tissues O 0 1.873553395759231e-10
of O 0 2.7686141573779466e-11
DM B-Disease 1 1.0
patients O 0 4.924142871232107e-08
, O 0 1.7117669857524137e-13
there O 0 4.3092217077642103e-13
is O 0 7.361150670135222e-14
a O 0 8.544351207465106e-13
tendency O 0 2.0638078745971455e-10
for O 0 5.747434321003164e-13
repeat O 0 9.789358212941579e-11
length O 0 1.1658318407881119e-11
and O 0 4.971327603048303e-12
somatic O 0 4.619310489673012e-10
mosaicism O 0 3.3050162606684808e-09
to O 0 6.673756599434588e-13
increase O 0 9.717150044677436e-13
with O 0 2.3235382259727266e-13
the O 0 5.229369888504198e-12
age O 0 3.3335295634984163e-10
of O 0 1.9164657450517104e-14
the O 0 1.887608559042464e-12
mouse O 0 1.624690497692427e-07
. O 0 7.502143350990309e-10

Furthermore O 0 1.0157552132739056e-08
, O 0 1.6409755498880685e-11
we O 0 3.721149094155357e-13
observed O 0 1.0817828431002388e-13
no O 0 1.8577157769993774e-13
correlation O 0 2.5051195926689696e-12
between O 0 3.547421687996599e-13
the O 0 2.096130127110518e-12
somatic O 0 3.1488960328118765e-09
mutation O 0 8.459832834262215e-09
rate O 0 7.717253680539216e-08
and O 0 1.3382296139285987e-11
tissue O 0 1.4219145860749904e-09
proliferation O 0 1.792532344779829e-08
capacity O 0 2.395297016288822e-10
. O 0 1.0270338746121155e-10

The O 0 1.401851690285838e-10
somatic O 0 3.3429049750566264e-08
mutation O 0 1.7238813043718437e-08
rates O 0 9.73767200207476e-09
in O 0 1.6935030580558091e-13
different O 0 4.006633553036397e-14
tissues O 0 3.1664660043312365e-12
were O 0 8.050797875580606e-12
also O 0 2.6666337324052214e-13
not O 0 9.250862201921548e-14
correlated O 0 7.779809240403279e-13
to O 0 5.541543989634988e-14
the O 0 4.962240470959833e-13
relative O 0 1.209449346228908e-10
inter O 0 8.16496648070597e-09
- O 0 3.773396262118922e-09
tissue O 0 1.2197713061823379e-08
difference O 0 3.566557466028186e-11
in O 0 1.2968111827438289e-12
transcriptional O 0 7.410962815646016e-11
levels O 0 3.733314872522708e-12
of O 0 1.0432802108586363e-15
the O 0 1.2535257527075336e-14
three O 0 8.712038116745133e-14
genes O 0 1.1527176782544224e-11
( O 0 1.7901438794862279e-12
DMAHP O 0 8.261811679233233e-09
, O 0 4.0080213453697056e-12
DMPK O 0 3.138650228606821e-08
and O 0 1.890978693075418e-11
59 O 0 5.22291272730957e-11
) O 0 7.729088907521692e-14
surrounding O 0 1.5822691464342786e-12
the O 0 1.563746528099319e-11
repeat O 0 1.637451241265353e-08
. O 0 1.7996415122012444e-11
. O 0 7.403276602868658e-11

A O 0 4.337225245620857e-09
novel O 0 4.343036597020955e-09
missense O 0 9.634658226786996e-07
mutation O 0 2.544642541124631e-08
in O 0 1.531297866286252e-10
patients O 0 1.5822202437121291e-09
from O 0 1.97633012385956e-12
a O 0 1.607162493366676e-11
retinoblastoma B-Disease 0 4.318942217196309e-07
pedigree O 0 5.9107346714881714e-06
showing O 0 3.03930605127789e-08
only O 0 1.4923258462307132e-10
mild O 0 5.957809889878263e-07
expression O 0 5.1638363723904845e-11
of O 0 3.316046981276244e-13
the O 0 7.994394209120959e-12
tumor B-Disease 0 2.433224608466844e-07
phenotype O 0 3.816211062712682e-07
. O 0 1.019065276608444e-09

We O 0 1.1500742025383204e-10
have O 0 2.2690554405020713e-13
used O 0 5.095131131241382e-13
single O 0 3.155505154048277e-12
strand O 0 4.223633887079359e-09
conformation O 0 1.4431904282741215e-10
polymorphism O 0 2.1623033918949375e-10
analysis O 0 4.290729663930515e-12
to O 0 1.7273129541278687e-13
study O 0 1.3898510163937172e-12
the O 0 4.704987484685508e-13
27 O 0 2.6515427006823522e-11
exons O 0 2.6650294818186815e-11
of O 0 2.4127206648045553e-14
the O 0 5.614937768211314e-13
RB1 O 0 1.3399090725840779e-09
gene O 0 2.4559881905972247e-11
in O 0 2.866714027618955e-13
individuals O 0 2.291609861127062e-14
from O 0 1.5564425562188816e-13
a O 0 1.2906527409317636e-11
family O 0 8.226658937404707e-11
showing O 0 1.715788755518588e-08
mild O 0 3.4921979477076093e-06
expression O 0 7.455281531010272e-11
of O 0 2.3474324155510484e-13
the O 0 4.396840096870802e-12
retinoblastoma B-Disease 0 3.9309946942012175e-07
phenotype O 0 6.08639220445184e-06
. O 0 5.665705682389444e-09

In O 0 1.4183058894001732e-10
this O 0 7.626875476660078e-13
family O 0 1.441439307324488e-12
affected O 0 4.248113633868039e-13
individuals O 0 7.441698590628012e-15
developed O 0 3.6793158797454595e-11
unilateral B-Disease 0 5.3936862968839705e-05
tumors I-Disease 1 1.0
and O 0 1.8480749153226839e-09
, O 0 7.005238403245961e-13
as O 0 5.839246187272495e-13
a O 0 4.009081749304505e-13
result O 0 9.446899642759354e-13
of O 0 3.073598640141936e-14
linkage O 0 1.6725096863012823e-09
analysis O 0 6.286495629614919e-11
, O 0 7.87276580732632e-12
unaffected O 0 2.2272743649409676e-09
mutation O 0 4.4070348065305964e-11
carriers O 0 1.8981563543185587e-10
were O 0 3.489151675917235e-11
also O 0 8.829123955382545e-13
identified O 0 4.531982428224168e-12
within O 0 2.8713378788340627e-13
the O 0 1.214261156901042e-11
pedigree O 0 3.953349221319513e-07
. O 0 4.31724961336144e-10

A O 0 1.3276706845033459e-08
single O 0 5.400250385756422e-11
band O 0 3.9978152732711436e-11
shift O 0 3.422122307750186e-11
using O 0 4.1468783268383547e-11
SSCP O 0 2.3049658182117128e-07
was O 0 1.8781151633895377e-10
identified O 0 2.1920514015061343e-11
in O 0 7.826766578594713e-13
exon O 0 1.92078047911437e-10
21 O 0 1.2059888677973252e-11
which O 0 1.9934257695052027e-13
resulted O 0 1.385320027094683e-12
in O 0 3.759898208749446e-12
a O 0 4.622331337134078e-11
missense O 0 5.112399321660632e-07
mutation O 0 1.961955709006702e-09
converting O 0 1.2234031565583336e-09
a O 0 3.6189812258058396e-10
cys O 0 0.000341558683430776
- O 0 8.705120535523747e-08
- O 0 5.902742472585487e-08
> O 0 1.6234561472927567e-09
arg O 0 8.025065056926906e-10
at O 0 1.0921562265675533e-11
nucleotide O 0 3.0827389252419124e-11
position O 0 1.0356222129859205e-10
28 O 0 2.3105121982336385e-11
in O 0 4.635148168063985e-12
the O 0 1.8764627438688786e-12
exon O 0 1.1397397692292088e-08
. O 0 3.5280475763066477e-10

The O 0 8.160630504683297e-11
mutation O 0 1.2892614753567955e-09
destroyed O 0 2.0443140513748403e-09
an O 0 7.849255967418145e-12
NdeI O 0 1.9428789244102518e-08
restriction O 0 3.5880403093102586e-09
enzyme O 0 5.753325371671281e-09
site O 0 1.0807662542688945e-09
. O 0 2.583677161105413e-10

Analysis O 0 3.059986986020391e-10
of O 0 3.2582416582480067e-13
all O 0 1.7191813023089558e-13
family O 0 3.8474450947227623e-13
members O 0 3.864680995471943e-15
demonstrated O 0 3.021455427434233e-13
that O 0 4.644346701925678e-14
the O 0 3.021472774668993e-13
missense O 0 1.7283677777868434e-07
mutation O 0 4.6405599363197325e-09
co O 0 3.393625291892022e-08
- O 0 4.0665422140762075e-09
segregated O 0 2.8514657302025626e-10
with O 0 1.123093154933863e-12
patients O 0 1.6403011171561843e-09
with O 0 4.301693549979557e-12
tumors B-Disease 1 1.0
or O 0 2.3097225465562587e-08
who O 0 2.6519095808197335e-09
, O 0 5.924270405840981e-13
as O 0 1.86361516496536e-12
a O 0 4.563922156863853e-12
result O 0 5.492576012067207e-12
of O 0 3.143769221184735e-14
linkage O 0 4.014321652867636e-10
analysis O 0 3.045987073679868e-11
had O 0 1.108281910688902e-09
been O 0 5.687202445092687e-11
predicted O 0 5.3196919092002304e-11
to O 0 7.54920960271098e-14
carry O 0 2.4650129160086465e-11
the O 0 6.42774548864633e-12
predisposing O 0 3.6319434570941667e-08
mutation O 0 6.731490476141744e-09
. O 0 1.0116557591643982e-09

These O 0 9.419142549260684e-12
observations O 0 2.524768762113272e-11
point O 0 6.821867289813488e-12
to O 0 7.402192465748303e-14
another O 0 4.2847000361785625e-13
region O 0 4.370026909783498e-12
of O 0 8.34633740159213e-14
the O 0 1.2749343681478509e-12
RB1 O 0 2.2381720921060833e-09
gene O 0 1.6730535359887888e-11
where O 0 2.4606464327052435e-13
mutations O 0 6.127750216966543e-12
only O 0 2.0036798826020275e-13
modify O 0 1.2921601288962137e-11
the O 0 4.49960977765701e-14
function O 0 2.392389400734246e-13
of O 0 1.3214491553412665e-14
the O 0 2.2345759140632304e-13
gene O 0 6.274448738352589e-10
and O 0 7.735177082190958e-11
raise O 0 4.0408665996638504e-12
important O 0 1.4205135548742143e-12
questions O 0 3.2129459683061246e-12
for O 0 5.318608306049445e-14
genetic O 0 3.42685324561387e-10
counseling O 0 1.0765773827969838e-09
in O 0 9.708184776913154e-13
families O 0 2.8223557930855125e-13
with O 0 8.274596421465122e-14
these O 0 9.722935347469819e-13
distinctive O 0 1.6920117529295453e-09
phenotypes O 0 1.0026277585950538e-08
. O 0 5.4566892671026324e-11
. O 0 1.2041116714822664e-10

Maternal B-Disease 0 4.791580431628972e-05
disomy I-Disease 0 0.0001021076604956761
and O 0 4.75604974781163e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 4.366425887525338e-09
with O 0 9.616920974842014e-13
gamete O 0 5.126950863854063e-09
complementation O 0 3.437370708070375e-07
in O 0 1.5921694518361562e-11
a O 0 1.5775450390442813e-11
case O 0 4.201470074627345e-11
of O 0 4.649392849886969e-13
familial O 0 2.2660255183382105e-07
translocation O 0 4.163646494248496e-08
( O 0 1.2617826228300544e-10
3 O 0 1.195563439915226e-11
; O 0 3.4467049440239927e-12
15 O 0 3.5621844016175963e-12
) O 0 3.165564327594489e-13
( O 0 1.0677537413267268e-12
p25 O 0 9.154271785050128e-10
; O 0 1.0191920007604494e-12
q11 O 0 6.502540728092754e-10
. O 0 1.2754938164688534e-12
2 O 0 3.856359242354612e-12
) O 0 3.3033098825741014e-12
. O 0 2.7245159253674878e-11

Maternal B-Disease 0 0.0017395406030118465
uniparental I-Disease 0 0.019198715686798096
disomy I-Disease 0 0.0006799678667448461
( I-Disease 0 6.022998633170573e-08
UPD I-Disease 1 0.9999992847442627
) I-Disease 0 3.990035298689909e-12
for I-Disease 0 7.056125296686297e-14
chromosome I-Disease 0 6.4693157497686116e-09
15 I-Disease 0 1.002144374429026e-11
is O 0 5.959559153676311e-14
responsible O 0 1.3063284991492868e-13
for O 0 3.462348815855623e-15
an O 0 4.711466185589172e-15
estimated O 0 1.9851202387628775e-13
30 O 0 6.457086384678568e-13
% O 0 1.6166641593137743e-13
of O 0 3.415843996545931e-14
cases O 0 7.771778359755288e-11
of O 0 8.03927058257159e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.617579918431147e-07
PWS B-Disease 1 1.0
) O 0 6.268709551449092e-09
. O 0 1.4426793093491597e-09

We O 0 1.2226194501252508e-09
report O 0 2.5738239664563345e-11
on O 0 3.570045192628768e-13
an O 0 6.897006430599609e-15
unusual O 0 1.6026771923471905e-12
case O 0 1.2176031016775113e-11
of O 0 9.279118543415593e-14
maternal B-Disease 0 2.317452674205356e-09
disomy I-Disease 0 3.370460532892139e-08
15 I-Disease 0 9.739273623687872e-12
in O 0 9.544056517318822e-11
PWS B-Disease 1 1.0
that O 0 3.2828585769945073e-12
is O 0 1.3330288750005442e-13
most O 0 9.75986801684918e-14
consistent O 0 3.86408266495053e-12
with O 0 5.2860611497544934e-15
adjacent O 0 4.702782867987976e-12
- O 0 3.6722875851324943e-09
1 O 0 8.99224965322798e-12
segregation O 0 8.354792552234258e-11
of O 0 2.506636967490681e-14
a O 0 6.094623503788421e-12
paternal O 0 3.2487182721752106e-08
t O 0 7.668539581118239e-08
( O 0 2.0188808957932736e-11
3 O 0 6.660305987282733e-12
; O 0 2.092547055770888e-12
15 O 0 7.0876546819087505e-12
) O 0 6.536764944435614e-13
( O 0 1.3324804584366468e-12
p25 O 0 1.433129614980544e-09
; O 0 1.8457082650441548e-12
q11 O 0 5.843902028956904e-10
. O 0 3.8330886316557955e-13
2 O 0 2.9642250026079564e-13
) O 0 2.2858390256574185e-14
with O 0 1.3126969333038772e-14
simultaneous O 0 7.812873958901179e-11
maternal O 0 1.084305800702623e-08
meiotic O 0 4.5331674414228473e-08
nondisjunction O 0 3.473406806620005e-08
for O 0 4.18886540037855e-12
chromosome O 0 1.0453279486455358e-07
15 O 0 7.761191134214585e-10
. O 0 2.680078659000884e-10

The O 0 1.165296747984712e-10
patient O 0 2.113465136233117e-08
( O 0 1.865397593336926e-11
J O 0 5.1093525854639665e-08
. O 0 2.8586001296106167e-13
B O 0 1.918887271301628e-10
. O 0 1.2556795033825171e-14
) O 0 1.2451950989679928e-14
, O 0 3.239797685228134e-14
a O 0 8.994028937413245e-13
17 O 0 4.626017971465224e-11
- O 0 5.211012177319674e-11
year O 0 3.413022642284602e-11
- O 0 3.032637752031775e-10
old O 0 2.192326675753975e-08
white O 0 3.228594128157347e-11
male O 0 3.570552881138056e-11
with O 0 4.7690753256224294e-12
PWS B-Disease 1 1.0
, O 0 3.7134019817419706e-12
was O 0 3.77296041631503e-11
found O 0 1.4818835178051493e-12
to O 0 3.118340614481803e-14
have O 0 4.219221272274559e-13
47 O 0 1.461429501720124e-12
chromosomes O 0 3.8260492864206075e-12
with O 0 2.0037410044995013e-13
a O 0 1.5392159768978786e-10
supernumerary O 0 5.8966648794012144e-05
, O 0 1.2958721769262826e-11
paternal O 0 3.956463956455991e-08
der O 0 0.00040708057349547744
( O 0 2.2670462729301732e-11
15 O 0 1.2921620154079938e-12
) O 0 1.3943660713089476e-14
consisting O 0 3.9932975275016463e-14
of O 0 7.055505946195265e-14
the O 0 3.08078146327162e-11
short O 0 2.0319084796938114e-06
arm O 1 0.7191758155822754
and O 0 7.30476928945123e-11
the O 0 8.916516613596825e-13
proximal O 0 1.3366067364017908e-08
long O 0 2.381454144995132e-09
arm O 0 1.2131851690355688e-05
of O 0 1.3051761277652063e-12
chromosome O 0 8.033791800698964e-07
15 O 0 2.2991022419205365e-09
, O 0 1.6151647727613572e-11
and O 0 6.929774809538713e-11
distal O 0 1.3945053751740488e-06
chromosome O 0 0.0010759199503809214
arm O 1 0.9644225239753723
3p O 0 0.002775875385850668
. O 0 2.666731901967978e-08

The O 0 9.679424622932586e-11
t O 0 2.62288555319401e-08
( O 0 5.151242279954893e-12
3 O 0 5.82117578966368e-13
; O 0 8.837307513380466e-14
15 O 0 1.5148010612791446e-13
) O 0 1.156856762349421e-14
was O 0 2.943111466341408e-12
present O 0 1.010438223570569e-14
in O 0 2.3648327762172683e-13
the O 0 1.4686682249585685e-14
balanced O 0 4.67104490937259e-13
state O 0 2.1921024633627002e-14
in O 0 1.0430570253003313e-12
the O 0 1.0649855563399369e-12
patients O 0 1.3148471200707945e-10
father O 0 7.263727119788399e-11
and O 0 4.6515681931258435e-12
a O 0 4.835954553472632e-11
sister O 0 7.136951580832829e-07
. O 0 4.705874578903035e-10

Fluorescent O 0 2.9221317277006165e-07
in O 0 3.201998111102e-10
situ O 0 2.3314981056898887e-09
hybridization O 0 8.752958774449482e-11
analysis O 0 1.631861486217634e-11
demonstrated O 0 9.607464997174464e-12
that O 0 3.442570664299871e-13
the O 0 8.00415983492897e-12
PWS B-Disease 1 1.0
critical O 0 1.3429633793915485e-10
region O 0 1.017903122901842e-10
resided O 0 8.152016839346743e-10
on O 0 6.6162192911833895e-12
the O 0 1.2635556392425612e-13
derivative O 0 6.409874020452122e-11
chromosome O 0 1.8730747508577394e-10
3 O 0 1.6985568767474701e-12
and O 0 4.844868538474156e-13
that O 0 1.9770189446047942e-13
there O 0 4.790179971431163e-12
was O 0 1.9446827481672813e-10
no O 0 2.7974040184980398e-12
deletion O 0 3.4566679379954834e-11
of O 0 5.417625779957115e-14
the O 0 1.0327712643420917e-11
PWS B-Disease 1 1.0
region O 0 1.016173256651598e-09
on O 0 5.540308212204081e-10
the O 0 1.7557938609968904e-12
normal O 0 4.6201387160493823e-10
pair O 0 3.283864014047566e-10
of O 0 2.5755843313136906e-13
15s O 0 1.1010291983692966e-10
present O 0 2.619001153100764e-12
in O 0 2.078768962521238e-10
J O 0 7.440608169417828e-05
. O 0 7.394009293726356e-10

B O 0 0.0006978195160627365
. O 0 2.612998706297276e-08

Methylation O 0 1.2538625071556453e-07
analysis O 0 3.860152752999113e-10
at O 0 1.9251772051531724e-11
exon O 0 7.552937442145691e-11
alpha O 0 1.129609600303283e-11
of O 0 1.922572513788235e-14
the O 0 5.935577956873647e-14
small O 0 1.0704499786573507e-11
nuclear O 0 1.229926915868873e-08
ribonucleoprotein O 0 1.0623566737422152e-07
- O 0 1.2810547067587663e-09
associated O 0 2.1568623276291277e-10
polypeptide O 0 1.4555127769710907e-08
N O 0 1.2301022422889218e-09
( O 0 3.362004468224211e-12
SNRPN O 0 1.1214679185300724e-09
) O 0 5.209496571102756e-13
gene O 0 3.2685915085650663e-10
showed O 0 2.309351376794666e-09
a O 0 1.303325850021686e-11
pattern O 0 2.5972162198684146e-09
characteristic O 0 8.452775979161942e-11
of O 0 9.826552549094258e-14
only O 0 1.589371212765145e-12
the O 0 7.884121957721368e-13
maternal O 0 2.7296163107592974e-09
chromosome O 0 1.0104454872816859e-07
15 O 0 7.454574180165707e-10
in O 0 5.356572962966766e-10
J O 0 0.0009600779740139842
. O 0 2.0493071684057895e-09

B O 0 0.0008803478558547795
. O 0 1.525079262876261e-08

Maternal B-Disease 0 2.9484490369213745e-05
disomy I-Disease 0 2.3539505491498858e-05
was O 0 3.73993458424593e-09
confirmed O 0 1.8626636691387866e-11
by O 0 1.9311024743802647e-14
polymerase O 0 6.866961166362984e-11
chain O 0 4.656789884260881e-11
reaction O 0 2.3276111940639943e-12
analysis O 0 9.559860498706274e-13
of O 0 3.306628245953319e-14
microsatellite O 0 1.7223750203854138e-09
repeats O 0 7.285028691406126e-10
at O 0 8.940362339338037e-12
the O 0 2.0109350924897573e-13
gamma O 0 1.1792042897695865e-09
- O 0 3.16824078083755e-09
aminobutyric O 0 4.199986136654843e-08
acid O 0 7.81094078305955e-10
receptor O 0 1.4136605774872635e-10
beta3 O 0 2.761312734023136e-09
subunit O 0 1.0585713416944031e-09
( O 0 3.168823883847871e-11
GABRB3 O 0 2.3638603963149762e-08
) O 0 1.5089804406009932e-11
locus O 0 3.209226884237637e-09
. O 0 1.25211441215356e-09

A O 0 3.9410466001754685e-08
niece O 0 9.227148893842241e-07
( O 0 9.488062419071852e-11
B O 0 7.558273451557795e-10
. O 0 1.1986859259089516e-13
B O 0 2.634568951886962e-11
. O 0 2.439460605564779e-15
) O 0 2.383541819727655e-15
with O 0 5.119928766161245e-15
45 O 0 1.964655516181399e-13
chromosomes O 0 1.8131187740424992e-12
and O 0 8.954556931020652e-13
the O 0 6.621944339440036e-14
derivative O 0 2.8906796400995916e-10
3 O 0 4.5075230982634384e-13
but O 0 1.6454095030926652e-12
without O 0 3.6635351328105636e-13
the O 0 8.79476477538485e-14
der O 0 6.353272397063847e-07
( O 0 3.5899633417900423e-13
15 O 0 9.935825220300926e-14
) O 0 1.2313361152916074e-14
demonstrated O 0 6.972885268317908e-13
a O 0 9.764606657969299e-12
phenotype O 0 3.4942302384877166e-09
consistent O 0 1.805521704367763e-10
with O 0 7.709565814527017e-14
that O 0 6.353001891917787e-13
reported O 0 4.560863631208889e-10
for O 0 1.9808689465192902e-13
haploinsufficiency O 0 8.002034590504081e-09
of O 0 1.0786393479789158e-12
distal O 0 2.483443211076519e-07
3 O 0 3.106777723971277e-09
p O 0 6.101240160205634e-06
. O 0 1.2726574238897115e-09

Uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999996423721313
associated O 0 3.963155492670012e-08
with O 0 6.627627613386977e-11
unbalanced O 0 2.6904848709818907e-05
segregation O 0 3.4913256730106923e-09
of O 0 2.6116720006248706e-13
non O 0 2.1086201673625737e-09
- O 0 2.1493367086122817e-08
Robertsonian O 0 4.949661658315563e-08
translocations O 0 2.3850424213378574e-07
has O 0 2.2132379262629343e-11
been O 0 2.4609903958444646e-12
reported O 0 8.109999477534657e-11
previously O 0 1.6293726350785631e-12
but O 0 3.06832987836958e-12
has O 0 1.0540983504895435e-13
not O 0 2.2930923381913465e-14
, O 0 4.460352680463794e-15
to O 0 4.557912664779123e-15
our O 0 6.961768028647831e-15
knowledge O 0 6.212203332040672e-14
, O 0 5.7583574037810715e-15
been O 0 4.3032257986998224e-13
observed O 0 1.2175484687300397e-13
in O 0 6.948336762728491e-13
a O 0 8.955193357695901e-12
case O 0 2.3522764291961096e-10
of O 0 1.0382996545876821e-11
PWS B-Disease 1 0.9999998807907104
. O 0 1.1823978462999207e-09

Furthermore O 0 8.17631207183922e-09
, O 0 3.01186679763088e-11
our O 0 7.891794856496048e-13
findings O 0 6.320092019174162e-13
are O 0 4.8657763609310026e-14
best O 0 1.380466704489769e-12
interpreted O 0 4.289976360261072e-12
as O 0 8.31286699632533e-13
true O 0 1.8450336744524343e-11
gamete O 0 3.5886562610443207e-09
complementation O 0 2.9874988172196026e-07
resulting O 0 4.0459993688735096e-10
in O 0 1.0809765305097585e-09
maternal B-Disease 0 4.053608063259162e-05
UPD I-Disease 1 1.0
15 I-Disease 0 8.453029920474364e-08
and O 0 1.4435001638446465e-08
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9998787641525269
- I-Disease 1 0.9999996423721313
Jampel I-Disease 1 0.9999923706054688
syndrome I-Disease 1 1.0
type I-Disease 0 1.4057698081160197e-06
2 I-Disease 0 4.5494275013879815e-11
and O 0 2.7366720001253952e-11
Stuve B-Disease 1 0.9889418482780457
- I-Disease 1 0.9999997615814209
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 4.88360523895337e-12
a O 0 4.967773154646027e-12
case O 0 4.074869261461167e-11
for O 0 2.110631954583761e-13
" O 0 3.406674942141308e-11
lumping O 0 5.549466997045727e-10
" O 0 2.143611121940836e-10
. O 0 4.4782118985287056e-11

Recent O 0 3.12244757827429e-10
studies O 0 4.478741683078269e-11
demonstrated O 0 7.845812541318331e-12
the O 0 1.2725740837352725e-14
existence O 0 2.625591801266869e-13
of O 0 8.658179357387379e-15
a O 0 7.089328039541765e-13
genetically O 0 3.7739825153870754e-11
distinct O 0 1.6445254880093074e-11
, O 0 1.9871706277013734e-12
usually O 0 6.246377655567958e-13
lethal O 0 1.2519937343802301e-11
form O 0 5.039396417522157e-12
of O 0 2.35843652550069e-13
the O 0 1.1308151637301478e-10
Schwartz B-Disease 1 0.9999966621398926
- I-Disease 1 0.9999990463256836
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 8.84927242594813e-09
SJS B-Disease 1 0.9998262524604797
) O 0 1.1345824453556919e-11
of O 0 1.953431773976666e-12
myotonia B-Disease 0 0.006495484616607428
and O 0 8.646010130064496e-09
skeletal B-Disease 1 0.9999376535415649
dysplasia I-Disease 1 1.0
, O 0 5.3624989865275197e-11
which O 0 4.410917811559223e-12
we O 0 5.5397134796075775e-11
called O 0 2.022409573143591e-09
SJS B-Disease 1 0.9999094009399414
type I-Disease 0 9.340092219645157e-07
2 I-Disease 0 3.708479079378435e-10
. O 0 1.900967994128422e-10

This O 0 5.435390360020165e-09
disorder O 0 0.003204461419954896
is O 0 3.366875138063885e-12
reminiscent O 0 1.1520896736616493e-10
of O 0 5.20234456370932e-14
another O 0 1.3225076415934733e-11
rare O 0 1.531690108080852e-09
condition O 0 1.0110012226505205e-05
, O 0 4.920178305577172e-13
the O 0 3.1817586759741445e-12
Stuve B-Disease 1 0.9999010562896729
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.060274948538336e-09
SWS B-Disease 0 0.00044600022374652326
) O 0 7.370178252419368e-12
, O 0 3.51482406547865e-13
which O 0 2.3762361436169277e-13
comprises O 0 8.16323842290495e-13
campomelia B-Disease 0 2.8568852172838888e-08
at O 0 1.5533577202297977e-10
birth O 0 8.121350258960547e-10
with O 0 1.0985094778259707e-11
skeletal B-Disease 1 0.9339011311531067
dysplasia I-Disease 1 0.9999996423721313
, O 0 1.254236298153799e-10
contractures B-Disease 0 1.0896370667978772e-06
, O 0 2.7289223658577555e-10
and O 0 9.598861289150662e-11
early B-Disease 0 9.139328227547594e-08
death I-Disease 0 1.3212004823515144e-09
. O 0 5.421706833486084e-11

To O 0 6.838389576824255e-11
test O 0 2.452884423354007e-11
for O 0 3.460910892724364e-14
possible O 0 1.2806397652401214e-12
nosologic O 0 1.7680097386119087e-08
identity O 0 2.0437164460762602e-10
between O 0 1.0030296905549907e-11
these O 0 3.195955999846234e-11
disorders O 0 1.9168792277923785e-06
, O 0 5.375660379618348e-14
we O 0 7.629301650071557e-14
reviewed O 0 2.0027247004880677e-13
the O 0 1.780436361832464e-15
literature O 0 4.508408891438359e-13
and O 0 7.229327948993572e-14
obtained O 0 9.8681978387416e-13
a O 0 7.444602660028332e-13
follow O 0 6.144170242028402e-12
- O 0 2.1327507815360747e-10
up O 0 1.5981998710556944e-11
of O 0 7.92854009442484e-15
the O 0 5.757986996273237e-14
only O 0 2.539767712545632e-13
two O 0 6.575777655682888e-14
surviving O 0 1.327914340987224e-11
patients O 0 1.1966265651974783e-11
, O 0 2.3974859302152395e-14
one O 0 8.256387923604586e-14
with O 0 3.7974042313426715e-12
SJS B-Disease 1 0.9845231771469116
type I-Disease 0 2.1410228256968367e-08
2 I-Disease 0 9.066148005942853e-12
at O 0 7.319932993077316e-10
age O 0 7.691119408015368e-10
10 O 0 4.862670596045282e-13
years O 0 1.9581161507780526e-13
and O 0 4.230936686611987e-14
another O 0 2.4832303639581166e-13
with O 0 5.90522693678236e-13
SWS B-Disease 0 0.00016209988098125905
at O 0 5.381149414951381e-10
age O 0 2.262653953089e-10
7 O 0 1.6380641634783366e-11
years O 0 1.574875299614753e-11
. O 0 2.071596019725952e-11

Patients O 0 2.9694227123400196e-05
reported O 0 7.988020911398053e-09
as O 0 8.118925670652644e-12
having O 0 6.64042015818822e-11
either O 0 1.0908404846077246e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 6.095460491906124e-08
SWS B-Disease 0 0.00012921950838062912
presented O 0 3.9695195047650955e-11
a O 0 3.209356608593894e-12
combination O 0 2.2657115072988177e-10
of O 0 6.754099233022282e-13
a O 0 3.6072106412987637e-10
severe O 0 7.44655471862643e-06
, O 0 3.555121752540913e-10
prenatal O 1 0.9899455904960632
- O 0 0.0006820765556767583
onset O 0 0.0029205253813415766
neuromuscular B-Disease 1 0.9999991655349731
disorder I-Disease 1 0.9999995231628418
( O 0 2.648056773857377e-10
with O 0 8.600195555708012e-11
congenital B-Disease 1 1.0
joint I-Disease 0 3.224665852030739e-05
contractures I-Disease 1 0.9999988079071045
, O 0 8.28394404379651e-05
respiratory O 1 1.0
and O 0 1.2957992456819056e-09
feeding O 0 1.924822967680484e-09
difficulties O 0 2.233821794206392e-09
, O 0 2.8929584964566823e-13
tendency O 0 4.3469436383780646e-11
to O 0 6.878650860714375e-12
hyperthermia B-Disease 0 7.733890015515499e-06
, O 0 8.851757000993832e-12
and O 0 3.0549571119337093e-12
frequent O 0 8.268665752098059e-10
death O 0 8.557889508153949e-09
in O 0 6.041540046020089e-10
infancy O 0 8.11617013596333e-08
) O 0 4.082603938075635e-14
with O 0 1.0894311609787894e-14
a O 0 3.249659872792132e-12
distinct O 0 5.942431546834825e-10
campomelic B-Disease 1 0.8097989559173584
- I-Disease 0 0.04776681214570999
metaphyseal I-Disease 0 0.09224115312099457
skeletal I-Disease 1 0.9992089867591858
dysplasia I-Disease 1 0.9999970197677612
. O 0 1.3316904912130667e-08

The O 0 4.8943570550574744e-12
similarity O 0 1.8481575644879733e-11
of O 0 1.2605556179499759e-14
the O 0 4.9095452638210635e-14
clinical O 0 8.151044075810354e-12
and O 0 9.229910672564623e-13
radiographic O 0 1.0236944625319211e-08
findings O 0 3.708521545409127e-10
is O 0 2.1998449069304815e-12
so O 0 5.388227841338078e-13
extensive O 0 4.004068669509475e-13
that O 0 5.104206445526172e-13
these O 0 1.5120365896847954e-12
disorders O 0 3.309850171717699e-08
appear O 0 1.787074481451878e-11
to O 0 8.977455823004632e-13
be O 0 2.5435809708485024e-11
a O 0 1.006362181088516e-11
single O 0 1.2179125763456256e-10
entity O 0 2.2772686847361e-08
. O 0 6.582796530096857e-09

The O 0 1.7579595765204736e-11
follow O 0 3.5903779949109094e-11
- O 0 1.233221857965816e-09
up O 0 1.1297453424152781e-11
observation O 0 4.354686056196044e-11
of O 0 1.65276795613227e-14
an O 0 5.607218519793761e-14
identical O 0 2.042647821720589e-11
and O 0 1.5211108197674128e-12
unique O 0 1.7055496554993499e-12
pattern O 0 6.590726542299308e-08
of O 0 3.358257075203319e-11
progressive O 0 2.240128424091381e-06
bone B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
in O 0 6.165647992162349e-10
the O 0 1.5221236814369488e-12
two O 0 4.0796034085632815e-12
patients O 0 1.3044307300980051e-10
( O 0 1.4446863844108648e-13
one O 0 9.84546754019544e-13
with O 0 3.949912966150215e-11
SJS B-Disease 1 0.9999984502792358
type I-Disease 0 8.764363883528858e-06
2 I-Disease 0 1.3910776697212413e-10
, O 0 8.52978191551168e-12
one O 0 4.507190627667246e-12
with O 0 1.5645700013333652e-11
SWS B-Disease 0 6.179186311783269e-05
) O 0 1.0598101172695773e-12
surviving O 0 9.09780098479196e-11
beyond O 0 1.3244318142202616e-10
infancy O 0 8.036514742570944e-08
adds O 0 1.6185455753436884e-10
to O 0 2.3981400090571092e-14
the O 0 2.5305986825355578e-14
evidence O 0 1.833959850303102e-12
in O 0 5.93420007143769e-13
favor O 0 3.83639647827394e-12
of O 0 6.60106125034525e-14
identity O 0 1.3546748167669875e-09
. O 0 1.2938526638972547e-10

The O 0 6.393049284403318e-11
hypothesis O 0 7.92021670470433e-10
that O 0 5.265403044130146e-11
SWS B-Disease 0 0.003328615101054311
and O 0 2.2574908609129807e-09
SJS B-Disease 1 0.9999427795410156
type I-Disease 0 6.840447497324931e-08
2 I-Disease 0 2.8956706824012635e-12
are O 0 1.4698011145848622e-13
the O 0 4.2792689964460395e-13
same O 0 5.094539456962366e-09
disorder O 0 3.2081627523439238e-06
should O 0 1.3074310514435417e-12
be O 0 5.786656689845543e-14
testable O 0 6.543841423595209e-12
by O 0 5.923182815536707e-14
molecular O 0 1.3876637686149884e-11
methods O 0 2.2871257665535438e-10
. O 0 1.5551325852070086e-11
. O 0 1.239122970897455e-10

A O 0 6.25106277851728e-09
mouse O 0 7.752587549703094e-08
model O 0 4.096248229501498e-09
of O 0 1.6793774704204623e-11
severe O 1 0.9999836683273315
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.014038518071174622
defects O 1 0.9999905824661255
in O 0 2.995222292412336e-09
hemostasis O 0 0.001500889309681952
and O 0 3.5432314859917824e-08
thrombosis B-Disease 0 0.0046418458223342896
. O 0 1.82422887906597e-09

von B-Disease 0 0.36934956908226013
Willebrand I-Disease 0 0.03158285468816757
factor I-Disease 0 1.5736877685412765e-06
( I-Disease 0 3.2047143605495876e-08
vWf I-Disease 0 0.00018179905600845814
) I-Disease 0 1.5046853150124662e-06
deficiency I-Disease 1 0.9999997615814209
causes O 0 0.017458658665418625
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 1.9661863461806206e-06
humans O 0 1.7819893116666208e-07
. O 0 3.9835401643983914e-09

We O 0 1.1018569390230937e-10
generated O 0 4.655393692071241e-12
a O 0 2.491624311387608e-12
mouse O 0 9.968912362268156e-10
model O 0 6.646806716137377e-11
for O 0 1.9840112354656964e-13
this O 0 1.8436430767460044e-12
disease O 0 9.93466489629391e-11
by O 0 3.184463055663084e-14
using O 0 1.1895992003962963e-11
gene O 0 2.3798238935057725e-09
targeting O 0 2.220111738893138e-08
. O 0 9.813085899423868e-10

vWf B-Disease 0 0.0010736810509115458
- I-Disease 1 0.9998241066932678
deficient I-Disease 1 0.9969743490219116
mice O 0 2.6683796022552997e-05
appeared O 0 2.4666343634294208e-08
normal O 0 9.881000462286238e-10
at O 0 1.4315681452770068e-11
birth O 0 1.7008683957792092e-12
; O 0 1.811865646395277e-14
they O 0 2.3979079897921973e-13
were O 0 1.8647252145176374e-11
viable O 0 3.3169267332766594e-09
and O 0 1.7131013621551894e-11
fertile O 0 8.075011770358742e-10
. O 0 5.508959399769253e-10

Neither O 0 7.568232831545174e-07
vWf O 0 1.4828367056907155e-05
nor O 0 2.339929551453679e-06
vWf O 0 3.441448643570766e-05
propolypeptide O 0 6.818102701799944e-05
( O 0 1.490961842876004e-08
von B-Disease 0 0.00022062550124246627
Willebrand I-Disease 0 3.4013690310530365e-05
antigen O 0 1.0499037728095573e-07
II O 0 5.1366345843462113e-08
) O 0 3.0237689522399913e-12
were O 0 1.0361848531981188e-11
detectable O 0 4.2774964126301995e-10
in O 0 1.4972452531264446e-12
plasma O 0 2.9997829220640426e-10
, O 0 5.8497169781734915e-12
platelets O 0 4.5712444940448904e-10
, O 0 8.444162253110066e-13
or O 0 1.7952292430400973e-11
endothelial O 0 2.071999169461769e-11
cells O 0 2.642515546658064e-11
of O 0 6.648799349626144e-14
the O 0 5.287599243002095e-13
homozygous O 0 8.257133643496672e-09
mutant O 0 6.742788372093855e-08
mice O 0 3.429928028708673e-06
. O 0 1.2160283890949586e-09

The O 0 1.3114083430298962e-10
mutant O 0 1.492562944349629e-07
mice O 0 3.5491779271978885e-05
exhibited O 0 1.0446060514368583e-06
defects O 0 0.0022164287511259317
in O 0 4.145367729635474e-11
hemostasis O 0 8.648471805372537e-08
with O 0 5.628665936119326e-12
a O 0 7.876919116966974e-10
highly O 0 1.4931353575775574e-07
prolonged O 0 0.0001403342030243948
bleeding O 1 0.9998025298118591
time O 0 2.3314036812216443e-10
and O 0 3.1336388345293287e-11
spontaneous O 0 1.9295307018829533e-10
bleeding O 0 5.466246875585057e-06
events O 0 8.963831196404093e-14
in O 0 1.6834614485847915e-13
approximately O 0 1.251481557273948e-13
10 O 0 6.967606830041162e-13
% O 0 7.07739802093682e-13
of O 0 6.123015506079299e-13
neonates O 0 3.1741276274033225e-08
. O 0 1.1958560530711537e-10

As O 0 7.593193435129209e-11
in O 0 1.3144346722171463e-12
the O 0 6.664442354096037e-14
human O 0 1.4597135349417312e-12
disease O 0 1.8067833895685226e-09
, O 0 1.4110831643779354e-13
the O 0 6.099862368685871e-14
factor O 0 2.3132945212167577e-11
VIII O 0 1.9298454390082043e-08
level O 0 6.288690401756725e-11
in O 0 4.731256077021573e-13
these O 0 2.8080296876793753e-13
mice O 0 4.449820512064662e-09
was O 0 1.182336450966659e-10
reduced O 0 6.659590955949979e-13
strongly O 0 2.867381083005577e-13
as O 0 1.5873828401909151e-13
a O 0 3.6427642586406295e-13
result O 0 1.1441393622454998e-12
of O 0 1.4681276485316308e-14
the O 0 5.208780997668916e-13
lack O 0 2.594570044922584e-11
of O 0 1.9814497739518815e-14
protection O 0 1.6240545150023045e-12
provided O 0 5.731036305245407e-13
by O 0 1.9777781842811315e-12
vWf O 0 7.13757870585141e-08
. O 0 1.8562424930479438e-09

Defective O 0 0.005214255768805742
thrombosis B-Disease 0 0.005569565109908581
in O 0 6.006920516554715e-10
mutant O 0 1.3919575714282928e-08
mice O 0 6.392695013346383e-06
was O 0 8.584652100296353e-09
also O 0 4.865920600477525e-12
evident O 0 1.069923403346218e-11
in O 0 2.12980024241749e-13
an O 0 2.5407939099018895e-14
in O 0 7.875915631477826e-13
vivo O 0 1.2363966517270342e-09
model O 0 2.875897298082464e-10
of O 0 1.5738002914766902e-11
vascular B-Disease 1 0.9997121691703796
injury I-Disease 0 0.0007950504077598453
. O 0 2.5577490125883173e-10

In O 0 1.0457752719350566e-10
this O 0 3.5930324470898056e-13
model O 0 1.7621019227087587e-11
, O 0 1.874465616362106e-13
the O 0 2.893201357743319e-13
exteriorized O 0 2.820140565518159e-08
mesentery O 0 3.817047655729766e-08
was O 0 1.781868763650607e-09
superfused O 0 3.0958107188894246e-09
with O 0 7.439520462344806e-13
ferric O 0 2.175467805898279e-09
chloride O 0 1.0558727503440224e-10
and O 0 8.069307375069279e-12
the O 0 6.389994870042992e-13
accumulation O 0 1.1234643423896351e-11
of O 0 5.894792304023816e-14
fluorescently O 0 1.5395456021138898e-09
labeled O 0 3.1389357779687543e-09
platelets O 0 5.353595611268247e-08
was O 0 1.99714800253048e-09
observed O 0 8.677833625292397e-12
by O 0 3.850853663722731e-12
intravital O 0 3.661937597598808e-08
microscopy O 0 1.8155242642592384e-08
. O 0 5.486958665201769e-10

We O 0 2.007310095919479e-09
conclude O 0 1.013929384896528e-09
that O 0 1.1584627029360972e-13
these O 0 9.583589618503835e-14
mice O 0 1.488940415406148e-09
very O 0 1.8568462739620983e-11
closely O 0 6.317339013017786e-11
mimic O 0 2.2787720155292845e-08
severe O 0 9.59010662882065e-07
human O 0 1.2447856967412463e-08
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.010556802153587341
will O 0 2.0185788596194243e-09
be O 0 7.286216768820353e-12
very O 0 2.6203353722942246e-12
useful O 0 4.730471114648693e-13
for O 0 4.486409955020178e-15
investigating O 0 4.140172091878641e-13
the O 0 1.9889394086780934e-14
role O 0 2.320225446234697e-13
of O 0 6.44452947698936e-15
vWf O 0 1.0431874114535944e-10
in O 0 1.3466151804752968e-11
normal O 0 4.6896051486555734e-09
physiology O 0 3.6610137144066357e-09
and O 0 5.8600351134086015e-12
in O 0 2.044530343636719e-11
disease O 0 3.9681382624223716e-09
models O 0 3.9310052435403975e-10
. O 0 5.149150203442865e-12
. O 0 6.928215640078506e-11

Oral O 0 1.6034501015838032e-07
contraceptives O 0 1.6804246115498245e-05
and O 0 1.8608453319912677e-11
the O 0 9.702372369066459e-13
risk O 0 1.4484231591893604e-08
of O 0 1.0996294153020614e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3888102607116934e-09

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 0.9999995231628418
Cancer I-Disease 0 0.003937764558941126
Clinical O 0 3.2803748695187096e-07
Study O 0 9.733340800011092e-10
Group O 0 4.05510247603047e-09
. O 0 7.713552574450944e-10

BACKGROUND O 0 2.995812110384577e-06
Women O 0 1.1868145355364845e-10
with O 0 4.948478692784475e-13
mutations O 0 2.480076977118273e-10
in O 0 2.6656942712227627e-12
either O 0 1.3380126867579278e-11
the O 0 2.3254855072846192e-12
BRCA1 O 0 6.515433170761753e-08
or O 0 8.327746131575609e-11
the O 0 8.013855963377725e-13
BRCA2 O 0 6.847676203847186e-09
gene O 0 1.9439780341024004e-10
have O 0 4.900017024078718e-12
a O 0 6.3871954600336345e-12
high O 0 1.994917120384798e-09
lifetime O 0 5.359128141257941e-10
risk O 0 2.4332530301762745e-06
of O 0 2.2276239519669616e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.4841809437580196e-09

Oral O 0 1.4207299727786449e-06
contraceptives O 0 0.00028229286544956267
protect O 0 1.6382938383685541e-07
against O 0 0.07115577161312103
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.3746241911991604e-11
general O 0 6.181122237311487e-13
, O 0 6.930243596874053e-13
but O 0 3.7606801353562425e-12
it O 0 2.864330951243832e-13
is O 0 2.1033849100936426e-14
not O 0 6.526371917935439e-14
known O 0 3.058150521012548e-13
whether O 0 4.518377588313277e-13
they O 0 1.2234736878127817e-12
also O 0 1.4995510800967782e-13
protect O 0 2.570803812884659e-13
against O 0 4.664868318016158e-12
hereditary B-Disease 0 1.2947139111929573e-06
forms I-Disease 0 1.6679047121215262e-07
of I-Disease 0 6.868135096738115e-05
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.69556243992497e-09

METHODS O 0 1.496728785355117e-08
We O 0 3.9221060427196974e-11
enrolled O 0 9.05265792883192e-11
207 O 0 3.0255603578055457e-10
women O 0 2.7785067649443995e-11
with O 0 7.9784695516949e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.311676016222066e-11
161 O 0 9.373924379774135e-12
of O 0 2.8855274255884435e-15
their O 0 1.6585887665458016e-13
sisters O 0 4.407009479567847e-11
as O 0 7.047466451561013e-13
controls O 0 3.950397509111525e-10
in O 0 9.649557194957303e-12
a O 0 7.046183775338832e-11
case O 0 5.866306995727655e-09
- O 0 1.5327158431333032e-09
control O 0 9.093541919469317e-09
study O 0 5.207785314098601e-10
. O 0 2.514389529917338e-10

All O 0 1.5483963070050955e-11
the O 0 5.077000560411993e-13
patients O 0 6.78051191582707e-12
carried O 0 4.26978070955375e-12
a O 0 8.599732037595231e-12
pathogenic O 0 4.853519186553967e-08
mutation O 0 2.4057955627654337e-10
in O 0 4.1677859080602175e-12
either O 0 2.2979687597235454e-11
BRCA1 O 0 8.182025368341783e-08
( O 0 1.4742021839375674e-11
179 O 0 1.3913084573324852e-10
women O 0 7.742022301027163e-12
) O 0 8.585665815449839e-13
or O 0 6.322428691696302e-10
BRCA2 O 0 6.65474435663782e-05
( O 0 4.2256789734018696e-10
28 O 0 1.24268084711332e-09
women O 0 9.921106297605675e-11
) O 0 5.312935855150691e-12
. O 0 7.697646686732895e-11

The O 0 2.4938127951568134e-11
control O 0 1.7114203110235593e-10
women O 0 1.3155839265199809e-11
were O 0 1.6230016462726038e-12
enrolled O 0 9.92757091811125e-13
regardless O 0 7.083958121706715e-14
of O 0 4.483516384593239e-16
whether O 0 1.036927095294897e-13
or O 0 3.765007836747936e-12
not O 0 1.5330681168990168e-11
they O 0 6.6984239335821094e-12
had O 0 4.9192542400655626e-11
either O 0 1.1288751183835544e-11
mutation O 0 8.718721855593969e-10
. O 0 2.4429080980326034e-10

Lifetime O 0 6.417172127015647e-09
histories O 0 3.478151988645095e-09
of O 0 2.4779690018655876e-13
oral O 0 1.6434476002302745e-10
- O 0 4.1689826590918244e-10
contraceptive O 0 4.828917266053168e-09
use O 0 8.093337632020248e-12
were O 0 2.11822816231777e-11
obtained O 0 1.0107398858844041e-12
by O 0 7.059207818987945e-14
interview O 0 2.3666774096042786e-10
or O 0 7.419681730992667e-13
by O 0 2.500610497477556e-14
written O 0 3.5039270204935413e-13
questionnaire O 0 1.3311944049246988e-13
and O 0 4.1457227157226575e-15
were O 0 5.2896140294517516e-14
compared O 0 4.386701776565999e-13
between O 0 1.777255643001241e-13
patients O 0 2.2287212006477652e-11
and O 0 1.5032164965914085e-13
control O 0 9.4181953902428e-11
women O 0 2.6452588383629738e-11
, O 0 2.684638535782602e-13
after O 0 1.2600832920497962e-12
adjustment O 0 6.693647372491007e-12
for O 0 5.960488264116154e-15
year O 0 1.1754070210635154e-13
of O 0 8.958272119171263e-15
birth O 0 1.619885892090167e-10
and O 0 1.7257603332487825e-11
parity O 0 6.421334575179571e-09
. O 0 4.584741961077832e-11

RESULTS O 0 2.555011313631894e-08
The O 0 2.4808785668156697e-12
adjusted O 0 1.8588571792932385e-09
odds O 0 1.8432354309538823e-08
ratio O 0 5.668778157996712e-07
for O 0 2.1578978248726344e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.350304035252492e-10
with O 0 1.4903581298762736e-13
any O 0 9.813820762982761e-13
past O 0 5.353562103176113e-13
use O 0 5.595608069779157e-13
of O 0 4.523514741494421e-14
oral O 0 1.336467742030223e-10
contraceptives O 0 6.239837375687785e-07
was O 0 4.058220426372827e-09
0 O 0 8.055471567569583e-11
. O 0 8.010608842923261e-11

5 O 0 4.0529893330365496e-10
( O 0 1.8342893176592767e-11
95 O 0 3.203782239502573e-10
percent O 0 1.376888576487545e-07
confidence O 0 2.3249715042084063e-08
interval O 0 5.283014910956174e-12
, O 0 3.782913178128518e-14
0 O 0 2.7486473248286222e-14
. O 0 9.214509750111056e-15
3 O 0 1.098302967127672e-13
to O 0 4.2915291546125056e-13
0 O 0 3.872316529929254e-12
. O 0 2.1508580506923725e-12
8 O 0 3.0507315423866643e-11
) O 0 4.003864514240396e-12
. O 0 4.5259643255413096e-11

The O 0 1.034871840999152e-10
risk O 0 3.5102356576999227e-09
decreased O 0 1.0163651031902532e-09
with O 0 4.3892691673104445e-14
increasing O 0 4.5326286127189697e-13
duration O 0 8.536109102549871e-13
of O 0 1.023624493680245e-15
use O 0 1.31909847628231e-12
( O 0 5.678722683061244e-12
P O 0 1.3572306833964376e-08
for O 0 1.6211631917537744e-13
trend O 0 2.515115449241989e-09
, O 0 5.715186353685842e-13
< O 0 8.813082208458667e-11
0 O 0 3.455991731942526e-13
. O 0 9.074062708907052e-14
001 O 0 1.6304116043364125e-11
) O 0 4.768422375028445e-15
; O 0 1.2383494633915783e-15
use O 0 3.523709915433798e-14
for O 0 2.5722889665730567e-14
six O 0 1.0827123702802921e-12
or O 0 4.351802772306623e-12
more O 0 3.312380480579441e-13
years O 0 6.908520522146133e-13
was O 0 1.0820392975716131e-12
associated O 0 7.210489258620278e-14
with O 0 3.3308386922231573e-15
a O 0 1.2945103973135974e-12
60 O 0 7.113970437039319e-12
percent O 0 1.9892820724010107e-09
reduction O 0 7.408361424321441e-11
in O 0 4.6367706896255356e-10
risk O 0 2.0231356145927748e-08
. O 0 1.286889900198318e-10

Oral O 0 4.791245373780839e-07
- O 0 2.288385445581298e-07
contraceptive O 0 3.568866873138177e-07
use O 0 2.0732572603154864e-10
protected O 0 3.442684999299672e-07
against O 0 0.022860076278448105
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
both O 0 1.0197826063413837e-13
for O 0 2.160756060973776e-15
carriers O 0 2.255937841047495e-12
of O 0 6.0871908404982415e-15
the O 0 2.9472743690028835e-12
BRCA1 O 0 3.541958903952036e-06
mutation O 0 2.3320676501015214e-09
( O 0 2.041043029032963e-11
odds O 0 1.034979479896947e-08
ratio O 0 6.3063176902744544e-09
, O 0 1.0814863544636455e-12
0 O 0 3.9849604193710475e-13
. O 0 5.505607769814777e-14
5 O 0 1.1180654655145589e-13
; O 0 6.224562559180649e-14
95 O 0 2.907300789001255e-10
percent O 0 2.907459247580846e-06
confidence O 0 4.6391375008170144e-07
interval O 0 6.919496225998856e-12
, O 0 2.802741898158892e-14
0 O 0 1.582171148110413e-14
. O 0 3.068383627692281e-15
3 O 0 3.608352223787026e-14
to O 0 4.43456679526371e-14
0 O 0 3.213152671450309e-13
. O 0 1.824113776693892e-13
9 O 0 1.1322320034659605e-12
) O 0 8.137765702726125e-15
and O 0 6.782208478774707e-15
for O 0 5.933737904850679e-16
carriers O 0 8.548703737086549e-13
of O 0 7.072856823196706e-15
the O 0 2.9225038188085417e-12
BRCA2 O 0 1.320681803917978e-06
mutation O 0 9.551983648492524e-10
( O 0 1.1369153882223593e-11
odds O 0 5.306715511466109e-09
ratio O 0 2.018836875450347e-09
, O 0 9.800576149243678e-13
0 O 0 3.602035119829039e-13
. O 0 2.869617521036871e-14
4 O 0 9.077178434900232e-14
; O 0 8.052801183039762e-14
95 O 0 3.9729150524969725e-10
percent O 0 1.0098767234012485e-05
confidence O 0 6.762403472748701e-07
interval O 0 1.0469203629015489e-11
, O 0 8.656747194080161e-14
0 O 0 3.192801247995855e-14
. O 0 2.1303679916613756e-14
2 O 0 1.4197083992358722e-13
to O 0 4.856007089493186e-13
1 O 0 4.382271889119549e-12
. O 0 2.3418970755695323e-12
1 O 0 6.673149012537127e-12
) O 0 2.0743981619247842e-12
. O 0 3.6854408413944384e-11

CONCLUSIONS O 0 1.6283506099057377e-08
Oral O 0 6.62964438902236e-09
- O 0 9.649756549379163e-09
contraceptive O 0 5.387727597394587e-08
use O 0 7.683770286703862e-11
may O 0 5.73744329823711e-10
reduce O 0 7.35519371103388e-12
the O 0 2.0563949848506624e-12
risk O 0 8.944814311462324e-08
of O 0 1.7315090472536099e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.4535767514932694e-11
women O 0 9.876110346196398e-12
with O 0 3.4642940100783337e-13
pathogenic O 0 7.412737090817245e-09
mutations O 0 6.793438034335963e-10
in O 0 1.5237569886417113e-11
the O 0 1.0394727613383115e-11
BRCA1 O 0 7.396085038635647e-06
or O 0 7.373524368858853e-08
BRCA2 O 0 0.0003314716159366071
gene O 0 8.983004954643548e-05

A O 0 7.240219979109952e-09
Japanese O 0 7.115989575368076e-09
family O 0 1.1866381488534472e-10
with O 0 1.775173931461982e-11
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.2594473207394596e-11
a O 0 9.724595434468242e-11
codon O 0 2.68920636870007e-08
291 O 0 7.393783363340845e-10
deletion O 0 1.0214860068913367e-09
: O 0 4.596978722161416e-13
a O 0 5.196952351967099e-13
clinical O 0 1.5846898793192565e-10
, O 0 6.082740105876894e-13
biochemical O 0 7.545784552753787e-10
, O 0 4.183172905292132e-12
pathological O 0 6.986147127463482e-08
, O 0 6.793897475848576e-12
and O 0 1.4087824656838777e-11
genetic O 0 1.1850062264784356e-08
report O 0 1.0914519066318462e-08
. O 0 3.2764749247071734e-10

We O 0 1.3279688459988392e-09
report O 0 2.7738152053036202e-11
a O 0 5.981529833075372e-13
Japanese O 0 4.8313446993075715e-11
family O 0 1.2129879566058488e-11
with O 0 2.793822118096756e-11
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.1018181567123975e-06
ALD B-Disease 1 1.0
) O 0 9.398163670903958e-12
with O 0 9.898429054492827e-14
a O 0 1.171422073925621e-11
three O 0 1.2959210527602183e-12
base O 0 5.077477500947669e-12
pair O 0 5.917017986689643e-10
deletion O 0 1.4228864309018263e-08
( O 0 3.285497568450424e-11
delGAG O 0 7.922789535541597e-09
291 O 0 2.9830158343457924e-09
) O 0 8.139267905493686e-12
in O 0 4.0750479379791926e-11
the O 0 7.345485886212089e-10
ALD B-Disease 1 1.0
gene O 0 2.1436466113300412e-07
. O 0 1.8368819798553204e-09

A O 0 1.3123748754395592e-09
variety O 0 1.4857986369021248e-11
of O 0 1.3681330374160083e-13
phenotypes O 0 8.148436786425961e-11
were O 0 8.433045060873834e-12
observed O 0 9.818744125048018e-13
within O 0 2.383244155409331e-13
this O 0 2.991204072627651e-12
family O 0 8.462583411805724e-11
. O 0 3.810545975979629e-11

While O 0 6.561583498765344e-10
the O 0 3.2294486095735264e-12
proband O 0 6.430431653825508e-08
( O 0 1.5104152650824432e-10
patient O 0 7.759330067358405e-09
1 O 0 2.208366519165783e-12
) O 0 2.8147970065894867e-13
was O 0 6.087144677202616e-11
classified O 0 2.8896747841788972e-11
as O 0 4.392177539638137e-13
having O 0 6.206853065369999e-13
a O 0 2.685831700273422e-13
rare O 0 1.4684045646085053e-11
intermediate O 0 5.5501839235638784e-11
type O 0 2.2041364289293597e-09
of O 0 1.2711441057730588e-12
adult O 0 1.504835367427404e-08
cerebral O 0 1.6534357882846962e-06
and O 0 1.1851434278398187e-09
cerebello O 0 0.0750492662191391
- O 0 8.205356425605714e-05
brain O 0 4.822578375751618e-06
stem O 0 6.234603389110305e-10
forms O 0 7.88906370785547e-11
, O 0 3.4638285295596205e-11
his O 0 3.6647199164185906e-11
younger O 0 1.168377394833442e-09
brother O 0 1.870125998504335e-10
( O 0 8.046376065440342e-12
patient O 0 3.6062770547573564e-09
2 O 0 2.1587490909441565e-12
) O 0 1.3595337963051568e-12
and O 0 5.951094478318097e-11
nephew O 0 1.2483586431244476e-07
( O 0 5.4177475006245146e-11
patient O 0 5.833706140379036e-08
3 O 0 6.398377053878912e-12
) O 0 5.204146141801758e-12
had O 0 9.486226915100815e-09
a O 0 4.563424305104036e-09
childhood O 0 3.5025394026888534e-05
ALD B-Disease 1 1.0
type O 0 4.0849325159797445e-05
. O 0 5.66719693395612e-09

Another O 0 2.0910947640118138e-08
nephew O 0 9.908031870509149e-07
( O 0 1.7374407468295772e-09
patient O 0 2.555781541957458e-08
4 O 0 3.2682643483911145e-12
) O 0 3.425900242746277e-13
of O 0 2.3974507275259516e-13
patient O 0 3.383794222600045e-08
1 O 0 4.5686861412097546e-12
was O 0 1.4730983100008643e-10
classified O 0 6.819229209087396e-11
as O 0 1.5010025557551931e-12
having O 0 1.3025331681293384e-11
an O 0 2.9943779660673853e-12
adolescent O 0 6.683221975833931e-09
form O 0 1.597462995217569e-10
. O 0 9.546683443772963e-10

The O 0 3.375486695711416e-11
tau O 0 3.3160710288804296e-10
level O 0 2.599870492503431e-11
in O 0 1.1301046903833267e-12
the O 0 6.2316250250271654e-12
cerebrospinal O 0 8.266503073173226e-07
fluid O 0 1.8679390478837377e-08
( O 0 2.542195065569075e-10
CSF O 0 0.0001078140630852431
) O 0 1.6758505390693235e-12
in O 0 2.9490073577553844e-11
patient O 0 1.0236417935516329e-08
1 O 0 6.511917307466808e-12
was O 0 1.7392776108238195e-09
as O 0 5.200147604189631e-12
high O 0 8.138119518552589e-12
as O 0 5.12026334417541e-14
that O 0 1.522157000324962e-14
of O 0 5.965074354602473e-14
patients O 0 1.9756687952288132e-10
with O 0 2.523849011726309e-11
Alzheimers B-Disease 1 0.9877969622612
disease I-Disease 0 5.0312039093114436e-05
( O 0 3.7777635186753145e-11
AD B-Disease 0 1.677160952340273e-07
) O 0 2.2043540603977618e-10
. O 0 4.468231618037777e-10

His O 0 1.0981801246146006e-08
brain O 0 4.1169687392539345e-07
magnetic O 0 1.5899070948677263e-09
resonance O 0 1.0892621027380756e-08
image O 0 1.1630994833922159e-08
( O 0 1.493721257794789e-10
MRI O 0 1.2543266166176181e-05
) O 0 2.8918362496299643e-11
showed O 0 5.089622732157295e-07
abnormalities B-Disease 1 0.5167902708053589
in I-Disease 0 2.2499049064789167e-12
the I-Disease 0 4.3229943279612937e-13
bilateral I-Disease 0 7.731463802507221e-10
cerebellar I-Disease 0 5.3863406179743833e-08
hemispheres I-Disease 0 1.607130343472818e-06
and O 0 1.776195190927865e-09
brain O 0 9.964947622620457e-08
stem O 0 6.678415043204211e-10
, O 0 9.228132581001747e-13
but O 0 8.290525384258007e-13
not O 0 2.7729871892624713e-13
in O 0 5.015603275586311e-13
the O 0 5.069561524045918e-12
cerebral O 0 9.337516530649737e-06
white O 0 7.795644130226265e-09
matter O 0 3.484511290618997e-10
, O 0 8.590707084501353e-14
where O 0 1.240331012268385e-14
marked O 0 3.307645769692197e-13
reductions O 0 1.3866185977207124e-11
of O 0 5.161187317505528e-15
the O 0 3.202225539854914e-13
cerebral O 0 4.816729237688833e-09
blood O 0 1.8263865420031777e-10
flow O 0 5.70757711926273e-11
and O 0 1.33910868505005e-10
oxygen O 0 2.3562010675881595e-10
metabolism O 0 1.5144634435415583e-09
were O 0 3.871237965608065e-12
clearly O 0 1.179117740945923e-11
demonstrated O 0 2.418274781812446e-12
by O 0 3.1609849286684533e-13
positron O 0 6.769718563504057e-09
emission O 0 4.3932942617175286e-08
tomography O 0 4.539739165920764e-05
( O 0 4.183713375738307e-09
PET O 0 7.36324352601514e-07
) O 0 4.0902192743885735e-10
. O 0 3.7957859078119327e-10

In O 0 2.1990049781095422e-09
patients O 0 3.3891296880028676e-08
2 O 0 7.0165947704814435e-12
and O 0 3.418493569815051e-12
3 O 0 1.5930435139435706e-12
, O 0 2.1353973006076749e-13
the O 0 3.9490353803857403e-13
autopsy O 0 3.698805173257824e-08
findings O 0 2.4644205079416004e-11
showed O 0 2.7314689399204894e-10
massive O 0 9.701271036499648e-11
demyelination B-Disease 1 0.9999995231628418
of I-Disease 0 1.6947448219090111e-12
the I-Disease 0 8.823236412325297e-12
cerebral I-Disease 0 5.5666737353021745e-06
white I-Disease 0 1.678367334001507e-09
matter I-Disease 0 5.4631150298023456e-11
with O 0 2.737858157959676e-14
sparing O 0 8.658159258989606e-12
of O 0 2.0310555808814718e-14
the O 0 2.9521391299407174e-13
U O 0 2.212085092878624e-08
- O 0 1.1491543716601882e-08
fibers O 0 2.2241254171717628e-08
, O 0 8.744488965393982e-13
compatible O 0 1.778444405631241e-11
with O 0 3.8409762702232633e-14
the O 0 2.2168733320414302e-13
findings O 0 5.963252114327133e-11
of O 0 4.4496190586273965e-12
childhood O 0 9.711529855849221e-07
ALD B-Disease 1 0.9999994039535522
. O 0 1.2806929960973434e-09

Oleic O 0 0.009773939847946167
and O 0 2.9353739439130777e-09
erucic O 0 1.460389853491506e-06
acids O 0 2.956478617477387e-09
( O 0 9.683002663574136e-12
Lorenzos O 0 3.2290636831078245e-10
Oil O 0 3.843678847426091e-11
) O 0 8.817709203860075e-14
were O 0 8.063483284944176e-14
administered O 0 1.7548957350222577e-13
to O 0 1.6982192019808495e-13
patients O 0 2.5488357952019314e-11
1 O 0 1.8458411882305015e-13
and O 0 4.295904777740223e-12
4 O 0 5.915801702671697e-13
, O 0 8.887647020248968e-14
but O 0 1.3120719246327572e-13
sufficient O 0 2.036848744139605e-13
effectiveness O 0 1.0084526963494156e-11
was O 0 2.5884849819135525e-11
not O 0 9.884510744628816e-13
obtained O 0 2.967701431821901e-11
. O 0 6.330027474410471e-11

The O 0 2.980805879904125e-11
findings O 0 3.1017358820273344e-11
in O 0 1.5286786593515789e-12
this O 0 7.468107214450917e-14
family O 0 2.93273218210377e-13
suggest O 0 6.097317746187048e-13
that O 0 2.9482831649142727e-14
delGAG291 O 0 5.757666218797475e-11
is O 0 1.8113057576171418e-14
part O 0 5.950994634140033e-14
of O 0 1.2381045014632323e-14
the O 0 5.386049679173555e-13
cause O 0 2.8860119155593722e-11
of O 0 7.559242403039346e-13
Japanese O 0 1.341902144957885e-08
ALD B-Disease 1 0.999974250793457
with O 0 1.1713500178492375e-12
phenotypic O 0 7.252037192984062e-09
variations O 0 1.3065860393624007e-08
. O 0 2.1934003502366295e-09

Moreover O 0 6.632224547331589e-09
, O 0 2.559644770444569e-12
although O 0 2.654424260690319e-13
the O 0 1.2977922027508117e-14
scale O 0 6.875581267523634e-12
of O 0 1.4724858024518436e-14
the O 0 1.9511258927962238e-13
study O 0 8.762120261122941e-13
is O 0 6.526944512207783e-14
limited O 0 7.256879016974416e-13
, O 0 6.121929677603555e-13
there O 0 2.01241345636205e-12
is O 0 1.1583323276248558e-13
a O 0 2.023813923520898e-13
possibility O 0 2.9678640187796868e-12
that O 0 9.891432291297964e-13
PET O 0 1.1666226873430219e-09
can O 0 1.263629218622997e-11
detect O 0 6.258256135538431e-09
an O 0 2.941480045648426e-11
insidious B-Disease 0 7.03047335264273e-05
lesion I-Disease 0 0.08133956789970398
which O 0 1.3598464021491452e-10
is O 0 4.878084481491074e-12
undetectable O 0 4.950468368569716e-10
by O 0 4.99034407547283e-13
computed O 0 7.51914808194698e-10
tomogram O 0 4.3081890055418626e-08
( O 0 2.537252699608139e-11
CT O 0 0.04118728265166283
) O 0 2.8217330815677455e-12
or O 0 4.869922173855734e-12
MRI O 0 1.707616981150295e-08
analysis O 0 3.37350243226342e-12
, O 0 1.9889064082744684e-13
and O 0 5.084013722164715e-14
that O 0 8.433901126580438e-15
the O 0 8.083208310593476e-14
higher O 0 1.5853822421529884e-10
level O 0 2.1238544777035795e-12
of O 0 2.3185595695966732e-15
tau O 0 8.160155494027488e-13
reflects O 0 9.21788958097719e-14
the O 0 1.880179531217694e-14
process O 0 1.2754889375590772e-12
of O 0 1.32306397283323e-13
neuronal B-Disease 0 4.209891102391339e-08
degeneration I-Disease 0 2.291808596055489e-05
in O 0 4.9469434770799126e-08
ALD B-Disease 1 1.0
. O 0 5.1210964358006095e-09

Lorenzos O 0 2.2171374780555198e-07
Oil O 0 3.1340423589654165e-09
should O 0 3.5830492219057763e-12
be O 0 3.991660382221193e-14
given O 0 1.7861005982056956e-14
in O 0 1.797259037558327e-13
the O 0 2.6948167547273527e-13
early O 0 2.020801526114724e-09
stage O 0 1.0827671398372374e-10
. O 0 3.931121053679654e-12
. O 0 3.1103675190991e-11

Nonsense O 0 6.528808444272727e-05
mutation O 0 1.1893406792751193e-07
in O 0 2.846884672447203e-10
exon O 0 6.826784471059e-09
4 O 0 1.4625736385887045e-11
of O 0 2.20953558726332e-14
human O 0 2.6941280152972813e-13
complement O 0 4.361510805295232e-11
C9 O 0 6.582645539765508e-09
gene O 0 7.718144456880793e-10
is O 0 3.403776392685298e-12
the O 0 1.402304108336777e-13
major O 0 1.490641117485314e-11
cause O 0 2.1880508516147756e-10
of O 0 2.156642052442148e-12
Japanese O 0 3.66856518496661e-08
complement B-Disease 0 7.85695490890248e-08
C9 I-Disease 0 0.0005579906865023077
deficiency I-Disease 0 0.0037773707881569862
. O 0 1.963344598010508e-09

Deficiency B-Disease 1 0.9999856948852539
of I-Disease 0 6.45575953805988e-12
the I-Disease 0 2.495738641791756e-12
ninth I-Disease 0 1.0895082058759442e-10
component I-Disease 0 5.684878349315747e-12
of I-Disease 0 1.0511705133447232e-14
human I-Disease 0 2.9708643856617145e-13
complement I-Disease 0 9.933850270149591e-11
( O 0 8.170111288896553e-12
C9 O 0 5.431400218469662e-09
) O 0 3.1939663587554623e-13
is O 0 1.9795722407209976e-14
the O 0 4.8804221535120925e-15
most O 0 2.619059754228187e-13
common O 0 2.241179242190583e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.150954911023689e-11
Japan O 0 6.399881319341105e-11
but O 0 5.683837515230161e-12
is O 0 1.5593070183585883e-13
rare O 0 4.399222305884187e-12
in O 0 9.318252766621349e-12
other O 0 1.9106825496773006e-12
countries O 0 4.537907809937236e-12
. O 0 5.485898887935825e-11

We O 0 3.532262815575393e-10
studied O 0 4.58265231317867e-11
the O 0 3.8129103417357604e-14
molecular O 0 1.947000286689482e-12
basis O 0 7.472631888272296e-12
of O 0 5.6992956361245906e-12
C9 B-Disease 0 0.07752439379692078
deficiency I-Disease 0 0.04563850164413452
in O 0 2.6732720204147853e-11
four O 0 4.649137845536e-12
Japanese O 0 6.431136734263987e-10
C9 B-Disease 0 1.692092041594151e-06
- I-Disease 0 6.034906618879177e-07
deficient I-Disease 0 0.0035830114502459764
patients O 0 6.7251035034132656e-06
who O 0 9.195642025616735e-10
had O 0 1.2505779523053207e-08
suffered O 0 0.006217048037797213
from O 0 1.0362831481813828e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.3681938249021641e-08

Direct O 0 1.9062773581879355e-09
sequencing O 0 1.8620118780177108e-09
of O 0 4.882962090224652e-12
amplified O 0 7.942671409466584e-09
C9 O 0 1.392733040006533e-08
cDNA O 0 6.222901083319243e-10
and O 0 8.751968767761742e-12
DNA O 0 2.3958679484792356e-10
revealed O 0 1.9561330333317528e-10
a O 0 4.3340595869134635e-12
nonsense O 0 2.5141897452840567e-09
substitution O 0 4.32430168062492e-11
( O 0 4.619816681983302e-12
CGA O 0 4.4731990556101664e-08
- O 0 2.49130027718536e-09
- O 0 3.6635914302252104e-09
> O 0 2.478629801405674e-10
TGA O 0 1.797366344646889e-08
) O 0 4.734758592139787e-13
at O 0 2.3282773278787694e-12
codon O 0 6.403703955992768e-11
95 O 0 4.486767728184571e-12
in O 0 8.18739119470141e-13
exon O 0 2.040405899794706e-10
4 O 0 1.716146148800224e-11
in O 0 1.067770524776357e-11
the O 0 1.5491959928434773e-12
four O 0 1.0853268977983888e-10
C9 B-Disease 0 2.1119207303854637e-05
- I-Disease 0 2.0992647478124127e-06
deficient I-Disease 0 4.54731889476534e-06
individuals O 0 2.933333784205239e-11
. O 0 7.765303677853552e-11

An O 0 1.8958407066449467e-10
allele O 0 3.874880150078752e-08
- O 0 1.914548741765998e-09
specific O 0 2.2973203200882253e-11
polymerase O 0 1.0391209004367852e-09
chain O 0 2.0656037991173548e-10
reaction O 0 5.7503103841061165e-12
system O 0 8.698609866263085e-13
designed O 0 2.0551756910874852e-12
to O 0 2.0612869321579713e-13
detect O 0 2.4570234735676877e-11
exclusively O 0 4.007116903917418e-13
only O 0 5.036588008634768e-13
one O 0 3.3500437666977856e-14
of O 0 1.7812584073077743e-15
the O 0 8.412986019640245e-14
normal O 0 2.2683091516206844e-11
and O 0 4.386141515093367e-13
mutant O 0 7.357343900782354e-11
alleles O 0 2.6320626234088706e-11
indicated O 0 3.623691902099324e-10
that O 0 1.6969596301069645e-13
all O 0 3.6409074268949765e-14
the O 0 1.8494312187928262e-14
four O 0 1.1031359338367977e-13
patients O 0 8.803379574796877e-13
were O 0 7.948605966132116e-14
homozygous O 0 4.172001286106841e-12
for O 0 1.0469445812675768e-14
the O 0 3.9783663695206264e-14
mutation O 0 1.6704453792426577e-11
in O 0 4.215563662035571e-12
exon O 0 1.519253750581484e-10
4 O 0 1.0443136806703723e-11
and O 0 2.325099748151649e-12
that O 0 3.2018224876972923e-13
the O 0 6.598156808250433e-13
parents O 0 2.8198190310524396e-11
of O 0 1.0836042349873787e-13
patient O 0 1.533326909886057e-09
2 O 0 2.241069092454029e-12
were O 0 1.7969874199774694e-10
heterozygous O 0 1.0542602524310496e-07
. O 0 2.9032334869505405e-10

The O 0 3.854853242168943e-11
common O 0 1.2884200650820077e-10
mutation O 0 2.6638419248214973e-10
at O 0 5.462635899178281e-11
codon O 0 3.099708822951186e-10
95 O 0 1.1929234509933107e-11
in O 0 2.231199816918328e-12
exon O 0 1.0763555602366637e-09
4 O 0 5.2853159349108836e-11
might O 0 7.823793835015636e-10
be O 0 1.83581470337979e-12
responsible O 0 9.783095557616694e-13
for O 0 3.219635251764871e-14
most O 0 8.760666346009638e-13
Japanese O 0 5.047128048829563e-09
C9 B-Disease 0 8.105253982648719e-06
deficiency I-Disease 0 4.9211244004254695e-06
. O 0 3.6022997085272124e-11
. O 0 1.4624851329969601e-10

BRCA1 O 0 1.4314796317194123e-06
required O 0 4.723517688098866e-10
for O 0 1.7442848380955223e-12
transcription O 0 4.180628465633163e-08
- O 0 5.8280345882621987e-08
coupled O 0 2.66565400863783e-08
repair O 0 1.5040546713862568e-05
of O 0 8.481530365186951e-13
oxidative O 0 4.1042702569882294e-10
DNA O 0 8.410392382529608e-09
damage O 0 2.0399486544420142e-08
. O 0 2.767105711232176e-10

The O 0 1.2820231987120678e-08
breast B-Disease 1 0.999998927116394
and I-Disease 1 0.999996542930603
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 1.7800597618133907e-07
gene O 0 6.093321758271486e-08
BRCA1 O 0 4.380187590413698e-07
encodes O 0 1.993570419855928e-09
a O 0 2.398121978774981e-10
zinc O 0 1.535770934424363e-06
finger O 0 7.034294867480639e-06
protein O 0 5.621314524972831e-09
of O 0 1.152985367770809e-12
unknown O 0 9.728478023163234e-10
function O 0 1.0190764204720537e-10
. O 0 2.44249315217715e-10

Association O 0 6.760834253549675e-11
of O 0 2.455628304593848e-14
the O 0 1.5975063069259554e-13
BRCA1 O 0 6.467251734143531e-10
protein O 0 1.2192322672299749e-11
with O 0 1.6667509454321335e-14
the O 0 3.85119453688576e-14
DNA O 0 3.381261659551882e-10
repair O 0 1.1344088335363267e-08
protein O 0 4.678434861737912e-10
Rad51 O 0 1.8272105606342848e-08
and O 0 3.6422731150564935e-12
changes O 0 2.9500299772444727e-12
in O 0 4.3183382217315547e-13
the O 0 2.5821645237050946e-14
phosphorylation O 0 2.00443004208517e-12
and O 0 1.3259925926364935e-12
cellular O 0 7.295151149833146e-10
localization O 0 4.640909531672399e-11
of O 0 1.2156722738112125e-15
the O 0 1.308250349143971e-14
protein O 0 2.3231314875277187e-12
after O 0 9.396850702073078e-13
exposure O 0 7.443839815379771e-12
to O 0 2.2186922167110462e-13
DNA O 0 5.838297623128597e-10
- O 0 1.003813004940568e-10
damaging O 0 2.3611540500567685e-10
agents O 0 3.4491007272485774e-11
are O 0 1.2783232859834431e-13
consistent O 0 2.5614664469347792e-12
with O 0 4.371595909569278e-15
a O 0 3.4435030781682086e-13
role O 0 4.81572030516797e-12
for O 0 2.0901286072998876e-13
BRCA1 O 0 4.4078043437423275e-09
in O 0 2.1085025392331147e-10
DNA O 0 1.1631708929371598e-07
repair O 0 9.935311936715152e-06
. O 0 8.052249422796365e-10

Here O 0 1.3780202756663584e-08
, O 0 3.72632914108495e-12
it O 0 9.829213587801353e-14
is O 0 7.606935236879539e-15
shown O 0 1.4365997269821101e-13
that O 0 1.8580841346874793e-13
mouse O 0 2.6178863521408857e-09
embryonic O 0 2.747323035734439e-09
stem O 0 8.236135329298122e-09
cells O 0 4.101058337369068e-08
deficient B-Disease 0 8.487164677717374e-07
in I-Disease 0 5.261725950778118e-12
BRCA1 I-Disease 0 1.851032038757694e-08
are O 0 6.044369432051111e-12
defective O 0 3.3609837135628595e-09
in O 0 1.065702756077036e-12
the O 0 3.482909693617274e-14
ability O 0 2.7247431741428407e-12
to O 0 1.2052334228285916e-13
carry O 0 1.8742172744334873e-11
out O 0 1.9235803921935357e-11
transcription O 0 1.4376011492345242e-08
- O 0 6.001505958863618e-09
coupled O 0 5.064601626969534e-09
repair O 0 3.5769189707934856e-06
of O 0 9.399229848215326e-14
oxidative O 0 1.4178453550117709e-11
DNA O 0 5.910171796408292e-10
damage O 0 2.6863495872220255e-09
, O 0 1.133457043500652e-12
and O 0 6.14958333821497e-13
are O 0 3.7420389595137216e-13
hypersensitive O 0 4.0650942167985704e-08
to O 0 1.5275797120295476e-12
ionizing O 0 5.675426240081549e-10
radiation O 0 9.338639195277665e-09
and O 0 1.2686578176879237e-10
hydrogen O 0 1.5212718584844964e-10
peroxide O 0 1.4841036772850202e-06
. O 0 9.475281670390245e-10

These O 0 6.627690757321503e-11
results O 0 5.663906149644404e-11
suggest O 0 3.2638801383821914e-11
that O 0 2.6153768820785794e-12
BRCA1 O 0 1.6021890303363762e-07
participates O 0 5.153630560500444e-12
, O 0 3.581426401646527e-14
directly O 0 3.4376086775322195e-14
or O 0 1.3169766926307558e-12
indirectly O 0 7.2183951524418255e-12
, O 0 5.392803174505967e-13
in O 0 1.4496425761179044e-11
transcription O 0 6.867782786912358e-08
- O 0 6.590384238336355e-09
coupled O 0 3.6082790089153605e-09
repair O 0 1.1425626098571229e-06
of O 0 2.617481697966134e-13
oxidative O 0 2.8867991330727705e-11
DNA O 0 8.372695314839973e-10
damage O 0 2.0476818018977383e-09
. O 0 8.202354594144534e-12
. O 0 8.244378096877725e-11

Truncation O 0 3.555353487172397e-06
mutations O 0 3.045628886866325e-07
in O 0 2.5614593779366146e-10
the O 0 4.501039298221432e-12
transactivation O 0 2.7579929451349017e-08
region O 0 3.0541968953912146e-10
of O 0 1.905521964176704e-12
PAX6 O 0 2.2912810493380675e-07
result O 0 2.687311484450561e-10
in O 0 4.1479063239702185e-11
dominant O 0 3.970396846852964e-07
- O 0 1.5580422996208654e-07
negative O 0 4.874058134873849e-08
mutants O 0 6.576963187399087e-07
. O 0 1.1993926962716728e-09

PAX6 O 0 5.9121259255334735e-05
is O 0 9.466447625783303e-10
a O 0 1.7926559542358333e-11
transcription O 0 4.619028215469001e-10
factor O 0 7.253257456457662e-12
with O 0 4.316120757238279e-14
two O 0 5.388227841338078e-13
DNA O 0 4.954672228052459e-10
- O 0 3.5149236299325537e-10
binding O 0 1.375319580443346e-10
domains O 0 8.607027313090043e-10
( O 0 5.392157640532469e-12
paired O 0 5.145474046841514e-10
box O 0 1.7688519537983893e-09
and O 0 1.2512138547471352e-10
homeobox O 0 1.3692590172809105e-08
) O 0 1.837650257657808e-12
and O 0 1.2918342610912514e-12
a O 0 3.605358372960055e-11
proline O 0 1.0335536160255288e-07
- O 0 2.0509220988174093e-09
serine O 0 2.942119294857548e-07
- O 0 2.7325452123250216e-08
threonine O 0 1.255721372217522e-06
( O 0 2.58766702510016e-10
PST O 0 2.2818608158559073e-07
) O 0 1.594102107260742e-11
- O 0 3.810554927152765e-10
rich O 0 6.498684923528231e-10
transactivation O 0 6.06568903549487e-07
domain O 0 1.5651602680577525e-08
. O 0 7.94346921573208e-10

PAX6 O 0 0.0018431900534778833
regulates O 0 2.3660542865400203e-05
eye O 0 0.0042265793308615685
development O 0 6.378874650714295e-10
in O 0 3.207192150744831e-11
animals O 0 7.102040310014157e-12
ranging O 0 2.7036952537917713e-11
from O 0 9.813296009131278e-13
jellyfish O 0 9.614871399055147e-12
to O 0 1.467954853810391e-13
Drosophila O 0 1.5898388508461814e-11
to O 0 2.335240833171992e-13
humans O 0 2.305634502763887e-11
. O 0 3.82785400598884e-11

Heterozygous O 0 9.68884978647111e-06
mutations O 0 1.694569675692037e-07
in O 0 7.087010145401251e-11
the O 0 6.272667389846387e-13
human O 0 1.5188841937657793e-12
PAX6 O 0 4.1265433736725754e-08
gene O 0 5.3497348773134945e-09
result O 0 1.232424162722623e-10
in O 0 2.015244091393975e-12
various O 0 3.2143602016199146e-13
phenotypes O 0 4.839768030784342e-10
, O 0 8.766901050602516e-13
including O 0 2.1633462382597557e-11
aniridia B-Disease 1 1.0
, O 0 9.206536901729123e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.135328606797884e-09
autosomal B-Disease 0 0.026183664798736572
dominant I-Disease 0 0.0017180131981149316
keratitis I-Disease 1 0.9999963045120239
, O 0 5.7703182676505094e-08
and O 0 1.0044001186315654e-08
familial B-Disease 1 0.9997949004173279
foveal I-Disease 1 0.9997857213020325
dysplasia I-Disease 1 1.0
. O 0 5.494934285366071e-08

It O 0 5.6096880612921396e-11
is O 0 1.3883745498752265e-13
believed O 0 1.839705254455537e-12
that O 0 3.504907478070647e-14
the O 0 1.064235640802283e-13
mutated O 0 1.446336117538749e-08
allele O 0 5.898282751104489e-09
of O 0 1.9675890691045472e-12
PAX6 O 0 4.977001566430772e-08
produces O 0 2.8781673225286575e-11
an O 0 1.0955774048387878e-12
inactive O 0 1.0738395728182581e-09
protein O 0 6.923938644654015e-10
and O 0 6.096559368451437e-10
aniridia B-Disease 1 1.0
is O 0 9.580227722238988e-10
caused O 0 7.0587102829478e-10
due O 0 6.591710510761573e-11
to O 0 1.2373957761213639e-11
genetic O 0 3.6755690047129974e-08
haploinsufficiency O 0 1.0959557812384446e-06
. O 0 1.5482176651815394e-09

However O 0 1.3852110569700926e-09
, O 0 1.1418263253307193e-12
several O 0 7.840330083297778e-14
truncation O 0 4.867939940034205e-10
mutations O 0 4.109957651987628e-10
have O 0 1.9493339234455398e-12
been O 0 8.359230733827328e-13
found O 0 1.2467505326740902e-12
to O 0 6.984555078401455e-14
occur O 0 4.997068297346585e-13
in O 0 2.8233142278059897e-13
the O 0 3.2056109611385e-13
C O 0 1.268065688009301e-07
- O 0 1.228012830312153e-10
terminal O 0 4.3983791608859235e-10
half O 0 4.941529390539712e-12
of O 0 4.92585640787975e-14
PAX6 O 0 4.047877144586209e-09
in O 0 5.088626568727772e-12
patients O 0 6.967095650400879e-11
with O 0 5.249574104408683e-13
Aniridia B-Disease 1 1.0
resulting O 0 1.9104393414459686e-11
in O 0 7.959230605321388e-13
mutant O 0 2.93889461377983e-11
proteins O 0 2.1418476801177144e-12
that O 0 8.053522855110823e-14
retain O 0 5.001695672218753e-12
the O 0 6.39940777777924e-14
DNA O 0 9.816245039040439e-11
- O 0 1.8818615069027267e-11
binding O 0 3.962981418720313e-12
domains O 0 2.4709533030797814e-11
but O 0 1.8580293553727145e-11
have O 0 4.521966134873878e-12
lost O 0 9.26634935449755e-10
most O 0 1.579548395292535e-13
of O 0 1.5340427360474237e-14
the O 0 6.746592759281078e-13
transactivation O 0 1.0208204059836135e-08
domain O 0 1.0855468746129304e-09
. O 0 2.3218314770812043e-10

It O 0 2.7700736149327554e-10
is O 0 3.77375040938599e-12
not O 0 2.332534393498925e-13
clear O 0 7.201669273947109e-13
whether O 0 1.2451030603679442e-13
such O 0 2.359327197585387e-13
mutants O 0 3.861526209902877e-08
really O 0 3.4101654478035925e-07
behave O 0 5.6611628579394946e-11
as O 0 2.0332273733582318e-13
loss O 0 3.886226410121374e-12
- O 0 1.1341453817759195e-11
of O 0 1.7421692343963513e-13
- O 0 5.860320562156573e-10
function O 0 3.740735152191199e-12
mutants O 0 8.770376092037679e-10
as O 0 2.395569680124776e-11
predicted O 0 1.7349562064783441e-10
by O 0 4.5238123143331865e-12
haploinsufficiency O 0 2.040610809217469e-07
. O 0 2.2528442999991682e-10

Contrary O 0 2.739291016240486e-09
to O 0 1.5676846756504381e-12
this O 0 3.956670467609655e-14
theory O 0 3.4270047737094966e-13
, O 0 2.957576471598368e-14
our O 0 4.803642767304932e-14
data O 0 4.927975562341036e-12
showed O 0 6.081656012124625e-11
that O 0 1.719213286273044e-14
these O 0 1.52779688450096e-14
mutants O 0 7.238196847447753e-11
are O 0 1.0138093299973464e-13
dominant O 0 1.2002714377956636e-09
- O 0 8.950387653250402e-10
negative O 0 6.644959582580157e-10
in O 0 4.252293309137123e-11
transient O 0 4.2693287793937884e-10
transfection O 0 1.112028247263197e-08
assays O 0 1.0698979480139315e-09
when O 0 1.1927703833305991e-12
they O 0 2.2097979641890614e-13
are O 0 2.8409986494414008e-14
coexpressed O 0 1.0744638512250049e-10
with O 0 2.662902992729699e-13
wild O 0 2.1968922236936805e-09
- O 0 7.019766599114519e-07
type O 0 2.88769592771132e-06
PAX6 O 0 2.863638110284228e-05
. O 0 5.87061643742004e-09

We O 0 1.3424306111176065e-10
found O 0 3.4660805042080467e-12
that O 0 2.2692751269672712e-14
the O 0 5.1765103976312427e-14
dominant O 0 2.701213475120312e-09
- O 0 3.970288098287256e-09
negative O 0 1.0970155894796108e-09
effects O 0 8.009757856974886e-10
result O 0 2.5890960382579653e-12
from O 0 6.34783973432404e-14
the O 0 1.9805165130505967e-14
enhanced O 0 2.50549234137587e-12
DNA O 0 7.604829092844323e-12
binding O 0 1.1314267665124556e-12
ability O 0 8.479835757191356e-12
of O 0 1.1090790558079128e-13
these O 0 1.8516180342459387e-12
mutants O 0 5.15956921631755e-09
. O 0 1.6561382820690085e-10

Kinetic O 0 1.9612635959731506e-09
studies O 0 2.359969997201006e-10
of O 0 2.5275221911084944e-13
binding O 0 1.9950759100328952e-10
and O 0 9.536959416633906e-11
dissociation O 0 2.76349276795429e-10
revealed O 0 6.755046522144426e-11
that O 0 5.121132399979293e-14
various O 0 1.4179304431982676e-13
truncation O 0 3.983638752202978e-09
mutants O 0 7.274563174064497e-09
have O 0 1.9320153116231253e-11
3 O 0 2.5948754863586165e-12
- O 0 1.8019710723571336e-10
5 O 0 1.688589372494942e-11
- O 0 7.931357792756444e-10
fold O 0 1.0174527192985394e-10
higher O 0 5.764234575766913e-12
affinity O 0 5.440274966628245e-13
to O 0 2.4558392157977144e-14
various O 0 1.9148069157278076e-14
DNA O 0 7.503223736771147e-12
- O 0 3.9270499287320793e-13
binding O 0 3.7826482939852524e-13
sites O 0 3.4235307731084186e-12
when O 0 3.933446450499201e-12
compared O 0 1.3663872117097853e-11
with O 0 4.5448586165125135e-14
the O 0 6.929477608039192e-13
wild O 0 1.1380252296078197e-09
- O 0 4.7569390204671436e-08
type O 0 1.8729377870840835e-07
PAX6 O 0 2.2963415631238604e-06
. O 0 1.2222020062679917e-09

These O 0 4.565227969960395e-12
results O 0 2.593410946064023e-12
provide O 0 1.2838650498628312e-13
a O 0 2.207322215633245e-12
new O 0 5.4942765614907074e-11
insight O 0 1.0297112468249381e-10
into O 0 2.4895612914938026e-13
the O 0 1.407601926727356e-13
role O 0 2.2040910763188037e-12
of O 0 3.6453269060005705e-14
mutant O 0 4.611132586873623e-10
PAX6 O 0 2.5813162096710585e-07
in O 0 6.325927004446896e-10
causing O 0 4.101644890397438e-08
aniridia B-Disease 1 1.0
. O 0 1.5801294994677306e-10
. O 0 1.4321642483050567e-10

Reversal O 0 1.3467117696563946e-06
of O 0 5.203287800625844e-10
severe O 0 0.005292949732393026
hypertrophic B-Disease 1 0.9999978542327881
cardiomyopathy I-Disease 1 1.0
and O 0 4.337704861967495e-09
excellent O 0 3.906023948729853e-08
neuropsychologic O 0 5.006010610486555e-07
outcome O 0 1.0375978964916044e-09
in O 0 1.435402213756376e-10
very B-Disease 0 6.5192971021588164e-09
- I-Disease 0 9.164736747280244e-10
long I-Disease 0 3.737836429262842e-10
- I-Disease 0 5.522825530235309e-10
chain I-Disease 0 4.1315129095664815e-08
acyl I-Disease 0 3.1387673971039476e-07
- I-Disease 0 1.2460351861420804e-08
coenzyme I-Disease 0 2.9600968787235615e-08
A I-Disease 0 5.001036029739225e-09
dehydrogenase I-Disease 0 3.969775207224302e-05
deficiency I-Disease 0 0.00010799990559462458
. O 0 9.316059035313629e-10

Very B-Disease 0 2.3768409107560728e-07
- I-Disease 0 7.230646303924004e-08
long I-Disease 0 1.6605707919836732e-09
- I-Disease 0 1.402828631036357e-09
chain I-Disease 0 8.385229399721084e-09
acyl I-Disease 0 4.74189221222332e-08
- I-Disease 0 1.1993057658088446e-09
coenzyme I-Disease 0 5.300249128481482e-10
A I-Disease 0 1.4026640959841075e-11
dehydrogenase I-Disease 0 1.0072739975441891e-08
( I-Disease 0 1.338824537344685e-11
VLCAD I-Disease 0 5.7764960814665756e-08
) I-Disease 0 4.6886342031093875e-11
deficiency I-Disease 0 8.898815622160328e-07
is O 0 4.704772270554269e-13
a O 0 2.9330652490111575e-11
disorder O 0 3.7467877973540453e-06
of O 0 3.662576223751636e-14
fatty O 0 8.002000173590318e-10
acid O 0 2.1483745338279903e-11
beta O 0 1.2102280982917435e-12
oxidation O 0 4.184079840409416e-13
that O 0 8.221956373111877e-14
reportedly O 0 3.5530950404094597e-10
has O 0 1.5717004087090203e-11
high O 0 5.768895583457834e-09
rates O 0 2.1935495624347823e-06
of O 0 3.0354067783594507e-12
morbidity O 0 2.332549229322467e-05
and O 0 2.378821140069931e-09
mortality O 0 1.2818203387610083e-08
. O 0 1.7721064893283511e-10

We O 0 1.214787576087062e-10
describe O 0 1.0585702453491663e-11
the O 0 1.4375726629066443e-13
outcome O 0 4.553444860749822e-12
of O 0 1.1903055852167249e-14
a O 0 5.375460927076192e-12
5 O 0 3.1443003582765083e-12
- O 0 1.501926222280403e-10
year O 0 5.401548652805843e-11
- O 0 9.516104571005712e-10
old O 0 5.068397967988858e-07
girl O 0 3.242466277697531e-07
with O 0 5.961933030596e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.2927155179642824e-10
was O 0 4.846044138889782e-12
first O 0 5.6760748445155995e-14
seen O 0 1.2014451933328729e-11
at O 0 5.336478221124041e-12
5 O 0 3.9008472016779927e-13
months O 0 1.0386641199899849e-11
of O 0 3.246020328071843e-14
age O 0 8.096197323670395e-11
with O 0 6.579221542568625e-12
severe O 0 0.0019759151618927717
hypertrophic B-Disease 1 0.999996542930603
cardiomyopathy I-Disease 1 1.0
, O 0 7.829039532225579e-06
hepatomegaly B-Disease 1 1.0
, O 0 1.633419856261753e-06
encephalopathy B-Disease 1 0.9949560761451721
, O 0 1.682964101412665e-09
and O 0 6.525965101644715e-09
hypotonia B-Disease 0 0.07341957092285156
. O 0 1.935908988670576e-09

Biochemical O 0 2.383546302553441e-07
studies O 0 7.199242446631615e-08
indicated O 1 0.8899493217468262
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 6.233108251763042e-09
by O 0 7.328960572108856e-13
a O 0 1.8879670049543051e-10
stable O 0 2.0371963671550475e-07
yet O 0 6.160005283639691e-10
inactive O 0 8.985491461999118e-09
enzyme O 0 5.716354056772843e-09
. O 0 8.165332993081975e-11

Molecular O 0 5.254412904776018e-09
genetic O 0 5.9705880239846465e-09
analysis O 0 3.924397751209341e-10
of O 0 1.558154321713856e-12
her O 0 2.638579577052269e-09
VLCAD O 0 7.3780506681941915e-06
gene O 0 4.232749262200741e-08
revealed O 0 1.523951098647558e-08
a O 0 1.3649707752971807e-10
T1372C O 0 1.7074638591907387e-08
( O 0 3.050935198922744e-11
F458L O 0 3.3712754810011347e-09
) O 0 8.63032909026451e-12
missense O 0 1.151111632680113e-07
mutation O 0 8.846302357312652e-09
and O 0 1.257532411536033e-10
a O 0 6.433001908945357e-10
1668 O 0 6.392868090188131e-05
ACAG O 0 1.04419141280232e-05
1669 O 0 5.44202123364812e-07
splice O 0 3.917860794899752e-06
site O 0 1.2501748969384607e-08
mutation O 0 2.0966986369330698e-07
. O 0 2.620568873012985e-09

After O 0 1.0263332406168502e-09
initial O 0 1.5958642740621087e-10
treatment O 0 6.169915273135373e-11
with O 0 3.5659417584564534e-13
intravenous O 0 1.5253723839592226e-09
glucose O 0 7.736323368590092e-07
and O 0 2.94780970466757e-11
carnitine O 0 1.3592765801817563e-09
, O 0 1.8700518293179175e-13
the O 0 1.5847570380544268e-13
patient O 0 1.445364716801123e-09
has O 0 8.813224130523045e-13
thrived O 0 5.56010404384466e-10
on O 0 1.4918462515681186e-12
a O 0 1.624628383212201e-11
low O 0 1.7495732436145772e-06
- O 0 4.544335041600789e-08
fat O 0 3.408634929868981e-09
diet O 0 3.029277523269869e-11
supplemented O 0 1.0010286870254514e-11
with O 0 1.216796303472878e-13
medium O 0 3.4938189230615535e-08
- O 0 1.301133978337532e-09
chain O 0 1.1876286620804422e-08
triglyceride O 0 2.8489894887684386e-08
oil O 0 2.262750209425235e-09
and O 0 2.4244550811403087e-11
carnitine O 0 3.4634093371010977e-09
and O 0 9.923637432629473e-12
avoidance O 0 3.009940519049792e-09
of O 0 1.0102773652376218e-12
fasting O 0 1.0338547795640807e-08
. O 0 3.3827760037574706e-11

Her O 0 2.593661702121608e-05
ventricular O 0 0.0037989714182913303
hypertrophy O 0 0.0001070576035999693
resolved O 0 8.868961742791726e-08
significantly O 0 2.119260766875186e-09
over O 0 2.9806565202128432e-12
1 O 0 1.1191968575866018e-12
year O 0 1.018682751000033e-12
, O 0 7.054053115284134e-14
and O 0 9.079555141587592e-13
cognitively O 0 1.4240641998952697e-09
, O 0 9.656120710964042e-14
she O 0 2.4017095603956484e-11
is O 0 1.7314945863818737e-14
in O 0 2.911301367623971e-14
the O 0 7.052219712469802e-15
superior O 0 2.2137307178343724e-12
range O 0 1.021874772300091e-11
for O 0 2.186229712888843e-12
age O 0 1.3028668421899425e-10
. O 0 2.8351673439508396e-11

Clinical O 0 8.234881931912241e-08
recognition O 0 8.592183076139293e-10
of O 0 3.3214280215076997e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.727255921097793e-11
important O 0 1.4029843909899031e-12
because O 0 2.008766417094243e-12
it O 0 4.012172267597175e-13
is O 0 8.329480090689054e-14
one O 0 6.9723496724447e-14
of O 0 3.587359020409096e-15
the O 0 2.484106670364028e-13
few O 0 5.565884211855554e-11
directly O 0 3.418012747835597e-11
treatable O 0 4.930745376441337e-07
causes O 0 3.410889903854297e-10
of O 0 1.224574608382767e-10
cardiomyopathy B-Disease 1 1.0
in O 0 1.1649422759774097e-08
children O 0 4.977964707109095e-10
. O 0 6.249622347409556e-12
. O 0 4.640865122751414e-11

Cloning O 0 8.559864816959362e-09
of O 0 1.3715093514013454e-12
a O 0 3.755154173723518e-12
novel O 0 1.4339074198843615e-11
member O 0 8.134701137522959e-13
of O 0 8.953898888064589e-15
the O 0 6.694767353335185e-13
low O 0 3.211623607057845e-07
- O 0 4.947469101068691e-09
density O 0 6.287911163971316e-11
lipoprotein O 0 8.806155449292419e-08
receptor O 0 4.079096171949459e-09
family O 0 1.86738957630439e-09
. O 0 5.367024602520587e-10

A O 0 1.0412238848900301e-09
gene O 0 1.3611652915912487e-09
encoding O 0 1.7377843608556987e-10
a O 0 2.042911629793198e-12
novel O 0 1.1599473118129033e-11
transmembrane O 0 3.34031274862312e-11
protein O 0 2.983281677249039e-10
was O 0 6.792631040974939e-11
identified O 0 1.1815259057593175e-12
by O 0 3.6453528252087565e-15
DNA O 0 6.294051217714536e-12
sequence O 0 2.7001315137768767e-13
analysis O 0 5.730719176109955e-13
within O 0 2.840425648593242e-13
the O 0 1.808146687931611e-11
insulin B-Disease 1 0.9999700784683228
- I-Disease 1 0.9999966621398926
dependent I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 7.774099586299599e-09
IDDM B-Disease 0 7.672034598726896e-07
) O 0 2.1136394717791163e-11
locus O 0 2.5797883829170587e-09
IDDM4 O 0 5.679643777511956e-07
on O 0 2.034860946409367e-09
chromosome O 0 2.7612516078079352e-06
11q13 O 0 1.2995519682590384e-06
. O 0 3.738073406367448e-09

Based O 0 1.257935422493972e-10
on O 0 5.922319058770942e-12
its O 0 2.937104227364318e-13
chromosomal O 0 7.377688859833142e-08
position O 0 2.3804970439300632e-08
, O 0 2.2237944992398173e-12
this O 0 6.242265547778264e-14
gene O 0 4.921412583014373e-11
is O 0 4.593490301671443e-13
a O 0 6.215916453430892e-13
candidate O 0 3.6745103487723085e-12
for O 0 6.209600433675078e-13
conferring O 0 5.752049392349079e-10
susceptibility O 0 3.813947557773645e-08
to O 0 3.401503523292604e-09
diabetes B-Disease 0 0.4822003245353699
. O 0 3.2902667257417306e-09

The O 0 5.015617435266684e-11
gene O 0 1.9974832898839168e-09
, O 0 4.424610417635977e-12
termed O 0 1.973823993139945e-09
low O 0 6.465087381002377e-07
- O 0 4.224764182936269e-08
density O 0 5.323569710058429e-11
lipoprotein O 0 9.706463188763337e-09
receptor O 0 4.305931305959021e-11
related O 0 7.014256536708174e-11
protein O 0 9.036493081593377e-11
5 O 0 3.439723983075793e-12
( O 0 1.6484595806443014e-12
LRP5 O 0 3.7012943820968758e-09
) O 0 2.0471153255614133e-13
, O 0 5.635997311209673e-14
encodes O 0 3.1334518313386184e-12
a O 0 7.451762731175426e-13
protein O 0 4.245452947526651e-11
of O 0 1.7574815572036356e-13
1615 O 0 1.771323310251205e-09
amino O 0 3.80598981150615e-12
acids O 0 1.1437596746446954e-12
that O 0 2.9285982039233775e-15
contains O 0 5.6931379844248585e-15
conserved O 0 1.8436245368888549e-13
modules O 0 3.771116665468588e-12
which O 0 8.458988717818805e-14
are O 0 4.122974883594491e-14
characteristic O 0 1.6491829603337838e-12
of O 0 1.9527702547973876e-14
the O 0 5.192842683632293e-12
low O 0 5.56751274416456e-06
- O 0 2.5570395578711214e-08
density O 0 3.8304925897847397e-10
lipoprotein O 0 3.2205286970565794e-06
( O 0 2.2248615449971254e-10
LDL O 0 4.319420270348928e-07
) O 0 7.784325267712333e-12
receptor O 0 3.1985677995116646e-10
family O 0 2.653668951246857e-10
. O 0 1.8013594782484432e-10

These O 0 2.7384107134653668e-11
modules O 0 4.656772190081426e-11
include O 0 1.5786268234459222e-13
a O 0 2.201041215607602e-12
putative O 0 2.1515576820174687e-10
signal O 0 3.134859871689599e-10
peptide O 0 4.656192532231929e-12
for O 0 2.2807522539959775e-14
protein O 0 1.3066532448050006e-12
export O 0 1.3370925200373307e-10
, O 0 7.671300118576585e-13
four O 0 3.440845915483881e-12
epidermal O 0 3.182540453394722e-09
growth O 0 4.756072202738437e-10
factor O 0 3.3107291214085066e-11
( O 0 5.70373262509527e-12
EGF O 0 4.186858859611675e-09
) O 0 1.340712263431243e-12
repeats O 0 3.2802063149039995e-11
with O 0 1.3816539871838035e-13
associated O 0 4.109814225050634e-11
spacer O 0 3.089183167048759e-07
domains O 0 1.0753705703692162e-09
, O 0 7.768643584329937e-13
three O 0 1.0288836839802973e-12
LDL O 0 3.2585543152663377e-08
- O 0 1.2081720346390767e-10
receptor O 0 6.030703020298844e-11
( O 0 3.073208788145765e-12
LDLR O 0 7.560353232349826e-09
) O 0 1.5231953068642334e-12
repeats O 0 1.267148747041702e-10
, O 0 7.983892410037829e-13
a O 0 6.9063466967903e-13
single O 0 1.0553668182422538e-11
transmembrane O 0 1.1768197527572966e-10
spanning O 0 9.732964434405744e-11
domain O 0 7.935605644826538e-11
, O 0 6.61536103674365e-12
and O 0 2.8508317668346495e-12
a O 0 1.4782003746049988e-11
cytoplasmic O 0 6.985825251604183e-09
domain O 0 1.3432055467887949e-08
. O 0 5.874387642990087e-10

The O 0 1.25530783684491e-11
encoded O 0 1.0898449503971008e-10
protein O 0 2.3082052935663455e-10
has O 0 2.530543049411582e-12
a O 0 1.7924766217754934e-13
unique O 0 5.288537077881295e-13
organization O 0 6.125389258315739e-12
of O 0 1.4024278700147663e-12
EGF O 0 4.7045595863437484e-08
and O 0 9.735377781705523e-11
LDLR O 0 9.112192600468916e-08
repeats O 0 1.829880275083795e-10
; O 0 1.4436370122331704e-13
therefore O 0 1.9649177575818688e-13
, O 0 1.9737145674336015e-13
LRP5 O 0 6.446295053308404e-09
likely O 0 2.394030459984542e-11
represents O 0 6.461287125995863e-13
a O 0 1.745246525422517e-12
new O 0 2.194933991506165e-11
category O 0 1.2187242326433534e-09
of O 0 7.049466262468163e-14
the O 0 2.1378773751301594e-11
LDLR O 0 3.488373522486654e-06
family O 0 2.5768265299319637e-10
. O 0 9.445486059966868e-11

Both O 0 3.217676125544244e-11
human O 0 1.331477636479228e-11
and O 0 1.9581180427108436e-11
mouse O 0 1.5554500976122654e-07
LRP5 O 0 5.743382871514768e-07
cDNAs O 0 1.926674153551744e-09
have O 0 1.8412077418261674e-12
been O 0 1.5952053046552894e-12
isolated O 0 2.4883532734332192e-11
and O 0 1.8711864468914235e-13
the O 0 2.802590829832749e-15
encoded O 0 1.2058961685115777e-12
mature O 0 6.687033739238846e-13
proteins O 0 1.1177706811082554e-14
are O 0 1.966617803528985e-15
95 O 0 1.2313414177178572e-13
% O 0 2.7007945372866694e-14
identical O 0 4.840584530430014e-12
, O 0 1.0771076955698455e-12
indicating O 0 1.029097251858957e-09
a O 0 1.7607321156631883e-10
high O 0 1.4093033406936684e-08
degree O 0 4.612331405695613e-09
of O 0 3.003836328979714e-14
evolutionary O 0 2.098130046437885e-12
conservation O 0 3.592874966724252e-13
. O 0 1.7353383270288236e-12
. O 0 5.472177572185544e-11

The O 0 1.9943036111413903e-10
APC B-Disease 0 1.624200329786163e-08
variants O 0 3.7842649014407925e-09
I1307K O 0 2.0010498147371436e-08
and O 0 3.0876095950815863e-12
E1317Q O 0 1.35986194527149e-10
are O 0 4.7906774033878996e-14
associated O 0 5.684783546677785e-11
with O 0 0.005174231715500355
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.4003150028418787e-10
but O 0 5.907663681165021e-12
not O 0 1.0807584211250387e-12
always O 0 9.478000849438839e-12
with O 0 4.34910150969893e-14
a O 0 4.971946118703663e-11
family O 0 1.085480039186848e-10
history O 0 1.0685778650820765e-10
. O 0 9.853780985613625e-11

Classical O 0 0.0036109709180891514
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.1181939953530673e-05
FAP B-Disease 0 5.966276148683392e-07
) O 0 6.636557969841306e-11
is O 0 2.840042437335377e-12
a O 0 1.0153589774519745e-10
high O 0 0.19256669282913208
- O 1 0.9999998807907104
penetrance O 1 0.999993085861206
autosomal B-Disease 1 0.9999971389770508
dominant I-Disease 1 0.9962202906608582
disease I-Disease 1 0.9976105690002441
that O 0 3.010592122820732e-11
predisposes O 0 6.914018246817477e-09
to O 0 8.188437991898945e-13
hundreds O 0 2.696185505760007e-12
or O 0 6.267504310680794e-12
thousands O 0 3.554264087907155e-12
of O 0 3.4349103561481797e-09
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.0006234046304598451
carcinoma I-Disease 1 1.0
and O 0 3.686347407882984e-11
that O 0 3.3573119870115853e-13
results O 0 3.2297936027048113e-12
from O 0 2.3566378340965366e-13
truncating O 0 5.816168102690256e-10
mutations O 0 5.666556668337819e-10
in O 0 5.463591818549718e-12
the O 0 2.1746267980793377e-12
APC B-Disease 0 2.4579636104249403e-09
gene O 0 4.968917721726029e-09
. O 0 5.979793327171024e-10

A O 0 2.0118188004403237e-08
variant O 0 3.218717210984323e-06
of O 0 9.182053728462591e-11
FAP B-Disease 0 8.720582513888075e-07
is O 0 7.632449339212144e-09
attenuated B-Disease 1 0.9989326596260071
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 7.040705796157454e-10
which O 0 7.901223620689068e-13
results O 0 1.1572905177573145e-12
from O 0 1.5964554439702738e-13
germ O 0 1.045929457177408e-05
- O 0 2.593524861538299e-08
line O 0 7.845207261603093e-10
mutations O 0 7.405578927865974e-11
in O 0 6.743315975055175e-12
the O 0 5.061134887920926e-13
5 O 0 1.1184457223215039e-12
and O 0 1.4706656031870935e-12
3 O 0 1.2544402094773893e-13
regions O 0 5.20651664143168e-13
of O 0 2.4916941882176247e-13
the O 0 1.724510118039646e-11
APC B-Disease 0 2.9340809781785993e-09
gene O 0 7.293527115592724e-09
. O 0 3.345274612875926e-10

Attenuated B-Disease 1 0.9999942779541016
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999997615814209
have O 0 9.711611959062338e-09
" O 0 4.0437544979177176e-10
multiple O 0 3.5355267602454887e-09
" O 1 0.9977549910545349
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.783498514486894e-10
typically O 0 3.3391275855443325e-11
fewer O 0 1.6883436922826567e-12
than O 0 9.441850513242089e-14
100 O 0 2.720893714329431e-13
) O 0 6.4091561105626e-14
without O 0 1.1803276455182865e-12
the O 0 1.1009041985324264e-12
florid O 0 2.1017918072629982e-07
phenotype O 0 6.797641116662589e-09
of O 0 1.253350288138444e-12
classical O 0 2.21670881650482e-09
FAP B-Disease 0 6.821672116075206e-08
. O 0 4.456205404679281e-10

Another O 0 1.468218213673822e-09
group O 0 1.9144674734405953e-10
of O 0 3.9485984469102287e-13
patients O 0 1.206155036959089e-10
with O 0 6.236541637933898e-14
multiple O 0 3.5814609611328763e-10
adenomas B-Disease 0 0.0002120086137438193
has O 0 6.799478757812949e-10
no O 0 8.113883176452674e-11
mutations O 0 4.27756136067714e-10
in O 0 5.326623690737886e-12
the O 0 4.360025524213079e-13
APC B-Disease 0 5.799172947407172e-11
gene O 0 4.6093628913723705e-11
, O 0 1.1054745443703218e-12
and O 0 6.003589010476762e-13
their O 0 2.799847213883627e-13
phenotype O 0 9.049260785154445e-10
probably O 0 9.104227927103636e-10
results O 0 7.595986339925531e-12
from O 0 5.578376844651844e-13
variation O 0 3.3048505598820554e-10
at O 0 4.851847812403776e-10
a O 0 3.879420656244248e-12
locus O 0 7.63793195357465e-11
, O 0 5.479015678655497e-12
or O 0 1.7307313568415417e-11
loci O 0 4.2633296198912873e-11
, O 0 2.1886080187744072e-12
elsewhere O 0 2.349792305178511e-10
in O 0 2.1658522197931518e-11
the O 0 5.715865281086252e-12
genome O 0 4.595460123546502e-10
. O 0 4.033747780241015e-10

Recently O 0 9.494972630363918e-08
, O 0 1.4753554281043968e-11
however O 0 1.2221606105616845e-12
, O 0 4.251994603307087e-14
a O 0 7.713658813253421e-13
missense O 0 1.0104204761773872e-07
variant O 0 2.855088325759425e-07
of O 0 6.454922100301852e-12
APC B-Disease 0 3.5044689372654148e-09
( O 0 8.434910755972247e-12
I1307K O 0 1.2479371980234077e-09
) O 0 1.1788157255887555e-12
was O 0 2.9091855660579036e-11
described O 0 9.545830922594312e-13
that O 0 1.1701452693358306e-14
confers O 0 9.46336433695072e-13
an O 0 2.823485057410792e-14
increased O 0 7.935671009207113e-10
risk O 0 2.886592483264394e-05
of O 0 8.448179869446903e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.3693170729245363e-11
including O 0 3.020711935794451e-13
multiple O 0 7.169372734372459e-11
adenomas B-Disease 0 1.0977425517921802e-05
, O 0 2.407094523704245e-10
in O 0 1.6582824002853158e-09
Ashkenazim O 0 0.00023563405557069927
. O 0 2.0527184396712528e-09

We O 0 2.4339130710870904e-10
have O 0 1.8313172159278857e-12
studied O 0 5.166861383187893e-11
a O 0 1.1164252031528599e-12
set O 0 1.9717968577359635e-12
of O 0 5.012042687889233e-14
164 O 0 1.930322152121633e-10
patients O 0 2.235576862519295e-10
with O 0 2.834549652289131e-12
multiple O 0 0.21228629350662231
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 3.7880768104514573e-06
/ I-Disease 1 0.8866329193115234
or I-Disease 0 0.129692941904068
carcinoma I-Disease 1 1.0
and O 0 2.359480610891751e-09
analyzed O 0 1.111267078357514e-08
codons O 0 5.983130080267074e-08
1263 O 0 1.4127837744126737e-07
- O 0 2.6095024807659684e-08
1377 O 0 8.961942654650557e-08
( O 0 8.278334961975276e-11
exon O 0 6.079319270213546e-09
15G O 0 2.7412630387857462e-08
) O 0 9.026664507007232e-13
of O 0 1.7693266353446292e-14
the O 0 2.81450725355889e-13
APC B-Disease 0 8.045659277700068e-11
gene O 0 7.735206919434745e-11
for O 0 1.1627645461059766e-12
germ O 0 3.7471165796887362e-06
- O 0 7.182070049793765e-08
line O 0 1.3310810231814685e-08
variants O 0 5.937475933137648e-08
. O 0 7.245936073374537e-10

Three O 0 6.003907926377394e-10
patients O 0 5.996834695487507e-10
with O 0 8.583270812850818e-14
the O 0 4.297189232053966e-13
I1307K O 0 1.0885324863707524e-09
allele O 0 3.711741469736296e-10
were O 0 2.5746732870701727e-11
detected O 0 3.191571729121989e-10
, O 0 4.620420054044817e-14
each O 0 4.305002602772619e-15
of O 0 7.24926642694558e-14
Ashkenazi O 0 3.477026311315967e-08
descent O 0 6.248916939455285e-09
. O 0 1.780875724666231e-10

Four O 0 2.319871628131409e-09
patients O 0 2.5412473902974853e-08
had O 0 8.796120776199956e-11
a O 0 5.6126921686716624e-12
germ O 0 4.8346100811613724e-05
- O 0 2.4407361820522055e-07
line O 0 6.766182281126021e-09
E1317Q O 0 1.9446252608190662e-08
missense O 0 3.160625539067041e-08
variant O 0 1.4459471842087623e-08
of O 0 4.677250340506811e-13
APC O 0 1.0738635675133779e-10
that O 0 1.556582147248589e-13
was O 0 3.845497531518305e-11
not O 0 1.9646629700713347e-13
present O 0 1.7574840983024774e-14
in O 0 1.4312890065856787e-12
controls O 0 1.8287332759214792e-09
; O 0 1.0849774448014674e-13
one O 0 6.034802784446805e-14
of O 0 8.69892831253477e-16
these O 0 9.483140320102126e-15
individuals O 0 2.4362349770466925e-14
had O 0 5.961844906643421e-10
an O 0 1.7266277383548578e-13
unusually O 0 2.0201519276841218e-11
large O 0 2.923165724234844e-13
number O 0 4.196166417808067e-12
of O 0 1.3622177387831447e-12
metaplastic B-Disease 0 2.4625740024930565e-06
polyps I-Disease 0 5.5363731377156e-08
of I-Disease 0 1.343679399516684e-12
the I-Disease 0 8.390015245052229e-12
colorectum I-Disease 0 1.679336065762982e-07
. O 0 2.3367102697235964e-10

There O 0 2.08704845072738e-10
is O 0 4.429057760737404e-13
increasing O 0 7.322026557114725e-14
evidence O 0 7.046391465106994e-13
that O 0 2.4283065792538028e-14
there O 0 9.301782434578687e-14
exist O 0 2.734776597887456e-12
germ O 0 4.4560316325714666e-08
- O 0 1.0968643354702934e-10
line O 0 2.8106263844085433e-11
variants O 0 3.5902274209131946e-11
of O 0 8.1690550997977e-15
the O 0 4.702697446409311e-14
APC B-Disease 0 9.55270237912309e-12
gene O 0 6.683134948226588e-12
that O 0 1.5473908233313433e-13
predispose O 0 7.619802011582522e-11
to O 0 2.2033082010351063e-13
the O 0 5.185938213147362e-14
development O 0 3.143021324973627e-13
of O 0 5.730336452743068e-13
multiple O 0 0.1532854586839676
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.01011976320296526
carcinoma I-Disease 1 1.0
, O 0 3.5064378484106484e-11
but O 0 5.345789349381347e-12
without O 0 9.71372288161021e-13
the O 0 5.00761162137292e-13
florid O 0 1.2499512536123802e-07
phenotype O 0 7.86668330476914e-09
of O 0 2.3404848480297613e-13
classical O 0 2.436937041050413e-10
FAP B-Disease 0 1.192708598551917e-09
, O 0 2.0213960713610923e-12
and O 0 2.0843160639279212e-13
possibly O 0 1.2160799710975168e-12
with O 0 1.0505731857103195e-14
importance O 0 5.163679206443561e-11
for O 0 7.5340376497479156e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 2.0038379844322662e-08
in O 0 2.2360394785758686e-12
the O 0 4.021977724282498e-14
general O 0 6.795341470512001e-14
population O 0 3.2913382848158423e-14
. O 0 1.8293899381460754e-12
. O 0 4.3708543728815386e-11

Genomic O 0 3.1127701305422306e-08
structure O 0 6.7794453384451e-10
of O 0 2.9501184481417475e-13
the O 0 3.850648098990828e-12
human O 0 4.273673859245264e-09
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999979734420776
diarrhea I-Disease 1 1.0
( O 0 1.9273593920843268e-07
CLD B-Disease 0 0.0010507970582693815
) O 0 2.2262114374171915e-10
gene O 0 4.175814893869756e-08
. O 0 2.602169812959687e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999996423721313
diarrhea I-Disease 1 1.0
( O 0 1.4091069715505e-05
CLD B-Disease 1 0.8021447062492371
) O 0 1.4312084850587325e-10
is O 0 6.89780611101698e-12
caused O 0 1.2985766108253305e-11
by O 0 1.0289582770897643e-12
mutations O 0 4.856220314763959e-09
in O 0 2.9778624011100874e-11
a O 0 5.7254014897145655e-12
gene O 0 2.1086835055861286e-10
which O 0 1.7777787705494652e-12
encodes O 0 6.211884340245888e-10
an O 0 1.7370776692060552e-11
intestinal O 0 2.118253178196028e-06
anion O 0 1.7013820752254105e-07
transporter O 0 1.995966158574447e-05
. O 0 8.928754624548674e-09

We O 0 2.04006433968118e-09
report O 0 1.641370789284835e-10
here O 0 9.829200170799468e-13
the O 0 6.2370851789761515e-15
complete O 0 1.7599874194747928e-13
genomic O 0 6.897911929149014e-12
organization O 0 3.435776619806208e-12
of O 0 3.93283462166074e-14
the O 0 6.047410293884281e-13
human O 0 2.0605815664875848e-11
CLD B-Disease 0 8.567758413846605e-08
gene O 0 1.4249655622133872e-10
which O 0 6.436354812837386e-13
spans O 0 5.6116430946495655e-12
approximately O 0 1.1243598283319778e-12
39kb O 0 1.6937407565364992e-07
, O 0 2.4891746649990942e-11
and O 0 2.702695012235523e-11
comprises O 0 1.0642875469812907e-11
21 O 0 1.13157032355371e-10
exons O 0 8.613107560506705e-09
. O 0 3.958898209255324e-10

All O 0 2.0732887628938101e-10
exon O 0 2.61831214487529e-08
/ O 0 1.7133524821133506e-08
intron O 0 7.45839301430351e-08
boundaries O 0 3.8806602375984767e-10
conform O 0 8.711644738923496e-09
to O 0 1.722806142537281e-12
the O 0 1.4414427984554834e-11
GT O 0 6.556984430972079e-07
/ O 0 7.565533906017663e-07
AG O 1 0.9995562434196472
rule O 0 7.412835678621832e-09
. O 0 4.384650698074921e-10

An O 0 2.416735908616907e-11
analysis O 0 5.73731730527105e-12
of O 0 2.900604357939686e-14
the O 0 2.8671951423329955e-13
putative O 0 1.95370192246358e-10
promoter O 0 1.7622382442183948e-09
region O 0 1.3017713296203937e-10
sequence O 0 4.382583532192008e-11
shows O 0 1.727081672120434e-10
a O 0 7.440038862771559e-11
putative O 0 1.1965120449985989e-08
TATA O 0 6.555909521921421e-07
box O 0 3.0753655178017425e-09
and O 0 1.7616055836278122e-10
predicts O 0 1.8792951639312605e-09
multiple O 0 1.4479568585801239e-11
transcription O 0 5.150491144689795e-10
factor O 0 2.492585825242255e-11
binding O 0 8.715524829616683e-11
sites O 0 2.0975290393465684e-09
. O 0 1.833899365699665e-09

The O 0 6.792705287139711e-12
genomic O 0 2.0893424490520118e-10
structure O 0 1.503723534579393e-10
was O 0 1.3115533659124878e-10
determined O 0 3.098895922856726e-12
using O 0 4.0775807209902926e-12
DNA O 0 1.6899981414297827e-10
from O 0 4.36127344091361e-13
several O 0 4.5027688717370895e-14
sources O 0 9.031658884314786e-13
including O 0 5.309000580735329e-14
multiple O 0 2.217868467005446e-12
large O 0 8.81328343638188e-11
- O 0 2.2693833670928143e-05
insert O 0 1.2689503137153224e-06
libaries O 0 1.351524758774758e-07
and O 0 3.975017797558378e-12
genomic O 0 2.4783555763185916e-10
DNA O 0 2.0472989969988475e-09
from O 0 4.6569057637890765e-11
Finnish O 0 2.7107745381727e-07
CLD B-Disease 0 0.0004913395387120545
patients O 0 7.609572207911697e-07
and O 0 1.9415916097109687e-10
controls O 0 7.221176474558888e-07
. O 0 9.39967992330537e-10

Exon O 0 1.7433211496609147e-07
- O 0 2.010399491325643e-08
specific O 0 5.195787550205111e-11
primers O 0 5.539592340397803e-09
developed O 0 1.2174575236834073e-10
in O 0 1.2444181969606394e-11
this O 0 1.4685709516949058e-13
study O 0 2.51033677352297e-13
will O 0 4.5165833014804493e-14
facilitate O 0 8.181631370660081e-13
mutation O 0 1.9793179682064954e-12
screening O 0 5.116432017643335e-12
studies O 0 1.8703309300621695e-12
of O 0 1.6432469669919528e-14
patients O 0 7.96125318447416e-12
with O 0 3.290233415039444e-14
the O 0 2.142580037001185e-11
disease O 0 2.2700898227867583e-07
. O 0 3.264074843745135e-10

Genomic O 0 1.3682774024914579e-08
sequencing O 0 3.004010151741454e-09
of O 0 3.1706601320152794e-12
a O 0 1.2661269255254126e-10
BAC O 0 8.76350259204628e-06
clone O 0 4.050791631016182e-07
H O 1 0.9999998807907104
_ O 0 5.5711414648218494e-11
RG364P16 O 0 8.28606405711696e-10
revealed O 0 6.381926237475355e-11
the O 0 1.770427100549702e-14
presence O 0 3.158724909239907e-13
of O 0 3.5462815223572886e-15
another O 0 8.171618763597177e-13
, O 0 6.128643870607214e-14
highly O 0 2.2825334287587817e-13
homologous O 0 1.4827853571722227e-12
gene O 0 4.672742748290659e-11
3 O 0 1.4459663934957012e-12
of O 0 3.6137935634401874e-14
the O 0 4.687130024383368e-12
CLD B-Disease 0 2.547586177570338e-07
gene O 0 7.737379625893936e-10
, O 0 4.981454918701056e-12
with O 0 6.888648587102461e-14
a O 0 1.094873432368193e-12
similar O 0 1.195704234409345e-12
genomic O 0 1.0169968339690527e-10
structure O 0 4.00523586518986e-10
, O 0 1.6967275024218353e-12
recently O 0 1.1159579510477968e-10
identified O 0 5.36016009355933e-10
as O 0 3.586367314234451e-11
the O 0 2.9305462501127977e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.6236899114119296e-07
( O 0 6.19512996458127e-10
PDS B-Disease 0 2.3909316837489314e-07
) O 0 1.636424676321191e-11
. O 0 7.57697203590535e-12
. O 0 1.234591040510935e-10

The O 0 3.02677244379268e-10
APCI1307K O 0 3.3561027521500364e-06
allele O 0 1.1810346904894686e-06
and O 0 1.2521604197957004e-08
cancer B-Disease 0 1.8249575077788904e-06
risk O 0 5.326875829325672e-09
in O 0 6.226789049657011e-12
a O 0 1.799843043701066e-12
community O 0 7.112012801596679e-13
- O 0 8.389279722298415e-12
based O 0 2.1948616969053036e-12
study O 0 2.520264162295116e-12
of O 0 1.8122053066071259e-13
Ashkenazi O 0 4.65570204610799e-09
Jews O 0 4.124916033743098e-11
. O 0 3.5477773496772613e-11

Mutations O 0 1.5928058019198943e-06
in O 0 9.129929590123709e-10
APC O 0 1.2258470682979805e-08
are O 0 3.1178499452361175e-12
classically O 0 1.1379399893485243e-06
associated O 0 9.749027363170626e-09
with O 0 9.810737111592971e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.5740811249997932e-06
FAP B-Disease 0 6.842743118795624e-07
) O 0 8.37154165433951e-11
, O 0 3.2372314464484964e-12
a O 0 8.001599383078428e-11
highly O 0 5.245746797299944e-05
penetrant O 1 0.9999991655349731
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.684430683075334e-06
by O 0 1.3177317570445268e-10
multiple O 0 5.1306418669128107e-08
intestinal O 0 0.017830073833465576
polyps B-Disease 0 1.316481939284131e-05
and O 0 2.1835221131194515e-11
, O 0 1.562343597593177e-13
without O 0 8.531811867239225e-13
surgical O 0 1.3037282364791736e-08
intervention O 0 1.0759861890363709e-09
, O 0 5.882900503545452e-13
the O 0 7.95206321580963e-14
development O 0 9.522890809243734e-11
of O 0 4.3549587758207053e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.6074217512596078e-09
CRC B-Disease 0 2.6055940338665096e-07
) O 0 2.52698504482618e-11
. O 0 1.1224389473429852e-10

APC B-Disease 0 3.0443104037658486e-07
is O 0 1.2425308004715419e-10
a O 0 1.879302269358618e-09
tumour O 1 1.0
- O 0 3.4086997402482666e-06
suppressor O 0 8.506923165896296e-08
gene O 0 8.487502256571133e-09
, O 0 1.9282750743365717e-11
and O 0 5.8093994025065765e-12
somatic O 0 1.2557983097849501e-08
loss O 0 2.6889088289294705e-08
occurs O 0 8.716776189743314e-10
in O 0 1.200178267879437e-08
tumours B-Disease 1 1.0
. O 0 3.876512444378477e-09

The O 0 3.388253566605215e-10
germline O 0 4.1842307041406457e-07
T O 0 1.8768319876016903e-07
- O 0 1.21769028194052e-09
to O 0 5.477291363520376e-12
- O 0 8.184250499532197e-10
A O 0 2.4847061907973256e-11
transversion O 0 8.748072821695985e-10
responsible O 0 1.0848249382133801e-12
for O 0 9.289189256938678e-15
the O 0 1.3204293615540902e-13
APC O 0 2.512251517927666e-10
I1307K O 0 4.1582459697764307e-10
allele O 0 4.401761455330444e-10
converts O 0 8.021877606623207e-11
the O 0 8.009683953418001e-13
wild O 0 3.22423095167057e-11
- O 0 1.2008530836382647e-09
type O 0 1.6782456535580081e-09
sequence O 0 5.358345277900467e-12
to O 0 2.0271449449604795e-12
a O 0 1.7308443567287668e-10
homopolymer O 0 4.121869551454438e-06
tract O 0 2.1080331862322055e-05
( O 0 1.647948860705739e-10
A8 O 0 1.0613015177796115e-07
) O 0 3.3926523699753797e-13
that O 0 1.4849129955155083e-13
is O 0 1.0950739013498856e-12
genetically O 0 2.3925688097392594e-08
unstable O 0 0.0011466039577499032
and O 0 4.84032203207363e-10
prone O 0 1.9056638933534487e-08
to O 0 1.3436313693604429e-11
somatic O 0 3.330990239192033e-08
mutation O 0 8.328074585506329e-08
. O 0 2.037008339783597e-09

The O 0 1.0626876462138668e-10
I1307K O 0 1.667919846681798e-08
allele O 0 1.4770555445409173e-08
was O 0 7.94656518365855e-09
found O 0 1.5388459950749223e-10
in O 0 4.999971964236849e-11
6 O 0 4.7016373433406144e-11
. O 0 4.7568952249443797e-11

1 O 0 2.1639383618321517e-09
% O 0 5.699711883022651e-11
of O 0 5.4550298739936e-13
unselected O 0 6.984987521718722e-07
Ashkenazi O 0 1.0917084125594556e-07
Jews O 0 4.1156113239626535e-11
and O 0 7.359459396061308e-12
higher O 0 5.549517095859713e-11
proportions O 0 4.309332751750716e-11
of O 0 1.9681885244857145e-13
Ashkenazim O 0 5.936931302130688e-07
with O 0 2.0477647355576778e-12
family O 0 3.3354104200800094e-11
or O 0 2.8428785367462517e-11
personal O 0 2.2442239733244662e-10
histories O 0 6.38529362717577e-09
of O 0 2.283405452566112e-12
CRC B-Disease 0 1.3853390612439398e-07
( O 0 7.163823700917504e-11
ref O 0 4.7624678245483665e-07
. O 0 6.182186707004433e-12
2 O 0 1.0359279406513267e-11
) O 0 1.0812435148610522e-11
. O 0 7.61111590419361e-11

To O 0 5.92675145072441e-11
evaluate O 0 5.454462922993564e-11
the O 0 7.314029210839929e-14
role O 0 2.0271603406313288e-12
of O 0 3.6139243453272435e-14
I1307K O 0 4.6264791997430166e-10
in O 0 5.94236118645064e-11
cancer B-Disease 0 9.585039428827713e-09
, O 0 6.84969051964468e-12
we O 0 1.7304178923094327e-11
genotyped O 0 4.821490318107635e-09
5 O 0 2.571624337088796e-12
, O 0 2.236982300785062e-12
081 O 0 1.3646078045326249e-08
Ashkenazi O 0 5.4805706639626806e-09
volunteers O 0 5.096271061405533e-12
in O 0 1.4238201546598606e-12
a O 0 5.151714124740359e-12
community O 0 1.6695216389917e-11
survey O 0 1.660421911076071e-09
. O 0 1.3286800826239897e-10

Risk O 0 2.665354656983254e-07
of O 0 8.756427007095002e-12
developing O 0 6.521179329865845e-06
colorectal B-Disease 1 1.0
, I-Disease 0 2.4435192358396307e-07
breast I-Disease 0 4.105991683900356e-05
and I-Disease 0 6.450707190630567e-10
other I-Disease 0 1.656529254046024e-11
cancers I-Disease 0 1.8131386525510607e-07
were O 0 1.201094605718378e-11
compared O 0 1.5301059030914388e-11
between O 0 1.221298452994124e-12
genotyped O 0 9.976373505082847e-09
I1307K O 0 4.962474875469525e-10
carriers O 0 4.892306004755653e-11
and O 0 4.488828200203271e-13
non O 0 1.7335329352552442e-11
- O 0 1.5059930733030136e-11
carriers O 0 5.778613698659285e-11
and O 0 9.310095012635133e-13
their O 0 7.223097852259927e-14
first O 0 4.312175616583147e-12
- O 0 2.1149025586364445e-10
degree O 0 3.561272610141941e-09
relatives O 0 5.571579864138698e-10
. O 0 4.06968868327251e-11

Sperm O 0 2.3274827398722664e-08
DNA O 0 7.807965829442765e-09
analysis O 0 1.5278785181482846e-10
in O 0 2.116132269414095e-11
a O 0 7.075316998950143e-10
Friedreich B-Disease 0 0.00020768890681210905
ataxia I-Disease 1 0.8468381762504578
premutation O 0 2.983299782499671e-05
carrier O 0 2.6730015179055044e-07
suggests O 0 1.04446007398451e-09
both O 0 5.055097399703223e-12
meiotic O 0 3.944970572433704e-09
and O 0 1.3214688024398846e-11
mitotic O 0 2.367255280688596e-10
expansion O 0 1.841721393447404e-11
in O 0 1.6926361354197006e-11
the O 0 3.3457750459042757e-12
FRDA B-Disease 0 9.017084323659219e-08
gene O 0 7.52080175914216e-09
. O 0 3.42247008511265e-10

Friedreich B-Disease 1 0.9943280816078186
ataxia I-Disease 1 0.9999978542327881
is O 0 4.607260279954062e-07
usually O 0 4.367300743268743e-09
caused O 0 6.962313364722306e-11
by O 0 7.789857084036789e-14
an O 0 8.199249113861884e-14
expansion O 0 3.302070422650516e-11
of O 0 9.719745624678366e-13
a O 0 1.5117649354579044e-09
GAA O 0 5.807439151794824e-08
trinucleotide O 0 2.9320627703555147e-08
repeat O 0 2.1249313419957616e-09
in O 0 2.541791256638337e-11
intron O 0 1.5024090416204672e-08
1 O 0 3.6738320718932016e-11
of O 0 2.0567038740496035e-13
the O 0 3.3301007350966527e-12
FRDA B-Disease 0 7.736914398037698e-08
gene O 0 1.3485990102424239e-08
. O 0 8.175871646365351e-10

Occasionally O 0 3.5468258374748984e-07
, O 0 3.8087658027485816e-11
a O 0 2.359724395051277e-12
fully O 0 2.4730079095647284e-12
expanded O 0 8.423399130985665e-12
allele O 0 3.713412632944113e-10
has O 0 4.464564135053806e-12
been O 0 1.3403620661295301e-12
found O 0 1.3775865214185612e-12
to O 0 8.734150420052975e-14
arise O 0 2.696483878197875e-12
from O 0 2.62175372557627e-13
a O 0 3.67273746137986e-12
premutation O 0 2.3495423384645164e-09
of O 0 5.2523754117718424e-14
100 O 0 3.055732099646602e-12
or O 0 1.7829419884929365e-10
less O 0 1.2230159107673444e-09
triplet O 0 2.068710728053702e-06
repeats O 0 7.681802571823937e-08
. O 0 8.549744245911484e-10

We O 0 2.505131657670745e-10
have O 0 6.064321137269624e-13
examined O 0 6.009905247073011e-12
the O 0 8.336692237421745e-15
sperm O 0 4.85532404212452e-12
DNA O 0 5.864075197647978e-11
of O 0 1.6463464299525457e-14
a O 0 1.451931023327413e-11
premutation O 0 1.9889195357336575e-07
carrier O 0 9.116382670981693e-08
. O 0 1.1683640721571464e-09

This O 0 3.118434330207087e-11
mans O 0 5.763385768631224e-09
leucocyte O 0 1.2176259112095522e-08
DNA O 0 4.264187669633657e-09
showed O 0 6.467918423069818e-10
one O 0 3.561654226755251e-12
normal O 0 1.835903928881777e-10
allele O 0 1.8166871340596913e-09
and O 0 3.222140609882018e-11
one O 0 3.0203565343223104e-12
allele O 0 2.631180551215806e-10
of O 0 3.507457453817697e-13
approximately O 0 1.2422601142203504e-11
100 O 0 1.2145258410090065e-10
repeats O 0 1.11504636635118e-08
. O 0 4.1548842144578657e-10

His O 0 9.01937691200061e-11
sperm O 0 1.0582261733560472e-09
showed O 0 9.094382191765504e-11
an O 0 2.5017697467691682e-14
expanded O 0 6.545476834152186e-12
allele O 0 4.650128726524372e-09
in O 0 2.7958400039551634e-09
a O 0 3.896579059414762e-09
tight O 0 7.085775450832443e-07
range O 0 1.0770245806313028e-10
centering O 0 3.177589302794104e-10
on O 0 1.5391747598680894e-10
a O 0 6.8008077468151296e-12
size O 0 1.9259446468189445e-11
of O 0 2.4428343462640223e-13
approximately O 0 1.5109245452005204e-11
320 O 0 3.767384182395972e-09
trinucleotide O 0 5.279741799313342e-07
repeats O 0 1.4190140973369125e-07
. O 0 1.1987751902253763e-09

His O 0 5.760352639327948e-09
affected O 0 2.5990415153387403e-08
son O 0 1.6086471532616997e-07
has O 0 2.5522700272673227e-11
repeat O 0 7.673064267299523e-11
sizes O 0 3.802748047010418e-11
of O 0 4.3470221454573743e-13
1040 O 0 8.802939488461448e-10
and O 0 1.4098576472942881e-11
540 O 0 3.428195061161432e-09
. O 0 8.671766082990473e-11

These O 0 1.9933821954198905e-11
data O 0 1.854361456055109e-11
suggest O 0 2.297108683824156e-12
that O 0 8.101529972055765e-14
expansion O 0 8.410524013346965e-12
occurs O 0 2.367767657288078e-12
in O 0 8.118921659104605e-13
two O 0 4.428314540148165e-13
stages O 0 3.416029828798295e-12
, O 0 7.060756195215526e-14
the O 0 2.4369320851622828e-14
first O 0 6.641730351461539e-13
during O 0 1.2883253491802193e-12
meiosis O 0 1.5169009711518688e-12
followed O 0 5.849803063825987e-13
by O 0 5.922098613364221e-14
a O 0 8.701235912345062e-12
second O 0 2.0044244042338732e-10
mitotic O 0 5.461411767271329e-09
expansion O 0 1.067209653982104e-09
. O 0 3.892677014061263e-10

We O 0 7.025386938863676e-10
also O 0 1.4953189511265896e-12
show O 0 1.931564934040675e-12
that O 0 5.800713371011817e-14
in O 0 4.770519916597049e-13
all O 0 2.6457946551423743e-14
informative O 0 6.4834622046094914e-12
carrier O 0 1.001945575118679e-11
father O 0 4.3606099633941575e-12
to O 0 1.1315642569004539e-13
affected O 0 8.39565049426394e-12
child O 0 1.0102533393174795e-10
transmissions O 0 2.964174461439484e-09
, O 0 3.3405637739521155e-13
with O 0 5.0393594157348894e-15
the O 0 1.1693152617508161e-14
notable O 0 4.2737463416299415e-13
exception O 0 1.842985616548609e-12
of O 0 1.1612118669510237e-14
the O 0 3.0923226761354894e-13
premutation O 0 4.722583213379039e-09
carrier O 0 5.333298247478524e-10
, O 0 5.263450265913239e-13
the O 0 3.2048453788794534e-14
expansion O 0 9.733014741386548e-12
size O 0 1.2495562917713698e-10
decreases O 0 4.810630227503054e-10
. O 0 1.2931611510780261e-11
. O 0 8.702900206047914e-11

The O 0 8.731681350182541e-11
R496H O 0 5.01772801086986e-09
mutation O 0 3.982246477018947e-10
of O 0 3.6852611890944575e-13
arylsulfatase O 0 8.73287717695348e-08
A O 0 1.3130008191808429e-09
does O 0 1.1195359084226197e-09
not O 0 9.220792462905081e-10
cause O 0 3.609437726481701e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.649079273136067e-08

Deficiency B-Disease 1 0.9999982118606567
of I-Disease 0 7.573479343658818e-11
arylsulfatase I-Disease 0 1.1494598766148556e-06
A I-Disease 0 5.003077507836906e-09
( O 0 2.4455884539698047e-10
ARSA O 0 3.3889925816765754e-06
) O 0 3.577785984143489e-11
enzyme O 0 3.8716002848104836e-08
activity O 0 2.52183269822126e-07
causes O 0 9.491657237958862e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 7.207497674244223e-06
MLD B-Disease 1 0.9999998807907104
) O 0 3.793949154839993e-09
. O 0 6.715150102643008e-10

A O 0 5.584509743528088e-09
number O 0 1.7818668415769956e-11
of O 0 1.381114515287829e-12
ARSA O 0 3.570671105990186e-05
gene O 0 4.068732195605662e-08
mutations O 0 1.4832354899851907e-08
responsible O 0 2.407562760264881e-10
for O 0 9.837030495729593e-11
MLD B-Disease 1 1.0
have O 0 2.114535629926806e-10
been O 0 1.6012152714850458e-10
identified O 0 1.6809430514186374e-09
. O 0 7.926893169640792e-11

Recently O 0 1.735070576103226e-08
, O 0 4.1680161926016535e-12
the O 0 1.7814979905769052e-13
R496H O 0 7.773932053645183e-10
mutation O 0 7.044785588217195e-11
of O 0 2.589504674056775e-13
ARSA O 0 3.664946177650563e-07
was O 0 2.7662283921814357e-11
proposed O 0 2.0635804263285928e-13
to O 0 1.4341631181247205e-13
be O 0 2.778727768715239e-12
a O 0 6.7788951535474595e-12
cause O 0 4.839241785070669e-10
of O 0 9.202462403212763e-11
MLD B-Disease 1 1.0
( O 0 6.982847633452138e-11
Draghia O 0 1.8216498531842262e-08
et O 0 5.926813706480516e-09
al O 0 8.362297165831478e-08
. O 0 1.0412552070571124e-10
, O 0 9.434947614850309e-12
1997 O 0 6.600891708230527e-12
) O 0 1.6606980547673178e-12
. O 0 3.0664359940146824e-11

We O 0 1.2342496469308628e-10
have O 0 8.112265741967717e-13
investigated O 0 1.7218633203280875e-12
the O 0 2.6309946178615894e-14
R496H O 0 1.3000789333972307e-10
mutation O 0 4.145539380523422e-12
and O 0 1.515084444621978e-13
found O 0 6.634627743029586e-13
this O 0 6.9940831826185296e-15
mutation O 0 2.0171017633963118e-12
at O 0 3.446948455831933e-12
a O 0 9.237219279409348e-13
relatively O 0 3.676040027933425e-11
high O 0 6.685522968563617e-11
frequency O 0 1.6483094403274556e-11
in O 0 7.701501112192255e-13
an O 0 1.2713052283802855e-14
African O 0 5.1617415311629167e-14
American O 0 3.397949781790144e-13
population O 0 1.435938702470073e-14
( O 0 7.695700630569458e-13
f O 0 2.0012700385763083e-09
= O 0 1.7600539081730204e-10
0 O 0 1.2043452173038371e-11
. O 0 7.018950958642689e-12
09 O 0 2.1818911954962772e-10
, O 0 1.9325784462315143e-12
n O 0 4.332485203928371e-10
= O 0 1.0496826741146492e-09
61 O 0 3.9032496679247686e-10
subjects O 0 2.8084103931291793e-09
) O 0 6.975964944588853e-11
. O 0 1.2826822937128668e-10

The O 0 2.2524146436886383e-10
ARSA O 0 1.501667838965659e-06
enzyme O 0 3.2883471501321537e-09
activity O 0 7.257471290600392e-10
in O 0 3.491520007142812e-12
subjects O 0 2.872463898684341e-11
with O 0 1.6230751822849526e-13
and O 0 2.7040292747970707e-12
without O 0 7.931118869292098e-13
the O 0 2.6472701526551734e-13
R496H O 0 2.927008635467132e-10
mutation O 0 2.4147867733192996e-11
was O 0 1.2174063146463965e-10
determined O 0 1.3227119920189434e-11
and O 0 4.900192122729574e-13
found O 0 2.997766748377706e-12
to O 0 3.394348062173147e-13
be O 0 2.3736020093867438e-11
normal O 0 1.0484579870961852e-09
. O 0 1.1496968654878259e-10

It O 0 9.258677852175268e-11
is O 0 2.597300358727489e-13
therefore O 0 2.5920940198952136e-13
concluded O 0 8.564784298448203e-12
that O 0 3.769991182298385e-14
the O 0 1.0920031426418092e-13
R496H O 0 5.511429090887532e-10
mutation O 0 5.055312418678071e-11
of O 0 4.018782106141733e-13
ARSA O 0 1.7922046424700966e-07
does O 0 1.855444270448814e-11
not O 0 2.353201726361387e-13
negatively O 0 1.4098058657985302e-12
influence O 0 6.660480543832503e-13
the O 0 2.8188695409998854e-13
activity O 0 1.8161734616217728e-10
of O 0 9.495271187159524e-14
ARSA O 0 1.4583493168629502e-07
and O 0 5.297151606242778e-12
is O 0 4.581992337632235e-13
not O 0 2.607780527977277e-12
a O 0 1.5878480821851504e-11
cause O 0 2.6087845217404038e-09
of O 0 3.929695235882491e-09
MLD B-Disease 1 1.0

Down O 0 1.979848093469627e-06
- O 0 6.781197470218103e-08
regulation O 0 2.2269897037574538e-09
of O 0 5.033994597038183e-13
transmembrane O 0 6.8119434537550205e-09
carbonic O 0 2.788809183584817e-07
anhydrases O 0 3.817346794221521e-07
in O 0 4.218706717296072e-09
renal B-Disease 1 0.9517455101013184
cell I-Disease 1 0.9999487400054932
carcinoma I-Disease 1 1.0
cell O 0 3.33218376908917e-05
lines O 0 6.076188885373313e-09
by O 0 1.418013016035724e-11
wild O 0 6.504318417199784e-09
- O 0 1.547950546409993e-06
type O 0 0.018661292269825935
von B-Disease 1 0.999976634979248
Hippel I-Disease 1 0.9990979433059692
- I-Disease 0 0.49161019921302795
Lindau I-Disease 0 0.17922444641590118
transgenes O 0 0.0006112237460911274
. O 0 7.903111765017456e-08

To O 0 1.2471942922864798e-10
discover O 0 1.4963968952841356e-09
genes O 0 7.942818069928137e-10
involved O 0 1.2233349055978948e-10
in O 0 5.636879851778076e-10
von B-Disease 1 0.9998406171798706
Hippel I-Disease 1 0.9995347261428833
- I-Disease 1 0.9974838495254517
Lindau I-Disease 1 0.9997864365577698
( O 0 2.2147869316313518e-08
VHL B-Disease 0 1.0450739864609204e-05
) O 0 4.767925498860848e-10
- O 0 4.324489566442935e-08
mediated O 0 1.0169453616981627e-06
carcinogenesis O 0 8.02361682872288e-06
, O 0 4.6041611495573065e-11
we O 0 1.2980813472729391e-11
used O 0 1.173174113411335e-09
renal B-Disease 0 0.4161147475242615
cell I-Disease 1 0.9999871253967285
carcinoma I-Disease 1 1.0
cell O 0 0.014815500937402248
lines O 0 1.6958626929408638e-06
stably O 0 3.3359613098582486e-06
transfected O 0 1.4166451478558884e-07
with O 0 3.501445314246787e-11
wild O 0 6.547122399780392e-09
- O 0 8.595076906203758e-06
type O 0 0.004241504240781069
VHL O 0 0.008234953507781029
- O 0 3.699948649682483e-07
expressing O 0 3.2682192507849095e-09
transgenes O 0 2.1219450445641996e-06
. O 0 2.6254569629458047e-09

Large O 0 7.340583696446856e-10
- O 0 1.5703783162734908e-08
scale O 0 4.864069702570362e-10
RNA O 0 1.1034707592116888e-09
differential O 0 1.0183769105776008e-10
display O 0 5.9567468145560465e-12
technology O 0 1.1753824580296168e-09
applied O 0 3.988173333246969e-11
to O 0 2.005277996604271e-13
these O 0 3.700023414824477e-13
cell O 0 2.4719741809065e-09
lines O 0 1.9065744816249008e-10
identified O 0 3.1916556203492874e-11
several O 0 1.7672095611962618e-13
differentially O 0 7.53784049067896e-11
expressed O 0 3.2365012362853274e-13
genes O 0 1.7737049676225247e-11
, O 0 1.0290538901688503e-13
including O 0 3.970376477135766e-14
an O 0 5.460296928147534e-13
alpha O 0 7.791537970369689e-10
carbonic O 0 2.450204128479072e-08
anhydrase O 0 4.896747896054876e-08
gene O 0 1.6867248930907408e-08
, O 0 9.24941165325599e-11
termed O 0 3.2376210157281093e-08
CA12 O 0 1.277171577385161e-05
. O 0 2.842881263731556e-09

The O 0 5.975625810145102e-12
deduced O 0 1.3089868078353106e-10
protein O 0 1.8419498565291903e-11
sequence O 0 1.2336411189459162e-12
was O 0 8.438917967201753e-12
classified O 0 5.085260337822639e-12
as O 0 2.7525518756649214e-13
a O 0 1.7086461369039685e-12
one O 0 4.967832048508036e-11
- O 0 1.7749904657193838e-08
pass O 0 3.0058211475392227e-09
transmembrane O 0 7.992959183411585e-09
CA O 0 2.740437032855425e-08
possessing O 0 1.9609183721236434e-10
an O 0 3.9860551925147147e-13
apparently O 0 7.358751386021822e-10
intact O 0 3.618290944640279e-10
catalytic O 0 9.010470147785554e-11
domain O 0 2.527929775231197e-11
in O 0 5.537713950592993e-12
the O 0 5.4803744008180555e-12
extracellular O 0 1.0023676111359237e-08
CA O 0 3.030769767065067e-05
module O 0 5.518334944554226e-08
. O 0 4.833854427843676e-10

Reintroduced O 0 3.227743832212582e-07
wild O 0 1.8500614373806457e-08
- O 0 1.4828952998868772e-06
type O 0 6.429462473533931e-07
VHL B-Disease 0 1.3012273711865419e-06
strongly O 0 3.330580533589256e-10
inhibited O 0 5.223954158140032e-09
the O 0 8.411386279334743e-13
overexpression O 0 4.187565572078e-11
of O 0 5.4446837392373854e-14
the O 0 4.957443960548757e-13
CA12 O 0 4.058251512617517e-09
gene O 0 2.664100884341991e-10
in O 0 6.768765669490362e-12
the O 0 4.4940242499569294e-11
parental O 0 5.268135646474548e-05
renal B-Disease 0 0.15251167118549347
cell I-Disease 1 0.9998513460159302
carcinoma I-Disease 1 1.0
cell O 0 0.004680629353970289
lines O 0 7.138182354538003e-06
. O 0 1.3588262959274289e-08

Similar O 0 9.816675250462481e-11
results O 0 2.18884268349262e-11
were O 0 3.6600917067107497e-13
obtained O 0 3.276551393486399e-13
with O 0 7.275724348086016e-14
CA9 O 0 1.2607033568201587e-06
, O 0 8.636548507606756e-13
encoding O 0 1.600304611049097e-11
another O 0 4.496834328515664e-12
transmembrane O 0 8.040493826300121e-10
CA O 0 2.809326247188437e-07
with O 0 6.02555765699675e-13
an O 0 9.875521624416739e-13
intact O 0 2.569201518198838e-09
catalytic O 0 1.5253054375108377e-09
domain O 0 1.128217519408281e-09
. O 0 3.814438487292904e-10

Although O 0 1.2181913811026845e-10
both O 0 1.3559341366722877e-12
domains O 0 3.386281186013029e-11
of O 0 7.642099809684801e-15
the O 0 2.348865459772531e-13
VHL B-Disease 0 1.2340313215730703e-09
protein O 0 6.09530958692317e-12
contribute O 0 8.724797143436214e-13
to O 0 7.344858228564011e-13
regulation O 0 3.271884985167617e-10
of O 0 2.1003191590443504e-13
CA12 O 0 2.0402053380053076e-08
expression O 0 2.1020286206097083e-11
, O 0 5.194246725445661e-13
the O 0 5.772303885960908e-14
elongin O 0 2.621722561269024e-10
binding O 0 1.2629088746995976e-11
domain O 0 6.664680612944451e-11
alone O 0 6.449091954907615e-11
could O 0 3.6192278340951844e-11
effectively O 0 1.388445469707733e-10
regulate O 0 5.42251932245108e-09
CA9 O 0 1.6448861060780473e-05
expression O 0 1.1228468821400384e-08
. O 0 1.1610707950637789e-09

We O 0 7.517832578685102e-09
mapped O 0 5.969815930484401e-08
CA12 O 0 2.090019734168891e-06
and O 0 1.398921534168096e-10
CA9 O 0 7.075612984408508e-07
loci O 0 1.205934796466579e-09
to O 0 1.2934324618296689e-11
chromosome O 0 5.950785819663906e-08
bands O 0 8.802103934613115e-09
15q22 O 0 4.55033273283334e-07
and O 0 4.414347498649107e-10
17q21 O 0 1.1182373071960683e-07
. O 0 5.531069491304663e-10

2 O 0 2.2176898095693787e-09
respectively O 0 1.678366473578663e-10
, O 0 1.9680769600821657e-12
regions O 0 3.87873413942863e-11
prone O 0 8.40136920032819e-08
to O 0 4.841083263429358e-12
amplification O 0 6.001503183306056e-10
in O 0 5.5604804614917125e-12
some O 0 8.820707836018626e-13
human O 0 1.7730048332276205e-11
cancers B-Disease 0 1.7346906133752782e-07
. O 0 1.6400220070877936e-10

Additional O 0 3.451212926552927e-11
experiments O 0 5.808737865709013e-11
are O 0 4.706477720571589e-13
needed O 0 3.986277887640943e-12
to O 0 9.460851156314898e-14
define O 0 7.964833762148793e-13
the O 0 1.0801437327033481e-13
role O 0 1.0025879432218332e-11
of O 0 3.3892504146086633e-13
CA O 0 3.430784545344068e-07
IX O 0 5.986278583947069e-09
and O 0 3.737449238983004e-11
CA O 0 8.980847177042506e-09
XII O 0 4.662044639225371e-10
enzymes O 0 8.648685934087297e-12
in O 0 8.154270309109965e-14
the O 0 5.3288641809748e-14
regulation O 0 8.01611138578906e-11
of O 0 8.499176704221054e-14
pH O 0 2.917498534427132e-11
in O 0 2.0093861741610902e-13
the O 0 1.4838824613505608e-13
extracellular O 0 1.3220109035261274e-11
microenvironment O 0 4.222311111856669e-10
and O 0 8.79896416144943e-13
its O 0 9.098758801517198e-14
potential O 0 2.7506955047051918e-12
impact O 0 4.5773322632225444e-11
on O 0 1.0234441072398681e-09
cancer B-Disease 0 2.3694170181443042e-08
cell O 0 3.0448813959083054e-06
growth O 0 5.0882199786883575e-08
. O 0 1.9583842880699365e-10

A O 0 2.907535101570602e-09
gene O 0 8.423395314594018e-09
encoding O 0 1.233153690272104e-09
a O 0 2.771884978491901e-11
transmembrane O 0 7.023135961681248e-10
protein O 0 6.552878795140771e-10
is O 0 3.8572339766673736e-12
mutated O 0 1.0645551107302254e-08
in O 0 6.485459946858896e-10
patients O 0 3.416337904127431e-06
with O 0 7.021414916152935e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.4089167709462345e-05
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 1 0.9999657869338989
( O 0 4.136576171731576e-05
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.8261505640992937e-09
. O 0 9.620182428449198e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.9155013433191925e-06
WFS B-Disease 0 0.002664341824129224
; O 0 1.4786728508298097e-09
OMIM O 0 1.9195251297787763e-05
222300 O 0 5.536151803653411e-08
) O 0 5.4810565808249834e-11
is O 0 2.0480391688115773e-11
an O 0 1.4340557907832618e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999974966049194
defined O 0 8.308267407386438e-10
by O 0 1.9402875139906683e-11
young O 0 9.238858567073294e-09
- O 0 7.055863449068056e-08
onset O 0 1.7710526662995107e-06
non O 0 6.046226417311118e-07
- O 0 1.6878888118299074e-06
immune O 0 0.00014363300579134375
insulin B-Disease 1 0.9999098777770996
- I-Disease 1 0.9994654059410095
dependent I-Disease 1 0.9998260140419006
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.8651975963734913e-08
progressive O 0 5.115203194350215e-08
optic B-Disease 1 0.9955926537513733
atrophy I-Disease 0 0.0002573131932877004
. O 0 1.0367575242753446e-08

Linkage O 0 5.38740835054341e-07
to O 0 6.66558336304135e-11
markers O 0 1.6083325782290103e-09
on O 0 7.03101327159672e-11
chromosome O 0 6.874649898236385e-07
4p O 0 2.3668755602557212e-05
was O 0 4.6743185322384306e-08
confirmed O 0 2.1936010785594817e-09
in O 0 2.5134488240707853e-11
five O 0 9.101198093774965e-12
families O 0 6.373298156586715e-12
. O 0 1.9057228017871353e-11

On O 0 2.3520116410047365e-10
the O 0 7.041957620322614e-13
basis O 0 1.2220043770286293e-12
of O 0 6.594165724528242e-14
meiotic O 0 1.1464642568626005e-07
recombinants O 0 1.1545804227353074e-05
and O 0 1.4957947103155789e-09
disease O 0 1.9522964578300162e-07
- O 0 7.31383453800305e-10
associated O 0 3.0599170419698396e-10
haplotypes O 0 6.83813823343371e-08
, O 0 1.2442187904970758e-11
the O 0 1.5451325115212189e-12
WFS B-Disease 0 1.8759480724384048e-07
gene O 0 9.184195071121337e-10
was O 0 8.895580799750391e-11
localized O 0 2.309742258566061e-10
to O 0 7.230396836810371e-12
a O 0 1.5678753850778548e-09
BAC O 0 0.00983873475342989
/ O 0 1.948977342181024e-06
P1 O 0 1.3458873581839725e-05
contig O 0 2.2141074396131444e-07
of O 0 6.158387059855552e-13
less O 0 1.2923179019963538e-11
than O 0 1.4444611956196396e-12
250 O 0 7.237779386243259e-12
kb O 0 1.868915511238356e-08
. O 0 4.948266102422494e-11

Mutations O 0 6.872945164104749e-07
in O 0 1.6399531732602668e-10
a O 0 8.540640417109557e-12
novel O 0 6.429478477398831e-11
gene O 0 1.7097279148003963e-09
( O 0 3.7158554011540446e-11
WFS1 O 0 7.315177352751334e-09
) O 0 7.550840920404756e-13
encoding O 0 4.555245070037017e-11
a O 0 2.8997496678145884e-12
putative O 0 1.292656259810343e-10
transmembrane O 0 4.7194092384073016e-11
protein O 0 2.5419706270457532e-11
were O 0 8.251279867699246e-12
found O 0 8.432916691336612e-12
in O 0 4.1376694822140014e-13
all O 0 5.121699234427596e-14
affected O 0 2.870615258086101e-13
individuals O 0 8.580221833053882e-15
in O 0 7.467042934493351e-13
six O 0 4.6662680663889233e-11
WFS B-Disease 0 1.7169026023111655e-07
families O 0 3.016470536895688e-12
, O 0 1.749308163601082e-13
and O 0 1.6338906410565818e-13
these O 0 2.8727884735782125e-14
mutations O 0 8.211526944523762e-12
were O 0 2.7502076137275733e-12
associated O 0 3.906440709106063e-12
with O 0 2.4421355779638554e-13
the O 0 6.336321051181315e-11
disease O 0 1.849290697464312e-06
phenotype O 0 1.051849608302291e-06
. O 0 1.3314459534896628e-09

WFS1 O 0 5.021693596063415e-06
appears O 0 4.030581202130179e-09
to O 0 1.452899866388746e-12
function O 0 1.3941814282908416e-12
in O 0 2.6331458714834444e-12
survival O 0 4.280777121667967e-10
of O 0 2.3693373313120845e-14
islet O 0 6.2634151198892596e-09
beta O 0 1.3600545134551112e-09
- O 0 5.108336420533988e-09
cells O 0 1.6156656013066595e-09
and O 0 4.391812954973595e-11
neurons O 0 1.8685072933344316e-10
. O 0 3.161776613094802e-12
. O 0 2.065543569518269e-11

Stable O 0 4.0989243643707596e-07
interaction O 0 6.063934077094046e-11
between O 0 2.347711218139703e-12
the O 0 5.663789817461802e-14
products O 0 3.338809090314143e-11
of O 0 8.980340715579026e-15
the O 0 4.256337849447428e-13
BRCA1 O 0 1.1096049234993188e-07
and O 0 9.98085572523344e-11
BRCA2 O 0 3.9231488813129545e-07
tumor B-Disease 0 3.262783465629582e-08
suppressor O 0 1.663059556733515e-08
genes O 0 4.544861376132303e-09
in O 0 8.928881245484632e-11
mitotic O 0 8.939728068924069e-09
and O 0 3.1675547601528464e-11
meiotic O 0 4.500979500221547e-08
cells O 0 2.7811143610279032e-08
. O 0 9.064168859929111e-10

BRCA1 O 0 0.0008753812871873379
and O 0 1.2736773857824346e-09
BRCA2 O 0 6.738519431337409e-08
account O 0 7.070290967275961e-12
for O 0 2.8983478621682005e-14
most O 0 3.953622504252255e-14
cases O 0 3.226036245865954e-13
of O 0 2.1971506103217464e-14
familial O 0 2.782255137390166e-08
, O 0 1.0690156225512393e-11
early O 0 3.5897518291250208e-09
onset O 0 2.2583925840535812e-07
breast B-Disease 0 1.352036861135275e-06
and I-Disease 0 4.1246320847676543e-07
/ I-Disease 1 0.9999992847442627
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.9392798958638444e-12
encode O 0 1.0332658340050926e-11
products O 0 1.3158329981166617e-10
that O 0 6.157127216931124e-14
each O 0 3.9852778195570426e-14
interact O 0 2.692824479025302e-12
with O 0 7.240126467106256e-12
hRAD51 O 0 2.0294554303745826e-07
. O 0 5.627211474568128e-10

Results O 0 9.12587783119534e-09
presented O 0 8.536883006060592e-11
here O 0 1.3857937367078854e-11
show O 0 2.1083568918500717e-11
that O 0 2.0392288118536994e-12
BRCA1 O 0 1.9204530588012858e-07
and O 0 2.2797900720017417e-11
BRCA2 O 0 4.683430532281818e-08
coexist O 0 1.254628761993004e-10
in O 0 2.2572291258349253e-12
a O 0 4.0499175193997594e-12
biochemical O 0 5.670286462589047e-10
complex O 0 2.2260712717603326e-10
and O 0 1.2647913966157276e-11
colocalize O 0 5.154139781637923e-09
in O 0 2.8834424431467554e-11
subnuclear O 0 3.258591618759965e-08
foci O 0 8.322101230362478e-09
in O 0 8.942067572514922e-12
somatic O 0 1.729418830365148e-10
cells O 0 4.5554124361579795e-10
and O 0 4.9170940756571024e-12
on O 0 2.684116221386007e-13
the O 0 1.68644632492828e-14
axial O 0 1.168999901220158e-12
elements O 0 8.920688840396984e-12
of O 0 8.788297238375431e-13
developing O 0 6.88290979766748e-10
synaptonemal O 0 1.5852121748594072e-07
complexes O 0 2.2362698359756905e-08
. O 0 3.5211569771043116e-10

Like O 0 2.5795880986834163e-08
BRCA1 O 0 2.897823833336588e-05
and O 0 1.7896685244878086e-09
RAD51 O 0 8.703826097189449e-06
, O 0 2.500815943218271e-10
BRCA2 O 0 6.899950335537142e-07
relocates O 0 5.3586528991900195e-08
to O 0 1.5226593597095217e-10
PCNA O 0 9.77119043454877e-07
+ O 0 9.392977506905709e-10
replication O 0 3.1604352468406205e-10
sites O 0 5.309069156522739e-11
following O 0 1.05812624287549e-11
exposure O 0 4.4979886482110487e-10
of O 0 4.023782717611779e-13
S O 0 7.6228623413499e-09
phase O 0 7.893653786172905e-11
cells O 0 1.410253719358323e-10
to O 0 1.4030922257379785e-11
hydroxyurea O 0 3.5470520742819645e-08
or O 0 4.797865993388939e-10
UV O 0 2.0104498332784715e-07
irradiation O 0 8.570700771315387e-08
. O 0 1.4721299734787863e-09

Thus O 0 1.5693834010122032e-09
, O 0 6.20429124742472e-11
BRCA1 O 0 1.4910504830822902e-07
and O 0 2.907066601331998e-11
BRCA2 O 0 7.0888690473225324e-09
participate O 0 1.2654229877492873e-12
, O 0 5.226973910123223e-13
together O 0 3.497497159509616e-13
, O 0 2.580796904308458e-13
in O 0 7.346035130022244e-13
a O 0 6.968886405445129e-12
pathway O 0 1.817525019376376e-10
( O 0 3.784187373179204e-12
s O 0 1.8142969071544002e-10
) O 0 5.912200525155786e-14
associated O 0 1.644414856019627e-12
with O 0 3.581316964989742e-14
the O 0 1.1597603574112908e-13
activation O 0 9.20190898305584e-13
of O 0 3.782956207402238e-14
double O 0 1.0579295217638673e-09
- O 0 6.259810447772907e-07
strand O 0 0.0002459213137626648
break O 0 0.00022640952374786139
repair O 0 0.21467682719230652
and O 0 6.2743049644709e-10
/ O 0 9.39957622847487e-09
or O 0 8.466361639536402e-11
homologous O 0 1.7622449055565426e-09
recombination O 0 9.846126580725922e-09
. O 0 1.3842629265070627e-09

Dysfunction O 0 4.371405339043122e-06
of O 0 3.3600794130568545e-13
this O 0 1.4949787284848637e-13
pathway O 0 1.0493977908865304e-10
may O 0 2.6974641964550017e-10
be O 0 2.1892874340657953e-13
a O 0 2.6572610756746273e-13
general O 0 1.5008587634420673e-13
phenomenon O 0 2.376954362504069e-11
in O 0 4.501193688610794e-12
the O 0 1.11608395051907e-13
majority O 0 2.175795486706114e-13
of O 0 1.7505087819818382e-14
cases O 0 1.3061629035304723e-11
of O 0 1.7634863838308923e-12
hereditary B-Disease 1 0.9245588779449463
breast I-Disease 0 0.47051921486854553
and I-Disease 0 0.0011355101596564054
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.853029503403832e-11
. O 0 1.2091057322027865e-10

A O 0 5.474239728187058e-09
novel O 0 1.9927151040377566e-09
Arg362Ser O 0 9.497726694007724e-08
mutation O 0 9.807734624445175e-10
in O 0 1.1647361027045111e-11
the O 0 2.5314312278312823e-12
sterol O 0 9.170801149593899e-07
27 O 0 1.0090083435443375e-08
- O 0 3.295776807021866e-08
hydroxylase O 0 1.9960147312758636e-07
gene O 0 3.0845532794643304e-09
( O 0 1.8805590765169633e-11
CYP27 O 0 8.739287515879823e-09
) O 0 3.67644310177509e-13
: O 0 1.561362936728164e-14
its O 0 2.8385558064215194e-14
effects O 0 2.1383219847570523e-11
on O 0 1.2274290958624867e-11
pre O 0 2.2700727964064527e-09
- O 0 5.715759116009522e-11
mRNA O 0 3.153876118600074e-11
splicing O 0 2.249006120225161e-10
and O 0 4.0113862752322316e-12
enzyme O 0 2.1352132562046933e-10
activity O 0 4.633491090810793e-10
. O 0 3.377006313476372e-11

A O 0 1.1023998380821354e-09
novel O 0 4.129428743393504e-10
C O 0 2.9330472273159103e-08
to O 0 1.4074980330541775e-12
A O 0 5.3633993080115516e-11
mutation O 0 5.6318904401164716e-11
in O 0 3.976178327563806e-12
the O 0 1.743277072176197e-12
sterol O 0 1.6639169189147651e-06
27 O 0 1.6328229435202957e-08
- O 0 3.80133258204296e-08
hydroxylase O 0 9.389228807776817e-07
gene O 0 1.5816929987977346e-08
( O 0 1.3486439742749212e-10
CYP27 O 0 3.78495279562685e-08
) O 0 2.156420007837223e-12
was O 0 2.555007420912414e-11
identified O 0 7.231348766317813e-12
by O 0 5.840346381427025e-14
sequencing O 0 1.3334429393996317e-10
amplified O 0 2.5151585258953446e-09
CYP27 O 0 5.652580181703115e-09
gene O 0 3.8852965289493113e-10
products O 0 5.536864300381694e-10
from O 0 7.0806958386848695e-12
a O 0 3.2274935501952484e-10
patient O 0 2.6120775942217733e-07
with O 0 1.233788349264131e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.0271673228933196e-09
CTX B-Disease 0 1.3586595741799101e-05
) O 0 2.3866048026732756e-10
. O 0 2.958315814538537e-10

The O 0 1.0034646030776528e-10
mutation O 0 2.3721742348215002e-09
changed O 0 6.267056318343123e-10
the O 0 2.6289556469272224e-12
adrenodoxin O 0 8.969703202410528e-09
cofactor O 0 1.761311807513266e-08
binding O 0 5.064686448008615e-10
residue O 0 1.4963548622404232e-08
362Arg O 0 1.517265779682475e-08
to O 0 3.934468723043594e-11
362Ser O 0 3.310696428115989e-08
( O 0 5.316446588521373e-11
CGT O 0 2.433576540283866e-08
362Arg O 0 4.05785671730996e-09
to O 0 1.3527162029403073e-11
AGT O 0 6.967238164179435e-08
362Ser O 0 5.821140791617552e-10
) O 0 5.440129683537132e-13
, O 0 9.743797430147513e-14
and O 0 7.461215754392056e-14
was O 0 8.936679521398538e-12
responsible O 0 2.924065069936921e-12
for O 0 1.41969292224986e-12
deficiency O 0 2.4679978061215024e-09
in O 0 4.7487563875755687e-14
the O 0 4.898687792215251e-13
sterol O 0 3.364558835983189e-07
27 O 0 2.9355531339092522e-09
- O 0 1.628139578713217e-08
hydroxylase O 0 9.114730659121051e-08
activity O 0 4.2774335184958545e-09
, O 0 4.3655511605851516e-13
as O 0 1.566557078285999e-13
confirmed O 0 1.626199609000567e-12
by O 0 1.2809586087702586e-14
expression O 0 4.295788171796572e-13
of O 0 6.160072096378843e-15
mutant O 0 2.1150185769425178e-11
cDNA O 0 8.671931228665386e-11
into O 0 6.656220019607417e-11
COS O 0 4.432205969351344e-06
- O 0 5.786958467979275e-09
1 O 0 3.176896939960372e-11
cells O 0 6.872913904665268e-10
. O 0 2.8980551292079326e-10

Quantitative O 0 1.7906733873473968e-08
analysis O 0 8.887135471979946e-11
showed O 0 6.811157193808981e-11
that O 0 2.439173503747307e-14
the O 0 8.868981294003504e-15
expression O 0 6.248117257953711e-13
of O 0 1.5214602310225506e-14
CYP27 O 0 7.162229143098386e-10
gene O 0 3.1740384626166573e-11
mRNA O 0 6.150337617666368e-12
in O 0 1.5587072648218236e-12
the O 0 7.094725197956397e-13
patient O 0 3.9151643038692896e-10
represented O 0 7.639138453752192e-12
52 O 0 1.3921135355587921e-09
. O 0 3.317716101847168e-10

5 O 0 8.690994590665468e-10
% O 0 8.679505898723239e-12
of O 0 3.0270263970096425e-14
the O 0 9.48477841405948e-13
normal O 0 6.578943168022988e-09
level O 0 3.657949720903275e-09
. O 0 4.156570573843332e-11

As O 0 5.186213611341195e-11
the O 0 3.425273031789494e-13
mutation O 0 1.8079881342059068e-11
occurred O 0 4.7918821688419655e-11
at O 0 2.082449664098096e-12
the O 0 7.510303685377695e-14
penultimate O 0 1.7767669280299714e-10
nucleotide O 0 1.3188727020219115e-11
of O 0 7.655378745198907e-14
exon O 0 5.943542324970963e-10
6 O 0 4.609828838098018e-11
( O 0 7.926465907248659e-12
- O 0 9.310179294175214e-10
2 O 0 1.377471661040408e-11
position O 0 8.915301830114686e-11
of O 0 4.1611909772955313e-13
exon O 0 2.1263708571694906e-09
6 O 0 2.5568025474598244e-10
- O 0 3.8824023995687185e-09
intron O 0 1.7918594608090643e-07
6 O 0 1.7648005279369272e-10
splice O 0 1.0600023969686845e-08
site O 0 4.1396944899796395e-11
) O 0 6.895276992609223e-13
of O 0 7.161254452121586e-15
the O 0 6.513177855122648e-14
gene O 0 6.551737624649334e-11
, O 0 3.6311586875358015e-13
we O 0 2.517697151021431e-13
hypothesized O 0 1.1433147180731074e-12
that O 0 7.563185985153854e-15
the O 0 4.997008869515006e-14
mutation O 0 1.8528281686691628e-10
may O 0 1.2570096352693128e-10
partially O 0 1.0159208196913738e-10
affect O 0 2.183938446753686e-11
the O 0 3.073259962488306e-13
normal O 0 1.5425603849816838e-10
splicing O 0 3.821851723984082e-10
efficiency O 0 5.5289675615632916e-11
in O 0 6.547811771950851e-12
exon O 0 2.0706143466497906e-09
6 O 0 9.491302188635586e-11
and O 0 1.2931315740427607e-11
cause O 0 1.5176051387788547e-11
alternative O 0 4.713561832514479e-11
splicing O 0 1.226828860723117e-09
elsewhere O 0 1.5779075823729727e-09
, O 0 7.393194129817759e-13
which O 0 3.9000415717012e-14
resulted O 0 2.5445585308953023e-13
in O 0 4.8960748649795605e-12
decreased O 0 1.5805893482934152e-08
transcript O 0 7.243341482165988e-09
in O 0 2.3419651634659644e-11
the O 0 1.1780926061077945e-11
patient O 0 1.6632213828415843e-08
. O 0 1.4923658142595997e-10

Transfection O 0 6.288009331001376e-07
of O 0 8.332095430274578e-12
constructed O 0 3.3019964540415003e-10
minigenes O 0 2.7394964519089626e-08
, O 0 3.2059657662994456e-13
with O 0 8.945534437710453e-15
or O 0 1.1029519311755998e-11
without O 0 2.928736897098161e-12
the O 0 1.2493351080229698e-13
mutation O 0 8.337372459088499e-12
, O 0 7.392555263687622e-14
into O 0 1.049356673603341e-12
COS O 0 6.764764179933991e-07
- O 0 1.1557255152894186e-10
1 O 0 7.240619779094737e-13
cells O 0 1.6091348739588618e-11
confirmed O 0 8.441223414701327e-11
that O 0 3.6866370416513417e-14
the O 0 3.0375001288090314e-14
mutant O 0 2.801058829327019e-10
minigene O 0 1.3081120187052875e-08
was O 0 6.872071661723211e-11
responsible O 0 3.4342220365211895e-13
for O 0 9.782003190046597e-15
a O 0 2.3637325820627386e-13
mRNA O 0 8.71723353224052e-12
species O 0 1.3171669972170813e-13
alternatively O 0 9.835811332070676e-11
spliced O 0 9.813001611291838e-08
at O 0 2.5582185259054313e-09
an O 0 4.4327978787617184e-11
activated O 0 1.139266387895077e-07
cryptic O 0 2.3627970335837745e-07
5 O 0 6.388063689133361e-11
splice O 0 5.709241079898675e-08
site O 0 4.801820607802654e-10
88 O 0 4.209204373939457e-10
bp O 0 3.040417695387987e-09
upstream O 0 4.0664450973171284e-11
from O 0 3.2872695451130474e-12
the O 0 2.4616380982223074e-12
3 O 0 7.148028263043171e-12
end O 0 7.04669447793016e-11
of O 0 2.119426189455334e-13
exon O 0 3.7206389080779445e-09
6 O 0 3.1361280239394773e-10
. O 0 2.8874561075475924e-10

Our O 0 9.68053207039965e-11
data O 0 1.4656791405553982e-11
suggest O 0 1.2183830333523105e-12
that O 0 1.3955474281604832e-14
the O 0 5.528853742019224e-14
C O 0 5.274914949282561e-10
to O 0 2.9102964477353485e-14
A O 0 1.8100203627580136e-11
mutation O 0 1.4274238041567244e-11
at O 0 4.505961142403647e-12
the O 0 4.013892625394366e-14
penultimate O 0 2.567004248055227e-11
nucleotide O 0 2.553934277602088e-12
of O 0 2.2473762759621374e-14
exon O 0 2.070759397287958e-10
6 O 0 7.354702784290179e-12
of O 0 4.32477370701425e-14
the O 0 4.263691450682311e-13
CYP27 O 0 5.824097648599036e-09
gene O 0 3.922016530988337e-11
not O 0 1.975719501196016e-12
only O 0 2.911180682369646e-13
causes O 0 4.269161846953695e-12
the O 0 6.865572693692812e-11
deficiency B-Disease 0 8.875856110535096e-06
in I-Disease 0 1.9090907240476573e-12
the I-Disease 0 1.3131090182208482e-12
sterol I-Disease 0 4.783305485034361e-07
27 I-Disease 0 7.3841750491965286e-09
- I-Disease 0 1.0151121720980427e-08
hydroxylase I-Disease 0 1.427922171615137e-07
activity I-Disease 0 1.2059170551026455e-08
, O 0 5.928139056032844e-12
but O 0 1.2057587567282368e-11
also O 0 1.1110805201233753e-12
partially O 0 5.486202811488816e-11
leads O 0 1.7926518559516214e-12
to O 0 2.665138888659907e-13
alternative O 0 2.1956249318666465e-11
pre O 0 8.393293171593541e-09
- O 0 2.0691130753203169e-10
mRNA O 0 3.9560955206185966e-11
splicing O 0 2.9541433188562394e-10
of O 0 4.100461561008101e-13
the O 0 1.6143755169478746e-12
gene O 0 2.466515436339023e-09
. O 0 2.3799678894320664e-10

To O 0 2.1306517314356732e-11
our O 0 7.658960813651527e-13
knowledge O 0 1.9178133473657377e-12
, O 0 5.726772138101022e-14
this O 0 7.214062721218155e-15
is O 0 1.2183237410460027e-14
the O 0 3.178856036365439e-14
first O 0 4.087953500014896e-12
report O 0 1.196010564891159e-11
regarding O 0 5.559151771729332e-13
effects O 0 5.2705752089099445e-12
on O 0 1.883310998471166e-12
pre O 0 1.9077821267199369e-10
- O 0 1.2263245106891585e-11
mRNA O 0 4.424770445876636e-12
splicing O 0 4.2077012013530535e-11
of O 0 1.565728713944902e-14
a O 0 8.968658606577085e-13
mutation O 0 3.811270743447892e-12
at O 0 4.96046346359913e-12
the O 0 1.5768693317243232e-13
- O 0 5.75000935754133e-10
2 O 0 4.3127350649041496e-12
position O 0 1.952286526885061e-10
of O 0 1.9896652142699367e-13
a O 0 3.1204949735297305e-10
5 O 0 2.7596197896273544e-11
splice O 0 2.1123433668890357e-07
site O 0 9.486461394203616e-09
. O 0 3.239342349914409e-09

ATM O 0 3.508064764901064e-05
germline O 0 4.08061077905586e-06
mutations O 0 1.7226032866801688e-07
in O 0 5.458836715988014e-10
classical O 0 1.2088394214515574e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999998807907104
in O 0 6.791027740149502e-10
the O 0 2.6131531834228117e-12
Dutch O 0 6.69871491609797e-09
population O 0 1.5923114606367084e-12
. O 0 2.4395822167955217e-11

Germline O 0 2.3180467906058766e-05
mutations O 0 3.7811292941114516e-07
in O 0 1.6352055820512135e-10
the O 0 4.958483710432171e-13
ATM O 0 2.1401234118201273e-09
gene O 0 6.911980710011534e-11
are O 0 1.0096796716849848e-13
responsible O 0 1.831285557224449e-12
for O 0 2.0537180896867957e-12
the O 0 4.223390703828045e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.6573631167411804
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.70684738249372e-10
. O 0 2.369848484118364e-10

In O 0 4.002761455623727e-10
our O 0 1.8490345973093403e-12
study O 0 2.89905686262637e-13
, O 0 3.721998973133314e-14
we O 0 7.232638153751442e-14
have O 0 3.320488415475831e-14
determined O 0 1.177395637583234e-12
the O 0 1.5852256844434837e-13
ATM O 0 9.816389479055943e-08
mutation O 0 7.296497434028382e-11
spectrum O 0 2.1822604487353736e-11
in O 0 2.0286739302322054e-11
19 O 0 2.5279393162103148e-11
classical O 0 9.498443143129975e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.706257866222586e-07
, O 0 2.7151846106209833e-14
including O 0 1.2141150037376855e-15
some O 0 6.05077350596399e-15
immigrant O 0 2.6500093352338494e-12
populations O 0 4.2060657664015275e-14
, O 0 2.2956217479784373e-14
as O 0 1.3380420903208456e-13
well O 0 3.835706708851805e-13
as O 0 1.9515994723051655e-12
12 O 0 2.1967830657852738e-13
of O 0 6.256339084900189e-15
Dutch O 0 5.83444570434466e-10
ethnic O 0 1.4482213171740366e-12
origin O 0 1.8730603179584193e-10
. O 0 6.596379553691634e-10

Both O 0 7.747432556604039e-11
the O 0 1.0516710115607286e-12
protein O 0 4.0338378470838876e-11
truncation O 0 2.3198671872393106e-09
test O 0 1.0908665082354219e-09
( O 0 1.1445677738919358e-11
PTT O 0 1.0826566310129238e-08
) O 0 6.214754730803074e-13
and O 0 1.322998243076523e-13
the O 0 3.910835143141472e-14
restriction O 0 6.53638532188694e-11
endonuclease O 0 1.6509298816913542e-08
fingerprinting O 0 2.5342661302829583e-09
( O 0 2.434379520882546e-12
REF O 0 6.163907717571249e-10
) O 0 5.393672027021942e-15
method O 0 4.7838384593717684e-14
were O 0 6.350334076947114e-14
used O 0 2.1682391396649764e-13
and O 0 5.013174120618857e-13
compared O 0 8.731539796746901e-13
for O 0 1.2514468162176163e-15
their O 0 2.857518163605112e-15
detection O 0 5.83111087627125e-13
efficiency O 0 2.1910920885818974e-13
, O 0 4.6718068324493045e-15
identifying O 0 6.072550231758789e-13
76 O 0 4.391811133513945e-12
% O 0 2.294336053608459e-13
and O 0 2.548167026775877e-13
60 O 0 1.1833098520139251e-12
% O 0 5.419685425271659e-13
of O 0 2.6489606948926214e-14
the O 0 2.8906215528839985e-12
mutations O 0 1.3790397712654112e-09
, O 0 2.3191129572275315e-11
respectively O 0 2.3850574293327043e-10
. O 0 1.5636876515845444e-10

Most O 0 1.0451191995164422e-10
patients O 0 9.224820907149933e-10
were O 0 3.3913859134176993e-12
found O 0 2.8950743712063964e-12
to O 0 1.3506497352835933e-13
be O 0 1.081247071044178e-12
compound O 0 2.943008059475005e-10
heterozygote O 0 1.3220713412920304e-07
. O 0 1.3521862518572902e-09

Seventeen O 0 3.9637225057731484e-08
mutations O 0 3.874198739595158e-09
were O 0 2.5379351398235883e-11
distinct O 0 1.9748755582249533e-12
, O 0 3.465258950011846e-13
of O 0 4.73734643025958e-15
which O 0 1.5787872311573414e-12
10 O 0 6.453195183081517e-13
were O 0 2.0788750929034983e-11
not O 0 7.524922525370403e-12
reported O 0 3.0877671530760153e-09
previously O 0 3.000664161589839e-10
. O 0 9.774524939443197e-11

Mutations O 0 2.4068407356026e-07
are O 0 2.931734022215693e-11
small O 0 1.8260164214023433e-11
deletions O 0 5.27192263177767e-08
or O 0 1.9296797049150882e-08
point O 0 5.101034261656423e-09
mutations O 0 2.959882294817362e-08
frequently O 0 2.851026525974021e-09
affecting O 0 4.356534688554348e-09
splice O 0 1.2565576525958022e-06
sites O 0 2.9999807082958796e-08
. O 0 4.079811599666527e-09

Moreover O 0 3.383587809935307e-08
, O 0 1.1305369834735401e-10
a O 0 1.2815427885559671e-10
16 O 0 4.3087433621025184e-10
. O 0 1.4682006999056085e-10

7 O 0 2.364414974920237e-08
- O 0 1.3056692615975862e-08
kb O 0 4.491492511249362e-09
genomic O 0 4.3587766729302757e-10
deletion O 0 1.9849415167083606e-10
of O 0 2.4579103807603406e-14
the O 0 9.322420900558306e-14
3 O 0 9.40719832760728e-13
end O 0 5.273803095617868e-12
of O 0 1.1331786762869321e-15
the O 0 5.6941806819829285e-15
gene O 0 3.2844996254027814e-12
, O 0 5.3567664626968936e-14
most O 0 7.570377294876043e-14
likely O 0 9.004264348022595e-12
a O 0 6.822618099817934e-13
result O 0 8.418271505231112e-13
of O 0 1.1891301575958201e-14
recombination O 0 1.6623586188146966e-12
between O 0 8.242985829499949e-13
two O 0 3.26032603692461e-12
LINE O 0 1.7538017704765707e-09
elements O 0 7.094894810544261e-11
, O 0 4.42994113614148e-11
was O 0 8.171163745629428e-10
identified O 0 1.1349190476295234e-09
. O 0 3.763990508165449e-11

The O 0 8.968235876150032e-12
most O 0 4.5327150778422254e-13
frequently O 0 5.936783616794505e-12
found O 0 1.2980838626219793e-11
mutation O 0 1.893931365903878e-11
, O 0 3.712365701305509e-13
identified O 0 5.827414245596074e-11
in O 0 1.7245650437217042e-12
three O 0 4.280819676603237e-13
unrelated O 0 3.2015813611341315e-11
Turkish O 0 1.4988734697851669e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
individuals O 0 3.9247400468456206e-11
, O 0 4.348185440178343e-12
was O 0 6.214369990820146e-11
previously O 0 2.938052579004591e-12
described O 0 2.7394909257738576e-12
to O 0 3.1369587374756314e-14
be O 0 1.8091936640225043e-13
a O 0 8.451106568024835e-13
Turkish O 0 3.732081754748151e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
founder O 0 1.0354142432333902e-07
mutation O 0 1.796033899381655e-07
. O 0 2.043148539243589e-09

The O 0 2.807554752917718e-12
presence O 0 4.252485516498261e-12
of O 0 2.1118791258952982e-14
a O 0 1.5305487996788991e-12
founder O 0 6.131646579365935e-11
mutation O 0 7.099808241317618e-11
among O 0 4.843233019496962e-13
relatively O 0 9.257378934604543e-13
small O 0 4.906636620442828e-13
ethnic O 0 3.91008379103594e-13
population O 0 1.922755811718021e-14
groups O 0 3.593345510467111e-14
in O 0 4.792517294474608e-13
Western O 0 1.1325371196413414e-11
Europe O 0 2.3045036101621008e-08
could O 0 1.0483101053893051e-09
indicate O 0 4.826426758253177e-11
a O 0 1.339391531712808e-11
high O 0 2.516188923884499e-10
carrier O 0 2.954385625031364e-10
frequency O 0 4.1468642408837297e-10
in O 0 7.2798407926844e-12
such O 0 3.169914417761044e-13
communities O 0 2.1233573926915383e-11
. O 0 7.859327078030276e-11

In O 0 7.564835424744842e-10
patients O 0 9.986725890698267e-10
of O 0 1.7241719865528603e-14
Dutch O 0 4.0306483151120176e-10
ethnic O 0 2.289972681965291e-13
origin O 0 4.688614080317066e-12
, O 0 2.443576591071306e-12
however O 0 1.5123192411911623e-12
, O 0 8.98603430164388e-14
no O 0 2.81904707910563e-13
significant O 0 4.774178556828101e-13
founder O 0 7.271434149247469e-11
effect O 0 2.572063673156322e-10
could O 0 1.256609927224872e-09
be O 0 1.3516329548657335e-11
identified O 0 6.329125556980841e-10
. O 0 2.5381238777377746e-11

The O 0 1.0613501397194192e-11
observed O 0 1.0272527620203142e-11
genetic O 0 3.902108497433332e-11
heterogeneity O 0 2.1153131329887387e-11
including O 0 4.9514595033698164e-14
the O 0 7.266667871813973e-14
relative O 0 1.8876213092600125e-10
high O 0 3.551626326370183e-09
percentage O 0 2.541530874644593e-10
of O 0 8.233694894508106e-14
splice O 0 2.3278680600924417e-06
- O 0 5.370877964594456e-09
site O 0 2.656849462656652e-10
mutations O 0 1.6010671899380213e-08
had O 0 1.1653027343072608e-07
no O 0 7.077743252592583e-11
reflection O 0 1.9589697919375482e-11
on O 0 3.811643708995227e-11
the O 0 1.7390701725905622e-11
phenotype O 0 7.524649703327668e-08
. O 0 2.1909490888205596e-10

All O 0 1.0472443051634528e-10
patients O 0 5.090233790028265e-10
manifested O 0 2.328279513630349e-10
classical O 0 1.7901680138265874e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
and O 0 6.6806789267293e-11
increased O 0 2.993956818575505e-11
cellular O 0 2.528337317286855e-09
radioresistant O 0 7.90405463302335e-10
DNA O 0 3.2570907082529743e-10
synthesis O 0 4.858664026663462e-10
. O 0 1.3140999399752218e-10

Determination O 0 4.418553523066748e-09
of O 0 2.897895682099638e-13
the O 0 3.611223665478218e-14
genomic O 0 9.220748296845382e-12
structure O 0 1.0550890890137499e-11
of O 0 1.9796781198394044e-14
the O 0 7.114740112161566e-13
COL4A4 O 0 9.765329878064222e-09
gene O 0 1.4331889841567858e-10
and O 0 1.188192773338148e-12
of O 0 3.5573801527135143e-14
novel O 0 3.4224637013302583e-10
mutations O 0 8.559755769965705e-06
causing O 0 1.4327169992611744e-06
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.281706201756606e-07

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 5.8123372781437865e-08
a O 0 7.967219772808676e-09
progressive O 0 4.664700554712908e-06
hematuric B-Disease 1 0.9999409914016724
glomerulonephritis I-Disease 1 1.0
characterized O 0 1.3925796338298824e-06
by O 0 2.511729435550336e-10
glomerular B-Disease 0 4.2297804611735046e-05
basement I-Disease 0 0.009616470895707607
membrane I-Disease 0 3.853904127026908e-05
abnormalities I-Disease 1 0.9943209886550903
and O 0 1.391981365242434e-12
associated O 0 3.3612927979181917e-12
with O 0 4.666797547361878e-13
mutations O 0 6.769121374539111e-10
in O 0 1.254769291941793e-11
either O 0 2.1174161382586654e-11
the O 0 7.349907141240841e-12
COL4A3 O 0 1.6176868200545869e-07
or O 0 3.962862329953687e-11
the O 0 1.945648937101696e-12
COL4A4 O 0 5.363987920503632e-09
gene O 0 1.0012659451552608e-10
, O 0 6.893462580273568e-13
which O 0 4.9993158484501476e-14
encode O 0 2.501015020084374e-11
the O 0 6.536344382412906e-12
alpha3 O 0 1.564353624416981e-07
and O 0 9.051345783994691e-11
alpha4 O 0 3.202222274012456e-07
type O 0 6.260643658606568e-06
IV O 0 6.807139811826346e-07
collagen O 0 2.9393085299034283e-08
chains O 0 3.052755914723093e-08
, O 0 1.6553100903871076e-11
respectively O 0 1.040221034309674e-10
. O 0 5.0481820113024156e-11

To O 0 1.462733406620842e-10
date O 0 3.8081138242773704e-10
, O 0 6.542877676284087e-13
mutation O 0 5.364726458206848e-12
screening O 0 6.156197079887349e-11
in O 0 2.30087129904355e-12
the O 0 3.61068630777648e-14
two O 0 9.097578376401905e-14
genes O 0 2.635212187351854e-11
has O 0 1.2307275858158828e-11
been O 0 1.0141513323569384e-10
hampered O 0 4.520044072364726e-08
by O 0 1.2019598098940432e-13
the O 0 3.217770559553468e-13
lack O 0 4.766956794577393e-12
of O 0 8.360928391141532e-15
genomic O 0 1.6285252660286353e-11
structure O 0 7.256969331015384e-11
information O 0 8.284590374829648e-11
. O 0 1.5715213852462995e-10

We O 0 1.9243751037123502e-09
report O 0 1.1022794482729026e-10
here O 0 7.598372885747606e-13
the O 0 5.402196990119583e-15
complete O 0 1.5754594623242774e-13
characterization O 0 7.679605215638041e-12
of O 0 9.803034171093974e-15
the O 0 5.950858431242115e-14
48 O 0 2.779130875082969e-12
exons O 0 6.203519035269389e-12
of O 0 1.9262796381851882e-14
the O 0 5.926112465332034e-13
COL4A4 O 0 6.631238225196512e-09
gene O 0 2.3484300615272957e-10
, O 0 1.0243525862610459e-12
a O 0 9.201697563632205e-13
comprehensive O 0 2.0089206340112575e-11
gene O 0 5.462200691752628e-10
screen O 0 2.2163673563113662e-08
, O 0 5.452444398756917e-11
and O 0 1.8655710656845237e-12
the O 0 4.922850796169713e-14
subsequent O 0 2.192688982856697e-13
detection O 0 1.773062426047023e-11
of O 0 4.391018798566293e-14
10 O 0 1.387011436693869e-13
novel O 0 2.705210621484211e-12
mutations O 0 1.21702550814895e-10
in O 0 1.6308284583876897e-11
eight O 0 5.829818294778022e-10
patients O 0 1.0601357871564687e-06
diagnosed O 0 0.0014496936928480864
with O 0 5.701751071285344e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.8376342104129435e-07

Furthermore O 0 2.5794832936298917e-09
, O 0 8.782771385162924e-12
we O 0 5.799564929860612e-13
identified O 0 2.239343042595432e-12
a O 0 3.510904674625115e-13
glycine O 0 1.9406659612641874e-10
to O 0 6.695840171384859e-13
alanine O 0 1.99419314395044e-10
substitution O 0 4.883856340176518e-12
in O 0 1.2311753179450324e-12
the O 0 1.265354872747801e-13
collagenous O 0 1.5169409062210093e-09
domain O 0 1.027045028884066e-11
that O 0 2.0178662614531856e-13
is O 0 2.071744062111594e-13
apparently O 0 1.2980101715687198e-10
silent O 0 6.70323310747456e-11
in O 0 1.3524008302123747e-12
the O 0 2.1731493557788917e-13
heterozygous O 0 2.4916838037292166e-10
carriers O 0 9.97815718939421e-10
, O 0 1.1260279167424336e-11
in O 0 2.0088489205427607e-10
11 O 0 3.0159616470903927e-10
. O 0 1.0745417056146067e-10

5 O 0 5.694542615231057e-10
% O 0 4.354060948591476e-12
of O 0 4.9448123276129435e-15
all O 0 2.2894694088693504e-14
control O 0 3.157341142007164e-12
individuals O 0 7.363903866026977e-14
, O 0 8.144062681181286e-13
and O 0 4.883996419097203e-12
in O 0 1.3553453498404977e-11
one O 0 4.83241138077295e-12
control O 0 6.986444062162533e-11
individual O 0 1.376356710894311e-13
homozygous O 0 7.178034555632706e-11
for O 0 1.9861770648305077e-13
this O 0 2.355029149123111e-13
glycine O 0 1.0623921742336506e-09
substitution O 0 2.380957930814276e-10
. O 0 5.849887241282659e-11

There O 0 2.934543719135263e-10
has O 0 4.1152792978893515e-12
been O 0 7.559126935507976e-13
no O 0 4.630444790619526e-13
previous O 0 1.7248042458260088e-13
finding O 0 3.2613815077395247e-13
of O 0 4.578370628037683e-15
a O 0 4.608865914780547e-13
glycine O 0 3.636263165573972e-11
substitution O 0 7.475364728268263e-13
that O 0 7.45265394536121e-14
is O 0 2.9851368908229495e-14
not O 0 9.054715798765406e-14
associated O 0 4.3697914752817424e-13
with O 0 7.399185837598729e-14
any O 0 1.9803988310362897e-11
obvious O 0 2.6670359254410414e-09
phenotype O 0 1.6556505499920604e-08
in O 0 1.4081538886323575e-11
homozygous O 0 3.3139861965736372e-09
individuals O 0 1.4014499630232713e-11
. O 0 1.9611988422152393e-10

Founder O 0 3.7453477830240445e-07
BRCA1 O 0 0.00014861879753880203
and O 0 2.3976016727544902e-09
BRCA2 O 0 6.36935237707803e-06
mutations O 0 1.2283210004682132e-08
in O 0 4.9024131976160845e-11
French O 0 6.866735446919847e-08
Canadian O 0 4.485153840505518e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4917034274475327e-09
. O 0 1.3037516899405688e-10

We O 0 2.5481952659056617e-10
have O 0 1.1238859235623844e-12
identified O 0 2.083042592582185e-11
four O 0 1.9309452311839365e-13
mutations O 0 3.719817422837002e-12
in O 0 2.8183805658200944e-13
each O 0 2.386067417866483e-14
of O 0 1.0506999865425234e-13
the O 0 1.9471990686525942e-10
breast B-Disease 0 0.0009284149273298681
cancer I-Disease 0 9.335371032648254e-06
- O 0 5.6899452260950056e-08
susceptibility O 0 2.279732846943716e-08
genes O 0 1.1616318573715034e-08
, O 0 8.705108162088138e-11
BRCA1 O 0 3.4053167041747656e-07
and O 0 4.5438600798641815e-11
BRCA2 O 0 9.041642812235295e-08
, O 0 9.575062097366693e-13
in O 0 1.9304672877612505e-12
French O 0 1.7150729547665833e-07
Canadian O 0 1.8472620695320074e-06
breast B-Disease 1 0.9992994070053101
cancer I-Disease 1 0.9840784072875977
and O 0 0.12452306598424911
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4126720904172885e-09
from O 0 5.6410716375854264e-11
Quebec O 0 1.4007385473746581e-08
. O 0 9.31700050443851e-10

To O 0 1.5263203201332232e-10
identify O 0 4.889342264391416e-10
founder O 0 6.870135016434631e-10
effects O 0 4.865855984803602e-08
, O 0 7.763585607722945e-11
we O 0 2.872341904255893e-12
examined O 0 5.1389266106371956e-12
independently O 0 1.96024706883291e-12
ascertained O 0 1.6746859454741525e-10
French O 0 3.4957484129627403e-10
Canadian O 0 1.0518731441422347e-09
cancer B-Disease 0 5.597968311121804e-09
families O 0 8.914561254978748e-13
for O 0 4.609951404443112e-15
the O 0 9.283131277299916e-15
distribution O 0 2.1761109895383074e-13
of O 0 1.9442706179848696e-14
these O 0 8.951004542602503e-13
eight O 0 1.4824610289343454e-11
mutations O 0 1.6569228211693598e-09
. O 0 1.1438175406830453e-10

Mutations O 0 2.7722750317593636e-08
were O 0 9.736900868917431e-11
found O 0 8.948414925713521e-12
in O 0 8.769292800595019e-13
41 O 0 1.2965595611036385e-11
of O 0 2.5160347980404674e-14
97 O 0 3.27199739524886e-10
families O 0 1.9447707333419828e-11
. O 0 7.324971185163065e-11

Six O 0 7.230004372971166e-10
of O 0 7.689519593984118e-14
eight O 0 1.1614301100720814e-12
mutations O 0 2.9030991152700913e-11
were O 0 1.3356720243717923e-11
observed O 0 3.811968969646973e-12
at O 0 2.0195742647666215e-11
least O 0 1.056107892111191e-11
twice O 0 5.019304416542525e-10
. O 0 1.4972383055589233e-10

The O 0 1.565443108475506e-09
BRCA1 O 0 1.59287028509425e-05
C4446T O 0 2.6634947403181286e-07
mutation O 0 4.238693396274584e-09
was O 0 1.6071910469150907e-10
the O 0 3.4996975478186754e-14
most O 0 5.626749744304729e-14
common O 0 2.689559946283948e-12
mutation O 0 1.942112790032091e-11
found O 0 4.332609271351373e-10
, O 0 1.4995173071991053e-12
followed O 0 1.5515499041801606e-12
by O 0 2.8057544894204145e-13
the O 0 3.134415990646566e-11
BRCA2 O 0 2.335801582376007e-05
8765delAG O 0 6.210859169186733e-07
mutation O 0 4.75604977623334e-08
. O 0 2.6554578536064355e-09

Together O 0 1.887952572054985e-10
, O 0 1.0854602806864566e-12
these O 0 1.069073147608006e-14
mutations O 0 1.826405563246092e-12
were O 0 1.7397492951473637e-12
found O 0 2.2790239747466634e-12
in O 0 7.928956428059075e-13
28 O 0 4.432886349658993e-13
of O 0 1.244581825938357e-15
41 O 0 1.0792711125848231e-12
families O 0 6.919723007212022e-15
identified O 0 2.359306109853132e-12
to O 0 2.2963675774291537e-13
have O 0 1.6997342769387025e-11
a O 0 5.12380762818232e-11
mutation O 0 6.514349948361087e-09
. O 0 5.532462266089055e-10

The O 0 8.658527367311208e-11
odds O 0 2.00159067098582e-09
of O 0 1.3657994277650048e-13
detection O 0 7.573042019870524e-12
of O 0 1.1660546931236554e-14
any O 0 3.110198188403801e-13
of O 0 7.123492029267094e-15
the O 0 2.3827896036485163e-13
four O 0 7.353047858094097e-12
BRCA1 O 0 8.477702095888162e-08
mutations O 0 3.763563238834422e-09
was O 0 3.56470621909466e-08
18 O 0 6.779894701214317e-11
. O 0 4.2726017168703834e-11

7x O 0 0.00034297973616048694
greater O 0 1.1728698012802852e-09
if O 0 1.4878666354523062e-10
one O 0 2.631808887574444e-13
or O 0 6.649272603874434e-13
more O 0 7.748809867412845e-14
cases O 0 1.233822939650242e-11
of O 0 5.499626309912742e-10
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.752951395150859e-10
also O 0 5.584220694361541e-13
present O 0 4.792569336178887e-14
in O 0 7.400266163748448e-12
the O 0 3.3902735219887292e-12
family O 0 1.4061926623121224e-10
. O 0 8.488530017780604e-11

The O 0 3.3429384260763584e-11
odds O 0 7.513227262556654e-10
of O 0 7.666249904857148e-14
detection O 0 5.829979294463827e-12
of O 0 1.1578986975778385e-14
any O 0 1.1862408841670224e-12
of O 0 2.9132512374685504e-14
the O 0 9.301928801871973e-13
four O 0 4.233017755761459e-11
BRCA2 O 0 9.900984423438786e-07
mutations O 0 2.1738264521786732e-08
was O 0 3.718193042345774e-08
5 O 0 1.426945506199928e-10
. O 0 2.0808119116644264e-10

3x O 0 2.2565598555956967e-05
greater O 0 4.191083036175769e-10
if O 0 3.4589234254589485e-11
there O 0 6.026350750885923e-13
were O 0 9.932855319499945e-13
at O 0 1.7959979749064547e-13
least O 0 1.1466286701047358e-14
five O 0 5.688536054422426e-15
cases O 0 1.359880632580135e-13
of O 0 2.8177194735454214e-13
breast B-Disease 0 2.6316533876524772e-06
cancer I-Disease 0 2.0817357437863393e-07
in O 0 1.626852680347568e-10
the O 0 1.166763994447928e-11
family O 0 2.3239404844943579e-10
. O 0 4.5612267435268805e-11

Interestingly O 0 1.443550274871086e-07
, O 0 2.7922440835187468e-12
the O 0 1.051186606970721e-14
presence O 0 1.0170208859100471e-12
of O 0 7.211974615596584e-14
a O 0 1.3494577677519715e-09
breast B-Disease 0 1.0695020137063693e-05
cancer I-Disease 0 2.7414094105893128e-08
case O 0 1.7429928333978495e-10
< O 0 8.417738728283553e-10
36 O 0 1.91266620597208e-12
years O 0 1.0067240010375178e-13
of O 0 4.2818442984782126e-15
age O 0 4.249647942572432e-12
was O 0 6.136811978724177e-13
strongly O 0 4.244871733847036e-14
predictive O 0 5.5580097815810525e-12
of O 0 1.929308543301275e-15
the O 0 1.0906786711035055e-14
presence O 0 1.6516784684741936e-13
of O 0 4.1599803978073155e-15
any O 0 7.524545223014378e-13
of O 0 2.286384006655682e-14
the O 0 7.294611963082342e-13
eight O 0 1.2158787865423903e-11
mutations O 0 6.397187779505487e-10
screened O 0 2.5499481637325516e-08
. O 0 1.3625341965806115e-09

Carriers O 0 4.375346307483596e-09
of O 0 3.01518033631043e-13
the O 0 6.637218715171284e-14
same O 0 4.2657736609545693e-13
mutation O 0 3.565188508997119e-12
, O 0 3.0288570046152485e-14
from O 0 1.458615468533965e-14
different O 0 4.1114233870730155e-14
families O 0 1.1754921309340555e-13
, O 0 6.014069874293567e-15
shared O 0 4.7397798712137465e-14
similar O 0 1.9584234407787893e-12
haplotypes O 0 1.3426951772643747e-09
, O 0 5.125075711043259e-12
indicating O 0 1.3405271337418867e-10
that O 0 1.7174179830006797e-13
the O 0 5.618448821421637e-14
mutant O 0 2.2642340780087977e-10
alleles O 0 3.728364145194618e-11
were O 0 6.238216887499703e-11
likely O 0 1.0388528232097016e-10
to O 0 1.2428702815189818e-13
be O 0 2.700492010999228e-13
identical O 0 7.469991422301425e-13
by O 0 3.5691108814066286e-14
descent O 0 1.0363335883889491e-10
for O 0 9.126916887189362e-14
a O 0 8.966816004984945e-12
mutation O 0 7.615283403872297e-11
in O 0 1.762108688130315e-11
the O 0 1.6437218339909743e-12
founder O 0 2.1107236791717554e-10
population O 0 6.8826402910282525e-12
. O 0 1.9302115461528047e-10

The O 0 7.879977052815956e-12
identification O 0 1.5686367135780976e-11
of O 0 5.418132305659573e-14
common O 0 3.021581040929533e-10
BRCA1 O 0 9.809080074774101e-05
and O 0 4.5724943831260134e-09
BRCA2 O 0 7.899207957962062e-06
mutations O 0 2.9229372255912267e-09
will O 0 1.1153440367464573e-12
facilitate O 0 4.1395975189373324e-12
carrier O 0 8.381671051660433e-11
detection O 0 6.84658510441416e-11
in O 0 9.170585298090561e-12
French O 0 2.7392829338168667e-07
Canadian O 0 2.7125843189423904e-06
breast B-Disease 1 0.9994469285011292
cancer I-Disease 1 0.9919549822807312
and O 0 0.29943984746932983
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3134097365252728e-08
. O 0 4.1245248882937346e-10

Are O 0 1.9564774245139915e-09
Dp71 O 0 6.038038691258407e-07
and O 0 4.09941192103247e-10
Dp140 O 0 9.400530132097629e-08
brain O 0 2.420975135919434e-07
dystrophin O 0 4.3737550470268616e-08
isoforms O 0 2.2251682718632537e-09
related O 0 2.656125042133084e-10
to O 0 7.91290036966652e-12
cognitive B-Disease 0 6.507199401539765e-08
impairment I-Disease 0 1.7255612192457193e-06
in O 0 6.470953217707631e-10
Duchenne B-Disease 0 0.003886052407324314
muscular I-Disease 0 0.1620434671640396
dystrophy I-Disease 1 0.9973945617675781
? O 0 5.839701316290302e-06

Molecular O 0 4.990630131374019e-09
study O 0 3.2963015650366856e-10
and O 0 2.3089349876492804e-11
neuropsychological O 0 9.656140331770757e-10
analysis O 0 4.005231910020335e-12
were O 0 6.3553324929077615e-12
performed O 0 4.437448238719943e-12
concurrently O 0 2.365203735990584e-12
on O 0 2.3878237928598445e-11
49 O 0 1.9015600205563032e-09
patients O 0 6.333472635233761e-10
with O 0 1.0717289035400146e-11
Duchenne B-Disease 0 0.0015810619806870818
muscular I-Disease 0 0.0010604271665215492
dystrophy I-Disease 1 0.6379602551460266
( O 0 1.0089583390993084e-08
DMD B-Disease 1 1.0
) O 0 2.8647162766959333e-11
in O 0 1.0167222966317446e-12
order O 0 1.421648579023535e-13
to O 0 8.454568561086853e-14
find O 0 1.066821891243519e-11
a O 0 4.1444780008066673e-13
molecular O 0 2.961327580722206e-12
explanation O 0 6.354969502020413e-12
for O 0 8.647290918257014e-14
the O 0 5.134642711013271e-13
cognitive B-Disease 0 1.3879033478048086e-09
impairment I-Disease 0 4.33967439761318e-09
observed O 0 2.8584383124363733e-12
in O 0 1.3433110526706038e-11
most O 0 1.2063443577403632e-09
DMD B-Disease 1 1.0
patients O 0 1.669826997385826e-05
. O 0 6.362689264349797e-10

Complete O 0 1.0519148052612337e-10
analysis O 0 2.092516090956842e-11
of O 0 3.8395552877509495e-14
the O 0 1.3528078397079257e-13
dystrophin O 0 3.544741999927936e-10
gene O 0 6.176936184765225e-10
was O 0 5.959616689032998e-10
performed O 0 2.2776160298054737e-12
to O 0 4.705478763794915e-14
define O 0 3.1332247994037e-12
the O 0 4.37581340519827e-13
localization O 0 4.693692101653824e-10
of O 0 6.502391398759133e-14
deletions O 0 9.873125650372572e-10
and O 0 9.968902439649874e-12
duplications O 0 1.697419538260192e-09
in O 0 1.1352079866411291e-11
relation O 0 1.2082797436197001e-11
to O 0 5.740280755069105e-13
the O 0 3.2249365938125107e-12
different O 0 3.519283753306013e-10
DMD B-Disease 1 1.0
promoters O 0 6.229188898032589e-07
. O 0 1.7499324211911471e-09

Qualitative O 0 2.4848333168847603e-08
analysis O 0 3.183874552892263e-10
of O 0 1.0188241716209065e-13
the O 0 6.34743071905447e-13
Dp71 O 0 2.3826580708430356e-09
transcript O 0 2.210687632953068e-09
and O 0 1.2348982513649132e-12
testing O 0 1.320271474612722e-12
for O 0 1.9136958202592468e-15
the O 0 1.4298188258986895e-15
specific O 0 2.6993423840018967e-14
first O 0 8.789336446157758e-13
exon O 0 8.212079627423208e-11
of O 0 3.0396521345961436e-13
Dp140 O 0 1.927302539783682e-09
were O 0 4.153362931358373e-10
also O 0 3.804465423251635e-12
carried O 0 1.1235098962281143e-10
out O 0 1.2589940201479521e-10
. O 0 5.408579140109282e-11

Neuropsychological O 0 6.0572251641133334e-06
analysis O 0 6.806930574754233e-09
assessed O 0 5.407047698469114e-09
verbal O 0 4.8955620002288924e-08
and O 0 5.208408704326928e-11
visuospatial O 0 3.546153095612681e-07
intelligence O 0 5.355268228868226e-09
, O 0 8.188833292011033e-12
verbal O 0 3.881610144418346e-09
memory O 0 7.744097585415943e-10
, O 0 8.838851525694302e-12
and O 0 2.970618195874408e-11
reading O 0 1.816061079296105e-08
skills O 0 2.7642810707106946e-08
. O 0 1.0052423476958339e-10

Comparison O 0 2.2585244785489067e-09
of O 0 6.188648226691795e-13
molecular O 0 3.245393537243402e-11
and O 0 3.2673416923423293e-12
psychometric O 0 2.4398962850114003e-09
findings O 0 1.8331490839185172e-11
demonstrated O 0 4.993097948990943e-12
that O 0 2.167651908663304e-13
deletions O 0 5.690047877315862e-10
and O 0 4.358539570925579e-12
duplications O 0 6.201182900511526e-10
that O 0 1.8972087898090628e-13
were O 0 2.2609347120200463e-12
localized O 0 2.7097872556947067e-11
in O 0 5.564607368641061e-12
the O 0 3.643618881003091e-13
distal O 0 1.218052048113094e-10
part O 0 2.041704045413484e-12
of O 0 6.515489238629116e-14
the O 0 1.2321473865078286e-13
gene O 0 2.467074045053863e-10
seemed O 0 5.873651787169365e-09
to O 0 1.6602790377327065e-13
be O 0 1.9908800628042067e-13
preferentially O 0 2.9524956698251392e-12
associated O 0 6.110324919650356e-12
with O 0 3.3709361257211468e-12
cognitive B-Disease 0 5.944557557313601e-08
impairment I-Disease 0 1.8091365916461655e-07
. O 0 1.2179243724652622e-10

Two O 0 4.169507517026716e-10
altered O 0 2.0209645512636598e-08
Dp71 O 0 8.614426150188592e-08
transcripts O 0 7.173497795776029e-09
and O 0 3.826925321775976e-12
two O 0 1.788573087378731e-13
deleted O 0 6.697468968308584e-11
Dp140 O 0 5.14344955515611e-11
DNA O 0 5.714437169984654e-12
sequences O 0 1.3155457626035094e-12
were O 0 5.599750264179137e-13
found O 0 4.866781348582261e-13
in O 0 2.038683349740722e-13
four O 0 5.902243212403679e-13
patients O 0 2.0758162549983084e-11
with O 0 9.875370920314763e-13
severe O 0 0.0004619969695340842
cerebral B-Disease 1 0.7944248914718628
dysfunction I-Disease 0 0.000124078564113006
. O 0 1.265714644205218e-09

These O 0 1.4347554394555928e-11
findings O 0 9.753420293634463e-12
suggest O 0 2.510706703304222e-12
that O 0 2.062355650568181e-14
some O 0 6.639241599255916e-15
sequences O 0 2.646815600894359e-13
located O 0 5.384899340668547e-13
in O 0 2.3679756072647606e-12
the O 0 1.063077238543618e-13
distal O 0 2.7581097128415166e-11
part O 0 6.363468237589875e-13
of O 0 4.881800276117275e-15
the O 0 2.1711429718960715e-14
gene O 0 1.9710380896875712e-11
and O 0 8.68828446687342e-12
, O 0 7.33981289375435e-14
in O 0 6.362166788407078e-14
particular O 0 4.24821094101302e-13
, O 0 2.570676419129392e-13
some O 0 2.9061781193356895e-12
DMD B-Disease 1 1.0
isoforms O 0 2.5680144122297577e-10
expressed O 0 1.781043736971688e-12
in O 0 3.460927724963092e-12
the O 0 5.526708431180527e-12
brain O 0 4.771564817929175e-06
may O 0 3.2139788053164864e-10
be O 0 1.2803632123709746e-13
related O 0 4.235225993694247e-13
to O 0 3.119518667904844e-14
the O 0 1.0018572343256649e-12
cognitive B-Disease 0 4.605544390301475e-09
impairment I-Disease 0 5.026875804503561e-09
associated O 0 2.281760891342799e-11
with O 0 2.9098862208698506e-10
DMD B-Disease 1 1.0
. O 0 1.2021753592605933e-09
. O 0 7.820422087689849e-10

I1307K O 0 8.135082680382766e-06
APC O 0 3.06737121036349e-07
and O 0 5.5848447394479805e-11
hMLH1 O 0 1.594788834324845e-08
mutations O 0 1.3210139648833774e-09
in O 0 1.134573771738312e-11
a O 0 2.1351918497169997e-11
non O 0 7.584878503053005e-09
- O 0 1.4266469117174552e-09
Jewish O 0 4.939546549564966e-10
family O 0 1.3232653861550148e-10
with O 0 1.852021487558364e-11
hereditary B-Disease 1 0.9999885559082031
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.926543001853133e-08

We O 0 9.128287709048166e-11
describe O 0 3.382298607856882e-11
a O 0 3.1054930762358657e-12
French O 0 5.920419265947885e-09
Canadian O 0 5.413717119040484e-08
hereditary B-Disease 1 0.9999992847442627
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.8742251124167524e-08
HNPCC B-Disease 0 2.977495751110837e-05
) O 0 7.592629303054821e-11
kindred O 0 2.1184804666063428e-07
which O 0 1.9210470020292192e-11
carries O 0 1.2216187783575805e-10
a O 0 1.8351500874480564e-11
novel O 0 2.2959283085821625e-10
truncating O 0 5.1031001646606455e-08
mutation O 0 2.4856390723471122e-08
in O 0 1.3289900291368895e-09
hMLH1 O 0 6.892544774927956e-07
. O 0 1.770080637619742e-09

Interestingly O 0 2.0645310883082857e-07
, O 0 9.262453651293079e-12
the O 0 8.226886511440712e-13
I1307K O 0 2.021526279705199e-09
APC O 0 8.952658614447273e-10
polymorphism O 0 1.879474353927435e-09
, O 0 2.5008692491022833e-13
associated O 0 4.794510058067636e-13
with O 0 2.19904982759608e-14
an O 0 1.0711024352617199e-13
increased O 0 6.657734918924518e-10
risk O 0 4.0042627347247617e-07
of O 0 3.425013872515592e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.0758454890846814e-11
is O 0 1.3016799823347552e-13
also O 0 1.3039933987202962e-13
present O 0 2.393421019101366e-13
in O 0 1.2840409291392518e-10
this O 0 1.6212050799047084e-11
family O 0 1.4945904236451923e-10
. O 0 5.463323196619463e-11

The O 0 1.5324549962336675e-10
I1307K O 0 3.291643224656582e-08
polymorphism O 0 1.175921724438922e-07
has O 0 1.1502820397579772e-11
previously O 0 3.1602030020616567e-12
only O 0 1.0078556370550495e-13
been O 0 5.327870848496896e-13
identified O 0 4.916100079105368e-12
in O 0 1.212982080230074e-13
individuals O 0 1.5628286425400928e-14
of O 0 1.7838161503469507e-14
self O 0 1.6366323851713105e-09
- O 0 3.938091630573126e-09
reported O 0 6.9475326824886e-08
Ashkenazi O 0 3.850624263890268e-09
Jewish O 0 3.3641357061187094e-11
origins O 0 2.436798984817301e-09
. O 0 7.304814531039483e-10

In O 0 3.823264621560796e-11
addition O 0 4.57541665145611e-13
, O 0 4.2237060745610455e-13
in O 0 4.548346833714578e-13
this O 0 1.1968171679394013e-13
family O 0 2.268329621357701e-12
, O 0 4.868171431292659e-14
there O 0 2.979563481792652e-13
appears O 0 1.2596250431595735e-11
to O 0 1.0591447695013773e-13
be O 0 2.2917217169099446e-12
no O 0 2.8504130479556355e-12
relationship O 0 3.048548609732582e-12
between O 0 1.099103514906781e-13
the O 0 2.204586068820652e-13
I1307K O 0 1.3331580284159372e-10
polymorphism O 0 4.2803999927842895e-11
and O 0 1.4605927144833997e-13
the O 0 2.0804226939265258e-14
presence O 0 2.7615247328444115e-12
or O 0 1.0052078613931315e-10
absence O 0 7.686774827764253e-11
of O 0 3.9125010197794963e-13
cancer B-Disease 0 2.369370477595112e-09
. O 0 1.4226672791217698e-11
. O 0 1.0588595972249593e-10

Identification O 0 2.4315989222145618e-09
of O 0 6.747969696040135e-13
a O 0 2.7964223818510714e-12
novel O 0 2.839507795560081e-11
mutation O 0 5.046564555133415e-11
of O 0 1.3639511341114602e-13
the O 0 1.9829376855795555e-12
CPO O 0 2.610407001668591e-09
gene O 0 5.1383217125611225e-11
in O 0 7.031546352120888e-12
a O 0 9.774152320840557e-11
Japanese O 0 3.098683265534419e-08
hereditary B-Disease 0 0.00012468000932130963
coproporphyria I-Disease 0 5.041130862082355e-05
family O 0 1.8641626908788567e-08
. O 0 6.29369778515354e-10

Hereditary B-Disease 1 0.9990014433860779
coproporphyria I-Disease 0 0.0015217880718410015
( O 0 2.3566798290630686e-08
HCP B-Disease 0 4.3373411244829185e-06
) O 0 3.4779828322895057e-11
is O 0 3.064288406351423e-12
an O 0 1.2225201753701675e-11
autosomal B-Disease 1 0.999991774559021
dominant I-Disease 1 0.999971866607666
disease I-Disease 1 0.9999674558639526
characterized O 0 1.169236263365292e-08
by O 0 1.9671621970251962e-11
a O 0 2.530799214639501e-08
deficiency B-Disease 0 0.027089346200227737
of I-Disease 0 6.626634462512937e-13
coproporphyrinogen I-Disease 0 4.873778891578695e-08
oxidase I-Disease 0 3.343045307246939e-08
( O 0 2.0496257469027057e-11
CPO O 0 4.3870955757085994e-09
) O 0 1.6688458340935464e-12
caused O 0 6.816612378723885e-12
by O 0 1.6540649329811058e-13
a O 0 3.873056736436453e-11
mutation O 0 4.477454240703338e-10
in O 0 5.985632822724796e-11
the O 0 1.805086982664683e-11
CPO O 0 1.217531178099307e-07
gene O 0 1.95306668615558e-08
. O 0 9.467079342684315e-10

Only O 0 6.685003661743849e-10
11 O 0 6.950769820823766e-11
mutations O 0 4.076354184756603e-11
of O 0 1.9259418414458232e-14
the O 0 4.021670420729234e-14
gene O 0 1.0220098378699305e-10
have O 0 7.097760313518053e-12
been O 0 2.549652676486769e-11
reported O 0 3.1786333565264613e-09
in O 0 4.3082831746588113e-10
HCP B-Disease 0 6.329127063509077e-05
patients O 0 3.14208250529191e-08
. O 0 2.463138859543079e-10

We O 0 4.3556272477651703e-10
report O 0 1.359882085411046e-11
another O 0 6.086384109378618e-13
mutation O 0 1.3097828377439669e-11
in O 0 1.0551233498024004e-11
a O 0 9.154075414352647e-11
Japanese O 0 8.92725537937622e-09
family O 0 9.672670303606523e-11
. O 0 6.636241556279288e-11

Polymerase O 0 4.1379639270644475e-08
chain O 0 1.4072861098668454e-08
reaction O 0 9.256316269024012e-10
- O 0 2.0371520026429835e-09
single O 0 2.0181762511173318e-11
strand O 0 6.26317575580515e-09
conformational O 0 2.1847688935761056e-10
polymorphism O 0 2.565146983712907e-09
and O 0 5.465277210826847e-13
direct O 0 9.63134953735345e-13
sequence O 0 1.8260328145391913e-12
analyses O 0 9.071700855789455e-12
demonstrated O 0 3.910063245404771e-12
a O 0 3.724204538507747e-12
C O 0 1.0102905179110167e-09
to O 0 1.0067840658378735e-12
T O 0 6.37953134763336e-10
substitution O 0 3.759267203085059e-12
in O 0 1.3160350630439521e-12
exon O 0 6.489391662922728e-11
1 O 0 1.176049058485007e-12
of O 0 2.0225816938705503e-14
the O 0 3.153878525528897e-13
CPO O 0 1.2728929021932345e-09
gene O 0 2.991451183986804e-11
at O 0 2.9182706598462893e-12
nucleotide O 0 4.463474295030023e-12
position O 0 6.9249749164168595e-12
85 O 0 3.000157631008471e-12
, O 0 3.6082649455121407e-13
which O 0 2.750127599607244e-13
lies O 0 3.764978780129713e-12
in O 0 1.1254976117758275e-11
the O 0 6.230172085695818e-13
putative O 0 1.4727218056176383e-10
presequence O 0 5.268821490211906e-10
for O 0 8.822823927608775e-14
targeting O 0 1.235556934542359e-10
to O 0 2.850528840747657e-11
mitochondria O 0 4.926378949221544e-08
. O 0 1.4805551229457592e-09

This O 0 6.11121431237649e-11
mutation O 0 5.22282606052471e-10
changes O 0 2.759202588631382e-12
the O 0 1.895866818570069e-13
codon O 0 1.3062059767143808e-10
for O 0 4.526043304248564e-14
glutamine O 0 1.4512312185299692e-10
to O 0 4.86710606713292e-13
a O 0 4.283680615085883e-12
termination O 0 6.997570300981693e-10
codon O 0 6.476040814717976e-10
at O 0 5.101026372134054e-12
amino O 0 4.647535134516545e-11
acid O 0 1.7953979969398404e-10
position O 0 2.0769459763148035e-10
29 O 0 8.591969358207052e-10
. O 0 1.58447227560643e-10

MaeI O 0 7.605190148751717e-07
restriction O 0 1.256490134160515e-09
analysis O 0 3.966749498318656e-11
showed O 0 3.6809374992508026e-11
two O 0 2.0702970926684584e-14
other O 0 1.0410663420202214e-14
carriers O 0 1.843605303142315e-11
in O 0 9.653294656686295e-12
the O 0 8.983197866130332e-12
family O 0 1.4463621966775975e-10
. O 0 2.7010355757584037e-11

The O 0 2.434372703419285e-10
C O 0 5.3444371587829664e-05
- O 0 0.00011970526247750968
T O 0 1.0189791282755323e-05
mutation O 0 5.286265869486328e-10
is O 0 1.0582367230768663e-12
located O 0 1.0656580869475296e-12
within O 0 9.62143450848607e-13
a O 0 1.1152211966403147e-11
recently O 0 1.1889103590512207e-10
proposed O 0 7.192636243547046e-13
putative O 0 7.747491537202222e-11
alternative O 0 4.44326034299003e-11
translation O 0 1.0343869094597835e-09
initiation O 0 1.4579062956876498e-10
codon O 0 2.7985502804028783e-09
( O 0 1.2091903867084142e-11
TIC O 0 3.639932799615053e-08
- O 0 2.3465138165867927e-10
1 O 0 1.0883626899022003e-12
) O 0 3.939546510734783e-14
, O 0 4.7882912268721895e-15
supporting O 0 3.0949411599073134e-14
that O 0 3.034293736409177e-13
TIC O 0 4.278341236840788e-07
- O 0 1.1220643164611133e-10
1 O 0 1.4515454810348771e-12
is O 0 1.951598469418156e-13
the O 0 1.0044856656524215e-13
real O 0 5.075981301949639e-10
TIC O 0 1.1108411079874259e-08
rather O 0 7.177370134857364e-13
than O 0 8.619039184622201e-13
TIC O 0 2.7975804783864078e-08
- O 0 7.285122505251707e-11
2 O 0 3.2401720195807115e-12
. O 0 7.587829019620185e-13
. O 0 1.477611262512557e-11

Human B-Disease 0 1.1298196822551176e-09
complement I-Disease 0 3.5143237653301185e-08
factor I-Disease 0 6.685455673505203e-07
H I-Disease 1 1.0
deficiency I-Disease 1 0.9997105002403259
associated O 0 8.335734946740558e-08
with O 0 1.7863655443761672e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.5361942473646195e-07

This O 0 2.2298437402090698e-11
study O 0 5.85481836623547e-12
reports O 0 5.6906172482551476e-12
on O 0 1.2420368553089922e-12
six O 0 1.2727161989231628e-12
cases O 0 6.995241191853907e-12
of O 0 1.5018215620762887e-12
deficiency B-Disease 0 4.933666559736594e-07
in I-Disease 0 2.91053666627919e-13
the I-Disease 0 1.2433107047702362e-14
human I-Disease 0 4.409533922353735e-14
complement I-Disease 0 1.7876360114410517e-12
regulatory I-Disease 0 1.1468825888982792e-10
protein I-Disease 0 2.700330063720724e-11
Factor I-Disease 0 5.397614299962328e-11
H I-Disease 1 0.999976396560669
( O 0 2.920582872767419e-11
FH O 0 1.0409304422864807e-06
) O 0 3.3234108824317654e-13
in O 0 2.1565915557259646e-13
the O 0 2.441780332345777e-14
context O 0 5.478043799828081e-12
of O 0 1.4729133169209818e-13
an O 0 5.189300725239043e-11
acute B-Disease 1 0.9891491532325745
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 8.152751362899835e-09

Five O 0 2.7558694909446402e-11
of O 0 1.4189009735492315e-14
the O 0 3.179486567691375e-14
cases O 0 3.4234114566593365e-13
were O 0 6.670244326496821e-13
observed O 0 5.146427988628188e-13
in O 0 8.024731053268841e-13
children O 0 4.0819929901514396e-12
presenting O 0 3.6560976468535955e-11
with O 0 1.3302250412294825e-09
idiopathic O 1 0.9999997615814209
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.00015982701734174043
HUS B-Disease 1 0.9999997615814209
) O 0 6.655290007984149e-08
. O 0 1.146266992435585e-08

Two O 0 1.9736337564246753e-11
of O 0 8.025032732523335e-14
the O 0 2.0126810645632737e-13
children O 0 3.932343600049348e-12
exhibited O 0 8.843070720132573e-11
a O 0 3.5924757613159386e-10
homozygous O 0 0.0818023681640625
deficiency O 0 0.13194535672664642
characterized O 0 4.668306713417891e-11
by O 0 3.1176404231662846e-13
the O 0 4.631955084245798e-13
absence O 0 6.705121700922856e-12
of O 0 8.309097280428739e-16
the O 0 9.182192902074462e-15
150 O 0 1.9078448131211456e-13
- O 0 1.2512012259602301e-11
kD O 0 3.141851501187176e-10
form O 0 1.7190446115200597e-12
of O 0 7.454999887811925e-14
Factor O 0 1.1476593286818826e-10
H O 1 1.0
and O 0 4.1582098007919566e-12
the O 0 1.544650807272247e-14
presence O 0 9.262201465867759e-13
, O 0 3.662890642381657e-14
upon O 0 2.0830910171169663e-14
immunoblotting O 0 2.711567081981059e-10
, O 0 5.661046447152235e-14
of O 0 7.017891902337309e-16
the O 0 8.146481671753372e-14
42 O 0 3.4126059617056725e-11
- O 0 5.946056841343861e-11
kD O 0 9.783375887195689e-09
Factor O 0 4.651173612923998e-10
H O 1 0.9999960660934448
- O 0 5.926720780813355e-10
like O 0 2.8260432188842444e-11
protein O 0 2.718257563483206e-10
1 O 0 8.332634929275606e-12
( O 0 5.2159019291175834e-12
FHL O 0 7.434815074702783e-08
- O 0 2.248757291489767e-10
1 O 0 2.027593587819454e-12
) O 0 1.0054441003728987e-13
and O 0 1.6512027747710156e-13
other O 0 1.086303247875564e-12
FH O 0 4.679252924688626e-06
- O 0 8.893680930599501e-11
related O 0 1.1612762140789101e-10
protein O 0 5.720789952867733e-10
( O 0 1.2239994608143068e-11
FHR O 0 1.7667288076950172e-08
) O 0 4.665349270099872e-12
bands O 0 4.852532820009969e-10
. O 0 1.8354871789139082e-10

Southern O 0 1.4404885284591273e-08
blot O 0 1.6638693978165975e-06
and O 0 1.0211461017040069e-11
PCR O 0 2.919526287392671e-10
analysis O 0 2.5662477243053317e-13
of O 0 1.2300866569911126e-15
DNA O 0 4.9051977757397225e-12
of O 0 3.844785462090361e-15
one O 0 8.995606993675298e-13
patient O 0 1.0902482389107959e-10
with O 0 4.381918818682079e-13
homozygous O 0 6.189188570715487e-05
deficiency O 0 0.018089206889271736
ruled O 0 3.4737615561830637e-10
out O 0 1.1359416011991197e-12
the O 0 1.2235446827262887e-14
presence O 0 3.80931397536699e-13
of O 0 5.3101520373238266e-15
a O 0 1.7039814654770669e-13
large O 0 4.0704763236247554e-13
deletion O 0 2.2645708919188934e-10
of O 0 4.045335166022804e-14
the O 0 7.994116436524368e-13
FH O 0 1.8722055017406092e-07
gene O 0 8.234116166683236e-11
as O 0 2.607079482852548e-12
the O 0 2.405287340828677e-13
underlying O 0 7.578612737368928e-10
defect O 0 6.851331169066555e-10
for O 0 8.440442897557354e-13
the O 0 3.0892854940844927e-10
deficiency O 0 0.0006187366670928895
. O 0 4.2133169175784246e-10

The O 0 7.473258990808862e-12
other O 0 5.563023457687277e-13
four O 0 4.201505679826689e-13
children O 0 1.7697731572331038e-13
presented O 0 3.6535705016937925e-13
with O 0 2.7801326778903457e-12
heterozygous O 0 0.0019828914664685726
deficiency O 0 8.560259448131546e-05
and O 0 1.2298000074892346e-12
exhibited O 0 3.2638305252907784e-11
a O 0 4.3941903067612476e-12
normal O 0 1.1371009689398193e-09
immunoblotting O 0 1.1652089071390037e-08
pattern O 0 3.8328384910357727e-10
of O 0 3.2561464375496785e-14
proteins O 0 6.283875871905542e-13
of O 0 3.382803274152614e-14
the O 0 1.4943418030766153e-11
FH O 0 0.00039121409645304084
family O 0 4.514387474952031e-10
. O 0 1.0106464970460749e-10

Factor B-Disease 0 0.0002994766691699624
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999728202819824
is O 0 8.416461971805234e-12
the O 0 6.906518000733552e-13
only O 0 1.4724332864091139e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.3484001692987135e-09
with O 0 1.3687510846960294e-10
HUS B-Disease 1 0.999964714050293
. O 0 4.437971323767442e-09

These O 0 2.584750295742122e-11
observations O 0 4.530653976986265e-11
suggest O 0 6.666575624869608e-11
a O 0 3.704191467446272e-12
role O 0 7.1088161399113226e-12
for O 0 1.5333450655019565e-12
FH O 0 7.528851710958406e-06
and O 0 3.241842558288077e-11
/ O 0 1.3710726776139381e-08
or O 0 2.9419358615889735e-10
FH O 0 1.5125204981814022e-06
receptors O 0 3.4045183339159735e-11
in O 0 1.6897740802088168e-12
the O 0 4.330933940470405e-13
pathogenesis O 0 9.11194120156722e-10
of O 0 1.972884095674532e-12
idiopathic O 0 9.750136086950079e-06
HUS B-Disease 1 0.9997455477714539
. O 0 5.181193252212779e-10
. O 0 9.984439941490564e-10

Further O 0 3.5504393869345563e-10
evidence O 0 2.1222924459496362e-11
for O 0 1.296009333922113e-13
a O 0 5.228509682500548e-13
major O 0 2.693949447199473e-12
ancient O 0 4.135222164691754e-10
mutation O 0 4.427339263202157e-06
underlying O 0 2.234705607406795e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
from O 0 3.643443602374674e-10
linkage O 0 7.116630484915731e-08
disequilibrium O 0 5.692376348065409e-08
studies O 0 3.663918057839055e-10
in O 0 5.601505370655957e-12
the O 0 3.075077898481021e-13
Japanese O 0 7.662855072698704e-11
population O 0 5.839613731808968e-13
. O 0 1.3140818294621326e-11

The O 0 7.184564765339019e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0007453268626704812
DM B-Disease 1 1.0
) O 0 3.1574587389116004e-10
mutation O 0 1.897375589976491e-09
is O 0 1.5594098928817246e-11
an O 0 5.020668776556381e-12
unstable O 0 2.4474878955516033e-05
( O 0 8.220071845421728e-11
CTG O 0 7.178633154580893e-08
) O 0 2.111705255103402e-11
n O 0 1.176793440471613e-09
repeat O 0 3.745445731340169e-09
, O 0 3.619274151211993e-12
present O 0 4.790140723312519e-13
at O 0 1.8875014398678225e-11
a O 0 7.572546647897915e-13
copy O 0 7.394756473821928e-10
number O 0 5.938706557767626e-13
of O 0 7.463365185199008e-14
5 O 0 1.193257905679479e-11
- O 0 1.7384682582388677e-09
37 O 0 2.404625942808991e-10
repeats O 0 1.3007288302002706e-10
on O 0 2.046836311553335e-11
normal O 0 3.570300652344649e-11
chromosomes O 0 1.4001727728640834e-11
but O 0 4.743158123210467e-12
amplified O 0 1.0167150107931455e-11
to O 0 1.1291582089918012e-13
50 O 0 8.370542757193955e-13
- O 0 1.0772417680104951e-11
3000 O 0 2.243940276647205e-11
copies O 0 1.8094250542333157e-09
on O 0 3.236670522710483e-07
DM B-Disease 1 1.0
chromosomes O 0 3.382271529517311e-08
. O 0 7.164059345754481e-10

Previous O 0 9.393693600756592e-10
findings O 0 8.851018529210108e-11
in O 0 5.787721864269901e-12
Caucasian O 0 3.5444396306871795e-09
populations O 0 2.3191393250243664e-11
of O 0 8.429277241484012e-13
a O 0 9.319478522229474e-08
DM B-Disease 1 1.0
founder O 0 1.8470917018120758e-09
chromosome O 0 9.583398252743791e-08
raise O 0 5.130812441578314e-10
a O 0 1.6113953921204072e-11
question O 0 1.466126352267505e-11
about O 0 1.0541587269980238e-13
the O 0 9.405502127189744e-15
molecular O 0 5.177895872482408e-13
events O 0 1.3130306304037775e-13
involved O 0 3.8493847866194475e-12
in O 0 6.958910878096525e-12
the O 0 6.064667539863733e-13
expansion O 0 1.40421715921768e-10
mutation O 0 2.063167414689815e-09
. O 0 3.8609332397854246e-10

To O 0 1.2270248705981146e-10
investigate O 0 1.1769274443906852e-10
whether O 0 7.217816622162587e-12
a O 0 4.0367531366214404e-12
founder O 0 3.6623929583479153e-11
chromosome O 0 1.2884059374940193e-09
for O 0 1.7633046715467837e-12
the O 0 1.5637503791854357e-10
DM B-Disease 1 1.0
mutation O 0 1.28441077218433e-10
exists O 0 3.0985825884288776e-12
in O 0 1.5528843402140557e-13
the O 0 1.695933093937528e-14
Japanese O 0 1.6925998363309658e-12
population O 0 1.0452242573517033e-15
, O 0 1.9418767334693394e-14
we O 0 8.159875769866987e-13
genotyped O 0 1.4329402941992697e-10
families O 0 2.5576217440584012e-14
using O 0 6.653852273851013e-13
polymorphic O 0 4.934517794374926e-10
markers O 0 6.919938511096291e-10
near O 0 2.3045287900202993e-09
the O 0 8.952597344014102e-12
( O 0 4.830838160052586e-11
CTG O 0 1.1731437155049207e-07
) O 0 2.992226952325261e-11
n O 0 5.140865511066295e-09
repeat O 0 3.37452590315479e-08
region O 0 3.403132442514334e-09
and O 0 3.0157545904963e-10
constructed O 0 1.1623919604630828e-08
haplotypes O 0 9.83944346444332e-07
. O 0 2.5875497300376082e-09

Six O 0 3.027043893322201e-10
different O 0 1.2650441675102209e-12
haplotypes O 0 6.036886546212372e-10
were O 0 3.391070757530201e-11
found O 0 2.3656757108803106e-10
and O 0 2.9477171814562553e-09
DM B-Disease 1 1.0
alleles O 0 4.826253841017092e-10
were O 0 2.713647084817694e-10
always O 0 4.519591090268449e-10
haplotype O 0 2.2267530042086037e-08
A O 0 1.202085986307111e-09
. O 0 4.317908530726555e-10

To O 0 3.453689070842536e-11
find O 0 5.92044677172332e-11
an O 0 3.1232750896193276e-14
origin O 0 5.557837176595193e-13
of O 0 1.9438035640177535e-14
the O 0 5.016004972491217e-13
( O 0 3.915399688497745e-12
CTG O 0 4.611865112025271e-09
) O 0 1.861174625875095e-12
n O 0 1.9347377866463233e-10
repeat O 0 1.3946702681622014e-09
mutation O 0 6.803444613234788e-11
and O 0 1.9618779257407626e-12
to O 0 8.091522786003724e-14
investigate O 0 7.364314778650349e-13
the O 0 4.548353135639706e-14
mechanism O 0 1.3449074753174584e-12
of O 0 1.016255412918251e-15
the O 0 8.189586331406196e-15
expansion O 0 1.2314548252650992e-12
mutation O 0 2.4035825413326606e-12
in O 0 2.8238205502205405e-13
the O 0 2.1144142955064303e-14
Japanese O 0 1.7008262203146995e-12
population O 0 2.063412917092944e-15
we O 0 9.206679608140048e-14
have O 0 2.5026145774307597e-14
studied O 0 2.261900736155731e-12
90 O 0 1.1703161226575554e-12
Japanese O 0 4.367942008087766e-09
DM B-Disease 1 1.0
families O 0 1.9539684540520463e-12
comprising O 0 5.218197835638039e-13
190 O 0 2.3111821484400608e-11
affected O 0 2.946325475261524e-11
and O 0 2.3306586695304166e-12
130 O 0 2.5090993518994686e-11
unaffected O 0 2.17022222415153e-08
members O 0 1.5777166031960554e-11
. O 0 1.2300828411415665e-10

The O 0 1.0501642090654517e-11
results O 0 2.7372932046021425e-11
suggest O 0 2.8827480767074087e-12
that O 0 6.899615292077152e-14
a O 0 4.2779221462972694e-13
few O 0 3.270621403914098e-12
common O 0 2.6247018881236928e-12
ancestral O 0 2.5837941161621636e-11
mutations O 0 9.584665006112658e-11
in O 0 2.4242784429223674e-12
both O 0 2.2109712064649623e-12
Caucasian O 0 2.4729642777998606e-09
and O 0 3.3343397487506365e-12
Japanese O 0 6.694132227702543e-12
populations O 0 2.3087817600667485e-14
have O 0 1.88790548813619e-14
originated O 0 1.1291157895818027e-12
by O 0 1.861037772455873e-14
expansion O 0 1.4406257220142549e-12
of O 0 5.185639041110392e-15
an O 0 1.5339080578088103e-14
ancestral O 0 4.8749060344022155e-11
n O 0 1.6241314959586362e-09
= O 0 2.622073891345167e-09
5 O 0 5.1987913973761124e-11
repeat O 0 8.309439802900442e-10
to O 0 5.50404860577558e-12
n O 0 1.8514371147304587e-09
= O 0 1.7014194497733115e-09
19 O 0 1.8330880147132689e-09
- O 0 5.141866044056087e-09
37 O 0 3.755787902903762e-10
copies O 0 4.4725054770822226e-09
. O 0 5.143844794552876e-10

These O 0 3.0411454604584165e-11
data O 0 7.880262414827754e-12
support O 0 3.217351650939074e-14
multistep O 0 1.9440336840315098e-10
models O 0 2.947608823689052e-10
of O 0 1.2787116200965731e-12
triplet O 0 1.1414784495400454e-07
repeat O 0 2.3271651272693816e-10
expansion O 0 3.71231127435645e-12
that O 0 1.2194961024076384e-13
have O 0 4.944155030045874e-14
been O 0 5.90833398915816e-14
proposed O 0 2.1689742287379216e-14
for O 0 2.3825701882338596e-14
both O 0 4.93713514515548e-10
DM B-Disease 1 1.0
and O 0 7.441802729601932e-10
Friedreichs B-Disease 0 3.892540405558975e-07
ataxia I-Disease 0 9.512295036984142e-06
. O 0 1.3447884472661542e-10
. O 0 2.1401752592353773e-10

The O 0 3.405633631006766e-12
molecular O 0 5.5271540816415055e-11
basis O 0 4.247067142415517e-10
of O 0 8.554168928753825e-09
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.5307042092183032e-11
the O 0 8.817238253541401e-14
western O 0 9.711856319150058e-12
Cape O 0 6.067766289419296e-10
, O 0 1.915835328922255e-12
South O 0 1.1879191207098128e-11
Africa O 0 9.814878076941369e-11
. O 0 5.203047021007379e-11

Deficiency B-Disease 1 0.9999864101409912
of I-Disease 0 7.998970409650585e-12
the I-Disease 0 3.3534099976029186e-12
sixth I-Disease 0 6.721053574798574e-11
component I-Disease 0 1.1262555991986556e-11
of I-Disease 0 6.116215694985331e-15
human I-Disease 0 1.152167011971017e-13
complement I-Disease 0 6.225735205145355e-11
( O 0 1.8798022166643946e-11
C6 O 0 2.7500910437794346e-09
) O 0 1.3548424806098663e-13
has O 0 8.011940991290573e-14
been O 0 9.781677421175083e-13
reported O 0 4.206732462375129e-10
in O 0 7.329967253826009e-13
a O 0 3.833644014218651e-13
number O 0 2.6423299515749253e-14
of O 0 1.9020076126200847e-15
families O 0 2.083933645492895e-14
from O 0 8.392339760957511e-15
the O 0 1.2588161510894945e-14
western O 0 4.469181968946856e-12
Cape O 0 1.1785043774192872e-10
, O 0 1.7981240411565902e-12
South O 0 8.987277068384092e-12
Africa O 0 2.725676628845264e-10
. O 0 7.433031967707393e-11

Meningococcal B-Disease 1 0.9999734163284302
disease I-Disease 1 0.9996991157531738
is O 0 1.1070883099151274e-09
endemic O 0 4.865248204311001e-10
in O 0 8.681277051392211e-12
the O 0 5.028246699220751e-13
Cape O 0 1.329085591583734e-10
and O 0 1.3139557801175594e-12
almost O 0 1.7152770902858355e-13
all O 0 4.053736631716735e-15
pedigrees O 0 2.355242736951091e-11
of O 0 4.97795503277311e-14
total O 0 1.6020173632114165e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.3463324045655014e-11
C6Q0 O 0 1.0565003094598069e-08
) O 0 3.5625899474402145e-13
have O 0 2.487615419644734e-13
been O 0 3.92574167618065e-12
ascertained O 0 1.8245166488739528e-10
because O 0 3.0020807888220258e-12
of O 0 1.6570277051528026e-12
recurrent O 0 7.300497964024544e-05
disease O 0 0.00032064656261354685
. O 0 3.5184399838072977e-09

We O 0 3.3435268442794097e-10
have O 0 9.843571270595763e-13
sequenced O 0 4.850011017798472e-12
the O 0 9.738631884421978e-14
expressed O 0 2.95744250486743e-13
exons O 0 7.501339133186846e-11
of O 0 1.1166205628318146e-13
the O 0 2.560050045216644e-12
C6 O 0 1.7703641885802313e-09
gene O 0 1.5193747301966987e-11
from O 0 2.573963720116368e-13
selected O 0 1.6167412731932923e-13
cases O 0 4.891526636865984e-13
and O 0 1.4065741030678397e-13
have O 0 5.931834342297326e-13
found O 0 7.892235476258946e-12
three O 0 2.258769750016973e-13
molecular O 0 1.8048923466906786e-09
defects O 0 3.3455510219937423e-06
leading O 0 8.639518787878497e-12
to O 0 1.9824725628475592e-12
total O 0 2.5600915831702764e-10
deficiency O 1 0.6924961805343628
879delG O 0 2.3779374913601714e-08
, O 0 7.751208529194198e-13
which O 0 8.019570386453082e-14
is O 0 3.710622643025331e-14
the O 0 2.2541633815618967e-14
common O 0 3.283494587336122e-10
defect O 0 5.173957262627482e-09
in O 0 4.954298690046377e-12
the O 0 1.0448312137353866e-12
Cape O 0 1.9574766807473054e-10
and O 0 3.196722617518355e-12
hitherto O 0 9.599525618853022e-10
unreported O 0 3.76993408712778e-10
, O 0 1.0910876152223081e-12
and O 0 1.4369949457790354e-12
1195delC O 0 9.018125690651857e-10
and O 0 1.2735465893670694e-12
1936delG O 0 1.0101878361590266e-10
, O 0 2.3981032478271984e-14
which O 0 5.6579344481040225e-15
have O 0 5.70655718859503e-14
been O 0 8.270719721072128e-13
previously O 0 1.24117003567209e-12
reported O 0 6.014219677830113e-11
in O 0 4.896922168977358e-13
African O 0 4.536696105589266e-12
- O 0 1.9152562868995915e-10
Americans O 0 2.6669770558651607e-11
. O 0 2.2262910265302693e-11

We O 0 1.0462626320872914e-09
also O 0 1.2517805802331194e-12
show O 0 1.626515870774281e-12
that O 0 6.875469432069542e-14
the O 0 2.6482348215381424e-13
879delG O 0 1.915594260992748e-08
and O 0 1.2373327362702469e-10
1195delC O 0 3.9359083530143835e-06
defects O 0 1.6310370483552106e-05
are O 0 4.025646054570467e-14
associated O 0 1.609959886759993e-12
with O 0 1.8061431256849447e-12
characteristic O 0 1.5834550595172914e-06
C6 O 0 0.02615906484425068
/ O 0 2.211651917605195e-06
C7 O 0 1.2436730401077511e-07
region O 0 3.4096345191692023e-10
DNA O 0 9.123841238078967e-09
marker O 0 2.953451927467654e-09
haplotypes O 0 1.7223529269472238e-08
, O 0 9.19307165114791e-12
although O 0 4.675769320339196e-13
small O 0 2.5439190684539703e-12
variations O 0 3.363546940970963e-10
were O 0 4.3063688726086014e-10
observed O 0 8.165675774440828e-11
. O 0 5.350137347037709e-11

The O 0 1.7467968738138495e-10
1936delG O 0 1.540516336717701e-07
defect O 0 9.008025614321014e-08
was O 0 8.374288068546676e-11
observed O 0 7.866517224945635e-13
only O 0 1.0395251825133511e-13
once O 0 1.2333541306308593e-12
in O 0 3.262545127721145e-13
the O 0 1.31214944508809e-13
Cape O 0 5.759973401020524e-11
, O 0 5.69373053479344e-13
but O 0 1.4462938496568462e-13
its O 0 1.5124476310571754e-14
associated O 0 2.6526201374332814e-11
haplotype O 0 2.1440181185994334e-08
could O 0 1.490335521658892e-09
be O 0 1.4304654682995022e-11
deduced O 0 1.6482986087140716e-09
. O 0 6.775215111165522e-11

The O 0 1.676183844501189e-11
data O 0 2.0112248672043975e-11
from O 0 1.5584567328048166e-13
the O 0 9.56109581155655e-14
haplotypes O 0 1.516786835020767e-10
indicate O 0 5.454202714472167e-11
that O 0 4.355851007035831e-14
these O 0 7.761378989317152e-15
three O 0 6.327025085491392e-14
molecular O 0 1.3146539412645097e-10
defects O 0 4.741503190075491e-08
account O 0 3.6505892167700005e-13
for O 0 1.0729018042922311e-13
the O 0 3.2113364051289395e-11
defects O 0 0.07391636073589325
in O 0 5.9091737579508585e-12
all O 0 1.3504231370295439e-13
the O 0 9.605714796712475e-14
38 O 0 5.963886069021429e-12
unrelated O 0 2.785447220099435e-11
C6Q0 O 0 3.146566562861608e-09
individuals O 0 2.42822905879847e-13
we O 0 5.632862340627931e-13
have O 0 1.7971357095612067e-13
studied O 0 1.2858759196321401e-11
from O 0 2.7434947217665206e-13
the O 0 8.812837612448554e-13
Cape O 0 4.0148961932828797e-10
. O 0 4.724155094892879e-11

We O 0 7.868765639074127e-10
have O 0 3.0752785300930396e-12
also O 0 1.3026759575554547e-13
observed O 0 3.1032002054814933e-13
the O 0 2.4307872338244496e-13
879delG O 0 3.185851937814732e-08
defect O 0 7.811689961556567e-09
in O 0 2.5761751672875866e-12
two O 0 4.590499508294599e-11
Dutch O 1 0.9999988079071045
C6 B-Disease 1 1.0
- I-Disease 1 0.9999982118606567
deficient I-Disease 1 1.0
kindreds O 0 2.4825651507853763e-06
, O 0 4.070695603514141e-12
but O 0 3.3306132374635866e-13
the O 0 5.700486334055468e-14
879delG O 0 1.295917928523238e-09
defect O 0 7.500684517935952e-10
in O 0 2.290885851245067e-13
the O 0 3.33740332461932e-14
Cape O 0 3.6975224965152265e-11
probably O 0 1.9069135159810457e-09
did O 0 1.9235658205163375e-11
not O 0 1.773899495176312e-13
come O 0 2.803662792379147e-13
from O 0 7.060581367615212e-14
The O 0 1.0790667133702553e-13
Netherlands O 0 7.200718354916091e-10
. O 0 1.6376165831374911e-12
. O 0 1.4239757810396991e-11

Complement B-Disease 1 0.9972436428070068
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.6515635787613974e-10
seven O 0 5.31674790998915e-12
further O 0 6.613796749849188e-12
molecular O 0 1.7359310433562314e-08
defects O 0 0.10251918435096741
and O 0 1.0102277521462089e-11
their O 0 5.323117164071633e-13
associated O 0 8.758018615884211e-11
marker O 0 4.926378949221544e-08
haplotypes O 0 3.1310200938605703e-06
. O 0 6.055895340750794e-09

Seven O 0 1.2877720001469584e-09
further O 0 6.409455431677369e-12
molecular O 0 4.798677427642062e-11
bases O 0 2.556583278412461e-10
of O 0 1.76440750898621e-09
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.3639740725768235e-10
described O 0 5.512585388167679e-10
. O 0 1.2872974908262336e-10

All O 0 1.2286963113616878e-11
these O 0 3.0393504553416495e-13
new O 0 6.696072949591292e-12
molecular O 0 1.5933194763562142e-09
defects O 0 8.086655611805327e-08
involve O 0 7.446977930147813e-12
single O 0 8.301040410607641e-11
- O 0 2.9191489225866007e-09
nucleotide O 0 6.687091852475291e-11
events O 0 2.072156031832084e-12
, O 0 1.4649683376111167e-12
deletions O 0 1.6747529751892642e-10
and O 0 2.4155363039651823e-12
substitutions O 0 3.691164995184293e-12
, O 0 2.0302810539545024e-14
some O 0 5.840254054835774e-15
of O 0 1.7847954051372714e-15
which O 0 2.965220029151755e-13
alter O 0 5.722284868170391e-10
splice O 0 1.1303311175936415e-08
sites O 0 2.7506877331440194e-10
, O 0 5.6763645867041745e-11
and O 0 4.586797261452169e-11
others O 0 8.802078510505851e-11
codons O 0 4.003129827623297e-09
. O 0 3.083956007232658e-11

They O 0 6.447370415330056e-11
are O 0 1.4122138517185662e-13
distributed O 0 8.120651910246621e-14
along O 0 5.989921015789323e-13
the O 0 1.205778966256732e-12
C7 O 0 2.11991557641511e-09
gene O 0 7.071481594733697e-11
, O 0 1.2228741240113972e-12
but O 0 3.365518584305671e-13
predominantly O 0 2.5263271292638723e-13
towards O 0 9.84496121778089e-13
the O 0 5.0467837374446045e-12
3 O 0 6.57112350643807e-11
end O 0 1.0460550203816865e-09
. O 0 1.15446534276753e-10

All O 0 1.0858729714013915e-11
were O 0 4.323342898959748e-12
found O 0 2.7649080941438697e-12
in O 0 5.057718566875424e-13
compound O 0 1.3157226697035895e-10
heterozygous O 0 1.9812094187443563e-09
individuals O 0 7.803101047254568e-12
. O 0 8.747317453705605e-11

The O 0 2.1895143476058365e-08
C6 O 0 0.3389204740524292
/ O 0 0.0005235201679170132
C7 O 0 4.211471605231054e-06
marker O 0 2.8273092311792425e-08
haplotypes O 0 1.64035583338773e-07
associated O 0 4.342937121037949e-09
with O 0 4.035900433296824e-11
most O 0 5.7578368739541474e-09
C7 B-Disease 0 0.4732280969619751
defects I-Disease 0 0.032630980014801025
are O 0 3.458657622454342e-12
tabulated O 0 8.78784156554957e-10
. O 0 6.616724095714899e-12
. O 0 7.837441112767962e-11

A O 0 6.218431547466707e-09
genome O 0 7.58629215003026e-10
- O 0 5.001989933361983e-09
wide O 0 7.7703260492612e-11
search O 0 1.002003410799368e-10
for O 0 8.606291677579203e-13
chromosomal O 0 1.7232524385235592e-07
loci O 0 1.3496995743267348e-09
linked O 0 1.2435212681793928e-07
to O 0 3.805369352960497e-10
mental O 0 2.991506562466384e-06
health O 0 8.152638564240533e-10
wellness O 0 7.008924551854534e-10
in O 0 2.2503511640931118e-12
relatives O 0 3.169410220382751e-11
at O 0 2.0549728585450566e-11
high O 0 1.74939424057996e-10
risk O 0 2.1704613661910344e-09
for O 0 6.789130455736592e-12
bipolar B-Disease 1 0.503165602684021
affective I-Disease 0 3.598822877393104e-05
disorder I-Disease 0 0.002093289280310273
among O 0 7.812407838703184e-12
the O 0 3.26048129467571e-12
Old O 0 4.5777454715789645e-07
Order O 0 4.4189617243173274e-11
Amish O 0 8.117576157928852e-07
. O 0 7.612759866937324e-10

Bipolar B-Disease 1 0.9999992847442627
affective I-Disease 1 0.9999279975891113
disorder I-Disease 1 0.9999984502792358
( O 0 3.812660622770636e-07
BPAD B-Disease 1 1.0
; O 0 1.0959473684124532e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999998807907104
) O 0 8.512574672936424e-11
is O 0 9.017871627388374e-13
characterized O 0 9.512066481698334e-12
by O 0 6.350385169974493e-13
episodes O 0 6.987687650727992e-10
of O 0 3.354433484453745e-12
mania B-Disease 0 1.7662421214481583e-06
and O 0 1.7800504126253003e-10
/ O 0 2.4381094476666476e-07
or O 0 1.9995720634824465e-09
hypomania B-Disease 0 3.3561859709152486e-06
interspersed O 0 7.28699189878057e-09
with O 0 3.3371584575586644e-12
periods O 0 8.204114609888791e-10
of O 0 2.792334505979932e-12
depression B-Disease 0 4.735538183808785e-08
. O 0 3.929564312832312e-11

Compelling O 0 2.100756013589944e-09
evidence O 0 2.4294361661292285e-11
supports O 0 3.804973697230096e-12
a O 0 9.121283372701128e-13
significant O 0 1.7851725956849473e-12
genetic O 0 5.628864596651795e-10
component O 0 7.568920490363951e-10
in O 0 1.77098370690576e-11
the O 0 1.8185079093610557e-12
susceptibility O 0 1.0231415714656578e-09
to O 0 1.3397705167506047e-10
develop O 0 3.876958203363756e-07
BPAD B-Disease 1 1.0
. O 0 9.170774362132761e-09

To O 0 1.1609130323719796e-10
date O 0 5.50447465386128e-10
, O 0 9.971939723615875e-13
however O 0 1.3320681363504505e-13
, O 0 1.9232106684106964e-14
linkage O 0 3.937907291917675e-11
studies O 0 1.2445225405777194e-11
have O 0 9.266582726846773e-13
attempted O 0 1.1685612547052138e-11
only O 0 2.0677921451928843e-13
to O 0 9.907249716792355e-14
identify O 0 5.267773717232416e-11
chromosomal O 0 1.8576212568177652e-08
loci O 0 1.3459278136451758e-10
that O 0 2.3384690451405676e-12
cause O 0 5.2698439362286464e-11
or O 0 2.29281260644143e-10
increase O 0 5.005115072398425e-11
the O 0 1.4140049374444796e-11
risk O 0 4.461012892420513e-09
of O 0 9.769035623843902e-13
developing O 0 7.730055529009405e-08
BPAD B-Disease 1 1.0
. O 0 2.3977160257260266e-09

To O 0 1.0326748137168273e-11
determine O 0 3.158835172600849e-12
whether O 0 4.983381871222214e-13
there O 0 1.3043025860748347e-12
could O 0 8.191066748486353e-12
be O 0 3.121871251093866e-13
protective O 0 8.308718296712314e-12
alleles O 0 2.501295177925744e-12
that O 0 3.3475289597587055e-13
prevent O 0 8.152738900646384e-12
or O 0 1.4561277184022003e-10
reduce O 0 4.662095709484504e-11
the O 0 2.198003931641601e-12
risk O 0 6.860598894542491e-11
of O 0 2.5355750011006768e-14
developing O 0 9.534818490308794e-10
BPAD B-Disease 1 1.0
, O 0 7.297826622523762e-13
similar O 0 2.3199202433231425e-13
to O 0 1.0269617187891322e-13
what O 0 9.964562812034283e-13
is O 0 2.7383284306519914e-14
observed O 0 8.340625011395847e-14
in O 0 1.1009798758440659e-12
other O 0 3.663484793303695e-10
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.7335385514224977e-12
we O 0 1.4745276397457041e-12
used O 0 1.2275304384079533e-10
mental O 0 1.2379132385831326e-06
health O 0 1.5040253487086375e-09
wellness O 0 1.807928740049647e-08
( O 0 1.6834054983316804e-11
absence O 0 1.8333073947829348e-10
of O 0 2.827528521650441e-13
any O 0 5.1196122896612906e-09
psychiatric B-Disease 0 0.13326354324817657
disorder I-Disease 0 2.3835264073568396e-06
) O 0 6.548271039991116e-13
as O 0 2.8934953391623885e-12
the O 0 3.4663979586041505e-12
phenotype O 0 1.096560424684867e-07
in O 0 9.22303899919541e-11
our O 0 1.433784341253741e-11
genome O 0 5.374192410534384e-11
- O 0 2.1743269407181742e-09
wide O 0 4.244273266174048e-10
linkage O 0 2.2038375391275622e-07
scan O 0 4.0728778003540356e-06
of O 0 2.133199216228232e-13
several O 0 2.710916614887676e-13
large O 0 6.330362449513682e-12
multigeneration O 0 3.40317137670354e-06
Old O 0 2.6019382204367503e-08
Order O 0 9.928522413937824e-12
Amish O 0 1.559590678823497e-08
pedigrees O 0 7.742240626384955e-09
exhibiting O 0 1.0143761386416372e-09
an O 0 2.5440550274064e-12
extremely O 0 3.783487656505713e-08
high O 0 5.852928808280922e-09
incidence O 0 3.321575832160306e-07
of O 0 2.2052874804057154e-10
BPAD B-Disease 1 1.0
. O 0 3.763700018311056e-09

We O 0 6.325429763309742e-11
have O 0 3.13801366618946e-13
found O 0 1.6226603394287054e-13
strong O 0 3.0516127819124605e-13
evidence O 0 9.622805888708993e-14
for O 0 1.0091553921719523e-14
a O 0 6.54252802108346e-13
locus O 0 2.692046863206343e-10
on O 0 5.011192572013101e-10
chromosome O 0 4.988195541955065e-06
4p O 0 8.956967576523311e-06
at O 0 5.283725679205986e-10
D4S2949 O 0 2.4306483492608777e-09
( O 0 1.3245290281238553e-12
maximum O 0 3.4507965061825185e-12
GENEHUNTER O 0 1.819823225446271e-08
- O 0 5.559298021928782e-10
PLUS O 0 2.493148187898697e-10
nonparametric O 0 1.3829811074117515e-08
linkage O 0 2.5456959207303953e-08
score O 0 1.2602919818860414e-09
= O 0 2.7833879645555726e-10
4 O 0 1.6396230076778928e-12
. O 0 6.447904818580874e-13
05 O 0 3.1442015657745515e-10
, O 0 1.1754210885867034e-12
P O 0 4.0697258896216226e-08
= O 0 5.761401078441253e-11
5 O 0 1.7716687492064231e-12
. O 0 4.902370826995184e-13
22 O 0 4.43714336106904e-12
x O 0 1.1681724476630961e-09
10 O 0 2.0660400473770935e-11
( O 0 1.4190844679906611e-11
- O 0 1.2620839928700889e-09
4 O 0 6.4248159743762745e-12
) O 0 2.321801605142948e-13
; O 0 4.125069155615918e-13
SIBPAL O 0 3.4020941619417044e-09
Pempirical O 0 5.237600353424909e-10
value O 0 1.3133450924018852e-11
< O 0 3.257183966987043e-10
3 O 0 6.350615562936146e-13
x O 0 2.5100485578910536e-10
10 O 0 6.053876584061202e-12
( O 0 5.783947973347914e-12
- O 0 5.4903820378982e-10
5 O 0 2.73229984644463e-12
) O 0 1.4347622753502903e-13
) O 0 7.376105206225586e-14
and O 0 7.500286741506101e-13
suggestive O 0 6.708761879359315e-10
evidence O 0 1.0865105473309433e-12
for O 0 8.479904332978766e-15
a O 0 3.0956037429599736e-13
locus O 0 2.306717733491226e-10
on O 0 8.719353572494981e-10
chromosome O 0 7.204126450233161e-05
4q O 0 0.001651865430176258
at O 0 1.5856007617998102e-09
D4S397 O 0 7.427654047376109e-09
( O 0 1.2846795675869327e-11
maximum O 0 4.971747319393316e-11
GENEHUNTER O 0 1.7605701430056797e-07
- O 0 2.651555641719483e-09
PLUS O 0 8.711524279725325e-10
nonparametric O 0 1.732718857283544e-08
linkage O 0 2.4861321890057297e-08
score O 0 7.092638698580345e-10
= O 0 2.080299960072196e-10
3 O 0 1.7089135011597034e-12
. O 0 7.187781728319742e-13
29 O 0 6.426473936338439e-11
, O 0 2.2815421427124782e-12
P O 0 4.2130560018449614e-07
= O 0 1.355379697365322e-10
2 O 0 1.9001035553994905e-12
. O 0 5.993394799549967e-13
57 O 0 5.947259351657408e-11
x O 0 7.024091086549333e-09
10 O 0 4.3892171147641434e-11
( O 0 1.6988493944936067e-11
- O 0 2.1072532607746552e-09
3 O 0 5.403617223814772e-12
) O 0 2.6776833788461074e-13
; O 0 3.1859836492099947e-13
SIBPAL O 0 2.8714914890315413e-09
Pempirical O 0 4.1726980204437325e-10
value O 0 6.407377666634018e-12
< O 0 1.265989257870359e-10
1 O 0 2.720717260425859e-13
x O 0 1.272884991854184e-10
10 O 0 7.150523229082495e-12
( O 0 4.5063909201448205e-12
- O 0 1.1379428510593925e-09
3 O 0 2.6157960346384623e-12
) O 0 3.207260778031844e-14
) O 0 6.893323531344947e-15
that O 0 9.042318963362571e-15
are O 0 3.6161171442210954e-14
linked O 0 8.668578077575262e-10
to O 0 7.095599108275508e-11
mental O 0 6.817704161221627e-07
health O 0 5.610514275389278e-10
wellness O 0 1.16174261322044e-08
. O 0 1.2821638195603668e-10

These O 0 1.6736856692234348e-11
findings O 0 2.393998541072584e-11
are O 0 2.180789457437854e-13
consistent O 0 1.1744714575878668e-11
with O 0 1.728327191378911e-14
the O 0 9.812092680245091e-14
hypothesis O 0 3.5601534741080965e-12
that O 0 6.151117348763765e-14
certain O 0 1.1783257746270093e-12
alleles O 0 9.734672096195496e-11
could O 0 5.1477089951790234e-11
prevent O 0 1.2554227622751934e-11
or O 0 1.2522261005898372e-10
modify O 0 4.0542266765974944e-10
the O 0 6.230100528352434e-13
clinical O 0 1.1769499264069339e-10
manifestations O 0 2.0626114705102339e-10
of O 0 1.3260109156532085e-11
BPAD B-Disease 1 1.0
and O 0 2.9024071340755242e-11
perhaps O 0 1.3660223126266136e-11
other O 0 2.489562809376844e-12
related O 0 2.322117431674542e-08
affective B-Disease 0 3.845232185994973e-06
disorders I-Disease 0 0.0015983347548171878
. O 0 1.0570863073766645e-09

Segregation O 0 8.23978625703603e-05
distortion O 0 2.8783186280634254e-05
in O 0 2.3008544758340577e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 5.940692560102434e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9927905797958374
DM B-Disease 1 1.0
) O 0 6.796768703409839e-10
is O 0 5.49381243622471e-12
an O 0 1.5882347520479456e-12
autosomal B-Disease 0 0.04980362951755524
dominant I-Disease 1 0.9818955659866333
disease I-Disease 1 0.9997790455818176
which O 0 7.214535080457551e-10
, O 0 7.645259425537176e-12
in O 0 2.089535792657027e-12
the O 0 3.8063508508295874e-13
typical O 0 3.302657869408421e-10
pedigree O 0 1.7938729612865245e-08
, O 0 1.0122969086243105e-12
shows O 0 9.873679998606555e-12
a O 0 6.274396974204066e-11
three O 0 3.1694764868195335e-11
generation O 0 5.345040521298472e-10
anticipation O 0 8.574991827714484e-10
cascade O 0 7.950752944907435e-08
. O 0 3.568588979874221e-09

This O 0 8.946474117088599e-11
results O 0 7.356927289592363e-10
in O 0 7.317769168402322e-10
infertility B-Disease 1 0.996067225933075
and O 0 1.1824502053059405e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.3777506064657246e-09
CDM B-Disease 0 3.71506665430843e-08
) O 0 4.951140951219013e-13
with O 0 2.4892658464018003e-14
the O 0 5.10723516429501e-13
disappearance O 0 1.0463384603198733e-09
of O 0 2.951629912706366e-11
DM B-Disease 1 1.0
in O 0 8.866225809089912e-11
that O 0 1.1036126873475993e-11
pedigree O 0 1.8341452800996194e-08
. O 0 6.432262361633079e-11

The O 0 3.721371301390608e-12
concept O 0 9.927991588554175e-12
of O 0 1.5072041921818102e-13
segregation O 0 1.7754457626306674e-10
distortion O 0 1.497889590140744e-10
, O 0 7.459679575438916e-14
where O 0 1.0819061202753822e-14
there O 0 2.409570379867127e-14
is O 0 2.73556168223308e-14
preferential O 0 4.89253949853552e-11
transmission O 0 3.968181616631483e-10
of O 0 2.3835520688263168e-14
the O 0 1.3973726147552268e-13
larger O 0 2.9293065369195848e-12
allele O 0 6.574686906013483e-10
at O 0 2.3199633880643944e-10
the O 0 2.349693495329319e-10
DM B-Disease 1 1.0
locus O 0 1.2320527931208858e-10
, O 0 1.405661004261205e-11
has O 0 2.143936070342356e-12
been O 0 3.0642710591166633e-12
put O 0 4.298339028457887e-12
forward O 0 1.4130714827420565e-12
to O 0 8.934216891689009e-14
explain O 0 2.427341314059639e-12
partially O 0 2.141668960231602e-11
the O 0 5.286157254112689e-13
maintenance O 0 2.565665679910012e-09
of O 0 1.0087682425496958e-11
DM B-Disease 1 1.0
in O 0 1.8739313920046463e-11
the O 0 4.575878521581589e-13
population O 0 8.12930343700724e-13
. O 0 3.0825151459135114e-11

In O 0 2.5172833262310235e-10
a O 0 4.040452347697787e-11
survey O 0 7.516219591163775e-11
of O 0 4.746053810372741e-12
DM B-Disease 1 1.0
in O 0 5.446946366172156e-11
Northern O 0 3.9755224112703047e-10
Ireland O 0 3.540380788535913e-08
, O 0 9.363113583071847e-12
59 O 0 2.3493651468697863e-11
pedigrees O 0 1.9255792516048587e-09
were O 0 3.219646424468259e-11
ascertained O 0 6.424188736531278e-09
. O 0 5.0659976214006974e-11

Sibships O 0 1.0629019442376375e-07
where O 0 5.601526621018538e-12
the O 0 3.6718302281069787e-14
status O 0 1.0195750493879885e-12
of O 0 3.430428167480108e-15
all O 0 1.4594448831959164e-14
the O 0 5.26758185546072e-15
members O 0 5.508220527643878e-15
had O 0 2.2633379545555776e-12
been O 0 1.2970282129137062e-13
identified O 0 6.740110314491787e-13
were O 0 3.0988704441056725e-13
examined O 0 1.5629346775125619e-12
to O 0 9.89277985295441e-15
determine O 0 1.7973619012394415e-13
the O 0 1.244058567100026e-13
transmission O 0 4.684560517276282e-10
of O 0 2.9463844558597074e-13
the O 0 1.740922822568436e-10
DM B-Disease 1 1.0
expansion O 0 1.1870154165150026e-11
from O 0 1.5297200355382512e-12
affected O 0 7.846755363527524e-12
parents O 0 1.3816494606397334e-12
to O 0 2.761943201001673e-14
their O 0 3.000121852336779e-13
offspring O 0 3.3959640655112366e-11
. O 0 1.7237929833546772e-11

Where O 0 6.583806416715632e-11
the O 0 4.204546433239642e-12
transmitting O 0 5.348431031393375e-08
parent O 0 2.8746278246671864e-08
was O 0 8.503203474674592e-09
male O 0 5.878299513817353e-10
, O 0 1.7257473228227127e-11
58 O 0 2.848742075567401e-10
. O 0 6.890248788193887e-11

3 O 0 3.510775836712554e-10
% O 0 4.163860662514951e-12
of O 0 3.7938364303130145e-15
the O 0 1.4838196115058745e-14
offspring O 0 9.709239705626982e-13
were O 0 3.827640461528947e-12
affected O 0 1.3418763713038406e-12
, O 0 3.3408043313091357e-14
and O 0 1.8173522853704577e-13
in O 0 3.0435040338644415e-13
the O 0 9.097631231257813e-14
case O 0 6.32155439106441e-12
of O 0 4.828184361105499e-15
a O 0 3.841177809854601e-12
female O 0 5.095165955815162e-11
transmitting O 0 5.1102883702469626e-08
parent O 0 9.83203563009738e-08
, O 0 3.5638392237302696e-10
68 O 0 1.3273693255655417e-08
. O 0 6.292713017330698e-10

7 O 0 2.567253076790621e-08
% O 0 1.8221066322432478e-10
were O 0 9.464836553396694e-11
affected O 0 1.7400664242828157e-10
. O 0 4.704741110583832e-11

Studies O 0 1.6033562033612725e-08
on O 0 4.0285116909011265e-10
meiotic O 0 3.711844343001758e-08
drive O 0 2.6247708451165863e-09
in O 0 8.66418581324524e-09
DM B-Disease 1 1.0
have O 0 2.6376800049687787e-12
shown O 0 4.469793133711486e-13
increased O 0 4.7022091081982964e-12
transmission O 0 6.201428259799968e-11
of O 0 6.430262054025809e-15
the O 0 2.803688372774154e-14
larger O 0 3.956153980799737e-12
allele O 0 2.668236742664476e-09
at O 0 1.2830255746720809e-09
the O 0 9.846383708378426e-10
DM B-Disease 1 1.0
locus O 0 1.9155570463169624e-09
in O 0 3.655966918092446e-10
non O 0 9.182763460557908e-05
- O 1 0.9978286623954773
DM O 1 1.0
heterozygotes O 0 2.098901319413926e-07
for O 0 5.790839335828579e-11
CTGn O 0 1.9833622388887306e-07
. O 0 3.4401800852457143e-10

This O 0 1.0890713678102237e-11
study O 0 9.978865607093712e-13
provides O 0 2.0203889288580162e-13
further O 0 1.8053157439020667e-13
evidence O 0 3.3970829621532417e-12
that O 0 1.610862918749456e-12
the O 0 3.013799487749935e-10
DM B-Disease 1 1.0
expansion O 0 2.7427246584998954e-10
tends O 0 2.446022273616677e-10
to O 0 6.042337311919221e-13
be O 0 8.805180543025592e-12
transmitted O 0 1.9689434527236926e-09
preferentially O 0 3.777716806041553e-09
. O 0 2.7692337312146265e-10

Diagnosis O 1 0.9985759258270264
of O 0 1.088535039883709e-08
hemochromatosis B-Disease 1 1.0
. O 0 3.061531472781098e-08

If O 0 1.0280328410772199e-07
untreated O 0 0.00012531253742054105
, O 0 1.7244361494306304e-09
hemochromatosis B-Disease 1 1.0
can O 0 6.376934180707394e-08
cause O 0 1.716247624017342e-07
serious O 0 0.31754040718078613
illness O 0 0.0007790085510350764
and O 0 4.275275619636254e-11
early B-Disease 0 2.618566696810376e-08
death I-Disease 0 5.1601639627918416e-11
, O 0 1.278372075081205e-13
but O 0 7.995717803133129e-13
the O 0 1.9079830488981375e-13
disease O 0 4.402636921696512e-09
is O 0 3.544704460511916e-12
still O 0 4.295638567075599e-10
substantially O 0 2.2460076465335987e-08
under O 0 2.756594064123874e-08
- O 0 0.46639570593833923
diagnosed O 0 0.0012135469587519765
. O 0 4.6835063605144e-10

The O 0 8.960746207542503e-12
cornerstone O 0 2.0867975403238148e-10
of O 0 9.822354653807666e-14
screening O 0 2.1762376622991297e-11
and O 0 1.1075469968230278e-12
case O 0 6.273755928827562e-13
detection O 0 9.841337814120443e-13
is O 0 2.0551028462540213e-14
the O 0 1.2294868729611618e-14
measurement O 0 1.3299725036552967e-11
of O 0 1.5409724819955006e-14
serum O 0 1.545333826180606e-11
transferrin O 0 9.853029503403832e-11
saturation O 0 9.600032574441641e-11
and O 0 1.314096075878679e-12
the O 0 7.894730875979139e-13
serum O 0 7.727041784200139e-10
ferritin O 0 1.303974954680598e-07
level O 0 3.945730409071757e-09
. O 0 1.7344366221028196e-10

Once O 0 1.1851961190245675e-08
the O 0 2.677987519239533e-11
diagnosis O 0 1.2783806369043305e-07
is O 0 8.120888401845494e-13
suspected O 0 6.559124443583642e-08
, O 0 5.426162991151173e-12
physicians O 0 1.126453791355786e-10
must O 0 2.155572812259643e-12
use O 0 3.544638887964524e-11
serum O 0 1.516380443433718e-08
ferritin O 0 6.392302793756244e-07
levels O 0 9.261760247625261e-09
and O 0 1.2877075794559545e-10
hepatic O 0 1.8778597166146938e-07
iron O 0 5.705974785996659e-07
stores O 0 1.8820873037839192e-07
on O 0 2.4964899036916677e-09
liver O 0 7.309197513905019e-08
biopsy O 0 3.0353959346030024e-07
specimens O 0 1.62331207503863e-11
to O 0 4.146201611210376e-13
assess O 0 4.2764253943561314e-11
patients O 0 4.1461820088350976e-11
for O 0 5.9527853464938236e-15
the O 0 2.4551133085619174e-14
presence O 0 1.873977709121455e-11
of O 0 7.905523458084929e-12
iron B-Disease 0 0.00014184675819706172
overload I-Disease 0 1.0492987030374934e-06
. O 0 3.2158062324150194e-10

Liver O 1 0.9987665414810181
biopsy O 1 0.994149923324585
is O 0 3.096398484836449e-11
also O 0 1.3314382148882364e-13
used O 0 1.476333568199359e-13
to O 0 6.181885651166188e-14
establish O 0 2.156740931680279e-12
the O 0 1.1694519051058672e-13
presence O 0 6.924698228022441e-12
or O 0 2.2142314370920957e-10
absence O 0 1.1128462040765896e-10
of O 0 1.734586188876716e-13
cirrhosis B-Disease 0 1.4698265937695965e-09
, O 0 1.5069110510194245e-13
which O 0 9.945191371818485e-14
can O 0 1.0382288778698623e-10
affect O 0 1.168784109495391e-07
prognosis O 0 4.261372305336408e-05
and O 0 7.703242210777006e-11
management O 0 9.127909539330403e-10
. O 0 3.342524174110295e-11

A O 0 8.092713166263366e-10
DNA O 0 1.0913827619418726e-09
- O 0 2.3737117826883036e-10
based O 0 9.919172254402309e-12
test O 0 1.9314000052061964e-11
for O 0 2.7616585979313955e-14
the O 0 1.6505855926843283e-13
HFE O 0 5.508499878459361e-09
gene O 0 4.096884984039484e-11
is O 0 1.4102597128279326e-13
commercially O 0 5.7583113624581905e-12
available O 0 5.114451397114639e-12
, O 0 3.267464695078798e-13
but O 0 5.367251781907001e-13
its O 0 1.0717926315884606e-14
place O 0 3.5191999054468015e-12
in O 0 2.979661873139805e-12
the O 0 2.132150575887004e-12
diagnosis O 0 2.4375560769840376e-07
of O 0 2.75723519536919e-12
hemochromatosis B-Disease 1 1.0
is O 0 1.6782576717222497e-10
still O 0 8.000866635882176e-11
being O 0 1.9565201889171213e-11
evaluated O 0 2.650568098339079e-10
. O 0 1.84000453762323e-11

Currently O 0 9.400146216975713e-10
, O 0 8.446771927739238e-13
the O 0 7.977354603175106e-15
most O 0 1.991566396660708e-14
useful O 0 3.628797566254671e-13
role O 0 1.5996406944277647e-13
for O 0 3.0545795317508777e-15
this O 0 1.6792597585905955e-14
test O 0 2.4805238158648324e-12
is O 0 1.3696702328086854e-14
in O 0 6.625734303659231e-14
the O 0 4.46279704814298e-14
detection O 0 2.7949521169690072e-11
of O 0 2.7466115319618734e-12
hemochromatosis B-Disease 1 1.0
in O 0 1.426019632239095e-11
the O 0 1.5538383026005714e-13
family O 0 6.347793926782253e-13
members O 0 4.502629365410677e-15
of O 0 2.0539106897324083e-15
patients O 0 1.5487439889577681e-12
with O 0 4.269790172605837e-15
a O 0 5.007537787204974e-12
proven O 0 3.536862358544113e-09
case O 0 2.1156168483749127e-10
of O 0 1.1831783111853483e-13
the O 0 2.3066461934950766e-11
disease O 0 1.238571627482088e-07
. O 0 1.810307875826922e-10

It O 0 2.0077686735398004e-10
is O 0 7.568248111544662e-12
crucial O 0 8.109647953169485e-10
to O 0 5.853986739801087e-10
diagnose O 1 0.9999991655349731
hemochromatosis B-Disease 1 1.0
before O 0 1.9759361748583615e-05
hepatic B-Disease 1 0.9998370409011841
cirrhosis I-Disease 0 0.3752848505973816
develops O 0 7.631003313690599e-07
because O 0 8.534054574127481e-10
phlebotomy O 0 6.607306568184868e-05
therapy O 0 9.679541835794225e-05
can O 0 1.1395963284144273e-08
avert O 0 8.436111238552257e-05
serious O 1 0.9987407326698303
chronic O 1 1.0
disease O 0 0.3101806640625
and O 0 1.0829281915647471e-10
can O 0 2.2735631086123753e-11
even O 0 1.5248092719022388e-11
lead O 0 1.6546503750491937e-11
to O 0 3.1736369175000556e-12
normal O 0 1.8526886691461186e-08
life O 0 6.622753456753117e-10
expectancy O 0 3.682898430668047e-10
. O 0 5.023358031625014e-13
. O 0 1.1555309660515878e-11

Prevalence O 0 2.651260729180649e-05
of O 0 1.0829070279383401e-11
the O 0 3.5124670099556665e-12
I1307K O 0 4.1642325143698145e-09
APC B-Disease 0 6.151587572666983e-10
gene O 0 2.616367400509745e-10
variant O 0 4.6752816729167535e-08
in O 0 4.590088031886097e-11
Israeli O 0 6.252919848570571e-10
Jews O 0 3.893304515584228e-12
of O 0 4.999170243486515e-15
differing O 0 1.7336831839923073e-13
ethnic O 0 3.0354920508603167e-13
origin O 0 2.427870404719812e-11
and O 0 6.315908351872679e-10
risk O 0 5.500627366927802e-07
for O 0 1.090890364707775e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6911954059395384e-09

BACKGROUND O 0 1.4414621546166018e-05
& O 0 6.110057171326844e-08
AIMS O 0 2.8449304023681066e-10
Israeli O 0 2.0680912538040275e-10
Jews O 0 1.2484359032671755e-11
of O 0 1.234476117249056e-13
European O 0 6.7141288084826556e-09
birth O 0 5.732666341629056e-09
, O 0 2.5571916112410165e-11
i O 0 2.0735588801557014e-09
. O 0 1.597795179042287e-14
e O 0 2.486753207867065e-12
. O 0 6.580997411517048e-14
, O 0 1.6162972924036595e-13
Ashkenazim O 0 5.501294420007241e-10
, O 0 2.3517781689089134e-14
have O 0 1.986730143463747e-13
the O 0 9.042470765219246e-12
highest O 1 0.9967369437217712
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 2.5056272079382325e-06
of O 0 1.8069728113974393e-13
any O 0 1.7440096242160585e-11
Israeli O 0 1.9357290881316658e-08
ethnic O 0 1.9115521665558077e-10
group O 0 2.4885267180252413e-09
. O 0 9.220616492555678e-10

The O 0 2.944535171245377e-10
I1307K O 0 2.4213672844553003e-08
APC B-Disease 0 2.84981416243113e-09
gene O 0 1.603324806254136e-09
variant O 0 2.69555414433853e-07
was O 0 4.030552247513697e-08
found O 0 7.39577232788946e-10
in O 0 2.4516882968228515e-10
6 O 0 1.4209269871834351e-10
. O 0 7.360151377255875e-11

1 O 0 3.507623358434131e-10
% O 0 2.0609774737528896e-12
of O 0 5.4022972576447145e-16
American O 0 8.096988520205767e-14
Jews O 0 8.001591468402569e-13
, O 0 1.6462688417345772e-13
28 O 0 1.065792202756266e-12
% O 0 1.126194271302769e-13
of O 0 7.565166348184535e-14
their O 0 6.345749259395461e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.457617931383993e-08
, O 0 2.341428049709715e-12
but O 0 1.0932254233819716e-11
not O 0 1.690863811812382e-12
in O 0 1.3002494914093887e-11
non O 0 2.4157808198310704e-08
- O 0 2.502821505601105e-09
Jews O 0 2.807878651811535e-10
. O 0 9.585943844259148e-11

We O 0 3.5324515534895795e-10
assessed O 0 1.6714182815569245e-10
the O 0 2.9387066781752513e-13
I1307K O 0 1.816132799703496e-09
prevalence O 0 2.961902501041891e-09
in O 0 1.0438789589672925e-12
Israeli O 0 9.388923666309168e-11
Jews O 0 6.958191076274212e-13
of O 0 1.3967610357914855e-15
differing O 0 4.978391424147535e-14
ethnic O 0 1.4962597133516553e-13
origin O 0 1.7960785636539356e-11
and O 0 3.520680136315235e-10
risk O 0 1.2807174698536983e-07
for O 0 1.973956820222611e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.462357150458729e-09

METHODS O 0 1.4305440387829549e-08
DNA O 0 3.0992730604140206e-09
samples O 0 6.163070054299169e-11
from O 0 1.5887165714933982e-12
500 O 0 5.193157102262314e-13
unrelated O 0 3.494564663683586e-12
Jews O 0 2.1177786087289707e-12
of O 0 2.5264605877750416e-14
European O 0 5.0832168335679384e-11
or O 0 2.0198015135419745e-11
non O 0 4.0853695426612546e-10
- O 0 7.542140523231211e-11
European O 0 1.3213327133831942e-11
origin O 0 4.637615378527693e-12
, O 0 1.885704049506276e-13
with O 0 6.699665965097723e-15
or O 0 4.473121525960799e-12
without O 0 2.3617325543151546e-12
a O 0 6.760801770852587e-13
personal O 0 5.276914669116728e-11
and O 0 4.847990897616228e-10
/ O 0 1.1237788157814066e-06
or O 0 1.8594707995589488e-09
family O 0 2.8381973854463283e-11
history O 0 6.618768467331337e-12
of O 0 1.4343216826924465e-13
neoplasia B-Disease 0 9.443748005821817e-09
, O 0 2.223858033487125e-12
were O 0 1.2453133142742434e-11
examined O 0 1.2608275534731206e-10
for O 0 1.3665727180238712e-14
the O 0 3.278587728454234e-14
I1307K O 0 2.013509636800137e-10
variant O 0 6.143953679149661e-10
by O 0 7.274701132285732e-13
the O 0 2.135822118123909e-12
allele O 0 4.660837937819906e-09
- O 0 1.6850872919249582e-09
specific O 0 1.0020091700813083e-10
oligonucleotide O 0 9.867675032637635e-08
( O 0 9.508448473027897e-10
ASO O 0 1.517713599241688e-06
) O 0 8.231850097406568e-12
method O 0 3.3028846324612005e-10
. O 0 1.7359821913309759e-10

RESULTS O 0 1.922746939442277e-08
In O 0 4.782967424898921e-12
persons O 0 7.726912100609884e-13
at O 0 2.6733064546757834e-12
average O 0 1.403901300767174e-10
risk O 0 4.78335770992544e-09
for O 0 3.224525002565315e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 4.162084218939377e-11
I1307K O 0 2.3687107830738796e-09
was O 0 6.287554366046777e-10
found O 0 5.92106849661711e-11
in O 0 3.583454366573591e-11
5 O 0 2.90427334959098e-11
. O 0 1.7798026941129308e-10

0 O 0 2.4337054593814855e-09
% O 0 2.3473988378097665e-11
of O 0 4.895089460730043e-14
120 O 0 3.870440860170854e-12
European O 0 1.1616888562215877e-09
and O 0 2.5767873945703457e-10
1 O 0 5.6518092289570276e-11
. O 0 6.858164730561e-11

6 O 0 1.1147656131527128e-08
% O 0 1.7332387261537185e-11
of O 0 4.342106033994146e-14
188 O 0 5.0346334740103416e-11
non O 0 2.225545969736231e-09
- O 0 4.828401678480532e-09
European O 0 3.4121586112156876e-10
Jews O 0 4.9597749518515144e-11
( O 0 1.080227313848825e-11
P O 0 1.8267575896402377e-08
= O 0 7.315519023887163e-11
0 O 0 7.817715225177935e-12
. O 0 4.6961497190967094e-12
08 O 0 1.7421718234711392e-10
) O 0 4.227948286611438e-12
. O 0 3.0838560871604415e-11

It O 0 5.952403014930496e-10
occurred O 0 5.175871731211146e-09
in O 0 1.2290674034076687e-10
15 O 0 8.253456251772207e-11
. O 0 4.312210657997362e-11

4 O 0 1.467151733436367e-09
% O 0 2.8038049312839597e-11
of O 0 1.348027321278894e-13
52 O 0 2.6827484678193514e-10
Ashkenazi O 0 9.133470939559629e-07
Israelis O 0 1.3421175992789358e-07
with O 0 8.743814006173523e-11
familial O 0 0.2318098247051239
cancer B-Disease 0 6.088557711336762e-05
( O 0 9.005303169828949e-10
P O 0 1.525134030089248e-05
= O 0 1.7412226105406603e-09
0 O 0 4.6480846949137344e-11
. O 0 4.829094155806013e-12
02 O 0 6.096803617516855e-10
) O 0 2.2570642999996532e-13
and O 0 8.022557770014094e-13
was O 0 1.9032790621320572e-10
not O 0 1.2692036007247443e-12
detected O 0 3.2118832593575064e-10
in O 0 6.134708626509555e-12
51 O 0 5.551369433587361e-11
non O 0 5.011393522380558e-10
- O 0 2.7863730767130335e-10
European O 0 6.642295047321056e-11
Jews O 0 1.2055357580254e-11
at O 0 5.893587007310686e-11
increased O 0 2.826486544815765e-10
cancer B-Disease 0 1.2067592258802051e-08
risk O 0 3.2534541727358146e-09
. O 0 6.773379773727939e-11

Colorectal B-Disease 1 0.9974550604820251
neoplasia I-Disease 0 0.0004089771828148514
occurred O 0 2.177706726058659e-08
personally O 0 3.551103022747526e-10
or O 0 1.9337554127418777e-11
in O 0 1.0654019983943885e-12
the O 0 6.765002783220425e-14
families O 0 1.243989720262073e-13
of O 0 5.555361722806842e-15
13 O 0 4.088652973046475e-13
of O 0 8.702949283814505e-15
20 O 0 9.802521207941117e-13
Ashkenazi O 0 2.471595705877405e-10
I1307K O 0 1.9122039021657322e-11
carriers O 0 2.2085317949449568e-11
, O 0 1.3348862488472835e-13
8 O 0 1.2194054360009643e-13
of O 0 2.279898656543382e-15
whom O 0 2.1752830439702997e-11
also O 0 3.0219139690590424e-11
had O 0 1.5326573343799055e-09
a O 0 9.64661336921857e-12
personal O 0 3.442451046442585e-10
or O 0 3.5970855183364847e-09
family O 0 1.2834949769668924e-10
history O 0 5.191161736584071e-11
of O 0 7.320834043145208e-12
noncolonic O 0 2.1566747818724252e-06
neoplasia B-Disease 0 1.0751254194474313e-05
. O 0 4.750933868535867e-09

CONCLUSIONS O 0 5.83279380350632e-08
The O 0 8.938180057205258e-12
I1307K O 0 5.880399722713037e-09
APC O 0 2.436724599874651e-09
variant O 0 5.757686594165534e-08
may O 0 2.9243968358017014e-10
represent O 0 7.22208209034958e-13
a O 0 8.95131711808883e-12
susceptibility O 0 2.511879149125207e-09
gene O 0 8.158366426869179e-09
for O 0 1.6266478441995247e-10
colorectal B-Disease 1 1.0
, I-Disease 0 7.962163914299047e-12
or I-Disease 0 1.9455943800483766e-11
other I-Disease 0 1.3234010241836014e-11
, I-Disease 0 1.1305865965649531e-10
cancers I-Disease 0 4.7912958507367875e-06
in O 0 2.0388148114225402e-10
Ashkenazi O 0 1.2730954779271997e-07
Jews O 0 2.0781336720898658e-11
, O 0 2.6942272197960637e-12
and O 0 2.0632783676033384e-12
partially O 0 4.0627723407737903e-10
explains O 0 2.5291851946107613e-10
the O 0 1.0160417429280755e-12
higher O 0 5.74171599154738e-09
incidence O 0 3.194900637026876e-05
of O 0 1.5296671335818246e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.6112051127190625e-09
European O 0 8.315595323438174e-09
Israelis O 0 7.502193284381065e-07
. O 0 8.032476350727791e-10

Systematic O 0 5.235385458490782e-09
analysis O 0 3.6344763310047767e-10
of O 0 2.6324430916352393e-12
coproporphyrinogen O 0 2.7158358761880663e-07
oxidase O 0 1.263543936147471e-06
gene O 0 3.150161137455143e-05
defects O 0 0.12210899591445923
in O 0 4.838337508417112e-10
hereditary B-Disease 0 0.01037583127617836
coproporphyria I-Disease 0 0.000194877982721664
and O 0 4.356252247816883e-09
mutation O 0 1.736590888867795e-07
update O 0 8.463401286462613e-07
. O 0 1.4535034287277426e-09

Hereditary B-Disease 1 0.999299168586731
coproporphyria I-Disease 0 0.007650383282452822
( O 0 6.853506562265466e-08
HC B-Disease 0 4.2138377466471866e-05
) O 0 4.423482066751028e-11
is O 0 5.028210920549059e-12
an O 0 1.4224230300563523e-11
acute O 0 0.07793600112199783
hepatic B-Disease 1 0.999998927116394
porphyria I-Disease 1 0.9999997615814209
with O 0 4.1647744808415155e-08
autosomal O 1 0.9999439716339111
dominant O 0 0.07088026404380798
inheritance O 0 0.0004293596721254289
caused O 0 1.0522854410055515e-07
by O 0 5.002433189904565e-11
deficient B-Disease 0 0.000732970132958144
activity I-Disease 0 3.210059551506106e-09
of I-Disease 0 7.111741751053557e-13
coproporphyrinogen I-Disease 0 8.923939276428428e-08
III I-Disease 0 1.682592554175244e-08
oxidase I-Disease 0 1.714287201082243e-08
( O 0 1.028103921441037e-10
CPO O 0 4.213562476707011e-08
) O 0 3.365920042686099e-11
. O 0 1.3004039511876897e-10

Clinical O 0 3.892933762017492e-07
manifestations O 0 9.689298252624212e-09
of O 0 7.406772135724882e-13
the O 0 7.334810710191153e-12
disease O 0 6.298963484141495e-08
are O 0 7.067685195774609e-13
characterized O 0 2.8233332338700734e-11
by O 0 2.079941037111399e-12
acute O 0 5.960531268556224e-08
attacks O 0 4.061025649093608e-08
of O 0 3.150659247386223e-11
neurological B-Disease 0 0.00021094578551128507
dysfunction I-Disease 0 3.287145204922126e-07
often O 0 1.6094296034774302e-11
precipitated O 0 2.0826375346505444e-11
by O 0 5.297489402982143e-14
drugs O 0 4.6325718261464033e-10
, O 0 2.2227894438259233e-12
fasting O 0 1.68152025636914e-09
, O 0 1.5047376322394057e-12
cyclical O 0 1.2961584694437533e-08
hormonal O 0 6.947781461263958e-09
changes O 0 2.8035429880390872e-11
, O 0 1.1165833882498255e-11
or O 0 2.2752585593366348e-08
infectious B-Disease 0 0.0007039871416054666
diseases I-Disease 0 0.020130500197410583
. O 0 1.209235378496487e-09

Skin O 1 1.0
photosensitivity O 1 0.9998617172241211
may O 0 0.0001700795255601406
also O 0 4.359132152464973e-11
be O 0 8.875335904580395e-13
present O 0 1.0085061041484322e-12
. O 0 6.142298475397823e-11

The O 0 2.001765281312018e-10
seven O 0 5.933187274820284e-11
exons O 0 9.034774040017624e-10
, O 0 1.0082522924198534e-12
the O 0 5.993223495606714e-13
exon O 0 3.1295144253817853e-09
/ O 0 6.495268323192249e-09
intron O 0 3.688054661665774e-08
boundaries O 0 6.760398907346143e-10
and O 0 3.075585272571679e-11
part O 0 5.1174667801967555e-12
of O 0 2.6349633737952904e-13
3 O 0 2.040855331952862e-12
noncoding O 0 1.4723371133396057e-10
sequence O 0 1.0663493742527064e-12
of O 0 3.802161832448282e-14
the O 0 1.6907920105235091e-13
CPO O 0 2.70143879488316e-10
gene O 0 1.592187666432654e-11
were O 0 5.0416940587660886e-12
systematically O 0 1.1399945223922181e-11
analyzed O 0 1.5941226203658454e-12
by O 0 2.749234488067659e-14
an O 0 9.29284454291926e-14
exon O 0 1.6900143784415178e-10
- O 0 6.335076213614954e-11
by O 0 2.1605297412241597e-11
- O 0 1.9126224160004313e-08
exon O 0 1.3969371082112048e-07
denaturing O 0 2.9530306164815556e-06
gradient O 0 5.899073229898022e-08
gel O 0 2.319884657708826e-07
electrophoresis O 0 9.171893466941583e-09
( O 0 1.116098463649351e-10
DGGE O 0 2.0795125621475563e-08
) O 0 1.4002040629387813e-12
strategy O 0 2.994191006244762e-11
followed O 0 3.679375326550577e-13
by O 0 7.574591283788634e-15
direct O 0 1.1545830480921837e-12
sequencing O 0 3.449686369894067e-11
in O 0 1.850277396575617e-11
seven O 0 7.089980078728297e-12
unrelated O 0 3.989628627465436e-10
heterozygous O 0 8.981982091427199e-08
HC B-Disease 0 4.874644218944013e-06
patients O 0 5.752315512808082e-09
from O 0 3.502365498314619e-12
France O 0 9.549584092383157e-07
, O 0 5.635178434992838e-11
Holland O 0 4.43589613041695e-07
, O 0 8.811396924601755e-12
and O 0 2.478642811831744e-11
Czech O 0 3.243435520161597e-09
Republic O 0 1.790937953494165e-10
. O 0 1.1321494852722935e-09

Seven O 0 1.2371869084759624e-09
novel O 0 4.918862539504687e-10
mutations O 0 5.728826302231482e-10
and O 0 7.664211279512223e-12
two O 0 7.784321689845164e-13
new O 0 1.0079528357798129e-11
polymorphisms O 0 1.4146870341846807e-08
were O 0 1.5595720270766833e-09
detected O 0 2.842325272922608e-07
. O 0 5.104729972060795e-10

Among O 0 3.819505267621537e-10
these O 0 2.1317277370397347e-12
mutations O 0 8.788070965382033e-11
two O 0 6.655908463271132e-13
are O 0 1.1837794199748286e-12
missense O 0 7.891679132399076e-08
( O 0 3.224427669312746e-11
G197W O 0 2.4967659051355895e-09
, O 0 3.622389064053544e-12
W427R O 0 9.117834820493442e-10
) O 0 6.295849258597386e-13
, O 0 1.933495410218894e-13
two O 0 1.5010533777320284e-13
are O 0 2.4961859836081235e-12
nonsense O 0 2.3371902102553577e-07
( O 0 3.814653020545178e-12
Q306X O 0 2.991595027257432e-10
, O 0 8.225631005324974e-13
Q385X O 0 2.84279849660507e-10
) O 0 3.724934314990047e-13
, O 0 2.986305593002253e-13
two O 0 2.4228105212722485e-14
are O 0 1.9728329077794635e-14
small O 0 5.778431119013439e-13
deletions O 0 4.434594913504952e-09
( O 0 4.405587006317546e-12
662de14bp O 0 3.9352213154764115e-10
; O 0 1.1876286629478039e-12
1168del3bp O 0 1.4546905902079743e-09
removing O 0 9.594797872880534e-11
a O 0 1.274711412813101e-11
glycine O 0 1.405927818609598e-09
at O 0 9.966811230499584e-12
position O 0 5.7365509911755375e-12
390 O 0 1.4376262333359868e-11
) O 0 1.1113024156505016e-13
, O 0 2.3594985015286396e-13
and O 0 8.139139861217115e-13
one O 0 7.423743694431884e-13
is O 0 1.3874796765071112e-13
a O 0 4.234178545975409e-12
splicing O 0 3.9873729207329234e-08
mutation O 0 3.065234510657433e-09
( O 0 6.65020538637151e-11
IVS1 O 0 3.0859914090797247e-07
- O 0 4.755149607404974e-09
15c O 0 1.857108173908273e-07
- O 0 2.967964984890159e-09
- O 0 4.26826440858008e-09
> O 0 1.393029164242776e-10
g O 0 6.497838378471954e-11
) O 0 1.2411481618932602e-13
which O 0 3.2912832615555887e-13
creates O 0 8.136660616109292e-12
a O 0 2.276557414804259e-11
new O 0 2.233752627311958e-10
acceptor O 0 1.4390350022708276e-09
splice O 0 9.268531897532739e-08
site O 0 4.843843104396228e-09
. O 0 6.429395904561375e-10

The O 0 4.49979671579559e-11
pathological O 0 3.2023663720792683e-09
significance O 0 1.4373082585228403e-11
of O 0 8.680407195989226e-14
the O 0 4.890155663218876e-13
point O 0 1.0970442609892217e-10
mutations O 0 1.4642413947996147e-09
G197W O 0 1.2295696683040092e-09
, O 0 1.4760049736259329e-12
W427R O 0 3.471721243819559e-10
, O 0 8.177418703118888e-13
and O 0 3.438115135472042e-13
the O 0 1.7544237005014118e-13
in O 0 3.2306404773585484e-10
- O 0 3.5470520742819645e-08
frame O 0 2.797180442826175e-08
deletion O 0 4.284128607423554e-09
390delGly O 0 2.7720408191100887e-09
were O 0 9.148990592899864e-12
assessed O 0 3.1605406226181687e-12
by O 0 5.539110548680821e-15
their O 0 1.366833434765036e-14
respective O 0 1.2996629597181175e-13
expression O 0 1.1381451336944792e-12
in O 0 1.4498408983792954e-12
a O 0 4.407873371858884e-12
prokaryotic O 0 2.2970212971290538e-12
system O 0 6.057049393298763e-13
using O 0 8.34265382471111e-12
site O 0 1.833500684611522e-09
- O 0 2.664534370921956e-09
directed O 0 3.217217325879318e-10
mutagenesis O 0 6.986067546677077e-08
. O 0 4.745735360245362e-09

These O 0 9.133913070336064e-11
mutations O 0 1.000842630993759e-09
resulted O 0 8.979018049914966e-12
in O 0 6.8981222643704765e-12
the O 0 6.608219830714357e-13
absence O 0 7.594729012350143e-11
or O 0 2.2283810213741262e-11
a O 0 1.2391481937767956e-11
dramatic O 0 1.439202645947546e-09
decrease O 0 4.243660089997547e-09
of O 0 9.92481184042271e-12
CPO O 0 2.7092082177659904e-07
activity O 0 1.531755167150095e-08
. O 0 1.6457406271097597e-10

The O 0 1.9893028196937834e-11
two O 0 3.070215089107098e-12
polymorphisms O 0 1.0956814344709187e-09
were O 0 9.112801659105774e-12
localized O 0 1.6782895906342077e-10
in O 0 1.4746070683968604e-11
noncoding O 0 7.11316339163659e-10
part O 0 1.825642718597531e-12
of O 0 2.2770835848948297e-14
the O 0 2.554540577009469e-14
gene O 0 1.2324070583491498e-11
1 O 0 2.6785008672841615e-13
) O 0 7.778707419945491e-14
a O 0 6.494366676379482e-12
C O 0 1.5199079825833905e-06
/ O 0 9.002597778362542e-08
G O 0 1.1491938955998648e-08
polymorphism O 0 2.9327450690175283e-08
in O 0 8.239772059104311e-11
the O 0 5.2282427519256824e-12
promotor O 0 1.8436677962085923e-08
region O 0 1.4420788174707155e-10
, O 0 6.401123121141383e-12
142 O 0 5.228674090917984e-11
bp O 0 1.9445538512741223e-09
upstream O 0 4.892119348509638e-11
from O 0 7.023580393498985e-13
the O 0 7.983263166201973e-14
transcriptional O 0 7.678554320156294e-11
initiation O 0 3.775946135625707e-12
site O 0 7.872825655286242e-12
( O 0 2.8134031562765394e-12
- O 0 5.947727310662287e-10
142C O 0 2.9845939053529946e-08
/ O 0 8.775450588416334e-09
G O 0 7.1510081189885e-10
) O 0 3.5241145938946783e-13
, O 0 1.3613288556320324e-13
and O 0 3.821481705298252e-13
2 O 0 1.7983562501568823e-13
) O 0 4.9010403754042725e-14
a O 0 2.290908782121015e-12
6 O 0 1.059343932019452e-11
bp O 0 4.374845818944095e-09
deletion O 0 6.310453826152695e-10
polymorphism O 0 7.793945488998588e-10
in O 0 3.104900885009254e-12
the O 0 3.067661142469591e-13
3 O 0 9.040673483277917e-13
noncoding O 0 8.844942833707847e-11
part O 0 1.360060393300333e-12
of O 0 6.441141429903638e-14
the O 0 9.338317879387104e-13
CPO O 0 2.4371893392327593e-09
gene O 0 6.787670425723036e-11
, O 0 5.162905693245623e-13
574 O 0 4.982198681391381e-11
bp O 0 1.16061188437655e-10
downstream O 0 6.757942729723743e-12
of O 0 5.9234055852018346e-15
the O 0 6.534493269833713e-14
last O 0 4.6748980554733865e-12
base O 0 9.361603967071933e-14
of O 0 3.8106614692608e-15
the O 0 3.0799261795458333e-13
normal O 0 8.270921725284097e-10
termination O 0 7.875431973225488e-10
codon O 0 2.1881727541028795e-09
( O 0 1.0289724801382238e-11
+ O 0 7.423146541896131e-10
574 O 0 4.338814196813701e-09
delATTCTT O 0 1.728269793943582e-08
) O 0 1.1220772228037745e-10
. O 0 1.4028787853614944e-10

Five O 0 1.758930556761129e-09
intragenic O 0 8.296382247863221e-08
dimorphisms O 0 3.158420014415242e-08
are O 0 5.995052544671697e-13
now O 0 7.841739952697824e-13
well O 0 1.2377178817447876e-13
characterized O 0 4.060721214577817e-13
and O 0 2.683716963935989e-13
the O 0 1.161912634248946e-13
high O 0 4.9793297957068106e-11
degree O 0 1.1796220944493285e-10
of O 0 5.369399789698602e-14
allelic O 0 2.2104336416806092e-10
heterogeneity O 0 4.201784475910131e-10
in O 0 7.328884027435478e-11
HC B-Disease 0 2.061115310425521e-06
is O 0 1.408435217412074e-12
demonstrated O 0 2.9585160276485167e-12
with O 0 1.1012187255826644e-13
seven O 0 6.181145547658196e-13
new O 0 6.382710657747148e-13
different O 0 6.090227606080079e-13
mutations O 0 3.0827444763570355e-11
making O 0 2.9244291016583546e-11
a O 0 4.951303689965103e-12
total O 0 3.7884677491460683e-13
of O 0 2.5150525108721955e-13
nineteen O 0 1.526912996041574e-08
CPO O 0 9.196559176416486e-07
gene B-Disease 0 9.102305966735003e-07
defects I-Disease 0 0.008590316399931908
reported O 0 1.1474504013619935e-08
so O 0 3.968754838656885e-11
far O 0 4.1245937221212614e-11
. O 0 5.496568911828037e-12
. O 0 4.3832857482550835e-11

Coincidence O 0 2.7680693293063996e-08
of O 0 2.184724840273433e-12
two O 0 8.117992497842785e-13
novel O 0 3.327270750586031e-11
arylsulfatase O 0 1.4525397773468285e-08
A O 0 1.266155930101931e-10
alleles O 0 2.4403525866745213e-09
and O 0 8.298158687969348e-11
mutation O 0 1.6871849695121455e-08
459 O 0 1.3970085532832854e-08
+ O 0 7.267975110636371e-09
1G O 0 1.8113360056304373e-07
> O 0 4.168428269224478e-09
A O 0 5.304049213727957e-11
within O 0 4.297232274880214e-12
a O 0 1.8670823220823252e-10
family O 0 5.730487750987834e-10
with O 0 2.076969846109833e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999998807907104
: O 0 1.8143304567064256e-11
molecular O 0 4.157910474256177e-11
basis O 0 3.713403542993099e-11
of O 0 1.0865851404404103e-12
phenotypic O 0 2.4109613860900936e-08
heterogeneity O 0 1.3735650838953006e-07
. O 0 3.895100242345961e-09

In O 0 9.254269017766603e-10
a O 0 5.01995320312254e-11
family O 0 2.338532666124049e-11
with O 0 2.0518414983565492e-13
three O 0 4.6188122770907114e-12
siblings O 0 2.994432479752618e-10
, O 0 1.2342243112944962e-13
one O 0 1.0914533843777233e-13
developed O 0 9.408086809603589e-11
classical O 0 2.9101999032832282e-08
late O 0 0.0029304008930921555
infantile O 1 0.9989008903503418
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.0012043816232108e-07
MLD B-Disease 1 0.9999996423721313
) O 0 2.704628881966542e-11
, O 0 1.704125447525573e-12
fatal O 0 5.607607267421599e-09
at O 0 1.2384759884298546e-09
age O 0 7.182885952694562e-10
5 O 0 1.4434202531138363e-12
years O 0 1.2299314127925398e-12
, O 0 1.117172353974974e-13
with O 0 7.342140675818676e-13
deficient O 0 3.6166726204100996e-05
arylsulfatase O 0 1.5660171825970792e-08
A O 0 2.682687127997241e-10
( O 0 3.643393226004932e-11
ARSA O 0 2.591745555946545e-07
) O 0 2.9513019632332327e-12
activity O 0 3.250642255370195e-10
and O 0 1.296049639137875e-12
increased O 0 6.617408704334693e-11
galactosylsulfatide O 0 1.5718053703039914e-07
( O 0 6.078400005549156e-10
GS O 1 1.0
) O 0 8.314651744889545e-11
excretion O 0 4.748161419598773e-09
. O 0 2.6214527770740403e-10

The O 0 6.067042701562997e-12
two O 0 5.431544970735391e-13
other O 0 3.2321335278334695e-13
siblings O 0 2.2259694087978232e-10
, O 0 1.0095800064002791e-12
apparently O 0 7.7399405995493e-08
healthy O 0 9.136606138326897e-09
at O 0 2.2070621372161092e-11
12 O 0 1.3043822749345124e-12
( O 0 4.5066635969912006e-13
1 O 0 3.76602785415181e-12
/ O 0 2.4645263607681045e-09
2 O 0 1.146761071518787e-12
) O 0 1.6485845620497347e-13
and O 0 3.421677004233903e-12
15 O 0 1.1264139577679688e-12
years O 0 1.0306115498775331e-13
, O 0 3.4121695252690943e-15
respectively O 0 7.12572362226993e-14
, O 0 2.436829932988844e-14
and O 0 1.2261947100050685e-13
their O 0 6.16951761488356e-14
father O 0 4.0756231722838265e-11
, O 0 4.897193219520479e-13
apparently O 0 3.463852094043318e-09
healthy O 0 5.253888990530697e-10
as O 0 9.828019474633631e-13
well O 0 1.3550861821531868e-12
, O 0 1.3933193249333897e-13
presented O 0 4.3046646976130365e-12
ARSA O 0 1.675108251220081e-06
and O 0 1.4809758974720921e-09
GS O 1 1.0
values O 0 1.0812573709648166e-12
within O 0 1.711316499749746e-13
the O 0 7.229193914499998e-13
range O 0 3.7904468452865103e-10
of O 0 9.606810486006978e-11
MLD B-Disease 1 1.0
patients O 0 2.0604772998922272e-07
. O 0 1.993565867941527e-10

Mutation O 0 7.424201697858734e-08
screening O 0 3.863380726443211e-09
and O 0 3.897881149794724e-12
sequence O 0 1.4979766559120034e-12
analysis O 0 1.6263051018719499e-12
disclosed O 0 1.9580592702794775e-10
the O 0 2.0191252912259844e-13
involvement O 0 1.051085954384412e-11
of O 0 2.637742759945775e-14
three O 0 1.7197453584891914e-13
different O 0 1.0091526139038853e-12
ARSA O 0 4.925072971673217e-07
mutations O 0 3.68150815388546e-10
being O 0 1.1130833234285209e-11
the O 0 9.545534799875952e-14
molecular O 0 7.381291758368214e-12
basis O 0 4.732151736436263e-12
of O 0 6.821967578514443e-13
intrafamilial O 0 4.071985060249972e-08
phenotypic O 0 4.214590987317024e-08
heterogeneity O 0 4.5278184757080453e-07
. O 0 5.027259941670081e-09

The O 0 3.4693781181260874e-10
late O 0 1.335849049155513e-07
infantile O 0 0.000439314084360376
patient O 0 1.68545466294745e-05
inherited O 0 1.6097993693620083e-06
from O 0 2.8953645037077536e-10
his O 0 2.310693997253921e-10
mother O 0 2.1988120213478624e-09
the O 0 1.968549021708066e-13
frequent O 0 4.56388919711781e-11
0 O 0 9.043338300429582e-11
- O 0 2.267261400845655e-08
type O 0 3.2935322451521643e-06
mutation O 0 2.2656020348676975e-07
459 O 0 2.5299355499441845e-08
+ O 0 1.8330880147132689e-09
1G O 0 3.177835239398519e-08
> O 0 6.892670878499985e-10
A O 0 5.891103577182477e-11
, O 0 2.033511596957749e-12
and O 0 1.6959217233672441e-12
from O 0 1.2456387483983367e-11
his O 0 6.449682454778838e-11
father O 0 1.4554170368885622e-10
a O 0 7.423049805041493e-13
novel O 0 7.47953348562147e-12
, O 0 6.558995425780256e-13
single O 0 1.5352863078077483e-11
basepair O 0 2.9453525840494876e-08
microdeletion O 0 5.322377205629891e-09
of O 0 3.2549248127518304e-13
guanine O 0 6.130105867363511e-10
at O 0 1.922751541316714e-11
nucleotide O 0 8.153101110908167e-11
7 O 0 7.460356117594547e-12
in O 0 2.38305425739882e-12
exon O 0 2.260972520318205e-09
1 O 0 1.379381192601059e-10
( O 0 6.510542105431227e-11
7delG O 0 4.784902429832982e-08
) O 0 5.8016515203096475e-11
. O 0 1.7042571520686778e-10

The O 0 7.043388788874339e-11
two O 0 4.390724589464767e-11
clinically O 0 2.39376586250728e-05
unaffected O 0 7.147509109017847e-07
siblings O 0 1.919953529494478e-09
carried O 0 6.879494196532221e-11
the O 0 3.008391929668064e-12
maternal O 0 9.033641390487901e-09
mutation O 0 5.6505857770616785e-09
459 O 0 7.992912998133761e-09
+ O 0 3.938662729296993e-09
1G O 0 3.609760668155104e-08
> O 0 1.8058256001651785e-09
A O 0 1.0033038982948383e-10
and O 0 4.838535388324017e-12
, O 0 2.8589928818475996e-13
on O 0 1.4900888682667368e-12
their O 0 2.8642000338315043e-13
paternal O 0 1.1747056660738053e-09
allele O 0 7.800921020262308e-10
, O 0 1.406521166896768e-12
a O 0 2.139720041774429e-12
novel O 0 2.7084282733236265e-11
cytosine O 0 1.1398065824508308e-09
to O 0 5.017155527836659e-12
thymidine O 0 1.2611944377738382e-08
transition O 0 2.847992397470023e-10
at O 0 1.2260609194569838e-10
nucleotide O 0 4.179500356915611e-10
2435 O 0 8.75807693034858e-09
in O 0 6.679439553541888e-12
exon O 0 1.2821718131661441e-09
8 O 0 4.640882469986174e-11
, O 0 2.9605183864307716e-13
resulting O 0 3.067415570677523e-13
in O 0 2.9776148994381524e-13
substitution O 0 4.990517981501297e-12
of O 0 1.6929960580149006e-13
alanine O 0 5.856356732891754e-09
464 O 0 2.71056399547831e-10
by O 0 8.13309142255747e-12
valine O 0 4.344648004916962e-06
( O 0 8.255786332345139e-11
A464V O 0 1.2065911825231979e-08
) O 0 9.446350646147295e-11
. O 0 2.1016247075955619e-10

The O 0 1.9805658502125567e-10
fathers O 0 2.055508208087531e-09
genotype O 0 1.7260330054114092e-08
thus O 0 2.4223764660824543e-10
was O 0 1.1584943671039127e-08
7delG O 0 1.6783958471933147e-06
/ O 0 1.3078758911433397e-06
A464V O 0 8.982236749943695e-07
. O 0 2.461378878493292e-09

Mutation O 0 4.832937179344299e-07
A464V O 0 1.9505655757257045e-07
was O 0 1.1169061231441901e-09
not O 0 7.260907912247372e-13
found O 0 1.53371651316625e-12
in O 0 2.952737663750038e-12
18 O 0 1.7216278749843106e-11
unrelated O 0 1.1972447921948515e-08
MLD B-Disease 1 1.0
patients O 0 1.0838632533705095e-06
and O 0 2.2053959353174335e-11
50 O 0 2.3417597722064087e-11
controls O 0 9.473970408180321e-08
. O 0 1.2329091081397792e-09

A464V O 0 3.1272033993445802e-06
, O 0 6.99105634494046e-11
although O 0 7.281118416524457e-12
clearly O 0 9.512234749875503e-11
modifying O 0 3.686969840543952e-09
ARSA O 0 5.160697128303582e-06
and O 0 6.4042473546521705e-09
GS O 1 1.0
levels O 0 1.3245411434326115e-09
, O 0 1.203756712364612e-12
apparently O 0 3.3595271009545513e-10
bears O 0 1.0934887023639206e-10
little O 0 9.456933153240143e-11
significance O 0 7.293916447388693e-13
for O 0 3.984274254921136e-14
clinical O 0 1.029035363864228e-11
manifestation O 0 1.0486434637302366e-10
of O 0 3.504786044716823e-11
MLD B-Disease 1 1.0
, O 0 5.6704241996330396e-11
mimicking O 0 6.56291332390424e-09
the O 0 2.1246740478098047e-11
frequent O 0 5.09298736517394e-08
ARSA O 0 0.004478194750845432
pseudodeficiency O 0 1.7738770111463964e-05
allele O 0 4.911845280730631e-06
. O 0 1.2589159936737815e-08

Our O 0 3.4216804389863853e-10
results O 0 1.1112845019201067e-11
demonstrate O 0 2.24138112583927e-12
that O 0 5.963516491605883e-14
in O 0 3.910024159916453e-13
certain O 0 6.3147217489734064e-12
genetic O 0 1.988209596959223e-08
conditions O 0 1.585314385010861e-05
MLD B-Disease 1 1.0
- O 0 3.5520752561524205e-08
like O 0 1.6357584176063256e-09
ARSA O 0 8.165470353560522e-05
and O 0 1.8124163281285632e-09
GS O 1 0.9999997615814209
values O 0 3.5959958968878603e-12
need O 0 2.9302677905657104e-12
not O 0 1.2625919190364931e-13
be O 0 2.2979961507361805e-14
paralleled O 0 3.2358547265298743e-12
by O 0 1.2062867252391613e-13
clinical O 0 2.2690513912237975e-09
disease O 0 5.320509366413262e-09
, O 0 6.041162036764247e-13
a O 0 1.9021847898897937e-12
finding O 0 3.664279643600388e-11
with O 0 3.362491708680526e-12
serious O 0 6.913625583138128e-08
diagnostic O 0 6.142049642221536e-07
and O 0 3.0025992803217605e-10
prognostic O 0 8.460617095806811e-07
implications O 0 6.541907282553439e-08
. O 0 1.5382833895571935e-09

Moreover O 0 8.881776381031159e-08
, O 0 6.155433801557919e-11
further O 0 3.440119369924055e-11
ARSA O 0 8.578665983804967e-06
alleles O 0 3.87709642168943e-09
functionally O 0 1.5055302782229774e-08
similar O 0 2.4671435033818412e-11
to O 0 1.7436228242490026e-12
A464V O 0 1.657099790719485e-09
might O 0 4.596948169344195e-11
exist O 0 3.3039966162301537e-12
which O 0 1.232926087613162e-12
, O 0 2.1087889464158072e-13
together O 0 1.2451149865918415e-13
with O 0 1.1980001680348545e-13
0 O 0 2.08033867910018e-11
- O 0 3.6219247601110283e-09
type O 0 2.886518188915943e-07
mutations O 0 4.803840525369196e-08
, O 0 2.2393909643314558e-11
may O 0 2.8453156497576515e-10
cause O 0 1.4815827731329279e-10
pathological O 0 7.997916213753342e-07
ARSA O 0 5.785322355222888e-05
and O 0 4.466674585756891e-09
GS O 1 1.0
levels O 0 1.2014526873382891e-10
, O 0 1.0193139599523268e-13
but O 0 2.2399013796092077e-13
not O 0 6.571517418771378e-13
clinical O 0 6.212331343791178e-11
outbreak O 0 5.67671153139937e-11
of O 0 1.0170262933683824e-13
the O 0 1.3359599017326307e-11
disease O 0 1.5855624369010002e-08
. O 0 4.017795211114228e-12
. O 0 4.034084177817476e-11

Human O 0 1.1339435559420963e-06
MLH1 O 1 0.9958155751228333
deficiency O 1 0.9997761845588684
predisposes O 0 3.8140475226100534e-05
to O 0 3.5098606243622044e-09
hematological B-Disease 0 0.012048373930156231
malignancy I-Disease 1 0.97945237159729
and O 0 1.1643069619537982e-08
neurofibromatosis B-Disease 0 0.04684450849890709
type I-Disease 0 0.029090596362948418
1 I-Disease 0 1.3083042205153106e-08
. O 0 1.6796291024689936e-09

Heterozygous O 0 5.286082341626752e-06
germ O 0 0.0003216989862266928
- O 0 2.0111328922212124e-05
line O 0 5.08762543205421e-09
mutations O 0 7.478057062471066e-10
in O 0 5.719092734113307e-12
the O 0 7.517229568855532e-13
DNA O 0 1.9903221293304796e-09
mismatch O 0 1.517771579528926e-07
repair O 0 3.434965094584186e-07
genes O 0 1.1098796548481005e-08
lead O 0 4.601917957813839e-09
to O 0 3.4813112392839685e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.69657120258671e-08

The O 0 2.718516800559456e-10
disease O 0 4.3901781765498527e-08
susceptibility O 0 1.059437870765123e-09
of O 0 8.062467523033828e-14
individuals O 0 4.819947392598056e-12
who O 0 1.0727565502577363e-09
constitutionally O 0 7.79835129804951e-09
lack O 0 2.087163775144063e-10
both O 0 4.343676026502541e-12
wild O 0 8.47961811878406e-10
- O 0 3.298072783763928e-07
type O 0 4.365483334822784e-07
alleles O 0 3.891335698114062e-09
is O 0 6.78622089078651e-11
unknown O 0 1.0116484538968962e-08
. O 0 1.608584043744088e-09

We O 0 3.292895678352892e-10
have O 0 1.9798500946327513e-12
identified O 0 1.6349272630167277e-11
three O 0 6.072303982340363e-14
offspring O 0 3.7639739415562534e-12
in O 0 7.151842594706193e-13
a O 0 9.094855424329751e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.2411204508566698e-08
who O 0 2.6593680382824836e-11
developed O 0 7.280875347071003e-10
hematological B-Disease 0 4.663071013055742e-05
malignancy I-Disease 0 0.00019175045599695295
at O 0 3.63984564710762e-10
a O 0 1.426362413597948e-11
very O 0 2.6626328919476805e-10
early O 0 3.4944700466610357e-09
age O 0 5.0095271680872244e-11
, O 0 5.514046589661682e-14
and O 0 1.1832799551390188e-13
at O 0 1.6157062666943833e-12
least O 0 1.3120543063474543e-13
two O 0 2.332034677941363e-14
of O 0 1.1955975929612856e-15
them O 0 6.76937889423912e-14
displayed O 0 3.899125119999347e-11
signs O 0 1.4063945563691505e-09
of O 0 4.865082945879062e-13
neurofibromatosis B-Disease 0 4.048337814310798e-06
type I-Disease 0 7.058958090055967e-06
1 I-Disease 0 1.6435707239637054e-09
( O 0 5.02167973870371e-10
NF1 B-Disease 0 3.196612397005083e-06
) O 0 1.193144749667141e-10
. O 0 3.198293296868826e-10

DNA O 0 8.784091676261596e-09
sequence O 0 1.2400923343758308e-10
analysis O 0 3.95290501720158e-11
and O 0 1.3190481693015066e-12
allele O 0 9.954244095666809e-10
- O 0 5.937356162277752e-10
specific O 0 2.0604871975304917e-11
amplification O 0 6.532338003850668e-10
in O 0 5.417716622546642e-11
two O 0 3.3619228928527534e-11
siblings O 0 2.254809894353116e-09
revealed O 0 7.316150463232418e-10
a O 0 5.291912741345328e-11
homozygous O 0 1.5066079868120141e-06
MLH1 O 0 2.1442554498207755e-05
mutation O 0 3.14000949686033e-08
( O 0 1.0176584575027903e-10
C676T O 0 2.421501221760991e-08
- O 0 7.231335530377692e-08
- O 0 1.4901038980497106e-07
> O 0 3.1641764763890023e-09
Arg226Stop O 0 1.876201594086524e-08
) O 0 2.8056397483045004e-11
. O 0 3.554143784834096e-11

Thus O 0 1.0538995232067805e-09
, O 0 1.6994392004754388e-11
a O 0 9.975141372631224e-12
homozygous O 0 3.226426059654841e-08
germ O 0 0.012540231458842754
- O 0 4.098363206139766e-05
line O 0 2.854418710285245e-07
MLH1 O 0 3.333655695314519e-05
mutation O 0 3.078471522144355e-08
and O 0 8.378106541861996e-11
consequent O 0 3.2130195393165195e-08
mismatch O 0 0.009433160535991192
repair O 1 0.9998762607574463
deficiency O 1 0.9999433755874634
results O 0 1.242716374250108e-09
in O 0 2.114308728096148e-11
a O 0 5.629627319869712e-10
mutator O 0 0.0012392428470775485
phenotype O 0 7.482724413421238e-06
characterized O 0 3.6506659917279194e-09
by O 0 7.24941565111159e-11
leukemia B-Disease 1 0.9998792409896851
and O 0 1.946915659800652e-07
/ O 1 0.9999963045120239
or O 1 0.9996862411499023
lymphoma B-Disease 1 1.0
associated O 0 1.3673981946737968e-08
with O 0 5.310324749374651e-11
neurofibromatosis B-Disease 0 0.13087981939315796
type I-Disease 0 0.008173463866114616
1 I-Disease 0 2.020874800834349e-09
. O 0 1.6864465379740068e-10
. O 0 4.248419949171023e-10

Missense O 0 5.07244149048347e-05
mutations O 0 5.107774541102117e-07
in O 0 2.4443203017199266e-10
the O 0 1.7018442319445548e-13
most O 0 3.5595793890577654e-14
ancient O 0 6.334900594547055e-13
residues O 0 9.070217493745147e-11
of O 0 2.593334008367358e-14
the O 0 4.897893614123905e-13
PAX6 O 0 2.6430335253735393e-08
paired O 0 1.063040877546939e-09
domain O 0 9.715386273256854e-10
underlie O 0 1.583636222157736e-09
a O 0 3.319619579222888e-11
spectrum O 0 5.839221883796597e-10
of O 0 7.702371726536761e-12
human O 0 1.6348797871046372e-08
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999982118606567
malformations I-Disease 1 0.9999244213104248
. O 0 2.140544985707038e-08

Mutations O 0 3.0531001016242953e-07
of O 0 2.982516360619525e-12
the O 0 5.628276707539404e-13
human O 0 9.021644542528406e-12
PAX6 O 0 1.0193552952841856e-06
gene O 0 1.964038574442384e-06
underlie O 0 6.926898640813306e-05
aniridia B-Disease 1 1.0
( O 0 2.3205526304082014e-05
congenital B-Disease 1 0.9999998807907104
absence I-Disease 0 1.3700532264238063e-08
of I-Disease 0 2.2162053279779076e-13
the I-Disease 0 9.824833004448696e-13
iris I-Disease 0 2.013179482673877e-06
) O 0 3.470261187785151e-12
, O 0 5.423366833748333e-13
a O 0 1.214349107381274e-11
rare O 0 1.547115147104705e-07
dominant O 1 0.9994820952415466
malformation B-Disease 1 0.999994158744812
of I-Disease 0 1.002936015487288e-11
the I-Disease 0 2.7390339996102853e-10
eye I-Disease 0 0.049541376531124115
. O 0 1.6472998964900398e-08

The O 0 9.136719159030804e-11
spectrum O 0 4.269125331024526e-10
of O 0 1.8147173217256118e-12
PAX6 O 0 4.710005327979161e-07
mutations O 0 5.001438907470401e-08
in O 0 1.7266709173568984e-09
aniridia B-Disease 1 1.0
patients O 0 2.0067031414328085e-07
is O 0 6.728238842804157e-14
highly O 0 6.283348407548628e-13
biased O 0 5.508570266599122e-10
, O 0 6.58853329424218e-14
with O 0 1.0603529434160229e-14
92 O 0 1.2023645100389668e-11
% O 0 1.4083242764247744e-13
of O 0 6.667057737727274e-15
all O 0 3.4816363659283256e-13
reported O 0 1.1667072863374983e-09
mutations O 0 1.7798161555671044e-10
leading O 0 6.987697226401579e-11
to O 0 8.392416102342981e-12
premature O 0 7.517240718790674e-10
truncation O 0 6.106996158772304e-11
of O 0 3.3156278016113067e-14
the O 0 6.991552925798492e-14
protein O 0 5.06064738725609e-11
( O 0 5.810396868505263e-12
nonsense O 0 9.526570643458854e-09
, O 0 4.538797180979326e-13
splicing O 0 1.9727014466397463e-10
, O 0 6.547521314188842e-13
insertions O 0 4.377097295726884e-10
and O 0 9.005156863250985e-12
deletions O 0 8.269911977443201e-10
) O 0 1.368415580502158e-12
and O 0 2.070856073427274e-12
just O 0 4.796023994613208e-11
2 O 0 1.2644380442856928e-13
% O 0 6.148477994100121e-14
leading O 0 2.457391386732899e-13
to O 0 1.8674274501967805e-14
substitution O 0 1.098915338067219e-12
of O 0 9.729195767982975e-15
one O 0 9.969810350549113e-13
amino O 0 2.1841124828864134e-12
acid O 0 5.374596709524504e-13
by O 0 7.068136732098131e-15
another O 0 5.384367431082726e-12
( O 0 1.5279449580574145e-11
missense O 0 1.5073581494107202e-07
) O 0 1.387868292512806e-10
. O 0 5.881305442656526e-10

The O 0 9.785862224720443e-12
extraordinary O 0 1.652401653007285e-11
conservation O 0 4.1802829644013717e-13
of O 0 5.729828063568126e-15
the O 0 8.206539695845491e-14
PAX6 O 0 1.8500110332553277e-09
protein O 0 2.4293110925666106e-11
at O 0 4.2931526389455854e-12
the O 0 7.243406314203296e-14
amino O 0 2.4890416117084868e-11
acid O 0 6.996605378395415e-11
level O 0 4.520086561987657e-12
amongst O 0 4.0924368386284493e-13
vertebrates O 0 7.516893357761845e-11
predicts O 0 5.196920116468107e-10
that O 0 3.4188327082546044e-12
pathological O 0 3.1125836130740936e-07
missense O 0 2.6886375508183846e-06
mutations O 0 7.533438406426285e-08
should O 0 1.3807104071172915e-10
in O 0 1.9343819081252267e-12
fact O 0 2.5123737725646356e-12
be O 0 1.0554669117868176e-12
common O 0 1.0006201596468589e-11
even O 0 1.9021602001845217e-11
though O 0 7.417166707213152e-12
they O 0 1.0779113062200918e-12
are O 0 2.5525206405994927e-13
hardly O 0 1.4240200685300408e-10
ever O 0 7.380338007401122e-11
seen O 0 1.8642223320597395e-09
in O 0 3.6493501553991337e-09
aniridia B-Disease 1 1.0
patients O 0 1.5562871169549908e-07
. O 0 1.628355089655642e-10

This O 0 1.3289684457074014e-11
indicates O 0 3.3233447244152003e-11
that O 0 7.134563258107476e-14
there O 0 5.962370354384294e-13
is O 0 6.919304403529489e-14
a O 0 2.1043863266539953e-12
heavy O 0 6.248370709727169e-07
ascertainment O 0 4.172050296347152e-07
bias O 0 4.367444361719208e-08
in O 0 1.1772434589663039e-11
the O 0 9.848392446606263e-14
selection O 0 9.349777896350275e-13
of O 0 3.186978743516429e-14
patients O 0 4.666328087821192e-12
for O 0 3.593914716607666e-14
PAX6 O 0 4.038376300030677e-09
mutation O 0 1.1157280654927604e-10
analysis O 0 7.166434112804154e-11
and O 0 5.829134050450158e-12
that O 0 3.890184615412684e-13
the O 0 4.2229830743423236e-12
missing O 0 7.691772907492123e-08
PAX6 O 0 5.168918050912907e-06
missense O 0 5.969052381260553e-06
mutations O 0 5.041661097493488e-07
frequently O 0 2.5091990707437617e-08
may O 0 1.8995418571421396e-08
underlie O 0 1.43128096041778e-08
phenotypes O 0 1.98552285723963e-08
distinct O 0 4.292242117287515e-09
from O 0 3.6807303871455588e-09
textbook O 0 0.002314069075509906
aniridia B-Disease 1 1.0
. O 0 1.5219670856936318e-08

Here O 0 2.773020746360544e-08
we O 0 2.4659062985987745e-11
present O 0 4.708452594828771e-13
four O 0 2.89220280754246e-13
novel O 0 3.801595149788284e-11
PAX6 O 0 3.8561685755666986e-07
missense O 0 4.296544773296773e-07
mutations O 0 5.11080493481586e-08
, O 0 8.957520836183619e-11
two O 0 2.3049164573490932e-12
in O 0 1.4467698740416868e-11
association O 0 1.2369733709549635e-11
with O 0 1.62683863776103e-12
atypical O 0 8.01436272013234e-07
phenotypes O 0 5.274116006148688e-07
ectopia B-Disease 0 4.413604528963333e-06
pupillae I-Disease 0 1.9517840428306954e-06
( O 0 1.6184034667965363e-10
displaced B-Disease 0 4.695017152833714e-10
pupils I-Disease 0 9.537515666124818e-09
) O 0 3.796855885251915e-11
and O 0 3.257428105030158e-09
congenital B-Disease 1 1.0
nystagmus I-Disease 0 7.235380962811178e-06
( O 0 6.555887777093261e-11
searching B-Disease 0 3.5338953985331045e-09
gaze I-Disease 0 1.8192851669596166e-08
) O 0 1.1957087880584694e-12
, O 0 9.989663176529495e-13
and O 0 2.7946683595764243e-12
two O 0 1.3534432906012195e-12
in O 0 5.149791357239586e-11
association O 0 3.870381879572671e-12
with O 0 9.975416895508307e-14
more O 0 3.0716791957208223e-12
recognizable O 0 6.45598134951797e-08
aniridia B-Disease 1 0.9999998807907104
phenotypes O 0 2.3490198941544804e-07
. O 0 1.2469759669286873e-09

Strikingly O 0 7.454277692886535e-06
, O 0 1.4931117453542697e-10
all O 0 4.9878509525772e-13
four O 0 2.3358645204717143e-13
mutations O 0 3.860251961834704e-12
are O 0 1.9456804196222796e-14
located O 0 7.567695385277129e-13
within O 0 3.650616863925399e-13
the O 0 2.7500187457091263e-12
PAX6 O 0 2.6698467436858664e-08
paired O 0 5.052191998089484e-10
domain O 0 1.9544772744684025e-10
and O 0 6.078846193774412e-12
affect O 0 1.7948902780728915e-11
amino O 0 2.1770170301887992e-12
acids O 0 7.032481693335091e-13
which O 0 1.1962322747486633e-14
are O 0 1.1944720555809741e-14
highly O 0 2.242928201024244e-13
conserved O 0 3.684713124896266e-13
in O 0 4.776567596315173e-12
all O 0 8.216485217898972e-14
known O 0 9.896602851458547e-13
paired O 0 5.323051721628502e-11
domain O 0 2.4184662605897245e-10
proteins O 0 3.6445346740521245e-10
. O 0 2.1686807905041405e-10

Our O 0 1.432150648073005e-10
results O 0 9.5118305593056e-12
support O 0 9.309627992549335e-14
the O 0 6.372295269577166e-14
hypothesis O 0 1.224813870118191e-12
that O 0 3.15821757038582e-14
the O 0 2.0676767115428325e-14
under O 0 9.58633671575837e-13
- O 0 8.455496719461664e-12
representation O 0 9.443134208614312e-13
of O 0 3.1804585549390085e-13
missense O 0 1.4200987834556145e-06
mutations O 0 4.175631929115298e-08
is O 0 8.7898100256667e-12
caused O 0 1.1860581093647848e-11
by O 0 7.558347936247045e-13
ascertainment O 0 3.191514252876004e-08
bias O 0 1.0590363253015767e-08
and O 0 3.586023188464904e-12
suggest O 0 1.3426399748939222e-11
that O 0 6.862498985954826e-14
a O 0 4.500264364718648e-13
substantial O 0 9.485619928417677e-11
burden O 0 3.732580466930813e-09
of O 0 4.513924227889793e-13
PAX6 B-Disease 0 5.4707154049538076e-05
- I-Disease 0 2.2281170458882116e-05
related I-Disease 0 1.7224754628841765e-05
disease I-Disease 0 0.1654115468263626
remains O 0 7.684792535656015e-08
to O 0 1.4024439162069191e-12
be O 0 1.1845817729505548e-11
uncovered O 0 7.099802523669041e-09
. O 0 2.756914271526134e-12
. O 0 2.6773694372650425e-11

The O 0 7.915228888988324e-11
chromosomal O 0 5.0017728625562086e-08
order O 0 7.56426518644382e-12
of O 0 1.99253631714795e-13
genes O 0 2.919526287392671e-10
controlling O 0 2.7145907743886255e-09
the O 0 3.649045475506707e-12
major O 0 2.210478848574393e-11
histocompatibility O 0 1.6615973041922416e-09
complex O 0 1.8792940814638115e-10
, O 0 6.802040267844811e-12
properdin O 0 2.356157047245233e-09
factor O 0 1.4962248107153187e-10
B O 0 4.553601584689204e-08
, O 0 9.528736306940733e-12
and O 0 3.053843400380174e-09
deficiency B-Disease 0 1.979317630684818e-06
of I-Disease 0 1.9683676888947177e-14
the I-Disease 0 5.546093640763916e-13
second I-Disease 0 3.551027180637156e-11
component I-Disease 0 7.44824549259171e-11
of I-Disease 0 2.387402341791356e-13
complement I-Disease 0 4.63491384161685e-10
. O 0 4.827404587182116e-10

The O 0 8.121743728939368e-12
relationship O 0 4.94753994717545e-11
of O 0 7.918565434437974e-15
the O 0 2.9966775453227e-14
genes O 0 1.270187427460101e-11
coding O 0 3.563044026488882e-10
for O 0 1.6849199715573276e-13
HLA O 0 2.0320053972788799e-10
to O 0 5.774462125910512e-14
those O 0 9.013894909344969e-14
coding O 0 4.7471786918107384e-11
for O 0 1.0269573142178065e-14
properdin O 0 1.4773611500817907e-10
Factor O 0 3.85875749756015e-12
B O 0 9.201904793698645e-10
allotypes O 0 1.7831904008946964e-10
and O 0 1.4143873789188022e-12
for O 0 2.8558769932240935e-12
deficiency B-Disease 0 4.333638514708582e-08
of I-Disease 0 1.9208488017405725e-15
the I-Disease 0 4.240744650514834e-14
second I-Disease 0 3.423400452007286e-12
component I-Disease 0 8.858209304962728e-12
of I-Disease 0 1.814050991399193e-14
complement I-Disease 0 2.470383099473228e-11
( O 0 9.633080791382476e-12
C2 O 0 7.126023660042335e-10
) O 0 9.395322654636232e-14
was O 0 3.310665977473981e-11
studied O 0 9.294986308416853e-11
in O 0 9.359483674198366e-13
families O 0 2.2717317935648518e-13
of O 0 2.3814707394683235e-14
patients O 0 1.9415842544834305e-10
with O 0 4.961059341113128e-12
connective O 0 0.3117524981498718
tissue O 1 0.9996219873428345
disorders O 1 0.9890930652618408
. O 0 5.120214807696755e-10

Patients O 0 2.986778417835012e-05
were O 0 4.421634239304417e-11
selected O 0 4.108211438137027e-13
because O 0 2.784127095534217e-13
they O 0 3.299051299070904e-13
were O 0 1.7656977225818937e-12
heterozygous O 0 2.2058892212850623e-10
or O 0 8.120133905553661e-12
homozygous O 0 5.343119013900832e-08
for O 0 3.6687332283236174e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.8303698556820791e-09

12 O 0 1.0647378090311577e-08
families O 0 3.635888812247856e-11
with O 0 5.736373290439467e-13
15 O 0 5.450892341662961e-12
matings O 0 2.9097225962004813e-08
informative O 0 3.109311137450277e-07
for O 0 4.307005951886822e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.503522722989814e-10
found O 0 1.252405124052558e-10
. O 0 1.160135442573873e-11

Of O 0 3.933838671477119e-11
57 O 0 1.4720851204685914e-09
informative O 0 2.7946349678842353e-09
meioses O 0 4.6036671363935966e-08
, O 0 6.022157056882749e-13
two O 0 1.4128597651628244e-14
crossovers O 0 1.0030259608995173e-11
were O 0 1.107143565194646e-12
noted O 0 1.4089592123220362e-12
between O 0 1.399755528500024e-12
the O 0 3.94448349538834e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
gene O 0 6.420079051716598e-11
and O 0 5.654962175610789e-13
the O 0 3.365325867369512e-13
HLA O 0 6.976650368528681e-09
- O 0 2.4885063454327394e-10
B O 0 5.531733959784901e-10
gene O 0 4.260655023236026e-11
, O 0 2.1183915895322397e-13
with O 0 4.89756144168331e-15
a O 0 1.908627336039137e-13
recombinant O 0 2.2936500788939274e-12
fraction O 0 1.0222062779563501e-11
of O 0 1.1534076645169922e-12
0 O 0 1.3364015449823796e-10
. O 0 1.4851306295859956e-10

035 O 0 0.0017096919473260641
. O 0 1.8369570398135693e-07

A O 0 3.1395604338513294e-08
lod O 0 2.165431851608446e-06
score O 0 2.508784846533274e-10
of O 0 1.871671898414154e-13
13 O 0 3.902277806444587e-12
was O 0 3.841866495074564e-12
calculated O 0 1.3780700755874897e-12
for O 0 8.869324003533963e-14
linkage O 0 1.8283738256741344e-07
between O 0 4.158130832365714e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.6098269378938e-11
HLA O 0 7.315986483291681e-09
- O 0 1.4397454062287096e-10
B O 0 5.193214192011908e-10
at O 0 5.400946074922419e-13
a O 0 6.077703986785699e-14
maximum O 0 6.362336872622887e-14
likelihood O 0 2.0186172069829034e-13
value O 0 4.985765354173152e-14
of O 0 7.486426059528657e-16
the O 0 1.0707833071285124e-14
recombinant O 0 5.127185568470916e-13
fraction O 0 3.574618899493398e-12
of O 0 8.61318882969947e-13
0 O 0 1.1473857974841906e-10
. O 0 8.969608389364225e-11

04 O 0 0.00010814470442710444
. O 0 3.125608571963312e-08

18 O 0 2.970566015392251e-08
families O 0 3.100641618458688e-11
with O 0 9.347050043684302e-13
21 O 0 1.6663465746136197e-11
informative O 0 2.55342053057106e-10
matings O 0 2.3099637758150493e-09
for O 0 1.6515745205909066e-13
both O 0 8.389562915905868e-13
properdin O 0 5.186743035068275e-09
Factor O 0 5.184532317348278e-11
B O 0 7.064087981234479e-09
allotype O 0 3.288334493589673e-09
and O 0 2.5060863106940445e-11
HLA O 0 4.48296191279951e-08
- O 0 1.0480121215294957e-09
B O 0 2.9606541662730024e-09
were O 0 2.5223717212141672e-11
found O 0 3.897243985861998e-11
. O 0 1.6914969425130266e-11

Of O 0 6.824798365334672e-11
72 O 0 1.3918534103041225e-09
informative O 0 2.4682380583840313e-09
meioses O 0 4.972769573896585e-08
, O 0 7.666999630659421e-13
three O 0 5.723769575709595e-14
recombinants O 0 1.5902126837552544e-10
were O 0 1.5868812340558147e-12
found O 0 1.1252072407499925e-12
, O 0 1.15038331305003e-14
giving O 0 2.264492948353663e-14
a O 0 5.4737037656366755e-14
recombinant O 0 2.6031590077968403e-12
fraction O 0 1.735041277317606e-11
of O 0 2.331681289019505e-12
0 O 0 3.266198422835487e-10
. O 0 2.8090196835250936e-10

042 O 0 7.184430432971567e-05
. O 0 3.079469834688098e-08

A O 0 3.7230261540344145e-08
lod O 0 5.074054115539184e-06
score O 0 3.616138499751287e-10
of O 0 8.043269013064541e-14
16 O 0 2.955515389715946e-12
between O 0 3.0027566804563532e-12
HLA O 0 3.093256850661419e-08
- O 0 7.087324616072976e-10
B O 0 1.8568905302274175e-09
and O 0 6.230349894852105e-13
Factor O 0 2.9212277128515263e-12
B O 0 8.016635133500927e-10
allotypes O 0 1.8943081825373298e-10
was O 0 7.479305369484379e-12
calculated O 0 4.1872814894247656e-13
at O 0 2.848368242658328e-13
a O 0 1.8403212100385168e-14
maximum O 0 3.219322188387566e-14
likelihood O 0 1.860502854209023e-13
value O 0 5.4576077679465915e-14
of O 0 5.532666745534584e-16
the O 0 9.830107885187064e-15
recombinant O 0 4.4703216822705727e-13
fraction O 0 2.6305457378333896e-12
of O 0 8.83343582742252e-13
0 O 0 1.311823566441106e-10
. O 0 1.348551409430243e-10

04 O 0 0.00016213266644626856
. O 0 4.1475246348454675e-08

A O 0 5.874813968631543e-10
crossover O 0 1.818752509707977e-10
was O 0 1.7009837982584486e-10
shown O 0 5.43446689559024e-13
to O 0 7.064096893159497e-14
have O 0 3.2809790041082865e-13
occurred O 0 1.557432351487198e-12
between O 0 1.2658659216061973e-14
genes O 0 6.189403915606018e-13
for O 0 7.45166986248309e-15
Factor O 0 4.252369940546674e-13
B O 0 1.0460605298634462e-10
and O 0 1.6092014873403393e-12
HLA O 0 8.346167312822672e-09
- O 0 4.892513616461258e-10
D O 0 1.3285692546105565e-09
, O 0 2.4620735138147776e-13
in O 0 5.103573813558526e-13
which O 0 5.1360851335835456e-12
HLA O 0 2.432388690465359e-08
- O 0 4.848462187290181e-10
D O 0 2.590379244438168e-09
segregared O 0 2.969493761995068e-09
with O 0 2.1997022259245824e-12
HLA O 0 2.2356218210006773e-08
- O 0 2.5862262331699526e-10
A O 0 2.4348512095428987e-10
and O 0 1.6497855859221033e-10
B O 0 1.911929636833065e-08
. O 0 2.405840457408992e-11

These O 0 3.8552928210977555e-12
studies O 0 6.27367602312745e-12
suggest O 0 1.6262181488577165e-12
that O 0 1.0322399198966527e-14
the O 0 4.959074244862338e-15
genes O 0 1.653359307102198e-12
for O 0 5.2566048166840726e-14
Factor O 0 1.1243502656688165e-10
B O 0 0.07321158051490784
and O 1 0.5047261118888855
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.1490550806854405e-13
located O 0 1.6187653431240512e-13
outside O 0 4.2953208806602305e-13
those O 0 6.50132481487195e-14
for O 0 7.741659554085303e-14
HLA O 0 2.942839305575262e-10
, O 0 1.5829256850598272e-14
that O 0 5.002108177264066e-15
the O 0 1.272367831212616e-14
order O 0 2.499128833564901e-13
of O 0 1.4887295226879288e-14
genese O 0 3.42541728315382e-09
is O 0 1.916182490457885e-12
HLA O 0 1.0209114664760932e-09
- O 0 1.0249590239042039e-11
A O 0 1.857788575754249e-11
, O 0 7.714762531065011e-13
- O 0 4.082578719533103e-11
B O 0 4.851570811759132e-10
, O 0 6.545785506510693e-13
- O 0 9.94478874249971e-11
D O 0 2.3632851231525365e-10
, O 0 1.483927726791262e-13
Factor O 0 4.2311423462115805e-12
B O 0 6.990930501160619e-09
allotype O 0 2.3329856446707709e-07
, O 0 7.065740419420763e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.696415902717463e-13
that O 0 3.2061336312889325e-15
the O 0 7.871972693108357e-15
genes O 0 2.174396496190667e-10
coding O 0 5.505792444182589e-08
for O 0 3.833461992286402e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.856339734707113e-11
Factor O 0 5.056836199779369e-11
B O 0 2.3668830451128997e-08
allotypes O 0 1.9095052206097307e-09
are O 0 2.6742689551544074e-13
approximately O 0 2.3852176744137976e-13
3 O 0 9.359609441650374e-13
- O 0 2.481359284711715e-10
- O 0 6.0919680411331e-10
5 O 0 1.9573778362036443e-12
centimorgans O 0 3.3186337011770206e-10
from O 0 1.4996052902054025e-13
the O 0 2.7602380559162143e-13
HLA O 0 7.72301889107041e-10
- O 0 3.013520422784355e-12
A O 0 3.670146651868489e-12
and O 0 3.692721042142244e-12
HLA O 0 2.9540379031800512e-09
- O 0 3.231465095510089e-11
B O 0 2.375875537974359e-11
loci O 0 7.994894351583126e-13
, O 0 5.627457863848634e-14
and O 0 1.5288841359920556e-14
that O 0 5.5745952999401455e-15
the O 0 1.971234387201405e-14
apparent O 0 1.7683307942939486e-11
lack O 0 1.0024463897861935e-11
of O 0 9.583731411819205e-15
recombinants O 0 4.692490146451789e-11
between O 0 2.7766007673407297e-14
the O 0 5.392532937114475e-14
Factor O 0 4.914347141032893e-12
B O 0 3.6466851760508234e-09
gene O 0 1.3135128540398e-07
and O 0 0.005355118773877621
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.727032099083317e-10
suggests O 0 2.8494689247038352e-11
that O 0 5.0595778380759654e-14
these O 0 2.7702261667862833e-14
two O 0 1.2956806851385783e-13
genes O 0 4.823895796701727e-11
lie O 0 1.9292398234505015e-10
in O 0 3.344135515379043e-12
close O 0 4.4576144858643474e-11
proximity O 0 4.162219180425808e-11
to O 0 4.14154231742625e-11
one O 0 1.3154063949194494e-10
another O 0 4.3302050833915473e-10
. O 0 3.7427155819003133e-10

Distribution O 0 2.1073245926039874e-10
of O 0 2.3209615652997062e-12
emerin O 0 1.1878262284881203e-07
and O 0 4.0121610894727766e-11
lamins O 0 1.1888597839515569e-07
in O 0 1.622192519201704e-10
the O 0 1.0884316885284573e-11
heart O 0 3.377224189193839e-08
and O 0 2.2606427146909525e-11
implications O 0 1.0292007524004276e-10
for O 0 7.955015118854547e-12
Emery B-Disease 1 0.9912689924240112
- I-Disease 1 0.7490414977073669
Dreifuss I-Disease 0 0.001536718918941915
muscular I-Disease 0 0.008531348779797554
dystrophy I-Disease 0 0.03003528155386448
. O 0 7.110223965156592e-09

Emerin O 0 1.3718473383050878e-05
is O 0 6.313664868695668e-11
a O 0 3.010952164678171e-12
nuclear O 0 1.6360034854612238e-11
membrane O 0 2.2881981032174536e-11
protein O 0 4.618964585811902e-11
which O 0 4.1557181957793676e-13
is O 0 8.383660519278857e-13
missing O 0 5.031717820180859e-10
or O 0 1.0027873670326315e-10
defective O 0 3.3320011993964727e-07
in O 0 2.1466808330927734e-09
Emery B-Disease 1 0.9999985694885254
- I-Disease 1 0.9995470643043518
Dreifuss I-Disease 0 0.006420177407562733
muscular I-Disease 0 0.18936428427696228
dystrophy I-Disease 1 0.9992326498031616
( O 0 1.2132304938461402e-08
EDMD B-Disease 1 1.0
) O 0 7.043284844243658e-10
. O 0 4.1101141934341e-10

It O 0 9.60692081442005e-11
is O 0 1.9116997481555265e-12
one O 0 2.5739832357554726e-13
member O 0 3.8072149599610583e-13
of O 0 1.422534914299542e-14
a O 0 7.720290379209516e-11
family O 0 5.920029050310305e-11
of O 0 4.3637863504988883e-13
lamina O 0 6.738710034426276e-09
- O 0 5.917492051921158e-10
associated O 0 4.2033057590096234e-11
proteins O 0 5.279952690340206e-12
which O 0 4.3932663496698554e-13
includes O 0 6.737861137084966e-13
LAP1 O 0 5.000294223123092e-08
, O 0 8.969398140878937e-12
LAP2 O 0 1.4265202707974822e-07
and O 0 7.00497784777987e-11
lamin O 0 1.1086059430454043e-06
B O 0 2.863207626546682e-08
receptor O 0 6.642716376958901e-10
( O 0 8.209213864240894e-11
LBR O 0 9.144470141109196e-07
) O 0 1.2181100572661308e-10
. O 0 6.459953683091157e-10

A O 0 1.386087120636148e-07
panel O 0 2.101978591184661e-09
of O 0 2.6720203198486725e-13
16 O 0 3.2851449425358448e-12
monoclonal O 0 1.7629434023724855e-10
antibodies O 0 8.128013262442835e-10
( O 0 2.353783140618404e-11
mAbs O 0 1.2287726391946308e-09
) O 0 2.8971013955880753e-12
has O 0 2.0867717276384923e-12
been O 0 2.5714623572842266e-12
mapped O 0 1.0950264132947307e-11
to O 0 2.064422851416614e-13
six O 0 1.069240927894198e-13
specific O 0 4.318572494104106e-15
sites O 0 2.446625259160118e-13
throughout O 0 4.302503720052947e-13
the O 0 4.575390088502884e-13
emerin O 0 3.630776235219457e-10
molecule O 0 3.351024969663885e-12
using O 0 5.251028778463507e-12
phage O 0 3.2968675012234883e-10
- O 0 3.822957922450243e-11
displayed O 0 1.6176365802422765e-12
peptide O 0 4.1256123409043333e-13
libraries O 0 1.2573489341707877e-12
and O 0 3.29466217762614e-13
has O 0 4.09488659343718e-14
been O 0 2.9028401861072584e-14
used O 0 1.2655020531927158e-13
to O 0 3.6712996466688186e-13
localize O 0 5.654563928203515e-09
emerin O 0 4.491888816460232e-08
in O 0 1.3031618319170324e-11
human O 0 6.816624955469086e-12
and O 0 2.8324068090945786e-10
rabbit O 0 7.606665349157993e-06
heart O 0 8.34100956126349e-06
. O 0 1.3087303463166222e-09

Several O 0 5.501199495938636e-10
mAbs O 0 9.156462965620449e-08
against O 0 9.69838098718867e-12
different O 0 1.96275005796831e-12
emerin O 0 4.06718614343049e-09
epitopes O 0 1.581028641339799e-09
did O 0 3.7951636278066303e-10
not O 0 1.5465861013738702e-12
recognize O 0 9.467539599516961e-12
intercalated O 0 2.690352662870765e-10
discs O 0 8.468583168053101e-09
in O 0 1.5544268996969812e-11
the O 0 1.438953340163196e-12
heart O 0 1.0993201904341277e-08
, O 0 1.1179765880414694e-12
though O 0 1.1026632081370669e-12
they O 0 2.2857619117779004e-13
recognized O 0 9.550128700006044e-13
cardiomyocyte O 0 1.1553074052983447e-09
nuclei O 0 1.368865350931392e-11
strongly O 0 2.061450316004354e-11
, O 0 1.0541110085499072e-12
both O 0 2.925329791771125e-13
at O 0 3.757577582419458e-11
the O 0 9.897264214783763e-13
rim O 0 3.085259381307992e-09
and O 0 1.706843416604542e-10
in O 0 3.237296264391176e-10
intranuclear O 0 9.739031270328269e-08
spots O 0 4.171108347605923e-09
or O 0 5.061817631712984e-10
channels O 0 7.76925617174129e-08
. O 0 1.5697037003548076e-09

A O 0 1.842715136035622e-08
polyclonal O 0 5.057876251157722e-07
rabbit O 0 8.798580779512122e-07
antiserum O 0 1.3094729922613624e-07
against O 0 1.59088311968425e-10
emerin O 0 6.130579066621067e-08
did O 0 4.5887051103310483e-11
recognize O 0 4.2884689939806653e-13
both O 0 2.9646136213241567e-14
nuclear O 0 1.3948842948752205e-11
membrane O 0 4.338395614977841e-11
and O 0 2.5166613584759467e-12
intercalated O 0 3.0314740301351506e-11
discs O 0 6.689875875487417e-10
but O 0 1.1992490334122863e-12
, O 0 6.152087963818024e-15
after O 0 9.017517838666965e-15
affinity O 0 1.2055185679999553e-13
purification O 0 2.703254558134721e-13
against O 0 1.423683762026562e-13
a O 0 9.008072066052364e-13
pure O 0 1.4136120052299361e-10
- O 0 1.563402065585251e-07
emerin O 0 3.4471469234631513e-07
band O 0 2.420122713342465e-10
on O 0 5.855275899552259e-12
a O 0 1.382187116497069e-12
western O 0 2.999678630488667e-11
blot O 0 1.8960301531478763e-05
, O 0 1.55042437222086e-10
it O 0 1.4330652983729486e-11
stained O 0 1.1523499097165768e-06
only O 0 1.0979899281449157e-11
the O 0 2.0335890089928643e-12
nuclear O 0 6.035010269300756e-10
membrane O 0 3.222303979200092e-09
. O 0 4.2250339338245624e-10

These O 0 8.143040929053935e-12
results O 0 9.542286232011588e-12
would O 0 3.046913578646365e-13
not O 0 1.3742423811326926e-13
be O 0 2.262184444759216e-13
expected O 0 4.523605448558676e-12
if O 0 1.935930934874111e-13
immunostaining O 0 1.4965073624750858e-10
at O 0 2.9593625727047934e-12
intercalated O 0 1.8989448902217987e-11
discs O 0 7.365393295266642e-10
were O 0 8.572973060616551e-12
due O 0 5.744497217317901e-13
to O 0 9.4984191004047e-15
a O 0 1.2122328965288864e-13
product O 0 1.0496269652049417e-12
of O 0 2.4015213645825484e-15
the O 0 1.4111368323854734e-13
emerin O 0 5.4521770431748e-10
gene O 0 7.044947264445156e-11
and O 0 2.340880093931741e-11
, O 0 3.8894354317114965e-13
therefore O 0 3.802947269159612e-13
, O 0 9.352002001581858e-14
cast O 0 7.581193485484139e-12
some O 0 2.339905613019111e-12
doubt O 0 1.2803693869023469e-11
upon O 0 7.240861149603386e-15
the O 0 1.1946907594879552e-14
hypothesis O 0 7.174280700766866e-12
that O 0 1.7437400481878917e-11
cardiac B-Disease 0 0.014909268356859684
defects I-Disease 0 0.2360576093196869
in O 0 2.2158042067843553e-09
EDMD B-Disease 1 1.0
are O 0 9.896159586242348e-11
caused O 0 6.985058365049923e-11
by O 0 7.688394734230164e-13
absence O 0 3.929423453286063e-10
of O 0 5.458932459713461e-13
emerin O 0 2.82693175535087e-08
from O 0 3.1347147100291295e-11
intercalated O 0 1.4924498970003697e-08
discs O 0 1.1892084330611397e-06
. O 0 8.675492546572627e-10

Although O 0 7.795700196489008e-10
emerin O 0 5.957986459748099e-08
was O 0 1.1152218037935313e-10
abundant O 0 9.98240661138905e-13
in O 0 7.515021591131266e-13
the O 0 8.57859044759747e-14
membranes O 0 3.783712579363829e-11
of O 0 3.731446101000631e-14
cardiomyocyte O 0 1.3186074454552e-09
nuclei O 0 8.265392710538055e-12
, O 0 3.69292530583154e-12
it O 0 2.1966792534272583e-12
was O 0 3.9916021599140095e-09
absent O 0 2.7241367148156392e-11
from O 0 1.4817387226050138e-13
many O 0 7.623163032896216e-14
non O 0 1.3738435389321069e-10
- O 0 5.72236147355909e-10
myocyte O 0 3.0844372389537966e-08
cells O 0 1.1827587798052264e-09
in O 0 6.875571639808342e-11
the O 0 1.2456957340645225e-11
heart O 0 5.0158451614379373e-08
. O 0 5.206782227595852e-10

This O 0 2.4003620271995096e-12
distribution O 0 1.5285999462738564e-12
of O 0 1.3695794986393756e-13
emerin O 0 6.079864167674032e-09
was O 0 3.396670097965959e-11
similar O 0 1.3021444274403937e-13
to O 0 3.024625566823945e-14
that O 0 6.096814405328471e-14
of O 0 1.8001845538328717e-14
lamin O 0 4.762855887463502e-09
A O 0 1.5924185581273065e-11
, O 0 1.3605758772232412e-13
a O 0 3.376938485788461e-13
candidate O 0 4.198840060365416e-12
gene O 0 8.677660257028208e-10
for O 0 4.2826679702567816e-12
an O 0 4.363705143756169e-12
autosomal O 0 2.624627768454957e-07
form O 0 2.395682940914412e-08
of O 0 7.57266338524687e-09
EDMD B-Disease 1 1.0
. O 0 8.868264345096577e-09

In O 0 6.017665254987037e-10
contrast O 0 6.503247385047928e-10
, O 0 1.0651633047809028e-10
lamin O 0 5.514812073670328e-06
B1 O 0 6.441697223635856e-06
was O 0 2.7441687810991766e-10
absent O 0 4.8524930601479e-11
from O 0 3.1515998036128756e-13
cardiomyocyte O 0 2.0737633832368374e-10
nuclei O 0 7.787399197711764e-12
, O 0 1.824260008461906e-13
showing O 0 2.731790661736344e-11
that O 0 3.5118440273873563e-12
lamin O 0 1.2624672081074095e-06
B1 O 0 2.956085332073144e-08
is O 0 3.081434711343575e-14
not O 0 9.610346034054883e-15
essential O 0 1.8678202701963992e-13
for O 0 3.60024535615215e-15
localization O 0 1.2935336829444921e-11
of O 0 4.4828515696087624e-15
emerin O 0 3.206312992887206e-10
to O 0 4.231107922792604e-13
the O 0 4.3428060626793386e-12
nuclear O 0 1.1612131700644568e-08
lamina O 0 3.090125488824924e-08
. O 0 1.764739882004207e-10

Lamin O 0 0.36543869972229004
B1 O 0 0.4515751004219055
is O 0 5.037028016907641e-10
also O 0 1.3342409642402853e-11
almost O 0 1.437050565350484e-11
completely O 0 4.5146997251777066e-09
absent O 0 6.421836840075912e-09
from O 0 6.248802864039504e-11
skeletal O 0 1.7017080153891584e-06
muscle O 0 3.640863255327531e-08
nuclei O 0 1.1528249466152829e-08
. O 0 1.0179559417622386e-09

In O 0 3.5068712378460987e-08
EDMD B-Disease 1 1.0
, O 0 5.6406598142322295e-12
the O 0 4.543853018997533e-14
additional O 0 3.5429184542731806e-13
absence O 0 1.6762669377556882e-11
of O 0 4.1598734006054183e-13
lamin O 0 3.5301357002026634e-06
B1 O 0 3.916218531685445e-07
from O 0 8.780125064500321e-12
heart O 0 3.970600559455306e-08
and O 0 9.885237073348208e-11
skeletal O 0 1.7460495200793957e-06
muscle O 0 8.039025445327752e-09
nuclei O 0 3.282471863763625e-11
which O 0 2.4431524511814295e-12
already O 0 7.363914339419964e-11
lack O 0 2.7611361114177058e-11
emerin O 0 5.265139790822104e-08
may O 0 8.302290799289125e-11
offer O 0 1.1072449380977734e-12
an O 0 2.2175740993393527e-14
alternative O 0 5.652754739987609e-12
explanation O 0 4.798137928641033e-11
of O 0 6.46843621959596e-14
why O 0 2.2609230460046703e-11
these O 0 4.335783441262661e-14
tissues O 0 5.277103407030914e-12
are O 0 9.981811655446898e-14
particularly O 0 1.4539180623329706e-11
affected O 0 2.2102639163357196e-11
. O 0 1.3737347847805892e-12
. O 0 2.348204963809053e-11

Genetic O 0 8.989488264887768e-08
mapping O 0 4.866327341090937e-09
of O 0 9.27498312527919e-13
the O 0 2.0337906705969466e-12
copper B-Disease 0 7.844795391065418e-08
toxicosis I-Disease 0 8.365693702216959e-07
locus O 0 1.599720356182388e-09
in O 0 5.840313788141316e-10
Bedlington O 0 2.1179108443902805e-05
terriers O 0 2.245499445052701e-06
to O 0 2.265529083778084e-11
dog O 0 1.8505485144260092e-08
chromosome O 0 7.411468061491178e-08
10 O 0 5.4022487872007474e-11
, O 0 2.0032261439928423e-12
in O 0 4.1702509501195806e-12
a O 0 3.019689706618145e-11
region O 0 1.4560562755505657e-09
syntenic O 0 9.22465005714912e-07
to O 0 2.946307477505461e-12
human O 0 1.6154853496597177e-11
chromosome O 0 7.153634129508646e-08
region O 0 1.2856180120479621e-08
2p13 O 0 4.473029093787773e-06
- O 0 1.8570442250620545e-07
p16 O 0 8.748596087571059e-07
. O 0 2.1551238571504427e-09

Abnormal O 1 0.999320387840271
hepatic B-Disease 1 0.9789776802062988
copper I-Disease 0 2.3724893253529444e-05
accumulation I-Disease 0 1.1444597491916397e-09
is O 0 7.3872562255696e-14
recognized O 0 7.74762673179212e-14
as O 0 5.143741769325638e-12
an O 0 1.8940841950421117e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.2991847597731976e-09
man O 0 1.9978048726443376e-07
, O 0 5.938754696344084e-12
mouse O 0 3.4592453346249386e-08
, O 0 9.592638489097638e-11
rat O 0 1.5648714679628029e-06
and O 0 6.857514556202204e-10
dog O 0 4.108636403543642e-06
. O 0 2.346921990081796e-09

The O 0 1.075166518316184e-11
major O 0 8.808304780005827e-12
cause O 0 7.309535615673823e-11
of O 0 2.4331352904694015e-12
hepatic B-Disease 0 0.00019313840311951935
copper I-Disease 0 2.3714284907327965e-05
accumulation I-Disease 0 3.1482234597035585e-09
in O 0 8.165581405483735e-11
man O 0 2.419806932607571e-08
is O 0 4.864693175198054e-13
a O 0 1.497634481706367e-11
dysfunctional O 0 7.721582306885466e-08
ATP7B O 0 1.328507011066904e-07
gene O 0 3.074745080766661e-08
, O 0 1.9635719439303756e-10
causing O 0 1.516987957472793e-08
Wilson B-Disease 0 1.1671061201923294e-06
disease I-Disease 0 0.000478007597848773
( O 0 3.132548220818876e-09
WD B-Disease 0 0.11350514739751816
) O 0 9.655531929553263e-10
. O 0 1.7376461380891328e-09

Mutations O 0 7.731176054903699e-08
in O 0 7.867905632563676e-11
the O 0 4.652364105940665e-13
ATP7B O 0 2.5030888473054347e-09
genes O 0 4.4074719568465426e-11
have O 0 3.234367634830093e-12
also O 0 2.7266760355658393e-13
been O 0 8.11986599919684e-13
demonstrated O 0 3.8545425531943955e-12
in O 0 1.4765265399230287e-11
mouse O 0 6.865805346478737e-08
and O 0 7.22628235028111e-10
rat O 0 4.835786739931791e-07
. O 0 3.4671882032100143e-10

The O 0 1.2028902873773006e-10
ATP7B O 0 7.67682308833173e-08
gene O 0 2.684935607177863e-09
has O 0 1.6079537007440692e-11
been O 0 2.0849773730430288e-12
excluded O 0 1.672811195119195e-11
in O 0 7.018103004123588e-13
the O 0 7.43407004249845e-14
much O 0 9.89145571006489e-12
rarer O 0 5.856803930726073e-09
human O 0 3.4778018138947875e-12
copper B-Disease 0 3.0307043630273256e-07
overload I-Disease 0 2.3732305010071286e-07
disease O 0 1.655003245559783e-08
non B-Disease 0 3.925560321249577e-09
- I-Disease 0 1.0646525439028665e-08
Indian I-Disease 0 1.4552371530029973e-09
childhood I-Disease 0 2.112537913490087e-06
cirrhosis I-Disease 0 3.145319624309195e-06
, O 0 6.1495630636343446e-12
indicating O 0 8.466091161452027e-10
genetic O 0 1.0904240177467273e-08
heterogeneity O 0 1.5029685584977415e-07
. O 0 4.1968126751612544e-09

By O 0 3.7466994784463026e-11
investigating O 0 5.414031445383216e-10
the O 0 6.888865346221795e-12
common O 0 7.504380228340324e-09
autosomal O 0 0.013823015615344048
recessive O 0 0.3190512955188751
copper B-Disease 0 6.215734174475074e-05
toxicosis I-Disease 0 7.170822937041521e-05
( O 0 7.438425431161022e-10
CT B-Disease 1 0.9987760186195374
) O 0 3.13705936227926e-11
in O 0 7.252430600512838e-11
Bedlington O 0 0.00014460887177847326
terriers O 0 4.645861918106675e-05
, O 0 5.753667507713001e-12
we O 0 2.841704465055689e-13
have O 0 1.6964021807837175e-14
identified O 0 1.8195904852302824e-12
a O 0 3.6698923522489324e-13
new O 0 1.104740973180418e-12
locus O 0 9.170660064672376e-11
involved O 0 2.1565702001957732e-10
in O 0 2.34242900631898e-08
progressive O 0 0.16115711629390717
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.753371918297944e-09

We O 0 5.369461542059639e-10
examined O 0 4.1098396907912615e-10
whether O 0 1.3578752922419057e-12
the O 0 1.4754701366942458e-12
WD B-Disease 0 2.628290076245321e-06
gene O 0 6.950885733658652e-08
ATP7B O 0 5.53232666788972e-06
was O 0 1.0799791061444353e-09
also O 0 1.982291067403885e-12
causative O 0 3.4506816848356436e-10
for O 0 1.270345997448838e-13
CT B-Disease 0 9.009654604597017e-06
by O 0 1.03649066326289e-12
investigating O 0 7.321507289326235e-11
the O 0 6.27063396867189e-13
chromosomal O 0 5.589339480138733e-08
co O 0 1.0303370601150164e-08
- O 0 1.877851207865433e-09
localization O 0 1.8425666548083086e-09
of O 0 3.009130759238504e-13
ATP7B O 0 1.8766096232525342e-08
and O 0 1.7975034438330595e-12
C04107 O 0 7.887995118194269e-11
, O 0 4.604101456096195e-14
using O 0 8.255431928338997e-13
fluorescence O 0 4.9459641243698726e-11
in O 0 1.1301073792047145e-11
situ O 0 2.216707511992766e-10
hybridization O 0 4.1635611625068236e-11
( O 0 1.1535710754684292e-11
FISH O 0 7.949001457063787e-10
) O 0 6.060727874429572e-12
. O 0 3.367255779762601e-11

C04107 O 0 1.858592440839857e-05
is O 0 2.2140624056365965e-10
an O 0 8.830639127918594e-13
anonymous O 0 7.112757050009577e-10
microsatellite O 0 3.2508008729337234e-08
marker O 0 1.577983610445699e-08
closely O 0 2.7165691918185075e-09
linked O 0 8.814422614022988e-08
to O 0 9.114931032172535e-10
CT B-Disease 1 0.9999611377716064
. O 0 5.6116409297146674e-09

However O 0 6.559759402335885e-09
, O 0 1.947674660440768e-10
BAC O 0 4.483679845179722e-07
clones O 0 6.667535856763607e-09
containing O 0 2.4217389205105633e-10
ATP7B O 0 4.730446789835696e-07
and O 0 2.943736227001281e-11
C04107 O 0 1.5386677487683187e-09
mapped O 0 2.6618710013970315e-10
to O 0 2.4133303862250433e-12
the O 0 2.8927340123968692e-12
canine O 0 2.09539479101295e-08
chromosome O 0 7.371190946514616e-08
regions O 0 3.2858327170259827e-09
CFA22q11 O 0 5.614448355117929e-07
and O 0 2.5273672044079376e-10
CFA10q26 O 0 1.333739341191631e-08
, O 0 7.02939713815437e-13
respectively O 0 9.212234924546592e-13
, O 0 2.690449893308442e-14
demonstrating O 0 3.0314937842987333e-13
that O 0 6.298356069545444e-14
WD B-Disease 0 9.054811300757137e-08
cannot O 0 9.698791769707782e-11
be O 0 1.2099949948246591e-12
homologous O 0 1.9788845909141095e-11
to O 0 2.6228014551876733e-11
CT B-Disease 1 0.9763171672821045
. O 0 1.5549117549085167e-09

The O 0 5.6213304844288103e-11
copper O 0 2.8671574003880096e-09
transport O 0 1.543425803829379e-10
genes O 0 1.5819607845912742e-09
CTR1 O 0 1.3260235220968752e-07
and O 0 1.4297780841221464e-11
CTR2 O 0 3.16637560615618e-08
were O 0 1.0760424669353785e-11
also O 0 4.950498561431815e-13
excluded O 0 2.3580417132795795e-12
as O 0 1.0009360555023397e-13
candidate O 0 3.356402883489956e-13
genes O 0 1.3242013388592433e-11
for O 0 1.2024098080057333e-12
CT B-Disease 1 0.999942421913147
since O 0 4.1648659521165143e-10
they O 0 1.4621768422776182e-12
both O 0 1.3319156704199447e-13
mapped O 0 6.64798563421165e-11
to O 0 4.757455714099468e-12
canine O 0 3.3212330663445755e-08
chromosome O 0 2.2076723382724595e-07
region O 0 4.089599059398097e-08
CFA11q22 O 0 1.097110452974448e-05
. O 0 4.6227150996003274e-09

2 O 0 3.164456359172618e-07
- O 0 8.570880709157791e-06
22 O 0 4.683856857923274e-09
. O 0 1.9947371532325064e-10

5 O 0 2.3710157392997644e-07
. O 0 4.216341942253621e-09

A O 0 3.2799218896428783e-09
transcribed O 0 2.541449495296888e-09
sequence O 0 1.5754942489509816e-11
identified O 0 3.051942032428201e-11
from O 0 1.14234427581357e-13
the O 0 7.672833044923208e-14
C04107 O 0 3.6094335853498194e-10
- O 0 2.6787230419933472e-11
containing O 0 5.5959312704467745e-12
BAC O 0 8.115504357419923e-08
was O 0 7.161924525656005e-11
found O 0 9.139237760677488e-13
to O 0 1.4650059933078198e-14
be O 0 2.1820947690908907e-14
homologous O 0 2.8480530108766777e-13
to O 0 6.998196374610396e-14
a O 0 4.084677745781057e-13
gene O 0 8.048360589096859e-11
expressed O 0 1.9244482851905886e-13
from O 0 1.4093454593459842e-13
human O 0 8.231453713092307e-13
chromosome O 0 2.2404154975674828e-08
2p13 O 0 2.3619312727873876e-08
- O 0 5.784364986993751e-09
p16 O 0 2.646372898595928e-08
, O 0 9.886834406724887e-12
a O 0 2.4276652736687776e-12
region O 0 3.3504258395433695e-11
devoid O 0 4.040608680977442e-10
of O 0 6.429505230087437e-14
any O 0 9.692610429545834e-12
positional O 0 3.6480558573970256e-09
candidate O 0 4.941035358640988e-10
genes O 0 4.8180087475202527e-08
. O 0 2.3514072911012818e-09

Molecular O 0 2.1919157600081007e-09
analysis O 0 1.1107107594776622e-10
of O 0 2.1734231168274443e-13
the O 0 6.015016501374759e-13
APC B-Disease 0 2.174803115373436e-10
gene O 0 9.115639493240124e-11
in O 0 6.497017333850774e-12
205 O 0 7.270116453295117e-11
families O 0 1.0756890170271483e-12
: O 0 2.4879284830220394e-13
extended O 0 6.069234004257851e-11
genotype O 0 1.0845418728422374e-05
- O 0 3.411529178265482e-06
phenotype O 0 4.804473405783938e-07
correlations O 0 1.919361380942064e-08
in O 0 2.407864879705457e-11
FAP B-Disease 0 1.2350832856444782e-10
and O 0 1.2453714004056343e-13
evidence O 0 1.4061340525110821e-13
for O 0 1.4122986905385632e-15
the O 0 2.8595027618005288e-15
role O 0 4.3534360144592554e-13
of O 0 1.0573679993098987e-14
APC B-Disease 0 4.279428200693047e-11
amino O 0 1.1319993553637886e-11
acid O 0 5.231806307626208e-11
changes O 0 5.555628179720884e-11
in O 0 2.3625952962902375e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.0002005091664614156
. O 0 2.849803282245489e-09

BACKGROUND O 0 2.3110100300982594e-05
/ O 0 1.6271280856017256e-07
AIMS O 0 3.3523261944168325e-10
The O 0 6.399057173901712e-13
development O 0 6.16699746824878e-11
of O 0 2.004828445478779e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.760507597127543e-11
a O 0 2.1693198452854556e-12
variable O 0 3.47890466434464e-11
range O 0 2.2335300275955206e-11
of O 0 1.7308096145543517e-12
extracolonic O 0 5.540777578971756e-07
manifestations O 0 1.813247507698179e-07
in O 0 4.324945621192455e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
( O 0 2.0180318927032204e-07
FAP B-Disease 0 1.2468986199110077e-07
) O 0 2.6957653123660386e-11
is O 0 1.0746697585647946e-12
the O 0 6.873555137608747e-14
result O 0 6.5472497215446346e-12
of O 0 3.707481506043733e-14
the O 0 2.582206367132689e-12
dominant O 0 4.7505557176918956e-07
inheritance O 0 2.5375043151143473e-06
of O 0 2.5058795927179744e-08
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999980926513672
coli I-Disease 1 1.0
( O 0 4.296306954643114e-08
APC B-Disease 0 5.98145319941068e-08
) O 0 6.213528302989602e-11
gene O 0 1.7226847504048237e-08
mutations O 0 1.5875254177899478e-07
. O 0 3.3497074003463467e-09

In O 0 1.3411305399557705e-10
this O 0 1.409950444158231e-13
study O 0 4.6340295018149416e-14
, O 0 2.194146946787488e-15
direct O 0 1.7731654903055394e-13
mutation O 0 5.584692864407659e-12
analysis O 0 2.154656010902589e-12
of O 0 1.6715519281771708e-14
the O 0 3.3551546957388823e-13
APC B-Disease 0 4.7512188627862884e-11
gene O 0 1.0845053327601661e-10
was O 0 1.2117006009670916e-10
performed O 0 3.4582748990874546e-12
to O 0 1.6867270655283179e-13
determine O 0 4.301367595438421e-11
genotype O 0 3.545169192875619e-06
- O 0 2.447054839649354e-06
phenotype O 0 5.514968037800827e-08
correlations O 0 1.1301521496420719e-08
for O 0 2.1681450038113503e-12
nine O 0 2.314834955663425e-11
extracolonic O 0 3.4734186638019082e-09
manifestations O 0 2.58401244845885e-10
and O 0 9.977267493091468e-13
to O 0 5.260195558754073e-14
investigate O 0 2.2809983069027595e-12
the O 0 1.0578511807843305e-12
incidence O 0 5.7205089554202004e-09
of O 0 1.2352704579707274e-12
APC B-Disease 0 2.523384834418607e-09
mutations O 0 7.325701711913268e-10
in O 0 1.2720209607852695e-10
non O 0 0.11815168708562851
- O 1 0.999998927116394
FAP O 1 0.9999662637710571
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.5050650503667384e-08

METHODS O 0 2.4174356738626557e-08
The O 0 7.806137680699266e-12
APC B-Disease 0 1.5535095432284152e-09
gene O 0 1.21761589699787e-09
was O 0 2.9160143744100253e-10
analysed O 0 3.791437441780232e-10
in O 0 3.4643355892316485e-12
190 O 0 8.438648391173587e-11
unrelated O 0 1.0698163466216215e-09
FAP B-Disease 0 4.774243222982477e-09
and O 0 1.8235000315280914e-11
15 O 0 1.1041290798319281e-10
non O 0 0.016783948987722397
- O 1 0.9999997615814209
FAP O 1 0.9999921321868896
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.1233974223378027e-07
using O 0 2.1897250679359104e-10
denaturing O 0 1.5701604070272879e-06
gradient O 0 1.9522959249229643e-08
gel O 0 8.045532950973211e-08
electrophoresis O 0 2.309333835270877e-09
, O 0 1.285321024960262e-12
the O 0 2.6254101296403418e-14
protein O 0 1.5853936219389908e-11
truncation O 0 1.2312946218173693e-09
test O 0 1.3983060265232439e-09
, O 0 4.1780112897994715e-13
and O 0 7.057390425096316e-14
direct O 0 7.775170264567866e-12
sequencing O 0 1.9867834044617894e-09
. O 0 4.954908150445192e-10

RESULTS O 0 1.4069693854423804e-08
Chain O 0 6.031615207291452e-10
terminating O 0 1.3178078628328649e-09
signals O 0 2.9784205657357177e-10
were O 0 2.8218621016262713e-12
only O 0 5.0511793369973496e-14
identified O 0 2.7966572200416318e-12
in O 0 6.22413795850485e-13
patients O 0 7.774721621708891e-13
belonging O 0 1.4696168544256483e-12
to O 0 2.1884315919758895e-13
the O 0 8.038947654255557e-13
FAP B-Disease 0 2.869902371305244e-10
group O 0 9.00677189080712e-12
( O 0 4.343891565894431e-12
105 O 0 5.181934881193229e-10
patients O 0 4.018890109591666e-09
) O 0 9.560923233675744e-12
. O 0 1.1886223949542085e-10

Amino O 0 3.859574704279112e-08
acid O 0 2.647442043368642e-09
changes O 0 1.7598707864260876e-12
were O 0 2.7137672534496837e-13
identified O 0 2.7104579431586062e-12
in O 0 2.249912224843581e-13
four O 0 8.156420959644362e-13
patients O 0 2.005674099025967e-11
, O 0 4.8306370297075685e-14
three O 0 5.523720044732505e-14
of O 0 7.516247654381757e-15
whom O 0 2.0475079964832332e-11
belonged O 0 3.8634817567384516e-10
to O 0 8.897302382696037e-13
the O 0 1.6835137884446683e-12
non O 0 3.674853843449455e-08
- O 0 1.595254239816768e-08
FAP O 0 6.662679741253896e-09
group O 0 2.6970536914916465e-09
of O 0 9.4198071565188e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.9533128579496406e-05
. O 0 3.5825678534884275e-10

Genotype O 1 0.9973777532577515
- O 1 0.9938449859619141
phenotype O 0 5.963527655694634e-06
correlations O 0 4.123372931985614e-08
identified O 0 1.1672860456002354e-09
significant O 0 1.4280882032480235e-11
differences O 0 1.421095685572027e-09
in O 0 5.849697809479082e-11
the O 0 4.1846867225754647e-13
nature O 0 1.6180809947127783e-12
of O 0 1.434769797002862e-14
certain O 0 8.58427912087123e-12
extracolonic O 0 8.415767638325633e-09
manifestations O 0 3.638499224134506e-10
in O 0 3.716266530617851e-11
FAP B-Disease 0 1.6713392891887224e-09
patients O 0 5.758415966283792e-10
belonging O 0 4.598072755879201e-10
to O 0 1.14146313928698e-11
three O 0 1.8861195591468594e-11
mutation O 0 4.984389789797206e-09
subgroups O 0 2.8793580852948253e-08
. O 0 9.339953255249611e-10

CONCLUSIONS O 0 8.29674604574393e-08
Extended O 0 2.012892519331899e-09
genotype O 0 1.8819357137545012e-05
- O 0 1.2802250239474233e-05
phenotype O 0 1.7029469745466486e-07
correlations O 0 1.72809837550858e-08
made O 0 1.6054875484616815e-10
in O 0 4.485886054977906e-12
this O 0 3.5015999838182085e-14
study O 0 1.8911571798580634e-13
may O 0 4.893666201433167e-12
have O 0 2.938795040652309e-14
the O 0 1.7812039854409132e-15
potential O 0 1.2158266201548612e-13
to O 0 6.014864984121154e-14
determine O 0 7.122955112022489e-13
the O 0 6.832120996334498e-14
most O 0 1.685292801579391e-13
appropriate O 0 1.6606599992710636e-12
surveillance O 0 4.0943717860564277e-10
and O 0 2.851467976669464e-12
prophylactic O 0 1.8121397715731291e-09
treatment O 0 1.4119008739932326e-10
regimens O 0 3.1785349352553283e-10
for O 0 1.547018264359823e-14
those O 0 6.906290589327874e-14
patients O 0 2.826667285654727e-12
with O 0 2.063516255112509e-14
mutations O 0 6.441273209256693e-11
associated O 0 6.945177072337216e-11
with O 0 1.7101533730801144e-11
life O 0 4.577720869036739e-09
threatening O 0 6.601277618756285e-06
conditions O 0 1.6612548279226758e-06
. O 0 7.832603454716036e-10

This O 0 1.2165236699945847e-11
study O 0 1.3393576612369396e-12
also O 0 2.6755173800747066e-14
provided O 0 9.905846183198754e-15
evidence O 0 1.4213910810075697e-13
for O 0 2.562518187416594e-15
the O 0 2.5721317572580463e-14
pathological O 0 1.7876820856965736e-10
nature O 0 1.0964658000989225e-12
of O 0 3.4492269202499384e-14
amino O 0 1.2219979368677247e-11
acid O 0 8.417248668901589e-12
changes O 0 4.2936907826938986e-13
in O 0 2.084504227214956e-12
APC O 0 2.3410329230699745e-10
associated O 0 7.028971588801669e-12
with O 0 2.8983160814920195e-13
both O 0 1.2792563015839864e-11
FAP B-Disease 0 1.0461209676293493e-09
and O 0 2.9918619665059154e-11
non O 0 0.25788792967796326
- O 1 0.9999991655349731
FAP O 1 0.9999871253967285
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.334221401019022e-05
. O 0 1.2966930480751149e-11
. O 0 3.390404623715426e-11

Inherited B-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999964237213135
and O 0 5.64507274702919e-07
cancer B-Disease 0 0.00010520038631511852
risk O 0 7.994075446049465e-08
of O 0 2.0993790473405882e-12
the O 0 3.2147375039759396e-11
APC O 0 5.855488893757865e-08
I1307K O 0 1.0438476039098532e-07
polymorphism O 0 9.201656894219923e-07
. O 0 2.3142545657606206e-09

Germ O 0 0.00018342742987442762
- O 0 3.835209281533025e-05
line O 0 3.964743200413068e-08
and O 0 3.125115444202464e-11
somatic O 0 2.7941449154411657e-09
truncating O 0 9.836622627545921e-10
mutations O 0 7.285667624756798e-10
of O 0 1.2352274693545884e-13
the O 0 1.20346007465022e-13
APC B-Disease 0 3.338197773761209e-11
gene O 0 2.7457381854278928e-11
are O 0 4.065386265475479e-13
thought O 0 5.145088521896213e-11
to O 0 5.547355543672472e-12
initiate O 0 2.4271616894111503e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 6.8302329054859e-06
formation O 0 3.518614510866769e-09
in O 0 4.831310889130691e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.945585376641247e-06
sporadic O 1 0.9999814033508301
colorectal O 1 1.0
carcinogenesis O 0 0.006937649101018906
, O 0 4.000176190288585e-09
respectively O 0 2.1618384860033757e-09
. O 0 1.3010713340033675e-10

Recently O 0 9.273819756572266e-08
, O 0 4.0710858295600616e-11
an O 0 4.436711848604391e-12
isoleucine O 0 4.389773948787479e-06
- O 0 2.7920684431137488e-08
- O 0 9.96905455963315e-08
> O 0 4.1530721084370725e-09
lysine O 0 2.7627208964986494e-08
polymorphism O 0 1.3587718505903013e-08
at O 0 2.0641227616025049e-10
codon O 0 1.9016951569028606e-08
1307 O 0 1.2721386610792251e-08
( O 0 8.044719404520784e-12
I1307K O 0 2.1056370536065572e-10
) O 0 9.016130398699362e-14
of O 0 2.08177108567526e-15
the O 0 9.920108354558033e-14
APC B-Disease 0 2.0350566717897145e-11
gene O 0 2.3565593920693573e-11
has O 0 5.063307086973501e-13
been O 0 3.230740870142912e-13
identified O 0 5.135781123294381e-12
in O 0 4.5058726715063724e-13
6 O 0 4.671080688044282e-13
% O 0 4.733268898354792e-13
- O 0 7.07500308338993e-11
7 O 0 5.432739327848601e-12
% O 0 6.773696187289957e-13
of O 0 1.8755840386656605e-14
the O 0 5.621131815222724e-13
Ashkenazi O 0 7.586031802730986e-10
Jewish O 0 5.028575212479014e-12
population O 0 2.149311978394408e-12
. O 0 7.718523736821581e-11

To O 0 7.963201625882377e-11
assess O 0 8.915492788474921e-10
the O 0 1.5700127829754162e-12
risk O 0 8.885898267196879e-11
of O 0 1.403306758177101e-14
this O 0 1.0247624824448812e-13
common O 0 2.4598417053267596e-11
APC B-Disease 0 7.48716255660753e-10
allelic O 0 7.972567606095993e-10
variant O 0 5.618579507427057e-06
in O 0 7.254748197738081e-06
colorectal O 1 1.0
carcinogenesis O 0 8.475019967590924e-06
, O 0 1.0454700993811628e-10
we O 0 1.6433833460727243e-12
have O 0 5.172799715695911e-14
analyzed O 0 1.5916313406139082e-12
a O 0 4.561326360022488e-13
large O 0 6.381983917030931e-12
cohort O 0 3.1758278229432335e-09
of O 0 1.0567562450103374e-12
unselected O 0 6.601356972169015e-07
Ashkenazi O 0 1.0327791954978238e-07
Jewish O 0 5.836449656904108e-10
subjects O 0 2.7361530818836854e-09
with O 0 3.576148752126862e-11
adenomatous B-Disease 0 5.466835773404455e-06
polyps I-Disease 0 1.4214942893886473e-06
and O 0 4.790767435536303e-11
. O 0 4.7746116088598356e-11
or O 1 0.9999442100524902
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.311487637239983e-11
for O 0 8.532669742208204e-14
the O 0 1.6804341121737232e-12
APC O 0 1.3227190009956757e-08
I1307K O 0 3.698269068763693e-08
polymorphism O 0 2.9359472364376415e-07
. O 0 2.2115860254245945e-09

The O 0 3.089921929433359e-10
APC O 0 4.1339092149428325e-08
I1307K O 0 1.0577424269797575e-08
allele O 0 1.0883004719630662e-08
was O 0 2.5732704855840893e-10
identified O 0 1.5761765156940832e-11
in O 0 1.0762985554885196e-12
48 O 0 3.2313030289693456e-12
( O 0 2.0288499070868216e-13
10 O 0 4.565989716854256e-14
. O 0 1.127663941228891e-14
1 O 0 1.1987498938371283e-13
% O 0 2.910126024706361e-13
) O 0 8.916614191792349e-14
of O 0 1.1441475750769564e-13
476 O 0 1.658807424753661e-09
patients O 0 1.4755293875623465e-08
. O 0 1.0859749904890137e-10

Compared O 0 3.3075073790911347e-09
with O 0 4.619144693476795e-13
the O 0 8.724010419234804e-14
frequency O 0 2.6365848740383946e-11
in O 0 2.86609755026368e-12
two O 0 2.1130515889008876e-14
separate O 0 2.0602246850794786e-14
population O 0 5.290721101513813e-15
control O 0 4.047415614466532e-12
groups O 0 1.6821230010028582e-13
, O 0 4.772758251982145e-13
the O 0 9.703334056393453e-13
APC O 0 2.303333523911988e-09
I1307K O 0 6.514943029500841e-10
allele O 0 3.8624944909138037e-10
is O 0 2.7995374031128395e-13
associated O 0 6.409317521161029e-13
with O 0 2.981074181994739e-14
an O 0 2.6928832495593143e-14
estimated O 0 5.218825046594822e-13
relative O 0 1.268999072490118e-10
risk O 0 3.436266604595062e-09
of O 0 5.252098127066229e-13
1 O 0 1.0226396812695882e-10
. O 0 2.0663365463136074e-10

5 O 0 2.3647807267934695e-07
- O 0 7.488168307645537e-07
1 O 0 7.606925089831407e-10
. O 0 2.895088058174622e-10

7 O 0 1.2630604828700598e-07
for O 0 1.2712405572656849e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.00038046803092584014
( O 0 6.511439165635124e-10
both O 0 2.9329377815301427e-10
P O 0 0.0006376158562488854
= O 0 1.1147125000832148e-08
. O 0 7.635295867780556e-11
01 O 0 1.518681713719161e-08
) O 0 2.153026194828822e-11
. O 0 1.0270749528640266e-10

Furthermore O 0 2.3159545392559266e-09
, O 0 8.282863110664618e-12
compared O 0 1.923265019465603e-11
with O 0 3.930084610612866e-13
noncarriers O 0 6.524734885715588e-08
, O 0 2.2485234160707357e-12
APC O 0 1.756197687274863e-10
I1307K O 0 1.1692419255027175e-10
carriers O 0 1.1088797935432382e-10
had O 0 2.929084752523181e-11
increased O 0 1.533342246576308e-12
numbers O 0 1.0206120887659709e-12
of O 0 3.5240611969376834e-13
adenomas B-Disease 0 0.13886141777038574
and O 0 0.002486081328243017
colorectal B-Disease 1 1.0
cancers I-Disease 0 0.0024045645259320736
per O 0 3.6609999476411303e-09
patient O 0 1.7074985407816712e-06
( O 0 2.3407203952885425e-10
P O 0 4.924391760141589e-06
= O 0 7.317365047221358e-10
. O 0 5.250017000996143e-12
03 O 0 6.812304054193419e-10
) O 0 2.6044636824811007e-13
, O 0 6.89977317901852e-14
as O 0 1.7359200285994164e-13
well O 0 2.691000634130747e-13
as O 0 3.2818051661637204e-13
a O 0 9.434911185657313e-12
younger O 0 1.4142708115727487e-09
age O 0 4.983586113227467e-11
at O 0 6.276192066057007e-11
diagnosis O 0 1.7000902019503883e-08
. O 0 5.086319906921766e-11

We O 0 2.510038843439588e-10
conclude O 0 1.0735502070646774e-10
that O 0 4.572456305186774e-14
the O 0 9.79163988388751e-14
APC O 0 5.415632386984726e-10
I1307K O 0 2.868813242518087e-10
variant O 0 1.0116117721281626e-08
leads O 0 8.609665758108065e-11
to O 0 1.8848754154698888e-11
increased O 0 2.0330423922132468e-06
adenoma B-Disease 1 1.0
formation O 0 2.6255294813259944e-11
and O 0 1.8383222461643145e-13
directly O 0 8.372917973103328e-14
contributes O 0 7.627922815958699e-13
to O 0 8.47416822585996e-14
3 O 0 1.3370070025067737e-12
% O 0 3.3484885871015724e-12
- O 0 1.0490176088895353e-10
4 O 0 2.007276723309248e-12
% O 0 4.189014857648027e-13
of O 0 4.4336957065807536e-14
all O 0 2.0550276758068975e-11
Ashkenazi O 0 9.366545782540925e-06
Jewish O 0 0.00040287754382006824
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.450083856966103e-09

The O 0 1.0008760313595655e-11
estimated O 0 2.6122960131852446e-12
relative O 0 3.08843575713702e-11
risk O 0 1.7880188649121997e-11
for O 0 1.9346452743854506e-14
carriers O 0 3.2474758993039643e-10
may O 0 2.9915708799066465e-11
justify O 0 7.506172766680308e-12
specific O 0 9.24765472531952e-13
clinical O 0 2.2397327048562232e-11
screening O 0 6.4210060879421604e-12
for O 0 2.979261192674436e-14
the O 0 1.9570472629612534e-14
360 O 0 1.733270861906111e-12
, O 0 2.7093956486462685e-14
000 O 0 8.948883436577307e-14
Americans O 0 4.420118446062625e-14
expected O 0 5.228768806819772e-13
to O 0 1.8687635599677795e-14
harbor O 0 1.71808817173158e-11
this O 0 2.8123433554291984e-14
allele O 0 3.160710929095423e-11
, O 0 1.3547237604719792e-13
and O 0 1.0858221060564693e-13
genetic O 0 1.2785537385762158e-11
testing O 0 3.7288973991911334e-11
in O 0 1.780452629947249e-12
the O 0 2.3573122078478226e-13
setting O 0 3.2023494099531202e-12
of O 0 2.322721550686302e-14
long O 0 4.977924322746574e-11
- O 0 9.435496828302803e-10
term O 0 7.415377201169804e-10
- O 0 7.70756375390036e-11
outcome O 0 7.143203129694742e-12
studies O 0 3.595941253098367e-12
may O 0 3.024461106906906e-12
impact O 0 3.182905761872634e-12
significantly O 0 2.2968681179236228e-08
on O 1 0.5120151042938232
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.703219076887308e-08
in O 0 2.0177481647315476e-12
this O 0 9.88175402508e-14
population O 0 2.3115016845043357e-13
. O 0 2.2997577800443203e-11

Localization O 0 3.179108176709633e-08
of O 0 3.9037051586046645e-13
human O 0 8.321512424448729e-13
BRCA1 O 0 1.17196696791666e-08
and O 0 6.034301530677411e-12
its O 0 5.166570296588624e-13
loss O 0 1.5915904705288142e-10
in O 0 4.0795353206668494e-11
high O 0 3.895894167271763e-07
- O 0 5.866169772161811e-07
grade O 0 6.677197461613105e-07
, O 0 2.185247122143963e-11
non B-Disease 0 0.0029210944194346666
- I-Disease 1 0.9988616704940796
inherited I-Disease 1 0.9999966621398926
breast I-Disease 1 0.9999984502792358
carcinomas I-Disease 1 1.0
. O 0 3.981103802175312e-08

Although O 0 3.876663573487704e-11
the O 0 4.593130888651265e-13
link O 0 3.287521990746889e-11
between O 0 5.036859384438541e-12
the O 0 5.165412889085452e-11
BRCA1 O 1 0.9998855590820312
tumour B-Disease 1 1.0
- O 0 1.1540134892129572e-07
suppressor O 0 4.920631724303348e-08
gene O 0 7.124086209842062e-08
and O 0 1.1497156116035967e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.9621181809463826e-12
established O 0 5.360059726795818e-13
, O 0 6.886546590140555e-14
the O 0 1.4732132343469456e-14
role O 0 3.894440759460993e-12
, O 0 1.5767611825576178e-13
if O 0 8.068344576435058e-14
any O 0 2.1374469848147587e-13
, O 0 8.744251118542393e-14
of O 0 1.4264256754394598e-14
BRCA1 O 0 2.000557408621262e-08
in O 0 2.511954533268579e-10
non B-Disease 0 0.001357520930469036
- I-Disease 0 0.11298228800296783
familial I-Disease 1 0.9534785747528076
cancers I-Disease 1 0.9990033507347107
is O 0 3.834366713029169e-10
unclear O 0 1.283912443028612e-08
. O 0 5.356889931640296e-10

BRCA1 O 0 0.0002699000760912895
mutations O 0 5.5357613604201106e-08
are O 0 1.3349359812009354e-11
rare O 0 7.607966340250627e-11
in O 0 2.4626739536515174e-10
sporadic B-Disease 0 0.2785460948944092
cancers I-Disease 1 0.9912393689155579
, O 0 1.4552699323377993e-10
but O 0 6.670696633959139e-11
loss O 0 6.960852727555533e-11
of O 0 6.34619242464822e-14
BRCA1 O 0 2.7409178926518507e-08
resulting O 0 3.2792037314710587e-12
from O 0 1.3746704512554442e-12
reduced O 0 1.0072532218019514e-11
expression O 0 5.0688463842929465e-12
or O 0 8.242502166910803e-12
incorrect O 0 4.427172795029577e-10
subcellular O 0 1.2013348538175705e-08
localization O 0 6.747906677873061e-09
is O 0 2.287733262378022e-13
postulated O 0 1.2169877952605823e-11
to O 0 1.822256944948239e-13
be O 0 1.8320287236035793e-13
important O 0 5.242829824794737e-13
in O 0 1.1997849762301893e-11
non B-Disease 0 1.1502328561618924e-05
- I-Disease 0 0.013899260200560093
familial I-Disease 1 0.999998927116394
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.003936128147643e-09

Epigenetic O 0 2.2272342903306708e-06
loss O 0 9.502491593593732e-08
, O 0 5.823877838317948e-12
however O 0 2.351206469103362e-12
, O 0 1.756918449700301e-13
has O 0 1.1421981795708275e-13
not O 0 2.7314844044381767e-14
received O 0 3.7494604589096564e-14
general O 0 3.582956820775626e-14
acceptance O 0 6.57611074969533e-12
due O 0 3.5917460412121516e-12
to O 0 1.421781529314936e-13
controversy O 0 5.927095836702478e-13
regarding O 0 3.393830355635785e-13
the O 0 3.453630813949303e-14
subcellular O 0 7.596283047028862e-10
localization O 0 9.972026676630108e-11
of O 0 2.6945376743118914e-14
BRCA1 O 0 4.844108447699114e-10
proteins O 0 3.123874206187316e-12
, O 0 2.185419949391268e-13
reports O 0 2.1248996485978555e-12
of O 0 2.302079061300183e-15
which O 0 4.1295149943868306e-14
have O 0 1.3986399928847537e-12
ranged O 0 1.0096729875785915e-11
from O 0 2.7327869717044644e-14
exclusively O 0 5.4779338481752635e-14
nuclear O 0 5.1472673345820397e-11
, O 0 2.8044008630080663e-13
to O 0 1.6059657943767736e-13
conditionally O 0 1.0201926803343753e-10
nuclear O 0 1.83754938348768e-11
, O 0 1.0884430970458173e-13
to O 0 1.4442147225845157e-14
the O 0 9.15415312996437e-13
ER O 0 4.576797891786555e-07
/ O 0 9.777290088663904e-10
golgi O 0 2.8132409735093233e-09
, O 0 1.4616636893893808e-12
to O 0 9.722526603250792e-13
cytoplasmic O 0 1.7169859978238833e-09
invaginations O 0 1.9425270281203666e-08
into O 0 7.0599823730199684e-12
the O 0 2.6253328937880793e-12
nucleus O 0 1.7045108380298046e-10
. O 0 4.7674950792719883e-11

In O 0 4.057499058962577e-10
an O 0 8.844748392890234e-13
attempt O 0 7.769718896044608e-11
to O 0 1.613065063466035e-11
resolve O 0 2.350331262945815e-09
this O 0 1.4632648391577074e-12
issue O 0 1.0826018553844463e-10
, O 0 1.2815855147951805e-12
we O 0 1.942019245068649e-12
have O 0 1.035427603032768e-12
comprehensively O 0 3.108358848091797e-10
characterized O 0 4.520632132520852e-11
19 O 0 2.173280132244937e-11
anti O 0 3.4589797692774482e-09
- O 0 1.807887350935289e-08
BRCA1 O 0 2.0955133095412748e-07
antibodies O 0 2.14234621154219e-08
. O 0 1.976219854427086e-09

These O 0 7.454627887204524e-11
reagents O 0 1.6102478239687912e-09
detect O 0 1.1985145098591943e-09
a O 0 2.0973670716850634e-11
220 O 0 3.1637281683316587e-10
- O 0 2.314603397834958e-09
kD O 0 1.6181274986593053e-08
protein O 0 5.747530784638855e-10
localized O 0 1.3059051617858586e-09
in O 0 1.1267970931316817e-11
discrete O 0 2.1891111146032927e-10
nuclear O 0 7.359920228822148e-09
foci O 0 1.6894681209578266e-08
in O 0 1.1441819713908785e-10
all O 0 2.4654629466464018e-12
epithelial O 0 1.025299706247651e-10
cell O 0 9.8429335793071e-09
lines O 0 5.939916336572537e-10
, O 0 9.49092556932693e-14
including O 0 4.208631429198761e-15
those O 0 8.120524347084764e-15
derived O 0 3.2220591212467342e-12
from O 0 1.920421321965904e-10
breast B-Disease 0 9.298400414081698e-07
malignancies I-Disease 0 5.468488780024927e-06
. O 0 4.9050927763971686e-09

Immunohistochemical O 0 0.0002083191939163953
staining O 0 9.905425031320192e-06
of O 0 5.160981017549027e-11
human O 0 8.730765416187225e-11
breast O 0 8.787815630739715e-08
specimens O 0 5.351640797179869e-10
also O 0 3.024335643031506e-11
revealed O 0 7.103229560101454e-09
BRCA1 O 0 3.3197370612469967e-06
nuclear O 0 5.196588404032809e-08
foci O 0 9.008211350192141e-07
in O 0 1.5844589640323647e-08
benign O 1 0.9999328851699829
breast O 0 0.39793115854263306
, O 0 1.3053356617831469e-08
invasive B-Disease 1 0.8407785892486572
lobular I-Disease 1 0.9999970197677612
cancers I-Disease 1 0.9999990463256836
and O 0 1.5829219819352147e-06
low B-Disease 1 0.9999375343322754
- I-Disease 1 0.9996235370635986
grade I-Disease 1 0.5130395889282227
ductal I-Disease 1 0.999848484992981
carcinomas I-Disease 1 1.0
. O 0 2.5572694539732765e-07

Conversely O 0 1.0177899412155966e-07
, O 0 4.0559566122366775e-11
BRCA1 O 0 1.9623982439043175e-08
expression O 0 3.32316708873126e-11
was O 0 7.738865798190275e-11
reduced O 0 8.175765294805848e-13
or O 0 9.453911178208818e-13
undetectable O 0 7.238804000664345e-11
in O 0 2.272806508968328e-13
the O 0 1.6727575948742926e-14
majority O 0 3.829916798200189e-13
of O 0 2.4057600529758805e-13
high O 0 4.8055867409857456e-06
- O 0 0.00022502723732031882
grade O 0 2.155202855647076e-05
, O 0 4.947693366119665e-10
ductal B-Disease 0 0.016015367582440376
carcinomas I-Disease 1 1.0
, O 0 7.193658863036134e-11
suggesting O 0 2.662571829681326e-10
that O 0 6.804969456854215e-13
absence O 0 4.281565119806929e-12
of O 0 2.0596234610935175e-14
BRCA1 O 0 4.6574186285397445e-08
may O 0 4.942757661496877e-11
contribute O 0 1.2201265659709387e-13
to O 0 4.2078309830636054e-14
the O 0 9.27494233217245e-14
pathogenesis O 0 6.427111620688208e-11
of O 0 1.0196032047631552e-14
a O 0 5.202923053330977e-13
significant O 0 1.3646212632112409e-11
percentage O 0 5.952247139617839e-09
of O 0 7.102405902986719e-12
sporadic B-Disease 1 0.9985257983207703
breast I-Disease 1 0.9970709085464478
cancers I-Disease 0 0.0643993616104126
. O 0 3.003349791086407e-10
. O 0 4.4254333531057455e-10

